[
    {
        "input": "3: HR, 114.0; 3: RR, 16.0; 3: SpO2, 100.0; 3: SBP, 126.0; 3: DBP, 63.0; 3: MAP, 84.0; 3: Temp, 98.2; 9: Pain, 0.0; 36: HR, 108.0; 36: RR, 18.0; 36: SpO2, 99.0; 36: SBP, 123.0; 36: DBP, 73.0; 36: MAP, 89.667; 38: SpO2, 99.0; 38: Perf, 0.32; 38: SBP, 123.0; 38: DBP, 73.0; 38: MAP, 89.667; 39: SpO2, 98.246; 39: Perf, 0.303; 40: SpO2, 98.941; 40: Perf, 0.264; 41: SpO2, 97.966; 41: Perf, 0.291; 42: SpO2, 99.070; 42: Perf, 0.266; 43: SpO2, 97.966; 43: Perf, 0.331; 44: SpO2, 98.254; 44: Perf, 0.302; 45: SpO2, 99.919; 45: Perf, 0.264; 46: SpO2, 100.0; 46: Perf, 0.251; 47: SpO2, 100.0; 47: Perf, 0.266; 48: SpO2, 100.0; 48: Perf, 0.286; 49: SpO2, 100.0; 49: Perf, 0.282; 50: SpO2, 100.0; 50: Perf, 0.297; 51: SpO2, 100.0; 51: Perf, 0.348; 52: SpO2, 99.655; 52: Perf, 0.328; 52: SBP, 110.0; 52: DBP, 73.0; 52: MAP, 85.333; 53: SpO2, 98.732; 53: Perf, 0.274; 54: SpO2, 100.0; 54: Perf, 0.534; 54: Pain, 0.0; 55: SpO2, 99.914; 55: Perf, 0.471; 56: SpO2, 99.136; 56: Perf, 0.417; 57: SpO2, 99.776; 57: Perf, 0.461; 58: SpO2, 99.559; 58: Perf, 0.428; 59: SpO2, 98.157; 59: Perf, 0.373; 60: SpO2, 99.897; 60: Perf, 0.304; 61: SpO2, 99.661; 61: Perf, 0.328; 62: SpO2, 99.0; 62: Perf, 0.323; 63: SpO2, 98.949; 63: Perf, 0.330; 64: SpO2, 99.655; 64: Perf, 0.363; 65: SpO2, 98.789; 65: Perf, 0.436; 66: WAM DIFTYP, AUTO; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: HEMATOCRIT (HCT), 32.6 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.11 K/uL; 66: PLATELET COUNT (PLT), 347 K/uL; 66: EOSINOPHIL % (AUTO DIFF), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: WHITE BLOOD CELLS (WBC), 12.3 K/uL; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.95 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 66: MONOCYTE % (AUTO DIFF), 9.6 %; 66: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 66: HEMOGLOBIN (HGB), 10.6 g/dL; 66: RED BLOOD CELLS (RBC), 3.92 MIL/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: BASOPHIL % (AUTO DIFF), 0.2 %; 66: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 66: MEAN CORPUSCULAR VOLUME (MCV), 83.2 fL; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 1.18 K/uL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: NEUTROPHIL % (AUTO DIFF), 82.1 %; 66: HR, 104.0; 66: RR, 16.0; 66: SpO2, 99.525; 66: Perf, 0.388; 66: SBP, 103.0; 66: DBP, 63.0; 66: MAP, 76.333; 67: SpO2, 99.138; 67: Perf, 0.552; 67: SBP, 103.0; 67: DBP, 63.0; 67: MAP, 76.333; 68: SpO2, 98.729; 68: Perf, 0.543; 69: SpO2, 98.586; 69: Perf, 0.541; 70: SpO2, 98.102; 70: Perf, 0.534; 71: SpO2, 98.0; 71: Perf, 0.458; 72: SpO2, 98.0; 72: Perf, 0.475; 73: SpO2, 98.475; 73: Perf, 0.447; 74: SpO2, 98.845; 74: Perf, 0.445; 75: SpO2, 98.712; 75: Perf, 0.485; 76: SpO2, 99.271; 76: Perf, 0.767; 77: SpO2, 98.276; 77: Perf, 0.812; 78: SpO2, 98.0; 78: Perf, 0.635; 79: SpO2, 98.655; 79: Perf, 0.639; 80: SpO2, 98.153; 80: Perf, 0.571; 81: SpO2, 98.458; 81: Perf, 0.606; 82: SpO2, 98.552; 82: Perf, 0.689; 82: SBP, 100.0; 82: DBP, 60.0; 82: MAP, 73.333; 83: SpO2, 98.068; 83: Perf, 0.686; 84: SpO2, 98.879; 84: Perf, 0.740; 85: SpO2, 98.525; 85: Perf, 0.788; 86: SpO2, 99.068; 86: Perf, 0.682; 87: SpO2, 98.552; 87: Perf, 1.312; 88: SpO2, 98.0; 88: Perf, 1.848; 89: SpO2, 97.845; 89: Perf, 1.742; 90: SpO2, 97.831; 90: Perf, 1.476; 91: SpO2, 98.0; 91: Perf, 1.267; 92: SARS-COV-2 RNA, Not Detected; 92: SpO2, 98.0; 92: Perf, 1.059; 93: SpO2, 98.0; 93: Perf, 1.031; 94: SpO2, 98.0; 94: Perf, 1.012; 95: SpO2, 98.169; 95: Perf, 0.956; 96: HR, 101.0; 96: RR, 18.0; 96: SpO2, 98.914; 96: Perf, 1.175; 96: SBP, 104.0; 96: DBP, 61.0; 96: MAP, 75.333; 97: SpO2, 98.576; 97: Perf, 1.789; 97: SBP, 104.0; 97: DBP, 61.0; 97: MAP, 75.333; 98: SpO2, 98.0; 98: Perf, 1.576; 99: SpO2, 98.0; 99: Perf, 1.743; 100: SpO2, 98.712; 100: Perf, 1.520; 101: SpO2, 98.103; 101: Perf, 1.484; 102: SpO2, 97.373; 102: Perf, 1.195; 103: SpO2, 98.153; 103: Perf, 0.925; 104: SpO2, 99.586; 104: Perf, 1.084; 105: SpO2, 99.424; 105: Perf, 1.391; 106: SpO2, 98.879; 106: Perf, 1.341; 107: SpO2, 100.0; 107: Perf, 1.634; 108: CORRECTED CALCIUM, 9.3 mg/dL; 108: ALKALINE PHOSPHATASE, 222 U/L; 108: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 108: ALT (SGPT), 138 U/L; 108: BILIRUBIN TOTAL, 1.9 mg/dL; 108: POTASSIUM, 3.8 mmol/L; 108: GLUCOSE, 134 mg/dL; 108: CALCIUM, 9.3 mg/dL; 108: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 108: SODIUM, 131 mmol/L; 108: CHLORIDE, 94 mmol/L; 108: PROTEIN TOTAL, 7.7 g/dL; 108: AST (SGOT), 61 U/L; 108: CO2, 23 mmol/L; 108: CREATININE, 0.98 mg/dL; 108: ANION GAP, 14 mmol/L; 108: ALBUMIN, 4.0 g/dL; 108: GLOBULIN, 3.7 g/dL; 0: Age, 76; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 114.0; 0: Triage RR, 16.0; 0: Triage SBP, 126.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the vital signs, labs, and potential signs of infection in the first two hours. Although there is mild tachycardia and slightly",
        "claims": [
            "elevated white blood cell count, the patient does not exhibit obvious signs of sepsis at this time.",
            "I reviewed the vital signs, labs, and potential signs of infection during the first two hours of the patient's admission.",
            "There is mild tachycardia present in the patient.",
            "The patient has a slightly elevated white blood cell count.",
            "The patient does not exhibit obvious signs of sepsis at this time."
        ],
        "relevant_claims": [
            "There is mild tachycardia present in the patient."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "Mild tachycardia can be associated with SIRS criteria, as one of the explicit criteria is a heart rate >90 bpm. If the patient's tachycardia meets or exceeds this threshold, it indicates systemic inflammation consistent with early sepsis. The alignment is moderate because the severity ('mild') isn't specified in relation to the threshold but suggests a potential match."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 0
    },
    {
        "input": "6: HR, 72.0; 6: RR, 18.0; 6: SpO2, 95.0; 6: SBP, 140.0; 6: DBP, 96.0; 6: MAP, 110.667; 6: Pain, 8.0; 6: Temp, 98.1; 19: HR, 79.0; 19: SpO2, 92.0; 19: SBP, 140.0; 19: DBP, 96.0; 19: MAP, 110.667; 20: SpO2, 97.333; 20: SBP, 140.0; 20: DBP, 96.0; 20: MAP, 110.667; 21: SpO2, 94.026; 22: SpO2, 94.379; 22: Perf, 1.397; 23: SpO2, 95.661; 23: Perf, 1.858; 24: SpO2, 93.052; 24: Perf, 2.022; 25: SpO2, 92.220; 25: Perf, 2.138; 26: SpO2, 93.475; 26: Perf, 2.172; 27: POC PH (V) ISTAT, 7.41; 27: POC TCO2 (V) ISTAT, 26 mmol/L; 27: POC LACTATE ISTAT, 1.58 mmol/L; 27: POC PCO2 (V) ISTAT, 38.8 mmHg; 27: POC PO2 (V) ISTAT, 30 mmHg; 27: POC HCO3 (V) ISTAT, 24.6 mmol/L; 27: POC O2 SATURATION ISTAT VENOUS, 58 %; 27: POC BASE EXCESS ISTAT, 0 mmol/L; 27: SpO2, 93.879; 27: Perf, 2.195; 28: SpO2, 94.643; 28: Perf, 2.079; 29: SpO2, 93.352; 30: SpO2, 92.661; 31: SpO2, 94.458; 31: Perf, 2.148; 32: SpO2, 94.879; 32: Perf, 2.341; 33: WAM DIFTYP, AUTO; 33: WHITE BLOOD CELLS (WBC), 12.6 K/uL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 83.4 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 33: RED BLOOD CELLS (RBC), 4.41 MIL/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 33: EOSINOPHIL % (AUTO DIFF), 0.0 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.53 K/uL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 33: HEMATOCRIT (HCT), 40.2 %; 33: MONOCYTE % (AUTO DIFF), 5.5 %; 33: HEMOGLOBIN (HGB), 13.5 g/dL; 33: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 33: PLATELET COUNT (PLT), 202 K/uL; 33: SpO2, 93.881; 33: Perf, 2.597; 34: SpO2, 93.569; 34: Perf, 2.418; 35: SpO2, 93.051; 35: Perf, 2.030; 35: SBP, 82.0; 35: DBP, 71.0; 35: MAP, 74.667; 36: SpO2, 93.932; 36: Perf, 1.853; 37: SpO2, 93.707; 37: Perf, 1.826; 38: SpO2, 93.559; 38: Perf, 1.822; 39: SpO2, 93.328; 39: Perf, 1.862; 40: SpO2, 94.797; 40: Perf, 2.180; 41: SpO2, 92.729; 41: Perf, 2.138; 42: SpO2, 93.586; 42: Perf, 2.102; 43: SpO2, 93.847; 43: Perf, 2.15; 44: SpO2, 92.397; 44: Perf, 2.078; 45: SpO2, 91.271; 45: Perf, 2.132; 46: SpO2, 90.793; 46: Perf, 2.216; 47: SpO2, 91.237; 47: Perf, 2.514; 48: SpO2, 91.983; 48: Perf, 2.57; 49: HR, 70.0; 49: SpO2, 92.914; 49: Perf, 2.288; 50: SpO2, 91.746; 50: Perf, 2.022; 51: SpO2, 92.879; 51: Perf, 2.147; 52: SpO2, 93.203; 52: Perf, 2.179; 53: SpO2, 92.203; 53: Perf, 2.168; 54: SpO2, 93.672; 54: Perf, 2.118; 55: SpO2, 93.373; 55: Perf, 2.159; 56: SpO2, 92.810; 56: Perf, 2.301; 57: SpO2, 92.780; 57: Perf, 2.435; 58: SpO2, 93.441; 58: Perf, 2.373; 59: SpO2, 92.414; 59: Perf, 2.294; 60: SpO2, 93.237; 60: Perf, 2.240; 61: SpO2, 93.138; 61: Perf, 1.998; 62: SpO2, 93.017; 62: Perf, 2.243; 63: SpO2, 94.136; 63: Perf, 2.593; 64: HR, 67.0; 64: SpO2, 94.828; 64: Perf, 2.848; 64: SBP, 122.0; 64: DBP, 80.0; 64: MAP, 94.0; 65: SpO2, 93.034; 65: Perf, 2.602; 65: SBP, 122.0; 65: DBP, 80.0; 65: MAP, 94.0; 66: SpO2, 91.948; 66: Perf, 2.722; 67: SpO2, 93.973; 67: Perf, 2.708; 68: ANION GAP, 14 mmol/L; 68: ALT (SGPT), 19 U/L; 68: CO2, 22 mmol/L; 68: ALBUMIN, 4.3 g/dL; 68: ALKALINE PHOSPHATASE, 63 U/L; 68: GLOBULIN, 3.1 g/dL; 68: BLOOD UREA NITROGEN (BUN), 17 mg/dL; 68: BILIRUBIN TOTAL, 0.9 mg/dL; 68: AST (SGOT), 23 U/L; 68: CALCIUM, 9.8 mg/dL; 68: CREATININE, 1.24 mg/dL; 68: POTASSIUM, 4.0 mmol/L; 68: EGFR REFIT WITHOUT RACE (2021), 56 mL/min/1.73 m2; 68: PROTEIN TOTAL, 7.4 g/dL; 68: CORRECTED CALCIUM, 9.6 mg/dL; 68: CHLORIDE, 96 mmol/L; 68: SODIUM, 132 mmol/L; 68: GLUCOSE, 124 mg/dL; 68: LIPASE, 41 U/L; 87: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: HR:, 68.0; 94: RR, 17.0; 94: SpO2, 93.448; 94: SBP, 134.0; 94: DBP, 69.0; 94: MAP, 90.667; 94: Pain, 0.0; 95: SpO2, 93.576; 95: SBP, 134.0; 95: DBP, 69.0; 95: MAP, 90.667; 96: SpO2, 93.862; 96: Perf, 2.867; 97: SpO2, 92.644; 97: Perf, 3.977; 98: SpO2, 92.534; 98: Perf, 4.487; 99: SpO2, 92.305; 99: Perf, 4.551; 100: SpO2, 91.542; 100: Perf, 4.468; 101: SpO2, 91.603; 101: Perf, 3.958; 102: SpO2, 90.678; 102: Perf, 4.415; 103: SpO2, 90.259; 103: Perf, 4.996; 104: SpO2, 90.729; 104: Perf, 5.183; 105: SpO2, 90.847; 105: Perf, 5.788; 106: SpO2, 92.966; 106: Perf, 3.739; 107: SpO2, 92.966; 107: Perf, 2.844; 108: SpO2, 94.069; 108: Perf, 2.802; 109: SpO2, 94.610; 109: Perf, 2.876; 110: SpO2, 95.345; 110: Perf, 2.937; 111: SpO2, 95.203; 111: Perf, 2.839; 112: SpO2, 94.814; 112: Perf, 2.809; 113: SpO2, 95.586; 113: Perf, 2.783; 114: SpO2, 95.254; 114: Perf, 2.725; 115: SpO2, 93.931; 115: Perf, 2.339; 116: SpO2, 90.983; 116: Perf, 2.184; 116: LR IV BOLUS -, 500 ML; 117: SpO, 2: 91.220; 117: Perf, 2.278; 118: SpO2, 91.534; 118: Perf, 2.451; 119: SpO2, 91.763; 119: Perf, 2.482; 0: Age, 88; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 72.0; 0: Triage RR, 18.0; 0: Triage SBP, 140.0; 0: Triage DBP, 96.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first noted that the patient\u2019s vital signs, including heart rate, respiratory rate, and body temperature, were mostly within normal limits. I then examined lab results, such as the lactate level and white blood cell count, which did not indicate severe infection or organ dysfunction. Although there was a transient drop in blood pressure, it returned to normal, suggesting no consistent hypotension. Therefore, the overall presentation does not point to a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs were mostly within normal limits.",
            "The vital signs included heart rate, respiratory rate, and body temperature.",
            "The lab results were examined, including the lactate level and white blood cell count.",
            "The lactate level and white blood cell count did not indicate severe infection or organ dysfunction.",
            "There was a transient drop in blood pressure.",
            "The blood pressure returned to normal after the transient drop.",
            "The return of blood pressure to normal suggests no consistent hypotension.",
            "The overall presentation does not point to a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The lab results were examined, including the lactate level and white blood cell count.",
            "The lactate level and white blood cell count did not indicate severe infection or organ dysfunction.",
            "The return of blood pressure to normal suggests no consistent hypotension."
        ],
        "alignment_scores": [
            0.4,
            0.7,
            0.7
        ],
        "alignment_category": [
            5,
            5,
            7
        ],
        "alignment_reasonings": [
            "The claim references examination of lactate levels, which is directly related to the Elevated Serum Lactate category if lactate is found to be \u22652 mmol/L. However, no specific level of lactate is mentioned in the claim hinting at sepsis, so the alignment is only partial. The inclusion of WBC count could also suggest alignment with SIRS Positivity, but without specific values, the direct connection to this category is limited. Therefore, the category alignment for Elevated Serum Lactate is recognized based on the mention of lactate examination, though it lacks a precise value.",
            "The claim mentions lactate levels, which are directly related to this category, as elevated serum lactate is used to assess sepsis risk. However, the claim indicates that the lactate level does not suggest a severe infection, thus showing partial relevance. While the WBC count also relates to the SIRS criteria, the primary focus of the claim is lactate levels, which aligns more specifically with category 5.",
            "The claim about blood pressure normalizing directly relates to the category concerned with hypotension as an indicator of sepsis. Although it suggests hypotension is not present, the fact that blood pressure normalization was notable implies that hypotension was a previous concern, which aligns moderately well with the concept of sepsis-associated hypotension."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 1
    },
    {
        "input": "7: HR, 122.0; 7: RR, 19.0; 7: SpO2, 96.0; 7: SBP, 141.0; 7: DBP, 99.0; 7: MAP, 113.0; 7: Temp, 101.7; 10: Pain, 5.0; 25: SpO2, 97.0; 28: SpO2, 95.0; 29: SpO2, 95.847; 29: Perf, 2.744; 30: SpO2, 96.0; 30: Perf, 2.426; 31: SpO2, 96.276; 31: Perf, 1.912; 32: SpO2, 95.508; 32: Perf, 2.054; 33: SpO2, 95.448; 33: Perf, 2.287; 34: SpO2, 95.0; 34: Perf, 2.120; 35: SpO2, 95.0; 35: Perf, 2.073; 36: SpO2, 94.931; 36: Perf, 2.025; 37: SpO2, 94.831; 37: Perf, 2.353; 38: SpO2, 94.948; 38: Perf, 2.507; 39: SpO2, 94.746; 39: Perf, 2.149; 40: SpO2, 94.793; 40: Perf, 2.478; 41: SpO2, 93.763; 41: Perf, 2.571; 41: SBP, 161.0; 41: DBP, 79.0; 41: MAP, 106.333; 42: SpO2, 94.458; 42: Perf, 2.453; 43: SpO2, 93.948; 43: Perf, 2.944; 44: SpO2, 93.915; 44: Perf, 3.298; 45: SpO2, 94.586; 45: Perf, 2.991; 46: SpO2, 93.441; 46: Perf, 2.730; 47: SpO2, 93.568; 47: Perf, 1.832; 48: SpO2, 94.576; 49: SpO2, 94.492; 49: Perf, 1.823; 50: SpO2, 94.259; 50: Perf, 1.940; 50: Pain, 0.0; 51: SpO2, 94.203; 51: Perf, 1.974; 52: SpO2, 93.780; 52: Perf, 1.835; 53: SpO2, 92.672; 53: Perf, 1.057; 54: SpO2, 92.034; 54: Perf, 1.235; 55: SpO2, 92.276; 55: Perf, 1.395; 56: SpO2, 93.237; 56: Perf, 1.808; 57: SpO2, 94.525; 57: Perf, 2.943; 58: SpO2, 94.190; 58: Perf, 4.109; 59: SpO2, 94.237; 59: Perf, 3.728; 60: SpO2, 94.103; 60: Perf, 3.958; 61: SpO2, 94.339; 61: Perf, 3.283; 62: SpO2, 95.085; 62: Perf, 2.947; 63: POC PH (V) ISTAT, 7.45; 63: POC O2 SATURATION ISTAT VENOUS, 73 %; 63: POC PCO2 (V) ISTAT, 36.4 mmHg; 63: POC TCO2 (V) ISTAT, 26 mmol/L; 63: POC PO2 (V) ISTAT, 37 mmHg; 63: POC HCO3 (V) ISTAT, 25.3 mmol/L; 63: POC BASE EXCESS ISTAT, 1 mmol/L; 63: POC LACTATE ISTAT, 2.11 mmol/L; 63: SpO2, 94.828; 63: Perf, 2.951; 64: SpO2, 94.729; 64: Perf, 2.876; 65: SpO2, 94.224; 65: Perf, 2.912; 66: SpO2, 94.068; 66: Perf, 2.771; 67: SpO2, 94.0; 67: Perf, 2.611; 68: SpO2, 93.793; 68: Perf, 2.431; 69: SpO2, 93.627; 69: Perf, 2.341; 70: SpO2, 93.828; 70: Perf, 2.342; 70: Pain, 10.0; 71: SpO2, 93.729; 71: Perf, 2.431; 72: SpO2, 93.879; 72: Perf, 2.424; 73: SpO2, 93.831; 73: Perf, 2.465; 74: SpO2, 94.508; 74: Perf, 2.437; 75: SpO2, 94.483; 75: Perf, 2.640; 76: SpO2, 94.407; 76: Perf, 2.442; 77: SpO2, 93.879; 77: Perf, 2.260; 78: SpO2, 93.424; 78: Perf, 2.185; 79: SpO2, 93.085; 79: Perf, 2.197; 80: SpO2, 93.517; 80: Perf, 2.056; 81: SpO2, 93.322; 81: Perf, 2.152; 82: SpO2, 93.931; 82: Perf, 2.176; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 93.831; 83: Perf, 2.772; 84: SpO2, 94.034; 84: Perf, 2.811; 85: SpO2, 93.310; 85: Perf, 1.924; 85: LR IV BOLUS -, 1000 ML; 86: SpO, 2: 92.949; 86: Perf, 1.520; 87: SpO2, 93.190; 87: Perf, 1.522; 88: SpO2, 93.492; 88: Perf, 1.592; 89: SpO2, 94.102; 89: Perf, 2.008; 90: HR, 112.263; 90: RR, 24.941; 90: SpO2, 94.241; 90: Perf, 2.526; 90: 1min HRV, 2.278; 90: 5min HRV, 2.278; 91: HR, 112.797; 91: RR, 25.695; 91: SpO2, 94.0; 91: Perf, 2.527; 91: 1min HRV, 2.096; 92: HR, 112.810; 92: RR, 25.328; 92: SpO2, 94.828; 92: Perf, 2.403; 92: 1min HRV, 1.882; 93: HR, 112.898; 93: RR, 25.864; 93: SpO2, 95.0; 93: Perf, 2.415; 93: 1min HRV, 1.685; 94: HR, 112.305; 94: RR, 24.356; 94: SpO2, 94.831; 94: Perf, 2.243; 94: 1min HRV, 3.770; 95: HR, 112.052; 95: RR, 24.569; 95: SpO2, 95.0; 95: Perf, 2.181; 95: 1min HRV, 1.974; 95: 5min HRV, 2.747; 96: HR, 112.237; 96: RR, 25.051; 96: SpO2, 94.847; 96: Perf, 2.044; 96: 1min HRV, 1.699; 97: HR, 112.172; 97: RR, 23.862; 97: SpO2, 95.672; 97: Perf, 2.615; 97: 1min HRV, 1.409; 100: 5min HRV, 1.576; 105: ALT (SGPT), 91 U/L; 105: SODIUM, 135 mmol/L; 105: ANION GAP, 13 mmol/L; 105: ALKALINE PHOSPHATASE, 48 U/L; 105: ALBUMIN, 3.4 g/dL; 105: AST (SGOT), 64 U/L; 105: PROTEIN TOTAL, 7.1 g/dL; 105: CREATININE, 1.13 mg/dL; 105: CHLORIDE, 99 mmol/L; 105: POTASSIUM, 4.3 mmol/L; 105: CO2, 23 mmol/L; 105: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 105: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 105: GLOBULIN, 3.7 g/dL; 105: CALCIUM, 9.0 mg/dL; 105: GLUCOSE, 203 mg/dL; 105: CORRECTED CALCIUM, 9.5 mg/dL; 105: BILIRUBIN TOTAL, 0.7 mg/dL; 115: C-REACTIVE PROTEIN (CRP), 7.0 mg/dL; 115: Pain, 10.0; 119: WHITE BLOOD CELLS (WBC), 5.0 K/uL; 119: HEMOGLOBIN (HGB), 12.6 g/dL; 119: MEAN CORPUSCULAR VOLUME (MCV), 91.8 fL; 119: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 119: HEMATOCRIT (HCT), 37.0 %; 119: PLATELET COUNT (PLT), 115 K/uL; 119: RED BLOOD CELLS (RBC), 4.03 MIL/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 119: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.52 K/uL; 119: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 119: METAMYELOCYTES % (MANUAL DIFF), 0.9 %; 119: BASOPHILS % (MANUAL DIFF), 0.9 %; 119: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.26 K/uL; 119: LYMPHOCYTES % (MANUAL DIFF), 3.5 %; 119: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 48.7 %; 119: EOSINOPHILS % (MANUAL DIFF), 10.4 %; 119: MONOCYTES % (MANUAL DIFF), 5.2 %; 119: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 3.98 K/uL; 119: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: NEUTROPHILS BANDS % (MANUAL DIFF), 30.4 %; 0: Age, 55; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.7; 0: Triage HR, 122.0; 0: Triage RR, 19.0; 0: Triage SBP, 141.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient\u2019s fever and tachycardia, which signaled possible infection and systemic stress. Then I examined lab values such as lactate and platelet count to see if there was any sign of organ dysfunction. I recognized that the combination of borderline elevated lactate, low platelets, and persistent high heart rate pointed to a heightened risk of sepsis.",
        "claims": [
            "The patient exhibited a fever.",
            "The patient exhibited tachycardia.",
            "The fever and tachycardia signaled possible infection.",
            "The fever and tachycardia indicated systemic stress.",
            "Lab values such as lactate and platelet count were examined.",
            "The examination of lab values aimed to identify signs of organ dysfunction.",
            "There was borderline elevated lactate in the lab values.",
            "There was a low platelet count in the lab values.",
            "The patient had a persistent high heart rate.",
            "The combination of borderline elevated lactate, low platelets, and persistent high heart rate indicated a heightened risk of sepsis."
        ],
        "relevant_claims": [
            "The patient exhibited a fever.",
            "The patient exhibited tachycardia.",
            "The fever and tachycardia signaled possible infection.",
            "The fever and tachycardia indicated systemic stress.",
            "Lab values such as lactate and platelet count were examined.",
            "The examination of lab values aimed to identify signs of organ dysfunction.",
            "There was borderline elevated lactate in the lab values.",
            "There was a low platelet count in the lab values.",
            "The patient had a persistent high heart rate.",
            "The combination of borderline elevated lactate, low platelets, and persistent high heart rate indicated a heightened risk of sepsis."
        ],
        "alignment_scores": [
            0.6,
            0.8,
            0.9,
            0.8,
            0.5,
            0.7,
            0.7,
            0.9,
            0.7,
            0.8
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            5,
            8,
            5,
            8,
            6,
            8
        ],
        "alignment_reasonings": [
            "A fever is one of the criteria in the SIRS category, specifically when the temperature is\u202f>\u202f38\u202f\u00b0C. Since the claim does not specify the exact temperature, it's not a strong alignment, but it's relevant to the SIRS category; thus, I assigned a moderate alignment rating.",
            "Tachycardia, defined as a heart rate >90 bpm, is one of the criteria for SIRS positivity, which helps identify systemic inflammation consistent with early sepsis. The claim aligns strongly with this category, but because SIRS requires the presence of \u22652 criteria to conclusively establish positivity, the alignment is not perfect, thus slightly less than 1.0 but still quite high.",
            "The claim references fever and tachycardia, which directly correspond to SIRS criteria\u2014a temperature outside the normal range and a heart rate >90 bpm. These are clear indicators of systemic inflammation that can suggest early sepsis, providing a strong alignment with the SIRS Positivity category. However, for full SIRS positivity, at least two criteria must be explicitly met, and although the symptoms strongly suggest SIRS, not all criteria are detailed in the claim, resulting in an alignment rating slightly less than perfect.",
            "The claim refers to fever and tachycardia, which align well with SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C and heart\u202frate\u202f>\u202f90\u202fbpm). Both symptoms indicate systemic stress, consistent with early sepsis. However, the specific temperature and heart rate are not provided, so while the match to the SIRS criteria is strong conceptually, it is not fully explicit, leading to a slightly less than perfect alignment rating.",
            "The claim references lab values, including lactate, which is directly related to the Elevated Serum Lactate category. However, the specific value of lactate is not provided, so it is unclear if it meets the threshold for posing a high risk. Although platelet count is mentioned and relates to SOFA, the claim does not specify derangements, making it indirectly related. The mention of lactate as a pertinent lab value suggests some relevance, warranting a moderate alignment rating.",
            "The focus on identifying signs of organ dysfunction aligns with the SOFA score, which assesses new organ dysfunction. While the claim does not specify an increase in SOFA component points, the examination of lab values for organ dysfunction is conceptually related to assessing SOFA scores. Therefore, it aligns moderately well.",
            "The claim mentions \"borderline elevated lactate,\" which directly connects to this category as elevated lactate levels indicate tissue hypoperfusion and correlate with increased sepsis risk. However, the term \"borderline\" suggests the lactate level may not clearly meet the \u22652 mmol/L criterion, so the alignment is moderate rather than full.",
            "The SOFA score includes platelet count as one of its components, where a count of less than 100\u202f\u00d7\u202f10\u2079/L indicates new organ dysfunction. The claim of a low platelet count closely aligns with this criterion, indicating a high sepsis risk, which justifies the strong alignment rating.",
            "A persistent high heart rate contributes to an elevated shock index, which measures hemodynamic instability and predicts severe sepsis risk. While the claim doesn't provide specific values to confirm an elevated shock index (heart rate \u00f7 systolic BP \u22651.0), a consistently high heart rate is a significant indicator and aligns moderately well with this category.",
            "The claim mentions low platelets, which is directly a SOFA criterion (<100 \u00d7 10\u2079/L), indicating organ dysfunction. The combination of indicators, including elevated lactate (which, while directly related to another criterion, does hint at tissue hypoperfusion) and persistent high heart rate, aligns strongly with the systemic dysfunction and heightened sepsis risk signaled by SOFA score increases. The alignment is high due to the combination of markers that collectively suggest new organ dysfunction, although not perfectly as lactate is part of another category\u2019s criteria."
        ],
        "final_alignment_score": 0.74,
        "accuracy": 1
    },
    {
        "input": "7: HR, 144.0; 7: RR, 18.0; 7: SpO2, 98.0; 7: SBP, 152.0; 7: DBP, 98.0; 7: MAP, 116.0; 7: Temp, 97.7; 19: RR, 36.0; 83: HR, 133.739; 83: RR, 22.636; 83: 1min HRV, 10.734; 83: SBP, 156.0; 83: DBP, 109.0; 83: MAP, 124.667; 83: LR IV BOLUS -, 1000 ML; 84: HR:, 132.264; 84: RR, 25.761; 84: SpO2, 96.519; 84: 1min HRV, 12.989; 85: HR, 129.170; 85: SpO2, 96.674; 85: 1min HRV, 12.830; 85: 5min HRV, 13.946; 86: HR, 131.635; 86: SpO2, 96.712; 86: 1min HRV, 16.313; 87: HR, 129.811; 87: RR, 20.0; 87: SpO2, 96.075; 87: 1min HRV, 9.957; 88: HR, 128.827; 88: RR, 21.231; 88: SpO2, 96.596; 88: 1min HRV, 12.831; 89: HR, 126.340; 89: RR, 20.057; 89: SpO2, 97.302; 89: 1min HRV, 10.653; 90: HR, 128.415; 90: RR, 17.208; 90: SpO2, 96.358; 90: 1min HRV, 11.254; 90: 5min HRV, 13.239; 91: HR, 125.577; 91: RR, 20.981; 91: SpO2, 97.0; 91: 1min HRV, 12.190; 91: SBP, 167.0; 91: DBP, 108.0; 91: MAP, 127.667; 92: HR, 124.604; 92: RR, 16.547; 92: SpO2, 97.321; 92: 1min HRV, 12.536; 93: HR, 125.811; 93: RR, 20.660; 93: SpO2, 96.755; 93: 1min HRV, 7.732; 94: HR, 122.830; 94: RR, 22.811; 94: SpO2, 97.038; 94: 1min HRV, 16.489; 95: HR, 120.717; 95: RR, 22.849; 95: SpO2, 96.755; 95: 1min HRV, 16.859; 95: 5min HRV, 15.336; 95: SBP, 167.0; 95: DBP, 108.0; 95: MAP, 127.667; 96: HR, 121.692; 96: RR, 25.192; 96: SpO2, 96.712; 96: Perf, 0.877; 96: 1min HRV, 7.205; 97: HR, 121.679; 97: RR, 22.830; 97: SpO2, 96.264; 97: Perf, 0.895; 97: 1min HRV, 13.014; 98: HR, 120.462; 98: RR, 20.635; 98: SpO2, 96.019; 98: Perf, 0.886; 98: 1min HRV, 10.239; 99: HR, 120.056; 99: RR, 26.093; 99: SpO2, 96.037; 99: Perf, 0.836; 99: 1min HRV, 10.386; 100: HR, 119.925; 100: RR, 23.943; 100: SpO2, 95.0; 100: Perf, 0.802; 100: 1min HRV, 19.736; 100: 5min HRV, 13.378; 101: HR, 123.292; 101: RR, 19.422; 101: SpO2, 96.020; 101: Perf, 0.8; 101: 1min HRV, 26.040; 102: SARS-COV-2 RNA, Not Detected; 102: HR, 129.909; 102: RR, 25.833; 102: SpO2, 97.098; 102: Perf, 0.8; 102: 1min HRV, 15.681; 103: HR, 128.442; 103: RR, 28.347; 103: SpO2, 97.75; 103: Perf, 0.757; 103: 1min HRV, 12.615; 104: HR, 125.321; 104: RR, 28.0; 104: SpO2, 98.660; 104: Perf, 0.692; 104: 1min HRV, 7.775; 105: HR, 125.537; 105: RR, 49.0; 105: SpO2, 97.444; 105: Perf, 0.71; 105: 1min HRV, 12.504; 105: 5min HRV, 17.522; 106: HR, 124.577; 106: SpO2, 98.481; 106: Perf, 0.752; 106: 1min HRV, 10.585; 106: SBP, 172.0; 106: DBP, 120.0; 106: MAP, 137.333; 107: HR, 123.264; 107: SpO2, 98.566; 107: Perf, 0.76; 107: 1min HRV, 9.122; 108: WAM DIFTYP, AUTO; 108: HEMOGLOBIN (HGB), 13.5 g/dL; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 9.3 %; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.26 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.2 pg; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 80.8 %; 108: EOSINOPHIL % (AUTO DIFF), 0.2 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 108: BASOPHIL % (AUTO DIFF), 0.9 %; 108: HEMATOCRIT (HCT), 40.8 %; 108: WHITE BLOOD CELLS (WBC), 13.9 K/uL; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 108: PLATELET COUNT (PLT), 215 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.29 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 103.3 fL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: HR, 123.192; 108: SpO2, 95.923; 108: Perf, 0.761; 108: 1min HRV, 11.873; 109: HR, 124.208; 109: SpO2, 96.340; 109: Perf, 0.791; 109: 1min HRV, 4.982; 110: HR, 125.692; 110: SpO2, 96.231; 110: Perf, 0.8; 110: 1min HRV, 5.283; 110: 5min HRV, 9.970; 111: HR, 126.623; 111: SpO2, 95.642; 111: Perf, 0.8; 111: 1min HRV, 5.043; 112: HR, 126.434; 112: SpO2, 97.113; 112: Perf, 0.8; 112: 1min HRV, 11.187; 113: HR, 127.231; 113: SpO2, 97.365; 113: Perf, 0.800; 113: 1min HRV, 10.667; 114: HR, 126.415; 114: SpO2, 97.868; 114: Perf, 0.876; 114: 1min HRV, 6.807; 115: HR, 126.096; 115: SpO2, 96.65; 115: Perf, 0.883; 115: 1min HRV, 6.921; 115: 5min HRV, 8.705; 116: HR, 121.943; 116: SpO2, 95.358; 116: Perf, 0.908; 116: 1min HRV, 6.774; 117: HR, 121.593; 117: SpO2, 94.630; 117: Perf, 0.94; 117: 1min HRV, 6.756; 118: HR, 122.365; 118: SpO2, 96.283; 118: Perf, 0.94; 118: 1min HRV, 3.852; 119: HR, 123.075; 119: SpO2, 97.302; 119: Perf, 0.950; 119: 1min HRV, 5.567; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 144.0; 0: Triage RR, 18.0; 0: Triage SBP, 152.0; 0: Triage DBP, 98.0; 0: Triage acuity, 2-Emergent; 0: CC, EAR PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed the persistently elevated heart rate, spurts of very high respiratory rate, and a mildly elevated white blood cell count pointing toward possible infection. I asked myself if these parameters met common sepsis criteria, and they seemed to align with tachycardia and abnormal respiratory signs. I double-checked for hypotension or other signs of organ dysfunction, but the alarming respiratory trends were enough. Therefore, I concluded the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The heart rate is persistently elevated.",
            "There are spurts of a very high respiratory rate.",
            "The white blood cell count is mildly elevated.",
            "The elevated heart rate, respiratory rate, and white blood cell count point toward possible infection.",
            "The observed parameters align with common sepsis criteria.",
            "The parameters meeting the common sepsis criteria include tachycardia and abnormal respiratory signs.",
            "I checked for hypotension or other signs of organ dysfunction.",
            "The alarming respiratory trends were sufficient for concern.",
            "I concluded that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is persistently elevated.",
            "There are spurts of a very high respiratory rate.",
            "The white blood cell count is mildly elevated.",
            "The elevated heart rate, respiratory rate, and white blood cell count point toward possible infection.",
            "The observed parameters align with common sepsis criteria.",
            "The parameters meeting the common sepsis criteria include tachycardia and abnormal respiratory signs.",
            "I checked for hypotension or other signs of organ dysfunction.",
            "The alarming respiratory trends were sufficient for concern.",
            "I concluded that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            0.8,
            1.0,
            0.3,
            1.0,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            3,
            2,
            2,
            4,
            2,
            7,
            4,
            4
        ],
        "alignment_reasonings": [
            "A persistently elevated heart rate is one of the SIRS criteria (heart rate >90 bpm), which can indicate systemic inflammation consistent with early sepsis. However, the claim doesn't specify how elevated the heart rate is or if other SIRS criteria are met, slightly reducing the alignment strength.",
            "The claim about \"spurts of a very high respiratory rate\" aligns most closely with the High qSOFA Score criterion, as one of the qSOFA components is a respiratory rate of \u226522/min, which indicates a higher risk of sepsis-related complications. While the claim doesn't specify exact numbers, the mention of a \"very high\" respiratory rate strongly implies a critical level consistent with this criterion. The rating is 0.8 because the claim suggests significant concern but lacks precise values to confirm the alignment beyond doubt.",
            "The statement about a mildly elevated white blood cell count suggests the presence of systemic inflammation or an infectious process, which is directly related to the SIRS criteria. However, the term \"mildly\" indicates it might not fully meet the threshold for SIRS criteria, hence a slightly lower alignment rating than maximum.",
            "The claim explicitly mentions elevated heart rate, respiratory rate, and white blood cell count, all of which are specific criteria under the SIRS category. This directly aligns with the conditions necessary for SIRS positivity, which is consistent with the identification of systemic inflammation in early sepsis. Therefore, the alignment is perfect.",
            "The claim is general and mentions alignment with common sepsis criteria, which could apply to multiple categories. The NEWS score is based on a range of observed parameters that collectively indicate clinical deterioration related to sepsis, making it a broad category potentially encompassing common sepsis criteria. The alignment is weak because the claim is vague and does not specify any particular parameters or scores.",
            "The claim directly mentions tachycardia and abnormal respiratory signs, which align with the SIRS criteria of heart rate >90 bpm and respiratory rate >20/min or PaCO\u2082 <32 mm\u202fHg. This explicitly matches two of the SIRS criteria, indicating a strong alignment with early sepsis detection based on systemic inflammation.",
            "The claim mentions checking for hypotension, which directly aligns with the definition of sepsis-associated hypotension. While it also refers to \"other signs of organ dysfunction,\" the primary focus on hypotension aligns more closely with this category than with organ dysfunction categories like SOFA Score Increase. The alignment is strong but not complete because it considers broader potential signs beyond hypotension.",
            "The claim highlights \"alarming respiratory trends,\" which suggests deranged vital signs that could contribute to an elevated NEWS score. Although it doesn't provide exact values or context to confirm a NEWS score of \u22655, the phrase \"alarming respiratory trends\" implies significant clinical concern compatible with early warning signs of deterioration such as those captured by NEWS. Therefore, alignment is moderate but not direct.",
            "The claim indicates a general assessment of high sepsis risk without specific details connected to any individual criteria. The Elevated NEWS Score is generally aligned with predicting imminent clinical deterioration, but since the claim lacks specific parameters such as a NEWS score value or particular vital sign derangements, the alignment is weak."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "4: HR, 110.0; 4: RR, 20.0; 4: SpO2, 95.0; 4: SBP, 121.0; 4: DBP, 75.0; 4: MAP, 90.333; 4: LPM O2, 2.0; 4: Pain, 9.0; 4: Temp, 101.0; 8: HR, 110.423; 8: SpO2, 97.286; 8: 1min HRV, 6.363; 9: HR, 109.491; 9: SpO2, 95.462; 9: 1min HRV, 7.100; 9: 5min HRV, 7.163; 10: HR, 109.019; 10: SpO2, 93.042; 10: 1min HRV, 5.598; 11: HR, 108.231; 11: SpO2, 100.0; 11: 1min HRV, 6.479; 12: HR, 108.057; 12: SpO2, 97.25; 12: 1min HRV, 6.938; 13: HR, 107.808; 13: SpO2, 92.0; 13: 1min HRV, 6.788; 14: HR, 108.057; 14: 1min HRV, 6.794; 14: 5min HRV, 6.848; 15: HR, 107.642; 15: 1min HRV, 8.627; 16: HR, 106.577; 16: SpO2, 100.0; 16: 1min HRV, 5.616; 17: HR, 106.736; 17: SpO2, 100.0; 17: 1min HRV, 8.881; 18: HR, 106.404; 18: SpO2, 100.0; 18: 1min HRV, 6.987; 19: HR, 106.660; 19: SpO2, 95.0; 19: 1min HRV, 5.812; 19: 5min HRV, 7.624; 20: HR, 104.981; 20: SpO2, 93.7; 20: 1min HRV, 5.233; 21: HR, 105.113; 21: SpO2, 86.75; 21: 1min HRV, 4.250; 22: HR, 104.981; 22: 1min HRV, 6.263; 23: HR, 104.904; 23: 1min HRV, 5.129; 24: HR, 105.264; 24: 1min HRV, 6.084; 24: 5min HRV, 5.666; 25: HR, 106.077; 25: 1min HRV, 3.849; 26: HR, 106.283; 26: 1min HRV, 4.909; 27: HR, 105.660; 27: SpO2, 99.5; 27: 1min HRV, 5.928; 27: LR IV BOLUS -, 1000 ML; 28: HR:, 106.038; 28: SpO2, 100.0; 28: 1min HRV, 6.198; 28: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 29: HR:, 105.585; 29: SpO2, 100.0; 29: 1min HRV, 6.069; 29: 5min HRV, 5.721; 30: HR, 104.827; 30: 1min HRV, 6.000; 30: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 31: HR:, 104.113; 31: 1min HRV, 5.008; 32: HR, 103.811; 32: 1min HRV, 4.507; 33: HR, 103.962; 33: 1min HRV, 5.163; 34: HR, 103.302; 34: SpO2, 97.0; 34: 1min HRV, 4.079; 34: 5min HRV, 5.647; 35: HR, 103.019; 35: SpO2, 99.0; 35: 1min HRV, 4.333; 36: HR, 104.208; 36: SpO2, 98.2; 36: 1min HRV, 4.511; 37: HR, 103.283; 37: SpO2, 97.0; 37: 1min HRV, 4.111; 38: HR, 103.192; 38: SpO2, 96.591; 38: 1min HRV, 8.164; 39: HR, 102.094; 39: SpO2, 100.0; 39: 1min HRV, 4.334; 39: 5min HRV, 6.205; 40: HR, 102.769; 40: SpO2, 100.0; 40: 1min HRV, 4.169; 41: HR, 103.019; 41: SpO2, 97.667; 41: 1min HRV, 4.208; 42: HR, 103.0; 42: SpO2, 100.0; 42: 1min HRV, 3.939; 43: HR, 102.269; 43: SpO2, 100.0; 43: 1min HRV, 4.882; 44: HR, 102.811; 44: SpO2, 100.0; 44: 1min HRV, 4.287; 44: 5min HRV, 4.601; 45: HR, 102.308; 45: SpO2, 99.922; 45: Perf, 0.195; 45: 1min HRV, 4.202; 49: 5min HRV, 4.202; 53: POC PH (V) ISTAT, 7.38; 53: POC LACTATE ISTAT, 0.60 mmol/L; 53: POC HCO3 (V) ISTAT, 27.6 mmol/L; 53: POC PO2 (V) ISTAT, 31 mmHg; 53: POC PCO2 (V) ISTAT, 46.3 mmHg; 53: POC BASE EXCESS ISTAT, 3 mmol/L; 53: POC O2 SATURATION ISTAT VENOUS, 59 %; 53: POC TCO2 (V) ISTAT, 29 mmol/L; 64: RSV, Not Detected; 64: SARS-COV-2 RNA, Not Detected; 64: INFLUENZA A, Not Detected; 64: INFLUENZA B, Not Detected; 65: WAM DIFTYP, AUTO; 65: LYMPHOCYTE % (AUTO DIFF), 4.8 %; 65: PLATELET COUNT (PLT), 100 K/uL; 65: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 65: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 65: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 65: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 65: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 65: BASOPHIL % (AUTO DIFF), 0.1 %; 65: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.39 K/uL; 65: HEMATOCRIT (HCT), 27.9 %; 65: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.41 K/uL; 65: MONOCYTE % (AUTO DIFF), 3.8 %; 65: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 65: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.0 pg; 65: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 65: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 65: HEMOGLOBIN (HGB), 9.3 g/dL; 65: MEAN CORPUSCULAR VOLUME (MCV), 95.9 fL; 65: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 65: EOSINOPHIL % (AUTO DIFF), 0.0 %; 65: NEUTROPHIL % (AUTO DIFF), 90.9 %; 65: NRBC PERCENT (HEMATOLOGY), 0.0 %; 65: WHITE BLOOD CELLS (WBC), 8.2 K/uL; 78: INR, 1.1; 78: PROTHROMBIN TIME, 14.0 seconds; 79: PART. THROMBOPLASTIN TIME, 35.6 seconds; 99: CALCIUM, 8.6 mg/dL; 99: AST (SGOT), 47 U/L; 99: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 99: PROTEIN TOTAL, 6.5 g/dL; 99: BILIRUBIN TOTAL, 0.3 mg/dL; 99: POTASSIUM, 3.5 mmol/L; 99: CORRECTED CALCIUM, 8.9 mg/dL; 99: GLOBULIN, 2.9 g/dL; 99: ANION GAP, 11 mmol/L; 99: ALKALINE PHOSPHATASE, 134 U/L; 99: GLUCOSE, 156 mg/dL; 99: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 99: CREATININE, 0.56 mg/dL; 99: SODIUM, 133 mmol/L; 99: CHLORIDE, 97 mmol/L; 99: CO2, 25 mmol/L; 99: LIPASE, 19 U/L; 99: ALT (SGPT), 45 U/L; 99: ALBUMIN, 3.6 g/dL; 103: HR, 95.0; 103: SpO2, 100.0; 103: SBP, 97.0; 103: DBP, 66.0; 103: MAP, 76.333; 103: LPM O2, 2.0; 103: Pain, 8.0; 103: Temp, 99.3; 104: KETAMINE, IVPB (ED/CDU PAIN INDICATION); 119: HR:, 91.0; 119: SpO2, 100.0; 119: SBP, 96.0; 119: DBP, 65.0; 119: MAP, 75.333; 119: LPM O2, 2.0; 119: Pain, 3.0; 0: Age, 65; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 121.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, VOMITING",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the patient\u2019s vital signs, labs, and recent trends, questioning whether they fulfilled sepsis criteria. The patient\u2019s normal lactate level and moderate vital sign improvements suggest that systemic infection risk is not escalating. Although the patient had fever and tachycardia initially, there is no strong evidence of severe infection or end-organ dysfunction. As a result, the risk of sepsis within 12 hours appears to be low.",
        "claims": [
            "I reviewed the patient\u2019s vital signs, labs, and recent trends.",
            "I questioned whether the patient fulfilled sepsis criteria.",
            "The patient\u2019s lactate level is normal.",
            "Moderate vital sign improvements suggest that systemic infection risk is not escalating.",
            "The patient had fever initially.",
            "The patient had tachycardia initially.",
            "There is no strong evidence of severe infection.",
            "There is no strong evidence of end-organ dysfunction.",
            "The risk of sepsis within 12 hours appears to be low."
        ],
        "relevant_claims": [
            "The patient had fever initially.",
            "The patient had tachycardia initially."
        ],
        "alignment_scores": [
            0.6,
            0.7
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions a fever, which is part of the criteria for SIRS positivity (temperature >38\u00b0C). However, without specific temperature reading, it is unclear if the fever meets the SIRS threshold. The fever is relevant to systemic inflammation and potential early sepsis, indicating a moderate alignment with the SIRS criteria.",
            "Tachycardia (elevated heart rate >90 bpm) is one of the criteria for SIRS, which signals potential early sepsis-related inflammation. The claim directly mentions tachycardia, aligning it with one of the SIRS criteria. However, since SIRS requires at least two criteria, the alignment rating is not maximum, as only one criterion is mentioned."
        ],
        "final_alignment_score": 0.6499999999999999,
        "accuracy": 0
    },
    {
        "input": "2: HR, 130.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 150.0; 2: DBP, 80.0; 2: MAP, 103.333; 2: Temp, 100.8; 49: POC PH (V) ISTAT, 7.43; 49: POC TCO2 (V) ISTAT, 28 mmol/L; 49: POC PO2 (V) ISTAT, 32 mmHg; 49: POC BASE EXCESS ISTAT, 2 mmol/L; 49: POC LACTATE ISTAT, 1.79 mmol/L; 49: POC O2 SATURATION ISTAT VENOUS, 63 %; 49: POC HCO3 (V) ISTAT, 26.6 mmol/L; 49: POC PCO2 (V) ISTAT, 40.5 mmHg; 57: SpO2, 98.706; 58: HR, 115.429; 58: RR, 34.846; 58: SpO2, 98.917; 58: Perf, 0.15; 58: 1min HRV, 7.583; 59: HR, 114.293; 59: RR, 21.190; 59: SpO2, 98.792; 59: Perf, 0.15; 59: 1min HRV, 10.194; 60: HR, 111.712; 60: RR, 19.220; 60: SpO2, 98.419; 60: 1min HRV, 7.770; 60: 5min HRV, 10.260; 60: Temp, 99.8; 61: HR, 113.948; 61: RR, 20.172; 61: SpO2, 97.979; 61: 1min HRV, 12.083; 62: HR, 111.25; 62: RR, 19.85; 62: SpO2, 99.909; 62: Perf, 0.12; 62: 1min HRV, 8.237; 63: HR, 112.828; 63: RR, 19.5; 63: SpO2, 100.0; 63: Perf, 0.08; 63: 1min HRV, 9.478; 64: HR, 115.017; 64: RR, 21.339; 64: SpO2, 99.333; 64: Perf, 0.087; 64: 1min HRV, 9.341; 65: HR, 113.879; 65: RR, 18.155; 65: SpO2, 98.75; 65: Perf, 0.1; 65: 1min HRV, 9.050; 65: 5min HRV, 11.233; 66: HR, 112.610; 66: RR, 19.169; 66: SpO2, 93.7; 66: 1min HRV, 7.226; 67: HR, 109.241; 67: RR, 20.914; 67: SpO2, 97.846; 67: 1min HRV, 16.590; 68: HR, 109.780; 68: RR, 25.322; 68: SpO2, 100.0; 68: 1min HRV, 6.405; 69: HR, 115.678; 69: RR, 21.390; 69: SpO2, 97.6; 69: 1min HRV, 13.991; 70: HR, 119.172; 70: RR, 24.172; 70: 1min HRV, 12.028; 70: 5min HRV, 20.794; 71: HR, 114.431; 71: RR, 19.983; 71: SpO2, 99.190; 71: 1min HRV, 6.842; 72: WAM DIFTYP, AUTO; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 72: EOSINOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 21.7 pg; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 72: HEMOGLOBIN (HGB), 11.2 g/dL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR VOLUME (MCV), 69.1 fL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.16 K/uL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 72: PLATELET COUNT (PLT), 284 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 72: HEMATOCRIT (HCT), 35.6 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: NEUTROPHIL % (AUTO DIFF), 81.5 %; 72: RED BLOOD CELLS (RBC), 5.15 MIL/uL; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: MONOCYTE % (AUTO DIFF), 6.9 %; 72: WHITE BLOOD CELLS (WBC), 11.1 K/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.02 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 72: HR, 114.797; 72: RR, 16.220; 72: SpO2, 99.0; 72: 1min HRV, 12.736; 73: HR, 116.593; 73: RR, 22.322; 73: SpO2, 99.667; 73: 1min HRV, 10.852; 74: INR, 1.1; 74: PROTHROMBIN TIME, 13.7 seconds; 74: HR, 114.271; 74: RR, 15.136; 74: SpO2, 99.158; 74: 1min HRV, 13.033; 75: PART. THROMBOPLASTIN TIME, 26.9 seconds; 75: HR, 115.983; 75: RR, 18.569; 75: SpO2, 99.172; 75: Perf, 0.335; 75: 1min HRV, 9.179; 75: 5min HRV, 11.055; 76: HR, 117.833; 76: RR, 20.333; 76: SpO2, 98.857; 76: Perf, 0.339; 76: 1min HRV, 20.298; 77: HR, 119.635; 77: RR, 18.315; 77: SpO2, 97.810; 77: 1min HRV, 11.138; 78: HR, 118.458; 78: RR, 15.915; 78: SpO2, 98.906; 78: 1min HRV, 7.851; 78: SBP, 136.0; 78: DBP, 86.0; 78: MAP, 102.667; 79: HR, 118.390; 79: RR, 21.864; 79: SpO2, 97.0; 79: 1min HRV, 10.976; 80: HR, 116.345; 80: RR, 19.190; 80: SpO2, 92.25; 80: 1min HRV, 6.229; 80: 5min HRV, 12.280; 81: HR, 117.068; 81: RR, 16.475; 81: SpO2, 100.0; 81: 1min HRV, 9.360; 82: HR, 114.948; 82: RR, 13.672; 82: SpO2, 99.0; 82: 1min HRV, 8.781; 83: HR, 113.831; 83: RR, 17.407; 83: SpO2, 98.0; 83: 1min HRV, 9.350; 84: SPECIFIC GRAVITY, URINE (UA): 1.014; 84: PROTEIN, URINE (UA): Negative; 84: GLUCOSE, URINE (UA): Negative; 84: PH, URINE (UA): 7.0; 84: NITRITE, URINE (UA): Negative; 84: LEUKOCYTE ESTERASE, URINE (UA): Negative; 84: KETONE, URINE (UA): Negative; 84: BLOOD, URINE (UA): Negative; 84: HR, 114.525; 84: RR, 19.186; 84: SpO2, 99.111; 84: 1min HRV, 12.467; 85: HR, 112.828; 85: RR, 16.103; 85: SpO2, 98.0; 85: 1min HRV, 8.069; 85: 5min HRV, 11.248; 85: SBP, 141.0; 85: DBP, 83.0; 85: MAP, 102.333; 85: Temp, 102.6; 86: HR, 119.357; 86: RR, 19.462; 86: SpO2, 87.762; 86: 1min HRV, 11.205; 87: HR, 114.0; 87: 1min HRV, 2.966; 90: POTASSIUM, 3.7 mmol/L; 90: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 90: PROTEIN TOTAL, 7.5 g/dL; 90: ALKALINE PHOSPHATASE, 167 U/L; 90: BILIRUBIN TOTAL, 0.7 mg/dL; 90: CO2, 23 mmol/L; 90: SODIUM, 138 mmol/L; 90: CREATININE, 0.82 mg/dL; 90: ALBUMIN, 4.7 g/dL; 90: CORRECTED CALCIUM, 9.0 mg/dL; 90: ALT (SGPT), 25 U/L; 90: AST (SGOT), 14 U/L; 90: CHLORIDE, 101 mmol/L; 90: GLOBULIN, 2.8 g/dL; 90: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 90: ANION GAP, 14 mmol/L; 90: GLUCOSE, 111 mg/dL; 90: CALCIUM, 9.6 mg/dL; 90: 5min HRV, 15.033; 92: RSV, Not Detected; 92: INFLUENZA B, Not Detected; 92: INFLUENZA A, Not Detected; 92: SARS-COV-2 RNA, Not Detected; 95: LR IV BOLUS -, 1000 ML; 96: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 100: HR, 103.0; 100: RR, 25.0; 100: SpO2, 97.0; 100: SBP, 126.0; 100: DBP, 80.0; 100: MAP, 95.333; 0: Age, 44; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 130.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, HIP PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I looked at the vital signs and laboratory characteristics, noting the presence of sustained tachycardia, recurring fevers, and elevated white blood cell counts. I questioned whether there was evidence of an infectious process, and the abnormal vital signs pointed toward a high likelihood of sepsis. I then challenged my reasoning by checking for signs of organ dysfunction or hypoperfusion, such as abnormal lactate or hypotension, but the combination of multiple systemic inflammatory responses still suggested significant risk. Thus, this patient meets criteria indicating a high risk of developing sepsis within 12 hours.",
        "claims": [
            "I looked at the vital signs and laboratory characteristics.",
            "I noted the presence of sustained tachycardia.",
            "I noted the presence of recurring fevers.",
            "I noted the presence of elevated white blood cell counts.",
            "I questioned whether there was evidence of an infectious process.",
            "The abnormal vital signs pointed toward a high likelihood of sepsis.",
            "I checked for signs of organ dysfunction or hypoperfusion.",
            "I looked for abnormal lactate.",
            "I looked for hypotension.",
            "The combination of multiple systemic inflammatory responses suggested significant risk.",
            "This patient meets criteria indicating a high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "I noted the presence of sustained tachycardia.",
            "The abnormal vital signs pointed toward a high likelihood of sepsis.",
            "I checked for signs of organ dysfunction or hypoperfusion.",
            "I looked for abnormal lactate.",
            "The combination of multiple systemic inflammatory responses suggested significant risk.",
            "This patient meets criteria indicating a high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.7,
            0.8,
            0.9,
            0.8
        ],
        "alignment_category": [
            2,
            4,
            8,
            5,
            2,
            4
        ],
        "alignment_reasonings": [
            "Sustained tachycardia aligns with the SIRS criteria, which includes heart rate >90 bpm. This is a specific indicator of systemic inflammation related to sepsis. Although the claim does not provide a specific heart rate threshold, the mention of \"sustained tachycardia\" strongly suggests it meets or exceeds the SIRS threshold, making the alignment quite strong but not perfectly quantified.",
            "The claim about \"abnormal vital signs\" suggests a systematic measurement approach like the NEWS score, which uses vital sign deviations to predict deterioration consistent with sepsis. While the claim does not specify the numerical NEWS score, it implies a high risk, which aligns generally well with the criteria but lacks specific numerical thresholds for a perfect match.",
            "The claim refers to checking for signs of organ dysfunction, which aligns with the purpose of SOFA (Sequential Organ Failure Assessment) scoring. Although no specific SOFA criteria are mentioned in the claim, the concept of looking for organ dysfunction is central to the SOFA score's goal in assessing sepsis risk. The alignment is indirect but relevant, as it corresponds with the overarching aim of the SOFA criteria to evaluate organ dysfunction in sepsis.",
            "The claim specifically references lactate, which directly relates to category 5. However, the claim does not mention if the lactate level was elevated (\u22652 mmol/L), so the alignment is strong but not perfect.",
            "The claim refers to \"multiple systemic inflammatory responses,\" which directly aligns with the SIRS criteria. The presence of \u22652 SIRS criteria is used to identify systemic inflammation consistent with early sepsis. Although the claim does not specify the exact number or nature of these responses, \"multiple\" strongly implies the presence of at least two criteria, reflecting significant alignment.",
            "The claim generally states that the patient is at high risk of developing sepsis within 12 hours. While it does not specify any particular criteria or measurements, an elevated NEWS score directly pertains to predicting imminent clinical deterioration, making it closely aligned with the claim. This alignment is strong, although not direct without specific NEWS components provided."
        ],
        "final_alignment_score": 0.7833333333333333,
        "accuracy": 0
    },
    {
        "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 119.0; 5: DBP, 63.0; 5: MAP, 81.667; 5: Temp, 97.9; 48: HR, 107.171; 48: RR, 21.667; 48: 1min HRV, 7.060; 48: SBP, 132.0; 48: DBP, 86.0; 48: MAP, 101.333; 49: HR, 103.707; 49: RR, 15.017; 49: 1min HRV, 7.922; 50: HR, 101.559; 50: RR, 13.593; 50: 1min HRV, 13.327; 50: 5min HRV, 15.889; 51: HR, 104.948; 51: RR, 18.052; 51: 1min HRV, 12.539; 52: HR, 108.780; 52: RR, 13.593; 52: 1min HRV, 9.291; 53: HR, 107.305; 53: RR, 16.288; 53: 1min HRV, 21.887; 54: HR, 107.741; 54: RR, 17.103; 54: 1min HRV, 9.699; 55: HR, 104.525; 55: RR, 13.729; 55: 1min HRV, 16.064; 55: 5min HRV, 16.311; 56: HR, 103.672; 56: RR, 16.586; 56: 1min HRV, 11.985; 57: HR, 98.949; 57: RR, 16.254; 57: 1min HRV, 18.393; 58: HR, 102.288; 58: RR, 15.847; 58: 1min HRV, 24.567; 59: HR, 101.603; 59: RR, 16.172; 59: 1min HRV, 14.703; 60: HR, 99.780; 60: RR, 19.017; 60: 1min HRV, 11.709; 60: 5min HRV, 18.947; 61: HR, 99.810; 61: RR, 20.776; 61: 1min HRV, 5.400; 62: HR, 100.475; 62: RR, 17.441; 62: 1min HRV, 4.773; 63: HR, 101.138; 63: RR, 17.345; 63: 1min HRV, 24.163; 64: HR, 100.864; 64: RR, 19.864; 64: 1min HRV, 14.177; 65: HR, 99.373; 65: RR, 19.254; 65: 1min HRV, 5.808; 65: 5min HRV, 13.977; 66: HR, 99.138; 66: RR, 18.052; 66: 1min HRV, 6.775; 67: HR, 101.780; 67: RR, 18.068; 67: 1min HRV, 6.950; 68: HR, 103.224; 68: RR, 16.897; 68: 1min HRV, 11.861; 69: HR, 102.525; 69: RR, 18.661; 69: 1min HRV, 25.985; 70: HR, 100.695; 70: RR, 18.576; 70: 1min HRV, 6.207; 70: 5min HRV, 16.112; 71: HR, 101.224; 71: RR, 18.5; 71: 1min HRV, 5.814; 72: HR, 101.203; 72: RR, 18.339; 72: 1min HRV, 30.666; 73: HR, 100.517; 73: RR, 18.086; 73: 1min HRV, 4.284; 74: HR, 101.390; 74: RR, 18.661; 74: 1min HRV, 4.836; 75: HR, 100.153; 75: RR, 18.356; 75: SpO2, 100.0; 75: 1min HRV, 5.396; 75: 5min HRV, 14.719; 75: SBP, 125.0; 75: DBP, 78.0; 75: MAP, 93.667; 76: HR, 100.586; 76: RR, 19.707; 76: 1min HRV, 6.736; 76: SBP, 125.0; 76: DBP, 78.0; 76: MAP, 93.667; 77: HR, 101.0; 77: RR, 19.915; 77: 1min HRV, 25.271; 78: HR, 102.207; 78: RR, 18.776; 78: 1min HRV, 7.651; 79: HR, 104.186; 79: RR, 19.339; 79: 1min HRV, 23.564; 80: HR, 99.559; 80: RR, 18.339; 80: 1min HRV, 5.302; 80: 5min HRV, 18.504; 81: HR, 99.276; 81: RR, 16.224; 81: 1min HRV, 10.391; 81: LR IV BOLUS -, 1000 ML; 82: HR:, 100.0; 82: RR, 14.407; 82: 1min HRV, 21.803; 83: POC PH (V) ISTAT, 7.41; 83: POC PCO2 (V) ISTAT, 35.4 mmHg; 83: POC TCO2 (V) ISTAT, 24 mmol/L; 83: POC HCO3 (V) ISTAT, 22.5 mmol/L; 83: POC BASE EXCESS ISTAT, -2 mmol/L; 83: POC PO2 (V) ISTAT, 37 mmHg; 83: POC O2 SATURATION ISTAT VENOUS, 72 %; 83: POC LACTATE ISTAT, 2.36 mmol/L; 83: HR, 99.948; 83: RR, 15.759; 83: 1min HRV, 10.178; 84: HR, 103.169; 84: RR, 16.407; 84: 1min HRV, 7.486; 85: HR, 100.627; 85: RR, 17.203; 85: 1min HRV, 18.625; 85: 5min HRV, 16.917; 86: HR, 100.121; 86: RR, 17.862; 86: 1min HRV, 14.181; 87: HR, 104.373; 87: RR, 16.220; 87: 1min HRV, 31.188; 88: HR, 106.397; 88: RR, 17.448; 88: 1min HRV, 25.171; 89: HR, 105.441; 89: RR, 20.017; 89: 1min HRV, 20.929; 90: HR, 103.661; 90: RR, 19.424; 90: 1min HRV, 12.967; 90: 5min HRV, 24.426; 91: HR, 102.724; 91: RR, 20.190; 91: 1min HRV, 10.363; 92: HR, 103.864; 92: RR, 19.576; 92: 1min HRV, 16.807; 93: HR, 103.259; 93: RR, 16.793; 93: 1min HRV, 26.245; 94: HR, 105.390; 94: RR, 19.475; 94: 1min HRV, 25.257; 95: SARS-COV-2 RNA, Not Detected; 95: HR, 101.914; 95: RR, 19.966; 95: 1min HRV, 6.939; 95: 5min HRV, 19.694; 96: HR, 101.814; 96: RR, 19.458; 96: 1min HRV, 6.218; 97: HR, 103.153; 97: RR, 19.356; 97: 1min HRV, 15.343; 98: HR, 103.741; 98: RR, 19.431; 98: 1min HRV, 11.374; 99: HR, 105.475; 99: RR, 18.034; 99: 1min HRV, 18.055; 100: HR, 101.655; 100: RR, 20.897; 100: 1min HRV, 14.612; 100: 5min HRV, 16.578; 101: ALKALINE PHOSPHATASE, 156 U/L; 101: GLOBULIN, 1.7 g/dL; 101: POTASSIUM, 4.1 mmol/L; 101: CHLORIDE, 102 mmol/L; 101: LIPASE, 70 U/L; 101: AST (SGOT), 36 U/L; 101: EGFR REFIT WITHOUT RACE (2021), 65 mL/min/1.73 m2; 101: ANION GAP, 13 mmol/L; 101: PROTEIN TOTAL, 5.7 g/dL; 101: CO2, 21 mmol/L; 101: ALBUMIN, 4.0 g/dL; 101: CALCIUM, 9.7 mg/dL; 101: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 101: ALT (SGPT), 14 U/L; 101: BILIRUBIN TOTAL, 0.3 mg/dL; 101: SODIUM, 136 mmol/L; 101: CORRECTED CALCIUM, 9.7 mg/dL; 101: CREATININE, 1.23 mg/dL; 101: GLUCOSE, 169 mg/dL; 101: HR, 104.136; 101: RR, 22.610; 101: 1min HRV, 22.822; 102: HR, 109.593; 102: RR, 18.373; 102: 1min HRV, 24.401; 103: HR, 106.448; 103: RR, 19.793; 103: 1min HRV, 68.019; 104: HR, 106.407; 104: RR, 17.610; 104: 1min HRV, 13.481; 105: HIGH SENSITIVITY TROPONIN, 7 ng/L; 105: HR, 104.328; 105: RR, 20.259; 105: SpO2, 100.0; 105: 1min HRV, 10.131; 105: 5min HRV, 35.905; 106: HR, 107.525; 106: RR, 18.576; 106: 1min HRV, 13.288; 107: HR, 106.458; 107: RR, 18.542; 107: 1min HRV, 9.333; 108: HR, 103.862; 108: RR, 24.103; 108: 1min HRV, 5.588; 109: HR, 103.831; 109: RR, 22.441; 109: 1min HRV, 5.072; 110: HR, 105.603; 110: RR, 21.655; 110: 1min HRV, 14.536; 110: 5min HRV, 12.758; 111: HR, 108.847; 111: RR, 19.763; 111: 1min HRV, 18.562; 112: HR, 106.695; 112: RR, 21.356; 112: 1min HRV, 23.629; 113: HR, 107.224; 113: RR, 18.172; 113: 1min HRV, 12.075; 114: HR, 106.678; 114: RR, 20.932; 114: 1min HRV, 20.000; 115: HR, 106.810; 115: RR, 18.948; 115: 1min HRV, 24.795; 115: 5min HRV, 21.082; 116: HR, 108.983; 116: RR, 22.593; 116: 1min HRV, 24.284; 117: HR, 115.508; 117: RR, 21.136; 117: 1min HRV, 18.287; 118: HR, 109.741; 118: RR, 20.052; 118: 1min HRV, 14.957; 119: HR, 105.932; 119: RR, 21.271; 119: 1min HRV, 22.043; 0: Age, 65; 0: Gender, M; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 119.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, PALPITATIONS,ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I examined the vital signs, looking for evidence of infection and organ dysfunction. The patient\u2019s heart rate is elevated, and there is a mild increase in lactate, but systolic blood pressure remains stable and there are no strong indications of acute end-organ failure. Although continued monitoring is recommended, these findings do not suggest a high likelihood of sepsis within the next 12 hours.",
        "claims": [
            "I examined the vital signs for evidence of infection and organ dysfunction.",
            "The patient's heart rate is elevated.",
            "There is a mild increase in lactate.",
            "Systolic blood pressure remains stable.",
            "There are no strong indications of acute end-organ failure.",
            "Continued monitoring is recommended.",
            "These findings do not suggest a high likelihood of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is elevated.",
            "There are no strong indications of acute end-organ failure."
        ],
        "alignment_scores": [
            0.7,
            0.7
        ],
        "alignment_category": [
            2,
            8
        ],
        "alignment_reasonings": [
            "An elevated heart rate is one of the criteria under SIRS (heart rate >90 bpm), which identifies systemic inflammation consistent with early sepsis. However, the claim does not specify if it meets the threshold (i.e., the exact heart rate is not given), but it suggests relevance. Therefore, the alignment is reasonably strong, though not absolute without specific values.",
            "The absence of acute end-organ failure is most closely related to the SOFA score, which assesses organ dysfunction. Although the claim indicates it's not strongly present, this suggests monitoring for signs of failure which is related to the SOFA assessment. The alignment is moderate because it references the concept of organ assessment, but does not directly support an increase in SOFA score, hence not a full alignment."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 0
    },
    {
        "input": "6: HR, 91.0; 6: RR, 20.0; 6: SpO2, 100.0; 6: SBP, 140.0; 6: DBP, 119.0; 6: MAP, 126.0; 6: Temp, 97.7; 89: HR, 86.122; 89: RR, 14.545; 89: SpO2, 99.611; 89: Perf, 1.259; 89: 1min HRV, 64.115; 90: HR, 83.644; 90: RR, 13.949; 90: SpO2, 99.034; 90: Perf, 1.051; 90: 1min HRV, 101.623; 90: 5min HRV, 86.748; 91: HR, 85.712; 91: RR, 16.102; 91: SpO2, 99.475; 91: Perf, 0.914; 91: 1min HRV, 87.323; 91: SBP, 136.0; 91: DBP, 51.0; 91: MAP, 79.333; 92: HR, 86.0; 92: RR, 14.638; 92: SpO2, 99.155; 92: Perf, 0.880; 92: 1min HRV, 90.021; 93: HR, 83.678; 93: RR, 14.0; 93: SpO2, 99.0; 93: Perf, 0.866; 93: 1min HRV, 74.305; 94: HR, 83.5; 94: RR, 14.431; 94: SpO2, 99.0; 94: Perf, 0.86; 94: 1min HRV, 58.107; 95: HR, 84.559; 95: RR, 15.898; 95: SpO2, 99.0; 95: Perf, 0.831; 95: 1min HRV, 54.349; 95: 5min HRV, 74.663; 96: HR, 83.569; 96: RR, 14.552; 96: SpO2, 99.0; 96: Perf, 0.846; 96: 1min HRV, 75.772; 96: SBP, 135.0; 96: DBP, 64.0; 96: MAP, 87.667; 97: HR, 82.254; 97: RR, 15.220; 97: SpO2, 99.0; 97: Perf, 0.851; 97: 1min HRV, 69.625; 98: HR, 84.271; 98: RR, 15.678; 98: SpO2, 98.831; 98: Perf, 0.818; 98: 1min HRV, 71.319; 99: HR, 83.069; 99: RR, 21.138; 99: SpO2, 99.121; 99: Perf, 0.781; 99: 1min HRV, 69.271; 100: HR, 83.983; 100: RR, 16.475; 100: SpO2, 98.831; 100: Perf, 0.745; 100: 1min HRV, 64.848; 100: 5min HRV, 70.448; 101: HR, 84.966; 101: RR, 15.661; 101: SpO2, 98.898; 101: Perf, 0.710; 101: 1min HRV, 70.236; 102: HR, 81.534; 102: RR, 15.879; 102: SpO2, 98.759; 102: Perf, 0.722; 102: 1min HRV, 64.743; 103: HR, 82.0; 103: RR, 14.424; 103: SpO2, 98.712; 103: Perf, 0.696; 103: 1min HRV, 60.270; 104: HR, 81.293; 104: RR, 13.224; 104: SpO2, 98.759; 104: Perf, 0.694; 104: 1min HRV, 75.829; 105: HR, 83.356; 105: RR, 14.746; 105: SpO2, 99.136; 105: Perf, 0.688; 105: 1min HRV, 64.337; 105: 5min HRV, 68.181; 106: HR, 82.763; 106: RR, 14.780; 106: SpO2, 98.644; 106: Perf, 0.685; 106: 1min HRV, 68.190; 107: HR, 81.603; 107: RR, 14.655; 107: SpO2, 99.0; 107: Perf, 0.680; 107: 1min HRV, 59.350; 108: HR, 81.220; 108: RR, 21.627; 108: SpO2, 98.932; 108: Perf, 0.709; 108: 1min HRV, 76.786; 109: HR, 80.966; 109: RR, 19.362; 109: SpO2, 99.0; 109: Perf, 0.725; 109: 1min HRV, 76.180; 110: HR, 80.661; 110: RR, 16.288; 110: SpO2, 99.0; 110: Perf, 0.707; 110: 1min HRV, 66.222; 110: 5min HRV, 70.035; 111: HR, 81.220; 111: RR, 23.169; 111: SpO2, 99.0; 111: Perf, 0.679; 111: 1min HRV, 77.056; 111: SBP, 136.0; 111: DBP, 64.0; 111: MAP, 88.0; 112: HR, 81.983; 112: RR, 18.586; 112: SpO2, 99.0; 112: Perf, 0.652; 112: 1min HRV, 60.951; 113: WAM DIFTYP, AUTO; 113: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 113: LYMPHOCYTE % (AUTO DIFF), 14.9 %; 113: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 113: HEMATOCRIT (HCT), 35.1 %; 113: HEMOGLOBIN (HGB), 10.9 g/dL; 113: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 113: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 113: NRBC PERCENT (HEMATOLOGY), 0.0 %; 113: RED BLOOD CELLS (RBC), 3.62 MIL/uL; 113: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.1 pg; 113: NEUTROPHIL % (AUTO DIFF), 75.4 %; 113: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 113: BASOPHIL % (AUTO DIFF), 0.5 %; 113: PLATELET COUNT (PLT), 252 K/uL; 113: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 113: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 113: EOSINOPHIL % (AUTO DIFF), 1.9 %; 113: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.25 K/uL; 113: WHITE BLOOD CELLS (WBC), 13.0 K/uL; 113: MONOCYTE % (AUTO DIFF), 6.7 %; 113: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 113: MEAN CORPUSCULAR VOLUME (MCV), 97.0 fL; 113: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 113: HR, 82.797; 113: RR, 14.271; 113: SpO2, 99.0; 113: Perf, 0.625; 113: 1min HRV, 70.045; 114: HR, 82.190; 114: RR, 19.414; 114: SpO2, 98.828; 114: Perf, 0.61; 114: 1min HRV, 61.600; 115: HR, 82.508; 115: RR, 13.017; 115: SpO2, 99.508; 115: Perf, 0.654; 115: 1min HRV, 63.268; 115: 5min HRV, 66.921; 116: HR, 82.155; 116: RR, 12.103; 116: SpO2, 99.397; 116: Perf, 0.662; 116: 1min HRV, 73.993; 117: HR, 81.576; 117: RR, 13.119; 117: SpO2, 99.0; 117: Perf, 0.662; 117: 1min HRV, 64.195; 118: HR, 81.763; 118: RR, 11.136; 118: SpO2, 99.0; 118: Perf, 0.653; 118: 1min HRV, 60.004; 119: HR, 79.017; 119: RR, 10.286; 119: SpO2, 99.0; 119: Perf, 0.659; 119: 1min HRV, 83.610; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 20.0; 0: Triage SBP, 140.0; 0: Triage DBP, 119.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS,APPETITE DECREASED,EAR PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I looked for concerning changes in vital signs and lab values to see if they might indicate an escalating infectious process. Although the patient\u2019s white blood cell count is mildly elevated, the heart rate, blood pressure, respiratory rate, and temperature remain relatively stable, with no substantial signs of acute organ dysfunction. Additionally, there is no strong evidence of hypotension or fever that would suggest significant hemodynamic compromise. Based on this information, the risk of sepsis within 12 hours appears to be low.",
        "claims": [
            "I looked for concerning changes in vital signs and lab values.",
            "I assessed vital signs and lab values to identify potential escalating infectious processes.",
            "The patient\u2019s white blood cell count is mildly elevated.",
            "The heart rate remains relatively stable.",
            "The blood pressure remains relatively stable.",
            "The respiratory rate remains relatively stable.",
            "The temperature remains relatively stable.",
            "There are no substantial signs of acute organ dysfunction.",
            "There is no strong evidence of hypotension.",
            "There is no strong evidence of fever.",
            "The absence of hypotension or fever suggests there is no significant hemodynamic compromise.",
            "Based on this information, the risk of sepsis within 12 hours appears to be low."
        ],
        "relevant_claims": [
            "There are no substantial signs of acute organ dysfunction.",
            "There is no strong evidence of hypotension.",
            "There is no strong evidence of fever.",
            "The absence of hypotension or fever suggests there is no significant hemodynamic compromise."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.3,
            0.7
        ],
        "alignment_category": [
            8,
            7,
            2,
            7
        ],
        "alignment_reasonings": [
            "The claim reports an absence of acute organ dysfunction, which indirectly relates to the SOFA Score, a measure of organ dysfunction. The lack of proof for organ dysfunction suggests low risk according to this category, hence a weak alignment.",
            "The claim directly mentions the absence of strong evidence of hypotension. This aligns with the category related to sepsis-associated hypotension. However, the alignment rating is low because the claim mentions the absence of the condition rather than its presence, indicating that sepsis risk is not confirmed on this basis.",
            "The claim \"There is no strong evidence of fever\" is loosely related to the SIRS criteria, where fever is one of the assessed parameters (temperature\u202f>\u202f38\u202f\u00b0C or\u202f<\u202f36\u202f\u00b0C). The absence of fever would suggest the patient does not meet this specific SIRS criterion, indicating a low alignment to SIRS positivity. However, it still has some relevance given that it assesses one of the criteria used for SIRS evaluation, albeit indirectly and negatively.",
            "The claim mentions the absence of hypotension, which is directly related to the Sepsis-Associated Hypotension category. This category corresponds to detecting significant hemodynamic compromise through hypotension, particularly in the context of sepsis. Even though the claim highlights a lack of hypotension, the category is still relevant because it assesses hemodynamic stability, indicating a potential lower risk of sepsis. Fever, although not directly mentioned in any category, indirectly relates to systemic inflammation and hemodynamic changes, further supporting the partial relevance of category 7."
        ],
        "final_alignment_score": 0.375,
        "accuracy": 0
    },
    {
        "input": "3: HR, 74.0; 3: RR, 18.0; 3: SpO2, 94.0; 3: SBP, 113.0; 3: DBP, 71.0; 3: MAP, 85.0; 3: Pain, 4.0; 3: Temp, 99.7; 7: Pain, 3.0; 31: SpO2, 94.462; 31: SBP, 137.0; 31: DBP, 75.0; 31: MAP, 95.667; 32: SpO2, 93.0; 33: SpO2, 94.725; 33: Perf, 14.482; 34: SpO2, 94.914; 34: Perf, 18.411; 35: SpO2, 94.883; 35: Perf, 19.336; 36: SpO2, 94.982; 36: Perf, 16.918; 37: SpO2, 95.695; 37: Perf, 17.487; 38: SpO2, 95.690; 38: Perf, 17.235; 39: SpO2, 94.966; 39: Perf, 16.932; 40: SpO2, 94.559; 40: Perf, 16.699; 41: HR, 70.0; 41: RR, 18.0; 41: SpO2, 95.879; 41: Perf, 14.595; 41: SBP, 136.0; 41: DBP, 69.0; 41: MAP, 91.333; 41: Pain, 3.0; 42: SpO2, 95.7; 42: Perf, 17.597; 42: SBP, 136.0; 42: DBP, 69.0; 42: MAP, 91.333; 43: SpO2, 95.983; 43: Perf, 16.952; 44: SpO2, 96.0; 44: Perf, 18.613; 45: SpO2, 96.0; 45: Perf, 18.248; 46: SpO2, 94.881; 46: Perf, 17.846; 47: SpO2, 95.862; 47: Perf, 13.458; 48: SpO2, 96.254; 48: Perf, 14.139; 49: SpO2, 95.690; 49: Perf, 15.089; 50: SpO2, 96.153; 50: Perf, 14.664; 51: SpO2, 96.0; 51: Perf, 16.012; 52: SpO2, 96.034; 52: Perf, 16.036; 53: SpO2, 95.763; 53: Perf, 15.591; 56: SARS-COV-2 RNA, Not Detected; 56: INFLUENZA A, Not Detected; 56: RSV, Not Detected; 56: INFLUENZA B, Not Detected; 61: WAM DIFTYP, AUTO; 61: HEMATOCRIT (HCT), 41.4 %; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.72 K/uL; 61: MEAN CORPUSCULAR VOLUME (MCV), 90.0 fL; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: PLATELET COUNT (PLT), 222 K/uL; 61: BASOPHIL % (AUTO DIFF), 0.1 %; 61: NEUTROPHIL % (AUTO DIFF), 87.1 %; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 17.23 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 61: LYMPHOCYTE % (AUTO DIFF), 3.4 %; 61: RED BLOOD CELLS (RBC), 4.60 MIL/uL; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 61: WHITE BLOOD CELLS (WBC), 19.8 K/uL; 61: HEMOGLOBIN (HGB), 13.8 g/dL; 61: MONOCYTE % (AUTO DIFF), 8.7 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 71: SpO2, 95.972; 71: Perf, 19.384; 72: SpO2, 95.638; 72: Perf, 19.893; 73: SpO2, 95.593; 73: Perf, 18.497; 74: SpO2, 95.542; 74: Perf, 19.283; 75: SpO2, 95.259; 75: Perf, 19.124; 76: SpO2, 94.492; 76: Perf, 17.902; 77: POC PH (V) ISTAT, 7.44; 77: POC HCO3 (V) ISTAT, 28.5 mmol/L; 77: POC BASE EXCESS ISTAT, 4 mmol/L; 77: POC PO2 (V) ISTAT, 43 mmHg; 77: POC LACTATE ISTAT, 0.69 mmol/L; 77: POC TCO2 (V) ISTAT, 30 mmol/L; 77: POC PCO2 (V) ISTAT, 41.8 mmHg; 77: POC O2 SATURATION ISTAT VENOUS, 80 %; 77: SpO2, 94.0; 77: Perf, 15.710; 78: SpO2, 95.119; 78: Perf, 15.465; 79: SpO2, 95.136; 79: Perf, 15.434; 80: SpO2, 94.069; 80: Perf, 15.169; 81: SpO2, 94.831; 81: Perf, 14.358; 82: SpO2, 94.069; 82: Perf, 14.436; 83: SpO2, 94.0; 83: Perf, 16.667; 84: SpO2, 94.0; 84: Perf, 16.033; 85: HIGH SENSITIVITY TROPONIN, 14 ng/L; 85: SpO2, 94.0; 85: Perf, 14.911; 86: SpO2, 94.949; 86: Perf, 14.176; 87: SpO2, 95.052; 87: Perf, 15.782; 88: ALT (SGPT), 70 U/L; 88: BILIRUBIN TOTAL, 0.9 mg/dL; 88: CORRECTED CALCIUM, 9.1 mg/dL; 88: POTASSIUM, 3.2 mmol/L; 88: SODIUM, 139 mmol/L; 88: CREATININE, 1.40 mg/dL; 88: ALBUMIN, 4.1 g/dL; 88: GLOBULIN, 2.6 g/dL; 88: EGFR REFIT WITHOUT RACE (2021), 53 mL/min/1.73 m2; 88: ANION GAP, 13 mmol/L; 88: CO2, 27 mmol/L; 88: AST (SGOT), 72 U/L; 88: GLUCOSE, 156 mg/dL; 88: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 88: PROTEIN TOTAL, 6.7 g/dL; 88: ALKALINE PHOSPHATASE, 133 U/L; 88: CALCIUM, 9.2 mg/dL; 88: CHLORIDE, 99 mmol/L; 88: SpO2, 95.407; 88: Perf, 13.756; 89: SpO2, 94.305; 89: Perf, 15.369; 90: SpO2, 94.103; 90: Perf, 15.427; 91: SpO2, 93.983; 91: Perf, 12.664; 92: SpO2, 93.190; 92: Perf, 15.533; 93: SpO2, 93.237; 93: Perf, 16.274; 94: SpO2, 93.407; 94: Perf, 12.725; 95: SpO2, 92.569; 95: Perf, 10.715; 96: SpO2, 94.034; 96: Perf, 13.330; 97: SpO2, 92.845; 97: Perf, 14.170; 98: SpO2, 93.254; 98: Perf, 12.813; 99: SpO2, 91.695; 99: Perf, 8.233; 100: SpO2, 92.690; 100: Perf, 13.570; 101: SpO2, 92.729; 101: Perf, 12.566; 102: SpO2, 92.448; 102: Perf, 15.272; 103: GLUCOSE, URINE (UA): Negative; 103: PH, URINE (UA): 5.0; 103: SPECIFIC GRAVITY, URINE (UA): 1.026; 103: NITRITE, URINE (UA): Negative; 103: KETONE, URINE (UA): Negative; 103: SpO2, 93.576; 103: Perf, 12.770; 104: SpO2, 91.466; 104: Perf, 12.215; 105: SpO2, 94.458; 105: Perf, 14.273; 106: SpO2, 93.458; 106: Perf, 11.702; 107: SpO2, 92.690; 107: Perf, 12.907; 108: SpO2, 92.475; 108: Perf, 12.899; 109: SpO2, 91.345; 109: Perf, 8.859; 110: SpO2, 92.492; 110: Perf, 13.471; 111: SpO2, 90.932; 111: Perf, 9.334; 112: SpO2, 95.172; 112: Perf, 14.262; 113: SpO2, 94.102; 113: Perf, 13.637; 114: SpO2, 93.0; 114: Perf, 13.566; 115: SpO2, 93.0; 115: Perf, 14.340; 116: SpO2, 93.0; 116: Perf, 13.576; 117: SpO2, 93.569; 117: Perf, 12.735; 118: SpO2, 94.407; 118: Perf, 8.632; 119: SpO2, 93.310; 119: Perf, 11.099; 0: Age, 73; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 113.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I began by reviewing the patient\u2019s vital signs, labs, and potential infection sources to see if key indicators of sepsis were present. I questioned whether the patient showed evidence of hemodynamic instability, organ dysfunction, or an elevated lactate level. Noting the stable blood pressure, relatively normal lactate, and absence of severe abnormalities in other parameters, I concluded that the near-term risk for sepsis is low.",
        "claims": [
            "I began by reviewing the patient\u2019s vital signs, labs, and potential infection sources.",
            "I was looking for key indicators of sepsis.",
            "I questioned whether the patient showed evidence of hemodynamic instability.",
            "I questioned whether the patient showed evidence of organ dysfunction.",
            "I questioned whether the patient showed an elevated lactate level.",
            "The patient has stable blood pressure.",
            "The patient has a relatively normal lactate level.",
            "There are no severe abnormalities in other parameters.",
            "I concluded that the near-term risk for sepsis is low."
        ],
        "relevant_claims": [
            "The patient has stable blood pressure."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            7
        ],
        "alignment_reasonings": [
            "The claim about \"stable blood pressure\" indirectly suggests that the patient does not have sepsis-associated hypotension, which this category targets. However, the absence of hypotension does not provide direct insight into sepsis risk, resulting in weak alignment."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "5: HR, 79.0; 5: RR, 18.0; 5: SpO2, 94.0; 5: SBP, 118.0; 5: DBP, 46.0; 5: MAP, 70.0; 5: Temp, 99.1; 69: WAM DIFTYP, AUTO; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 69: WHITE BLOOD CELLS (WBC), 15.8 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.65 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 69: BASOPHIL % (AUTO DIFF), 0.3 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.42 K/uL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: HEMOGLOBIN (HGB), 9.4 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 69: LYMPHOCYTE % (AUTO DIFF), 2.7 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 92.7 %; 69: EOSINOPHIL % (AUTO DIFF), 0.0 %; 69: MONOCYTE % (AUTO DIFF), 3.9 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 69: HEMATOCRIT (HCT), 29.9 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 24.4 %; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 220 K/uL; 69: RED BLOOD CELLS (RBC), 3.15 MIL/uL; 80: HR, 79.0; 80: 1min HRV, 0.632; 80: SBP, 115.0; 80: DBP, 56.0; 80: MAP, 75.667; 81: HR, 77.627; 81: RR, 26.727; 81: SpO2, 95.828; 81: 1min HRV, 11.200; 82: HR, 74.552; 82: RR, 21.397; 82: SpO2, 90.466; 82: Perf, 1.034; 82: 1min HRV, 7.666; 83: HR, 72.559; 83: RR, 23.136; 83: SpO2, 92.373; 83: Perf, 1.478; 83: 1min HRV, 4.965; 84: HR, 71.259; 84: RR, 26.483; 84: SpO2, 92.741; 84: Perf, 1.973; 84: 1min HRV, 1.575; 84: 5min HRV, 26.452; 85: HR, 71.0; 85: RR, 24.576; 85: SpO2, 94.254; 85: Perf, 1.915; 85: 1min HRV, 4.954; 86: HR, 71.0; 86: RR, 21.237; 86: SpO2, 93.898; 86: Perf, 2.031; 86: 1min HRV, 0.982; 87: HR, 70.310; 87: RR, 21.121; 87: SpO2, 93.517; 87: Perf, 2.059; 87: 1min HRV, 4.349; 88: HR, 70.0; 88: RR, 20.712; 88: SpO2, 92.661; 88: Perf, 2.121; 88: 1min HRV, 0.977; 89: HR, 70.0; 89: RR, 20.259; 89: SpO2, 92.155; 89: Perf, 2.087; 89: 1min HRV, 7.373; 89: 5min HRV, 7.905; 90: HR, 69.949; 90: RR, 19.492; 90: SpO2, 92.610; 90: Perf, 2.144; 90: 1min HRV, 1.040; 91: HR, 70.0; 91: RR, 18.746; 91: SpO2, 92.271; 91: Perf, 2.171; 91: 1min HRV, 0.737; 92: HR, 70.0; 92: RR, 17.569; 92: SpO2, 92.379; 92: Perf, 2.239; 92: 1min HRV, 8.331; 93: HR, 70.0; 93: RR, 17.780; 93: SpO2, 91.576; 93: Perf, 2.413; 93: 1min HRV, 0.865; 94: HR, 70.0; 94: RR, 17.310; 94: SpO2, 91.724; 94: Perf, 2.581; 94: 1min HRV, 0.730; 94: 5min HRV, 3.782; 94: SBP, 102.0; 94: DBP, 57.0; 94: MAP, 72.0; 95: HR, 70.0; 95: RR, 17.797; 95: SpO2, 92.442; 95: Perf, 2.55; 95: 1min HRV, 1.324; 95: SBP, 102.0; 95: DBP, 57.0; 95: MAP, 72.0; 96: HR, 70.0; 96: RR, 23.610; 96: SpO2, 92.695; 96: Perf, 2.430; 96: 1min HRV, 1.110; 97: HR, 72.276; 97: RR, 25.0; 97: SpO2, 95.0; 97: Perf, 1.765; 97: 1min HRV, 101.809; 98: HR, 71.169; 98: RR, 26.373; 98: SpO2, 96.678; 98: Perf, 1.388; 98: 1min HRV, 20.553; 99: HR, 71.0; 99: RR, 24.466; 99: SpO2, 96.810; 99: Perf, 1.301; 99: 1min HRV, 5.030; 99: 5min HRV, 47.921; 99: NORMOSOL-R IV BOLUS -, 1000 ML; 100: HR:, 70.983; 100: RR, 26.254; 100: SpO2, 96.797; 100: Perf, 1.325; 100: 1min HRV, 31.615; 101: HR, 70.052; 101: RR, 22.190; 101: SpO2, 96.690; 101: Perf, 1.399; 101: 1min HRV, 0.887; 102: HR, 70.0; 102: RR, 24.831; 102: SpO2, 97.153; 102: Perf, 1.319; 102: 1min HRV, 0.702; 103: HR, 70.0; 103: RR, 24.237; 103: SpO2, 96.390; 103: Perf, 1.486; 103: 1min HRV, 0.833; 104: HR, 70.0; 104: RR, 21.776; 104: SpO2, 96.966; 104: Perf, 1.278; 104: 1min HRV, 0.877; 104: 5min HRV, 14.315; 105: HR, 70.0; 105: RR, 20.390; 105: SpO2, 96.508; 105: Perf, 1.329; 105: 1min HRV, 0.787; 106: HR, 70.0; 106: RR, 23.086; 106: SpO2, 96.103; 106: Perf, 1.450; 106: 1min HRV, 0.884; 107: HR, 70.0; 107: RR, 23.0; 107: SpO2, 96.305; 107: Perf, 1.023; 107: 1min HRV, 0.746; 108: HR, 70.0; 108: RR, 18.983; 108: SpO2, 96.288; 108: Perf, 1.068; 108: 1min HRV, 0.762; 109: HR, 70.0; 109: RR, 22.017; 109: SpO2, 96.517; 109: Perf, 0.975; 109: 1min HRV, 0.715; 109: 5min HRV, 0.781; 110: HR, 70.0; 110: RR, 17.712; 110: SpO2, 96.390; 110: Perf, 0.929; 110: 1min HRV, 0.772; 111: HR, 70.0; 111: RR, 21.914; 111: SpO2, 96.879; 111: Perf, 0.999; 111: 1min HRV, 0.665; 112: HR, 70.0; 112: RR, 21.915; 112: SpO2, 96.322; 112: Perf, 0.921; 112: 1min HRV, 0.640; 113: HR, 70.0; 113: RR, 22.638; 113: SpO2, 98.224; 113: Perf, 0.748; 113: 1min HRV, 0.715; 114: HR, 70.0; 114: RR, 19.017; 114: SpO2, 97.085; 114: Perf, 0.698; 114: 1min HRV, 0.565; 114: 5min HRV, 0.677; 115: HR, 70.0; 115: RR, 19.237; 115: SpO2, 97.475; 115: Perf, 0.734; 115: 1min HRV, 0.925; 116: HR, 70.0; 116: RR, 20.345; 116: SpO2, 98.155; 116: Perf, 0.717; 116: 1min HRV, 6.745; 117: HR, 70.0; 117: RR, 19.746; 117: SpO2, 95.98; 117: Perf, 0.707; 117: 1min HRV, 1.062; 118: HR, 70.0; 118: RR, 24.983; 118: SpO2, 96.436; 118: Perf, 0.771; 118: 1min HRV, 3.949; 119: HR, 70.0; 119: RR, 23.0; 119: SpO2, 97.328; 119: Perf, 0.813; 119: 1min HRV, 0.969; 119: 5min HRV, 3.700; 0: Age, 87; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 79.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 46.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient's advanced age and borderline hypotension along with elevated WBC and neutrophil counts, which raised my suspicion for infection and early sepsis. I questioned whether the vitals suggested organ dysfunction, especially since the diastolic blood pressure was low and the respiratory rate occasionally rose above 22 breaths/min. I also looked for signs of fever, which was mildly present. Finally, the combination of these factors (older age, high WBC, borderline hemodynamics, and elevated RR) was enough to conclude a high likelihood of sepsis risk.",
        "claims": [
            "The patient is of advanced age.",
            "The patient has borderline hypotension.",
            "The patient has elevated white blood cell (WBC) counts.",
            "The patient has elevated neutrophil counts.",
            "The elevated WBC and neutrophil counts raised suspicion for infection and early sepsis.",
            "The vitals suggested possible organ dysfunction.",
            "The diastolic blood pressure was low.",
            "The respiratory rate occasionally rose above 22 breaths/min.",
            "Signs of fever were mildly present.",
            "The combination of advanced age, high WBC, borderline hemodynamics, and elevated respiratory rate indicates a high likelihood of sepsis risk."
        ],
        "relevant_claims": [
            "The patient is of advanced age.",
            "The patient has borderline hypotension.",
            "The patient has elevated white blood cell (WBC) counts.",
            "The patient has elevated neutrophil counts.",
            "The elevated WBC and neutrophil counts raised suspicion for infection and early sepsis.",
            "The vitals suggested possible organ dysfunction.",
            "The diastolic blood pressure was low.",
            "The respiratory rate occasionally rose above 22 breaths/min.",
            "Signs of fever were mildly present.",
            "The combination of advanced age, high WBC, borderline hemodynamics, and elevated respiratory rate indicates a high likelihood of sepsis risk."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            1.0,
            0.8,
            0.9,
            0.7,
            0.3,
            0.7,
            0.3,
            0.8
        ],
        "alignment_category": [
            1,
            7,
            2,
            2,
            2,
            8,
            7,
            3,
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim refers to the patient being of \"advanced age,\" which suggests they are likely in the older age group. Although the exact age is not specified, the term \"advanced age\" generally aligns with the concept of increased age-related sepsis susceptibility described in this category. Therefore, while it strongly hints at the category of Elderly Susceptibility, the lack of precise age information reduces the alignment slightly from a perfect score.",
            "The claim of \"borderline hypotension\" suggests that the patient's blood pressure is low, which aligns with the category identifying hypotension as a sign of progression towards septic shock. Although the claim doesn't provide specific measurements to confirm the thresholds in this category, the concept of borderline hypotension closely relates to the early stages or potential risk factors of sepsis-associated hypotension. Therefore, the alignment is fairly strong but not complete without specific data.",
            "Elevated white blood cell counts are explicitly part of the SIRS criteria used to detect systemic inflammation, which can be indicative of early sepsis. The claim directly matches one of the specific indicators listed under the SIRS criteria, implying a perfect alignment with this category.",
            "Elevated neutrophil counts typically suggest an inflammatory or infectious process, closely related to the criteria used to determine SIRS positivity. While the claim does not explicitly mention WBC > 12,000/\u00b5L as stated in the SIRS criteria, elevated neutrophils are a component of the white blood cell count, which makes this category the most appropriate. The alignment is strong but not perfect, as the claim does not provide a direct SIRS value or other criteria from the list.",
            "Elevated WBC is explicitly part of the SIRS criteria, which are used to identify systemic inflammatory response potentially due to an infection or early sepsis. The mention of elevated neutrophil counts further supports the suspicion of an infectious process, making the alignment with SIRS criteria strong, though not perfect, as only one SIRS criterion is clearly met.",
            "The SOFA score is designed to track organ dysfunction, which aligns directly with the concept of potential organ dysfunction highlighted in the claim. However, the claim lacks specific details such as the exact measurements or changes in SOFA components, so while the category is correct, the alignment is not perfectly strong.",
            "The claim mentions \"low diastolic blood pressure,\" which implies potential blood pressure instability. Although the claim does not specify if the systolic blood pressure or mean arterial pressure (MAP) meet the criteria for sepsis-associated hypotension, the notion of low blood pressure relates to this category. The alignment is weak as specific criteria for SBP or MAP are not mentioned.",
            "The claim mentions a respiratory rate occasionally rising above 22 breaths/min, which aligns with one of the components of a high qSOFA score (respiratory rate \u2265 22/min). Although the claim doesn't specify if the other qSOFA criteria are met, the respiratory rate itself is a direct component of the qSOFA criteria, suggesting a noteworthy alignment.",
            "The claim mentions mild signs of fever, which is related to the temperature criterion of SIRS (>38\u00b0C). However, since the fever is only mildly present, it does not explicitly meet the threshold needed to fulfill the SIRS criteria, resulting in a low, indirect alignment.",
            "The claim mentions a high WBC and elevated respiratory rate, both of which are specific SIRS criteria. While advanced age and borderline hemodynamics play a role, they are less directly linked to SIRS criteria but enhance the assessment of systemic inflammation consistent with early sepsis. Therefore, the strongest alignment is with the SIRS category, and the combination of criteria somewhat supports a high likelihood of sepsis risk, but not all elements directly match SIRS, warranting a slight deduction in alignment rating."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "2: HR, 110.0; 2: RR, 20.0; 2: SpO2, 99.0; 2: SBP, 170.0; 2: DBP, 125.0; 2: MAP, 140.0; 2: Temp, 98.3; 7: Pain, 8.0; 23: POC, HCG, ISTAT QUALITATIVE: Negative; 23: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 35: SpO2, 96.875; 35: SBP, 166.0; 35: DBP, 133.0; 35: MAP, 144.0; 36: SpO2, 96.729; 36: Perf, 2.419; 36: SBP, 181.0; 36: DBP, 117.0; 36: MAP, 138.333; 37: SpO2, 96.793; 37: Perf, 3.050; 38: SpO2, 98.407; 38: Perf, 3.127; 39: SpO2, 97.810; 39: Perf, 3.470; 40: SpO2, 96.864; 40: Perf, 2.914; 41: SpO2, 97.305; 41: Perf, 2.716; 42: SpO2, 98.690; 42: Perf, 4.093; 43: SpO2, 99.0; 43: Perf, 4.271; 44: SpO2, 98.879; 44: Perf, 4.363; 45: SpO2, 98.898; 45: Perf, 3.121; 46: SpO2, 98.034; 46: Perf, 3.241; 47: SpO2, 98.345; 47: Perf, 5.429; 48: SpO2, 98.339; 48: Perf, 4.260; 49: SpO2, 98.121; 49: Perf, 5.469; 50: SpO2, 98.085; 50: Perf, 4.044; 51: SpO2, 98.441; 51: Perf, 3.807; 52: SpO2, 98.121; 52: Perf, 4.583; 53: SpO2, 99.086; 53: Perf, 2.823; 54: SpO2, 98.898; 54: Perf, 2.241; 55: SpO2, 98.831; 55: Perf, 2.983; 56: SpO2, 98.695; 56: Perf, 3.286; 57: SpO2, 98.0; 57: Perf, 4.375; 58: SpO2, 98.220; 58: Perf, 4.053; 59: SpO2, 97.793; 59: Perf, 4.217; 60: SpO2, 98.0; 60: Perf, 2.665; 61: SpO2, 98.712; 61: Perf, 2.182; 62: SpO2, 98.466; 62: Perf, 3.111; 63: SpO2, 98.475; 63: Perf, 2.669; 64: SpO2, 98.741; 64: Perf, 2.308; 65: SpO2, 99.0; 65: Perf, 2.785; 66: SpO2, 98.186; 66: Perf, 3.892; 67: ALT (SGPT), 79 U/L; 67: CHLORIDE, 103 mmol/L; 67: BILIRUBIN TOTAL, 0.4 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 148 mL/min/1.73 m2; 67: ALBUMIN, 4.2 g/dL; 67: CO2, 23 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 128 mL/min/1.73 m2; 67: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 67: CREATININE, 0.65 mg/dL; 67: SODIUM, 138 mmol/L; 67: PROTEIN TOTAL, 8.0 g/dL; 67: GLUCOSE, 130 mg/dL; 67: GLOBULIN, 3.8 g/dL; 67: CALCIUM, 9.5 mg/dL; 67: ANION GAP, 12 mmol/L; 67: CORRECTED CALCIUM, 9.3 mg/dL; 67: POTASSIUM, 4.3 mmol/L; 67: ALKALINE PHOSPHATASE, 109 U/L; 67: AST (SGOT), 48 U/L; 67: SpO2, 98.552; 67: Perf, 2.511; 68: SpO2, 98.458; 68: Perf, 2.268; 69: SpO2, 98.138; 69: Perf, 3.142; 70: WAM DIFTYP, AUTO; 70: LYMPHOCYTE % (AUTO DIFF), 31.8 %; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: RED BLOOD CELLS (RBC), 5.35 MIL/uL; 70: NEUTROPHIL % (AUTO DIFF), 57.8 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 11.8 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.0 pg; 70: PLATELET COUNT (PLT), 258 K/uL; 70: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 2.3 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 86.2 fL; 70: HEMATOCRIT (HCT), 46.1 %; 70: BASOPHIL % (AUTO DIFF), 0.4 %; 70: HEMOGLOBIN (HGB), 15.5 g/dL; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.97 K/uL; 70: SpO2, 98.983; 70: Perf, 4.796; 71: SpO2, 98.638; 71: Perf, 4.103; 72: SpO2, 97.898; 72: Perf, 5.212; 73: SpO2, 97.949; 73: Perf, 6.655; 74: SpO2, 97.810; 74: Perf, 6.88; 75: SpO2, 97.712; 75: Perf, 7.503; 76: SpO2, 98.017; 76: Perf, 5.833; 77: SpO2, 98.068; 77: Perf, 5.273; 78: SpO2, 98.153; 78: Perf, 3.641; 79: SpO2, 97.534; 79: Perf, 4.4; 80: SpO2, 97.203; 80: Perf, 4.165; 81: SpO2, 97.569; 81: Perf, 4.237; 82: SpO2, 98.390; 82: Perf, 2.841; 83: SpO2, 98.407; 83: Perf, 1.946; 84: SpO2, 97.845; 84: Perf, 3.521; 85: SpO2, 98.017; 85: Perf, 3.399; 86: SpO2, 97.828; 86: Perf, 5.287; 87: SpO2, 97.542; 87: Perf, 5.983; 88: SpO2, 97.492; 88: Perf, 6.082; 89: SpO2, 97.534; 89: Perf, 6.151; 90: SpO2, 98.0; 90: Perf, 6.157; 91: SpO2, 98.103; 91: Perf, 4.832; 92: SpO2, 97.847; 92: Perf, 5.332; 92: ACETAMINOPHEN, 325 MG PO TABS; 92: IBUPROFEN, 400 MG PO TABS; 93: SpO2, 97.712; 93: Perf, 5.169; 93: LR IV BOLUS -, 1000 ML; 94: SpO, 2: 99.414; 94: Perf, 1.990; 94: Pain, 10.0; 94: HYDROMORPHONE, 1 MG/ML INJ SYRG; 95: SpO, 2: 99.0; 95: Perf, 3.394; 96: SpO2, 98.983; 96: Perf, 2.202; 97: SpO2, 98.305; 97: Perf, 3.937; 98: SARS-COV-2 RNA, Not Detected; 98: SpO2, 97.949; 98: Perf, 5.096; 99: SpO2, 97.810; 99: Perf, 4.267; 100: SpO2, 97.847; 100: Perf, 3.105; 101: SpO2, 97.776; 101: Perf, 2.793; 102: SpO2, 97.797; 102: Perf, 3.051; 103: SpO2, 98.328; 103: Perf, 2.511; 104: SpO2, 97.932; 104: Perf, 2.896; 105: SpO2, 97.5; 105: Perf, 2.787; 106: SpO2, 97.017; 106: Perf, 3.046; 107: SpO2, 96.797; 107: Perf, 3.829; 108: SpO2, 96.328; 108: Perf, 4.211; 109: SpO2, 96.508; 109: Perf, 4.35; 110: SpO2, 96.441; 110: Perf, 4.361; 111: SpO2, 96.914; 111: Perf, 4.117; 112: SpO2, 96.949; 112: Perf, 4.180; 113: SpO2, 97.672; 113: Perf, 3.597; 114: SpO2, 97.136; 114: Perf, 3.844; 115: SpO2, 97.793; 115: Perf, 3.008; 116: SpO2, 98.729; 116: Perf, 1.443; 117: SpO2, 99.448; 117: Perf, 1.378; 118: SpO2, 99.356; 118: Perf, 1.376; 119: SpO2, 98.627; 119: Perf, 1.548; 0: Age, 19; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 170.0; 0: Triage DBP, 125.0; 0: Triage acuity, 3-Urgent; 0: CC, BLOOD IN URINE,ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I examined the patient\u2019s vital signs and laboratory results for signs of systemic infection and organ dysfunction. The temperature remained normal, the blood pressure was consistently high rather than low, and no dangerously abnormal laboratory values were evident. Although there was mild tachycardia and a slightly elevated white blood cell count, these findings alone did not strongly suggest evolving sepsis. Based on this information, I concluded the patient was not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I examined the patient\u2019s vital signs and laboratory results for signs of systemic infection and organ dysfunction.",
            "The patient's temperature remained normal.",
            "The patient's blood pressure was consistently high.",
            "No dangerously abnormal laboratory values were evident.",
            "The patient exhibited mild tachycardia.",
            "The patient had a slightly elevated white blood cell count.",
            "The findings of mild tachycardia and a slightly elevated white blood cell count did not strongly suggest evolving sepsis.",
            "Based on this information, I concluded the patient was not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's blood pressure was consistently high."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            6
        ],
        "alignment_reasonings": [
            "The claim about consistently high blood pressure does not directly align with any specific sepsis prediction criteria. Elevated shock index involves both heart rate and blood pressure, primarily focusing on haemodynamic instability, but high blood pressure alone does not fit this definition. Thus, the alignment is marginally related to this category due to the focus on blood pressure, but its relevance to sepsis prediction is weak."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "6: Pain, 0.0; 16: HR, 110.0; 16: RR, 13.0; 16: SpO2, 97.0; 16: SBP, 126.0; 16: DBP, 108.0; 16: MAP, 114.0; 16: Temp, 97.7; 35: HR, 106.5; 35: RR, 24.346; 35: 1min HRV, 16.264; 36: HR, 108.483; 36: RR, 22.741; 36: SpO2, 86.5; 36: 1min HRV, 9.079; 37: HR, 106.458; 37: RR, 21.780; 37: 1min HRV, 19.289; 37: 5min HRV, 15.922; 38: HR, 104.793; 38: RR, 19.517; 38: SpO2, 97.4; 38: 1min HRV, 28.309; 39: HR, 106.237; 39: RR, 19.627; 39: SpO2, 98.0; 39: 1min HRV, 15.942; 40: HR, 101.254; 40: RR, 21.559; 40: SpO2, 99.714; 40: 1min HRV, 13.774; 41: HR, 102.086; 41: RR, 19.293; 41: SpO2, 99.459; 41: 1min HRV, 13.604; 42: HR, 102.898; 42: RR, 22.898; 42: SpO2, 99.0; 42: 1min HRV, 19.309; 42: 5min HRV, 20.796; 43: HR, 104.172; 43: RR, 20.310; 43: SpO2, 98.5; 43: Perf, 0.09; 43: 1min HRV, 13.262; 44: HR, 102.559; 44: RR, 23.898; 44: SpO2, 100.0; 44: Perf, 0.09; 44: 1min HRV, 12.124; 45: HR, 105.845; 45: RR, 22.483; 45: SpO2, 86.25; 45: Perf, 0.09; 45: 1min HRV, 8.539; 46: HR, 107.763; 46: RR, 23.237; 46: 1min HRV, 70.170; 47: HR, 101.407; 47: RR, 21.119; 47: SpO2, 96.409; 47: 1min HRV, 15.426; 47: 5min HRV, 36.245; 48: HR, 100.207; 48: RR, 20.517; 48: SpO2, 100.0; 48: 1min HRV, 27.094; 49: HR, 98.237; 49: RR, 20.119; 49: SpO2, 99.0; 49: 1min HRV, 12.805; 50: HR, 97.948; 50: RR, 24.276; 50: SpO2, 98.773; 50: Perf, 0.08; 50: 1min HRV, 16.305; 51: HR, 99.068; 51: RR, 25.390; 51: SpO2, 98.275; 51: Perf, 0.085; 51: 1min HRV, 35.372; 52: HR, 104.593; 52: RR, 19.102; 52: SpO2, 96.632; 52: Perf, 0.09; 52: 1min HRV, 10.054; 52: 5min HRV, 26.196; 53: HR, 103.931; 53: RR, 22.5; 53: SpO2, 99.390; 53: 1min HRV, 12.152; 54: HR, 103.203; 54: RR, 19.814; 54: SpO2, 100.0; 54: 1min HRV, 11.907; 55: HR, 104.259; 55: RR, 20.207; 55: SpO2, 99.933; 55: 1min HRV, 7.388; 56: HR, 105.661; 56: RR, 19.475; 56: SpO2, 99.939; 56: 1min HRV, 13.360; 57: HR, 104.724; 57: RR, 22.966; 57: SpO2, 100.0; 57: 1min HRV, 12.334; 57: 5min HRV, 12.666; 57: SBP, 99.0; 57: DBP, 65.0; 57: MAP, 76.333; 58: HR, 102.525; 58: RR, 20.220; 58: SpO2, 100.0; 58: 1min HRV, 20.083; 59: HR, 98.328; 59: RR, 16.862; 59: SpO2, 99.545; 59: Perf, 0.100; 59: 1min HRV, 34.211; 60: HR, 100.034; 60: RR, 19.203; 60: SpO2, 100.0; 60: Perf, 0.1; 60: 1min HRV, 10.732; 61: POC PH (V) ISTAT, 7.55; 61: POC HCO3 (V) ISTAT, 26.0 mmol/L; 61: POC LACTATE ISTAT, 1.13 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC PO2 (V) ISTAT, 33 mmHg; 61: POC PCO2 (V) ISTAT, 30.0 mmHg; 61: POC TCO2 (V) ISTAT, 27 mmol/L; 61: POC BASE EXCESS ISTAT, 4 mmol/L; 61: HR, 97.661; 61: RR, 19.508; 61: SpO2, 90.267; 61: 1min HRV, 10.219; 62: HR, 95.644; 62: RR, 20.322; 62: SpO2, 98.0; 62: 1min HRV, 17.941; 62: 5min HRV, 25.552; 63: HR, 94.483; 63: RR, 22.017; 63: SpO2, 95.0; 63: 1min HRV, 19.813; 63: SBP, 109.0; 63: DBP, 65.0; 63: MAP, 79.667; 64: HR, 95.288; 64: RR, 21.695; 64: 1min HRV, 9.077; 65: HR, 94.259; 65: RR, 21.897; 65: SpO2, 100.0; 65: 1min HRV, 35.389; 66: HR, 94.712; 66: RR, 22.814; 66: 1min HRV, 12.444; 67: HR, 95.576; 67: RR, 19.407; 67: SpO2, 99.0; 67: 1min HRV, 13.691; 67: 5min HRV, 20.499; 68: HR, 102.983; 68: RR, 21.190; 68: SpO2, 93.333; 68: 1min HRV, 29.881; 69: HR, 105.983; 69: RR, 19.759; 69: 1min HRV, 19.558; 70: HR, 105.898; 70: RR, 21.119; 70: 1min HRV, 20.311; 71: HR, 103.864; 71: RR, 19.390; 71: 1min HRV, 28.157; 72: HR, 94.831; 72: RR, 18.729; 72: SpO2, 98.946; 72: 1min HRV, 32.574; 72: 5min HRV, 38.943; 73: HR, 91.241; 73: RR, 23.483; 73: SpO2, 96.877; 73: 1min HRV, 26.875; 74: HR, 92.763; 74: RR, 23.254; 74: SpO2, 98.773; 74: 1min HRV, 27.392; 74: NORMOSOL-R IV BOLUS -, 1000 ML; 75: HR:, 87.534; 75: RR, 21.103; 75: SpO2, 95.188; 75: 1min HRV, 30.984; 76: HR, 87.237; 76: RR, 19.102; 76: SpO2, 99.25; 76: 1min HRV, 33.549; 77: HR, 88.534; 77: RR, 21.690; 77: SpO2, 99.077; 77: 1min HRV, 31.958; 77: 5min HRV, 34.560; 78: HR, 87.881; 78: RR, 22.814; 78: SpO2, 99.179; 78: 1min HRV, 14.725; 78: SBP, 103.0; 78: DBP, 61.0; 78: MAP, 75.0; 79: HR, 85.525; 79: RR, 17.0; 79: SpO2, 99.125; 79: Perf, 0.16; 79: 1min HRV, 24.524; 80: HR, 87.586; 80: RR, 21.828; 80: SpO2, 98.233; 80: Perf, 0.16; 80: 1min HRV, 23.789; 81: HR, 88.966; 81: RR, 17.322; 81: SpO2, 95.346; 81: 1min HRV, 20.920; 82: 5min HRV, 23.024; 94: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 94: PROTEIN TOTAL, 6.3 g/dL; 94: SODIUM, 131 mmol/L; 94: MAGNESIUM, 2.0 mg/dL; 94: AST (SGOT), 20 U/L; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: CREATININE, 0.46 mg/dL; 94: POTASSIUM, 3.8 mmol/L; 94: ANION GAP, 10 mmol/L; 94: BILIRUBIN TOTAL, 1.0 mg/dL; 94: ALBUMIN, 3.2 g/dL; 94: GLUCOSE, 124 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 94: ALKALINE PHOSPHATASE, 71 U/L; 94: ALT (SGPT), 14 U/L; 94: CO2, 25 mmol/L; 94: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 94: CHLORIDE, 96 mmol/L; 94: GLOBULIN, 3.1 g/dL; 94: CALCIUM, 8.6 mg/dL; 104: SARS-COV-2 RNA, Not Detected; 113: TROPONIN I, <.017 ng/mL; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 110.0; 0: Triage RR, 13.0; 0: Triage SBP, 126.0; 0: Triage DBP, 108.0; 0: Triage acuity, 2-Emergent; 0: CC, GENERAL WEAKNESS,COUGH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first examined the vital signs for significant hypotension or prolonged tachycardia. Next, I looked at the laboratory results, particularly the normal lactate level, which does not suggest severe organ dysfunction. Finally, given the patient\u2019s relatively stable vitals and unremarkable labs, I concluded that they are not at high risk of developing sepsis in the next 12 hours.",
        "claims": [
            "The vital signs were first examined for significant hypotension or prolonged tachycardia.",
            "Laboratory results were also reviewed.",
            "The lactate level was found to be normal.",
            "A normal lactate level does not suggest severe organ dysfunction.",
            "The patient had relatively stable vital signs.",
            "The laboratory results were unremarkable.",
            "Based on these observations, it was concluded that the patient is not at high risk of developing sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "A normal lactate level does not suggest severe organ dysfunction."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            5
        ],
        "alignment_reasonings": [
            "The claim discusses lactate levels in context of organ dysfunction, which aligns with the category focusing on elevated serum lactate as an indicator of severe sepsis risk. The mention of normal lactate implies an absence of this risk, so the alignment is indirect but significant enough to rate moderately high."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "5: HR, 95.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 131.0; 5: DBP, 71.0; 5: MAP, 91.0; 5: Pain, 10.0; 5: Temp, 100.0; 7: Pain, 10.0; 15: SpO2, 97.914; 15: Perf, 3.922; 15: SBP, 135.0; 15: DBP, 78.0; 15: MAP, 97.0; 16: SpO2, 97.621; 16: Perf, 4.766; 16: SBP, 128.0; 16: DBP, 76.0; 16: MAP, 93.333; 17: SpO2, 98.0; 17: Perf, 4.448; 18: SpO2, 97.431; 18: Perf, 4.878; 19: SpO2, 97.0; 19: Perf, 4.727; 20: SpO2, 97.508; 20: Perf, 4.079; 21: SpO2, 97.328; 21: Perf, 4.229; 22: SpO2, 97.831; 22: Perf, 3.967; 23: SpO2, 98.293; 23: Perf, 2.087; 24: SpO2, 97.729; 24: Perf, 3.178; 25: SpO2, 97.458; 25: Perf, 3.914; 26: SpO2, 97.759; 26: Perf, 3.689; 27: SpO2, 97.814; 27: Perf, 3.198; 28: SpO2, 97.345; 28: Perf, 3.3; 29: SpO2, 97.068; 29: Perf, 3.367; 30: SpO2, 97.0; 30: Perf, 3.384; 31: SpO2, 97.241; 31: Perf, 3.321; 32: SpO2, 97.932; 32: Perf, 3.390; 33: SpO2, 97.414; 33: Perf, 3.948; 34: SpO2, 97.119; 34: Perf, 4.267; 35: SpO2, 97.322; 35: Perf, 3.937; 36: SpO2, 97.569; 36: Perf, 3.674; 37: SpO2, 97.288; 37: Perf, 3.535; 38: SpO2, 97.845; 38: Perf, 3.626; 39: SpO2, 97.545; 39: Perf, 3.52; 40: SpO2, 97.805; 41: SpO2, 97.390; 41: Perf, 2.040; 42: SpO2, 97.542; 42: Perf, 3.324; 43: SpO2, 97.241; 43: Perf, 2.687; 44: SpO2, 97.051; 44: Perf, 2.293; 45: SpO2, 97.017; 45: Perf, 2.477; 46: SpO2, 97.0; 46: Perf, 2.558; 47: SpO2, 97.237; 47: Perf, 2.516; 48: SpO2, 97.0; 48: Perf, 2.645; 49: SpO2, 97.542; 49: Perf, 2.349; 50: SpO2, 97.328; 50: Perf, 2.295; 51: SpO2, 97.492; 51: Perf, 2.235; 52: SpO2, 97.814; 52: Perf, 2.463; 53: SpO2, 97.517; 53: Perf, 3.578; 54: SpO2, 97.153; 54: Perf, 3.237; 55: SpO2, 97.121; 55: Perf, 3.452; 56: SpO2, 97.017; 56: Perf, 4.274; 57: SpO2, 98.085; 57: Perf, 3.315; 58: SpO2, 97.379; 58: Perf, 3.838; 59: SpO2, 96.966; 59: Perf, 4.163; 60: SpO2, 96.759; 60: Perf, 3.612; 61: SpO2, 96.949; 61: Perf, 2.512; 62: SpO2, 97.0; 62: Perf, 2.677; 63: SpO2, 96.915; 63: Perf, 2.779; 64: SpO2, 97.305; 64: Perf, 2.938; 65: SpO2, 97.172; 65: Perf, 3.611; 66: SpO2, 98.932; 66: Perf, 2.547; 67: SpO2, 98.407; 67: Perf, 2.685; 68: SpO2, 97.914; 68: Perf, 2.764; 69: SpO2, 97.915; 69: Perf, 3.33; 70: SpO2, 97.862; 70: Perf, 2.763; 71: SpO2, 97.966; 71: Perf, 2.603; 72: SpO2, 97.759; 72: Perf, 3.783; 73: SpO2, 97.424; 73: Perf, 4.199; 74: SpO2, 96.746; 74: Perf, 3.387; 75: SpO2, 96.707; 75: Perf, 3.408; 76: SpO2, 96.780; 76: Perf, 3.828; 77: SpO2, 97.138; 77: Perf, 4.055; 78: SpO2, 97.271; 78: Perf, 4.364; 79: SpO2, 97.797; 79: Perf, 4.315; 80: SpO2, 98.0; 80: Perf, 4.72; 81: SpO2, 98.068; 81: Perf, 3.370; 82: SpO2, 97.914; 82: Perf, 4.015; 83: SpO2, 97.492; 83: Perf, 3.757; 84: SpO2, 97.763; 84: Perf, 3.819; 85: SpO2, 97.897; 85: Perf, 3.276; 86: SpO2, 97.864; 86: Perf, 3.438; 87: SpO2, 97.638; 87: Perf, 4.142; 88: SpO2, 97.339; 88: Perf, 3.754; 89: POC, HCG, ISTAT QUALITATIVE: Negative; 89: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 89: SpO2, 97.356; 89: Perf, 3.648; 90: SpO2, 97.759; 90: Perf, 2.604; 91: SpO2, 97.831; 91: Perf, 3.684; 91: LR IV BOLUS -, 1000 ML; 92: SpO, 2: 97.345; 92: Perf, 3.88; 93: SpO2, 97.288; 93: Perf, 3.398; 94: SpO2, 97.492; 94: Perf, 2.554; 95: SpO2, 97.259; 95: Perf, 3.043; 96: SpO2, 97.797; 96: Perf, 2.942; 97: SpO2, 97.793; 97: Perf, 2.923; 98: SpO2, 98.153; 98: Perf, 4.124; 99: SpO2, 98.190; 99: Perf, 4.331; 100: SpO2, 98.542; 100: Perf, 3.513; 101: SpO2, 98.203; 101: Perf, 3.262; 102: SpO2, 98.345; 102: Perf, 3.276; 103: SpO2, 98.305; 103: Perf, 3.638; 104: SpO2, 98.224; 104: Perf, 3.374; 105: SpO2, 98.0; 105: Perf, 3.113; 106: SpO2, 98.0; 106: Perf, 3.541; 107: SpO2, 98.0; 107: Perf, 3.784; 108: SpO2, 98.322; 108: Perf, 3.647; 109: SpO2, 98.293; 109: Perf, 2.863; 110: SpO2, 98.136; 110: Perf, 3.490; 111: WAM DIFTYP, AUTO; 111: PLATELET COUNT (PLT), 335 K/uL; 111: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 111: RED BLOOD CELLS (RBC), 4.56 MIL/uL; 111: HEMOGLOBIN (HGB), 12.0 g/dL; 111: EOSINOPHIL % (AUTO DIFF), 0.0 %; 111: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.62 K/uL; 111: MONOCYTE ABSOLUTE (AUTO DIFF), 1.12 K/uL; 111: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 111: NEUTROPHIL % (AUTO DIFF), 79.7 %; 111: BASOPHIL % (AUTO DIFF), 0.2 %; 111: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 111: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 111: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 111: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 111: RED CELL DISTRIBUTION WIDTH (RDW), 15.5 %; 111: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 111: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.3 pg; 111: MONOCYTE % (AUTO DIFF), 8.4 %; 111: HEMATOCRIT (HCT), 37.5 %; 111: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 111: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 111: MEAN CORPUSCULAR VOLUME (MCV), 82.2 fL; 111: NRBC PERCENT (HEMATOLOGY), 0.0 %; 111: SpO2, 98.034; 111: Perf, 3.432; 112: SpO2, 97.983; 112: Perf, 3.777; 113: SpO2, 98.0; 113: Perf, 4.029; 114: SpO2, 98.0; 114: Perf, 3.815; 115: SpO2, 98.034; 115: Perf, 3.668; 116: SpO2, 98.0; 116: Perf, 3.089; 117: SpO2, 98.121; 117: Perf, 3.028; 118: SpO2, 97.678; 118: Perf, 3.533; 119: SpO2, 97.086; 119: Perf, 3.043; 0: Age, 34; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 37.8; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 71.0; 0: Triage acuity, 5-Non-Urgent; 0: CC, PAIN TOOTH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the patient\u2019s vital signs, laboratory results, and clinical presentation to assess for signs of severe infection or organ dysfunction. While there is a borderline elevated temperature and a mildly elevated white blood cell count, the blood pressure and respiratory rate remain within stable ranges, and there are no clear indicators of serious systemic compromise. These findings make an imminent sepsis diagnosis less likely within the next 12 hours.",
        "claims": [
            "I reviewed the patient\u2019s vital signs, laboratory results, and clinical presentation.",
            "I assessed the patient for signs of severe infection or organ dysfunction.",
            "The patient has a borderline elevated temperature.",
            "The patient has a mildly elevated white blood cell count.",
            "The blood pressure remains within a stable range.",
            "The respiratory rate remains within a stable range.",
            "There are no clear indicators of serious systemic compromise.",
            "These findings suggest that an imminent sepsis diagnosis is less likely within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has a borderline elevated temperature.",
            "There are no clear indicators of serious systemic compromise."
        ],
        "alignment_scores": [
            0.3,
            0.2
        ],
        "alignment_category": [
            2,
            4
        ],
        "alignment_reasonings": [
            "A borderline elevated temperature suggests potential relevance to systemic inflammation, which falls under SIRS criteria. However, the term \"borderline\" implies the temperature may not meet the exact threshold (>38\u00b0C) for SIRS positivity, resulting in a weak alignment.",
            "The claim suggests the absence of clear indicators of serious systemic compromise. An Elevated NEWS Score, which predicts clinical deterioration and sepsis, requires concrete signs of compromise to be relevant. Since the claim mentions a lack of such indicators, there is a very low alignment with categories predicting imminent deterioration, such as Elevated NEWS Score. However, some indirect relevance exists as the lack of clear compromise slightly touches upon the criterion, justifying a minimal alignment rating."
        ],
        "final_alignment_score": 0.25,
        "accuracy": 1
    },
    {
        "input": "7: HR, 117.0; 7: RR, 21.0; 7: SpO2, 99.0; 7: SBP, 143.0; 7: DBP, 92.0; 7: MAP, 109.0; 7: Pain, 1.0; 7: Temp, 98.4; 25: POC, HCG, ISTAT QUALITATIVE: Positive; 25: POC, BHCG, ISTAT QUANTITATIVE: >2000.0 IU/L; 35: WAM DIFTYP, AUTO; 35: MEAN CORPUSCULAR VOLUME (MCV), 82.4 fL; 35: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 35: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 35: MONOCYTE ABSOLUTE (AUTO DIFF), 0.73 K/uL; 35: PLATELET COUNT (PLT), 229 K/uL; 35: RED BLOOD CELLS (RBC), 5.22 MIL/uL; 35: MONOCYTE % (AUTO DIFF), 9.4 %; 35: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.7 pg; 35: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 35: EOSINOPHIL % (AUTO DIFF), 0.4 %; 35: HEMATOCRIT (HCT), 43.0 %; 35: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 35: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 35: LYMPHOCYTE % (AUTO DIFF), 25.2 %; 35: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 35: HEMOGLOBIN (HGB), 15.0 g/dL; 35: WHITE BLOOD CELLS (WBC), 7.8 K/uL; 35: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.96 K/uL; 35: BASOPHIL % (AUTO DIFF), 0.3 %; 35: NRBC PERCENT (HEMATOLOGY), 0.0 %; 35: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.02 K/uL; 35: NEUTROPHIL % (AUTO DIFF), 64.3 %; 35: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.9 g/dL; 36: SpO2, 99.333; 37: SpO2, 99.458; 37: Perf, 1.035; 38: SpO2, 99.153; 38: Perf, 0.986; 39: SpO2, 99.0; 39: Perf, 1.041; 40: SpO2, 99.085; 40: Perf, 0.993; 41: SpO2, 99.517; 41: Perf, 0.938; 42: SpO2, 99.051; 42: Perf, 0.87; 43: SpO2, 99.0; 43: Perf, 1.305; 44: SpO2, 98.879; 44: Perf, 2.141; 45: SpO2, 98.746; 45: Perf, 1.711; 46: SpO2, 98.586; 46: Perf, 1.433; 47: SpO2, 98.932; 47: Perf, 1.495; 48: SpO2, 99.0; 48: Perf, 1.245; 49: SpO2, 99.0; 49: Perf, 1.705; 50: SpO2, 99.0; 50: Perf, 1.848; 51: SpO2, 99.310; 51: Perf, 1.121; 52: SpO2, 99.458; 52: Perf, 0.928; 53: SpO2, 99.864; 53: Perf, 0.844; 53: LR IV BOLUS -, 1000 ML; 54: SpO, 2: 99.5; 54: Perf, 0.705; 55: SpO2, 99.593; 55: Perf, 0.620; 56: SpO2, 100.0; 56: Perf, 0.649; 57: SpO2, 99.237; 57: Perf, 0.774; 58: SpO2, 99.203; 58: Perf, 0.742; 59: SpO2, 100.0; 59: Perf, 0.723; 60: SpO2, 99.458; 60: Perf, 0.647; 61: SpO2, 100.0; 61: Perf, 0.638; 62: GLUCOSE, URINE (UA): Negative; 62: SPECIFIC GRAVITY, URINE (UA): 1.028; 62: BLOOD, URINE (UA): Negative; 62: NITRITE, URINE (UA): Negative; 62: PH, URINE (UA): 6.0; 62: SpO2, 99.288; 62: Perf, 0.617; 63: SpO2, 99.931; 63: Perf, 0.602; 64: SpO2, 99.759; 64: Perf, 0.59; 65: INR, 1.3; 65: PART. THROMBOPLASTIN TIME, 29.9 seconds; 65: PROTHROMBIN TIME, 16.4 seconds; 65: SpO2, 99.229; 65: Perf, 0.584; 66: POTASSIUM, 3.2 mmol/L; 66: ALKALINE PHOSPHATASE, 165 U/L; 66: AST (SGOT), 103 U/L; 66: ALT (SGPT), 222 U/L; 66: CREATININE, 0.47 mg/dL; 66: GLOBULIN, 3.6 g/dL; 66: SODIUM, 135 mmol/L; 66: EGFR REFIT WITHOUT RACE (2021), 123 mL/min/1.73 m2; 66: CALCIUM, 9.8 mg/dL; 66: GLUCOSE, 104 mg/dL; 66: CORRECTED CALCIUM, 9.5 mg/dL; 66: ANION GAP, 15 mmol/L; 66: BILIRUBIN TOTAL, 1.0 mg/dL; 66: PROTEIN TOTAL, 8.0 g/dL; 66: LIPASE, 66 U/L; 66: CO2, 23 mmol/L; 66: ALBUMIN, 4.4 g/dL; 66: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 142 mL/min/1.73 m2; 66: CHLORIDE, 97 mmol/L; 66: SpO2, 100.0; 66: Perf, 0.583; 67: SpO2, 100.0; 67: Perf, 0.564; 68: SpO2, 100.0; 68: Perf, 0.563; 69: SpO2, 100.0; 69: Perf, 0.597; 70: SpO2, 99.881; 70: Perf, 0.587; 71: SpO2, 99.897; 71: Perf, 0.568; 72: SpO2, 100.0; 72: Perf, 0.541; 73: SpO2, 99.931; 73: Perf, 0.524; 74: SpO2, 100.0; 74: Perf, 0.507; 75: SpO2, 100.0; 75: Perf, 0.523; 76: SARS-COV-2 RNA, Not Detected; 76: SpO2, 100.0; 76: Perf, 0.531; 77: SpO2, 100.0; 77: Perf, 0.511; 78: SpO2, 100.0; 78: Perf, 0.512; 79: SpO2, 100.0; 79: Perf, 0.500; 80: SpO2, 100.0; 80: Perf, 0.504; 81: SpO2, 99.793; 81: Perf, 0.511; 82: SpO2, 99.271; 82: Perf, 0.52; 83: SpO2, 99.931; 83: Perf, 0.522; 84: SpO2, 100.0; 84: Perf, 0.553; 85: ANTIBODY SCREEN 3, NEG; 85: ABO/RH (AUTOMATION), O Positive; 85: BLOOD TYPE VERIFICATION-AUTOMATION, O Positive; 85: SpO2, 100.0; 85: Perf, 0.55; 86: SpO2, 99.914; 86: Perf, 0.55; 87: SpO2, 99.220; 87: Perf, 0.55; 88: SpO2, 100.0; 88: Perf, 0.524; 89: SpO2, 100.0; 89: Perf, 0.529; 90: SpO2, 100.0; 90: Perf, 0.527; 91: SpO2, 100.0; 91: Perf, 0.525; 92: SpO2, 100.0; 92: Perf, 0.54; 93: SpO2, 99.8; 93: Perf, 0.534; 94: SpO2, 100.0; 94: Perf, 0.528; 95: SpO2, 99.845; 95: Perf, 0.547; 96: SpO2, 100.0; 96: Perf, 0.53; 97: SpO2, 99.949; 97: Perf, 0.53; 98: SpO2, 99.842; 98: Perf, 0.53; 99: SpO2, 99.881; 99: Perf, 0.53; 100: SpO2, 99.931; 100: Perf, 0.53; 101: SpO2, 99.982; 101: Perf, 0.538; 102: SpO2, 100.0; 102: Perf, 0.539; 103: SpO2, 100.0; 103: Perf, 0.56; 104: SpO2, 100.0; 104: Perf, 0.575; 105: SpO2, 99.911; 105: Perf, 0.562; 106: SpO2, 98.538; 106: Perf, 0.56; 107: SpO2, 99.288; 107: Perf, 0.552; 108: SpO2, 99.707; 108: Perf, 0.559; 109: SpO2, 99.864; 109: Perf, 0.571; 110: SpO2, 99.931; 110: Perf, 0.58; 111: SpO2, 100.0; 111: Perf, 0.584; 112: SpO2, 100.0; 112: Perf, 0.586; 112: DOXYLAMINE-PYRIDOXINE (VIT B, 6) 10-10 MG PO TBEC; 112: ZZZ, IMS TEMPLATE; 113: SpO2, 100.0; 113: Perf, 0.649; 114: SpO2, 100.0; 114: Perf, 0.693; 115: SpO2, 100.0; 115: Perf, 0.658; 116: SpO2, 100.0; 116: Perf, 0.625; 0: Age, 41; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.9; 0: Triage HR, 117.0; 0: Triage RR, 21.0; 0: Triage SBP, 143.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the patient\u2019s vital signs and laboratory results for indications of infection and organ dysfunction. Although the heart rate is elevated, other vital signs remain relatively stable, and the labs do not strongly suggest sepsis. Additionally, the blood pressure, oxygen saturation, and white blood cell count appear normal. As a result, there is no compelling evidence that this patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I reviewed the patient\u2019s vital signs and laboratory results.",
            "I looked for indications of infection and organ dysfunction.",
            "The heart rate is elevated.",
            "Other vital signs remain relatively stable.",
            "The laboratory results do not strongly suggest sepsis.",
            "The blood pressure appears normal.",
            "The oxygen saturation appears normal.",
            "The white blood cell count appears normal.",
            "There is no compelling evidence that this patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is elevated.",
            "The laboratory results do not strongly suggest sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.2
        ],
        "alignment_category": [
            2,
            5
        ],
        "alignment_reasonings": [
            "An elevated heart rate is one of the SIRS criteria (heart rate >90 bpm), which identifies systemic inflammation consistent with early sepsis. However, without additional context confirming the heart rate exceeds 90 bpm or other criteria are present, the alignment is not perfect but remains strong.",
            "The claim indicates that laboratory results do not strongly suggest sepsis, implying an absence of expected findable abnormalities like elevated serum lactate, often used to flag sepsis. The alignment is weak because serum lactate is just one laboratory measure, but it's a significant indicator in sepsis assessments. However, without explicit data, the claim only hints at a negative result, limiting the alignment strength."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "23: HR, 110.0; 23: RR, 18.0; 23: SpO2, 99.0; 23: SBP, 108.0; 23: DBP, 51.0; 23: MAP, 70.0; 23: Pain, 0.0; 23: Temp, 100.6; 51: HR, 102.542; 51: RR, 18.780; 51: 1min HRV, 30.357; 52: HR, 101.707; 52: RR, 20.155; 52: 1min HRV, 3.753; 53: HR, 104.932; 53: RR, 20.983; 53: SpO2, 98.0; 53: 1min HRV, 30.198; 53: 5min HRV, 25.872; 54: HR, 109.966; 54: RR, 22.707; 54: 1min HRV, 9.378; 55: HR, 108.271; 55: RR, 19.339; 55: SpO2, 98.278; 55: 1min HRV, 22.000; 56: HR, 107.345; 56: RR, 19.362; 56: SpO2, 98.15; 56: 1min HRV, 31.490; 57: HR, 105.881; 57: RR, 17.458; 57: SpO2, 98.0; 57: 1min HRV, 14.197; 58: HR, 102.847; 58: RR, 19.966; 58: 1min HRV, 8.543; 58: 5min HRV, 22.600; 59: HR, 107.431; 59: RR, 19.397; 59: SpO2, 81.0; 59: 1min HRV, 20.253; 60: HR, 106.288; 60: RR, 18.780; 60: 1min HRV, 10.695; 61: HR, 107.103; 61: RR, 19.241; 61: 1min HRV, 14.181; 62: HR, 107.458; 62: RR, 17.695; 62: SpO2, 95.207; 62: 1min HRV, 9.273; 63: HR, 110.203; 63: RR, 19.390; 63: SpO2, 83.444; 63: 1min HRV, 26.656; 63: 5min HRV, 18.861; 64: HR, 106.690; 64: RR, 16.328; 64: SpO2, 92.0; 64: 1min HRV, 10.083; 64: SBP, 119.0; 64: DBP, 58.0; 64: MAP, 78.333; 65: HR, 104.593; 65: RR, 17.508; 65: 1min HRV, 3.740; 66: HR, 102.121; 66: RR, 19.707; 66: SpO2, 99.0; 66: 1min HRV, 7.077; 67: HR, 99.220; 67: RR, 19.254; 67: 1min HRV, 34.203; 68: HR, 97.288; 68: RR, 19.0; 68: 1min HRV, 3.403; 68: 5min HRV, 25.038; 69: HR, 98.310; 69: RR, 18.966; 69: SpO2, 97.4; 69: Perf, 0.146; 69: 1min HRV, 34.288; 70: HR, 96.864; 70: RR, 19.797; 70: SpO2, 99.0; 70: Perf, 0.18; 70: 1min HRV, 5.437; 71: HR, 97.207; 71: RR, 19.414; 71: SpO2, 98.846; 71: Perf, 0.180; 71: 1min HRV, 7.924; 72: HR, 99.136; 72: RR, 19.864; 72: SpO2, 99.492; 72: Perf, 0.511; 72: 1min HRV, 9.633; 73: HR, 101.627; 73: RR, 19.186; 73: SpO2, 99.791; 73: Perf, 0.436; 73: 1min HRV, 49.909; 73: 5min HRV, 29.921; 74: HR, 100.759; 74: RR, 18.672; 74: SpO2, 100.0; 74: Perf, 0.183; 74: 1min HRV, 20.317; 75: HR, 99.136; 75: RR, 16.932; 75: 1min HRV, 28.707; 76: HR, 98.966; 76: RR, 18.862; 76: 1min HRV, 35.558; 77: HR, 96.966; 77: RR, 18.458; 77: SpO2, 100.0; 77: Perf, 0.1; 77: 1min HRV, 10.755; 78: HR, 96.458; 78: RR, 19.746; 78: 1min HRV, 4.215; 78: 5min HRV, 25.348; 79: HR, 96.172; 79: RR, 19.155; 79: SpO2, 100.0; 79: Perf, 0.21; 79: 1min HRV, 25.924; 80: HR, 95.610; 80: RR, 19.525; 80: SpO2, 100.0; 80: Perf, 0.191; 80: 1min HRV, 10.023; 81: HR, 95.828; 81: RR, 19.931; 81: SpO2, 100.0; 81: Perf, 0.198; 81: 1min HRV, 25.357; 82: HR, 96.017; 82: RR, 20.576; 82: SpO2, 100.0; 82: Perf, 0.298; 82: 1min HRV, 8.397; 83: HR, 97.186; 83: RR, 19.932; 83: SpO2, 99.508; 83: Perf, 0.428; 83: 1min HRV, 9.429; 83: 5min HRV, 18.159; 84: HR, 98.138; 84: RR, 20.948; 84: SpO2, 99.156; 84: Perf, 0.339; 84: 1min HRV, 37.668; 85: HR, 96.661; 85: RR, 18.644; 85: SpO2, 100.0; 85: Perf, 0.201; 85: 1min HRV, 25.358; 86: HR, 96.310; 86: RR, 18.603; 86: SpO2, 100.0; 86: Perf, 0.254; 86: 1min HRV, 34.768; 87: HR, 97.373; 87: RR, 19.288; 87: SpO2, 100.0; 87: Perf, 0.271; 87: 1min HRV, 25.799; 88: HR, 98.259; 88: RR, 21.103; 88: SpO2, 99.469; 88: Perf, 0.433; 88: 1min HRV, 28.125; 88: 5min HRV, 31.007; 89: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 90: NS IV BOLUS -, 30 ML/KG; 91: POC PH (V) ISTAT, 7.44; 91: POC PCO2 (V) ISTAT, 47.9 mmHg; 91: POC O2 SATURATION ISTAT VENOUS, 65 %; 91: POC HCO3 (V) ISTAT, 32.5 mmol/L; 91: POC TCO2 (V) ISTAT, 34 mmol/L; 91: POC PO2 (V) ISTAT, 33 mmHg; 91: POC BASE EXCESS ISTAT, 8 mmol/L; 91: POC LACTATE ISTAT, 0.72 mmol/L; 93: HR, 97.0; 93: RR, 19.0; 93: SpO2, 100.0; 93: SBP, 88.0; 93: DBP, 48.0; 93: MAP, 61.333; 95: WAM DIFTYP, AUTO; 95: HEMOGLOBIN (HGB), 11.5 g/dL; 95: WHITE BLOOD CELLS (WBC), 28.8 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.0 %; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.44 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 89.3 fL; 95: BASOPHIL % (AUTO DIFF), 0.3 %; 95: NRBC PERCENT (HEMATOLOGY), 0.0 %; 95: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 27.13 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.44 K/uL; 95: HEMATOCRIT (HCT), 35.7 %; 95: LYMPHOCYTE % (AUTO DIFF), 1.5 %; 95: RED BLOOD CELLS (RBC), 4.00 MIL/uL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 95: MONOCYTE % (AUTO DIFF), 2.6 %; 95: NEUTROPHIL % (AUTO DIFF), 94.1 %; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 95: PLATELET COUNT (PLT), 255 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.8 pg; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.2 g/dL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.75 K/uL; 104: HR, 92.0; 104: RR, 19.0; 104: SpO2, 99.0; 104: SBP, 90.0; 104: DBP, 41.0; 104: MAP, 57.333; 113: PART. THROMBOPLASTIN TIME, 37.1 seconds; 116: INR, 1.1; 116: PROTHROMBIN TIME, 14.2 seconds; 118: HR, 92.0; 118: RR, 13.0; 118: SpO2, 100.0; 118: SBP, 106.0; 118: DBP, 82.0; 118: MAP, 90.0; 0: Age, 69; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 108.0; 0: Triage DBP, 51.0; 0: Triage acuity, 3-Urgent; 0: CC, ACUTE NEUROLOGICAL PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient\u2019s elevated WBC count and fever, which raise suspicion of an infection. Then, I recognized the episodes of hypotension (SBP < 90 mmHg) alongside persistent tachycardia as an indication of possible organ perfusion compromise. Moreover, the vital signs over time (including temperature and heart rate) point to an ongoing inflammatory or infectious process. Taken together, these findings suggest a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient has an elevated WBC count.",
            "An elevated WBC count raises suspicion of an infection.",
            "The patient has a fever.",
            "Episodes of hypotension are present, with systolic blood pressure (SBP) less than 90 mmHg.",
            "Hypotension alongside persistent tachycardia indicates possible organ perfusion compromise.",
            "The patient's vital signs have been monitored over time.",
            "The vital signs include temperature and heart rate.",
            "The vital signs point to an ongoing inflammatory or infectious process.",
            "The combination of these findings suggests a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated WBC count.",
            "An elevated WBC count raises suspicion of an infection.",
            "The patient has a fever.",
            "Episodes of hypotension are present, with systolic blood pressure (SBP) less than 90 mmHg.",
            "Hypotension alongside persistent tachycardia indicates possible organ perfusion compromise.",
            "The vital signs point to an ongoing inflammatory or infectious process.",
            "The combination of these findings suggests a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            1.0,
            1.0,
            0.5,
            1.0,
            0.8,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            7,
            6,
            2,
            4
        ],
        "alignment_reasonings": [
            "An elevated white blood cell (WBC) count is explicitly one of the criteria listed under SIRS Positivity, which identifies systemic inflammation consistent with early sepsis. This directly aligns with the claim, leading to a perfect alignment rating.",
            "The claim highlights an elevated white blood cell (WBC) count, which is explicitly part of the SIRS criteria. These criteria are used to identify systemic inflammation consistent with early sepsis, aligning perfectly with the expert category.",
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis.",
            "The claim directly references hypotension, specifically noting systolic blood pressure (SBP) less than 90 mmHg. This is explicitly described in the sepsis-associated hypotension category, indicating a strong predictor of progression toward septic shock, which perfectly aligns with the category description.",
            "The claim discusses hypotension combined with persistent tachycardia, both of which are components of the shock index, emphasizing hemodynamic instability. While it does not explicitly refer to the shock index value, the description aligns well with this category, as both hypotension and tachycardia together suggest haemodynamic instability associated with severe sepsis risk.",
            "The claim mentions \"vital signs\" suggesting an \"inflammatory or infectious process,\" which aligns with the SIRS criteria that involve evaluating vital signs like temperature, heart rate, and respiratory rate for signs of systemic inflammation. While the exact criteria are not detailed, the concept of assessing vital signs to identify systemic inflammation is moderately aligned with the SIRS criteria.",
            "The claim vaguely indicates a high risk of sepsis, which could align with having an elevated NEWS score, as it predicts imminent clinical deterioration. However, there are no specific findings or vitals data mentioned that directly match any expert category, so the alignment is weak and indirect."
        ],
        "final_alignment_score": 0.7571428571428571,
        "accuracy": 1
    },
    {
        "input": "6: POC PH (V) ISTAT, 7.40; 6: POC LACTATE ISTAT, 0.71 mmol/L; 6: POC TCO2 (V) ISTAT, 19 mmol/L; 6: POC BASE EXCESS ISTAT, -7 mmol/L; 6: POC O2 SATURATION ISTAT VENOUS, 60 %; 6: POC PCO2 (V) ISTAT, 29.3 mmHg; 6: POC PO2 (V) ISTAT, 31 mmHg; 6: POC HCO3 (V) ISTAT, 18.0 mmol/L; 6: HR, 121.914; 6: RR, 17.690; 6: SpO2, 95.375; 6: 1min HRV, 1.823; 7: HR, 120.917; 7: RR, 20.717; 7: SpO2, 92.481; 7: 1min HRV, 6.958; 7: 5min HRV, 5.598; 8: HR, 119.483; 8: RR, 17.655; 8: SpO2, 96.975; 8: 1min HRV, 9.738; 9: HR, 122.0; 9: RR, 16.345; 9: SpO2, 96.294; 9: 1min HRV, 8.179; 10: HR, 120.525; 10: RR, 18.475; 10: SpO2, 88.769; 10: 1min HRV, 3.283; 10: LR IV BOLUS -, 1000 ML; 11: HR:, 119.448; 11: RR, 17.914; 11: SpO2, 89.429; 11: 1min HRV, 23.147; 11: ACETAMINOPHEN, 500 MG PO TABS; 12: HR:, 120.085; 12: RR, 14.051; 12: SpO2, 97.771; 12: 1min HRV, 7.207; 12: 5min HRV, 13.143; 12: SBP, 173.0; 12: DBP, 62.0; 12: MAP, 99.0; 13: HR, 120.966; 13: RR, 13.169; 13: SpO2, 96.971; 13: Perf, 0.165; 13: 1min HRV, 10.376; 13: Pain, 0.0; 13: Temp, 102.4; 14: HR, 120.879; 14: RR, 16.983; 14: SpO2, 98.2; 14: Perf, 0.16; 14: 1min HRV, 14.064; 15: HR, 122.356; 15: RR, 17.169; 15: SpO2, 95.0; 15: 1min HRV, 15.639; 16: HR, 122.847; 16: RR, 19.034; 16: SpO2, 98.741; 16: 1min HRV, 15.173; 17: HR, 123.085; 17: RR, 18.102; 17: 1min HRV, 11.870; 17: 5min HRV, 13.939; 18: HR, 122.052; 18: RR, 16.379; 18: SpO2, 92.308; 18: 1min HRV, 11.822; 18: SBP, 173.0; 18: DBP, 62.0; 18: MAP, 99.0; 19: HR, 121.915; 19: RR, 15.644; 19: 1min HRV, 9.792; 20: HR, 121.690; 20: RR, 15.793; 20: 1min HRV, 10.705; 21: HR, 120.695; 21: RR, 15.864; 21: SpO2, 85.457; 21: 1min HRV, 11.401; 22: HR, 121.845; 22: RR, 17.259; 22: SpO2, 94.048; 22: 1min HRV, 14.298; 22: 5min HRV, 11.833; 23: HR, 126.576; 23: RR, 18.373; 23: SpO2, 99.75; 23: 1min HRV, 11.039; 24: HR, 122.508; 24: RR, 15.559; 24: SpO2, 98.0; 24: 1min HRV, 6.847; 25: HR, 120.086; 25: RR, 19.069; 25: 1min HRV, 9.427; 26: HR, 117.763; 26: RR, 14.898; 26: 1min HRV, 11.920; 27: HR, 115.672; 27: RR, 12.552; 27: SpO2, 99.647; 27: 1min HRV, 17.602; 27: 5min HRV, 20.318; 27: SBP, 123.0; 27: DBP, 60.0; 27: MAP, 81.0; 28: HR, 113.797; 28: RR, 14.254; 28: SpO2, 99.695; 28: Perf, 0.213; 28: 1min HRV, 16.678; 29: HR, 113.186; 29: RR, 16.254; 29: SpO2, 99.711; 29: Perf, 0.238; 29: 1min HRV, 11.265; 30: HR, 111.914; 30: RR, 14.328; 30: SpO2, 98.877; 30: Perf, 0.267; 30: 1min HRV, 9.598; 30: SBP, 123.0; 30: DBP, 60.0; 30: MAP, 81.0; 31: HR, 113.254; 31: RR, 21.593; 31: SpO2, 97.136; 31: Perf, 0.297; 31: 1min HRV, 11.016; 32: HR, 113.707; 32: RR, 14.655; 32: SpO2, 96.483; 32: Perf, 0.34; 32: 1min HRV, 12.366; 32: 5min HRV, 12.877; 33: HR, 112.746; 33: RR, 14.356; 33: SpO2, 96.814; 33: Perf, 0.374; 33: 1min HRV, 14.593; 33: SBP, 139.0; 33: DBP, 65.0; 33: MAP, 89.667; 34: HR, 112.288; 34: RR, 15.492; 34: SpO2, 98.237; 34: Perf, 0.428; 34: 1min HRV, 14.612; 35: HR, 111.241; 35: RR, 16.810; 35: SpO2, 99.690; 35: Perf, 0.468; 35: 1min HRV, 17.067; 36: HR, 111.237; 36: RR, 15.220; 36: SpO2, 99.797; 36: Perf, 0.480; 36: 1min HRV, 13.064; 37: 5min HRV, 15.203; 42: HR, 109.0; 42: RR, 13.0; 42: SpO2, 99.0; 50: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 50: RED CELL DISTRIBUTION WIDTH (RDW), 14.3 %; 50: RED BLOOD CELLS (RBC), 2.92 MIL/uL; 50: WHITE BLOOD CELLS (WBC), 1.1 K/uL; 50: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 50: HEMOGLOBIN (HGB), 9.2 g/dL; 50: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 50: HEMATOCRIT (HCT), 27.1 %; 50: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.5 pg; 50: PLATELET COUNT (PLT), 299 K/uL; 50: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 0.66 K/uL; 50: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.15 K/uL; 50: MONOCYTES % (MANUAL DIFF), 17.9 %; 50: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 50: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 51.7 %; 50: METAMYELOCYTES % (MANUAL DIFF), 5.4 %; 50: LYMPHOCYTES % (MANUAL DIFF), 14.3 %; 50: NEUTROPHILS BANDS % (MANUAL DIFF), 10.7 %; 50: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.19 K/uL; 51: NITRITE, URINE (UA): Negative; 51: GLUCOSE, URINE (UA): Negative; 51: SPECIFIC GRAVITY, URINE (UA): 1.011; 51: KETONE, URINE (UA): Negative; 51: PH, URINE (UA): 8.0; 52: HIGH SENSITIVITY TROPONIN, 13 ng/L; 58: RSV, Not Detected; 58: SARS-COV-2 RNA, Not Detected; 58: INFLUENZA B, Not Detected; 58: INFLUENZA A, Not Detected; 90: ANION GAP, 18 mmol/L; 90: CHLORIDE, 95 mmol/L; 90: LIPASE, 15 U/L; 90: ALT (SGPT), 102 U/L; 90: CALCIUM, 8.2 mg/dL; 90: CREATININE, 5.54 mg/dL; 90: ALKALINE PHOSPHATASE, 121 U/L; 90: CO2, 16 mmol/L; 90: AST (SGOT), 27 U/L; 90: CORRECTED CALCIUM, 9.2 mg/dL; 90: GLUCOSE, 127 mg/dL; 90: BILIRUBIN TOTAL, 0.5 mg/dL; 90: SODIUM, 129 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 88 mg/dL; 90: GLOBULIN, 3.0 g/dL; 90: EGFR REFIT WITHOUT RACE (2021), 10 mL/min/1.73 m2; 90: PROTEIN TOTAL, 5.8 g/dL; 90: ALBUMIN, 2.8 g/dL; 90: POTASSIUM, 4.9 mmol/L; 114: HR, 91.0; 114: RR, 12.0; 114: SpO2, 97.0; 114: SBP, 100.0; 114: DBP, 51.0; 114: MAP, 67.333; 117: CEFEPIME, 2 GRAM/20 ML IV PUSH; 0: Age:, 75; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 39.1; 0: Triage HR, 123.0; 0: Triage RR, 13.0; 0: Triage SBP, 173.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I noted the patient\u2019s persistent tachycardia, fever, and eventual drop in blood pressure, indicating possible hemodynamic instability. Then I examined the labs showing acute kidney injury and markedly low white blood cell count, suggesting organ dysfunction and a possible immunocompromised state. Finally, I recognized the administration of broad-spectrum antibiotics, which supports concern for serious infection. Considering these points together, the patient appears to be at high risk of sepsis within 12 hours.",
        "claims": [
            "The patient has persistent tachycardia.",
            "The patient has a fever.",
            "The patient has an eventual drop in blood pressure.",
            "The drop in blood pressure indicates possible hemodynamic instability.",
            "The labs show acute kidney injury.",
            "The labs show a markedly low white blood cell count.",
            "A markedly low white blood cell count suggests organ dysfunction.",
            "A markedly low white blood cell count suggests a possible immunocompromised state.",
            "Broad-spectrum antibiotics were administered to the patient.",
            "The administration of broad-spectrum antibiotics supports concern for serious infection.",
            "Considering these points, the patient appears to be at high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has persistent tachycardia.",
            "The patient has a fever.",
            "The patient has an eventual drop in blood pressure.",
            "The drop in blood pressure indicates possible hemodynamic instability.",
            "The labs show acute kidney injury.",
            "A markedly low white blood cell count suggests organ dysfunction.",
            "A markedly low white blood cell count suggests a possible immunocompromised state.",
            "Broad-spectrum antibiotics were administered to the patient.",
            "The administration of broad-spectrum antibiotics supports concern for serious infection.",
            "Considering these points, the patient appears to be at high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.5,
            0.8,
            0.7,
            0.9,
            0.6,
            0.9,
            1.0,
            0.8,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            7,
            6,
            8,
            8,
            2,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "Tachycardia is defined as a heart rate greater than 90 bpm, which is one of the criteria for SIRS. While the claim does not mention other SIRS criteria, the presence of tachycardia alone is strongly aligned with SIRS positivity. Therefore, the alignment is high, but not perfect, as the claim does not specify meeting the other criterion needed for SIRS positivity.",
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis.",
            "The claim mentions an \"eventual drop in blood pressure,\" which aligns conceptually with the category of sepsis-associated hypotension. This category specifically mentions a significant drop in blood pressure as indicative of progressing towards septic shock. While the exact details (such as specific values like SBP or MAP) are not provided, the mention of a drop in blood pressure is explicitly related to this category's primary concern, suggesting a strong alignment. However, the lack of specific thresholds prevents a full alignment rating of 1.0.",
            "The claim mentions a drop in blood pressure, suggesting hemodynamic instability. While it does not specify heart rate, which is necessary for calculating the shock index, the thematic focus on hemodynamic concerns is relevant. However, without the full criteria (heart rate data), the alignment cannot be perfect, hence the rating of 0.7.",
            "Acute kidney injury is relevant to the SOFA score, specifically in the creatinine measurement criterion, which would reflect renal dysfunction. The claim strongly implies an increase in the SOFA score, indicating new organ dysfunction and a high risk for sepsis, making this alignment deep and highly relevant.",
            "A markedly low white blood cell count is not directly a SOFA criterion but can suggest possible new organ dysfunction, which aligns with the concept of SOFA's use in sepsis assessment. However, it does not explicitly confirm a \u22652 points SOFA increase, resulting in a partial alignment.",
            "A low white blood cell count is one of the SIRS criteria, which can indicate systemic inflammation consistent with early sepsis. The alignment is strong as an abnormal white blood cell count (either high or low) is specifically mentioned as a part of these criteria, reflecting a high probability of systemic infection. However, since only one criterion is mentioned, the alignment is not perfect, hence the rating of 0.9.",
            "The administration of broad-spectrum antibiotics directly aligns with clinician suspicion of a serious infection, which this category uses to anchor sepsis risk assessment. This action is explicitly stated in the category and implies a high suspicion of sepsis, leading to perfect alignment.",
            "The claim directly references the administration of broad-spectrum antibiotics, which is a key component of the category. This action indicates a strong suspicion of serious infection, aligning well with the category that focuses on early intervention due to infection concerns, even though it does not specify the timing within two hours.",
            "The claim is vague and doesn't specify particular symptoms or measurements. However, it suggests an overall clinical assessment consistent with sepsis prediction, analogous to the use of a NEWS score to predict clinical deterioration. The alignment is weak because the claim doesn't provide any specific data or scoring that directly maps to the NEWS score or any other category."
        ],
        "final_alignment_score": 0.7299999999999999,
        "accuracy": 0
    },
    {
        "input": "2: HR, 118.203; 2: RR, 29.864; 2: 1min HRV, 19.480; 3: HR, 119.772; 3: RR, 31.491; 3: SpO2, 93.0; 3: 1min HRV, 13.682; 3: 5min HRV, 17.005; 3: SBP, 128.0; 3: DBP, 58.0; 3: MAP, 81.333; 3: Pain, 0.0; 3: Temp, 97.7; 4: HR, 117.932; 4: RR, 30.593; 4: 1min HRV, 5.148; 5: HR, 115.305; 5: RR, 28.949; 5: 1min HRV, 10.322; 6: HR, 114.780; 6: RR, 28.525; 6: 1min HRV, 11.839; 7: HR, 115.610; 7: RR, 31.085; 7: SpO2, 93.714; 7: 1min HRV, 2.882; 8: HR, 114.862; 8: RR, 31.190; 8: 1min HRV, 5.909; 8: 5min HRV, 9.255; 9: HR, 114.932; 9: RR, 29.610; 9: 1min HRV, 8.274; 9: LPM O2, 40.0; 10: HR, 116.534; 10: RR, 28.483; 10: 1min HRV, 4.634; 11: HR, 116.390; 11: RR, 32.288; 11: 1min HRV, 5.701; 12: HR, 117.136; 12: RR, 32.508; 12: 1min HRV, 3.381; 13: HR, 115.966; 13: RR, 31.207; 13: SpO2, 94.0; 13: 1min HRV, 6.246; 13: 5min HRV, 6.479; 13: SBP, 119.0; 13: DBP, 61.0; 13: MAP, 80.333; 14: HR, 115.288; 14: RR, 34.322; 14: 1min HRV, 5.104; 14: SBP, 119.0; 14: DBP, 61.0; 14: MAP, 80.333; 15: HR, 116.172; 15: RR, 33.034; 15: SpO2, 95.0; 15: 1min HRV, 4.809; 16: HR, 114.672; 16: RR, 28.983; 16: SpO2, 95.167; 16: 1min HRV, 5.476; 17: HR, 113.033; 17: RR, 28.733; 17: SpO2, 63.0; 17: 1min HRV, 12.735; 18: HR, 117.293; 18: RR, 34.759; 18: SpO2, 74.25; 18: 1min HRV, 2.955; 18: 5min HRV, 9.442; 19: HR, 115.559; 19: RR, 31.475; 19: 1min HRV, 4.644; 20: HR, 114.983; 20: RR, 30.534; 20: SpO2, 84.571; 20: 1min HRV, 4.050; 21: HR, 117.288; 21: RR, 32.627; 21: 1min HRV, 14.262; 22: HR, 118.254; 22: RR, 34.847; 22: 1min HRV, 5.690; 23: HR, 117.672; 23: RR, 31.603; 23: 1min HRV, 4.177; 23: 5min HRV, 9.773; 24: HR, 117.864; 24: RR, 32.729; 24: SpO2, 69.905; 24: 1min HRV, 3.418; 25: HR, 119.293; 25: RR, 32.397; 25: SpO2, 68.0; 25: 1min HRV, 4.237; 26: HR, 117.576; 26: RR, 34.339; 26: SpO2, 92.333; 26: 1min HRV, 3.865; 27: HR, 117.203; 27: RR, 32.746; 27: SpO2, 82.857; 27: 1min HRV, 7.649; 28: HR, 117.259; 28: RR, 34.845; 28: SpO2, 93.964; 28: 1min HRV, 11.532; 28: 5min HRV, 7.533; 28: SBP, 129.0; 28: DBP, 68.0; 28: MAP, 88.333; 29: HR, 117.797; 29: RR, 33.203; 29: SpO2, 93.068; 29: Perf, 1.153; 29: 1min HRV, 5.902; 29: SBP, 129.0; 29: DBP, 68.0; 29: MAP, 88.333; 29: LPM O2, 50.0; 29: CEFEPIME, 2 GRAM/20 ML IV PUSH; 30: HR:, 115.690; 30: RR, 31.655; 30: SpO2, 91.276; 30: Perf, 0.995; 30: 1min HRV, 6.757; 31: HR, 120.203; 31: RR, 35.881; 31: SpO2, 89.983; 31: Perf, 1.044; 31: 1min HRV, 5.140; 32: HR, 118.644; 32: RR, 32.746; 32: SpO2, 93.542; 32: Perf, 1.100; 32: 1min HRV, 3.802; 33: HR, 115.155; 33: RR, 26.983; 33: SpO2, 96.138; 33: Perf, 0.922; 33: 1min HRV, 11.808; 33: 5min HRV, 11.632; 37: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 39: HR:, 122.0; 39: RR, 34.0; 39: SpO2, 93.0; 41: HR, 126.0; 41: RR, 36.0; 41: SpO2, 90.0; 41: LPM O2, 70.0; 43: HR, 122.0; 43: RR, 34.0; 43: SpO2, 95.0; 55: LPM O2, 50.0; 58: ALKALINE PHOSPHATASE, 72 U/L; 58: EGFR FOR AFRICAN AMERICAN, 69 mL/min/1.73 m2; 58: AST (SGOT), 127 U/L; 58: GLUCOSE, 136 mg/dL; 58: CREATININE, 1.11 mg/dL; 58: PROTEIN TOTAL, 6.9 g/dL; 58: EGFR REFIT WITHOUT RACE (2021), 60 mL/min/1.73 m2; 58: POTASSIUM, 4.1 mmol/L; 58: ALBUMIN, 3.3 g/dL; 58: ALT (SGPT), 84 U/L; 58: ANION GAP, 11 mmol/L; 58: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 58: CO2, 26 mmol/L; 58: CHLORIDE, 105 mmol/L; 58: CALCIUM, 9.1 mg/dL; 58: SODIUM, 142 mmol/L; 58: GLOBULIN, 3.6 g/dL; 58: BILIRUBIN TOTAL, 0.5 mg/dL; 58: CORRECTED CALCIUM, 9.7 mg/dL; 59: INR, 1.1; 59: PROTHROMBIN TIME, 14.2 seconds; 70: WAM DIFTYP, AUTO; 70: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 70: HEMOGLOBIN (HGB), 9.8 g/dL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.4 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 1.01 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 94.8 fL; 70: BASOPHIL % (AUTO DIFF), 0.3 %; 70: NRBC PERCENT (HEMATOLOGY), 1.9 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 21.2 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.8 pg; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 70: WHITE BLOOD CELLS (WBC), 22.7 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 4.0 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 19.79 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 70: HEMATOCRIT (HCT), 29.2 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 70: NEUTROPHIL % (AUTO DIFF), 87.2 %; 70: EOSINOPHIL % (AUTO DIFF), 0.0 %; 70: MONOCYTE % (AUTO DIFF), 4.1 %; 70: RED BLOOD CELLS (RBC), 3.08 MIL/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.42 K/uL; 70: PLATELET COUNT (PLT), 500 K/uL; 89: PART. THROMBOPLASTIN TIME, 20.3 seconds; 0: Age, 86; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 115.0; 0: Triage RR, 32.0; 0: Triage SBP, 128.0; 0: Triage DBP, 58.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I began by questioning whether the patient\u2019s elevated heart rate and respiratory rate could indicate systemic infection. Then, I noted repeated low oxygen saturation levels despite high supplemental oxygen requirements, which further suggested a severe physiologic disturbance. I also asked myself why broad-spectrum antibiotics and aggressive oxygen therapy were being administered so quickly, and realized that clinicians likely suspected severe infection. Lastly, seeing the markedly elevated white blood cell count reinforced the likelihood of septic processes. Consequently, I concluded that this patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient has an elevated heart rate and respiratory rate.",
            "An elevated heart rate and respiratory rate could indicate systemic infection.",
            "The patient has repeated low oxygen saturation levels despite high supplemental oxygen requirements.",
            "Repeated low oxygen saturation levels suggest a severe physiologic disturbance.",
            "Broad-spectrum antibiotics and aggressive oxygen therapy were administered quickly.",
            "The rapid administration of treatment suggests that clinicians likely suspected severe infection.",
            "The patient's white blood cell count is markedly elevated.",
            "A markedly elevated white blood cell count reinforces the likelihood of septic processes.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate and respiratory rate.",
            "An elevated heart rate and respiratory rate could indicate systemic infection.",
            "The patient has repeated low oxygen saturation levels despite high supplemental oxygen requirements.",
            "Repeated low oxygen saturation levels suggest a severe physiologic disturbance.",
            "Broad-spectrum antibiotics and aggressive oxygen therapy were administered quickly.",
            "The rapid administration of treatment suggests that clinicians likely suspected severe infection.",
            "The patient's white blood cell count is markedly elevated.",
            "A markedly elevated white blood cell count reinforces the likelihood of septic processes.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            1.0,
            1.0,
            0.7,
            0.7,
            0.8,
            0.8,
            1.0,
            1.0,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            8,
            8,
            9,
            9,
            2,
            2,
            4
        ],
        "alignment_reasonings": [
            "An elevated heart rate and respiratory rate are both explicit components of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm and respiratory rate\u202f>\u202f20/min). The presence of these criteria suggests systemic inflammation consistent with early sepsis. The claim matches very well with this category, so it is rated a perfect alignment.",
            "The claim specifically mentions an elevated heart rate and respiratory rate, both of which are explicitly listed as criteria for SIRS positivity. The presence of two or more SIRS criteria indicates systemic inflammation which is consistent with early signs of sepsis, making this a direct and strong alignment.",
            "The claim about low oxygen saturation levels despite high supplemental oxygen suggests significant issues with the patient's oxygenation status. This aligns with the SOFA criteria related to impaired oxygenation (such as PaO\u2082/FiO\u2082 ratio), which indicates potential organ dysfunction, a component of sepsis risk. However, the specific SOFA criteria are not explicitly mentioned, so alignment is strong conceptually but not definitively, warranting a slightly less than full rating.",
            "Low oxygen saturation is indicative of potential respiratory dysfunction, which aligns with the SOFA score component for impaired oxygenation (PaO\u2082/FiO\u2082). Though oxygen saturation isn't directly listed as a criterion, it conceptually reflects impaired organ function associated with sepsis, thereby representing a fairly strong alignment with this category.",
            "The administration of broad-spectrum antibiotics is directly mentioned in the category, strongly aligning with it. The addition of \"aggressive oxygen therapy\" suggests a need for urgent intervention but is not specifically part of the category criteria. Therefore, while the antibiotics component aligns closely with the category, the inclusion of oxygen therapy, which isn't directly related to the category, slightly reduces the alignment rating.",
            "The claim describes \"rapid administration of treatment,\" which indicates prompt clinical response due to suspicion of severe infection. This aligns well with Category 9, which involves early action like administering antibiotics or drawing blood cultures when serious infection is suspected. However, the claim does not explicitly mention antibiotics or cultures, thus the alignment is high but not perfect.",
            "The claim highlights a markedly elevated white blood cell count, which is explicitly one of the SIRS criteria. The SIRS criteria are used to identify systemic inflammation indicative of early sepsis, ensuring a perfect alignment with this category.",
            "The claim specifically mentions a markedly elevated white blood cell count, which is explicitly part of the SIRS criteria used to identify systemic inflammation associated with early sepsis. This makes the alignment with the SIRS Positivity category strong and direct.",
            "The claim broadly indicates a high risk of sepsis, which could be associated with multiple factors like deranged vitals predicting imminent deterioration, similar to what the NEWS score assesses. However, without explicitly mentioning any specific clinical parameters or scores, the alignment with any particular category is weak and speculative. Therefore, the category selected reflects a general predictor of clinical deterioration compatible with sepsis risk, but only weakly aligns without specific data."
        ],
        "final_alignment_score": 0.8111111111111111,
        "accuracy": 1
    },
    {
        "input": "5: HR, 88.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 95.0; 5: DBP, 67.0; 5: MAP, 76.333; 5: LPM O2, 2.0; 5: Temp, 98.2; 30: SpO2, 84.833; 31: SpO2, 88.586; 31: Perf, 0.691; 32: SpO2, 94.914; 32: Perf, 0.687; 33: SpO2, 95.567; 33: Perf, 0.734; 35: SpO2, 93.0; 36: SpO2, 90.449; 36: Perf, 0.51; 37: SpO2, 94.882; 37: SBP, 117.0; 37: DBP, 73.0; 37: MAP, 87.667; 38: HR, 88.9; 38: RR, 17.3; 38: SpO2, 92.897; 38: Perf, 0.577; 38: 1min HRV, 14.986; 39: HR, 89.780; 39: RR, 17.169; 39: SpO2, 93.712; 39: Perf, 0.677; 39: 1min HRV, 30.180; 40: HR, 88.407; 40: RR, 17.305; 40: SpO2, 92.434; 40: Perf, 0.698; 40: 1min HRV, 22.725; 40: 5min HRV, 24.935; 41: HR, 92.552; 41: RR, 19.276; 41: Perf, 0.7; 41: 1min HRV, 8.933; 42: HR, 88.102; 42: RR, 19.932; 42: SpO2, 96.0; 42: Perf, 0.702; 42: 1min HRV, 7.636; 43: HR, 86.175; 43: RR, 14.579; 43: SpO2, 96.807; 43: Perf, 0.838; 43: 1min HRV, 57.636; 44: HR, 86.881; 44: RR, 14.203; 44: SpO2, 95.898; 44: Perf, 0.925; 44: 1min HRV, 10.901; 45: HR, 86.288; 45: RR, 14.610; 45: SpO2, 96.373; 45: Perf, 0.903; 45: 1min HRV, 10.896; 45: 5min HRV, 31.860; 46: HR, 83.931; 46: RR, 9.255; 46: SpO2, 97.190; 46: Perf, 0.938; 46: 1min HRV, 10.150; 46: SBP, 105.0; 46: DBP, 72.0; 46: MAP, 83.0; 47: HR, 82.220; 47: RR, 7.271; 47: SpO2, 97.915; 47: Perf, 1.276; 47: 1min HRV, 9.098; 48: HR, 82.862; 48: RR, 11.793; 48: SpO2, 97.776; 48: Perf, 1.498; 48: 1min HRV, 7.660; 49: HR, 80.763; 49: RR, 13.102; 49: SpO2, 98.0; 49: Perf, 1.572; 49: 1min HRV, 8.148; 50: HR, 80.017; 50: RR, 10.203; 50: SpO2, 98.0; 50: Perf, 1.647; 50: 1min HRV, 7.351; 50: 5min HRV, 16.456; 51: HR, 80.586; 51: RR, 10.862; 51: SpO2, 98.0; 51: Perf, 1.438; 51: 1min HRV, 12.821; 52: HR, 82.186; 52: RR, 16.898; 52: SpO2, 97.780; 52: Perf, 1.173; 52: 1min HRV, 11.858; 53: HR, 83.534; 53: RR, 16.379; 53: SpO2, 97.776; 53: Perf, 1.011; 53: 1min HRV, 7.071; 54: HR, 84.121; 54: RR, 15.586; 54: SpO2, 97.586; 54: Perf, 1.138; 54: 1min HRV, 59.900; 55: HR, 83.305; 55: RR, 15.153; 55: SpO2, 97.576; 55: Perf, 1.345; 55: 1min HRV, 6.728; 55: 5min HRV, 30.099; 56: HR, 84.672; 56: RR, 17.534; 56: SpO2, 98.017; 56: Perf, 1.370; 56: 1min HRV, 8.407; 57: HR, 84.712; 57: RR, 16.559; 57: SpO2, 98.085; 57: Perf, 1.307; 57: 1min HRV, 10.786; 58: HR, 84.328; 58: RR, 14.776; 58: SpO2, 97.621; 58: Perf, 1.295; 58: 1min HRV, 8.478; 59: HR, 82.644; 59: RR, 14.407; 59: SpO2, 98.881; 59: Perf, 1.187; 59: 1min HRV, 10.463; 60: HR, 82.220; 60: RR, 14.458; 60: SpO2, 98.644; 60: Perf, 1.084; 60: 1min HRV, 8.076; 60: 5min HRV, 12.758; 60: SBP, 106.0; 60: DBP, 69.0; 60: MAP, 81.333; 60: LPM O2, 2.0; 61: POC PH (V) ISTAT, 7.44; 61: POC PO2 (V) ISTAT, 37 mmHg; 61: POC HCO3 (V) ISTAT, 29.5 mmol/L; 61: POC TCO2 (V) ISTAT, 31 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC BASE EXCESS ISTAT, 5 mmol/L; 61: POC PCO2 (V) ISTAT, 43.5 mmHg; 61: POC LACTATE ISTAT, 1.26 mmol/L; 61: HR, 83.241; 61: RR, 15.448; 61: SpO2, 98.086; 61: Perf, 1.09; 61: 1min HRV, 9.775; 61: SBP, 106.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 82.898; 62: RR, 16.661; 62: SpO2, 98.068; 62: Perf, 1.344; 62: 1min HRV, 7.296; 63: HR, 83.569; 63: RR, 17.052; 63: SpO2, 97.897; 63: Perf, 1.436; 63: 1min HRV, 27.513; 64: HR, 81.627; 64: RR, 17.576; 64: SpO2, 98.102; 64: Perf, 1.201; 64: 1min HRV, 11.323; 65: HR, 82.053; 65: RR, 17.877; 65: SpO2, 98.754; 65: Perf, 1.020; 65: 1min HRV, 60.692; 65: 5min HRV, 31.430; 66: HR, 82.0; 66: RR, 13.407; 66: SpO2, 97.424; 66: Perf, 0.810; 66: 1min HRV, 10.620; 67: HR, 82.136; 67: RR, 11.407; 67: SpO2, 98.0; 67: Perf, 0.766; 67: 1min HRV, 8.232; 68: HR, 81.776; 68: RR, 10.862; 68: SpO2, 97.759; 68: Perf, 1.136; 68: 1min HRV, 9.964; 69: HR, 80.814; 69: RR, 10.542; 69: SpO2, 97.153; 69: Perf, 1.262; 69: 1min HRV, 12.166; 70: HR, 81.914; 70: RR, 10.534; 70: SpO2, 97.172; 70: Perf, 1.313; 70: 1min HRV, 11.149; 70: 5min HRV, 11.017; 84: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON, 4 MG PO TBDL; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: BASOPHIL % (AUTO DIFF), 0.4 %; 89: LYMPHOCYTE % (AUTO DIFF), 16.8 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.82 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 18.1 %; 89: HEMOGLOBIN (HGB), 9.7 g/dL; 89: HEMATOCRIT (HCT), 30.2 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.27 K/uL; 89: RED BLOOD CELLS (RBC), 3.17 MIL/uL; 89: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 95.3 fL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.05 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.60 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.5 %; 89: NEUTROPHIL % (AUTO DIFF), 65.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.69 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 89: PLATELET COUNT (PLT), 153 K/uL; 89: MONOCYTE % (AUTO DIFF), 12.5 %; 89: NRBC PERCENT (HEMATOLOGY), 0.4 %; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 89: EOSINOPHIL % (AUTO DIFF), 0.3 %; 111: TROPONIN I, <.017 ng/mL; 118: BNP NT-PRO, 204 pg/mL; 0: Age, 61; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 88.0; 0: Triage RR, 18.0; 0: Triage SBP, 95.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, BREAST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first reviewed the patient\u2019s vital signs and labs over the initial hours, paying special attention to blood pressure, heart rate, temperature, and oxygen saturation. Then I assessed markers of possible infection or organ dysfunction, such as lactate and WBC count. Although there is a mild elevation in WBC, the lactate remains within normal range and there is no sustained hypotension or abnormal temperature. Based on this evidence, there does not appear to be a high risk of sepsis within the next 12 hours.",
        "claims": [
            "I first reviewed the patient\u2019s vital signs and labs over the initial hours.",
            "I paid special attention to blood pressure.",
            "I paid special attention to heart rate.",
            "I paid special attention to temperature.",
            "I paid special attention to oxygen saturation.",
            "I assessed markers of possible infection or organ dysfunction.",
            "I assessed the lactate level.",
            "I assessed the WBC count.",
            "There is a mild elevation in WBC.",
            "The lactate remains within normal range.",
            "There is no sustained hypotension.",
            "There is no abnormal temperature.",
            "Based on this evidence, there does not appear to be a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There is no sustained hypotension."
        ],
        "alignment_scores": [
            0.4
        ],
        "alignment_category": [
            7
        ],
        "alignment_reasonings": [
            "The claim directly mentions the absence of sustained hypotension, which is the focus of this category. While it doesn't provide evidence of sepsis-related hypotension, acknowledging its absence has some relevance to assessing sepsis risk. However, since it's about a lack of the described condition, the alignment is only partial."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "5: HR, 62.0; 5: RR, 30.0; 5: SpO2, 82.0; 5: SBP, 140.0; 5: DBP, 65.0; 5: MAP, 90.0; 5: LPM O2, 4.0; 5: Pain, 8.0; 5: Temp, 98.1; 6: RR, 30.0; 6: SpO2, 92.0; 6: LPM O2, 6.0; 18: Pain, 7.0; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA B, Not Detected; 77: RSV, Not Detected; 77: INFLUENZA A, Not Detected; 84: SpO2, 93.629; 85: HR, 50.1; 85: RR, 16.686; 85: SpO2, 93.286; 85: 1min HRV, 19.687; 86: HR, 50.326; 86: RR, 20.017; 86: SpO2, 91.745; 86: 1min HRV, 21.685; 87: HR, 54.966; 87: RR, 15.881; 87: SpO2, 88.678; 87: 1min HRV, 221.895; 88: HR, 52.723; 88: RR, 17.966; 88: SpO2, 90.534; 88: 1min HRV, 28.500; 88: 5min HRV, 125.288; 89: HR, 53.562; 89: RR, 15.322; 89: SpO2, 91.017; 89: Perf, 0.56; 89: 1min HRV, 22.452; 90: HR, 52.339; 90: RR, 16.881; 90: SpO2, 87.525; 90: Perf, 0.608; 90: 1min HRV, 169.545; 91: HR, 52.568; 91: RR, 23.552; 91: SpO2, 87.121; 91: Perf, 0.798; 91: 1min HRV, 46.723; 92: HR, 50.965; 92: RR, 19.052; 92: SpO2, 86.259; 92: Perf, 1.532; 92: 1min HRV, 32.224; 93: HR, 52.169; 93: RR, 14.305; 93: SpO2, 85.390; 93: Perf, 1.841; 93: 1min HRV, 202.136; 93: 5min HRV, 136.025; 93: LPM O2, 6.0; 94: HR, 53.276; 94: RR, 19.603; 94: SpO2, 86.707; 94: Perf, 1.810; 94: 1min HRV, 243.408; 95: HR, 51.288; 95: RR, 24.085; 95: SpO2, 88.559; 95: Perf, 1.322; 95: 1min HRV, 22.266; 96: HR, 49.678; 96: RR, 19.780; 96: SpO2, 96.712; 96: Perf, 1.31; 96: 1min HRV, 63.848; 97: HR, 50.017; 97: RR, 16.690; 97: SpO2, 97.603; 97: Perf, 1.289; 97: 1min HRV, 223.779; 98: HR, 49.254; 98: RR, 16.0; 98: SpO2, 98.746; 98: Perf, 1.253; 98: 1min HRV, 18.557; 98: 5min HRV, 161.749; 99: POC PH (V) ISTAT, 7.44; 99: POC BASE EXCESS ISTAT, 7 mmol/L; 99: POC HCO3 (V) ISTAT, 30.8 mmol/L; 99: POC TCO2 (V) ISTAT, 32 mmol/L; 99: POC PCO2 (V) ISTAT, 45.7 mmHg; 99: POC LACTATE ISTAT, 1.75 mmol/L; 99: POC O2 SATURATION ISTAT VENOUS, 47 %; 99: POC PO2 (V) ISTAT, 25 mmHg; 99: HR, 48.034; 99: RR, 16.879; 99: SpO2, 98.586; 99: Perf, 1.23; 99: 1min HRV, 20.593; 100: HR, 47.783; 100: RR, 16.35; 100: SpO2, 98.733; 100: Perf, 1.227; 100: 1min HRV, 19.668; 101: HR, 47.224; 101: RR, 18.362; 101: SpO2, 99.0; 101: Perf, 1.400; 101: 1min HRV, 11.765; 102: HR, 47.278; 102: RR, 22.390; 102: SpO2, 98.203; 102: Perf, 1.942; 102: 1min HRV, 24.580; 103: HR, 47.212; 103: RR, 21.138; 103: SpO2, 97.552; 103: Perf, 2.18; 103: 1min HRV, 29.295; 103: 5min HRV, 23.281; 104: HR, 46.424; 104: RR, 21.034; 104: SpO2, 97.220; 104: Perf, 2.167; 104: 1min HRV, 34.762; 105: HR, 47.810; 105: RR, 17.345; 105: SpO2, 97.172; 105: Perf, 1.823; 105: 1min HRV, 146.607; 106: HR, 46.407; 106: RR, 20.661; 106: SpO2, 98.525; 106: Perf, 1.007; 106: 1min HRV, 18.834; 107: HR, 45.431; 107: RR, 22.707; 107: SpO2, 97.172; 107: Perf, 1.056; 107: 1min HRV, 12.632; 108: WAM DIFTYP, AUTO; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.77 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 81.2 %; 108: WHITE BLOOD CELLS (WBC), 9.8 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.97 K/uL; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.9 pg; 108: HEMOGLOBIN (HGB), 16.8 g/dL; 108: EOSINOPHIL % (AUTO DIFF), 3.2 %; 108: HEMATOCRIT (HCT), 54.0 %; 108: LYMPHOCYTE % (AUTO DIFF), 6.8 %; 108: MEAN CORPUSCULAR VOLUME (MCV), 96.1 fL; 108: MONOCYTE % (AUTO DIFF), 7.8 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 108: RED BLOOD CELLS (RBC), 5.62 MIL/uL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 108: BASOPHIL % (AUTO DIFF), 0.8 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: PLATELET COUNT (PLT), 209 K/uL; 108: HR, 45.847; 108: RR, 23.475; 108: SpO2, 96.407; 108: Perf, 0.972; 108: 1min HRV, 8.665; 108: 5min HRV, 74.502; 109: HR, 46.831; 109: RR, 24.576; 109: SpO2, 95.339; 109: Perf, 1.153; 109: 1min HRV, 34.172; 110: HR, 47.483; 110: RR, 17.207; 110: SpO2, 95.138; 110: Perf, 0.853; 110: 1min HRV, 23.770; 111: HR, 47.559; 111: RR, 14.915; 111: SpO2, 97.356; 111: Perf, 0.789; 111: 1min HRV, 20.254; 112: HR, 47.897; 112: RR, 16.241; 112: SpO2, 97.724; 112: Perf, 0.800; 112: 1min HRV, 27.911; 113: HR, 45.441; 113: RR, 18.441; 113: SpO2, 97.119; 113: Perf, 0.822; 113: 1min HRV, 18.948; 113: 5min HRV, 34.415; 114: HR, 46.780; 114: RR, 20.356; 114: SpO2, 96.441; 114: Perf, 1.242; 114: 1min HRV, 177.614; 115: HR, 46.0; 115: RR, 26.828; 115: SpO2, 95.034; 115: Perf, 1.25; 115: 1min HRV, 0.0; 115: Pain, 4.0; 116: HR, 46.780; 116: RR, 19.780; 116: SpO2, 96.636; 116: Perf, 1.298; 116: 1min HRV, 177.184; 117: HR, 45.634; 117: RR, 19.305; 117: SpO2, 97.610; 117: Perf, 1.520; 117: 1min HRV, 10.559; 118: HR, 46.111; 118: RR, 17.603; 118: SpO2, 97.448; 118: Perf, 1.65; 118: 1min HRV, 0.0; 118: 5min HRV, 171.327; 119: HR, 46.958; 119: RR, 24.831; 119: SpO2, 96.695; 119: Perf, 1.619; 119: 1min HRV, 25.599; 0: Age, 62; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 62.0; 0: Triage RR, 30.0; 0: Triage SBP, 140.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first checked if the patient\u2019s vitals hinted toward an infectious process or severe organ dysfunction, focusing on parameters like heart rate, blood pressure, oxygen saturation, and lactate. The labs do not show elevated WBC or lactate, and the patient\u2019s vital signs, while indicating respiratory distress, are not clearly suggestive of a septic process. Although the respiratory rate is high, there is no definitive evidence of sepsis within the data provided, making the risk of sepsis in the next 12 hours unlikely.",
        "claims": [
            "The patient's vitals were checked for indications of an infectious process or severe organ dysfunction.",
            "Parameters such as heart rate, blood pressure, oxygen saturation, and lactate were focused on during the assessment.",
            "The lab results do not show elevated white blood cell counts (WBC) or lactate levels.",
            "The patient's vital signs indicate respiratory distress.",
            "The vital signs are not clearly suggestive of a septic process.",
            "The respiratory rate is high.",
            "There is no definitive evidence of sepsis within the data provided.",
            "The risk of sepsis in the next 12 hours is unlikely based on the available data."
        ],
        "relevant_claims": [
            "The lab results do not show elevated white blood cell counts (WBC) or lactate levels.",
            "The patient's vital signs indicate respiratory distress.",
            "The vital signs are not clearly suggestive of a septic process.",
            "The respiratory rate is high.",
            "There is no definitive evidence of sepsis within the data provided."
        ],
        "alignment_scores": [
            0.5,
            0.6,
            0.3,
            0.7,
            0.2
        ],
        "alignment_category": [
            2,
            4,
            4,
            3,
            9
        ],
        "alignment_reasonings": [
            "The claim directly relates to the SIRS criteria, which includes elevated WBC as a measure. Although the lab results do not show elevated WBCs, the mention of WBC levels indicates a consideration of the SIRS criteria, suggesting observational alignment. The absence of elevated lactate levels slightly touches on another category (Elevated Serum Lactate), yet it is less directly aligned. Therefore, the SIRS Positivity category is more relevant, but since the criteria are not met, the alignment is partial.",
            "Respiratory distress could be part of a deranged vital sign profile, which is captured under the NEWS score system that tracks vital sign abnormalities. Although respiratory distress isn't explicitly quantified here, it aligns conceptually with the NEWS score's purpose in identifying patients at risk of sepsis through changes in vital signs. The alignment is indirect but relevant.",
            "The claim suggests that the vital signs do not strongly indicate sepsis, which aligns somewhat with the idea of an elevated NEWS score that predicts clinical deterioration. Since there is an implication that the observable signs are not deranged, the NEWS score would likely be low, suggesting lower risk. Therefore, there's a weak but relevant connection, as NEWS is directly based on vital sign derangements, specifically predicting sepsis when elevated.",
            "The claim specifically mentions a high respiratory rate, which is a component of the qSOFA score (respiratory rate \u226522/min). Although the claim does not provide the exact number to confirm whether it meets the qSOFA threshold, the mention of a high respiratory rate directly aligns with this category. The alignment is strong, but not complete, due to lack of specific quantitative detail.",
            "The claim that there is \"no definitive evidence of sepsis within the data provided\" implies a low suspicion of sepsis, relating to the category of clinician suspicion of serious infection. While there is no direct action like ordering antibiotics or cultures, the consideration of evidence aligns slightly with the process of ruling out infection. The alignment rating is low due to the lack of specific, concrete measures taken to confirm or treat potential sepsis."
        ],
        "final_alignment_score": 0.4600000000000001,
        "accuracy": 1
    },
    {
        "input": "6: HR, 86.0; 6: RR, 20.0; 6: SpO2, 98.0; 6: SBP, 115.0; 6: DBP, 62.0; 6: MAP, 79.667; 6: Temp, 97.3; 22: HR, 98.414; 22: RR, 31.643; 22: SpO2, 91.727; 22: 1min HRV, 110.846; 22: 5min HRV, 110.846; 23: HR, 98.136; 23: RR, 34.356; 23: SpO2, 92.0; 23: 1min HRV, 117.374; 23: SBP, 131.0; 23: DBP, 77.0; 23: MAP, 95.0; 24: HR, 95.534; 24: RR, 32.310; 24: 1min HRV, 113.171; 25: HR, 101.0; 25: RR, 29.898; 25: SpO2, 99.0; 25: 1min HRV, 162.398; 26: HR, 95.052; 26: RR, 29.517; 26: 1min HRV, 103.722; 27: HR, 100.220; 27: RR, 33.610; 27: 1min HRV, 138.512; 27: 5min HRV, 129.593; 28: HR, 95.407; 28: RR, 32.949; 28: 1min HRV, 125.817; 29: HR, 96.241; 29: RR, 34.931; 29: 1min HRV, 116.094; 30: HR, 88.407; 30: RR, 34.441; 30: 1min HRV, 109.284; 31: HR, 105.828; 31: RR, 30.397; 31: 1min HRV, 147.138; 32: HR, 98.322; 32: RR, 25.288; 32: 1min HRV, 138.014; 32: 5min HRV, 131.883; 33: HR, 90.017; 33: RR, 24.627; 33: 1min HRV, 92.595; 34: HR, 93.678; 34: RR, 29.627; 34: 1min HRV, 144.850; 35: HR, 93.828; 35: RR, 27.724; 35: 1min HRV, 120.825; 36: HR, 90.305; 36: RR, 27.576; 36: 1min HRV, 99.692; 37: HR, 92.759; 37: RR, 35.966; 37: 1min HRV, 125.839; 37: 5min HRV, 122.075; 38: HR, 92.949; 38: RR, 25.169; 38: 1min HRV, 131.881; 38: SBP, 115.0; 38: DBP, 69.0; 38: MAP, 84.333; 39: HR, 90.431; 39: RR, 28.448; 39: 1min HRV, 108.780; 40: HR, 90.356; 40: RR, 26.915; 40: 1min HRV, 135.773; 41: HR, 95.983; 41: RR, 26.407; 41: SpO2, 97.0; 41: 1min HRV, 145.704; 42: HR, 98.017; 42: RR, 33.052; 42: 1min HRV, 147.904; 42: 5min HRV, 135.808; 43: HR, 91.576; 43: RR, 32.75; 43: 1min HRV, 144.543; 44: HR, 100.644; 44: RR, 30.475; 44: 1min HRV, 99.454; 45: HR, 104.345; 45: RR, 27.672; 45: 1min HRV, 118.998; 46: HR, 102.034; 46: RR, 28.864; 46: 1min HRV, 137.662; 47: HR, 109.172; 47: RR, 29.086; 47: 1min HRV, 148.420; 47: 5min HRV, 137.077; 48: HR, 109.119; 48: RR, 23.196; 48: 1min HRV, 152.448; 49: HR, 102.559; 49: RR, 28.811; 49: 1min HRV, 167.416; 50: HR, 118.086; 50: RR, 32.224; 50: 1min HRV, 174.658; 51: HR, 96.949; 51: RR, 27.102; 51: 1min HRV, 141.684; 52: HR, 105.810; 52: RR, 23.483; 52: 1min HRV, 175.727; 52: 5min HRV, 167.496; 53: HR, 104.492; 53: RR, 22.644; 53: 1min HRV, 144.027; 53: SBP, 116.0; 53: DBP, 85.0; 53: MAP, 95.333; 54: HR, 102.931; 54: RR, 29.774; 54: 1min HRV, 146.443; 55: HR, 98.458; 55: RR, 33.310; 55: SpO2, 97.0; 55: 1min HRV, 140.776; 56: HR, 97.915; 56: RR, 35.864; 56: 1min HRV, 148.741; 57: HR, 111.828; 57: RR, 31.655; 57: 1min HRV, 154.844; 57: 5min HRV, 152.574; 58: HR, 109.508; 58: RR, 31.203; 58: 1min HRV, 160.695; 59: HR, 98.397; 59: RR, 36.534; 59: 1min HRV, 178.628; 60: HR, 91.593; 60: RR, 32.208; 60: 1min HRV, 133.466; 61: HR, 98.068; 61: RR, 40.339; 61: 1min HRV, 144.123; 62: HR, 96.810; 62: RR, 34.069; 62: 1min HRV, 146.344; 62: 5min HRV, 158.031; 63: HR, 98.593; 63: RR, 32.831; 63: 1min HRV, 156.849; 64: HR, 106.517; 64: RR, 37.741; 64: 1min HRV, 152.933; 65: HR, 97.203; 65: RR, 27.983; 65: 1min HRV, 169.895; 66: HR, 99.322; 66: RR, 29.797; 66: 1min HRV, 142.021; 67: HR, 96.966; 67: RR, 34.121; 67: 1min HRV, 128.693; 67: 5min HRV, 151.593; 68: HR, 93.492; 68: RR, 27.763; 68: 1min HRV, 119.736; 68: SBP, 103.0; 68: DBP, 67.0; 68: MAP, 79.0; 69: HR, 92.397; 69: RR, 26.690; 69: 1min HRV, 121.414; 70: HR, 88.780; 70: RR, 25.746; 70: 1min HRV, 151.117; 71: HR, 92.424; 71: RR, 29.356; 71: 1min HRV, 165.078; 72: HR, 105.810; 72: RR, 29.190; 72: 1min HRV, 177.500; 72: 5min HRV, 154.698; 73: HR, 97.508; 73: RR, 26.780; 73: 1min HRV, 174.835; 74: HR, 93.534; 74: RR, 26.534; 74: 1min HRV, 128.705; 75: HR, 97.424; 75: RR, 25.136; 75: SpO2, 98.818; 75: 1min HRV, 163.474; 76: HR, 96.661; 76: RR, 28.593; 76: SpO2, 93.4; 76: 1min HRV, 134.870; 77: ANION GAP, 12 mmol/L; 77: POTASSIUM, 4.1 mmol/L; 77: PROTEIN TOTAL, 7.2 g/dL; 77: CO2, 23 mmol/L; 77: GLUCOSE, 166 mg/dL; 77: ALBUMIN, 3.8 g/dL; 77: GLOBULIN, 3.4 g/dL; 77: ALKALINE PHOSPHATASE, 94 U/L; 77: CHLORIDE, 102 mmol/L; 77: EGFR FOR AFRICAN AMERICAN, 57 mL/min/1.73 m2; 77: AST (SGOT), 94 U/L; 77: ALT (SGPT), 76 U/L; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: CALCIUM, 9.1 mg/dL; 77: CORRECTED CALCIUM, 9.3 mg/dL; 77: EGFR REFIT WITHOUT RACE (2021), 49 mL/min/1.73 m2; 77: SODIUM, 137 mmol/L; 77: MAGNESIUM, 2.1 mg/dL; 77: CREATININE, 1.24 mg/dL; 77: BILIRUBIN TOTAL, 0.9 mg/dL; 77: BNP NT-PRO, 2309 pg/mL; 77: HR, 91.603; 77: RR, 28.534; 77: 1min HRV, 137.927; 77: 5min HRV, 149.995; 78: HR, 96.390; 78: RR, 27.424; 78: 1min HRV, 143.471; 79: HR, 94.138; 79: RR, 26.741; 79: 1min HRV, 122.539; 80: HR, 90.627; 80: RR, 30.136; 80: 1min HRV, 126.110; 81: HR, 102.305; 81: RR, 28.525; 81: 1min HRV, 138.593; 82: HR, 91.983; 82: RR, 30.379; 82: 1min HRV, 135.501; 82: 5min HRV, 135.292; 83: HR, 104.695; 83: RR, 26.305; 83: 1min HRV, 142.713; 83: SBP, 126.0; 83: DBP, 98.0; 83: MAP, 107.333; 84: TROPONIN I, <.017 ng/mL; 84: HR, 96.435; 84: RR, 41.448; 84: 1min HRV, 111.796; 85: RR, 40.085; 86: RR, 38.724; 87: HR, 124.944; 87: RR, 32.661; 87: 1min HRV, 15.413; 87: 5min HRV, 143.679; 88: HR, 113.475; 88: RR, 20.068; 88: 1min HRV, 102.226; 89: HR, 114.949; 89: RR, 36.155; 89: 1min HRV, 96.557; 90: HR, 115.356; 90: RR, 34.237; 90: 1min HRV, 130.746; 91: HR, 117.893; 91: RR, 35.038; 91: 1min HRV, 140.391; 92: 5min HRV, 126.029; 98: D-DIMER ELISA, >10000 ng/mL FEU; 100: SARS-COV-2 RNA, Not Detected; 112: SpO2, 93.0; 113: HR, 100.0; 113: RR, 33.35; 113: 1min HRV, 112.194; 114: HR, 114.0; 114: RR, 27.379; 114: 1min HRV, 134.805; 114: SBP, 128.0; 114: DBP, 81.0; 114: MAP, 96.667; 115: HR, 108.322; 115: RR, 37.034; 115: 1min HRV, 147.034; 116: HR, 98.828; 116: RR, 24.0; 116: 1min HRV, 124.792; 117: HR, 101.136; 117: RR, 23.322; 117: 1min HRV, 117.243; 117: 5min HRV, 134.779; 118: HR, 101.879; 118: RR, 33.328; 118: 1min HRV, 102.420; 119: HR, 100.644; 119: RR, 34.458; 119: 1min HRV, 105.178; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 86.0; 0: Triage RR, 20.0; 0: Triage SBP, 115.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I examined the vital signs and labs, noting persistent tachycardia, high respiratory rates, and signs of possible organ stress in an elderly patient. I compared these findings to sepsis criteria, which often include elevated heart rate and respiration rate alongside potential indicators of organ dysfunction. These factors raised concern for an infection-driven process. With the patient\u2019s advanced age and fluctuating blood pressures, the overall risk for sepsis appeared significant. Therefore, I concluded that the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I examined the vital signs and labs of an elderly patient.",
            "The patient exhibited persistent tachycardia.",
            "The patient had high respiratory rates.",
            "There were signs of possible organ stress in the patient.",
            "I compared these findings to sepsis criteria.",
            "Sepsis criteria often include elevated heart rate and respiration rate.",
            "Sepsis criteria may also include potential indicators of organ dysfunction.",
            "The observed factors raised concern for an infection-driven process.",
            "The patient\u2019s advanced age contributed to the assessment.",
            "The patient had fluctuating blood pressures.",
            "The overall risk for sepsis appeared significant.",
            "I concluded that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient exhibited persistent tachycardia.",
            "The patient had high respiratory rates.",
            "There were signs of possible organ stress in the patient.",
            "Sepsis criteria often include elevated heart rate and respiration rate.",
            "Sepsis criteria may also include potential indicators of organ dysfunction.",
            "The observed factors raised concern for an infection-driven process.",
            "The patient\u2019s advanced age contributed to the assessment.",
            "The patient had fluctuating blood pressures."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.6,
            0.7,
            0.7,
            0.3,
            1.0,
            0.4
        ],
        "alignment_category": [
            2,
            3,
            8,
            2,
            8,
            9,
            1,
            7
        ],
        "alignment_reasonings": [
            "Persistent tachycardia (heart rate >90 bpm) is directly listed as one of the criteria for SIRS, which identifies systemic inflammation and is consistent with early sepsis. Although the claim only mentions one SIRS criterion (tachycardia), it still serves as a relevant indicator. Therefore, the alignment is strong but not perfect, as SIRS positivity requires two or more criteria.",
            "The claim of \"high respiratory rates\" aligns with the qSOFA criterion, which cites a respiratory rate of \u226522/min as a significant indicator of sepsis risk. However, since the claim does not specify the exact rate and the qSOFA score requires a combination of criteria, the alignment is not perfect but still strongly relevant.",
            "The claim mentions \"signs of possible organ stress,\" which indirectly suggests organ dysfunction. The SOFA score is used to identify organ dysfunction, thus the alignment is conceptual but not specific. The claim does not provide explicit details like changes in PaO\u2082/FiO\u2082, platelets, bilirubin, creatinine, or GCS that are included in the SOFA criteria; therefore, the alignment is moderate rather than strong.",
            "The claim mentions elevated heart rate and respiration rate, both of which are specifically listed as SIRS criteria used to identify systemic inflammation consistent with early sepsis. While the claim does not provide specific values to definitively confirm SIRS positivity, mentioning both criteria aligns moderately well with this category, indicating potential relevance to SIRS-based evaluation.",
            "The claim refers to \"potential indicators of organ dysfunction,\" which is most closely associated with the SOFA score that assesses organ dysfunction using specific criteria. Although the claim does not specify a \u22652 point increase, the general mention of \"indicators of organ dysfunction\" aligns conceptually with the SOFA score's focus. Thus, the alignment is indirect but notably relevant.",
            "The claim suggests a suspicion of an infection-driven process, which aligns with the intention behind early antibiotic or culture orders when there's a concern about infection. However, the claim does not specify any concrete actions taken (like administering antibiotics or ordering cultures), which weakens the alignment with this category compared to a direct reference to clinical actions. Thus, a moderate rating is suitable.",
            "The claim states that advanced age contributed to the assessment, which directly aligns with the \"Elderly Susceptibility\" category that recognizes advanced age (\u2265\u202f65\u202fyears) as a factor increasing susceptibility to sepsis. The alignment is exact, warranting a perfect score.",
            "Fluctuating blood pressures might lead or relate to hypotension or indicate haemodynamic instability, which aligns with the concept of sepsis-associated hypotension. However, the claim does not specifically mention sustained low blood pressure or the specific criteria outlined in the category (e.g., SBP <90 mmHg), so the alignment is indirect and not strongly established."
        ],
        "final_alignment_score": 0.6375,
        "accuracy": 1
    },
    {
        "input": "10: HR, 92.0; 10: RR, 16.0; 10: SpO2, 97.0; 10: SBP, 159.0; 10: DBP, 92.0; 10: MAP, 114.333; 10: Temp, 99.3; 67: POC, BHCG, ISTAT QUANTITATIVE: 6.9 IU/L; 71: POC PH (V) ISTAT, 7.32; 71: POC HCO3 (V) ISTAT, 20.7 mmol/L; 71: POC O2 SATURATION ISTAT VENOUS, 26 %; 71: POC PO2 (V) ISTAT, 19 mmHg; 71: POC BASE EXCESS ISTAT, -5 mmol/L; 71: POC TCO2 (V) ISTAT, 22 mmol/L; 71: POC LACTATE ISTAT, 0.69 mmol/L; 71: POC PCO2 (V) ISTAT, 40.5 mmHg; 76: POC POTASSIUM ISTAT, 6.6 mmol/L; 76: POC HGB (CALC) ISTAT, 12.9 g/dL; 76: POC SODIUM ISTAT, 134 mmol/L; 76: POC GLUCOSE ISTAT, 83 mg/dL; 76: POC HCT ISTAT, 38 %; 89: PART. THROMBOPLASTIN TIME, 35.2 seconds; 90: INR, 1.6; 90: PROTHROMBIN TIME, 18.5 seconds; 92: WAM DIFTYP, AUTO; 92: MONOCYTE ABSOLUTE (AUTO DIFF), 1.23 K/uL; 92: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 92: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.67 K/uL; 92: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 92: LYMPHOCYTE % (AUTO DIFF), 18.7 %; 92: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 92: EOSINOPHIL % (AUTO DIFF), 1.5 %; 92: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 92: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 92: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 92: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 92: NEUTROPHIL % (AUTO DIFF), 70.2 %; 92: MONOCYTE % (AUTO DIFF), 8.6 %; 92: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 92: HEMATOCRIT (HCT), 31.0 %; 92: PLATELET COUNT (PLT), 378 K/uL; 92: BASOPHIL % (AUTO DIFF), 0.4 %; 92: NRBC PERCENT (HEMATOLOGY), 0.0 %; 92: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 92: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 92: HEMOGLOBIN (HGB), 9.9 g/dL; 92: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.02 K/uL; 92: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 101: POC GLUCOSE BY METER, 98 mg/dL; 104: POC, BHCG, ISTAT QUANTITATIVE: 6.1 IU/L; 105: LIPASE, 11 U/L; 106: POC PH (V) ISTAT, 7.27; 106: POC PO2 (V) ISTAT, 22 mmHg; 106: POC BASE EXCESS ISTAT, -5 mmol/L; 106: POC LACTATE ISTAT, 1.44 mmol/L; 106: POC O2 SATURATION ISTAT VENOUS, 31 %; 106: POC PCO2 (V) ISTAT, 46.6 mmHg; 106: POC TCO2 (V) ISTAT, 23 mmol/L; 106: POC HCO3 (V) ISTAT, 21.6 mmol/L; 106: HR, 42.882; 106: RR, 17.5; 106: SpO2, 97.667; 106: Perf, 4.819; 106: 1min HRV, 16.461; 107: HR, 45.310; 107: RR, 16.966; 107: SpO2, 96.534; 107: Perf, 3.883; 107: 1min HRV, 27.125; 107: SBP, 139.0; 107: DBP, 84.0; 107: MAP, 102.333; 108: HR, 45.797; 108: RR, 13.712; 108: SpO2, 97.390; 108: Perf, 3.778; 108: 1min HRV, 27.967; 109: HR, 46.879; 109: RR, 15.5; 109: SpO2, 97.259; 109: Perf, 3.888; 109: 1min HRV, 41.979; 109: 5min HRV, 45.213; 110: HR, 44.864; 110: RR, 17.186; 110: SpO2, 97.780; 110: Perf, 4.039; 110: 1min HRV, 36.671; 111: HR, 44.729; 111: RR, 17.288; 111: SpO2, 97.475; 111: Perf, 6.292; 111: 1min HRV, 28.818; 112: HR, 44.172; 112: RR, 18.517; 112: SpO2, 96.914; 112: Perf, 6.863; 112: 1min HRV, 45.926; 113: HR, 44.356; 113: RR, 15.814; 113: SpO2, 96.322; 113: Perf, 5.662; 113: 1min HRV, 42.383; 114: SODIUM, 131 mmol/L; 114: SODIUM, 131 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: ALT (SGPT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: GLUCOSE, 88 mg/dL; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: ALT (SGPT), 21 U/L; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: ANION GAP, 14 mmol/L; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: GLUCOSE, 88 mg/dL; 114: CHLORIDE, 98 mmol/L; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CHLORIDE, 98 mmol/L; 114: GLOBULIN, 4.3 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: CO2, 19 mmol/L; 114: AST (SGOT), 21 U/L; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CO2, 19 mmol/L; 114: ALBUMIN, 3.9 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: GLOBULIN, 4.3 g/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ANION GAP, 14 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: AST (SGOT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ALBUMIN, 3.9 g/dL; 114: HR, 42.052; 114: RR, 16.552; 114: SpO2, 96.707; 114: Perf, 4.959; 114: 1min HRV, 39.438; 114: 5min HRV, 47.285; 115: HR, 42.102; 115: RR, 16.525; 115: SpO2, 96.0; 115: Perf, 4.387; 115: 1min HRV, 29.882; 115: SBP, 121.0; 115: DBP, 77.0; 115: MAP, 91.667; 116: HR, 43.305; 116: RR, 15.729; 116: SpO2, 96.254; 116: Perf, 4.035; 116: 1min HRV, 46.183; 117: HR, 41.845; 117: RR, 16.276; 117: SpO2, 96.276; 117: Perf, 4.256; 117: 1min HRV, 22.321; 118: HR, 41.373; 118: RR, 17.102; 118: SpO2, 96.458; 118: Perf, 4.405; 118: 1min HRV, 38.386; 119: HR, 44.534; 119: RR, 17.276; 119: SpO2, 96.5; 119: Perf, 4.310; 119: 1min HRV, 124.121; 119: 5min HRV, 73.300; 0: Age, 28; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 92.0; 0: Triage RR, 16.0; 0: Triage SBP, 159.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, LEG SWELLING,EMESIS,FEVER",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I examined the patient\u2019s vital signs, lab results, and potential causes for infection or organ dysfunction. The blood pressure remains fairly stable, lactate levels are not significantly elevated, and the respiratory rate is generally within normal limits. Although some labs are abnormal (including an elevated creatinine), there is no clear evidence of severe infection or shock at this time. Therefore, the risk of sepsis within the next 12 hours appears low.",
        "claims": [
            "I examined the patient\u2019s vital signs.",
            "I examined the patient\u2019s lab results.",
            "I examined potential causes for infection or organ dysfunction.",
            "The blood pressure remains fairly stable.",
            "Lactate levels are not significantly elevated.",
            "The respiratory rate is generally within normal limits.",
            "Some lab results are abnormal, including an elevated creatinine.",
            "There is no clear evidence of severe infection at this time.",
            "There is no clear evidence of shock at this time.",
            "The risk of sepsis within the next 12 hours appears low."
        ],
        "relevant_claims": [
            "Some lab results are abnormal, including an elevated creatinine.",
            "There is no clear evidence of severe infection at this time."
        ],
        "alignment_scores": [
            0.8,
            0.2
        ],
        "alignment_category": [
            8,
            9
        ],
        "alignment_reasonings": [
            "The claim mentions an elevated creatinine level, which is specifically listed as a criterion under the SOFA score for assessing organ dysfunction related to sepsis risk. The direct mention of an elevated creatinine aligns well with the 'SOFA Score Increase' category as a consistent indicator of renal impairment and potential sepsis progression. The alignment is strong, though the claim does not specify the exact extent of the increase or the total SOFA score.",
            "The claim indicates an absence of clear evidence of severe infection, which indirectly suggests that the clinician might not yet find it necessary to initiate early antibiotic treatment or culture orders. This aligns minimally with the category concerning clinician suspicion of infection, since there is an implication that such actions are not required without clear evidence. Thus, the alignment is weak."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 0
    },
    {
        "input": "10: HR, 125.0; 10: RR, 20.0; 10: SpO2, 96.0; 10: SBP, 116.0; 10: DBP, 66.0; 10: MAP, 82.667; 10: Pain, 8.0; 10: Temp, 99.1; 55: SpO2, 96.364; 56: SpO2, 97.814; 56: Perf, 3.785; 57: POC PH (V) ISTAT, 7.47; 57: POC PCO2 (V) ISTAT, 38.9 mmHg; 57: POC BASE EXCESS ISTAT, 5 mmol/L; 57: POC LACTATE ISTAT, 1.53 mmol/L; 57: POC PO2 (V) ISTAT, 44 mmHg; 57: POC HCO3 (V) ISTAT, 28.4 mmol/L; 57: POC TCO2 (V) ISTAT, 30 mmol/L; 57: POC O2 SATURATION ISTAT VENOUS, 83 %; 57: SpO2, 97.75; 57: Perf, 4.13; 58: SpO2, 97.545; 60: SpO2, 97.5; 62: SpO2, 97.892; 62: Perf, 2.504; 63: HR, 120.688; 63: RR, 29.0; 63: SpO2, 97.482; 63: Perf, 2.431; 63: 1min HRV, 4.649; 63: SBP, 115.0; 63: DBP, 74.0; 63: MAP, 87.667; 64: HR, 121.288; 64: RR, 23.593; 64: SpO2, 96.966; 64: Perf, 2.527; 64: 1min HRV, 5.019; 65: HR, 120.914; 65: RR, 23.207; 65: SpO2, 96.724; 65: Perf, 2.408; 65: 1min HRV, 5.123; 65: LR IV BOLUS -, 1000 ML; 66: HR:, 120.983; 66: RR, 24.475; 66: SpO2, 96.898; 66: Perf, 2.540; 66: 1min HRV, 9.017; 66: 5min HRV, 6.528; 66: SBP, 115.0; 66: DBP, 74.0; 66: MAP, 87.667; 67: HR, 120.172; 67: RR, 19.828; 67: SpO2, 96.603; 67: Perf, 2.773; 67: 1min HRV, 4.176; 68: HR, 117.847; 68: RR, 26.475; 68: SpO2, 96.169; 68: Perf, 3.083; 68: 1min HRV, 3.796; 69: HR, 116.424; 69: RR, 27.881; 69: SpO2, 96.763; 69: Perf, 3.132; 69: 1min HRV, 3.793; 70: HR, 115.586; 70: RR, 30.172; 70: SpO2, 96.724; 70: Perf, 2.924; 70: 1min HRV, 3.025; 71: HR, 115.458; 71: RR, 31.322; 71: SpO2, 96.508; 71: Perf, 3.087; 71: 1min HRV, 4.311; 71: 5min HRV, 7.879; 72: HR, 116.759; 72: RR, 27.810; 72: SpO2, 96.603; 72: Perf, 2.989; 72: 1min HRV, 4.088; 73: HR, 116.203; 73: RR, 26.763; 73: SpO2, 97.203; 73: Perf, 2.665; 73: 1min HRV, 7.695; 74: HR, 115.644; 74: RR, 30.881; 74: SpO2, 97.373; 74: Perf, 2.693; 74: 1min HRV, 3.287; 75: HR, 114.672; 75: RR, 31.397; 75: SpO2, 97.172; 75: Perf, 2.736; 75: 1min HRV, 3.565; 76: HR, 115.237; 76: RR, 27.085; 76: SpO2, 96.966; 76: Perf, 2.905; 76: 1min HRV, 3.617; 76: 5min HRV, 5.477; 77: HR, 115.086; 77: RR, 28.845; 77: SpO2, 96.948; 77: Perf, 2.516; 77: 1min HRV, 3.056; 78: HR, 115.169; 78: RR, 29.356; 78: SpO2, 97.492; 78: Perf, 2.126; 78: 1min HRV, 5.350; 79: HR, 114.381; 79: RR, 35.0; 79: SpO2, 97.107; 79: Perf, 1.866; 79: 1min HRV, 2.431; 81: 5min HRV, 4.226; 90: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: INR:, 1.1; 94: PROTHROMBIN TIME, 15.1 seconds; 102: SpO2, 95.962; 103: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 103: RED BLOOD CELLS (RBC), 3.10 MIL/uL; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.8 pg; 103: MEAN CORPUSCULAR VOLUME (MCV), 84.8 fL; 103: HEMOGLOBIN (HGB), 8.3 g/dL; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 103: HEMATOCRIT (HCT), 26.3 %; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 103: PLATELET COUNT (PLT), 331 K/uL; 103: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.51 K/uL; 103: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.49 K/uL; 103: MONOCYTES % (MANUAL DIFF), 0.0 %; 103: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 103: NEUTROPHILS BANDS % (MANUAL DIFF), 7.8 %; 103: EOSINOPHILS % (MANUAL DIFF), 3.5 %; 103: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 82.6 %; 103: LYMPHOCYTES % (MANUAL DIFF), 6.1 %; 103: HR, 112.581; 103: RR, 18.032; 103: SpO2, 97.559; 103: 1min HRV, 7.885; 104: PART. THROMBOPLASTIN TIME, 32.3 seconds; 104: HR, 112.707; 104: RR, 28.879; 104: SpO2, 97.466; 104: Perf, 1.069; 104: 1min HRV, 5.442; 105: HR, 113.780; 105: RR, 24.034; 105: SpO2, 97.305; 105: Perf, 1.174; 105: 1min HRV, 2.973; 106: HR, 113.797; 106: RR, 22.712; 106: SpO2, 97.0; 106: Perf, 1.143; 106: 1min HRV, 4.693; 106: 5min HRV, 5.928; 107: HR, 112.448; 107: RR, 27.672; 107: SpO2, 97.707; 107: Perf, 1.229; 107: 1min HRV, 4.238; 108: HR, 113.186; 108: RR, 24.390; 108: SpO2, 97.678; 108: Perf, 1.205; 108: 1min HRV, 5.694; 109: HR, 112.638; 109: RR, 26.672; 109: SpO2, 97.534; 109: Perf, 1.260; 109: 1min HRV, 4.334; 110: HR, 112.661; 110: RR, 24.373; 110: SpO2, 98.0; 110: Perf, 1.144; 110: 1min HRV, 4.286; 111: HR, 115.448; 111: RR, 21.397; 111: SpO2, 98.0; 111: Perf, 1.383; 111: 1min HRV, 4.708; 111: 5min HRV, 7.053; 112: HR, 114.949; 112: RR, 20.220; 112: SpO2, 98.339; 112: Perf, 1.131; 112: 1min HRV, 9.737; 113: HR, 114.305; 113: RR, 25.542; 113: SpO2, 97.627; 113: Perf, 1.18; 113: 1min HRV, 9.114; 114: BLOOD, URINE (UA): Negative; 114: KETONE, URINE (UA): Negative; 114: SPECIFIC GRAVITY, URINE (UA): 1.003; 114: NITRITE, URINE (UA): Negative; 114: LEUKOCYTE ESTERASE, URINE (UA): Negative; 114: PROTEIN, URINE (UA): Negative; 114: GLUCOSE, URINE (UA): Negative; 114: PH, URINE (UA): 6.0; 114: HR, 114.259; 114: RR, 24.845; 114: SpO2, 97.155; 114: Perf, 1.245; 114: 1min HRV, 7.585; 115: HR, 114.068; 115: RR, 28.017; 115: SpO2, 97.102; 115: Perf, 1.962; 115: 1min HRV, 9.362; 116: HR, 113.914; 116: RR, 25.431; 116: SpO2, 96.948; 116: Perf, 1.619; 116: 1min HRV, 5.658; 116: 5min HRV, 8.827; 117: HR, 113.034; 117: RR, 22.119; 117: SpO2, 97.797; 117: Perf, 1.397; 117: 1min HRV, 6.426; 118: HR, 112.983; 118: RR, 25.729; 118: SpO2, 97.898; 118: Perf, 1.529; 118: 1min HRV, 4.914; 119: HR, 113.845; 119: RR, 24.638; 119: SpO2, 98.0; 119: Perf, 1.743; 119: 1min HRV, 9.732; 0: Age, 45; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 125.0; 0: Triage RR, 20.0; 0: Triage SBP, 116.0; 0: Triage DBP, 66.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I started by examining vital signs such as heart rate, blood pressure, respiration rate, and temperature to see if they pointed toward sepsis criteria. I compared these findings with lab results, particularly lactate and white blood cell counts, to look for evidence of systemic infection or hypoperfusion. While the patient is tachycardic and has a fever complaint, their lactate is within normal limits and there is no clear indication of organ dysfunction. Therefore, I concluded that the patient is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I started by examining vital signs such as heart rate, blood pressure, respiration rate, and temperature.",
            "I examined vital signs to see if they pointed toward sepsis criteria.",
            "I compared the findings of vital signs with lab results.",
            "I particularly focused on lactate and white blood cell counts in my comparison.",
            "I looked for evidence of systemic infection or hypoperfusion.",
            "The patient is tachycardic.",
            "The patient has a fever complaint.",
            "The patient's lactate is within normal limits.",
            "There is no clear indication of organ dysfunction in the patient.",
            "I concluded that the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient is tachycardic."
        ],
        "alignment_scores": [
            0.8
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "Tachycardia (heart rate > 90 bpm) is one of the specific criteria mentioned under the SIRS category used to identify systemic inflammation consistent with early sepsis. The alignment rating is high because tachycardia is directly listed as a SIRS criterion, but the final SIRS positivity requires meeting at least two criteria, so it is not a perfect alignment by itself."
        ],
        "final_alignment_score": 0.8,
        "accuracy": 1
    },
    {
        "input": "3: HR, 87.0; 3: RR, 16.0; 3: SpO2, 90.0; 3: SBP, 134.0; 3: DBP, 80.0; 3: MAP, 98.0; 3: Temp, 99.5; 6: Pain, 0.0; 29: POC PH (V) ISTAT, 7.42; 29: POC HCO3 (V) ISTAT, 37.4 mmol/L; 29: POC PCO2 (V) ISTAT, 58.4 mmHg; 29: POC TCO2 (V) ISTAT, 39 mmol/L; 29: POC PO2 (V) ISTAT, 49 mmHg; 29: POC O2 SATURATION ISTAT VENOUS, 83 %; 29: POC BASE EXCESS ISTAT, 13 mmol/L; 29: POC LACTATE ISTAT, 1.38 mmol/L; 61: INR, 1.2; 61: WAM DIFTYP, AUTO; 61: PROTHROMBIN TIME, 15.4 seconds; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 23.28 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 61: WHITE BLOOD CELLS (WBC), 26.0 K/uL; 61: NEUTROPHIL % (AUTO DIFF), 89.4 %; 61: BASOPHIL % (AUTO DIFF), 0.2 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.8 pg; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 61: HEMOGLOBIN (HGB), 9.5 g/dL; 61: MEAN CORPUSCULAR VOLUME (MCV), 66.1 fL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MONOCYTE % (AUTO DIFF), 4.2 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 61: RED BLOOD CELLS (RBC), 5.05 MIL/uL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: LYMPHOCYTE % (AUTO DIFF), 5.3 %; 61: PLATELET COUNT (PLT), 365 K/uL; 61: HEMATOCRIT (HCT), 33.4 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.4 g/dL; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 62: CHLORIDE, 94 mmol/L; 62: GLUCOSE, 129 mg/dL; 62: CALCIUM, 9.1 mg/dL; 62: ANION GAP, 7 mmol/L; 62: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 62: ALBUMIN, 3.7 g/dL; 62: AST (SGOT), 15 U/L; 62: BILIRUBIN TOTAL, 0.3 mg/dL; 62: SODIUM, 136 mmol/L; 62: PROTEIN TOTAL, 7.5 g/dL; 62: CORRECTED CALCIUM, 9.3 mg/dL; 62: CREATININE, 0.33 mg/dL; 62: CO2, 35 mmol/L; 62: PART. THROMBOPLASTIN TIME, 36.4 seconds; 62: GLOBULIN, 3.8 g/dL; 62: ALKALINE PHOSPHATASE, 101 U/L; 62: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 62: ALT (SGPT), 12 U/L; 62: EGFR REFIT WITHOUT RACE (2021), 117 mL/min/1.73 m2; 62: POTASSIUM, 4.3 mmol/L; 85: HR, 161.0; 85: RR, 23.0; 85: SpO2, 97.0; 85: SBP, 127.0; 85: DBP, 90.0; 85: MAP, 102.333; 85: LPM O2, 2.0; 88: WAM DIFTYP, AUTO; 88: RED BLOOD CELLS (RBC), 4.88 MIL/uL; 88: HEMOGLOBIN (HGB), 9.2 g/dL; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 1.17 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.6 g/dL; 88: EOSINOPHIL % (AUTO DIFF), 0.0 %; 88: MONOCYTE % (AUTO DIFF), 4.6 %; 88: MEAN CORPUSCULAR VOLUME (MCV), 66.0 fL; 88: LYMPHOCYTE % (AUTO DIFF), 5.8 %; 88: WHITE BLOOD CELLS (WBC), 25.6 K/uL; 88: PLATELET COUNT (PLT), 346 K/uL; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: BASOPHIL % (AUTO DIFF), 0.2 %; 88: NEUTROPHIL % (AUTO DIFF), 88.7 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 88: HEMATOCRIT (HCT), 32.2 %; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.9 pg; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.49 K/uL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 22.66 K/uL; 96: PHOSPHORUS, 2.9 mg/dL; 96: MAGNESIUM, 2.2 mg/dL; 102: LR IV BOLUS -, 500 ML; 105: CEFEPIME, 2 GRAM/20 ML IV PUSH; 110: GLUCOSE, 118 mg/dL; 110: CO2, 33 mmol/L; 110: MAGNESIUM, 2.3 mg/dL; 110: CREATININE, 0.31 mg/dL; 110: ANION GAP, 8 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: ALKALINE PHOSPHATASE, 95 U/L; 110: CALCIUM, 9.0 mg/dL; 110: PHOSPHORUS, 2.9 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: PROTEIN TOTAL, 7.2 g/dL; 110: BILIRUBIN TOTAL, 0.3 mg/dL; 110: POTASSIUM, 4.1 mmol/L; 110: CORRECTED CALCIUM, 9.3 mg/dL; 110: CHLORIDE, 95 mmol/L; 110: AST (SGOT), 14 U/L; 110: SODIUM, 136 mmol/L; 110: ALBUMIN, 3.6 g/dL; 110: ALT (SGPT), 9 U/L; 110: GLOBULIN, 3.6 g/dL; 110: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 110: HR, 94.0; 110: RR, 21.0; 110: SpO2, 95.0; 110: SBP, 128.0; 110: DBP, 87.0; 110: MAP, 100.667; 110: LPM O2, 2.0; 111: TROPONIN I, <.017 ng/mL; 114: MAGNESIUM SULFATE IN WATER, 2 GRAM/50 ML (4 %) IV PGBK; 0: Age:, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 87.0; 0: Triage RR, 16.0; 0: Triage SBP, 134.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed the patient\u2019s very high white blood cell count, significant tachycardia, and indications of possible infection (e.g., antibiotic administration). I questioned whether the elevated WBC and heart rate might be driven by non-infectious causes, but the administration of broad-spectrum antibiotics suggests a strong suspicion of infection. Considering these factors together, I assessed the patient\u2019s risk for sepsis as high.",
        "claims": [
            "The patient has a very high white blood cell count.",
            "The patient has significant tachycardia.",
            "There are indications of possible infection, such as antibiotic administration.",
            "The elevated white blood cell count and heart rate could potentially be driven by non-infectious causes.",
            "The administration of broad-spectrum antibiotics suggests a strong suspicion of infection.",
            "Considering these factors together, the patient's risk for sepsis was assessed as high."
        ],
        "relevant_claims": [
            "The patient has a very high white blood cell count.",
            "There are indications of possible infection, such as antibiotic administration.",
            "The elevated white blood cell count and heart rate could potentially be driven by non-infectious causes.",
            "The administration of broad-spectrum antibiotics suggests a strong suspicion of infection.",
            "Considering these factors together, the patient's risk for sepsis was assessed as high."
        ],
        "alignment_scores": [
            1.0,
            0.9,
            0.7,
            0.9,
            0.3
        ],
        "alignment_category": [
            2,
            9,
            2,
            9,
            8
        ],
        "alignment_reasonings": [
            "A very high white blood cell count is specifically mentioned as a criterion for SIRS positivity, indicating systemic inflammation. Therefore, it directly aligns with this category, reflecting a strong association with early sepsis identification.",
            "The claim mentions \"antibiotic administration,\" which directly corresponds to the category concerning early orders of antibiotics as an indication of clinician suspicion of serious infection. This aligns strongly with the category, although the timing (within 2 hours) is not explicitly stated, slightly reducing the match from perfect alignment.",
            "Elevated white blood cell count and increased heart rate are both SIRS criteria. However, the claim suggests the possibility of non-infectious causes, which reduces the confidence that these findings are truly reflective of systemic inflammation due to sepsis. Therefore, while both criteria match, the alignment is not perfect due to the ambiguity introduced by considering non-infectious causes.",
            "The claim directly mentions the administration of broad-spectrum antibiotics, which is a key indicator in this category indicating the clinician's strong suspicion of a serious infection. While the timing of the antibiotic administration (within 2 hours) isn't explicitly stated in the claim, the alignment with the category is still strong due to the specific mention of antibiotics, which is a critical component of the criterion.",
            "The claim about assessing a high risk for sepsis could align with the SOFA Score category because it generally involves evaluating multiple factors to determine the risk of sepsis. However, since the claim doesn't specify the factors or criteria used, the alignment is weak and somewhat indirect. Other categories require specific clinical data points, while SOFA can involve a more comprehensive assessment, which vaguely aligns with general risk assessment methods mentioned in the claim."
        ],
        "final_alignment_score": 0.7599999999999999,
        "accuracy": 1
    },
    {
        "input": "3: HR, 85.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 147.0; 3: DBP, 53.0; 3: MAP, 84.333; 3: Temp, 98.8; 11: Pain, 3.0; 13: POC PH (V) ISTAT, 7.44; 13: POC PCO2 (V) ISTAT, 32.8 mmHg; 13: POC BASE EXCESS ISTAT, -2 mmol/L; 13: POC PO2 (V) ISTAT, 29 mmHg; 13: POC O2 SATURATION ISTAT VENOUS, 60 %; 13: POC HCO3 (V) ISTAT, 22.3 mmol/L; 13: POC LACTATE ISTAT, 0.96 mmol/L; 13: POC TCO2 (V) ISTAT, 23 mmol/L; 31: WAM DIFTYP, AUTO; 31: NEUTROPHIL % (AUTO DIFF), 73.4 %; 31: MEAN CORPUSCULAR VOLUME (MCV), 91.9 fL; 31: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 31: PLATELET COUNT (PLT), 88 K/uL; 31: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 31: RED BLOOD CELLS (RBC), 3.47 MIL/uL; 31: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 31: MONOCYTE % (AUTO DIFF), 10.0 %; 31: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 31: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.25 K/uL; 31: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 31: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.69 K/uL; 31: NRBC PERCENT (HEMATOLOGY), 0.0 %; 31: BASOPHIL % (AUTO DIFF), 0.9 %; 31: EOSINOPHIL % (AUTO DIFF), 3.5 %; 31: HEMATOCRIT (HCT), 31.9 %; 31: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 31: RED CELL DISTRIBUTION WIDTH (RDW), 18.7 %; 31: LYMPHOCYTE % (AUTO DIFF), 10.9 %; 31: MONOCYTE ABSOLUTE (AUTO DIFF), 0.23 K/uL; 31: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 31: HEMOGLOBIN (HGB), 10.2 g/dL; 31: WHITE BLOOD CELLS (WBC), 2.3 K/uL; 44: INR, 0.9; 44: PROTHROMBIN TIME, 12.5 seconds; 45: PART. THROMBOPLASTIN TIME, 37.0 seconds; 61: EGFR FOR AFRICAN AMERICAN, 105 mL/min/1.73 m2; 61: CO2, 21 mmol/L; 61: CALCIUM, 10.0 mg/dL; 61: ANION GAP, 10 mmol/L; 61: SODIUM, 133 mmol/L; 61: CORRECTED CALCIUM, 10.2 mg/dL; 61: AST (SGOT), 16 U/L; 61: GLUCOSE, 91 mg/dL; 61: ALKALINE PHOSPHATASE, 135 U/L; 61: PROTEIN TOTAL, 6.2 g/dL; 61: ALT (SGPT), 25 U/L; 61: ALBUMIN, 3.8 g/dL; 61: CHLORIDE, 102 mmol/L; 61: GLOBULIN, 2.4 g/dL; 61: EGFR REFIT WITHOUT RACE (2021), 91 mL/min/1.73 m2; 61: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 61: CREATININE, 0.64 mg/dL; 61: POTASSIUM, 4.6 mmol/L; 61: BILIRUBIN TOTAL, 0.2 mg/dL; 70: SpO2, 89.632; 71: SpO2, 99.25; 73: SpO2, 98.556; 74: SpO2, 100.0; 75: SpO2, 98.6; 76: HR, 83.0; 76: SpO2, 98.679; 76: SBP, 147.0; 76: DBP, 66.0; 76: MAP, 93.0; 76: Pain, 0.0; 77: SpO2, 96.340; 78: SpO2, 96.558; 79: SpO2, 96.868; 79: Perf, 0.45; 80: SpO2, 97.736; 80: Perf, 0.469; 81: SpO2, 97.830; 81: Perf, 0.486; 82: SpO2, 97.509; 82: Perf, 0.452; 83: SpO2, 97.472; 83: Perf, 0.434; 84: SpO2, 97.057; 84: Perf, 0.474; 85: SpO2, 96.519; 85: Perf, 0.469; 86: SpO2, 96.623; 86: Perf, 0.450; 87: SpO2, 96.774; 87: Perf, 0.452; 88: SpO2, 97.808; 88: Perf, 0.466; 89: SpO2, 98.245; 89: Perf, 0.462; 90: SpO2, 97.769; 90: Perf, 0.443; 91: TROPONIN I, <.017 ng/mL; 91: SpO2, 97.792; 91: Perf, 0.426; 92: SpO2, 96.358; 92: Perf, 0.439; 93: SpO2, 96.462; 93: Perf, 0.419; 94: SpO2, 96.245; 94: Perf, 0.416; 95: SpO2, 96.377; 95: Perf, 0.434; 96: SpO2, 97.245; 96: Perf, 0.419; 97: SpO2, 96.654; 97: Perf, 0.424; 98: SpO2, 96.774; 98: Perf, 0.434; 99: SpO2, 96.744; 99: Perf, 0.42; 100: SpO2, 95.0; 100: Perf, 0.42; 101: SpO2, 97.0; 101: Perf, 0.42; 102: SpO2, 99.692; 102: Perf, 0.413; 103: SpO2, 99.707; 103: Perf, 0.427; 104: SpO2, 98.667; 104: Perf, 0.507; 105: SpO2, 98.731; 105: Perf, 0.503; 106: SpO2, 99.113; 106: Perf, 0.448; 107: SpO2, 99.226; 107: Perf, 0.454; 108: SpO2, 99.377; 108: Perf, 0.501; 109: SpO2, 98.642; 109: Perf, 0.570; 110: SpO2, 98.885; 110: Perf, 0.520; 111: SpO2, 99.453; 111: Perf, 0.479; 112: SpO2, 98.885; 112: Perf, 0.478; 113: SpO2, 99.114; 113: Perf, 0.481; 114: SpO2, 98.792; 114: Perf, 0.512; 115: SpO2, 98.923; 115: Perf, 0.51; 116: SpO2, 98.302; 116: Perf, 0.550; 117: SpO2, 98.096; 117: Perf, 0.555; 118: SpO2, 98.547; 118: Perf, 0.525; 119: SpO2, 98.528; 119: Perf, 0.515; 0: Age, 84; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 85.0; 0: Triage RR, 18.0; 0: Triage SBP, 147.0; 0: Triage DBP, 53.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,ANAL PAIN,GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I began by noting the patient\u2019s age, presenting symptoms, and vital signs, then asked myself if there were significant hemodynamic abnormalities or evidence of organ dysfunction. I focused on key lab results\u2014particularly the lactate level, which remained normal, and the stable vital signs (such as MAP near mid-80s to 90s). I verified that the patient did not clearly meet sepsis criteria, as there was no severe tachycardia or high lactate. Finally, I concluded that although some lab values (like the low WBC) warrant monitoring, they do not indicate a high sepsis risk within 12 hours.",
        "claims": [
            "The patient\u2019s age, presenting symptoms, and vital signs were noted.",
            "Significant hemodynamic abnormalities were assessed.",
            "Evidence of organ dysfunction was evaluated.",
            "Key lab results were focused on during the assessment.",
            "The lactate level remained normal.",
            "The vital signs were stable.",
            "The MAP was near mid-80s to 90s.",
            "The patient did not clearly meet sepsis criteria.",
            "There was no severe tachycardia present in the patient.",
            "The lactate level was not high.",
            "Some lab values, such as low WBC, warrant monitoring.",
            "Low WBC does not indicate a high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "The lactate level remained normal.",
            "The patient did not clearly meet sepsis criteria.",
            "There was no severe tachycardia present in the patient.",
            "Some lab values, such as low WBC, warrant monitoring.",
            "Low WBC does not indicate a high sepsis risk within 12 hours."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.2,
            0.5,
            0.7
        ],
        "alignment_category": [
            5,
            2,
            2,
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions lactate levels, directly relating to the category concerning elevated serum lactate as a sepsis risk factor. However, the claim states that lactate levels are normal, which indicates the absence of this particular risk factor. The alignment is therefore weak, as normal lactate levels do not indicate heightened sepsis risk according to this criterion.",
            "The claim suggests that the patient does not fully meet specific criteria for sepsis, which implies they might not have met the thresholds for recognized sepsis markers like those in the SIRS criteria. Since SIRS criteria are often used as an early measure for sepsis identification and the claim indicates a lack of clear sepsis criteria, the SIRS category is somewhat relevant. However, due to the lack of specific detail in the claim and the possibility of considering alternative categories, the alignment is weak.",
            "The claim refers to the absence of severe tachycardia. While tachycardia is one of the SIRS criteria (heart\u202frate\u202f>\u202f90\u202fbpm), the claim states its absence rather than presence. Therefore, the alignment is weak, as the absence of tachycardia may decrease the likelihood of meeting SIRS criteria. However, since it is still related to one of the components, there is minimal relevance.",
            "The claim mentions low white blood cell count (WBC), which is explicitly part of the SIRS criteria for identifying systemic inflammation (WBC > 12,000/\u00b5L or < 4,000/\u00b5L). However, the claim is vague in suggesting that it merely warrants monitoring without confirming SIRS positivity (as it requires at least two criteria). This gives it a moderate but not definitive alignment.",
            "The claim references \"low WBC,\" which is one of the specific criteria under SIRS for identifying systemic inflammation (WBC < 4,000/\u00b5L). However, the claim states that low WBC does not indicate a high sepsis risk, suggesting a cautious view of its relevance. While it aligns with a SIRS criterion, the claim implies a lesser concern, hence a partial alignment."
        ],
        "final_alignment_score": 0.38,
        "accuracy": 0
    },
    {
        "input": "10: HR, 77.0; 10: RR, 26.0; 10: SpO2, 94.0; 10: SBP, 124.0; 10: DBP, 62.0; 10: MAP, 82.667; 10: Temp, 96.5; 82: SpO2, 89.0; 83: SpO2, 90.429; 84: SpO2, 90.492; 84: Perf, 4.452; 84: SBP, 154.0; 84: DBP, 70.0; 84: MAP, 98.0; 85: SpO2, 96.466; 85: Perf, 4.148; 86: HR, 71.381; 86: RR, 16.0; 86: SpO2, 97.593; 86: Perf, 2.966; 86: 1min HRV, 16.155; 86: SBP, 154.0; 86: DBP, 70.0; 86: MAP, 98.0; 86: LPM O2, 4.0; 87: HR, 71.517; 87: RR, 16.621; 87: SpO2, 97.845; 87: Perf, 2.527; 87: 1min HRV, 66.844; 88: HR, 71.068; 88: RR, 18.305; 88: SpO2, 99.102; 88: Perf, 6.147; 88: 1min HRV, 88.071; 88: 5min HRV, 71.322; 89: HR, 69.712; 89: RR, 17.373; 89: SpO2, 99.0; 89: Perf, 6.267; 89: 1min HRV, 99.938; 89: SBP, 144.0; 89: DBP, 77.0; 89: MAP, 99.333; 90: HR, 68.655; 90: RR, 19.638; 90: SpO2, 98.931; 90: Perf, 5.382; 90: 1min HRV, 93.795; 91: HR, 68.068; 91: RR, 18.051; 91: SpO2, 99.0; 91: Perf, 3.774; 91: 1min HRV, 108.446; 92: HR, 67.914; 92: RR, 19.621; 92: SpO2, 99.207; 92: Perf, 2.366; 92: 1min HRV, 144.427; 93: HR, 66.576; 93: RR, 22.169; 93: SpO2, 99.339; 93: Perf, 2.173; 93: 1min HRV, 110.827; 93: 5min HRV, 113.988; 94: HR, 65.627; 94: RR, 18.288; 94: SpO2, 98.881; 94: Perf, 2.096; 94: 1min HRV, 110.571; 95: HR, 65.172; 95: RR, 19.759; 95: SpO2, 99.379; 95: Perf, 3.281; 95: 1min HRV, 77.063; 96: POC PH (V) ISTAT, 7.31; 96: POC TCO2 (V) ISTAT, 30 mmol/L; 96: POC BASE EXCESS ISTAT, 2 mmol/L; 96: POC O2 SATURATION ISTAT VENOUS, 64 %; 96: POC PCO2 (V) ISTAT, 57.5 mmHg; 96: POC LACTATE ISTAT, 0.93 mmol/L; 96: POC PO2 (V) ISTAT, 37 mmHg; 96: POC HCO3 (V) ISTAT, 28.7 mmol/L; 96: HR, 65.542; 96: RR, 19.153; 96: SpO2, 99.102; 96: Perf, 1.754; 96: 1min HRV, 27.516; 97: HR, 68.948; 97: RR, 24.897; 97: SpO2, 98.621; 97: Perf, 1.487; 97: 1min HRV, 45.742; 98: HR, 67.034; 98: RR, 21.712; 98: SpO2, 99.085; 98: Perf, 1.493; 98: 1min HRV, 104.683; 98: 5min HRV, 81.792; 99: HR, 67.932; 99: RR, 20.525; 99: SpO2, 99.0; 99: Perf, 1.597; 99: 1min HRV, 120.171; 100: HR, 66.862; 100: RR, 19.621; 100: SpO2, 99.052; 100: Perf, 1.658; 100: 1min HRV, 94.356; 101: HR, 66.831; 101: RR, 23.169; 101: SpO2, 99.136; 101: Perf, 1.661; 101: 1min HRV, 75.248; 102: HR, 65.862; 102: RR, 19.448; 102: SpO2, 99.138; 102: Perf, 1.378; 102: 1min HRV, 32.203; 103: HR, 65.492; 103: RR, 18.424; 103: SpO2, 99.237; 103: Perf, 1.368; 103: 1min HRV, 22.240; 103: 5min HRV, 79.378; 104: HR, 66.552; 104: RR, 26.276; 104: SpO2, 99.224; 104: Perf, 1.556; 104: 1min HRV, 102.855; 105: HR, 64.949; 105: RR, 19.288; 105: SpO2, 99.237; 105: Perf, 1.84; 105: 1min HRV, 23.225; 106: HR, 65.729; 106: RR, 21.475; 106: SpO2, 99.0; 106: Perf, 1.560; 106: 1min HRV, 19.443; 107: HR, 64.603; 107: RR, 24.466; 107: SpO2, 99.776; 107: Perf, 1.227; 107: 1min HRV, 85.820; 108: HR, 63.339; 108: RR, 23.695; 108: SpO2, 99.847; 108: Perf, 1.352; 108: 1min HRV, 26.607; 108: 5min HRV, 65.054; 109: HR, 63.138; 109: RR, 25.052; 109: SpO2, 100.0; 109: Perf, 1.304; 109: 1min HRV, 111.949; 110: HR, 62.695; 110: RR, 22.966; 110: SpO2, 100.0; 110: Perf, 1.205; 110: 1min HRV, 34.180; 111: HR, 65.424; 111: RR, 24.898; 111: SpO2, 99.831; 111: Perf, 1.268; 111: 1min HRV, 76.669; 112: HR, 66.448; 112: RR, 21.948; 112: SpO2, 99.897; 112: Perf, 1.413; 112: 1min HRV, 123.017; 112: Temp, 97.9; 113: HR, 64.915; 113: RR, 23.797; 113: SpO2, 100.0; 113: Perf, 1.788; 113: 1min HRV, 99.817; 113: 5min HRV, 98.123; 114: HR, 64.741; 114: RR, 21.103; 114: SpO2, 99.828; 114: Perf, 1.588; 114: 1min HRV, 154.840; 115: HR, 64.305; 115: RR, 24.051; 115: SpO2, 99.864; 115: Perf, 1.443; 115: 1min HRV, 156.988; 116: HR, 64.797; 116: RR, 22.0; 116: SpO2, 99.949; 116: Perf, 1.362; 116: 1min HRV, 112.948; 117: HR, 64.759; 117: RR, 24.741; 117: SpO2, 99.828; 117: Perf, 1.498; 117: 1min HRV, 138.767; 117: LPM O2, 2.0; 118: SARS-COV-2 RNA, Not Detected; 118: HR, 62.881; 118: RR, 23.424; 118: SpO2, 100.0; 118: Perf, 1.646; 118: 1min HRV, 122.625; 118: 5min HRV, 139.282; 119: WAM DIFTYP, AUTO; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 119: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 119: NRBC PERCENT (HEMATOLOGY), 0.0 %; 119: HEMATOCRIT (HCT), 35.3 %; 119: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.30 K/uL; 119: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 119: NEUTROPHIL % (AUTO DIFF), 76.3 %; 119: RED CELL DISTRIBUTION WIDTH (RDW), 14.0 %; 119: MONOCYTE % (AUTO DIFF), 7.6 %; 119: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 119: RED BLOOD CELLS (RBC), 3.82 MIL/uL; 119: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 119: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 119: BASOPHIL % (AUTO DIFF), 0.5 %; 119: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 119: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 119: MEAN CORPUSCULAR VOLUME (MCV), 92.4 fL; 119: PLATELET COUNT (PLT), 147 K/uL; 119: EOSINOPHIL % (AUTO DIFF), 3.2 %; 119: HEMOGLOBIN (HGB), 11.2 g/dL; 119: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 119: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 119: HR, 62.966; 119: RR, 23.138; 119: SpO2, 99.603; 119: Perf, 1.539; 119: 1min HRV, 132.912; 0: Age, 72; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 35.8; 0: Triage HR, 77.0; 0: Triage RR, 26.0; 0: Triage SBP, 124.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, MULTIPLE COMPLAINTS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first noted the patient\u2019s slightly low temperature and elevated respiratory rate, which can be early indicators of infection. Next, I checked for other signals of serious infection, such as elevated lactate and significant changes in white blood cell count, but the lactate level was normal and the WBC count did not show a major abnormality. The patient\u2019s blood pressure and heart rate remained relatively stable, with no clear signs of acute organ dysfunction. Therefore, I concluded that there is not a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient's temperature is slightly low.",
            "The patient's respiratory rate is elevated.",
            "A slightly low temperature and elevated respiratory rate can be early indicators of infection.",
            "I checked for other signals of serious infection.",
            "Elevated lactate is a signal of serious infection.",
            "Significant changes in white blood cell count are a signal of serious infection.",
            "The lactate level was normal.",
            "The white blood cell count did not show a major abnormality.",
            "The patient's blood pressure remained relatively stable.",
            "The patient's heart rate remained relatively stable.",
            "There were no clear signs of acute organ dysfunction.",
            "I concluded that there is not a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's temperature is slightly low.",
            "A slightly low temperature and elevated respiratory rate can be early indicators of infection.",
            "The white blood cell count did not show a major abnormality."
        ],
        "alignment_scores": [
            0.5,
            0.7,
            0.2
        ],
        "alignment_category": [
            2,
            2,
            2
        ],
        "alignment_reasonings": [
            "A slightly low temperature relates to one of the SIRS criteria (temperature < 36\u00b0C), which supports identifying systemic inflammation or early sepsis. While the claim doesn\u2019t quantify \"slightly low,\" it suggests potential alignment with SIRS, contributing partially to the sepsis prediction.",
            "The claim mentions both a \"slightly low temperature\" and \"elevated respiratory rate,\" which relate to the SIRS criteria",
            "The mention of white blood cell count relates to SIRS criteria, as a WBC > 12,000/\u00b5L or < 4,000/\u00b5L is part of the systemic inflammatory response syndrome. However, the claim notes that there is no major abnormality in the WBC count, which suggests that this specific SIRS criterion is not met. The alignment is thus minimal, as the absence of abnormality does not support sepsis suspicion."
        ],
        "final_alignment_score": 0.4666666666666666,
        "accuracy": 1
    },
    {
        "input": "12: HR, 131.0; 12: RR, 26.0; 12: SpO2, 97.0; 12: SBP, 112.0; 12: DBP, 63.0; 12: MAP, 79.333; 12: Pain, 8.0; 12: Temp, 99.1; 16: HR, 130.224; 16: RR, 31.759; 16: SpO2, 96.810; 16: Perf, 2.298; 16: 1min HRV, 2.130; 17: HR, 130.271; 17: RR, 30.661; 17: SpO2, 96.169; 17: Perf, 2.430; 17: 1min HRV, 2.049; 18: HR, 129.879; 18: RR, 29.517; 18: SpO2, 96.328; 18: Perf, 2.537; 18: 1min HRV, 4.819; 19: HR, 129.661; 19: RR, 33.458; 19: SpO2, 97.0; 19: Perf, 2.426; 19: 1min HRV, 3.290; 20: HR, 128.695; 20: RR, 30.390; 20: SpO2, 96.373; 20: Perf, 2.076; 20: 1min HRV, 2.228; 20: 5min HRV, 3.789; 21: HR, 128.810; 21: RR, 30.638; 21: SpO2, 96.931; 21: Perf, 2.043; 21: 1min HRV, 2.866; 22: HR, 127.407; 22: RR, 31.864; 22: SpO2, 96.814; 22: Perf, 1.983; 22: 1min HRV, 2.082; 23: HR, 127.414; 23: RR, 31.052; 23: SpO2, 95.845; 23: Perf, 1.876; 23: 1min HRV, 2.009; 24: POC PH (V) ISTAT, 7.47; 24: POC PO2 (V) ISTAT, 47 mmHg; 24: POC LACTATE ISTAT, 1.31 mmol/L; 24: POC TCO2 (V) ISTAT, 15 mmol/L; 24: POC PCO2 (V) ISTAT, 19.9 mmHg; 24: POC O2 SATURATION ISTAT VENOUS, 87 %; 24: POC BASE EXCESS ISTAT, -9 mmol/L; 24: POC HCO3 (V) ISTAT, 14.4 mmol/L; 24: HR, 127.051; 24: RR, 32.576; 24: SpO2, 96.288; 24: Perf, 2.031; 24: 1min HRV, 2.624; 25: HR, 127.328; 25: RR, 31.345; 25: SpO2, 95.914; 25: Perf, 1.939; 25: 1min HRV, 2.888; 25: 5min HRV, 3.467; 26: HR, 127.407; 26: RR, 26.644; 26: SpO2, 95.593; 26: Perf, 1.900; 26: 1min HRV, 7.509; 27: HR, 127.932; 27: RR, 29.983; 27: SpO2, 95.780; 27: Perf, 1.887; 27: 1min HRV, 3.685; 28: HR, 127.983; 28: RR, 31.793; 28: SpO2, 94.569; 28: Perf, 2.606; 28: 1min HRV, 1.864; 29: HR, 127.542; 29: RR, 29.492; 29: SpO2, 94.0; 29: Perf, 2.147; 29: 1min HRV, 2.224; 30: 5min HRV, 4.540; 67: PROTEIN TOTAL, 7.2 g/dL; 67: ALKALINE PHOSPHATASE, 91 U/L; 67: ALT (SGPT), 13 U/L; 67: EGFR REFIT WITHOUT RACE (2021), 9 mL/min/1.73 m2; 67: CHLORIDE, 99 mmol/L; 67: GLOBULIN, 3.9 g/dL; 67: CO2, 12 mmol/L; 67: AST (SGOT), 14 U/L; 67: SODIUM, 133 mmol/L; 67: BILIRUBIN TOTAL, 0.8 mg/dL; 67: ANION GAP, 22 mmol/L; 67: ALBUMIN, 3.3 g/dL; 67: CALCIUM, 8.9 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 11 mL/min/1.73 m2; 67: GLUCOSE, 164 mg/dL; 67: CREATININE, 5.68 mg/dL; 67: CORRECTED CALCIUM, 9.5 mg/dL; 67: POTASSIUM, 4.7 mmol/L; 67: BLOOD UREA NITROGEN (BUN), 79 mg/dL; 72: INR, 1.3; 72: PROTHROMBIN TIME, 16.1 seconds; 73: PART. THROMBOPLASTIN TIME, 49.0 seconds; 73: CEFEPIME, 2 GRAM/20 ML IV PUSH; 82: HR:, 113.0; 82: RR, 27.0; 82: SpO2, 97.0; 82: Temp, 102.4; 85: VANCOMYCIN-WATER INJECT (PEG), 1.25 GRAM/250 ML IV PGBK; 86: WAM, DIFTYP: AUTO; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 29.65 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.3 %; 86: RED BLOOD CELLS (RBC), 3.66 MIL/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.0 %; 86: HEMATOCRIT (HCT), 32.2 %; 86: LYMPHOCYTE % (AUTO DIFF), 2.1 %; 86: HEMOGLOBIN (HGB), 10.4 g/dL; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: PLATELET COUNT (PLT), 420 K/uL; 86: MONOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.1 %; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.34 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 94.9 %; 86: WHITE BLOOD CELLS (WBC), 31.2 K/uL; 86: MEAN CORPUSCULAR VOLUME (MCV), 88.0 fL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.8 %; 86: METAMYELOCYTE/MYELOCYTE/PROMYELOCYTE (SLIDE REVIEW), 54 %; 86: LR IV BOLUS -, 30 ML/KG (ED FOR BMI <= 30); 90: HR:, 116.0; 90: RR, 26.0; 90: SpO2, 97.0; 90: SBP, 95.0; 90: DBP, 56.0; 90: MAP, 69.0; 110: HR, 110.0; 110: RR, 29.0; 110: SpO2, 95.0; 110: SBP, 96.0; 110: DBP, 58.0; 110: MAP, 70.667; 0: Age, 73; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 131.0; 0: Triage RR, 26.0; 0: Triage SBP, 112.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,ABDOMINAL PAIN,NAUSEA",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noticed the patient\u2019s elevated heart rate, respiratory rate, and blood pressure trends, which could indicate systemic stress. Then I looked for signs of infection, such as fever and high WBC count. I also checked for potential organ dysfunction, evidenced by the elevated creatinine and low eGFR indicating kidney injury. Combining these findings suggested a high risk of developing sepsis within the next 12 hours. This led me to conclude that the patient is at high risk of sepsis.",
        "claims": [
            "The patient has an elevated heart rate, respiratory rate, and blood pressure trends.",
            "Elevated heart rate, respiratory rate, and blood pressure trends could indicate systemic stress.",
            "Signs of infection were assessed by looking for fever and high WBC count.",
            "Potential organ dysfunction was checked by evaluating elevated creatinine and low eGFR.",
            "Elevated creatinine and low eGFR indicate kidney injury.",
            "Combining these findings suggested a high risk of developing sepsis within the next 12 hours.",
            "The combination of these findings led to the conclusion that the patient is at high risk of sepsis."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate, respiratory rate, and blood pressure trends.",
            "Elevated heart rate, respiratory rate, and blood pressure trends could indicate systemic stress.",
            "Signs of infection were assessed by looking for fever and high WBC count.",
            "Potential organ dysfunction was checked by evaluating elevated creatinine and low eGFR.",
            "Elevated creatinine and low eGFR indicate kidney injury.",
            "Combining these findings suggested a high risk of developing sepsis within the next 12 hours.",
            "The combination of these findings led to the conclusion that the patient is at high risk of sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.8,
            0.8,
            1.0,
            0.3,
            0.6
        ],
        "alignment_category": [
            2,
            2,
            2,
            8,
            8,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions an elevated heart rate and respiratory rate, both of which are part of the SIRS criteria. However, the alignment is not perfect because elevated blood pressure is not explicitly part of the SIRS definition. The presence of two relevant criteria (elevated heart rate and respiratory rate) provides a moderate alignment with the SIRS Positivity category.",
            "The claim mentions elevated heart rate and respiratory rate, both of which are directly listed within the SIRS criteria. SIRS criteria include heart rate\u202f>\u202f90 bpm and respiratory rate\u202f>\u202f20/min, which are indicators of systemic inflammatory response. While blood pressure trends are mentioned, they are not part of the SIRS criteria, so the alignment is not perfect. However, the presence of two relevant criteria provides a strong, but not complete, alignment with the SIRS category.",
            "The claim involves assessment for fever and high WBC count, which are both explicit criteria within the SIRS criteria for identifying systemic inflammation consistent with early sepsis. While the claim does not specify exact values, assessing for these signs strongly aligns with SIRS Positivity, since temperature and WBC count are key components. The lack of specific values slightly reduces the alignment from perfect.",
            "The claim involves evaluating organ dysfunction through elevated creatinine and low eGFR. Elevated creatinine is specifically included in the SOFA score for assessing renal function. While low eGFR isn't directly mentioned in SOFA, it is relevant to assessing kidney function and potential dysfunction. Hence, the alignment with the SOFA score criteria is strong but not perfect due to indirect citation of eGFR.",
            "Elevated creatinine is directly related to the kidney function component of the SOFA score, where an increase in creatinine is a criterion for assessing organ dysfunction. Therefore, this aligns perfectly with the SOFA Score Increase category for high sepsis risk.",
            "The claim refers to an aggregation of findings that collectively predict a high risk of sepsis. While the specific findings or scores aren't detailed, the description of indicating a \"high risk of developing sepsis\" aligns conceptually with the purpose of the NEWS score, which compiles various clinical parameters to assess the risk of deterioration. The alignment is not strong due to lack of specifics, hence a moderate rating is assigned.",
            "The claim is broad and does not directly mention specific clinical criteria. However, the phrase \"combination of these findings\" implies an aggregate assessment, which suggests a systematic evaluation of multiple observations\u2014akin to how the NEWS score consolidates various vital signs to predict deterioration. The alignment is somewhat indirect, due to the vague nature of the claim, but suggests a comprehensive consideration like the NEWS scores."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 97.0; 2: SBP, 206.0; 2: DBP, 115.0; 2: MAP, 145.333; 3: SpO2, 97.185; 4: SpO2, 97.019; 4: Perf, 0.720; 5: SpO2, 97.491; 5: Perf, 0.742; 6: SpO2, 97.208; 6: Perf, 0.717; 7: SpO2, 98.0; 7: Perf, 0.701; 8: HR, 103.0; 8: RR, 18.0; 8: SpO2, 97.623; 8: Perf, 0.68; 8: SBP, 206.0; 8: DBP, 115.0; 8: MAP, 145.333; 8: Pain, 10.0; 9: SpO2, 97.615; 9: Perf, 0.680; 10: SpO2, 97.604; 10: Perf, 0.69; 11: SpO2, 98.0; 11: Perf, 0.772; 12: SpO2, 97.830; 12: Perf, 0.758; 13: SpO2, 97.566; 13: Perf, 0.740; 14: SpO2, 98.154; 14: Perf, 0.769; 15: SpO2, 98.189; 15: Perf, 0.763; 16: SpO2, 97.846; 16: Perf, 0.704; 17: SpO2, 97.283; 17: Perf, 0.726; 18: SpO2, 97.0; 18: Perf, 0.831; 19: SpO2, 97.242; 20: SpO2, 97.115; 20: Perf, 0.737; 21: SpO2, 96.923; 21: Perf, 0.927; 22: SpO2, 97.0; 23: SpO2, 97.586; 23: Perf, 1.114; 24: HR, 100.0; 24: RR, 18.0; 24: SpO2, 94.111; 24: SBP, 197.0; 24: DBP, 103.0; 24: MAP, 134.333; 25: SpO2, 97.0; 25: SBP, 197.0; 25: DBP, 103.0; 25: MAP, 134.333; 27: SpO2, 97.364; 28: SpO2, 97.623; 28: Perf, 1.001; 29: SpO2, 97.0; 29: Perf, 1.053; 31: SpO2, 88.0; 33: WAM DIFTYP, AUTO; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.39 K/uL; 33: LYMPHOCYTE % (AUTO DIFF), 14.0 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 33: MEAN CORPUSCULAR VOLUME (MCV), 99.5 fL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: PLATELET COUNT (PLT), 376 K/uL; 33: MONOCYTE % (AUTO DIFF), 7.3 %; 33: HEMOGLOBIN (HGB), 12.5 g/dL; 33: HEMATOCRIT (HCT), 39.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 77.1 %; 33: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.98 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.89 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 0.1 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 33: RED BLOOD CELLS (RBC), 3.96 MIL/uL; 33: SpO2, 94.0; 34: ACETAMINOPHEN, 325 MG PO TABS; 35: SpO, 2: 97.917; 36: SpO2, 97.308; 36: Perf, 0.873; 36: AMPICILLIN-SULBACTAM, 3 GRAM/100 ML MINIBAG PLUS; 37: SpO, 2: 97.170; 37: Perf, 0.920; 38: SpO2, 97.0; 38: Perf, 0.895; 39: SpO2, 97.0; 39: Perf, 0.892; 40: SpO2, 97.0; 40: Perf, 0.86; 41: SpO2, 97.0; 41: Perf, 0.827; 42: SpO2, 97.744; 43: SpO2, 98.0; 43: Perf, 0.891; 44: SpO2, 97.588; 44: Perf, 1.045; 45: SpO2, 97.0; 45: Perf, 0.975; 46: SpO2, 96.731; 46: Perf, 1.045; 47: SpO2, 96.302; 47: Perf, 1.191; 48: SpO2, 96.654; 48: Perf, 1.225; 49: SpO2, 97.0; 49: Perf, 1.303; 50: SpO2, 97.0; 50: Perf, 1.328; 51: SpO2, 97.0; 51: Perf, 1.327; 52: SpO2, 97.0; 52: Perf, 1.391; 53: SpO2, 97.0; 53: Perf, 1.318; 54: SpO2, 96.868; 54: Perf, 1.406; 55: SpO2, 96.0; 55: Perf, 1.390; 56: SpO2, 96.226; 56: Perf, 1.419; 57: SpO2, 96.327; 57: Perf, 1.422; 58: SpO2, 96.0; 58: Perf, 1.384; 59: SpO2, 95.774; 59: Perf, 1.254; 60: SpO2, 96.096; 60: Perf, 1.303; 61: SpO2, 96.264; 61: Perf, 1.389; 62: SpO2, 96.0; 62: Perf, 1.226; 63: SpO2, 95.340; 63: Perf, 1.125; 64: SpO2, 96.962; 64: Perf, 1.310; 65: SpO2, 97.0; 65: Perf, 1.818; 66: AST (SGOT), 33 U/L; 66: GLUCOSE, 102 mg/dL; 66: ALBUMIN, 4.3 g/dL; 66: PROTEIN TOTAL, 7.3 g/dL; 66: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 66: BILIRUBIN TOTAL, 1.5 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 78 mL/min/1.73 m2; 66: SODIUM, 138 mmol/L; 66: CREATININE, 0.76 mg/dL; 66: GLOBULIN, 3.0 g/dL; 66: EGFR REFIT WITHOUT RACE (2021), 67 mL/min/1.73 m2; 66: ALKALINE PHOSPHATASE, 150 U/L; 66: ANION GAP, 13 mmol/L; 66: CO2, 23 mmol/L; 66: CALCIUM, 9.4 mg/dL; 66: CHLORIDE, 102 mmol/L; 66: CORRECTED CALCIUM, 9.2 mg/dL; 66: POTASSIUM, 4.3 mmol/L; 66: ALT (SGPT), 28 U/L; 66: SpO2, 96.943; 66: Perf, 1.860; 67: SpO2, 96.827; 67: Perf, 1.841; 68: SpO2, 96.0; 68: Perf, 1.759; 69: SpO2, 96.113; 69: Perf, 1.695; 70: SpO2, 95.951; 70: Perf, 1.700; 71: SpO2, 96.0; 71: Perf, 1.540; 72: SpO2, 96.173; 72: Perf, 1.488; 73: SpO2, 96.0; 73: Perf, 1.600; 74: SpO2, 95.151; 74: Perf, 1.457; 75: SpO2, 95.904; 75: Perf, 1.517; 76: SpO2, 95.925; 76: Perf, 1.477; 77: SpO2, 95.058; 77: Perf, 1.363; 78: SpO2, 96.0; 78: Perf, 1.658; 79: SpO2, 95.642; 79: Perf, 1.595; 80: SpO2, 95.327; 80: Perf, 1.426; 81: SpO2, 95.226; 81: Perf, 1.360; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 95.0; 82: Perf, 1.314; 83: SpO2, 94.509; 83: Perf, 1.301; 84: SpO2, 94.538; 84: Perf, 1.324; 85: SpO2, 94.725; 85: Perf, 1.390; 104: SpO2, 96.365; 104: Perf, 1.140; 105: SpO2, 96.0; 105: Perf, 1.179; 106: SpO2, 96.0; 106: Perf, 1.165; 107: SpO2, 96.0; 108: SpO2, 96.721; 108: Perf, 1.267; 109: SpO2, 96.635; 109: Perf, 1.278; 110: SpO2, 96.245; 110: Perf, 1.290; 111: SpO2, 96.0; 111: Perf, 1.262; 112: SpO2, 96.282; 112: Perf, 1.303; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 113: SpO, 2: 97.0; 113: Perf, 1.497; 114: SpO2, 97.0; 114: Perf, 1.674; 115: SpO2, 97.189; 115: Perf, 1.635; 116: SpO2, 96.942; 116: Perf, 1.490; 117: SpO2, 97.377; 117: Perf, 1.634; 118: SpO2, 97.226; 118: Perf, 1.614; 119: SpO2, 96.635; 119: Perf, 1.432; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.4; 0: Triage HR, 103.0; 0: Triage RR, 18.0; 0: Triage SBP, 206.0; 0: Triage DBP, 115.0; 0: Triage acuity, 3-Urgent; 0: CC, JAW SWELLING",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first evaluated the patient\u2019s vital signs, noting that while the WBC count is slightly elevated and the heart rate is mildly tachycardic, there is no clear indication of organ dysfunction or hypotension. Next, I considered that the patient\u2019s blood pressure is actually quite high and that their respiratory rate and temperature remain within an acceptable range. These observations do not meet multiple sepsis criteria (such as qSOFA or severe SIRS), suggesting a lower risk for imminent sepsis. Therefore, the data do not strongly support a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs were evaluated.",
            "The WBC count is slightly elevated.",
            "The heart rate is mildly tachycardic.",
            "There is no clear indication of organ dysfunction.",
            "There is no clear indication of hypotension.",
            "The patient's blood pressure is quite high.",
            "The patient's respiratory rate is within an acceptable range.",
            "The patient's temperature is within an acceptable range.",
            "These observations do not meet multiple sepsis criteria.",
            "The criteria considered include qSOFA and severe SIRS.",
            "The observations suggest a lower risk for imminent sepsis.",
            "The data do not strongly support a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is mildly tachycardic.",
            "There is no clear indication of organ dysfunction.",
            "There is no clear indication of hypotension.",
            "The patient's blood pressure is quite high."
        ],
        "alignment_scores": [
            0.5,
            0.7,
            0.6,
            0.3
        ],
        "alignment_category": [
            2,
            8,
            7,
            6
        ],
        "alignment_reasonings": [
            "Mild tachycardia (elevated heart rate) is one of the SIRS criteria, which include a heart rate >90 bpm. The claim mentions a condition that is a direct component of the SIRS criteria but does not specify if the heart rate exceeds 90 bpm. Thus, there is a relevant but partial alignment with the SIRS Positivity category.",
            "The SOFA Score Increase category is concerned with identifying organ dysfunction. The claim specifically notes \"no clear indication of organ dysfunction,\" which aligns with the absence of SOFA Score markers. Therefore, this category addresses the presence (or in this case, the absence) of the criteria that signify organ dysfunction, offering relevant context for the patient's risk of sepsis. While the claim negates dysfunction rather than confirms it, it remains highly relevant to the category's focus on organ function assessment.",
            "The claim directly mentions the absence of hypotension, which relates to the category focused on sepsis-associated hypotension. Although the claim does not meet the criteria, it specifically addresses it by negation, indicating its consideration in assessing sepsis risk, thus reflecting moderate alignment.",
            "The claim mentions that the patient's blood pressure is quite high, which indirectly relates to the concept of hemodynamic parameters involved in shock index calculation (heart rate \u00f7 systolic BP). While high blood pressure alone does not directly indicate elevated shock index, it relates to cardiovascular status. Therefore, the alignment with the category is indirect and relatively weak."
        ],
        "final_alignment_score": 0.5249999999999999,
        "accuracy": 1
    },
    {
        "input": "4: HR, 106.0; 4: RR, 18.0; 4: SpO2, 95.0; 4: SBP, 118.0; 4: DBP, 57.0; 4: MAP, 77.333; 4: Temp, 100.6; 11: Pain, 10.0; 78: INFLUENZA B, Not Detected; 78: RSV, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 86: WAM DIFTYP, AUTO; 86: MONOCYTE % (AUTO DIFF), 3.2 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.37 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.89 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.2 %; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 93.9 %; 86: HEMOGLOBIN (HGB), 12.1 g/dL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.1 %; 86: PLATELET COUNT (PLT), 296 K/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.1 %; 86: MEAN CORPUSCULAR VOLUME (MCV), 83.9 fL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 86: LYMPHOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 86: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.9 pg; 86: HEMATOCRIT (HCT), 36.4 %; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: RED BLOOD CELLS (RBC), 4.34 MIL/uL; 89: SpO2, 96.0; 89: Perf, 4.079; 90: AST (SGOT), 114 U/L; 90: PROTEIN TOTAL, 6.9 g/dL; 90: ALT (SGPT), 110 U/L; 90: CREATININE, 0.54 mg/dL; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.6 mg/dL; 90: ALBUMIN, 4.0 g/dL; 90: ALKALINE PHOSPHATASE, 96 U/L; 90: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 90: POTASSIUM, 3.9 mmol/L; 90: CHLORIDE, 101 mmol/L; 90: GLUCOSE, 133 mg/dL; 90: SODIUM, 137 mmol/L; 90: ANION GAP, 15 mmol/L; 90: CO2, 21 mmol/L; 90: CORRECTED CALCIUM, 9.4 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 90: CALCIUM, 9.4 mg/dL; 90: HR, 84.517; 90: RR, 21.292; 90: SpO2, 95.458; 90: Perf, 4.041; 90: 1min HRV, 10.199; 91: HR, 83.949; 91: RR, 23.932; 91: SpO2, 95.590; 91: Perf, 3.659; 91: 1min HRV, 11.842; 91: 5min HRV, 11.409; 91: SBP, 116.0; 91: DBP, 50.0; 91: MAP, 72.0; 92: HR, 83.879; 92: RR, 27.276; 92: SpO2, 94.408; 92: Perf, 4.016; 92: 1min HRV, 9.479; 93: HR, 83.644; 93: RR, 26.017; 93: SpO2, 95.0; 93: Perf, 5.217; 93: 1min HRV, 10.131; 94: HR, 85.362; 94: RR, 23.397; 94: SpO2, 94.207; 94: Perf, 5.130; 94: 1min HRV, 10.629; 95: HR, 85.017; 95: RR, 22.847; 95: SpO2, 93.881; 95: Perf, 5.692; 95: 1min HRV, 11.154; 96: HR, 86.103; 96: RR, 22.017; 96: SpO2, 93.172; 96: Perf, 6.053; 96: 1min HRV, 6.565; 96: 5min HRV, 12.675; 97: HR, 88.797; 97: RR, 23.356; 97: SpO2, 91.763; 97: Perf, 5.578; 97: 1min HRV, 7.669; 98: HR, 88.475; 98: RR, 24.407; 98: SpO2, 92.407; 98: Perf, 5.426; 98: 1min HRV, 9.469; 99: HR, 89.207; 99: RR, 25.948; 99: SpO2, 92.172; 99: Perf, 5.348; 99: 1min HRV, 6.386; 100: HR, 86.966; 100: RR, 25.237; 100: SpO2, 92.068; 100: Perf, 5.777; 100: 1min HRV, 9.830; 101: HR, 86.914; 101: RR, 23.397; 101: SpO2, 94.155; 101: Perf, 6.101; 101: 1min HRV, 9.211; 101: 5min HRV, 11.822; 102: HR, 86.542; 102: RR, 24.0; 102: SpO2, 92.156; 102: Perf, 5.225; 102: 1min HRV, 5.188; 102: SBP, 110.0; 102: DBP, 58.0; 102: MAP, 75.333; 103: HR, 87.780; 103: RR, 23.678; 103: SpO2, 91.780; 103: Perf, 4.880; 103: 1min HRV, 7.196; 104: HR, 87.845; 104: RR, 25.397; 104: SpO2, 91.707; 104: Perf, 4.783; 104: 1min HRV, 8.222; 105: HR, 88.525; 105: RR, 26.814; 105: SpO2, 92.051; 105: Perf, 4.338; 105: 1min HRV, 7.789; 106: HIGH SENSITIVITY TROPONIN, 4 ng/L; 106: HR, 88.931; 106: RR, 25.759; 106: SpO2, 92.517; 106: Perf, 4.301; 106: 1min HRV, 8.454; 106: 5min HRV, 10.096; 107: HR, 88.847; 107: RR, 28.763; 107: SpO2, 92.712; 107: Perf, 4.237; 107: 1min HRV, 8.968; 108: HR, 88.322; 108: RR, 27.695; 108: SpO2, 94.831; 108: Perf, 4.0; 108: 1min HRV, 12.599; 109: HR, 88.897; 109: RR, 25.276; 109: SpO2, 96.0; 109: Perf, 4.164; 109: 1min HRV, 19.491; 110: HR, 86.797; 110: RR, 25.288; 110: SpO2, 96.0; 110: Perf, 4.062; 110: 1min HRV, 18.006; 111: HR, 85.241; 111: RR, 25.534; 111: SpO2, 95.534; 111: Perf, 4.561; 111: 1min HRV, 11.685; 111: 5min HRV, 18.796; 112: HR, 86.254; 112: RR, 25.847; 112: SpO2, 95.0; 112: Perf, 4.068; 112: 1min HRV, 14.892; 113: HR, 85.492; 113: RR, 26.373; 113: SpO2, 94.492; 113: Perf, 4.149; 113: 1min HRV, 12.022; 114: HR, 85.155; 114: RR, 23.362; 114: SpO2, 94.759; 114: Perf, 4.107; 114: 1min HRV, 17.338; 114: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 115: HR:, 85.966; 115: RR, 25.119; 115: SpO2, 94.932; 115: Perf, 3.909; 115: 1min HRV, 18.567; 115: SBP, 110.0; 115: DBP, 58.0; 115: MAP, 75.333; 115: Pain, 10.0; 116: HR, 94.586; 116: RR, 23.483; 116: SpO2, 95.224; 116: Perf, 2.791; 116: 1min HRV, 9.841; 116: 5min HRV, 32.305; 117: HR, 93.407; 117: RR, 20.458; 117: SpO2, 95.912; 117: Perf, 2.549; 117: 1min HRV, 28.365; 117: SBP, 132.0; 117: DBP, 60.0; 117: MAP, 84.0; 118: HR, 85.695; 118: RR, 26.695; 118: SpO2, 96.424; 118: Perf, 3.112; 118: 1min HRV, 16.910; 119: HR, 88.931; 119: RR, 22.603; 119: SpO2, 97.362; 119: Perf, 4.151; 119: 1min HRV, 14.827; 0: Age, 68; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first observed the patient\u2019s fever and tachycardia, which raised my concern for an infectious process. Next, I noted the significantly elevated white blood cell count, especially with neutrophil predominance, pointing toward a possible severe infection. I also considered the patient\u2019s low diastolic pressure and need for antibiotic therapy as critical signs of potential sepsis. Based on these clues, I concluded the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I first observed the patient\u2019s fever.",
            "The patient has tachycardia.",
            "The fever and tachycardia raised my concern for an infectious process.",
            "I noted the significantly elevated white blood cell count.",
            "The white blood cell count shows neutrophil predominance.",
            "Neutrophil predominance points toward a possible severe infection.",
            "I considered the patient\u2019s low diastolic pressure as a critical sign of potential sepsis.",
            "The patient has a need for antibiotic therapy.",
            "The need for antibiotic therapy is a critical sign of potential sepsis.",
            "Based on these clues, I concluded the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has tachycardia.",
            "The fever and tachycardia raised my concern for an infectious process.",
            "I noted the significantly elevated white blood cell count.",
            "The white blood cell count shows neutrophil predominance.",
            "Neutrophil predominance points toward a possible severe infection.",
            "I considered the patient\u2019s low diastolic pressure as a critical sign of potential sepsis.",
            "The patient has a need for antibiotic therapy.",
            "The need for antibiotic therapy is a critical sign of potential sepsis.",
            "Based on these clues, I concluded the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            1.0,
            0.8,
            0.7,
            0.7,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            2,
            7,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is one of the specific criteria listed for SIRS positivity. While the claim does not specify the heart rate number, tachycardia is directly related to the SIRS criteria for identifying systemic inflammation consistent with early sepsis. The alignment is fairly strong, but it would be stronger if additional SIRS criteria were met.",
            "The claim mentions fever and tachycardia, both of which are criteria in the SIRS category (temperature >38\u00b0C and heart rate >90 bpm, respectively). These signs indicate systemic inflammation, which aligns closely with SIRS criteria, suggesting early signs of sepsis. However, since the exact temperature and heart rate are not provided in the claim to confirm meeting both criteria, the alignment is not perfect.",
            "The claim directly references an \"elevated white blood cell count,\" which is one of the criteria explicitly listed under SIRS Positivity for identifying systemic inflammation consistent with early sepsis. The alignment is perfect as it matches one of the key indicators in this category.",
            "Neutrophil predominance implies an increase in total white blood cell count, which is a sign of inflammation or infection and is conceptually related to elevated WBC levels. While the claim does not explicitly mention elevated WBC, the reference to neutrophil predominance suggests an inflammatory response, which aligns closely with the SIRS criteria. The alignment rating is high but not perfect, as the claim does not explicitly state the WBC count itself.",
            "Neutrophil predominance suggests a response to infection, consistent with the inflammatory process associated with SIRS criteria. While it does not directly mention temperature, heart rate, respiratory rate, PaCO\u2082, or specific WBC counts, it aligns with the underlying concept of systemic inflammation. The alignment is not perfect, as it does not fully satisfy the SIRS criteria, but it is closely related.",
            "The claim mentions low diastolic pressure as a critical sign, which suggests hemodynamic instability consistent with hypotension. While the claim does not specify systolic blood pressure (SBP) or mean arterial pressure (MAP), low diastolic pressure can contribute to sepsis-associated hypotension, relevant to Category 7. However, the absence of specific values like SBP or MAP results in partial rather than full alignment.",
            "The claim indicates the need for antibiotic therapy, which implies a suspicion of serious infection. This corresponds with clinician behavior relevant to sepsis risk. However, the claim does not specify the timing (within 2 hours) or any culture orders, so it is not a perfect alignment, resulting in a slightly less than full rating.",
            "The claim centers on the need for antibiotic therapy due to suspicions of sepsis. This aligns with the category concerning early initiation of antibiotics as a component of sepsis risk assessment. However, the claim does not specify the timing of the antibiotics initiation (within 2 hours), so it doesn't fully meet the category's criteria, making the alignment significant but not complete.",
            "The claim suggests a general high risk of sepsis, which aligns with predictive scoring systems like the NEWS. However, without specific vitals or scores mentioned, the alignment is weak\u2014though the intent of predicting risk is conceptually aligned with what a NEWS score aims to achieve."
        ],
        "final_alignment_score": 0.711111111111111,
        "accuracy": 1
    },
    {
        "input": "5: HR, 89.0; 5: RR, 26.0; 5: SpO2, 99.422; 5: SBP, 134.0; 5: DBP, 89.0; 5: MAP, 104.0; 5: Temp, 98.0; 6: HR, 82.0; 6: RR, 25.0; 6: SpO2, 100.0; 6: Perf, 1.743; 6: 1min HRV, 8.815; 7: HR, 82.441; 7: RR, 24.983; 7: SpO2, 100.0; 7: Perf, 1.750; 7: 1min HRV, 13.853; 8: HR, 87.914; 8: RR, 19.672; 8: SpO2, 100.0; 8: Perf, 1.710; 8: 1min HRV, 19.853; 9: HR, 87.593; 9: RR, 24.797; 9: SpO2, 100.0; 9: Perf, 1.685; 9: 1min HRV, 11.920; 10: HR, 86.186; 10: RR, 20.915; 10: SpO2, 100.0; 10: Perf, 1.863; 10: 1min HRV, 15.067; 10: 5min HRV, 23.610; 11: HR, 82.586; 11: RR, 28.431; 11: SpO2, 100.0; 11: Perf, 2.261; 11: 1min HRV, 49.671; 12: HR, 84.254; 12: RR, 25.051; 12: SpO2, 100.0; 12: Perf, 2.640; 12: 1min HRV, 23.906; 13: HR, 82.707; 13: RR, 27.845; 13: SpO2, 100.0; 13: Perf, 2.562; 13: 1min HRV, 14.888; 14: HR, 83.051; 14: RR, 23.678; 14: SpO2, 100.0; 14: Perf, 2.033; 14: 1min HRV, 64.432; 15: HR, 81.288; 15: RR, 24.712; 15: SpO2, 100.0; 15: Perf, 1.790; 15: 1min HRV, 14.575; 15: 5min HRV, 40.136; 15: SBP, 127.0; 15: DBP, 77.0; 15: MAP, 93.667; 16: HR, 81.0; 16: RR, 24.5; 16: SpO2, 100.0; 16: Perf, 1.82; 16: 1min HRV, 0.0; 18: POC PH (V) ISTAT, 7.29; 18: POC PO2 (V) ISTAT, 19 mmHg; 18: POC PCO2 (V) ISTAT, 68.2 mmHg; 18: POC LACTATE ISTAT, 0.77 mmol/L; 18: POC HCO3 (V) ISTAT, 33.0 mmol/L; 18: POC TCO2 (V) ISTAT, 35 mmol/L; 18: POC BASE EXCESS ISTAT, 6 mmol/L; 18: POC O2 SATURATION ISTAT VENOUS, 22 %; 20: HR, 83.0; 20: RR, 27.0; 20: SpO2, 100.0; 20: 5min HRV, 0.0; 20: SBP, 132.0; 20: DBP, 77.0; 20: MAP, 95.333; 23: HR, 81.0; 23: RR, 22.0; 23: SpO2, 100.0; 23: SBP, 132.0; 23: DBP, 77.0; 23: MAP, 95.333; 23: LPM O2, 15.0; 24: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 25: HR:, 85.0; 25: RR, 27.0; 25: SpO2, 100.0; 59: ALBUTEROL SULFATE, 90 MCG/ACTUATION INH HFAA; 66: RR:, 25.0; 66: SpO2, 100.0; 66: LPM O2, 12.0; 80: HR, 81.0; 80: RR, 23.0; 80: SpO2, 100.0; 80: LPM O2, 3.0; 90: INR, 1.1; 90: PROTHROMBIN TIME, 13.6 seconds; 91: PART. THROMBOPLASTIN TIME, 29.2 seconds; 99: WAM DIFTYP, AUTO; 99: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 99: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.43 K/uL; 99: MEAN CORPUSCULAR VOLUME (MCV), 95.1 fL; 99: RED CELL DISTRIBUTION WIDTH (RDW), 13.6 %; 99: EOSINOPHIL % (AUTO DIFF), 2.0 %; 99: PLATELET COUNT (PLT), 136 K/uL; 99: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 99: MONOCYTE % (AUTO DIFF), 9.3 %; 99: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 99: HEMOGLOBIN (HGB), 14.2 g/dL; 99: BASOPHIL % (AUTO DIFF), 0.4 %; 99: NEUTROPHIL % (AUTO DIFF), 58.2 %; 99: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 99: LYMPHOCYTE % (AUTO DIFF), 29.8 %; 99: WHITE BLOOD CELLS (WBC), 9.3 K/uL; 99: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.78 K/uL; 99: NRBC PERCENT (HEMATOLOGY), 0.0 %; 99: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 99: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.19 K/uL; 99: HEMATOCRIT (HCT), 44.3 %; 99: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 99: RED BLOOD CELLS (RBC), 4.66 MIL/uL; 99: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 105: D-DIMER ELISA, 522 ng/mL FEU; 105: HR, 82.0; 105: RR, 20.0; 105: SpO2, 100.0; 105: SBP, 119.0; 105: DBP, 74.0; 105: MAP, 89.0; 105: LPM O2, 3.0; 107: POTASSIUM, 3.9 mmol/L; 107: ALT (SGPT), 23 U/L; 107: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 107: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 107: EGFR FOR AFRICAN AMERICAN, 106 mL/min/1.73 m2; 107: GLOBULIN, 2.6 g/dL; 107: ANION GAP, 9 mmol/L; 107: SODIUM, 144 mmol/L; 107: BILIRUBIN TOTAL, 0.6 mg/dL; 107: MAGNESIUM, 2.1 mg/dL; 107: AST (SGOT), 25 U/L; 107: CALCIUM, 9.0 mg/dL; 107: ALBUMIN, 4.4 g/dL; 107: CORRECTED CALCIUM, 8.7 mg/dL; 107: ALKALINE PHOSPHATASE, 65 U/L; 107: CREATININE, 0.88 mg/dL; 107: CHLORIDE, 103 mmol/L; 107: PROTEIN TOTAL, 7.0 g/dL; 107: GLUCOSE, 128 mg/dL; 107: CO2, 32 mmol/L; 107: HR, 70.55; 107: RR, 20.2; 107: SpO2, 98.0; 107: 1min HRV, 16.197; 108: HR, 69.717; 108: RR, 21.483; 108: SpO2, 98.45; 108: Perf, 10.850; 108: 1min HRV, 18.305; 108: SBP, 162.0; 108: DBP, 70.0; 108: MAP, 100.667; 109: HR, 70.741; 109: RR, 23.603; 109: SpO2, 98.0; 109: Perf, 10.095; 109: 1min HRV, 14.727; 110: HR, 70.525; 110: RR, 23.678; 110: SpO2, 97.729; 110: Perf, 10.250; 110: 1min HRV, 18.191; 110: 5min HRV, 17.916; 111: HR, 69.593; 111: RR, 21.678; 111: SpO2, 98.0; 111: Perf, 11.894; 111: 1min HRV, 17.194; 112: HR, 68.845; 112: RR, 22.069; 112: SpO2, 98.172; 112: Perf, 11.066; 112: 1min HRV, 18.784; 113: HR, 68.932; 113: RR, 23.898; 113: SpO2, 98.0; 113: Perf, 11.114; 113: 1min HRV, 17.758; 114: HR, 68.983; 114: RR, 19.983; 114: SpO2, 98.034; 114: Perf, 9.912; 114: 1min HRV, 17.644; 115: HR, 68.881; 115: RR, 21.441; 115: SpO2, 98.0; 115: Perf, 10.051; 115: 1min HRV, 14.015; 115: 5min HRV, 17.415; 116: HR, 67.797; 116: RR, 21.915; 116: SpO2, 97.881; 116: Perf, 10.571; 116: 1min HRV, 19.510; 117: HR, 68.259; 117: RR, 23.586; 117: SpO2, 98.0; 117: Perf, 10.108; 117: 1min HRV, 37.164; 118: HR, 68.525; 118: RR, 23.627; 118: SpO2, 98.0; 118: Perf, 9.978; 118: 1min HRV, 14.901; 119: HR, 68.138; 119: RR, 17.828; 119: SpO2, 98.362; 119: Perf, 9.379; 119: 1min HRV, 11.541; 0: Age, 64; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 89.0; 0: Triage RR, 26.0; 0: Triage SBP, 134.0; 0: Triage DBP, 89.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I considered whether the patient\u2019s vital signs or labs indicated an imminent risk of sepsis, focusing on temperature, heart rate, blood pressure, and lactate levels. I noted that the patient\u2019s lactate was within a normal range, the white blood cell count was not significantly elevated, and blood pressures were relatively stable. While the respiratory rate was elevated, there were no strong signs of systemic infection or organ dysfunction. Thus, the data do not support a high risk of sepsis within the next 12 hours.",
        "claims": [
            "I considered whether the patient\u2019s vital signs or labs indicated an imminent risk of sepsis.",
            "I focused on temperature, heart rate, blood pressure, and lactate levels.",
            "The patient\u2019s lactate was within a normal range.",
            "The white blood cell count was not significantly elevated.",
            "Blood pressures were relatively stable.",
            "The respiratory rate was elevated.",
            "There were no strong signs of systemic infection.",
            "There were no signs of organ dysfunction.",
            "The data do not support a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The respiratory rate was elevated.",
            "There were no strong signs of systemic infection.",
            "The data do not support a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.2
        ],
        "alignment_category": [
            2,
            9,
            4
        ],
        "alignment_reasonings": [
            "An elevated respiratory rate is directly mentioned in the SIRS criteria (respiratory rate > 20/min). The claim aligns with one aspect of the SIRS Positivity category; however, without additional information on accompanying criteria (such as temperature, heart rate, or WBC count), it does not fully meet the threshold for SIRS positivity. The alignment is strong enough due to its direct relevance to the category but not complete.",
            "The claim suggests low suspicion of systemic infection, which inversely relates to the logic behind early antibiotic/culture orders (i.e., high suspicion would prompt ordering these within 2 hours). Since there\u2019s a lack of strong infection indicators, it indirectly touches on the absence of a need for urgent sepsis-related actions. However, since there is no direct reference to clinical actions taken or not taken within a critical time frame, the alignment is quite weak.",
            "The claim suggests a low risk of sepsis, which implies the absence of indicators predicting imminent clinical deterioration. The Elevated NEWS Score category relates to predictions of clinical deterioration, with a higher score indicating higher risk. However, the claim does not directly mention a lack of elevated NEWS score or similar specifics, but the general implication of low risk aligns minimally with the opposite of what this category assesses."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 1
    },
    {
        "input": "5: HR, 116.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 100.0; 5: DBP, 53.0; 5: MAP, 68.667; 5: Temp, 98.8; 10: Pain, 0.0; 51: SpO2, 97.0; 51: Perf, 4.984; 52: SpO2, 97.089; 52: Perf, 4.915; 53: SpO2, 98.595; 54: SpO2, 96.5; 54: Perf, 4.248; 55: SpO2, 96.102; 55: Perf, 4.384; 55: SBP, 131.0; 55: DBP, 110.0; 55: MAP, 117.0; 56: HR, 131.0; 56: RR, 18.0; 56: SpO2, 94.517; 56: Perf, 4.223; 57: SpO2, 97.086; 57: Perf, 4.379; 58: SpO2, 96.390; 58: Perf, 5.404; 58: SBP, 136.0; 58: DBP, 73.0; 58: MAP, 94.0; 59: SpO2, 96.397; 59: Perf, 5.06; 60: SpO2, 95.729; 60: Perf, 5.474; 61: SpO2, 95.542; 61: Perf, 5.584; 62: SpO2, 94.190; 62: Perf, 6.141; 63: SpO2, 93.339; 63: Perf, 6.243; 64: SpO2, 92.707; 64: Perf, 6.196; 65: SpO2, 92.831; 65: Perf, 5.624; 66: SpO2, 93.655; 66: Perf, 5.275; 67: SpO2, 93.466; 67: Perf, 5.632; 68: SpO2, 92.0; 68: Perf, 5.250; 69: SpO2, 94.483; 69: Perf, 5.079; 70: SpO2, 95.644; 70: Perf, 4.544; 71: WAM DIFTYP, AUTO; 71: MONOCYTE % (AUTO DIFF), 12.4 %; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.17 K/uL; 71: HEMATOCRIT (HCT), 29.4 %; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.60 K/uL; 71: EOSINOPHIL % (AUTO DIFF), 0.7 %; 71: PLATELET COUNT (PLT), 194 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 90.2 fL; 71: BASOPHIL % (AUTO DIFF), 0.2 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 71: LYMPHOCYTE % (AUTO DIFF), 7.3 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 71: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.27 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: HEMOGLOBIN (HGB), 10.3 g/dL; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 71: WHITE BLOOD CELLS (WBC), 17.4 K/uL; 71: RED BLOOD CELLS (RBC), 3.26 MIL/uL; 71: NEUTROPHIL % (AUTO DIFF), 78.4 %; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: SpO2, 96.627; 71: Perf, 3.934; 72: HR, 128.0; 72: RR, 15.0; 72: SpO2, 96.948; 72: Perf, 3.796; 72: SBP, 111.0; 72: DBP, 58.0; 72: MAP, 75.667; 73: SpO2, 95.169; 73: Perf, 3.323; 74: SpO2, 95.862; 74: Perf, 3.46; 75: SpO2, 95.949; 75: Perf, 4.404; 76: SpO2, 96.424; 76: Perf, 4.125; 77: SpO2, 95.386; 77: Perf, 4.499; 78: SpO2, 95.847; 78: Perf, 4.029; 79: SpO2, 93.931; 79: Perf, 5.616; 80: SpO2, 93.712; 80: Perf, 5.950; 81: SpO2, 92.576; 81: Perf, 6.079; 82: SpO2, 91.5; 82: Perf, 6.108; 83: SpO2, 91.288; 83: Perf, 5.687; 84: SpO2, 92.759; 84: Perf, 4.941; 85: SpO2, 91.695; 85: Perf, 4.881; 86: SpO2, 94.155; 86: Perf, 4.166; 87: SpO2, 92.356; 87: Perf, 5.018; 88: SpO2, 92.017; 88: Perf, 4.251; 89: SARS-COV-2 RNA, Not Detected; 89: SpO2, 92.678; 89: Perf, 4.758; 90: SpO2, 93.431; 90: Perf, 4.360; 91: SpO2, 93.085; 91: Perf, 4.184; 92: SpO2, 92.138; 92: Perf, 4.353; 93: SpO2, 93.15; 93: Perf, 3.918; 94: SpO2, 92.982; 94: Perf, 4.616; 95: SpO2, 91.458; 95: Perf, 4.198; 96: SpO2, 92.508; 96: Perf, 3.947; 97: SpO2, 95.017; 97: Perf, 2.862; 98: SpO2, 95.172; 98: Perf, 3.838; 99: SpO2, 95.103; 99: Perf, 4.120; 100: SpO2, 95.155; 100: Perf, 3.586; 101: SpO2, 95.847; 101: Perf, 3.316; 102: SpO2, 96.483; 102: Perf, 3.631; 103: SpO2, 96.525; 103: Perf, 4.056; 104: SpO2, 95.339; 104: Perf, 4.778; 105: SpO2, 95.741; 105: Perf, 4.193; 106: SpO2, 95.305; 106: Perf, 4.879; 107: SpO2, 95.390; 107: Perf, 4.927; 108: HIGH SENSITIVITY TROPONIN, 12 ng/L; 108: SpO2, 94.627; 108: Perf, 5.704; 117: HR, 129.0; 117: RR, 17.0; 117: SpO2, 98.0; 117: SBP, 131.0; 117: DBP, 69.0; 117: MAP, 89.667; 119: ALKALINE PHOSPHATASE, 557 U/L; 119: ALBUMIN, 1.9 g/dL; 119: CALCIUM, 7.5 mg/dL; 119: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 119: ANION GAP, 13 mmol/L; 119: ALT (SGPT), 63 U/L; 119: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 119: CHLORIDE, 92 mmol/L; 119: POTASSIUM, 4.0 mmol/L; 119: PROTEIN TOTAL, 4.6 g/dL; 119: GLUCOSE, 110 mg/dL; 119: CORRECTED CALCIUM, 9.2 mg/dL; 119: SODIUM, 128 mmol/L; 119: GLOBULIN, 2.7 g/dL; 119: AST (SGOT), 64 U/L; 119: CO2, 23 mmol/L; 119: BILIRUBIN TOTAL, 5.7 mg/dL; 119: CREATININE, 0.72 mg/dL; 119: LIPASE, 48 U/L; 0: Age, 66; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 116.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient\u2019s advanced age, hypotension, and tachycardia at triage as potential red flags for sepsis. I then focused on the markedly elevated white blood cell count, abnormal liver function tests, and low albumin, which can represent signs of infection and organ dysfunction. These findings, combined with the clinical presentation of shortness of breath, raised my concern for sepsis. Consequently, I determined the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient is of advanced age.",
            "Hypotension is noted as a potential red flag for sepsis.",
            "Tachycardia is noted as a potential red flag for sepsis.",
            "The white blood cell count is markedly elevated.",
            "Abnormal liver function tests can represent signs of infection and organ dysfunction.",
            "Low albumin can represent signs of infection and organ dysfunction.",
            "The clinical presentation includes shortness of breath.",
            "The combination of findings raised concern for sepsis.",
            "The patient is determined to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient is of advanced age.",
            "Hypotension is noted as a potential red flag for sepsis.",
            "Tachycardia is noted as a potential red flag for sepsis.",
            "The white blood cell count is markedly elevated.",
            "Abnormal liver function tests can represent signs of infection and organ dysfunction.",
            "Low albumin can represent signs of infection and organ dysfunction.",
            "The clinical presentation includes shortness of breath.",
            "The combination of findings raised concern for sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.8,
            1.0,
            0.7,
            0.6,
            0.5,
            0.3
        ],
        "alignment_category": [
            1,
            7,
            2,
            2,
            8,
            8,
            3,
            9
        ],
        "alignment_reasonings": [
            "The claim refers to the patient being of \"advanced age,\" which suggests they are likely in the older age group. Although the exact age is not specified, the term \"advanced age\" generally aligns with the concept of increased age-related sepsis susceptibility described in this category. Therefore, while it strongly hints at the category of Elderly Susceptibility, the lack of precise age information reduces the alignment slightly from a perfect score.",
            "The claim mentions hypotension as a red flag for sepsis, directly aligning with this category, which identifies hypotension as a warning sign of sepsis progression. Though the exact blood pressure criteria aren\u2019t specified in the claim, the conceptual link is strong, leading to a high alignment rating.",
            "Tachycardia (increased heart rate) is explicitly part of the SIRS criteria (heart rate >90 bpm), which signals systemic inflammation consistent with early sepsis. The claim identifies tachycardia as a potential red flag, aligning with using SIRS criteria to flag sepsis risk. Although not conclusive on its own, it is a significant part of this category, hence the high alignment rating.",
            "An elevated white blood cell count is directly listed among the SIRS criteria. The claim indicates a marked increase in WBC, which is used to identify systemic inflammation indicative of early sepsis, thus aligning perfectly with this category.",
            "Abnormal liver function tests could imply elevated bilirubin levels, which are part of the SOFA score criteria, indicating potential organ dysfunction. This relates conceptually to a SOFA score increase, though the claim doesn't specify exact values or increases in SOFA score components, hence the partial alignment.",
            "Low albumin levels are not a direct component of the SOFA criteria but are indicative of organ dysfunction, which aligns with the overall purpose of the SOFA score to identify sepsis-related organ dysfunction. While not explicitly part of SOFA, the emphasis on organ dysfunction makes moderate alignment appropriate.",
            "Shortness of breath can be associated with an increased respiratory rate (\u226522/min), which is a component of the qSOFA score for assessing high risk of sepsis-related organ dysfunction and mortality. However, the claim does not provide specific respiratory rate values or confirm other qSOFA criteria, thus limiting the alignment to a moderate level.",
            "The claim indicates concern for sepsis but lacks specific clinical actions or criteria that point directly to one of the expert categories. The notion of concern for sepsis does align somewhat with the heightened vigilance and potential for early interventions, which is why there is a minimal alignment with the \u201cEarly Antibiotic/Culture Orders\u201d category, as these are usually considered when sepsis is suspected. However, the lack of details on concrete actions or specific criterion alignment results in a low alignment rating."
        ],
        "final_alignment_score": 0.6875,
        "accuracy": 1
    },
    {
        "input": "2: HR, 84.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 149.0; 2: DBP, 90.0; 2: MAP, 109.667; 2: Temp, 97.5; 9: Pain, 7.0; 29: SpO2, 99.615; 29: SBP, 133.0; 29: DBP, 66.0; 29: MAP, 88.333; 30: SpO2, 99.052; 30: Perf, 1.447; 31: SpO2, 99.136; 31: Perf, 1.132; 32: SpO2, 98.864; 32: Perf, 1.162; 33: SpO2, 98.678; 33: Perf, 1.168; 34: SpO2, 98.172; 34: Perf, 1.263; 35: SpO2, 97.729; 35: Perf, 1.112; 36: SpO2, 98.793; 36: Perf, 1.055; 37: SpO2, 99.932; 37: Perf, 2.007; 38: SpO2, 99.475; 38: Perf, 1.981; 39: SpO2, 100.0; 39: Perf, 1.991; 40: SpO2, 100.0; 40: Perf, 2.05; 40: SBP, 134.0; 40: DBP, 64.0; 40: MAP, 87.333; 41: SpO2, 100.0; 41: Perf, 1.834; 42: SpO2, 100.0; 42: Perf, 2.230; 43: SpO2, 100.0; 43: Perf, 2.98; 44: SpO2, 100.0; 44: Perf, 2.706; 45: SpO2, 100.0; 45: Perf, 2.465; 46: SpO2, 100.0; 46: Perf, 1.636; 47: SpO2, 100.0; 47: Perf, 1.171; 48: SpO2, 100.0; 48: Perf, 1.506; 49: SpO2, 100.0; 49: Perf, 1.302; 50: SpO2, 100.0; 50: Perf, 1.425; 51: SpO2, 100.0; 51: Perf, 1.422; 52: SpO2, 100.0; 52: Perf, 1.737; 53: SpO2, 99.949; 53: Perf, 1.718; 54: HR, 89.0; 54: SpO2, 99.776; 54: Perf, 2.102; 54: SBP, 149.0; 54: DBP, 87.0; 54: MAP, 107.667; 55: SpO2, 100.0; 55: Perf, 2.118; 55: SBP, 149.0; 55: DBP, 87.0; 55: MAP, 107.667; 56: SpO2, 99.948; 56: Perf, 1.947; 57: SpO2, 100.0; 57: Perf, 1.568; 58: SpO2, 100.0; 58: Perf, 1.255; 59: SpO2, 100.0; 59: Perf, 1.162; 60: SpO2, 100.0; 60: Perf, 1.636; 61: SpO2, 100.0; 61: Perf, 2.113; 62: SpO2, 100.0; 62: Perf, 2.164; 63: SpO2, 100.0; 63: Perf, 2.545; 64: SpO2, 100.0; 64: Perf, 1.976; 65: SpO2, 100.0; 65: Perf, 2.252; 66: SpO2, 100.0; 66: Perf, 2.494; 67: SpO2, 100.0; 67: Perf, 3.019; 68: SpO2, 100.0; 68: Perf, 2.882; 69: SpO2, 100.0; 69: Perf, 2.967; 70: SpO2, 100.0; 70: Perf, 2.846; 70: SBP, 161.0; 70: DBP, 59.0; 70: MAP, 93.0; 71: SpO2, 100.0; 71: Perf, 3.402; 72: SpO2, 100.0; 72: Perf, 3.417; 73: SpO2, 100.0; 73: Perf, 4.680; 74: SpO2, 100.0; 74: Perf, 4.734; 75: SpO2, 100.0; 75: Perf, 4.657; 76: SpO2, 100.0; 76: Perf, 4.039; 77: SpO2, 100.0; 77: Perf, 5.079; 78: SpO2, 100.0; 78: Perf, 6.706; 79: SpO2, 100.0; 79: Perf, 6.602; 80: SpO2, 100.0; 80: Perf, 2.713; 81: SpO2, 100.0; 81: Perf, 2.343; 82: SpO2, 100.0; 82: Perf, 4.020; 83: SARS-COV-2 RNA, Not Detected; 83: SpO2, 100.0; 83: Perf, 4.951; 84: SpO2, 100.0; 84: Perf, 4.196; 85: SpO2, 100.0; 85: Perf, 3.677; 85: SBP, 143.0; 85: DBP, 68.0; 85: MAP, 93.0; 85: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 86: SpO2, 100.0; 86: Perf, 4.171; 87: SpO2, 100.0; 87: Perf, 4.629; 88: SpO2, 100.0; 88: Perf, 6.049; 89: SpO2, 100.0; 89: Perf, 6.075; 90: HIGH SENSITIVITY TROPONIN, <4 ng/L; 90: SpO2, 100.0; 90: Perf, 5.209; 91: SpO2, 100.0; 91: Perf, 4.779; 92: SpO2, 100.0; 92: Perf, 4.859; 93: SpO2, 100.0; 93: Perf, 6.634; 94: SpO2, 100.0; 94: Perf, 5.851; 95: SpO2, 99.966; 95: Perf, 6.213; 96: SpO2, 99.797; 96: Perf, 5.211; 97: GLOBULIN, 4.5 g/dL; 97: CORRECTED CALCIUM, 9.1 mg/dL; 97: CALCIUM, 8.4 mg/dL; 97: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 97: PROTEIN TOTAL, 7.6 g/dL; 97: CREATININE, 0.78 mg/dL; 97: ALT (SGPT), 92 U/L; 97: ALBUMIN, 3.1 g/dL; 97: GLUCOSE, 88 mg/dL; 97: CO2, 24 mmol/L; 97: AST (SGOT), 182 U/L; 97: SODIUM, 139 mmol/L; 97: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 97: ALKALINE PHOSPHATASE, 593 U/L; 97: BILIRUBIN TOTAL, 3.1 mg/dL; 97: POTASSIUM, 3.9 mmol/L; 97: CHLORIDE, 103 mmol/L; 97: ANION GAP, 12 mmol/L; 97: C-REACTIVE PROTEIN (CRP), 2.4 mg/dL; 97: SpO2, 100.0; 97: Perf, 3.267; 98: SpO2, 100.0; 98: Perf, 4.380; 99: HR, 89.0; 99: RR, 17.0; 99: SpO2, 100.0; 99: Perf, 3.140; 99: SBP, 148.0; 99: DBP, 75.0; 99: MAP, 99.333; 100: SpO2, 100.0; 100: Perf, 2.549; 100: SBP, 148.0; 100: DBP, 75.0; 100: MAP, 99.333; 101: SpO2, 100.0; 101: Perf, 2.340; 102: SpO2, 100.0; 102: Perf, 3.034; 103: SpO2, 99.897; 103: Perf, 3.312; 104: SpO2, 100.0; 104: Perf, 3.47; 115: Pain, 4.0; 118: WAM DIFTYP, AUTO; 118: LYMPHOCYTE % (AUTO DIFF), 31.0 %; 118: HEMATOCRIT (HCT), 34.7 %; 118: BASOPHIL % (AUTO DIFF), 1.0 %; 118: PLATELET COUNT (PLT), 65 K/uL; 118: NEUTROPHIL % (AUTO DIFF), 51.8 %; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.2 fL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 118: RED BLOOD CELLS (RBC), 3.57 MIL/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.50 K/uL; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: EOSINOPHIL % (AUTO DIFF), 3.8 %; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.35 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 118: MONOCYTE % (AUTO DIFF), 12.1 %; 0: Age, 78; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 84.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I began by examining the patient\u2019s vital signs for any red flags like fever, low blood pressure, or elevated heart rate. I then reviewed the laboratory results for indications of infection or organ dysfunction, noting that the patient\u2019s WBC count is low but that other markers remain relatively stable. I considered potential sources of infection based on the patient\u2019s presenting complaint and abnormal liver enzymes. However, the patient\u2019s clinical data and stable vitals did not strongly suggest an acute infectious process leading to sepsis. Therefore, I concluded the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I examined the patient\u2019s vital signs for red flags.",
            "Red flags for sepsis include fever, low blood pressure, and elevated heart rate.",
            "I reviewed the laboratory results for indications of infection or organ dysfunction.",
            "The patient\u2019s WBC count is low.",
            "Other laboratory markers remain relatively stable.",
            "I considered potential sources of infection based on the patient\u2019s presenting complaint.",
            "The patient has abnormal liver enzymes.",
            "The patient\u2019s clinical data did not strongly suggest an acute infectious process leading to sepsis.",
            "The patient\u2019s stable vitals did not strongly suggest an acute infectious process leading to sepsis.",
            "I concluded the patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s clinical data did not strongly suggest an acute infectious process leading to sepsis.",
            "The patient\u2019s stable vitals did not strongly suggest an acute infectious process leading to sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim indicates that the clinical data does not strongly suggest an acute infectious process, implying a low suspicion for sepsis. This indirectly suggests that urgent actions such as administering antibiotics or obtaining cultures were likely not taken, connecting to the category for antibiotic/culture orders. However, the absence of specific clinical actions dilutes the alignment, thus resulting in a moderate-low alignment rating.",
            "The claim mentions stable vitals, implying that there is no current indication of clinical deterioration, which would be assessed using the NEWS score. While it does not directly indicate low NEWS or discuss sepsis-typical NEWS findings, stable vitals indirectly suggest a low NEWS score, aligning somewhat with the lack of imminent clinical deterioration covered by this category. The connection is indirect and not strongly established, thus a lower alignment rating is provided."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "8: HR, 112.0; 8: RR, 22.0; 8: SpO2, 92.0; 8: SBP, 120.0; 8: DBP, 73.0; 8: MAP, 88.667; 8: Pain, 10.0; 8: Temp, 102.4; 17: SpO2, 96.0; 17: LPM O2, 2.0; 66: SpO2, 98.478; 67: SpO2, 98.387; 67: SBP, 117.0; 67: DBP, 82.0; 67: MAP, 93.667; 68: SpO2, 98.891; 68: Perf, 0.407; 69: HR, 108.325; 69: RR, 44.0; 69: SpO2, 98.638; 69: Perf, 0.381; 69: 1min HRV, 41.156; 70: HR, 108.559; 70: RR, 45.661; 70: SpO2, 98.915; 70: Perf, 0.297; 70: 1min HRV, 5.363; 70: 5min HRV, 28.514; 71: HR, 108.068; 71: RR, 37.729; 71: SpO2, 98.780; 71: Perf, 0.294; 71: 1min HRV, 13.637; 72: POC PH (V) ISTAT, 7.36; 72: POC TCO2 (V) ISTAT, 23 mmol/L; 72: POC O2 SATURATION ISTAT VENOUS, 19 %; 72: POC PCO2 (V) ISTAT, 38.5 mmHg; 72: POC BASE EXCESS ISTAT, -4 mmol/L; 72: POC HCO3 (V) ISTAT, 21.5 mmol/L; 72: POC LACTATE ISTAT, 1.65 mmol/L; 72: POC PO2 (V) ISTAT, 15 mmHg; 72: HR, 109.293; 72: RR, 37.052; 72: SpO2, 98.310; 72: Perf, 0.303; 72: 1min HRV, 11.081; 73: HR, 108.983; 73: RR, 40.966; 73: SpO2, 98.593; 73: Perf, 0.307; 73: 1min HRV, 6.493; 74: HR, 109.741; 74: RR, 38.379; 74: SpO2, 98.603; 74: Perf, 0.296; 74: 1min HRV, 18.011; 75: HR, 110.949; 75: RR, 37.576; 75: SpO2, 98.475; 75: Perf, 0.286; 75: 1min HRV, 9.440; 75: 5min HRV, 13.032; 76: HR, 109.644; 76: RR, 36.441; 76: SpO2, 97.741; 76: Perf, 0.28; 76: 1min HRV, 7.183; 77: HR, 110.276; 77: RR, 35.690; 77: SpO2, 98.448; 77: Perf, 0.281; 77: 1min HRV, 7.025; 78: HR, 110.237; 78: RR, 43.407; 78: SpO2, 98.525; 78: Perf, 0.269; 78: 1min HRV, 7.783; 79: HR, 111.241; 79: RR, 38.638; 79: SpO2, 98.482; 79: Perf, 0.259; 79: 1min HRV, 10.516; 80: HR, 110.592; 80: RR, 37.695; 80: SpO2, 99.352; 80: Perf, 0.258; 80: 1min HRV, 10.900; 80: 5min HRV, 8.904; 81: HR, 109.362; 81: RR, 39.776; 81: SpO2, 99.583; 81: Perf, 0.230; 81: 1min HRV, 13.018; 81: Pain, 0.0; 82: HR, 110.339; 82: RR, 40.542; 82: SpO2, 99.814; 82: Perf, 0.247; 82: 1min HRV, 8.560; 83: HR, 109.763; 83: RR, 39.017; 83: SpO2, 100.0; 83: Perf, 0.238; 83: 1min HRV, 13.194; 84: HR, 111.088; 84: RR, 36.879; 84: SpO2, 99.878; 84: Perf, 0.246; 84: 1min HRV, 10.999; 85: HR, 113.475; 85: RR, 38.644; 85: SpO2, 99.508; 85: Perf, 0.278; 85: 1min HRV, 9.971; 85: 5min HRV, 12.858; 86: HR, 111.155; 86: RR, 33.845; 86: SpO2, 99.259; 86: Perf, 0.383; 86: 1min HRV, 14.009; 87: HR, 110.508; 87: RR, 41.932; 87: SpO2, 99.254; 87: Perf, 0.294; 87: 1min HRV, 5.862; 88: HR, 111.424; 88: RR, 40.847; 88: SpO2, 98.966; 88: Perf, 0.262; 88: 1min HRV, 4.613; 89: HR, 110.741; 89: RR, 41.483; 89: SpO2, 98.414; 89: Perf, 0.271; 89: 1min HRV, 2.881; 90: HR, 110.458; 90: RR, 40.831; 90: SpO2, 98.322; 90: Perf, 0.288; 90: 1min HRV, 4.093; 90: 5min HRV, 7.499; 91: HR, 111.466; 91: RR, 39.552; 91: SpO2, 98.155; 91: Perf, 0.272; 91: 1min HRV, 4.415; 92: HR, 111.220; 92: RR, 39.102; 92: SpO2, 98.356; 92: Perf, 0.274; 92: 1min HRV, 12.221; 93: HR, 111.627; 93: RR, 39.915; 93: SpO2, 98.966; 93: Perf, 0.280; 93: 1min HRV, 2.886; 94: HR, 111.414; 94: RR, 41.983; 94: SpO2, 99.448; 94: Perf, 0.296; 94: 1min HRV, 2.454; 95: HR, 110.814; 95: RR, 40.644; 95: SpO2, 98.966; 95: Perf, 0.308; 95: 1min HRV, 3.129; 95: 5min HRV, 6.370; 96: HR, 111.224; 96: RR, 39.759; 96: SpO2, 99.483; 96: Perf, 0.332; 96: 1min HRV, 2.579; 97: HR, 110.932; 97: RR, 39.932; 97: SpO2, 99.695; 97: Perf, 0.334; 97: 1min HRV, 49.577; 98: HR, 111.559; 98: RR, 39.983; 98: SpO2, 99.780; 98: Perf, 0.330; 98: 1min HRV, 3.696; 99: HR, 113.172; 99: RR, 42.103; 99: SpO2, 98.707; 99: Perf, 0.323; 99: 1min HRV, 5.145; 99: PIPERACILLIN-TAZOBACTAM-DEXTRS, 3.375 GRAM/50 ML IV PGBK; 100: HR:, 112.746; 100: RR, 43.661; 100: SpO2, 99.102; 100: Perf, 0.328; 100: 1min HRV, 6.513; 100: 5min HRV, 23.550; 101: HR, 114.190; 101: RR, 41.603; 101: SpO2, 99.190; 101: Perf, 0.33; 101: 1min HRV, 5.972; 102: HR, 114.695; 102: RR, 41.492; 102: SpO2, 98.552; 102: Perf, 0.33; 102: 1min HRV, 11.769; 103: HR, 114.373; 103: RR, 44.847; 103: SpO2, 99.843; 103: Perf, 0.338; 103: 1min HRV, 10.364; 104: HR, 114.310; 104: RR, 42.603; 104: SpO2, 99.862; 104: Perf, 0.327; 104: 1min HRV, 8.266; 105: INR, 1.3; 105: PROTHROMBIN TIME, 16.5 seconds; 105: HR, 114.186; 105: RR, 38.407; 105: SpO2, 99.169; 105: Perf, 0.3; 105: 1min HRV, 13.973; 105: 5min HRV, 10.070; 106: PART. THROMBOPLASTIN TIME, 34.9 seconds; 106: HR, 113.776; 106: RR, 42.138; 106: SpO2, 99.172; 106: Perf, 0.3; 106: 1min HRV, 7.621; 107: HR, 112.085; 107: RR, 39.305; 107: SpO2, 98.746; 107: Perf, 0.306; 107: 1min HRV, 54.041; 108: HR, 113.746; 108: RR, 41.508; 108: SpO2, 99.169; 108: Perf, 0.313; 108: 1min HRV, 54.108; 109: HR, 111.966; 109: RR, 40.017; 109: SpO2, 99.143; 109: Perf, 0.32; 109: 1min HRV, 9.468; 110: HR, 113.746; 110: RR, 39.746; 110: SpO2, 98.562; 110: Perf, 0.318; 110: 1min HRV, 4.468; 110: 5min HRV, 35.284; 111: HR, 113.897; 111: RR, 42.293; 111: SpO2, 99.103; 111: Perf, 0.327; 111: 1min HRV, 4.217; 112: HR, 112.932; 112: RR, 42.305; 112: SpO2, 98.831; 112: Perf, 0.343; 112: 1min HRV, 4.204; 113: HR, 112.207; 113: RR, 41.569; 113: SpO2, 99.466; 113: Perf, 0.396; 113: 1min HRV, 5.945; 114: HR, 112.831; 114: RR, 41.407; 114: SpO2, 99.305; 114: Perf, 0.383; 114: 1min HRV, 3.358; 115: HR, 113.017; 115: RR, 42.136; 115: SpO2, 99.475; 115: Perf, 0.405; 115: 1min HRV, 6.819; 115: 5min HRV, 5.540; 116: HR, 112.155; 116: RR, 41.862; 116: SpO2, 99.569; 116: Perf, 0.380; 116: 1min HRV, 3.962; 117: HR, 112.797; 117: RR, 42.576; 117: SpO2, 99.847; 117: Perf, 0.382; 117: 1min HRV, 2.799; 118: HR, 112.224; 118: RR, 41.310; 118: SpO2, 99.517; 118: Perf, 0.397; 118: 1min HRV, 4.919; 119: HR, 112.254; 119: RR, 44.492; 119: SpO2, 99.593; 119: Perf, 0.429; 119: 1min HRV, 2.948; 0: Age, 75; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 39.1; 0: Triage HR, 112.0; 0: Triage RR, 22.0; 0: Triage SBP, 120.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I observed that the patient\u2019s fever, elevated heart rate, and increased respiratory rate meet recognized criteria associated with sepsis risk. Although the lactate level is not significantly elevated, the patient\u2019s advanced age and ongoing intravenous antibiotic treatment underscore concerns for possible infection and deteriorating physiology. Consistent abnormalities in vital signs over the first two hours also suggest a systemic inflammatory response. Thus, it is reasonable to conclude that the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient has a fever, elevated heart rate, and increased respiratory rate.",
            "The patient's fever, elevated heart rate, and increased respiratory rate meet recognized criteria associated with sepsis risk.",
            "The lactate level is not significantly elevated.",
            "The patient's advanced age raises concerns for possible infection.",
            "The ongoing intravenous antibiotic treatment underscores concerns for possible infection.",
            "There are concerns for deteriorating physiology.",
            "Consistent abnormalities in vital signs over the first two hours suggest a systemic inflammatory response.",
            "It is reasonable to conclude that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has a fever, elevated heart rate, and increased respiratory rate.",
            "The patient's fever, elevated heart rate, and increased respiratory rate meet recognized criteria associated with sepsis risk.",
            "The patient's advanced age raises concerns for possible infection.",
            "The ongoing intravenous antibiotic treatment underscores concerns for possible infection.",
            "There are concerns for deteriorating physiology.",
            "Consistent abnormalities in vital signs over the first two hours suggest a systemic inflammatory response.",
            "It is reasonable to conclude that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            1.0,
            1.0,
            0.8,
            0.7,
            0.5,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            1,
            9,
            4,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim includes three specific indicators\u2014fever, elevated heart rate, and increased respiratory rate\u2014all of which are part of the criteria used to identify SIRS positivity. Since the presence of two or more SIRS criteria are necessary to identify systemic inflammation consistent with early sepsis, this aligns perfectly with the category.",
            "The claim explicitly mentions fever, elevated heart rate, and increased respiratory rate, all of which are components of the SIRS criteria. With the presence of at least two of these criteria, the claim aligns perfectly with the identification of systemic inflammation consistent with early sepsis as specified in the SIRS criteria.",
            "The claim cites \"advanced age,\" which aligns with the Elderly Susceptibility category that emphasizes increased sepsis risk in individuals aged 65 years and older. However, the claim does not specify an exact age, resulting in an alignment slightly less than perfect.",
            "The claim mentions intravenous antibiotic treatment, which indicates ongoing management of a suspected or confirmed infection. While it reflects a strong suspicion of infection, the timing of initiation (within the first 2 hours) is not confirmed in the claim. Thus, the alignment with initiating antibiotic treatment is substantial but not complete without specific timing information.",
            "The claim about concerns for deteriorating physiology generally points to a broad assessment of clinical deterioration, which is in line with what the NEWS score aims to detect through aggregated vital sign metrics. However, the claim does not specify actual NEWS-related metrics or scores, leading to a moderate alignment rather than strong.",
            "The claim regarding consistent abnormalities in vital signs aligns with the concept of an elevated NEWS score, which is designed to predict clinical deterioration from abnormal vitals. However, since it doesn't specify the NEWS score and lacks direct mention of SIRS criteria, the alignment is not perfect but still significant.",
            "The claim suggests a general high risk of sepsis without providing specific factors or clinical data. While multiple sepsis risk criteria could theoretically apply, the elevated NEWS score predicts imminent clinical deterioration, aligning conceptually with the claim of high sepsis risk. However, due to the lack of specific supporting evidence or reference to any concrete criteria mentioned, the alignment is weak."
        ],
        "final_alignment_score": 0.7142857142857143,
        "accuracy": 1
    },
    {
        "input": "5: HR, 104.0; 5: RR, 18.0; 5: SpO2, 98.0; 5: SBP, 126.0; 5: DBP, 78.0; 5: MAP, 94.0; 5: Pain, 7.0; 5: Temp, 99.9; 18: SBP, 126.0; 18: DBP, 86.0; 18: MAP, 99.333; 20: HR, 129.333; 20: 1min HRV, 10.333; 21: HR, 124.169; 21: RR, 20.098; 21: SpO2, 99.711; 21: 1min HRV, 33.530; 22: HR, 122.707; 22: RR, 11.466; 22: SpO2, 98.571; 22: 1min HRV, 17.122; 23: HR, 122.085; 23: RR, 14.085; 23: SpO2, 97.219; 23: 1min HRV, 24.052; 24: HR, 117.914; 24: RR, 17.724; 24: SpO2, 100.0; 24: 1min HRV, 21.285; 24: 5min HRV, 25.823; 25: HR, 122.220; 25: RR, 16.627; 25: SpO2, 99.808; 25: Perf, 0.192; 25: 1min HRV, 24.577; 25: SBP, 116.0; 25: DBP, 78.0; 25: MAP, 90.667; 26: HR, 117.746; 26: RR, 18.153; 26: SpO2, 99.679; 26: Perf, 0.206; 26: 1min HRV, 20.401; 27: HR, 124.672; 27: RR, 26.879; 27: SpO2, 99.552; 27: Perf, 0.2; 27: 1min HRV, 26.780; 28: HR, 123.627; 28: RR, 25.542; 28: SpO2, 96.894; 28: Perf, 0.2; 28: 1min HRV, 23.114; 29: HR, 123.052; 29: RR, 20.724; 29: SpO2, 99.707; 29: 1min HRV, 29.700; 29: 5min HRV, 26.483; 30: HR, 124.593; 30: RR, 16.186; 30: SpO2, 99.949; 30: 1min HRV, 22.922; 31: HR, 125.559; 31: RR, 19.305; 31: SpO2, 99.909; 31: 1min HRV, 28.814; 32: HR, 129.931; 32: RR, 28.155; 32: SpO2, 99.875; 32: Perf, 0.214; 32: 1min HRV, 28.843; 33: HR, 129.712; 33: RR, 26.254; 33: SpO2, 99.947; 33: Perf, 0.22; 33: 1min HRV, 25.706; 34: HR, 146.724; 34: RR, 30.155; 34: Perf, 0.22; 34: 1min HRV, 32.094; 34: 5min HRV, 35.024; 35: HR, 133.554; 35: RR, 27.847; 35: 1min HRV, 32.280; 36: HR, 123.441; 36: RR, 15.797; 36: 1min HRV, 35.801; 37: HR, 128.879; 37: RR, 24.828; 37: 1min HRV, 28.475; 38: HR, 132.051; 38: RR, 20.542; 38: 1min HRV, 16.376; 39: HR, 128.603; 39: RR, 20.069; 39: 1min HRV, 16.487; 39: 5min HRV, 30.643; 40: HR, 128.610; 40: RR, 16.712; 40: 1min HRV, 15.154; 40: SBP, 107.0; 40: DBP, 84.0; 40: MAP, 91.667; 41: HR, 121.483; 41: RR, 21.397; 41: 1min HRV, 19.597; 42: HR, 124.068; 42: RR, 20.373; 42: 1min HRV, 22.711; 43: HR, 116.780; 43: RR, 21.153; 43: 1min HRV, 16.104; 44: HR, 116.379; 44: RR, 19.914; 44: 1min HRV, 15.746; 44: 5min HRV, 25.775; 45: HR, 114.356; 45: RR, 20.746; 45: 1min HRV, 14.980; 46: HR, 113.724; 46: RR, 20.293; 46: 1min HRV, 22.211; 47: HR, 111.797; 47: RR, 21.017; 47: 1min HRV, 12.082; 48: HR, 111.288; 48: RR, 19.559; 48: 1min HRV, 19.268; 49: HR, 109.017; 49: RR, 18.345; 49: 1min HRV, 23.235; 49: 5min HRV, 20.667; 50: HR, 110.898; 50: RR, 18.576; 50: 1min HRV, 14.002; 51: HR, 115.966; 51: RR, 16.397; 51: 1min HRV, 18.354; 52: HR, 113.254; 52: RR, 19.898; 52: 1min HRV, 30.575; 53: HR, 111.898; 53: RR, 24.644; 53: 1min HRV, 22.842; 54: HR, 111.172; 54: RR, 23.534; 54: 1min HRV, 20.992; 54: 5min HRV, 24.145; 55: HR, 111.644; 55: RR, 17.237; 55: 1min HRV, 16.907; 56: HR, 115.121; 56: RR, 21.845; 56: 1min HRV, 29.425; 57: HR, 113.305; 57: RR, 19.746; 57: 1min HRV, 21.649; 58: HR, 116.712; 58: RR, 24.169; 58: 1min HRV, 28.961; 59: HR, 112.948; 59: RR, 21.069; 59: 1min HRV, 33.231; 59: 5min HRV, 27.756; 60: HR, 112.576; 60: RR, 22.441; 60: 1min HRV, 27.150; 61: HR, 114.328; 61: RR, 18.259; 61: 1min HRV, 29.118; 62: HR, 107.780; 62: RR, 18.492; 62: 1min HRV, 21.263; 63: HR, 105.661; 63: RR, 17.847; 63: 1min HRV, 15.294; 64: HR, 107.259; 64: RR, 17.793; 64: 1min HRV, 17.259; 64: 5min HRV, 29.527; 65: HR, 103.119; 65: RR, 20.339; 65: 1min HRV, 13.472; 66: HR, 104.931; 66: RR, 18.5; 66: 1min HRV, 11.080; 67: HR, 105.661; 67: RR, 19.186; 67: 1min HRV, 11.420; 68: HR, 104.678; 68: RR, 19.373; 68: 1min HRV, 12.364; 69: HR, 104.5; 69: RR, 17.828; 69: 1min HRV, 12.741; 69: 5min HRV, 13.261; 70: HR, 103.593; 70: RR, 16.898; 70: 1min HRV, 15.759; 71: HR, 103.172; 71: RR, 19.5; 71: 1min HRV, 18.602; 72: HR, 103.0; 72: RR, 18.203; 72: 1min HRV, 23.638; 73: HR, 102.190; 73: RR, 15.741; 73: 1min HRV, 18.132; 74: HR, 102.305; 74: RR, 20.254; 74: 1min HRV, 32.681; 74: 5min HRV, 23.049; 75: HR, 101.475; 75: RR, 16.881; 75: 1min HRV, 21.624; 76: HR, 100.534; 76: RR, 19.810; 76: 1min HRV, 16.212; 77: HR, 100.017; 77: RR, 17.949; 77: 1min HRV, 17.357; 78: HR, 102.121; 78: RR, 18.190; 78: 1min HRV, 13.711; 79: HR, 99.153; 79: RR, 17.661; 79: 1min HRV, 17.442; 79: 5min HRV, 18.412; 80: HR, 99.102; 80: RR, 18.763; 80: 1min HRV, 14.854; 81: HR, 97.5; 81: RR, 20.966; 81: 1min HRV, 12.589; 82: HR, 98.814; 82: RR, 18.475; 82: 1min HRV, 18.978; 83: HR, 96.672; 83: RR, 19.0; 83: 1min HRV, 13.628; 84: HR, 101.678; 84: RR, 21.288; 84: 1min HRV, 22.110; 84: 5min HRV, 20.979; 85: HR, 102.508; 85: RR, 20.085; 85: 1min HRV, 18.928; 85: LR IV BOLUS -, 1000 ML; 86: SARS-COV-, 2 RNA: Not Detected; 86: HR, 102.397; 86: RR, 17.707; 86: 1min HRV, 24.139; 87: HR, 101.610; 87: RR, 19.661; 87: 1min HRV, 30.701; 88: HR, 110.259; 88: RR, 19.207; 88: 1min HRV, 29.053; 89: HR, 115.8; 89: RR, 19.870; 89: 1min HRV, 31.107; 89: 5min HRV, 35.486; 0: Age, 25; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 104.0; 0: Triage RR, 18.0; 0: Triage SBP, 126.0; 0: Triage DBP, 78.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,FEMALE GENITAL PROBLEM",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I first noticed the patient\u2019s persistent tachycardia and periodic tachypnea, which are key vital sign abnormalities. Then I asked whether these signs, along with a fever and likely infection source (\u201cfemale genital problem\u201d), suggest a systemic response. Reflecting on criteria for possible sepsis, I concluded that a high heart rate, elevated respiratory rate, and fever in the context of a potential infection indicate significant sepsis risk within the next 12 hours.",
        "claims": [
            "The patient exhibits persistent tachycardia.",
            "Persistent tachycardia is a key vital sign abnormality.",
            "The patient exhibits periodic tachypnea.",
            "Periodic tachypnea is a key vital sign abnormality.",
            "I inquired whether the vital signs suggest a systemic response.",
            "The patient's fever may indicate a possible infection source.",
            "The likely infection source is a \"female genital problem.\"",
            "I reflected on criteria for possible sepsis.",
            "A high heart rate indicates a significant risk of sepsis.",
            "An elevated respiratory rate indicates a significant risk of sepsis.",
            "Fever indicates a significant risk of sepsis.",
            "The context of a potential infection increases the risk of sepsis.",
            "These combined factors suggest significant sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient exhibits persistent tachycardia.",
            "Persistent tachycardia is a key vital sign abnormality.",
            "The patient exhibits periodic tachypnea.",
            "Periodic tachypnea is a key vital sign abnormality.",
            "I inquired whether the vital signs suggest a systemic response.",
            "The patient's fever may indicate a possible infection source.",
            "The likely infection source is a \"female genital problem.\"",
            "A high heart rate indicates a significant risk of sepsis.",
            "An elevated respiratory rate indicates a significant risk of sepsis.",
            "Fever indicates a significant risk of sepsis.",
            "The context of a potential infection increases the risk of sepsis.",
            "These combined factors suggest significant sepsis risk within the next 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.7,
            0.7,
            0.3,
            0.7,
            0.3,
            0.8,
            0.8,
            0.8,
            0.3,
            0.2
        ],
        "alignment_category": [
            2,
            2,
            3,
            3,
            2,
            2,
            9,
            2,
            3,
            2,
            9,
            4
        ],
        "alignment_reasonings": [
            "Persistent tachycardia relates to the SIRS criteria since a heart rate >90 bpm is listed as one criterion for systemic inflammation and potential early sepsis. While the claim indicates persistent tachycardia, it does not specify if other SIRS criteria are met, resulting in a partial but relevant alignment.",
            "Tachycardia, or elevated heart rate (>90 bpm), is one of the SIRS criteria indicating systemic inflammation consistent with early sepsis. The claim specifically mentions tachycardia as a significant abnormality, which directly aligns with one of the SIRS criteria, but it doesn't provide additional context about other criteria being met, so the alignment is strong but not perfect.",
            "Tachypnea, which describes an increased respiratory rate, is a component of the qSOFA score (respiratory rate\u202f\u2265\u202f22\u202f/min). Although \"periodic tachypnea\" does not directly provide the rate, the presence of tachypnea suggests a likely concern for a high respiratory rate. Therefore, this aligns reasonably well with the high qSOFA score but lacks a specific quantification to fully confirm alignment.",
            "The claim mentions \"periodic tachypnea,\" which refers to episodes of rapid breathing. This closely aligns with the qSOFA criteria, where a respiratory rate of \u226522/min is one of the indicators. While the claim does not specify the exact respiratory rate, periodic tachypnea strongly hints at the possibility of meeting the qSOFA threshold, making the alignment significant but not definitive.",
            "The claim pertains to an inquiry about vital signs suggesting a systemic response, which aligns conceptually with SIRS criteria used to identify systemic inflammation. However, it is vague and doesn't specify whether any criteria are met, resulting in a low alignment rating.",
            "The presence of fever is directly related to the temperature criterion within the SIRS category (>38\u00b0C). While the claim mentions fever as an indication of potential infection, it doesn't explicitly state if the temperature threshold is met, nor does it include a second SIRS criterion. Thus, the alignment is moderately strong but not complete.",
            "The claim suggests a potential source of infection, which may prompt clinician suspicion of sepsis and possible early interventions. However, the claim doesn't directly mention any specific actions, such as ordering antibiotics or cultures, which would more strongly align with this category. The alignment is present but weak due to the lack of explicit clinical actions.",
            "A high heart rate is one of the criteria for SIRS positivity, which helps identify systemic inflammation consistent with early sepsis. While the claim doesn't specify that other SIRS criteria are met, the high heart rate alone is a significant factor in assessing sepsis risk, hence the strong but not complete alignment.",
            "An elevated respiratory rate is explicitly part of the qSOFA score criteria (respiratory rate \u226522/min). While the claim links the elevated respiratory rate directly to sepsis risk, the qSOFA score considers this as one component among others. The claim strongly aligns but does not specify all components of a high qSOFA score, hence a 0.8 rating.",
            "Fever is specifically mentioned under the SIRS criteria as a sign of systemic inflammation and potential early sepsis. However, the SIRS criteria require two signs, and the claim references only one (fever), which slightly reduces the alignment strength. Nonetheless, fever's identification as a sepsis risk aligns strongly with SIRS Positivity.",
            "The claim discusses the context of a potential infection, which indicates suspicion of infection\u2014a point where a clinician might consider actions like ordering antibiotics or cultures. However, there is no mention of concrete clinical actions being taken, so the alignment is weak and indirect, resulting in a low alignment rating.",
            "The claim mentions \"combined factors\" that suggest significant sepsis risk, which aligns broadly with the idea of aggregated scores predicting deterioration, like the NEWS. However, the claim is quite vague and doesn't specify factors, leading to a weak alignment with the category."
        ],
        "final_alignment_score": 0.575,
        "accuracy": 0
    },
    {
        "input": "7: HR, 100.0; 7: RR, 16.0; 7: SpO2, 93.364; 7: Pain, 10.0; 7: Temp, 97.5; 8: SpO2, 96.0; 9: HR, 97.714; 9: 1min HRV, 46.887; 9: 5min HRV, 46.887; 9: SBP, 80.0; 9: DBP, 56.0; 9: MAP, 64.0; 10: HR, 99.339; 10: 1min HRV, 38.734; 11: HR, 98.414; 11: SpO2, 98.476; 11: 1min HRV, 37.015; 12: HR, 97.763; 12: 1min HRV, 37.484; 13: HR, 97.458; 13: SpO2, 100.0; 13: Perf, 0.11; 13: 1min HRV, 27.611; 14: HR, 97.018; 14: SpO2, 100.0; 14: Perf, 0.11; 14: 1min HRV, 22.578; 14: 5min HRV, 33.647; 15: HR, 97.034; 15: 1min HRV, 29.255; 16: HR, 95.672; 16: 1min HRV, 29.521; 17: HR, 94.644; 17: SpO2, 95.667; 17: 1min HRV, 20.008; 18: HR, 97.034; 18: SpO2, 97.474; 18: 1min HRV, 39.668; 19: HR, 95.75; 19: SpO2, 98.733; 19: 1min HRV, 26.890; 19: 5min HRV, 30.244; 19: SBP, 93.0; 19: DBP, 67.0; 19: MAP, 75.667; 20: HR, 96.153; 20: SpO2, 85.5; 20: 1min HRV, 29.099; 20: SBP, 93.0; 20: DBP, 67.0; 20: MAP, 75.667; 21: HR, 98.155; 21: SpO2, 100.0; 21: 1min HRV, 16.114; 22: HR, 95.508; 22: SpO2, 99.966; 22: 1min HRV, 19.910; 23: HR, 95.424; 23: SpO2, 100.0; 23: 1min HRV, 23.032; 24: HR, 94.810; 24: SpO2, 100.0; 24: 1min HRV, 13.884; 24: 5min HRV, 22.364; 25: HR, 92.966; 25: SpO2, 100.0; 25: 1min HRV, 9.650; 26: HR, 93.138; 26: SpO2, 100.0; 26: 1min HRV, 5.931; 27: HR, 94.695; 27: 1min HRV, 32.017; 28: HR, 93.5; 28: SpO2, 99.4; 28: 1min HRV, 36.406; 29: HR, 96.881; 29: SpO2, 99.0; 29: 1min HRV, 39.831; 29: 5min HRV, 30.991; 30: HR, 96.627; 30: SpO2, 100.0; 30: 1min HRV, 28.922; 31: HR, 95.796; 31: SpO2, 100.0; 31: 1min HRV, 28.161; 32: HR, 95.746; 32: SpO2, 96.556; 32: 1min HRV, 15.114; 33: HR, 95.293; 33: SpO2, 91.8; 33: 1min HRV, 18.812; 34: HR, 97.448; 34: SpO2, 93.95; 34: 1min HRV, 10.198; 34: 5min HRV, 22.786; 35: HR, 97.085; 35: SpO2, 94.5; 35: 1min HRV, 15.337; 35: ASPIRIN, 81 MG PO CHEW; 35: ACETAMINOPHEN, 500 MG PO TABS; 36: HR, 98.241; 36: SpO2, 95.518; 36: 1min HRV, 24.382; 37: HR, 97.492; 37: SpO2, 93.096; 37: 1min HRV, 45.606; 38: HR, 97.310; 38: SpO2, 93.85; 38: Perf, 0.24; 38: 1min HRV, 44.786; 39: HR, 97.305; 39: SpO2, 95.474; 39: Perf, 0.24; 39: 1min HRV, 40.561; 39: 5min HRV, 38.341; 40: HR, 97.0; 40: SpO2, 99.2; 40: Perf, 0.24; 40: 1min HRV, 39.062; 41: HR, 96.983; 41: SpO2, 100.0; 41: 1min HRV, 48.266; 42: HR, 97.356; 42: SpO2, 99.0; 42: 1min HRV, 40.408; 43: HR, 95.621; 43: SpO2, 100.0; 43: 1min HRV, 42.188; 44: HR, 96.5; 44: SpO2, 100.0; 44: 1min HRV, 37.516; 44: 5min HRV, 42.290; 45: HR, 92.847; 45: SpO2, 100.0; 45: 1min HRV, 23.501; 46: HR, 94.397; 46: SpO2, 100.0; 46: 1min HRV, 29.513; 47: HR, 93.034; 47: SpO2, 98.647; 47: 1min HRV, 32.125; 48: HR, 95.667; 48: SpO2, 99.143; 48: 1min HRV, 14.480; 49: HR, 93.831; 49: SpO2, 99.531; 49: 1min HRV, 16.465; 49: 5min HRV, 25.851; 50: HR, 93.661; 50: SpO2, 98.571; 50: 1min HRV, 13.106; 51: HR, 93.207; 51: 1min HRV, 11.248; 52: HR, 92.525; 52: 1min HRV, 12.237; 53: HR, 92.534; 53: SpO2, 100.0; 53: 1min HRV, 11.557; 54: HR, 92.508; 54: SpO2, 96.143; 54: 1min HRV, 6.789; 54: 5min HRV, 11.654; 54: Pain, 10.0; 55: HR, 92.559; 55: SpO2, 100.0; 55: 1min HRV, 9.271; 56: HR, 92.862; 56: SpO2, 99.853; 56: 1min HRV, 8.397; 57: HR, 92.237; 57: SpO2, 100.0; 57: 1min HRV, 9.517; 58: HR, 92.655; 58: SpO2, 99.955; 58: Perf, 0.15; 58: 1min HRV, 9.605; 59: HR, 93.0; 59: SpO2, 100.0; 59: Perf, 0.15; 59: 1min HRV, 6.399; 59: 5min HRV, 8.951; 60: HR, 92.897; 60: SpO2, 100.0; 60: Perf, 0.2; 60: 1min HRV, 7.052; 61: HR, 92.949; 61: SpO2, 100.0; 61: Perf, 0.21; 61: 1min HRV, 6.408; 62: HR, 92.492; 62: SpO2, 100.0; 62: Perf, 0.229; 62: 1min HRV, 7.471; 63: HR, 92.138; 63: 1min HRV, 8.428; 64: HR, 93.305; 64: SpO2, 100.0; 64: Perf, 0.216; 64: 1min HRV, 18.790; 64: 5min HRV, 10.843; 65: HR, 88.298; 65: SpO2, 100.0; 65: Perf, 0.23; 65: 1min HRV, 14.646; 66: HR, 91.559; 66: SpO2, 100.0; 66: 1min HRV, 13.013; 67: HR, 92.644; 67: SpO2, 100.0; 67: 1min HRV, 24.961; 68: HR, 91.724; 68: SpO2, 100.0; 68: 1min HRV, 43.105; 69: HR, 92.655; 69: SpO2, 96.95; 69: 1min HRV, 33.333; 69: 5min HRV, 28.986; 70: HR, 91.552; 70: SpO2, 93.75; 70: 1min HRV, 51.283; 71: HR, 90.492; 71: SpO2, 99.933; 71: Perf, 0.15; 71: 1min HRV, 22.465; 72: HR, 91.153; 72: SpO2, 99.867; 72: Perf, 0.155; 72: 1min HRV, 5.308; 73: HR, 91.741; 73: SpO2, 99.848; 73: Perf, 0.159; 73: 1min HRV, 22.532; 74: HR, 89.729; 74: SpO2, 99.595; 74: Perf, 0.160; 74: 1min HRV, 24.310; 74: 5min HRV, 26.494; 75: HR, 90.667; 75: SpO2, 100.0; 75: Perf, 0.165; 75: 1min HRV, 23.716; 76: HR, 91.729; 76: SpO2, 100.0; 76: Perf, 0.178; 76: 1min HRV, 22.482; 77: HR, 93.135; 77: SpO2, 97.852; 77: Perf, 0.18; 77: 1min HRV, 3.623; 78: HR, 97.52; 78: SpO2, 97.167; 78: 1min HRV, 37.103; 78: SBP, 72.0; 78: DBP, 54.0; 78: MAP, 60.0; 79: HR, 98.288; 79: SpO2, 98.667; 79: 1min HRV, 25.253; 79: 5min HRV, 35.545; 79: SBP, 72.0; 79: DBP, nan; 79: MAP, nan; 80: HR, 98.034; 80: SpO2, 100.0; 80: Perf, 0.22; 80: 1min HRV, 30.413; 80: SBP, 69.0; 80: DBP, 52.0; 80: MAP, 57.667; 81: HR, 97.949; 81: SpO2, 100.0; 81: Perf, 0.255; 81: 1min HRV, 28.517; 81: SBP, 69.0; 81: DBP, 52.0; 81: MAP, 57.667; 82: HR, 98.068; 82: SpO2, 100.0; 82: Perf, 0.279; 82: 1min HRV, 31.266; 83: HR, 97.621; 83: SpO2, 100.0; 83: Perf, 0.299; 83: 1min HRV, 23.406; 84: 5min HRV, 28.597; 86: NS IV BOLUS -, 250 ML; 94: HR:, 93.0; 94: SpO2, 100.0; 94: SBP, 86.0; 94: DBP, 68.0; 94: MAP, 74.0; 100: SARS-COV-2 RNA, Not Detected; 109: HR, 87.0; 109: SpO2, 100.0; 109: SBP, 76.0; 109: DBP, 48.0; 109: MAP, 57.333; 117: INR, 1.2; 117: PROTHROMBIN TIME, 15.1 seconds; 118: PART. THROMBOPLASTIN TIME, 47.1 seconds; 118: NS IV BOLUS -, 250 ML; 0: Age:, 65; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 16.0; 0: Triage SBP, 93.0; 0: Triage DBP, 67.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I first check if the patient\u2019s presentation and vitals suggest an active infection along with unstable hemodynamics to meet sepsis criteria. While the blood pressure is often quite low, there is no clear sign of a suspected or confirmed infection, and the patient\u2019s temperature remains normal or slightly low. I remind myself that sepsis requires both infection and organ dysfunction criteria. Here, repeated hypotension may indicate another form of shock, such as cardiogenic, rather than sepsis. After reviewing the vital signs, medications, and labs, I conclude they do not indicate a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient's presentation and vitals are checked for signs of an active infection and unstable hemodynamics.",
            "The patient's blood pressure is often quite low.",
            "There is no clear sign of a suspected or confirmed infection in the patient.",
            "The patient's temperature remains normal or slightly low.",
            "Sepsis requires both infection and organ dysfunction criteria.",
            "Repeated hypotension may indicate another form of shock, such as cardiogenic shock, rather than sepsis.",
            "After reviewing the vital signs, medications, and labs, it is concluded that they do not indicate a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's blood pressure is often quite low.",
            "There is no clear sign of a suspected or confirmed infection in the patient.",
            "The patient's temperature remains normal or slightly low."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.2
        ],
        "alignment_category": [
            7,
            9,
            2
        ],
        "alignment_reasonings": [
            "The claim about the patient's blood pressure being \"often quite low\" suggests potential hypotension, which aligns with the sepsis-associated hypotension category. However, without specific values, we cannot fully confirm hypotension as defined. It suggests a moderate alignment with this criterion.",
            "The claim suggests no suspicion of infection, relating conceptually to the absence of early antibiotic or culture orders that typically indicate suspected infection. The alignment is weak since the lack of infection reduces the relevance of early antibiotic/culture actions, but it\u2019s the most fitting category given the claim context.",
            "The SIRS criteria include temperature abnormalities, specifically a temperature >38\u00b0C or <36\u00b0C. A normal or slightly low temperature does not meet these specifications but suggests a possibility for concern if it changes. Thus, the alignment is weak with this category."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 0
    },
    {
        "input": "3: HR, 121.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 129.0; 3: DBP, 87.0; 3: MAP, 101.0; 3: Temp, 99.3; 16: SpO2, 96.45; 16: Perf, 0.6; 17: HR, 133.538; 17: RR, 22.158; 17: SpO2, 97.130; 17: Perf, 0.471; 17: 1min HRV, 16.532; 18: HR, 133.305; 18: RR, 21.966; 18: SpO2, 96.625; 18: Perf, 0.406; 18: 1min HRV, 19.165; 18: SBP, 114.0; 18: DBP, 76.0; 18: MAP, 88.667; 19: HR, 139.339; 19: RR, 18.746; 19: SpO2, 97.186; 19: Perf, 0.443; 19: 1min HRV, 20.527; 19: 5min HRV, 20.534; 20: HR, 131.103; 20: RR, 23.862; 20: SpO2, 96.793; 20: Perf, 0.505; 20: 1min HRV, 16.418; 21: HR, 130.086; 21: RR, 22.190; 21: SpO2, 97.138; 21: Perf, 0.542; 21: 1min HRV, 12.962; 22: HR, 129.103; 22: RR, 20.5; 22: SpO2, 96.931; 22: Perf, 0.499; 22: 1min HRV, 9.228; 23: HR, 131.356; 23: RR, 21.898; 23: SpO2, 97.356; 23: Perf, 0.426; 23: 1min HRV, 11.118; 24: HR, 131.390; 24: RR, 21.932; 24: SpO2, 97.441; 24: Perf, 0.427; 24: 1min HRV, 12.103; 24: 5min HRV, 13.005; 25: HR, 131.948; 25: RR, 21.914; 25: SpO2, 97.276; 25: Perf, 0.387; 25: 1min HRV, 10.485; 26: HR, 133.322; 26: RR, 22.390; 26: SpO2, 97.695; 26: Perf, 0.369; 26: 1min HRV, 13.968; 27: HR, 133.121; 27: RR, 22.517; 27: SpO2, 98.034; 27: Perf, 0.367; 27: 1min HRV, 16.834; 28: HR, 130.119; 28: RR, 22.068; 28: SpO2, 97.279; 28: Perf, 0.408; 28: 1min HRV, 10.430; 29: HR, 129.169; 29: RR, 20.814; 29: SpO2, 97.424; 29: Perf, 0.623; 29: 1min HRV, 5.235; 29: 5min HRV, 13.384; 29: SBP, 113.0; 29: DBP, 72.0; 29: MAP, 85.667; 30: HR, 129.017; 30: RR, 21.931; 30: SpO2, 98.023; 30: Perf, 0.61; 30: 1min HRV, 8.060; 30: SBP, 113.0; 30: DBP, 72.0; 30: MAP, 85.667; 31: HR, 130.0; 31: RR, 22.655; 31: SpO2, 98.0; 31: Perf, 0.628; 31: 1min HRV, 7.261; 32: HR, 130.810; 32: RR, 21.621; 32: SpO2, 98.0; 32: Perf, 0.555; 32: 1min HRV, 5.514; 33: HR, 130.661; 33: RR, 25.169; 33: SpO2, 98.0; 33: Perf, 0.507; 33: 1min HRV, 10.328; 34: 5min HRV, 8.431; 61: POC PH (V) ISTAT, 7.41; 61: POC LACTATE ISTAT, 1.49 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 77 %; 61: POC PO2 (V) ISTAT, 41 mmHg; 61: POC TCO2 (V) ISTAT, 24 mmol/L; 61: POC BASE EXCESS ISTAT, -2 mmol/L; 61: POC PCO2 (V) ISTAT, 36.8 mmHg; 61: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC CREATININE ISTAT, 0.2 mg/dL; 66: POC EGFR REFIT WITHOUT RACE (2021), 169 mL/min/1.73 m2; 78: RSV, Not Detected; 78: INFLUENZA B, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 84: WAM DIFTYP, AUTO; 84: NEUTROPHIL % (AUTO DIFF), 70.3 %; 84: PLATELET COUNT (PLT), 275 K/uL; 84: WHITE BLOOD CELLS (WBC), 7.6 K/uL; 84: EOSINOPHIL % (AUTO DIFF), 1.1 %; 84: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 84: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 84: BASOPHIL % (AUTO DIFF), 0.4 %; 84: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 84: NRBC PERCENT (HEMATOLOGY), 0.0 %; 84: MONOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 84: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 84: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 84: HEMATOCRIT (HCT), 47.6 %; 84: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.35 K/uL; 84: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 84: LYMPHOCYTE % (AUTO DIFF), 21.1 %; 84: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 84: RED BLOOD CELLS (RBC), 5.91 MIL/uL; 84: MONOCYTE % (AUTO DIFF), 6.8 %; 84: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.2 pg; 84: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 84: HEMOGLOBIN (HGB), 14.9 g/dL; 84: MEAN CORPUSCULAR VOLUME (MCV), 80.5 fL; 97: INR, 1.0; 97: PROTHROMBIN TIME, 13.8 seconds; 98: PART. THROMBOPLASTIN TIME, 32.9 seconds; 111: HIGH SENSITIVITY TROPONIN, <4 ng/L; 112: SODIUM, 137 mmol/L; 112: AST (SGOT), 57 U/L; 112: PROTEIN TOTAL, 8.1 g/dL; 112: BILIRUBIN TOTAL, 0.5 mg/dL; 112: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 112: ALKALINE PHOSPHATASE, 165 U/L; 112: GLUCOSE, 146 mg/dL; 112: CHLORIDE, 107 mmol/L; 112: GLOBULIN, 4.1 g/dL; 112: ANION GAP, 10 mmol/L; 112: POTASSIUM, 4.1 mmol/L; 112: EGFR REFIT WITHOUT RACE (2021), 181 mL/min/1.73 m2; 112: CREATININE, 0.16 mg/dL; 112: CALCIUM, 9.4 mg/dL; 112: CORRECTED CALCIUM, 9.4 mg/dL; 112: ALBUMIN, 4.0 g/dL; 112: ALT (SGPT), 122 U/L; 112: C-REACTIVE PROTEIN (CRP), 2.1 mg/dL; 112: CO2, 20 mmol/L; 119: HR, 120.0; 119: RR, 20.0; 119: SpO2, 96.0; 119: SBP, 120.0; 119: DBP, 90.0; 119: MAP, 100.0; 119: Pain, 0.0; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 121.0; 0: Triage RR, 22.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, VASCULAR ACCESS PROBLEM",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "While reviewing the data, I focused on signs that might indicate sepsis risk, such as elevated heart rate, respiratory rate, and any indication of infection. I noted that the patient\u2019s tachycardia and respiratory rate are borderline high but that blood pressure, lactate level, and white blood cell count remain within acceptable ranges. Additionally, lab results do not suggest severe infection or organ dysfunction. Based on these observations, the patient does not appear to be at high risk for developing sepsis in the next 12 hours.",
        "claims": [
            "I focused on signs that might indicate sepsis risk.",
            "Signs that might indicate sepsis risk include elevated heart rate, respiratory rate, and any indication of infection.",
            "The patient exhibits tachycardia.",
            "The patient\u2019s respiratory rate is borderline high.",
            "The patient's blood pressure remains within acceptable ranges.",
            "The patient's lactate level remains within acceptable ranges.",
            "The patient's white blood cell count remains within acceptable ranges.",
            "Lab results do not suggest severe infection.",
            "Lab results do not suggest organ dysfunction.",
            "Based on these observations, the patient does not appear to be at high risk for developing sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "Signs that might indicate sepsis risk include elevated heart rate, respiratory rate, and any indication of infection.",
            "The patient exhibits tachycardia.",
            "Lab results do not suggest severe infection."
        ],
        "alignment_scores": [
            0.8,
            0.5,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            9
        ],
        "alignment_reasonings": [
            "The claim mentions elevated heart rate and respiratory rate, both of which are specific criteria listed under the Systemic Inflammatory Response Syndrome (SIRS) criteria (heart rate >90 bpm and respiratory rate >20/min). Additionally, the mention of \"any indication of infection\" aligns with the SIRS concept of systemic inflammation potentially due to an infectious process. While specific numeric values are not provided in the claim, the alignment with two SIRS criteria suggests a strong connection. However, the vague reference to infection without further specifics somewhat limits a perfect alignment, leading to a slightly deducted score.",
            "Tachycardia alone is one of the criteria listed under the Systemic Inflammatory Response Syndrome (SIRS), which includes a heart\u202frate of\u202f>\u202f90\u202fbpm. While the presence of tachycardia alone does not fulfill the requirement of SIRS (which needs at least two criteria), it is still directly related to the SIRS criteria, warranting a moderate alignment rating.",
            "The claim about lab results not suggesting severe infection implies a low suspicion of infection, which contrasts with the active steps in Category 9 (ordering antibiotics/cultures due to suspicion). While there is some conceptual overlap about infection status, the alignment is weak because Category 9 focuses on positive clinical action for suspected sepsis, not the absence of evidence for infection."
        ],
        "final_alignment_score": 0.5333333333333333,
        "accuracy": 0
    },
    {
        "input": "4: HR, 95.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 92.0; 4: DBP, 64.0; 4: MAP, 73.333; 4: Temp, 97.5; 5: SBP, 86.0; 5: DBP, 59.0; 5: MAP, 68.0; 8: Pain, 2.0; 38: POC PH (V) ISTAT, 7.36; 38: POC LACTATE ISTAT, 2.34 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 38: POC HCO3 (V) ISTAT, 29.3 mmol/L; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC PO2 (V) ISTAT, 24 mmHg; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 40 %; 44: WAM DIFTYP, AUTO; 44: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 44: NEUTROPHIL % (AUTO DIFF), 58.6 %; 44: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 44: RED CELL DISTRIBUTION WIDTH (RDW), 15.0 %; 44: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.38 K/uL; 44: HEMOGLOBIN (HGB), 11.4 g/dL; 44: EOSINOPHIL % (AUTO DIFF), 4.4 %; 44: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 44: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 44: NRBC PERCENT (HEMATOLOGY), 0.0 %; 44: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.66 K/uL; 44: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.03 K/uL; 44: MONOCYTE % (AUTO DIFF), 5.3 %; 44: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.7 pg; 44: BASOPHIL % (AUTO DIFF), 0.5 %; 44: HEMATOCRIT (HCT), 38.3 %; 44: MEAN CORPUSCULAR VOLUME (MCV), 86.5 fL; 44: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.8 g/dL; 44: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 44: LYMPHOCYTE % (AUTO DIFF), 30.9 %; 44: PLATELET COUNT (PLT), 425 K/uL; 44: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 44: RED BLOOD CELLS (RBC), 4.43 MIL/uL; 45: SpO2, 97.435; 46: SpO2, 95.0; 46: Perf, 0.797; 47: SpO2, 94.949; 47: Perf, 0.570; 48: SpO2, 97.222; 48: Perf, 0.413; 48: SBP, 106.0; 48: DBP, 63.0; 48: MAP, 77.333; 49: SpO2, 96.627; 49: Perf, 0.574; 50: SpO2, 95.379; 50: Perf, 0.486; 51: SpO2, 95.356; 51: Perf, 0.394; 52: SpO2, 95.759; 52: Perf, 0.377; 53: SpO2, 96.949; 53: Perf, 0.411; 54: SpO2, 97.0; 54: Perf, 0.439; 55: SpO2, 96.586; 55: Perf, 0.461; 56: SpO2, 97.0; 56: Perf, 0.387; 57: INR, 1.0; 57: PROTHROMBIN TIME, 13.5 seconds; 57: PART. THROMBOPLASTIN TIME, 27.1 seconds; 57: SpO2, 97.0; 57: Perf, 0.376; 58: HR, 79.0; 58: SpO2, 96.475; 58: Perf, 0.393; 59: HR, 79.0; 59: SpO2, 97.0; 59: Perf, 0.442; 59: SBP, 102.0; 59: DBP, 64.0; 59: MAP, 76.667; 60: SpO2, 97.333; 60: Perf, 0.45; 60: SBP, 102.0; 60: DBP, 64.0; 60: MAP, 76.667; 61: SpO2, 96.627; 61: Perf, 0.591; 62: SpO2, 96.207; 62: Perf, 0.531; 63: SpO2, 97.017; 63: Perf, 0.563; 64: SpO2, 96.678; 64: Perf, 0.502; 65: SpO2, 96.860; 65: Perf, 0.598; 66: SpO2, 96.483; 66: Perf, 0.573; 67: SpO2, 95.759; 67: Perf, 0.473; 68: SpO2, 94.576; 68: Perf, 0.374; 69: SpO2, 95.136; 69: Perf, 0.384; 70: SpO2, 95.397; 70: Perf, 0.361; 71: SpO2, 96.644; 71: Perf, 0.393; 72: SpO2, 96.879; 72: Perf, 0.448; 73: SpO2, 96.898; 73: Perf, 0.455; 74: SpO2, 97.0; 74: Perf, 0.478; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CALCIUM, 9.7 mg/dL; 75: GLUCOSE, 133 mg/dL; 75: CO2, 26 mmol/L; 75: AST (SGOT), 24 U/L; 75: ALBUMIN, 4.1 g/dL; 75: CORRECTED CALCIUM, 9.6 mg/dL; 75: PROTEIN TOTAL, 7.8 g/dL; 75: ANION GAP, 10 mmol/L; 75: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 75: CREATININE, 0.74 mg/dL; 75: GLOBULIN, 3.7 g/dL; 75: ALT (SGPT), 11 U/L; 75: BILIRUBIN TOTAL, 0.3 mg/dL; 75: SODIUM, 136 mmol/L; 75: ALKALINE PHOSPHATASE, 86 U/L; 75: CHLORIDE, 100 mmol/L; 75: POTASSIUM, 4.9 mmol/L; 75: SpO2, 97.190; 75: Perf, 0.538; 76: SpO2, 97.305; 76: Perf, 0.482; 77: SpO2, 96.897; 77: Perf, 0.432; 78: SpO2, 97.155; 78: Perf, 0.404; 79: SpO2, 97.661; 79: Perf, 0.421; 80: SARS-COV-2 RNA, Not Detected; 80: SpO2, 96.525; 80: Perf, 0.404; 81: SpO2, 96.695; 81: Perf, 0.383; 82: SpO2, 96.603; 82: Perf, 0.349; 82: LR IV BOLUS -, 1000 ML; 83: SpO, 2: 96.704; 83: Perf, 0.351; 84: SpO2, 96.604; 85: SpO2, 95.845; 86: SpO2, 96.576; 86: Perf, 0.305; 87: SpO2, 96.707; 87: Perf, 0.307; 88: SpO2, 96.522; 88: Perf, 0.3; 89: SpO2, 97.537; 89: Perf, 0.3; 90: SpO2, 97.0; 90: Perf, 0.382; 91: SpO2, 96.288; 91: Perf, 0.401; 92: SpO2, 94.915; 92: Perf, 0.369; 93: SpO2, 96.949; 93: Perf, 0.290; 94: SpO2, 95.310; 94: Perf, 0.277; 95: SpO2, 96.644; 95: Perf, 0.301; 96: SpO2, 95.537; 96: Perf, 0.269; 97: SpO2, 96.064; 97: Perf, 0.260; 98: SpO2, 97.091; 98: Perf, 0.255; 99: SpO2, 96.612; 99: Perf, 0.264; 100: SpO2, 96.409; 100: Perf, 0.242; 101: SpO2, 96.231; 101: Perf, 0.246; 102: SpO2, 96.735; 102: Perf, 0.238; 103: SpO2, 97.0; 103: Perf, 0.235; 104: SpO2, 97.217; 104: Perf, 0.236; 105: SpO2, 96.6; 105: Perf, 0.217; 106: SpO2, 96.675; 106: Perf, 0.224; 107: SpO2, 96.081; 107: Perf, 0.240; 108: SpO2, 96.806; 108: Perf, 0.232; 109: SpO2, 96.25; 109: Perf, 0.225; 110: SpO2, 96.759; 110: Perf, 0.220; 111: SpO2, 96.379; 111: Perf, 0.216; 112: SpO2, 96.455; 112: Perf, 0.222; 113: SpO2, 97.125; 113: Perf, 0.221; 114: SpO2, 96.318; 114: Perf, 0.227; 115: SpO2, 96.241; 115: Perf, 0.227; 116: SpO2, 96.714; 116: Perf, 0.216; 117: SpO2, 97.135; 117: Perf, 0.224; 118: SpO2, 97.318; 118: Perf, 0.227; 119: SpO2, 97.467; 119: Perf, 0.21; 0: Age, 90; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I noted the patient\u2019s mild hypotension and slightly elevated lactate but also saw overall stable vitals and normal white blood cell counts. I considered whether there were signs of infection, organ dysfunction, or persistent hemodynamic instability, which would point to high sepsis risk. The data suggests the patient\u2019s condition remained relatively controlled and not indicative of a new or worsening septic process.",
        "claims": [
            "The patient has mild hypotension.",
            "The patient has slightly elevated lactate.",
            "The patient's overall vitals are stable.",
            "The patient has normal white blood cell counts.",
            "I considered signs of infection.",
            "I considered signs of organ dysfunction.",
            "I considered signs of persistent hemodynamic instability.",
            "Signs of infection, organ dysfunction, or persistent hemodynamic instability would indicate a high risk of sepsis.",
            "The data suggests the patient's condition remained relatively controlled.",
            "The patient's condition is not indicative of a new septic process.",
            "The patient\u2019s condition is not indicative of a worsening septic process."
        ],
        "relevant_claims": [
            "The patient has mild hypotension.",
            "The patient has slightly elevated lactate."
        ],
        "alignment_scores": [
            0.7,
            0.7
        ],
        "alignment_category": [
            7,
            5
        ],
        "alignment_reasonings": [
            "The claim of \"mild hypotension\" relates to the concept of sepsis-associated hypotension outlined in category 7. However, \"mild\" is a vague descriptor and does not specify whether the systolic blood pressure is <90 mmHg, mean arterial pressure is <70 mmHg, or if there is a \u226540 mmHg drop from baseline. Due to this lack of specificity, the alignment is partial but significant, as mild hypotension can be an early indicator of worsening hemodynamics as described in this category.",
            "The claim refers to \"slightly elevated lactate,\" which aligns with the category concerning serum lactate levels. Since the exact value of the lactate level isn't provided and may not necessarily reach the \u22652 mmol/L threshold, the alignment is not perfect, but it is significant, as lactate elevation is a known marker for tissue hypoperfusion often associated with sepsis risk."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 99.0; 4: SBP, 141.0; 4: DBP, 92.0; 4: MAP, 108.333; 4: Pain, 6.0; 4: Temp, 97.9; 9: Pain, 7.0; 28: HR, 97.0; 28: RR, 15.0; 28: SpO2, 99.0; 28: SBP, 149.0; 28: DBP, 99.0; 28: MAP, 115.667; 28: Pain, 7.0; 29: SBP, 149.0; 29: DBP, 99.0; 29: MAP, 115.667; 30: SpO2, 98.833; 30: Perf, 2.51; 31: SpO2, 98.847; 31: Perf, 2.238; 32: SpO2, 98.103; 32: Perf, 1.899; 33: SpO2, 96.763; 33: Perf, 2.299; 34: SpO2, 97.034; 34: Perf, 2.379; 35: SpO2, 96.593; 35: Perf, 2.486; 36: SpO2, 98.322; 36: Perf, 2.368; 37: SpO2, 98.569; 37: Perf, 2.020; 38: SpO2, 97.0; 38: Perf, 2.242; 39: SpO2, 96.793; 39: Perf, 2.375; 40: SpO2, 97.814; 40: Perf, 2.22; 41: SpO2, 98.898; 41: Perf, 1.982; 42: SpO2, 98.983; 42: Perf, 1.713; 43: SpO2, 99.034; 43: Perf, 1.991; 44: SpO2, 97.5; 44: Perf, 2.662; 45: SpO2, 97.814; 45: Perf, 2.922; 46: SpO2, 98.322; 46: Perf, 2.619; 47: SpO2, 98.793; 47: Perf, 2.243; 48: SpO2, 97.407; 48: Perf, 1.931; 49: SpO2, 97.724; 49: Perf, 1.593; 50: SpO2, 97.898; 50: Perf, 1.594; 51: SpO2, 97.915; 51: Perf, 1.571; 52: SpO2, 98.776; 52: Perf, 1.957; 53: SpO2, 98.661; 53: Perf, 2.086; 54: SpO2, 98.328; 54: Perf, 1.897; 55: SpO2, 98.102; 55: Perf, 1.603; 56: SpO2, 98.322; 56: Perf, 1.592; 57: SpO2, 98.534; 57: Perf, 1.642; 58: SpO2, 99.237; 58: Perf, 1.675; 59: SpO2, 97.810; 59: Perf, 1.644; 60: SpO2, 97.729; 60: Perf, 1.421; 61: SpO2, 97.729; 61: Perf, 1.236; 62: SpO2, 98.103; 62: Perf, 1.116; 63: SpO2, 98.102; 63: Perf, 1.111; 64: SpO2, 98.862; 64: Perf, 1.314; 65: SpO2, 98.288; 65: Perf, 1.637; 66: SpO2, 98.810; 66: Perf, 1.958; 67: SpO2, 98.780; 67: Perf, 1.529; 68: SpO2, 97.831; 68: Perf, 1.272; 69: SpO2, 98.379; 69: Perf, 1.351; 70: SpO2, 98.254; 70: Perf, 1.663; 71: SpO2, 97.879; 71: Perf, 1.607; 72: SpO2, 98.746; 72: Perf, 1.151; 73: SpO2, 97.475; 73: Perf, 1.061; 74: SpO2, 97.466; 74: Perf, 1.162; 75: SpO2, 97.661; 75: Perf, 1.278; 76: SpO2, 98.155; 76: Perf, 1.366; 77: SpO2, 98.0; 77: Perf, 1.219; 78: SpO2, 99.034; 78: Perf, 0.794; 79: SpO2, 98.707; 79: Perf, 0.774; 80: SpO2, 97.254; 80: Perf, 1.277; 81: SpO2, 97.138; 81: Perf, 1.397; 82: SpO2, 96.949; 82: Perf, 1.276; 83: SpO2, 97.254; 83: Perf, 0.825; 84: SpO2, 97.483; 84: Perf, 1.056; 85: SpO2, 98.441; 85: Perf, 1.759; 86: SpO2, 98.086; 86: Perf, 1.750; 87: SpO2, 98.627; 87: Perf, 1.313; 88: SpO2, 98.051; 88: Perf, 1.599; 89: SpO2, 98.672; 89: Perf, 1.206; 89: SBP, 151.0; 89: DBP, 87.0; 89: MAP, 108.333; 90: SpO2, 98.864; 90: Perf, 1.203; 91: SpO2, 99.431; 91: Perf, 1.215; 92: SpO2, 98.881; 92: Perf, 1.043; 93: CHLORIDE, 105 mmol/L; 93: GLOBULIN, 2.6 g/dL; 93: ALKALINE PHOSPHATASE, 89 U/L; 93: CREATININE, 1.25 mg/dL; 93: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 93: ALT (SGPT), 29 U/L; 93: EGFR REFIT WITHOUT RACE (2021), 68 mL/min/1.73 m2; 93: AST (SGOT), 29 U/L; 93: CO2, 21 mmol/L; 93: POTASSIUM, 3.6 mmol/L; 93: GLUCOSE, 109 mg/dL; 93: ALBUMIN, 4.3 g/dL; 93: CORRECTED CALCIUM, 8.6 mg/dL; 93: PROTEIN TOTAL, 6.9 g/dL; 93: CALCIUM, 8.8 mg/dL; 93: ANION GAP, 13 mmol/L; 93: SODIUM, 139 mmol/L; 93: BILIRUBIN TOTAL, 0.6 mg/dL; 93: LIPASE, 23 U/L; 93: SpO2, 99.136; 93: Perf, 0.841; 94: SpO2, 98.931; 94: Perf, 0.738; 95: SpO2, 98.203; 95: Perf, 1.045; 96: SpO2, 98.293; 96: Perf, 1.207; 97: SARS-COV-2 RNA, Not Detected; 97: SpO2, 99.458; 97: Perf, 1.211; 98: SpO2, 99.259; 98: Perf, 1.108; 99: SpO2, 100.0; 99: Perf, 0.684; 100: SpO2, 99.932; 100: Perf, 0.549; 101: SpO2, 99.276; 101: Perf, 0.588; 102: SpO2, 98.780; 102: Perf, 0.494; 103: SpO2, 99.052; 103: Perf, 0.49; 104: SpO2, 98.424; 104: Perf, 0.535; 105: SpO2, 98.305; 105: Perf, 0.428; 106: SpO2, 98.897; 106: Perf, 0.391; 107: SpO2, 97.763; 107: Perf, 0.546; 108: SpO2, 98.483; 108: Perf, 0.491; 109: SpO2, 96.593; 109: Perf, 0.523; 110: SpO2, 97.627; 110: Perf, 0.64; 111: SpO2, 97.707; 111: Perf, 0.719; 112: SpO2, 98.525; 112: Perf, 0.737; 113: SpO2, 98.155; 113: Perf, 0.561; 114: SpO2, 97.525; 114: Perf, 0.627; 115: SpO2, 98.085; 115: Perf, 0.650; 116: PLATELET COUNT (PLT), 215 K/uL; 116: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.0 g/dL; 116: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 116: HEMATOCRIT (HCT), 37.6 %; 116: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 116: RED BLOOD CELLS (RBC), 4.01 MIL/uL; 116: MEAN CORPUSCULAR VOLUME (MCV), 93.8 fL; 116: HEMOGLOBIN (HGB), 12.8 g/dL; 116: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.9 pg; 116: NEUTROPHILS BANDS % (MANUAL DIFF), 10.4 %; 116: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.68 K/uL; 116: LYMPHOCYTES % (MANUAL DIFF), 8.7 %; 116: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.17 K/uL; 116: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.09 K/uL; 116: BASOPHILS % (MANUAL DIFF), 1.7 %; 116: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 71.4 %; 116: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 116: MONOCYTES % (MANUAL DIFF), 5.2 %; 116: EOSINOPHILS % (MANUAL DIFF), 2.6 %; 116: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 116: SpO2, 99.069; 116: Perf, 0.680; 117: SpO2, 98.864; 117: Perf, 0.548; 118: SpO2, 99.439; 118: Perf, 0.634; 119: SpO2, 98.75; 119: Perf, 0.77; 0: Age, 54; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 141.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, FLANK PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first reviewed the patient\u2019s vital signs and noted that blood pressure, heart rate, and temperature remained relatively stable, indicating no clear signs of infection or systemic inflammation. Then I questioned whether the lab results revealed any abnormalities suggesting sepsis, but the WBC count, renal function, and other markers were not significantly concerning. Next, I considered the clinical presentation of flank pain, which can sometimes be associated with infection, yet there was no substantive evidence of severe infection or organ dysfunction. Finally, I concluded that the patient does not exhibit sufficient indicators of sepsis risk within the next 12 hours.",
        "claims": [
            "The patient's vital signs were reviewed.",
            "Blood pressure, heart rate, and temperature remained relatively stable.",
            "Stable vital signs indicate no clear signs of infection or systemic inflammation.",
            "Lab results were questioned for abnormalities suggesting sepsis.",
            "The WBC count was not significantly concerning.",
            "Renal function was not significantly concerning.",
            "Other markers were not significantly concerning.",
            "The clinical presentation included flank pain.",
            "Flank pain can sometimes be associated with infection.",
            "There was no substantive evidence of severe infection.",
            "There was no substantive evidence of organ dysfunction.",
            "The patient does not exhibit sufficient indicators of sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "There was no substantive evidence of organ dysfunction."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            8
        ],
        "alignment_reasonings": [
            "The claim indicates a lack of organ dysfunction, which is directly related to the SOFA score as it assesses organ function. The absence of organ dysfunction suggests no significant increase in the SOFA score, linking it to this criterion. However, while directly related, it is an inverse assertion (absence rather than presence), so the alignment is strong but not perfect."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "7: Pain, 7.0; 32: HR, 117.0; 32: RR, 32.0; 32: SpO2, 86.0; 32: SBP, 109.0; 32: DBP, 68.0; 32: MAP, 81.667; 32: Pain, 10.0; 32: Temp, 100.9; 36: SpO2, 96.0; 36: LPM O2, 4.0; 68: WAM DIFTYP, AUTO; 68: RED BLOOD CELLS (RBC), 5.46 MIL/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 68: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 68: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: NEUTROPHIL % (AUTO DIFF), 80.3 %; 68: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.20 K/uL; 68: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 68: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 68: MONOCYTE % (AUTO DIFF), 5.2 %; 68: MEAN CORPUSCULAR VOLUME (MCV), 74.0 fL; 68: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.05 K/uL; 68: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 68: EOSINOPHIL % (AUTO DIFF), 0.4 %; 68: NRBC PERCENT (HEMATOLOGY), 0.0 %; 68: HEMOGLOBIN (HGB), 13.6 g/dL; 68: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: PLATELET COUNT (PLT), 312 K/uL; 68: HEMATOCRIT (HCT), 40.4 %; 68: LYMPHOCYTE % (AUTO DIFF), 13.6 %; 68: BASOPHIL % (AUTO DIFF), 0.4 %; 68: WHITE BLOOD CELLS (WBC), 7.7 K/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 68: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 85: SpO2, 98.0; 86: SpO2, 98.625; 86: Perf, 2.463; 86: SBP, 109.0; 86: DBP, 73.0; 86: MAP, 85.0; 87: HR, 113.469; 87: RR, 27.0; 87: SpO2, 99.155; 87: Perf, 2.662; 87: 1min HRV, 19.790; 87: 5min HRV, 19.790; 88: HR, 112.390; 88: RR, 21.492; 88: SpO2, 98.644; 88: Perf, 2.950; 88: 1min HRV, 20.380; 89: HR, 110.603; 89: RR, 27.207; 89: SpO2, 98.586; 89: Perf, 2.988; 89: 1min HRV, 18.547; 90: HR, 107.508; 90: RR, 27.237; 90: SpO2, 98.797; 90: Perf, 4.969; 90: 1min HRV, 11.911; 91: HR, 106.559; 91: RR, 22.780; 91: SpO2, 99.0; 91: Perf, 5.491; 91: 1min HRV, 7.818; 92: HR, 107.448; 92: RR, 21.603; 92: SpO2, 98.931; 92: Perf, 5.781; 92: 1min HRV, 17.544; 92: 5min HRV, 19.342; 92: SBP, 105.0; 92: DBP, 77.0; 92: MAP, 86.333; 92: LPM O2, 4.0; 93: HR, 106.458; 93: RR, 27.153; 93: SpO2, 99.152; 93: Perf, 5.267; 93: 1min HRV, 9.148; 93: SBP, 105.0; 93: DBP, 77.0; 93: MAP, 86.333; 94: HR, 105.397; 94: RR, 27.448; 94: SpO2, 98.931; 94: Perf, 4.354; 94: 1min HRV, 11.650; 95: HR, 105.983; 95: RR, 24.458; 95: SpO2, 98.475; 95: Perf, 5.262; 95: 1min HRV, 7.859; 96: HR, 104.966; 96: RR, 26.254; 96: SpO2, 98.0; 96: Perf, 5.722; 96: 1min HRV, 9.993; 97: HR, 104.759; 97: RR, 28.569; 97: SpO2, 98.345; 97: Perf, 5.849; 97: 1min HRV, 26.592; 97: 5min HRV, 15.220; 98: HR, 106.051; 98: RR, 28.017; 98: SpO2, 98.475; 98: Perf, 4.902; 98: 1min HRV, 13.398; 99: POC PH (V) ISTAT, 7.44; 99: POC LACTATE ISTAT, 0.97 mmol/L; 99: POC TCO2 (V) ISTAT, 36 mmol/L; 99: POC PCO2 (V) ISTAT, 51.2 mmHg; 99: POC O2 SATURATION ISTAT VENOUS, 86 %; 99: POC BASE EXCESS ISTAT, 10 mmol/L; 99: POC HCO3 (V) ISTAT, 34.4 mmol/L; 99: POC PO2 (V) ISTAT, 51 mmHg; 99: HR, 102.362; 99: RR, 23.259; 99: SpO2, 98.0; 99: Perf, 5.626; 99: 1min HRV, 9.641; 100: HR, 103.119; 100: RR, 26.407; 100: SpO2, 98.0; 100: Perf, 6.064; 100: 1min HRV, 9.006; 101: HR, 105.552; 101: RR, 21.793; 101: SpO2, 98.017; 101: Perf, 6.432; 101: 1min HRV, 26.363; 102: HR, 105.746; 102: RR, 21.576; 102: SpO2, 98.492; 102: Perf, 6.412; 102: 1min HRV, 15.509; 102: 5min HRV, 18.497; 103: LIPASE, 7 U/L; 103: HR, 103.559; 103: RR, 21.322; 103: SpO2, 97.966; 103: Perf, 7.953; 103: 1min HRV, 10.207; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 103.966; 104: RR, 22.931; 104: SpO2, 98.190; 104: Perf, 6.394; 104: 1min HRV, 12.384; 105: HR, 102.797; 105: RR, 22.898; 105: SpO2, 98.0; 105: Perf, 7.407; 105: 1min HRV, 9.324; 106: HR, 106.552; 106: RR, 26.207; 106: SpO2, 97.638; 106: Perf, 6.102; 106: 1min HRV, 22.177; 107: HR, 105.051; 107: RR, 20.458; 107: SpO2, 97.542; 107: Perf, 7.189; 107: 1min HRV, 15.540; 107: 5min HRV, 16.297; 108: HR, 102.203; 108: RR, 26.271; 108: SpO2, 98.0; 108: Perf, 8.579; 108: 1min HRV, 8.521; 108: SBP, 104.0; 108: DBP, 68.0; 108: MAP, 80.0; 109: HR, 102.862; 109: RR, 19.431; 109: SpO2, 98.0; 109: Perf, 7.502; 109: 1min HRV, 7.261; 110: HR, 102.322; 110: RR, 22.508; 110: SpO2, 98.0; 110: Perf, 8.154; 110: 1min HRV, 11.387; 111: HR, 100.224; 111: RR, 23.552; 111: SpO2, 98.0; 111: Perf, 7.929; 111: 1min HRV, 13.069; 112: HR, 100.729; 112: RR, 22.237; 112: SpO2, 98.0; 112: Perf, 7.754; 112: 1min HRV, 10.293; 112: 5min HRV, 11.824; 113: HR, 99.966; 113: RR, 24.864; 113: SpO2, 98.0; 113: Perf, 7.96; 113: 1min HRV, 13.281; 114: HR, 99.586; 114: RR, 24.603; 114: SpO2, 98.0; 114: Perf, 8.212; 114: 1min HRV, 12.548; 115: HR, 98.763; 115: RR, 22.390; 115: SpO2, 98.0; 115: Perf, 8.311; 115: 1min HRV, 10.531; 116: HR, 100.362; 116: RR, 22.362; 116: SpO2, 98.0; 116: Perf, 7.152; 116: 1min HRV, 24.455; 117: HR, 98.441; 117: RR, 21.373; 117: SpO2, 98.0; 117: Perf, 7.441; 117: 1min HRV, 13.903; 117: 5min HRV, 16.747; 118: HR, 97.034; 118: RR, 24.085; 118: SpO2, 98.0; 118: Perf, 7.582; 118: 1min HRV, 11.218; 119: HR, 96.879; 119: RR, 22.638; 119: SpO2, 98.0; 119: Perf, 8.531; 119: 1min HRV, 11.097; 0: Age, 23; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 32.0; 0: Triage SBP, 109.0; 0: Triage DBP, 68.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN,ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I first notice that the patient meets some SIRS criteria (fever, tachycardia, tachypnea), which can raise concern. However, I also see that the lactate level is normal, the blood pressure remains stable, and the white blood cell count is not elevated. I ask myself if there are any signs of organ failure or shock, and the normal lactate and adequate oxygen saturation (with minimal supplemental oxygen) suggest there aren\u2019t. Finally, I conclude that the overall risk of sepsis within 12 hours is not high given these findings.",
        "claims": [
            "The patient meets some SIRS criteria, including fever, tachycardia, and tachypnea.",
            "Meeting some SIRS criteria can raise concern.",
            "The lactate level is normal.",
            "The blood pressure remains stable.",
            "The white blood cell count is not elevated.",
            "The normal lactate suggests there are no signs of organ failure.",
            "Adequate oxygen saturation is maintained with minimal supplemental oxygen.",
            "The adequate oxygen saturation suggests there are no signs of shock.",
            "The overall risk of sepsis within 12 hours is not high given these findings."
        ],
        "relevant_claims": [
            "The patient meets some SIRS criteria, including fever, tachycardia, and tachypnea.",
            "The white blood cell count is not elevated."
        ],
        "alignment_scores": [
            1.0,
            0.3
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim explicitly mentions three criteria\u2014fever, tachycardia, and tachypnea\u2014that are part of the SIRS criteria. Meeting two or more of these criteria identifies systemic inflammation consistent with early sepsis, thus presenting a direct and strong alignment with SIRS Positivity.",
            "The claim concerning the white blood cell count is directly related to the SIRS criteria, which includes elevated or lowered WBC counts as indicators. In this case, the WBC is not elevated, which technically suggests the absence of one positive SIRS criterion, hence a weak inverse alignment."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 0
    },
    {
        "input": "12: SpO2, 98.026; 13: HR, 117.0; 13: RR, 18.0; 13: SpO2, 97.0; 13: SBP, 148.0; 13: DBP, 99.0; 13: MAP, 115.333; 13: Pain, 0.0; 13: Temp, 97.9; 14: SpO2, 96.877; 14: SBP, 148.0; 14: DBP, 99.0; 14: MAP, 115.333; 15: SpO2, 96.559; 15: Perf, 0.549; 16: SpO2, 96.121; 16: Perf, 0.543; 17: SpO2, 95.717; 17: Perf, 0.54; 18: SpO2, 96.339; 18: Perf, 0.569; 19: SpO2, 96.155; 19: Perf, 0.618; 20: SpO2, 94.929; 20: Perf, 0.62; 21: SpO2, 94.312; 21: Perf, 0.62; 22: SpO2, 94.214; 22: Perf, 0.631; 23: SpO2, 95.489; 23: Perf, 0.899; 24: SpO2, 94.466; 24: Perf, 0.986; 25: SpO2, 95.390; 25: Perf, 0.890; 26: SpO2, 95.707; 26: Perf, 0.893; 27: SpO2, 95.339; 27: Perf, 0.886; 28: SpO2, 95.932; 28: Perf, 0.794; 29: SpO2, 95.476; 29: Perf, 0.73; 30: SpO2, 95.695; 31: SpO2, 95.121; 31: Perf, 0.726; 32: SpO2, 95.881; 32: Perf, 0.751; 33: SpO2, 95.593; 33: Perf, 0.769; 34: SpO2, 95.828; 34: Perf, 0.635; 35: SpO2, 95.932; 35: Perf, 0.645; 36: SpO2, 96.517; 36: Perf, 0.65; 37: SpO2, 95.746; 37: Perf, 0.65; 37: Temp, 99.9; 38: SpO2, 95.1; 38: Perf, 0.65; 39: SpO2, 97.0; 39: Perf, 0.65; 40: Perf, 0.65; 41: SpO2, 95.769; 41: Perf, 0.654; 42: SpO2, 97.0; 42: Perf, 0.67; 43: SpO2, 95.35; 43: Perf, 0.704; 44: SpO2, 94.288; 44: Perf, 0.715; 45: SpO2, 93.421; 45: Perf, 0.72; 46: SpO2, 94.0; 46: Perf, 0.727; 47: SpO2, 94.458; 47: Perf, 0.74; 48: SpO2, 94.379; 48: Perf, 0.741; 49: SpO2, 94.153; 49: Perf, 0.844; 50: SpO2, 94.356; 50: Perf, 1.115; 51: SpO2, 94.524; 51: Perf, 1.12; 51: LR IV BOLUS -, 500 ML; 52: SpO, 2: 94.373; 52: Perf, 1.12; 53: SpO2, 94.569; 53: Perf, 1.139; 54: SpO2, 93.830; 54: Perf, 1.238; 55: SpO2, 93.714; 55: Perf, 1.176; 56: SpO2, 95.190; 56: Perf, 0.968; 57: SpO2, 94.169; 57: Perf, 0.96; 58: SpO2, 94.466; 58: Perf, 0.96; 59: SpO2, 93.712; 59: Perf, 0.946; 60: SpO2, 95.0; 60: Perf, 0.894; 61: SpO2, 95.017; 61: Perf, 0.882; 62: SpO2, 95.441; 62: Perf, 0.883; 63: SpO2, 94.707; 63: Perf, 0.87; 64: SpO2, 95.017; 64: Perf, 0.861; 65: SpO2, 94.644; 65: Perf, 0.857; 66: SpO2, 95.310; 66: Perf, 0.742; 67: SpO2, 94.824; 67: Perf, 0.69; 68: INR, 1.9; 68: PROTHROMBIN TIME, 21.2 seconds; 68: SpO2, 94.655; 69: PART. THROMBOPLASTIN TIME, 79.5 seconds; 69: SpO2, 96.525; 69: Perf, 0.725; 70: SpO2, 96.822; 70: Perf, 0.7; 71: SpO2, 95.085; 72: SpO2, 94.644; 72: Perf, 0.757; 73: WAM DIFTYP, AUTO; 73: POTASSIUM, 5.2 mmol/L; 73: CO2, 21 mmol/L; 73: GLUCOSE, 115 mg/dL; 73: BLOOD UREA NITROGEN (BUN), 51 mg/dL; 73: CALCIUM, 8.8 mg/dL; 73: CHLORIDE, 103 mmol/L; 73: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 73: ANION GAP, 14 mmol/L; 73: SODIUM, 138 mmol/L; 73: CREATININE, 1.15 mg/dL; 73: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: RED CELL DISTRIBUTION WIDTH (RDW), 15.8 %; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.15 K/uL; 73: EOSINOPHIL % (AUTO DIFF), 0.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 73: MONOCYTE % (AUTO DIFF), 0.3 %; 73: NEUTROPHIL % (AUTO DIFF), 87.1 %; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: PLATELET COUNT (PLT), 106 K/uL; 73: RED BLOOD CELLS (RBC), 3.70 MIL/uL; 73: LYMPHOCYTE % (AUTO DIFF), 11.8 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 73: HEMATOCRIT (HCT), 33.8 %; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.83 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 91.4 fL; 73: HEMOGLOBIN (HGB), 10.5 g/dL; 73: SpO2, 94.759; 73: Perf, 0.619; 74: SpO2, 95.083; 74: Perf, 0.627; 74: SBP, 127.0; 74: DBP, 67.0; 74: MAP, 87.0; 75: Perf, 0.63; 76: SpO2, 93.6; 76: Perf, 0.617; 77: SpO2, 94.621; 77: Perf, 0.6; 78: SpO2, 95.179; 78: Perf, 0.6; 79: SpO2, 95.542; 79: Perf, 0.6; 80: SpO2, 92.625; 80: Perf, 0.6; 81: SpO2, 91.722; 82: SpO2, 92.1; 83: SpO2, 95.957; 84: SpO2, 94.797; 85: SpO2, 95.552; 86: SpO2, 96.4; 87: SpO2, 99.4; 88: SpO2, 97.308; 90: SpO2, 95.739; 91: SpO2, 94.356; 92: SpO2, 94.293; 93: SpO2, 94.831; 94: SpO2, 95.220; 95: SpO2, 94.5; 95: Perf, 0.516; 96: SpO2, 94.780; 96: Perf, 0.531; 97: SpO2, 95.172; 97: Perf, 0.547; 98: SpO2, 95.390; 98: Perf, 0.573; 99: SpO2, 95.085; 99: Perf, 0.603; 100: SpO2, 94.845; 100: Perf, 0.638; 101: SpO2, 94.525; 101: Perf, 0.655; 102: SpO2, 93.333; 102: Perf, 0.66; 111: SpO2, 83.875; 112: SpO2, 94.931; 112: Perf, 0.38; 113: SpO2, 95.0; 113: Perf, 0.352; 114: SpO2, 95.746; 114: Perf, 0.358; 115: SpO2, 95.897; 115: Perf, 0.361; 116: SpO2, 94.830; 116: Perf, 0.274; 117: HR, 130.0; 117: SpO2, 94.0; 117: Temp, 103.1; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.6; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 99.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noted the patient\u2019s advanced age, persistently elevated heart rate, and rising fever as potential red flags. I also saw concerning lab results such as elevated INR and low platelets, which can signal infection-related coagulopathy. These findings, along with signs of possible organ stress, raise the suspicion of sepsis.",
        "claims": [
            "The patient is of advanced age.",
            "The patient has a persistently elevated heart rate.",
            "The patient has a rising fever.",
            "Advanced age, elevated heart rate, and rising fever are potential red flags.",
            "The lab results show an elevated INR.",
            "The lab results show low platelets.",
            "Elevated INR and low platelets can signal infection-related coagulopathy.",
            "The findings suggest signs of possible organ stress.",
            "The combination of these findings raises the suspicion of sepsis."
        ],
        "relevant_claims": [
            "The patient is of advanced age.",
            "The patient has a persistently elevated heart rate.",
            "Advanced age, elevated heart rate, and rising fever are potential red flags.",
            "The lab results show an elevated INR.",
            "Elevated INR and low platelets can signal infection-related coagulopathy.",
            "The findings suggest signs of possible organ stress.",
            "The combination of these findings raises the suspicion of sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.9,
            0.6,
            0.7,
            0.5,
            0.4
        ],
        "alignment_category": [
            1,
            2,
            2,
            8,
            8,
            8,
            9
        ],
        "alignment_reasonings": [
            "The claim refers to the patient being of \"advanced age,\" which suggests they are likely in the older age group. Although the exact age is not specified, the term \"advanced age\" generally aligns with the concept of increased age-related sepsis susceptibility described in this category. Therefore, while it strongly hints at the category of Elderly Susceptibility, the lack of precise age information reduces the alignment slightly from a perfect score.",
            "A persistently elevated heart rate (>90 bpm) is one of the criteria for SIRS. This directly suggests systemic inflammation consistent with early sepsis, making it highly relevant to the SIRS Positivity category. However, as the claim doesn\u2019t mention other SIRS criteria being met, the alignment rating is high but not full (0.8).",
            "The claim mentions \"elevated heart rate\" and \"rising fever,\" which correspond to two of the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C and heart\u202frate\u202f>\u202f90\u202fbpm). While \"advanced age\" aligns with the \"Elderly Susceptibility\" category, the combination of criteria here more strongly supports the identification of systemic inflammation consistent with early sepsis as per the SIRS criteria. The alignment is high, as two explicit SIRS criteria are referenced, but not a perfect 1.0 because the age consideration introduces a slight divergence from solely SIRS criteria.",
            "An elevated INR may indicate coagulation abnormalities, which can be indirectly related to the SOFA score through the coagulation component (e.g., platelet count, which is part of the SOFA criteria). While INR itself is not directly mentioned, coagulation issues suggest possible organ dysfunction. Thus, the alignment is indirect but meaningful.",
            "The claim refers to coagulopathy indicated by elevated INR and low platelets. Low platelet count is directly relevant to the SOFA score, as it includes platelets\u202f<\u202f100\u202f\u00d7\u202f10\u2079/L in its criteria. Although INR is not a SOFA measure, it is related to liver dysfunction, which can affect bilirubin levels, another SOFA component. This makes the alignment reasonably strong, though not perfect, as INR is not directly part of SOFA scoring.",
            "The claim about \"organ stress\" suggests a potential issue with organ function, aligning this with the SOFA Score assessment of organ dysfunction, even though it doesn\u2019t specify particular organs or metrics measured by SOFA. The alignment is indirect because the claim is vague without specific details that match SOFA criteria.",
            "The claim conveys a general suspicion of sepsis, which is conceptually aligned with early actions such as ordering antibiotics or blood cultures. However, the claim lacks specific actions like \u201cadministration of antibiotics\u201d or \u201cdrawing of blood cultures\u201d that would solidify a stronger rating. Therefore, the alignment is weak but present."
        ],
        "final_alignment_score": 0.6714285714285715,
        "accuracy": 1
    },
    {
        "input": "11: HR, 124.0; 11: RR, 24.0; 11: SpO2, 96.0; 11: SBP, 110.0; 11: DBP, 65.0; 11: MAP, 80.0; 11: Temp, 97.9; 32: HR, 123.588; 32: RR, 18.0; 32: SpO2, 96.067; 32: Perf, 0.2; 32: 1min HRV, 6.990; 32: SBP, 117.0; 32: DBP, 73.0; 32: MAP, 87.667; 33: HR, 120.208; 33: RR, 19.604; 33: 1min HRV, 2.968; 34: HR, 119.173; 34: RR, 17.942; 34: SpO2, 97.0; 34: Perf, 0.15; 34: 1min HRV, 4.574; 35: HR, 117.981; 35: RR, 16.547; 35: SpO2, 96.5; 35: Perf, 0.14; 35: 1min HRV, 2.616; 35: 5min HRV, 7.779; 35: SBP, 113.0; 35: DBP, 69.0; 35: MAP, 83.667; 36: HR, 118.132; 36: RR, 15.736; 36: 1min HRV, 5.070; 36: SBP, 113.0; 36: DBP, 69.0; 36: MAP, 83.667; 37: HR, 117.0; 37: RR, 16.0; 37: 1min HRV, 1.732; 38: HR, 117.113; 38: RR, 15.434; 38: SpO2, 95.0; 38: Perf, 0.207; 38: 1min HRV, 2.010; 39: HR, 116.019; 39: RR, 15.038; 39: SpO2, 95.0; 39: Perf, 0.21; 39: 1min HRV, 2.276; 40: HR, 116.075; 40: RR, 15.642; 40: 1min HRV, 2.121; 40: 5min HRV, 4.496; 41: HR, 115.623; 41: RR, 15.415; 41: SpO2, 95.0; 41: Perf, 0.233; 41: 1min HRV, 1.634; 42: HR, 115.717; 42: RR, 15.396; 42: SpO2, 95.333; 42: Perf, 0.22; 42: 1min HRV, 2.719; 43: HR, 115.755; 43: RR, 15.717; 43: SpO2, 95.963; 43: Perf, 0.226; 43: 1min HRV, 1.995; 44: HR, 115.462; 44: RR, 15.0; 44: SpO2, 94.288; 44: Perf, 0.281; 44: 1min HRV, 2.2; 45: HR, 115.340; 45: RR, 14.075; 45: SpO2, 94.472; 45: Perf, 0.278; 45: 1min HRV, 1.998; 45: 5min HRV, 2.160; 46: HR, 115.340; 46: RR, 13.660; 46: SpO2, 94.038; 46: Perf, 0.276; 46: 1min HRV, 2.547; 47: HR, 115.0; 47: RR, 13.923; 47: SpO2, 94.135; 47: Perf, 0.275; 47: 1min HRV, 3.042; 48: HR, 115.245; 48: RR, 14.019; 48: SpO2, 94.617; 48: Perf, 0.266; 48: 1min HRV, 2.396; 49: HR, 117.808; 49: RR, 17.981; 49: SpO2, 95.432; 49: Perf, 0.238; 49: 1min HRV, 5.660; 50: HR, 119.849; 50: RR, 18.453; 50: SpO2, 96.208; 50: Perf, 0.328; 50: 1min HRV, 2.571; 50: 5min HRV, 9.206; 51: HR, 119.170; 51: RR, 17.321; 51: SpO2, 95.264; 51: Perf, 0.421; 51: 1min HRV, 2.345; 52: HR, 118.288; 52: RR, 17.577; 52: SpO2, 95.08; 52: Perf, 0.331; 52: 1min HRV, 2.746; 53: HR, 118.519; 53: RR, 18.759; 53: SpO2, 95.630; 53: Perf, 0.334; 53: 1min HRV, 3.235; 54: HR, 118.519; 54: RR, 19.385; 54: SpO2, 94.212; 54: Perf, 0.363; 54: 1min HRV, 1.890; 55: HR, 117.547; 55: RR, 18.566; 55: SpO2, 95.0; 55: Perf, 0.332; 55: 1min HRV, 2.645; 55: 5min HRV, 3.315; 56: HR, 116.769; 56: RR, 18.385; 56: SpO2, 95.0; 56: Perf, 0.333; 56: 1min HRV, 4.047; 57: HR, 118.472; 57: RR, 21.830; 57: SpO2, 95.774; 57: Perf, 0.297; 57: 1min HRV, 8.639; 58: HR, 118.321; 58: RR, 20.208; 58: SpO2, 96.302; 58: Perf, 0.278; 58: 1min HRV, 4.660; 59: HR, 117.5; 59: RR, 16.981; 59: SpO2, 95.865; 59: Perf, 0.261; 59: 1min HRV, 4.249; 60: HR, 115.981; 60: RR, 15.962; 60: SpO2, 94.604; 60: Perf, 0.295; 60: 1min HRV, 1.728; 60: 5min HRV, 6.621; 61: HR, 115.558; 61: RR, 16.077; 61: SpO2, 94.404; 61: Perf, 0.293; 61: 1min HRV, 3.394; 62: HR, 115.509; 62: RR, 16.547; 62: SpO2, 95.0; 62: Perf, 0.267; 62: 1min HRV, 1.862; 63: HR, 115.981; 63: RR, 16.792; 63: SpO2, 95.115; 63: Perf, 0.258; 63: 1min HRV, 1.911; 64: HR, 116.654; 64: RR, 17.404; 64: SpO2, 95.654; 64: Perf, 0.279; 64: 1min HRV, 3.281; 65: HR, 118.889; 65: RR, 18.037; 65: SpO2, 95.0; 65: Perf, 0.319; 65: 1min HRV, 8.971; 65: 5min HRV, 7.523; 66: HR, 119.481; 66: RR, 19.615; 66: SpO2, 95.385; 66: Perf, 0.316; 66: 1min HRV, 3.115; 66: SBP, 108.0; 66: DBP, 76.0; 66: MAP, 86.667; 67: HR, 118.943; 67: RR, 18.264; 67: SpO2, 95.264; 67: Perf, 0.389; 67: 1min HRV, 2.462; 68: HR, 118.868; 68: RR, 18.019; 68: SpO2, 95.0; 68: Perf, 0.353; 68: 1min HRV, 3.067; 69: HR, 117.904; 69: RR, 18.192; 69: SpO2, 95.0; 69: Perf, 0.343; 69: 1min HRV, 2.331; 70: HR, 117.415; 70: RR, 17.057; 70: SpO2, 95.0; 70: Perf, 0.326; 70: 1min HRV, 2.257; 70: 5min HRV, 3.951; 71: HR, 118.788; 71: RR, 18.25; 71: SpO2, 95.0; 71: Perf, 0.294; 71: 1min HRV, 5.300; 72: HR, 120.094; 72: RR, 18.377; 72: SpO2, 95.340; 72: Perf, 0.285; 72: 1min HRV, 1.663; 73: HR, 119.283; 73: RR, 18.094; 73: SpO2, 95.528; 73: Perf, 0.277; 73: 1min HRV, 6.112; 74: HR, 118.692; 74: RR, 16.962; 74: SpO2, 95.385; 74: Perf, 0.294; 74: 1min HRV, 4.186; 75: HR, 118.075; 75: RR, 16.528; 75: SpO2, 95.811; 75: Perf, 0.311; 75: 1min HRV, 3.037; 75: 5min HRV, 5.208; 76: HR, 119.308; 76: RR, 17.538; 76: SpO2, 94.173; 76: Perf, 0.370; 76: 1min HRV, 5.686; 77: HR, 117.396; 77: RR, 15.623; 77: SpO2, 93.925; 77: Perf, 0.396; 77: 1min HRV, 2.105; 78: HR, 118.321; 78: RR, 16.755; 78: SpO2, 94.0; 78: Perf, 0.371; 78: 1min HRV, 3.661; 79: HR, 118.151; 79: RR, 16.623; 79: SpO2, 94.0; 79: Perf, 0.396; 79: 1min HRV, 2.929; 80: HR, 117.463; 80: RR, 15.056; 80: SpO2, 94.0; 80: Perf, 0.372; 80: 1min HRV, 1.731; 80: 5min HRV, 4.406; 81: HR, 117.5; 81: RR, 15.0; 81: SpO2, 93.923; 81: Perf, 0.317; 81: 1min HRV, 2.825; 82: HR, 119.370; 82: RR, 15.630; 82: SpO2, 93.833; 82: Perf, 0.315; 82: 1min HRV, 6.033; 83: HR, 117.679; 83: RR, 15.830; 83: SpO2, 94.0; 83: Perf, 0.320; 83: 1min HRV, 2.040; 84: HR, 116.788; 84: RR, 15.077; 84: SpO2, 93.423; 84: Perf, 0.391; 84: 1min HRV, 2.008; 85: 5min HRV, 5.663; 95: HR, 119.0; 95: RR, 17.0; 95: SpO2, 95.0; 95: SBP, 115.0; 95: DBP, 73.0; 95: MAP, 87.0; 116: POC PH (V) ISTAT, 7.43; 116: POC PCO2 (V) ISTAT, 46.2 mmHg; 116: POC LACTATE ISTAT, 2.90 mmol/L; 116: POC HCO3 (V) ISTAT, 30.7 mmol/L; 116: POC PO2 (V) ISTAT, 38 mmHg; 116: POC TCO2 (V) ISTAT, 32 mmol/L; 116: POC BASE EXCESS ISTAT, 6 mmol/L; 116: POC O2 SATURATION ISTAT VENOUS, 73 %; 118: POC, HCG, ISTAT QUALITATIVE: Negative; 118: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 0: Age, 52; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 124.0; 0: Triage RR, 24.0; 0: Triage SBP, 110.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, EDEMA,JAUNDICE,ABNORMAL LAB",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed the patient's persistently elevated heart rate, borderline low blood pressure, and an elevated lactate value. Next, I considered how these findings, along with abnormal labs and signs of possible organ dysfunction (such as jaundice), could signal a high likelihood of sepsis. Finally, I reflected on how prolonged tachycardia and borderline hypotension might indicate poor perfusion and an ongoing infectious or inflammatory process. This led me to conclude that the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient has a persistently elevated heart rate.",
            "The patient has borderline low blood pressure.",
            "The patient has an elevated lactate value.",
            "The patient's findings include abnormal labs.",
            "The patient shows signs of possible organ dysfunction, such as jaundice.",
            "These findings could signal a high likelihood of sepsis.",
            "Prolonged tachycardia might indicate poor perfusion.",
            "Borderline hypotension might indicate an ongoing infectious process.",
            "The patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has a persistently elevated heart rate.",
            "The patient has borderline low blood pressure.",
            "The patient has an elevated lactate value.",
            "The patient's findings include abnormal labs.",
            "These findings could signal a high likelihood of sepsis.",
            "Prolonged tachycardia might indicate poor perfusion.",
            "Borderline hypotension might indicate an ongoing infectious process."
        ],
        "alignment_scores": [
            0.8,
            0.6,
            1.0,
            0.3,
            0.3,
            0.6,
            0.7
        ],
        "alignment_category": [
            2,
            7,
            5,
            8,
            4,
            6,
            7
        ],
        "alignment_reasonings": [
            "A persistently elevated heart rate (>90 bpm) is one of the criteria for SIRS. This directly suggests systemic inflammation consistent with early sepsis, making it highly relevant to the SIRS Positivity category. However, as the claim doesn\u2019t mention other SIRS criteria being met, the alignment rating is high but not full (0.8).",
            "The claim mentions borderline low blood pressure, which is conceptually related to sepsis-associated hypotension. However, without specific values indicating hypotension as defined by the category (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop), the alignment is moderate rather than strong. The claim suggests potential hemodynamic instability, relevant to this category.",
            "The claim directly references an elevated lactate value, which is specifically addressed by the \"Elevated Serum Lactate (\u22652 mmol/L)\" category. Elevated lactate levels are strong indicators of tissue hypoperfusion and increased sepsis risk, making this a perfect alignment with the category.",
            "The claim is vague and does not specify which abnormal lab findings are present. While the SOFA score measures various lab-related components like PaO\u2082/FiO\u2082, platelets, bilirubin, creatinine, each indicating new organ dysfunction, the claim is too general to directly match any specific SOFA element. The weak alignment comes from the fact that abnormal labs often hint at potential issues with organ function, which is relevant to SOFA but is not sufficiently detailed to assess a stronger alignment.",
            "The claim is a vague assertion about a high likelihood of sepsis without specifying which criteria or findings are present. Among the expert categories, an elevated NEWS score broadly represents a pattern of vital sign derangement, aligning with the concept of an increased risk of sepsis. However, given the lack of specificity in the claim, the alignment is weak.",
            "Tachycardia (elevated heart rate) can contribute to an elevated Shock Index, which is calculated as heart rate divided by systolic blood pressure. Prolonged tachycardia might suggest poor perfusion, which aligns conceptually with hemodynamic instability indicated by an elevated Shock Index. However, since the claim does not provide specific values for heart rate or blood pressure, the alignment is indirect.",
            "The claim refers to \"borderline hypotension,\" which suggests a concern for low blood pressure related to an infectious process. While the claim does not provide specific blood pressure values reaching the thresholds defined in this category, the context aligns closely with sepsis-associated hypotension by indicating potential progression toward septic shock. The alignment is moderate but not complete due to the lack of explicit BP values."
        ],
        "final_alignment_score": 0.6142857142857142,
        "accuracy": 1
    },
    {
        "input": "4: HR, 97.746; 4: RR, 22.186; 4: SpO2, 94.559; 4: Perf, 0.646; 4: 1min HRV, 11.968; 4: SBP, 92.0; 4: DBP, 66.0; 4: MAP, 74.667; 5: HR, 98.759; 5: RR, 23.724; 5: SpO2, 94.862; 5: Perf, 0.741; 5: 1min HRV, 8.708; 6: HR, 100.746; 6: RR, 26.729; 6: SpO2, 90.763; 6: Perf, 0.651; 6: 1min HRV, 5.674; 7: HR, 100.644; 7: RR, 28.102; 7: SpO2, 89.068; 7: Perf, 0.558; 7: 1min HRV, 12.144; 8: HR, 99.017; 8: RR, 27.690; 8: SpO2, 90.66; 8: Perf, 0.624; 8: 1min HRV, 8.066; 8: 5min HRV, 11.353; 9: HR, 97.288; 9: RR, 24.424; 9: SpO2, 91.576; 9: Perf, 0.602; 9: 1min HRV, 7.119; 9: SBP, 83.0; 9: DBP, 64.0; 9: MAP, 70.333; 10: HR, 96.627; 10: RR, 26.712; 10: SpO2, 92.0; 10: Perf, 0.704; 10: 1min HRV, 9.393; 10: SBP, 83.0; 10: DBP, 64.0; 10: MAP, 70.333; 10: Temp, 100.9; 11: HR, 96.776; 11: RR, 22.207; 11: SpO2, 92.621; 11: Perf, 0.637; 11: 1min HRV, 9.644; 12: HR, 97.034; 12: RR, 22.847; 12: SpO2, 92.017; 12: Perf, 0.600; 12: 1min HRV, 5.245; 13: HR, 96.879; 13: RR, 22.034; 13: SpO2, 92.088; 13: Perf, 0.632; 13: 1min HRV, 14.753; 13: 5min HRV, 9.971; 14: HR, 96.339; 14: RR, 21.119; 14: SpO2, 94.339; 14: Perf, 0.657; 14: 1min HRV, 10.121; 14: SBP, 90.0; 14: DBP, 60.0; 14: MAP, 70.0; 15: HR, 95.949; 15: RR, 22.492; 15: SpO2, 94.763; 15: Perf, 0.840; 15: 1min HRV, 4.013; 15: SBP, 90.0; 15: DBP, 60.0; 15: MAP, 70.0; 16: HR, 96.845; 16: RR, 22.259; 16: SpO2, 94.569; 16: Perf, 0.876; 16: 1min HRV, 3.703; 17: HR, 96.237; 17: RR, 22.627; 17: SpO2, 94.881; 17: Perf, 0.765; 17: 1min HRV, 6.290; 18: HR, 96.690; 18: RR, 21.793; 18: SpO2, 94.795; 18: Perf, 0.773; 18: 1min HRV, 4.852; 18: 5min HRV, 6.426; 19: HR, 97.254; 19: RR, 22.339; 19: SpO2, 94.526; 19: Perf, 0.814; 19: 1min HRV, 3.623; 19: SBP, 85.0; 19: DBP, 61.0; 19: MAP, 69.0; 20: HR, 96.186; 20: RR, 20.678; 20: SpO2, 94.0; 20: Perf, 0.843; 20: 1min HRV, 4.718; 21: HR, 96.052; 21: RR, 22.172; 21: SpO2, 94.0; 21: Perf, 0.719; 21: 1min HRV, 5.543; 22: HR, 96.593; 22: RR, 25.831; 22: SpO2, 94.0; 22: Perf, 0.723; 22: 1min HRV, 6.151; 23: HR, 97.552; 23: RR, 25.569; 23: SpO2, 95.672; 23: Perf, 0.807; 23: 1min HRV, 44.425; 23: 5min HRV, 20.809; 24: HR, 95.424; 24: RR, 24.492; 24: SpO2, 92.644; 24: Perf, 0.812; 24: 1min HRV, 4.431; 24: SBP, 94.0; 24: DBP, 84.0; 24: MAP, 87.333; 25: HR, 95.932; 25: RR, 23.441; 25: SpO2, 90.424; 25: Perf, 0.442; 25: 1min HRV, 7.390; 26: HR, 96.586; 26: RR, 23.5; 26: SpO2, 92.793; 26: Perf, 0.369; 26: 1min HRV, 7.642; 27: HR, 95.898; 27: RR, 22.407; 27: SpO2, 92.542; 27: Perf, 0.37; 27: 1min HRV, 10.837; 28: HR, 95.948; 28: RR, 23.241; 28: SpO2, 92.086; 28: Perf, 0.37; 28: 1min HRV, 2.685; 28: 5min HRV, 7.882; 29: SBP, 82.0; 29: DBP, 67.0; 29: MAP, 72.0; 44: POC PH (V) ISTAT, 7.45; 44: POC LACTATE ISTAT, 0.79 mmol/L; 44: POC PCO2 (V) ISTAT, 49.2 mmHg; 44: POC HCO3 (V) ISTAT, 34.0 mmol/L; 44: POC O2 SATURATION ISTAT VENOUS, 72 %; 44: POC BASE EXCESS ISTAT, 10 mmol/L; 44: POC TCO2 (V) ISTAT, 35 mmol/L; 44: POC PO2 (V) ISTAT, 37 mmHg; 47: SpO2, 94.0; 47: LPM O2, 15.0; 53: HR, 86.0; 53: RR, 34.0; 53: SpO2, 98.0; 53: SBP, 102.0; 53: DBP, 61.0; 53: MAP, 74.667; 57: LR IV BOLUS -, 500 ML; 58: HR:, 88.0; 58: RR, 20.0; 58: SpO2, 98.0; 58: SBP, 86.0; 58: DBP, 61.0; 58: MAP, 69.333; 58: Temp, 100.2; 68: HR, 87.0; 68: RR, 27.0; 68: SpO2, 93.0; 68: SBP, 92.0; 68: DBP, 66.0; 68: MAP, 74.667; 68: Temp, 100.2; 83: HR, 85.0; 83: RR, 20.0; 83: SpO2, 94.0; 83: Temp, 100.2; 88: HR, 85.0; 88: RR, 20.0; 88: SpO2, 96.0; 88: SBP, 84.0; 88: DBP, 59.0; 88: MAP, 67.333; 88: Temp, 100.2; 88: LR IV BOLUS -, 500 ML; 94: SODIUM:, 131 mmol/L; 94: GLOBULIN, 4.0 g/dL; 94: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 94: GLUCOSE, 128 mg/dL; 94: POTASSIUM, 4.3 mmol/L; 94: ALKALINE PHOSPHATASE, 159 U/L; 94: ALT (SGPT), 31 U/L; 94: CALCIUM, 8.5 mg/dL; 94: PROTEIN TOTAL, 7.1 g/dL; 94: ANION GAP, 10 mmol/L; 94: CREATININE, 0.55 mg/dL; 94: AST (SGOT), 51 U/L; 94: CHLORIDE, 94 mmol/L; 94: ALBUMIN, 3.1 g/dL; 94: CO2, 27 mmol/L; 94: BILIRUBIN TOTAL, 0.3 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 5 mg/dL; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 98: HR:, 84.0; 98: RR, 22.0; 98: SpO2, 96.0; 98: SBP, 86.0; 98: DBP, 58.0; 98: MAP, 67.333; 98: Temp, 100.0; 113: HR, 80.0; 113: RR, 17.0; 113: SpO2, 96.0; 113: SBP, 84.0; 113: DBP, 57.0; 113: MAP, 66.0; 113: Temp, 99.7; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 97.0; 0: Triage RR, 21.0; 0: Triage SBP, 83.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed signs of infection (fever, possible respiratory involvement) along with concerning vital signs (persistent hypotension and elevated respiratory rate). I questioned whether these vitals indicated early organ dysfunction and weighed if the patient\u2019s hemodynamics could stabilize quickly. After confirming that the blood pressure and breathing rate remained abnormal despite interventions, I concluded that the patient is at high risk for sepsis within the next 12 hours.",
        "claims": [
            "I noticed signs of infection, including fever and possible respiratory involvement.",
            "The patient has concerning vital signs, such as persistent hypotension and elevated respiratory rate.",
            "I questioned whether the abnormal vital signs indicated early organ dysfunction.",
            "I weighed whether the patient\u2019s hemodynamics could stabilize quickly.",
            "The blood pressure remained abnormal despite interventions.",
            "The breathing rate remained abnormal despite interventions.",
            "I concluded that the patient is at high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "I noticed signs of infection, including fever and possible respiratory involvement.",
            "The patient has concerning vital signs, such as persistent hypotension and elevated respiratory rate.",
            "I questioned whether the abnormal vital signs indicated early organ dysfunction.",
            "The blood pressure remained abnormal despite interventions.",
            "The breathing rate remained abnormal despite interventions."
        ],
        "alignment_scores": [
            0.7,
            0.9,
            0.6,
            0.7,
            0.8
        ],
        "alignment_category": [
            2,
            7,
            8,
            7,
            3
        ],
        "alignment_reasonings": [
            "The claim references fever and possible respiratory involvement, which are aspects of the SIRS criteria (e.g., temperature\u202f>\u202f38\u202f\u00b0C and respiratory\u202frate\u202f>\u202f20\u202f/min). While the specific measurements for these criteria are not provided, the mention of fever and respiratory issues strongly suggests systemic inflammation consistent with early sepsis, aligning it well with the SIRS category.",
            "The claim mentions \"persistent hypotension,\" which directly corresponds to the category of Sepsis-Associated Hypotension. The mention of an \"elevated respiratory rate\" could also relate to a criteria for SIRS or qSOFA, but the most explicit alignment is with the hypotension aspect. Since the claim doesn\u2019t provide specific systolic or MAP values, there's a slight uncertainty; however, the overall description strongly aligns with the category.",
            "The claim concerns abnormal vital signs potentially indicating early organ dysfunction. While it doesn't explicitly state an increase in SOFA score components, the context of organ dysfunction aligns conceptually with the SOFA criteria. The alignment is indirect, as it mentions signs that could lead to increased SOFA scores such as impaired vitals, but does not provide details confirming a SOFA score increase.",
            "The claim indicates persistent abnormal blood pressure despite interventions, which can suggest issues related to sepsis-associated hypotension or progression towards septic shock. While the exact values for blood pressure are not given, the fact that it remained abnormal and required intervention suggests a significant issue. However, without specific numerical data on the blood pressure, the alignment is not perfect, therefore the rating is 0.7.",
            "The claim mentions an abnormal breathing rate, suggesting a persistent respiratory rate issue despite interventions. A respiratory rate of \u226522 per minute is a component of the qSOFA score, which evaluates sepsis risk. While the claim doesn't specify the exact respiratory rate, the persistence of abnormal breathing despite interventions suggests a significant level of concern consistent with a qSOFA scoring criterion. The alignment is relatively strong due to the mention of abnormal breathing, but not perfect because it doesn\u2019t specify the exact rate."
        ],
        "final_alignment_score": 0.74,
        "accuracy": 1
    },
    {
        "input": "5: HR, 106.0; 5: RR, 32.0; 5: SpO2, 99.0; 5: SBP, 123.0; 5: DBP, 78.0; 5: MAP, 93.0; 5: Pain, 0.0; 5: Temp, 98.8; 27: SpO2, 95.804; 27: Perf, 0.518; 28: SpO2, 95.915; 28: Perf, 0.875; 29: SpO2, 93.810; 29: Perf, 0.93; 30: SpO2, 93.731; 30: Perf, 0.93; 31: HR, 105.0; 31: SpO2, 95.5; 31: Perf, 0.921; 31: SBP, 118.0; 31: DBP, 88.0; 31: MAP, 98.0; 32: SpO2, 94.926; 32: Perf, 0.769; 33: SpO2, 94.895; 33: Perf, 0.76; 34: SpO2, 95.0; 34: Perf, 0.76; 35: SpO2, 97.0; 35: Perf, 0.603; 36: HR, 101.952; 36: SpO2, 97.103; 36: Perf, 0.532; 36: 1min HRV, 35.120; 37: HR, 105.542; 37: SpO2, 96.441; 37: Perf, 0.586; 37: 1min HRV, 22.801; 38: HR, 104.845; 38: SpO2, 95.776; 38: Perf, 0.601; 38: 1min HRV, 17.379; 39: HR, 103.475; 39: SpO2, 95.881; 39: Perf, 0.698; 39: 1min HRV, 21.945; 39: 5min HRV, 25.526; 40: HR, 104.776; 40: SpO2, 95.259; 40: Perf, 0.889; 40: 1min HRV, 23.186; 41: HR, 107.186; 41: SpO2, 94.458; 41: Perf, 0.937; 41: 1min HRV, 27.290; 42: HR, 102.814; 42: SpO2, 94.712; 42: Perf, 1.16; 42: 1min HRV, 26.491; 43: HR, 104.983; 43: SpO2, 93.897; 43: Perf, 1.168; 43: 1min HRV, 19.577; 44: HR, 106.0; 44: SpO2, 95.085; 44: Perf, 0.625; 44: 1min HRV, 22.391; 44: 5min HRV, 24.972; 45: HR, 101.517; 45: SpO2, 94.690; 45: Perf, 0.590; 45: 1min HRV, 36.524; 46: HR, 106.186; 46: SpO2, 96.339; 46: Perf, 0.64; 46: 1min HRV, 41.338; 47: HR, 106.034; 47: SpO2, 95.576; 47: Perf, 0.64; 47: 1min HRV, 24.015; 48: HR, 101.431; 48: SpO2, 97.017; 48: Perf, 0.638; 48: 1min HRV, 27.987; 49: HR, 105.271; 49: SpO2, 96.026; 49: Perf, 0.623; 49: 1min HRV, 27.465; 49: 5min HRV, 36.044; 50: HR, 105.475; 50: SpO2, 95.458; 50: Perf, 0.709; 50: 1min HRV, 32.442; 51: HR, 104.569; 51: SpO2, 95.414; 51: Perf, 0.74; 51: 1min HRV, 29.709; 52: HR, 104.508; 52: SpO2, 94.0; 52: Perf, 0.74; 52: 1min HRV, 29.782; 53: HR, 109.086; 53: Perf, 0.74; 53: 1min HRV, 21.648; 54: HR, 108.237; 54: Perf, 0.74; 54: 1min HRV, 29.355; 54: 5min HRV, 30.426; 55: HR, 106.305; 55: SpO2, 91.417; 55: Perf, 0.74; 55: 1min HRV, 28.756; 56: HR, 100.034; 56: SpO2, 90.0; 56: 1min HRV, 30.972; 57: HR, 103.593; 57: 1min HRV, 26.173; 58: HR, 100.0; 58: 1min HRV, 36.792; 59: HR, 109.305; 59: 1min HRV, 33.558; 59: 5min HRV, 36.879; 60: HR, 102.017; 60: 1min HRV, 32.222; 61: HR, 107.780; 61: 1min HRV, 25.075; 62: HR, 109.136; 62: 1min HRV, 18.568; 63: HR, 107.483; 63: 1min HRV, 39.046; 64: HR, 109.356; 64: 1min HRV, 32.715; 64: 5min HRV, 33.510; 65: HR, 96.627; 65: SpO2, 91.484; 65: 1min HRV, 30.208; 66: HR, 102.293; 66: SpO2, 94.64; 66: 1min HRV, 31.751; 67: HR, 100.339; 67: SpO2, 96.913; 67: Perf, 0.65; 67: 1min HRV, 34.148; 68: HR, 106.034; 68: SpO2, 96.833; 68: Perf, 0.65; 68: 1min HRV, 31.407; 69: HR, 101.153; 69: SpO2, 97.0; 69: Perf, 0.402; 69: 1min HRV, 29.794; 69: 5min HRV, 36.688; 70: HR, 98.627; 70: SpO2, 96.949; 70: Perf, 0.405; 70: 1min HRV, 26.562; 71: HR, 111.034; 71: SpO2, 97.25; 71: Perf, 0.41; 71: 1min HRV, 20.913; 72: HR, 109.644; 72: SpO2, 94.857; 72: 1min HRV, 36.253; 73: POC, HCG, ISTAT QUALITATIVE: Negative; 73: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 73: HR, 101.759; 73: 1min HRV, 34.292; 74: HR, 105.780; 74: 1min HRV, 41.076; 74: 5min HRV, 41.376; 75: POC PH (V) ISTAT, 7.38; 75: POC LACTATE ISTAT, <.30 mmol/L; 75: POC HCO3 (V) ISTAT, 19.6 mmol/L; 75: POC O2 SATURATION ISTAT VENOUS, 86 %; 75: POC PCO2 (V) ISTAT, 33.3 mmHg; 75: POC TCO2 (V) ISTAT, 21 mmol/L; 75: POC PO2 (V) ISTAT, 53 mmHg; 75: POC BASE EXCESS ISTAT, -6 mmol/L; 75: HR, 107.724; 75: SpO2, 96.0; 75: 1min HRV, 29.352; 76: HR, 109.695; 76: SpO2, 96.0; 76: 1min HRV, 30.434; 77: HR, 106.627; 77: SpO2, 96.2; 77: 1min HRV, 24.569; 78: HR, 104.724; 78: SpO2, 96.0; 78: 1min HRV, 28.498; 79: HR, 110.661; 79: 1min HRV, 27.035; 79: 5min HRV, 30.151; 80: HR, 108.207; 80: 1min HRV, 18.073; 81: HR, 108.407; 81: SpO2, 99.0; 81: 1min HRV, 21.980; 82: HR, 106.983; 82: SpO2, 98.0; 82: 1min HRV, 26.322; 83: HR, 110.776; 83: 1min HRV, 24.902; 84: HR, 105.169; 84: 1min HRV, 25.793; 84: 5min HRV, 24.952; 85: HR, 107.724; 85: 1min HRV, 25.418; 86: HR, 107.661; 86: 1min HRV, 29.177; 87: HR, 107.220; 87: 1min HRV, 22.764; 88: SARS-COV-2 RNA, Not Detected; 88: HR, 108.845; 88: 1min HRV, 34.501; 89: HR, 105.915; 89: SpO2, 100.0; 89: 1min HRV, 23.263; 89: 5min HRV, 27.878; 90: HR, 105.138; 90: SpO2, 100.0; 90: 1min HRV, 21.307; 91: HR, 106.068; 91: SpO2, 99.0; 91: Perf, 1.246; 91: 1min HRV, 39.280; 92: HR, 107.915; 92: SpO2, 99.0; 92: Perf, 0.983; 92: 1min HRV, 27.151; 93: HR, 106.810; 93: SpO2, 99.0; 93: Perf, 0.870; 93: 1min HRV, 21.717; 94: HR, 107.0; 94: SpO2, 99.0; 94: Perf, 0.943; 94: 1min HRV, 17.297; 94: 5min HRV, 27.470; 118: WAM DIFTYP, AUTO; 118: BASOPHIL % (AUTO DIFF), 0.3 %; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 118: PLATELET COUNT (PLT), 279 K/uL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 118: HEMOGLOBIN (HGB), 10.6 g/dL; 118: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 118: MONOCYTE % (AUTO DIFF), 7.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 118: NEUTROPHIL % (AUTO DIFF), 76.0 %; 118: EOSINOPHIL % (AUTO DIFF), 2.7 %; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: HEMATOCRIT (HCT), 33.5 %; 118: WHITE BLOOD CELLS (WBC), 9.6 K/uL; 118: LYMPHOCYTE % (AUTO DIFF), 13.3 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 98.5 fL; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.28 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.31 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 0: Age, 23; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 106.0; 0: Triage RR, 32.0; 0: Triage SBP, 123.0; 0: Triage DBP, 78.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I first noted the elevated heart rate and respiratory rate, then checked for other signs of sepsis such as significant hypotension, abnormal lactate, or markedly abnormal lab values. Although the patient displays tachycardia and tachypnea, her blood pressure remains stable and her lactate is normal. There is no evidence of organ dysfunction based on the provided labs, and her oxygen saturation is generally acceptable. Therefore, the current data does not indicate a high risk of sepsis within the next 12 hours.",
        "claims": [
            "I first noted the elevated heart rate and respiratory rate.",
            "I checked for other signs of sepsis such as significant hypotension, abnormal lactate, or markedly abnormal lab values.",
            "The patient displays tachycardia.",
            "The patient displays tachypnea.",
            "The patient's blood pressure remains stable.",
            "The patient's lactate is normal.",
            "There is no evidence of organ dysfunction based on the provided labs.",
            "The patient's oxygen saturation is generally acceptable.",
            "The current data does not indicate a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "I first noted the elevated heart rate and respiratory rate.",
            "The patient displays tachycardia.",
            "The patient displays tachypnea.",
            "There is no evidence of organ dysfunction based on the provided labs."
        ],
        "alignment_scores": [
            1.0,
            0.8,
            0.7,
            0.8
        ],
        "alignment_category": [
            2,
            2,
            3,
            8
        ],
        "alignment_reasonings": [
            "Both an elevated heart rate and increased respiratory rate are explicitly listed as criteria under SIRS (Systemic Inflammatory Response Syndrome), which identifies systemic inflammation consistent with early sepsis. The claim directly aligns with the presence of\u202f\u2265\u202f2 SIRS criteria, making the category alignment strong and complete.",
            "Tachycardia, defined as a heart rate >90 beats per minute, is a specific criterion within the SIRS criteria. The claim directly relates to this category, indicating a significant degree of alignment, although it requires at least one other criterion for full SIRS positivity. Thus, the alignment is high but not perfect due to the need for additional criteria to satisfy SIRS completely.",
            "Tachypnea, which refers to an elevated respiratory rate, is a component of the qSOFA criteria (specifically respiratory rate\u202f\u2265\u202f22/min). While the claim doesn't provide the exact respiratory rate to confirm it meets the qSOFA threshold, the presence of tachypnea is strongly suggestive of meeting it, indicating a significant alignment with this category.",
            "The claim relates to the absence of organ dysfunction, which the SOFA score directly measures. An increase of \u22652 points in the SOFA score confirms organ dysfunction and high sepsis risk, so the lack of organ dysfunction aligns with this category by suggesting a low risk. The reference to the absence of these indicators is strongly relevant but not perfectly aligned, as the claim does not explicitly refer to a SOFA score or its specific criteria."
        ],
        "final_alignment_score": 0.825,
        "accuracy": 0
    },
    {
        "input": "3: SpO2, 95.566; 3: Perf, 1.128; 4: SpO2, 94.811; 4: Perf, 0.859; 5: RR, 28.667; 5: SpO2, 88.321; 5: Perf, 0.710; 5: 1min HRV, 192.045; 6: HR, 87.510; 6: RR, 18.358; 6: SpO2, 86.736; 6: Perf, 0.617; 6: 1min HRV, 190.778; 7: HR, 84.615; 7: RR, 24.756; 7: SpO2, 94.173; 7: Perf, 0.719; 7: 1min HRV, 151.921; 7: 5min HRV, 200.315; 8: HR, 79.667; 8: RR, 17.333; 8: SpO2, 97.551; 8: Perf, 0.640; 8: SBP, 81.0; 8: DBP, 67.0; 8: MAP, 71.667; 8: LPM O2, 15.0; 8: Pain, 0.0; 8: Temp, 95.5; 9: HR, 80.896; 9: SpO2, 97.698; 9: Perf, 0.721; 9: 1min HRV, 123.937; 10: HR, 73.521; 10: SpO2, 95.0; 10: Perf, 0.766; 10: 1min HRV, 345.717; 10: SBP, 103.0; 10: DBP, 61.0; 10: MAP, 75.0; 11: HR, 54.913; 11: SpO2, 95.887; 11: Perf, 0.672; 11: 1min HRV, 55.263; 12: HR, 0.0; 12: SpO2, 96.472; 12: Perf, 0.808; 12: 5min HRV, 222.786; 13: POC PH (V) ISTAT, 7.34; 13: POC PO2 (V) ISTAT, 26 mmHg; 13: POC TCO2 (V) ISTAT, 39 mmol/L; 13: POC LACTATE ISTAT, 1.75 mmol/L; 13: POC HCO3 (V) ISTAT, 36.6 mmol/L; 13: POC PCO2 (V) ISTAT, 68.0 mmHg; 13: POC O2 SATURATION ISTAT VENOUS, 40 %; 13: POC BASE EXCESS ISTAT, 11 mmol/L; 13: HR, 0.0; 13: SpO2, 96.623; 13: Perf, 0.706; 13: 1min HRV, 178.75; 14: HR, 0.0; 14: SpO2, 97.852; 14: Perf, 0.518; 14: 1min HRV, 3.583; 15: HR, 0.0; 15: SpO2, 97.135; 15: Perf, 0.586; 15: 1min HRV, 8.225; 16: HR, 0.0; 16: SpO2, 97.585; 16: Perf, 0.585; 17: HR, 0.0; 17: SpO2, 97.774; 17: Perf, 0.55; 17: 1min HRV, 133.625; 17: 5min HRV, 125.316; 18: HR, 0.0; 18: SpO2, 96.925; 18: Perf, 0.553; 18: 1min HRV, 213.992; 19: HR, 6.276; 19: SpO2, 97.132; 19: Perf, 0.56; 19: 1min HRV, 93.679; 20: HR, 0.0; 20: SpO2, 97.596; 20: Perf, 0.56; 20: 1min HRV, 0.0; 21: HR, 0.0; 21: SpO2, 98.0; 21: Perf, 0.564; 21: 1min HRV, 0.0; 22: HR, 0.0; 22: SpO2, 97.269; 22: Perf, 0.574; 22: 5min HRV, 167.366; 23: HR, 0.0; 23: SpO2, 96.415; 23: Perf, 0.59; 23: SBP, 103.0; 23: DBP, 74.0; 23: MAP, 83.667; 24: HR, 0.0; 24: SpO2, 97.811; 24: Perf, 0.619; 25: HR, 0.0; 25: SpO2, 98.0; 25: Perf, 0.63; 26: HR, 0.0; 26: SpO2, 97.755; 26: Perf, 0.675; 27: HR, 0.0; 27: SpO2, 97.442; 27: Perf, 0.749; 28: HR, 14.6; 28: RR, 7.286; 28: SpO2, 98.113; 28: Perf, 0.786; 28: 1min HRV, 126.031; 29: HR, 0.0; 29: RR, 13.510; 29: SpO2, 98.019; 29: Perf, 0.809; 29: 1min HRV, 100.75; 30: HR, 0.0; 30: RR, 18.885; 30: SpO2, 97.885; 30: Perf, 0.8; 30: 1min HRV, 258.922; 31: HR, 33.793; 31: RR, 15.574; 31: SpO2, 97.704; 31: Perf, 0.790; 31: 1min HRV, 99.035; 32: HR, 15.778; 32: RR, 17.615; 32: SpO2, 96.942; 32: Perf, 0.688; 32: 1min HRV, 79.568; 32: 5min HRV, 173.597; 33: HR, 63.727; 33: RR, 32.547; 33: SpO2, 97.642; 33: Perf, 0.56; 33: 1min HRV, 59.396; 34: HR, 23.1; 34: RR, 23.788; 34: SpO2, 97.0; 34: Perf, 0.635; 34: 1min HRV, 20.603; 35: HR, 0.0; 35: RR, 24.767; 35: SpO2, 96.870; 35: Perf, 0.611; 36: HR, 16.818; 36: RR, 16.923; 36: SpO2, 96.717; 36: Perf, 0.6; 36: 1min HRV, 56.853; 37: HR, 31.882; 37: RR, 27.673; 37: SpO2, 95.308; 37: Perf, 0.601; 37: 1min HRV, 53.233; 37: 5min HRV, 56.500; 38: HR, 41.0; 38: RR, 28.075; 38: SpO2, 96.522; 38: Perf, 0.61; 38: 1min HRV, 65.923; 38: SBP, 100.0; 38: DBP, 63.0; 38: MAP, 75.333; 42: 5min HRV, 65.923; 46: WAM DIFTYP, AUTO; 46: NEUTROPHIL % (AUTO DIFF), 88.2 %; 46: HEMATOCRIT (HCT), 44.5 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: RED BLOOD CELLS (RBC), 4.53 MIL/uL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: HEMOGLOBIN (HGB), 14.3 g/dL; 46: MONOCYTE % (AUTO DIFF), 3.2 %; 46: EOSINOPHIL % (AUTO DIFF), 0.3 %; 46: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 46: LYMPHOCYTE % (AUTO DIFF), 7.6 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 98.2 fL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: PLATELET COUNT (PLT), 113 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.43 K/uL; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 54: RR, 30.0; 54: SpO2, 97.0; 61: PROTEIN TOTAL, 7.9 g/dL; 61: CREATININE, 0.64 mg/dL; 61: ALT (SGPT), 17 U/L; 61: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 61: BILIRUBIN TOTAL, 0.3 mg/dL; 61: SODIUM, 138 mmol/L; 61: CORRECTED CALCIUM, 9.8 mg/dL; 61: ANION GAP, 8 mmol/L; 61: GLUCOSE, 78 mg/dL; 61: AST (SGOT), 40 U/L; 61: POTASSIUM, 5.2 mmol/L; 61: CO2, 27 mmol/L; 61: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 61: ALBUMIN, 2.6 g/dL; 61: GLOBULIN, 5.3 g/dL; 61: BNP NT-PRO, 2199 pg/mL; 61: CHLORIDE, 103 mmol/L; 61: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 61: CALCIUM, 8.7 mg/dL; 61: ALKALINE PHOSPHATASE, 115 U/L; 67: HR, 71.0; 67: RR, 28.0; 67: SpO2, 99.0; 67: SBP, 104.0; 67: DBP, 51.0; 67: MAP, 68.667; 72: TROPONIN I, <.017 ng/mL; 83: SARS-COV-2 RNA, Not Detected; 105: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 110: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age, 75; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 35.3; 0: Triage HR, 72.0; 0: Triage RR, 28.0; 0: Triage SBP, 103.0; 0: Triage DBP, 61.0; 0: Triage acuity, 2-Emergent; 0: CC, RESPIRATORY DISTRESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed the patient\u2019s advanced age and low temperature, along with a high respiratory rate and borderline blood pressures, which raised concern for sepsis. I then looked for additional markers, such as the elevated neutrophil count and signs of possible organ dysfunction in the labs, which further supported the suspicion of infection. Finally, I weighed the abnormal vital signs, labs, and clinical presentation together and concluded the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient is of advanced age.",
            "The patient has a low temperature.",
            "The patient has a high respiratory rate.",
            "The patient has borderline blood pressures.",
            "The combination of advanced age, low temperature, high respiratory rate, and borderline blood pressures raised concern for sepsis.",
            "Additional markers were sought to support the suspicion of infection.",
            "The patient has an elevated neutrophil count.",
            "The labs showed signs of possible organ dysfunction.",
            "The elevated neutrophil count and signs of possible organ dysfunction further supported the suspicion of infection.",
            "The abnormal vital signs, labs, and clinical presentation were weighed together.",
            "The conclusion was reached that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient is of advanced age.",
            "The patient has a high respiratory rate.",
            "The patient has borderline blood pressures.",
            "The combination of advanced age, low temperature, high respiratory rate, and borderline blood pressures raised concern for sepsis.",
            "Additional markers were sought to support the suspicion of infection.",
            "The patient has an elevated neutrophil count.",
            "The labs showed signs of possible organ dysfunction.",
            "The elevated neutrophil count and signs of possible organ dysfunction further supported the suspicion of infection.",
            "The abnormal vital signs, labs, and clinical presentation were weighed together."
        ],
        "alignment_scores": [
            0.8,
            0.5,
            0.5,
            0.8,
            0.6,
            0.7,
            0.8,
            0.7,
            0.7
        ],
        "alignment_category": [
            1,
            3,
            7,
            2,
            9,
            2,
            8,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim refers to the patient being of \"advanced age,\" which suggests they are likely in the older age group. Although the exact age is not specified, the term \"advanced age\" generally aligns with the concept of increased age-related sepsis susceptibility described in this category. Therefore, while it strongly hints at the category of Elderly Susceptibility, the lack of precise age information reduces the alignment slightly from a perfect score.",
            "A high respiratory rate is directly aligned with the qSOFA criteria, which includes respiratory rate \u226522/min. However, the claim does not specify if the respiratory rate meets the qSOFA threshold of \u226522/min, so while the claim is indicative of potential high sepsis risk, it does not fully confirm alignment without specific information. Therefore, the alignment rating is moderate.",
            "Borderline blood pressure suggests potential hemodynamic instability and brings to mind sepsis-associated hypotension. However, the claim does not specify blood pressure values like SBP < 90 mmHg or MAP < 70 mmHg. Therefore, while related, the alignment is only moderate, as the specific criteria for sepsis-associated hypotension are not fully met.",
            "The claim mentions a combination of factors that align closely with SIRS criteria, particularly advanced age, low temperature, and high respiratory rate, which are indicators of systemic inflammation associated with early sepsis. Although borderline blood pressures suggest additional concerns, these are more directly related to haemodynamic instability or shock, which falls outside strict SIRS criteria but indicates potential sepsis progression. The strong overlap with multiple SIRS criteria justifies a high alignment rating, though it isn't a perfect 1.0 because not every item perfectly matches the SIRS definition.",
            "The claim suggests that additional markers were sought due to a suspicion of infection, which aligns with category 9, where clinician suspicion of serious infection prompts further investigation. However, the claim doesn't confirm the administration of antibiotics or culture orders, preventing a perfect alignment, but it still indicates actions toward confirming infection risk.",
            "An elevated neutrophil count is indicative of an inflammatory or infectious response, which is conceptually related to the systemic inflammation identified by SIRS criteria, especially the elevated white blood cell count criteria. While neutrophil count isn't specifically listed as a SIRS criterion, it supports the presence of systemic inflammation, which is why the alignment rating is somewhat strong but not perfect.",
            "The claim mentions signs of possible organ dysfunction, which aligns with the SOFA Score Increase category, as SOFA scores are used to assess organ dysfunction in the context of sepsis. Though it doesn't provide specific information about which organ or how dysfunction was measured (e.g., platelets, bilirubin, creatinine), it aligns strongly with the concept of organ dysfunction indicated by increased SOFA scores.",
            "The mention of organ dysfunction aligns with the SOFA criteria, which track such dysfunction to assess sepsis risk. An elevated neutrophil count suggests infection, indirectly related to sepsis assessment, slightly lowering the perfect alignment. The claim partially fits both SIRS and SOFA categories, but the specific mention of organ dysfunction leans the alignment towards the SOFA criteria.",
            "The claim mentions \"abnormal vital signs\" and suggests a broader assessment of the patient's condition, including labs and clinical presentation. The NEWS score incorporates vital signs to predict clinical deterioration, which is compatible with sepsis, making it the most aligned. However, since the claim does not strictly quantify these elements or explicitly mention the NEWS scoring method, the alignment is not perfect, but meaningful."
        ],
        "final_alignment_score": 0.6777777777777778,
        "accuracy": 1
    },
    {
        "input": "4: HR, 152.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 150.0; 4: DBP, 102.0; 4: MAP, 118.0; 4: Temp, 97.2; 24: Pain, 5.0; 57: SpO2, 100.0; 57: Perf, 0.247; 58: SpO2, 100.0; 58: Perf, 0.346; 59: SpO2, 100.0; 59: Perf, 0.383; 60: SpO2, 100.0; 60: Perf, 0.339; 61: SpO2, 100.0; 61: Perf, 0.721; 62: SpO2, 100.0; 62: Perf, 1.018; 63: SpO2, 100.0; 63: Perf, 0.941; 64: SpO2, 100.0; 64: Perf, 0.551; 65: SpO2, 100.0; 65: Perf, 0.336; 66: HR, 142.0; 66: RR, 11.0; 66: SpO2, 100.0; 66: Perf, 0.311; 67: SpO2, 100.0; 67: Perf, 0.243; 68: HR, 142.444; 68: RR, 30.6; 68: SpO2, 100.0; 68: Perf, 0.229; 68: 1min HRV, 12.486; 69: HR, 143.678; 69: RR, 14.271; 69: SpO2, 100.0; 69: Perf, 0.249; 69: 1min HRV, 7.575; 70: HR, 142.069; 70: RR, 20.431; 70: SpO2, 100.0; 70: Perf, 0.267; 70: 1min HRV, 5.002; 71: HR, 143.068; 71: RR, 16.136; 71: SpO2, 100.0; 71: Perf, 0.304; 71: 1min HRV, 6.348; 71: 5min HRV, 7.438; 72: HR, 141.569; 72: RR, 15.552; 72: SpO2, 100.0; 72: Perf, 0.481; 72: 1min HRV, 5.429; 73: HR, 141.559; 73: RR, 15.983; 73: SpO2, 100.0; 73: Perf, 0.340; 73: 1min HRV, 11.586; 74: HR, 146.741; 74: RR, 19.931; 74: SpO2, 100.0; 74: Perf, 0.334; 74: 1min HRV, 7.123; 75: HR, 142.169; 75: RR, 17.186; 75: SpO2, 100.0; 75: Perf, 0.285; 75: 1min HRV, 16.123; 76: HR, 148.475; 76: RR, 22.847; 76: SpO2, 100.0; 76: Perf, 0.271; 76: 1min HRV, 10.443; 76: 5min HRV, 12.894; 77: HR, 143.0; 77: RR, 18.241; 77: SpO2, 100.0; 77: Perf, 0.218; 77: 1min HRV, 8.013; 78: HR, 141.678; 78: RR, 13.186; 78: SpO2, 100.0; 78: Perf, 0.204; 78: 1min HRV, 7.869; 79: HR, 143.322; 79: RR, 17.186; 79: SpO2, 100.0; 79: Perf, 0.191; 79: 1min HRV, 5.016; 80: HR, 145.862; 80: RR, 21.483; 80: SpO2, 100.0; 80: Perf, 0.19; 80: 1min HRV, 14.273; 81: HR, 150.593; 81: RR, 24.136; 81: SpO2, 100.0; 81: Perf, 0.220; 81: 1min HRV, 4.908; 81: 5min HRV, 12.638; 82: HR, 147.724; 82: RR, 20.155; 82: SpO2, 100.0; 82: Perf, 0.193; 82: 1min HRV, 6.422; 83: HR, 145.864; 83: RR, 19.610; 83: SpO2, 100.0; 83: Perf, 0.198; 83: 1min HRV, 16.707; 84: HR, 146.103; 84: RR, 15.379; 84: SpO2, 100.0; 84: Perf, 0.203; 84: 1min HRV, 5.428; 85: HR, 146.881; 85: RR, 19.746; 85: SpO2, 100.0; 85: Perf, 0.2; 85: 1min HRV, 5.309; 86: HR, 147.690; 86: RR, 17.586; 86: SpO2, 100.0; 86: Perf, 0.2; 86: 1min HRV, 6.579; 86: 5min HRV, 9.290; 87: HR, 147.831; 87: RR, 16.932; 87: 1min HRV, 6.513; 88: HR, 146.373; 88: RR, 17.644; 88: 1min HRV, 5.914; 89: HR, 146.345; 89: RR, 18.966; 89: SpO2, 100.0; 89: Perf, 0.19; 89: 1min HRV, 4.308; 90: HR, 144.763; 90: RR, 19.559; 90: SpO2, 100.0; 90: Perf, 0.172; 90: 1min HRV, 6.645; 91: HR, 143.510; 91: RR, 16.830; 91: SpO2, 100.0; 91: Perf, 0.177; 91: 1min HRV, 6.265; 91: 5min HRV, 7.416; 92: HR, 143.94; 92: RR, 16.6; 92: SpO2, 100.0; 92: Perf, 0.177; 92: 1min HRV, 5.722; 93: HR, 145.458; 93: RR, 19.203; 93: SpO2, 100.0; 93: Perf, 0.179; 93: 1min HRV, 12.575; 94: HR, 145.466; 94: RR, 19.914; 94: SpO2, 100.0; 94: Perf, 0.276; 94: 1min HRV, 3.769; 95: HR, 140.983; 95: RR, 28.966; 95: SpO2, 100.0; 95: Perf, 0.435; 95: 1min HRV, 7.861; 96: HR, 141.915; 96: RR, 19.475; 96: SpO2, 100.0; 96: Perf, 0.645; 96: 1min HRV, 7.151; 96: 5min HRV, 9.919; 97: HR, 141.207; 97: RR, 15.810; 97: SpO2, 100.0; 97: Perf, 0.418; 97: 1min HRV, 8.263; 98: HR, 141.441; 98: RR, 15.542; 98: SpO2, 100.0; 98: Perf, 0.271; 98: 1min HRV, 5.571; 99: HR, 140.879; 99: RR, 16.121; 99: SpO2, 100.0; 99: Perf, 0.212; 99: 1min HRV, 6.727; 100: HR, 141.542; 100: RR, 17.492; 100: SpO2, 100.0; 100: Perf, 0.225; 100: 1min HRV, 6.407; 101: HR, 141.831; 101: RR, 17.068; 101: SpO2, 100.0; 101: Perf, 0.186; 101: 1min HRV, 8.050; 101: 5min HRV, 7.225; 102: HR, 135.224; 102: RR, 22.741; 102: SpO2, 100.0; 102: Perf, 0.207; 102: 1min HRV, 18.650; 103: HR, 137.288; 103: RR, 17.932; 103: SpO2, 100.0; 103: Perf, 0.205; 103: 1min HRV, 10.367; 104: HR, 139.483; 104: RR, 18.828; 104: SpO2, 100.0; 104: Perf, 0.205; 104: 1min HRV, 10.576; 105: HR, 139.983; 105: RR, 19.322; 105: SpO2, 100.0; 105: Perf, 0.185; 105: 1min HRV, 6.975; 106: SARS-COV-2 RNA, Not Detected; 106: HR, 139.864; 106: RR, 19.203; 106: SpO2, 100.0; 106: Perf, 0.192; 106: 1min HRV, 7.106; 106: 5min HRV, 12.724; 107: HR, 137.103; 107: RR, 15.759; 107: SpO2, 100.0; 107: Perf, 0.256; 107: 1min HRV, 6.563; 108: HR, 139.525; 108: RR, 18.593; 108: SpO2, 100.0; 108: Perf, 0.316; 108: 1min HRV, 5.620; 109: HR, 142.172; 109: RR, 19.672; 109: SpO2, 100.0; 109: Perf, 0.279; 109: 1min HRV, 7.703; 110: HR, 143.797; 110: RR, 15.898; 110: SpO2, 100.0; 110: Perf, 0.261; 110: 1min HRV, 5.670; 111: HR, 142.763; 111: RR, 17.085; 111: SpO2, 100.0; 111: Perf, 0.269; 111: 1min HRV, 6.064; 111: 5min HRV, 9.558; 112: HR, 143.172; 112: RR, 24.379; 112: SpO2, 100.0; 112: Perf, 0.222; 112: 1min HRV, 6.416; 113: HR, 146.136; 113: RR, 20.525; 113: SpO2, 100.0; 113: Perf, 0.214; 113: 1min HRV, 10.223; 114: HR, 142.983; 114: RR, 21.0; 114: SpO2, 100.0; 114: Perf, 0.235; 114: 1min HRV, 6.139; 115: HR, 146.153; 115: RR, 21.203; 115: SpO2, 100.0; 115: Perf, 0.246; 115: 1min HRV, 4.909; 116: HR, 148.845; 116: RR, 28.776; 116: SpO2, 100.0; 116: Perf, 0.22; 116: 1min HRV, 5.657; 116: 5min HRV, 9.084; 117: HR, 149.305; 117: RR, 22.729; 117: SpO2, 100.0; 117: Perf, 0.22; 117: 1min HRV, 4.460; 118: HR, 145.949; 118: RR, 20.814; 118: SpO2, 100.0; 118: Perf, 0.213; 118: 1min HRV, 5.542; 119: HR, 149.362; 119: RR, 19.431; 119: SpO2, 100.0; 119: Perf, 0.245; 119: 1min HRV, 6.651; 0: Age, 32; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 152.0; 0: Triage RR, 16.0; 0: Triage SBP, 150.0; 0: Triage DBP, 102.0; 0: Triage acuity, 2-Emergent; 0: CC, EMESIS,DIZZINESS,CHEST PRESSURE",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I began by examining the patient\u2019s vitals\u2014particularly heart rate, respiratory rate, and temperature\u2014to see if they strongly suggested infection. While the heart rate remains elevated and there are occasional increases in respiratory rate, there is no significant fever or laboratory indication of infection in the data. Additionally, the patient\u2019s blood pressure is not low, and other signs commonly associated with sepsis (e.g., hypotension, markedly abnormal temperatures) are not present. Thus, the overall picture does not strongly support high sepsis risk within the next 12 hours.",
        "claims": [
            "I began by examining the patient's vitals.",
            "I particularly focused on heart rate, respiratory rate, and temperature.",
            "The examination aimed to see if the vitals strongly suggested infection.",
            "The heart rate remains elevated.",
            "There are occasional increases in respiratory rate.",
            "There is no significant fever present in the data.",
            "There is no laboratory indication of infection in the data.",
            "The patient's blood pressure is not low.",
            "Signs commonly associated with sepsis are not present.",
            "Hypotension is not present in this patient.",
            "Markedly abnormal temperatures are not present in this patient.",
            "The overall picture does not strongly support high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The heart rate remains elevated.",
            "There is no significant fever present in the data.",
            "There is no laboratory indication of infection in the data.",
            "The patient's blood pressure is not low.",
            "Hypotension is not present in this patient.",
            "Markedly abnormal temperatures are not present in this patient."
        ],
        "alignment_scores": [
            0.5,
            0.3,
            0.3,
            0.2,
            0.6,
            0.2
        ],
        "alignment_category": [
            6,
            2,
            9,
            7,
            7,
            2
        ],
        "alignment_reasonings": [
            "While an elevated heart rate is one component of the shock index, the claim doesn't provide information about the systolic blood pressure needed to fully evaluate the shock index. However, an elevated heart rate is a key factor in calculating shock index and suggests potential haemodynamic instability, aligning partially with this category.",
            "The absence of significant fever is relevant to SIRS criteria, which includes temperature deviations as a factor. However, the claim doesn't confirm whether the patient's temperature is outside of the SIRS thresholds, only that a significant fever is not present, thus making it less directly aligned.",
            "The claim notes the absence of laboratory data supporting infection, indirectly relating to the consideration or absence of clinical suspicion which may lead to early antibiotic administration or culture orders. The alignment is weak as it primarily highlights the lack of evidence rather than actions based on suspicion.",
            "The claim suggests that the patient's blood pressure is not low, which is relevant to ruling out sepsis-associated hypotension. However, the information provided is negative (what is not present), and does not directly confirm any of the specific criteria like low SBP or MAP or a significant drop in SBP from baseline. The alignment is therefore weak as it is an inference from the absence of hypotension.",
            "The claim refers to the absence of hypotension, which is directly related to the category of Sepsis-Associated Hypotension. While it is not confirming the presence of a high sepsis risk factor, it is still closely associated as it indicates that a common sign of sepsis-related deterioration is not present. Therefore, it aligns with the category but demonstrates the factor is not contributing to risk, warranting an intermediate alignment rating.",
            "The claim mentions that markedly abnormal temperatures are not present, which weakly relates to the SIRS criteria that involve temperature thresholds (>38\u00b0C or <36\u00b0C). The absence of abnormal temperatures suggests that the SIRS criterion for temperature is not met, therefore indicating a low likelihood of systemic inflammation based on this measure alone. The alignment is weak because it references an absence of a SIRS feature, rather than the presence, relevance, or threshold exceeding it in the SIRS criteria."
        ],
        "final_alignment_score": 0.35000000000000003,
        "accuracy": 0
    },
    {
        "input": "3: HR, 106.0; 3: RR, 18.0; 3: SpO2, 99.0; 3: SBP, 133.0; 3: DBP, 83.0; 3: MAP, 99.667; 3: Temp, 97.9; 6: Pain, 8.0; 6: Pain, 5.0; 38: POC PH (V) ISTAT, 7.36; 38: POC PO2 (V) ISTAT, 34 mmHg; 38: POC PCO2 (V) ISTAT, 53.4 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 61 %; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC LACTATE ISTAT, 0.90 mmol/L; 38: POC HCO3 (V) ISTAT, 29.9 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 40: SpO2, 98.9; 40: Perf, 2.592; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 41: SpO, 2: 99.224; 41: Perf, 2.862; 42: SpO2, 98.948; 42: Perf, 2.541; 43: SpO2, 98.966; 43: Perf, 2.984; 44: SpO2, 98.436; 44: Perf, 2.976; 45: SpO2, 98.322; 45: Perf, 3.164; 46: SpO2, 98.310; 46: Perf, 3.478; 47: WAM DIFTYP, AUTO; 47: BASOPHIL ABSOLUTE (AUTO DIFF), 0.09 K/uL; 47: PLATELET COUNT (PLT), 370 K/uL; 47: NEUTROPHIL % (AUTO DIFF), 63.1 %; 47: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.43 K/uL; 47: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.80 K/uL; 47: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 47: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 47: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.3 pg; 47: BASOPHIL % (AUTO DIFF), 1.0 %; 47: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.23 K/uL; 47: MEAN CORPUSCULAR VOLUME (MCV), 89.0 fL; 47: EOSINOPHIL % (AUTO DIFF), 2.5 %; 47: HEMOGLOBIN (HGB), 13.9 g/dL; 47: RED BLOOD CELLS (RBC), 4.91 MIL/uL; 47: HEMATOCRIT (HCT), 43.7 %; 47: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.8 g/dL; 47: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 47: LYMPHOCYTE % (AUTO DIFF), 26.4 %; 47: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 47: NRBC PERCENT (HEMATOLOGY), 0.0 %; 47: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 47: MONOCYTE % (AUTO DIFF), 6.7 %; 47: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 47: SpO2, 98.797; 47: Perf, 3.236; 48: SpO2, 98.138; 48: Perf, 3.093; 49: SpO2, 97.780; 49: Perf, 3.111; 50: SpO2, 98.271; 50: Perf, 3.193; 51: SpO2, 97.914; 51: Perf, 3.141; 52: SpO2, 97.881; 52: Perf, 2.574; 53: SpO2, 98.655; 53: Perf, 1.647; 54: SpO2, 99.2; 54: Perf, 1.737; 55: SpO2, 98.875; 55: Perf, 1.658; 56: SpO2, 98.763; 56: Perf, 0.683; 57: SpO2, 98.831; 57: Perf, 0.945; 58: SpO2, 98.552; 58: Perf, 0.899; 59: SpO2, 98.705; 59: Perf, 1.609; 60: SpO2, 98.086; 60: Perf, 2.193; 61: SpO2, 98.475; 61: Perf, 1.659; 62: SpO2, 98.0; 62: Perf, 1.693; 63: SpO2, 97.345; 63: Perf, 1.119; 64: SpO2, 97.0; 64: Perf, 0.674; 65: SpO2, 96.466; 65: Perf, 0.71; 66: SpO2, 95.971; 66: Perf, 0.729; 67: SpO2, 98.138; 67: Perf, 1.856; 68: SpO2, 97.818; 68: Perf, 2.067; 69: SpO2, 98.780; 69: Perf, 2.496; 70: SpO2, 98.155; 70: Perf, 3.193; 71: SpO2, 98.186; 71: Perf, 2.602; 72: SpO2, 98.271; 72: Perf, 2.089; 73: SpO2, 98.517; 73: Perf, 1.809; 74: SpO2, 97.831; 74: Perf, 1.508; 75: SpO2, 97.897; 75: Perf, 1.814; 76: HR, 79.0; 76: SpO2, 98.322; 76: Perf, 1.851; 76: Pain, 2.0; 77: CREATININE, 0.97 mg/dL; 77: ALT (SGPT), 37 U/L; 77: CHLORIDE, 102 mmol/L; 77: ALKALINE PHOSPHATASE, 115 U/L; 77: GLOBULIN, 3.1 g/dL; 77: POTASSIUM, 4.1 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 93 mL/min/1.73 m2; 77: SODIUM, 142 mmol/L; 77: BILIRUBIN TOTAL, 0.3 mg/dL; 77: CALCIUM, 9.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 4.9 g/dL; 77: CO2, 29 mmol/L; 77: GLUCOSE, 121 mg/dL; 77: AST (SGOT), 30 U/L; 77: PROTEIN TOTAL, 8.0 g/dL; 77: CORRECTED CALCIUM, 9.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 107 mL/min/1.73 m2; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: SpO2, 98.661; 77: Perf, 1.894; 78: SpO2, 98.155; 78: Perf, 1.599; 79: SpO2, 98.288; 79: Perf, 1.339; 80: SpO2, 98.649; 80: Perf, 1.626; 81: SpO2, 99.271; 81: Perf, 0.797; 82: SpO2, 99.576; 82: Perf, 0.516; 83: SpO2, 99.431; 83: Perf, 0.709; 84: SpO2, 99.814; 84: Perf, 0.594; 85: SpO2, 99.483; 85: Perf, 1.451; 86: SpO2, 98.847; 86: Perf, 1.900; 87: SpO2, 98.931; 87: Perf, 2.788; 88: SpO2, 98.847; 88: Perf, 3.167; 89: SpO2, 98.780; 89: Perf, 3.262; 90: SpO2, 98.776; 90: Perf, 3.402; 91: SpO2, 98.845; 91: Perf, 2.487; 92: SpO2, 98.729; 92: Perf, 2.223; 93: SpO2, 98.534; 93: Perf, 2.077; 94: SpO2, 98.783; 94: Perf, 1.206; 95: SpO2, 98.810; 95: Perf, 1.407; 96: SpO2, 98.864; 96: Perf, 1.919; 97: SpO2, 99.121; 97: Perf, 1.476; 98: SpO2, 98.797; 98: Perf, 1.537; 99: SpO2, 98.983; 99: Perf, 1.331; 100: SpO2, 98.0; 100: Perf, 1.937; 101: SpO2, 98.390; 101: Perf, 1.659; 102: SpO2, 98.466; 102: Perf, 1.656; 103: SpO2, 98.0; 103: Perf, 1.959; 104: SpO2, 98.567; 104: Perf, 1.748; 105: SpO2, 99.035; 105: Perf, 1.988; 106: SpO2, 99.0; 106: Perf, 2.469; 107: SpO2, 99.0; 107: Perf, 2.539; 108: SpO2, 99.0; 108: Perf, 1.821; 109: SpO2, 98.898; 109: Perf, 2.148; 110: SpO2, 99.0; 110: Perf, 1.34; 111: NITRITE, URINE (UA): Positive; 111: PH, URINE (UA): 6.0; 111: KETONE, URINE (UA): Negative; 111: SPECIFIC GRAVITY, URINE (UA): 1.028; 111: GLUCOSE, URINE (UA): Negative; 111: SpO2, 99.0; 111: Perf, 1.149; 112: SpO2, 99.0; 112: Perf, 1.797; 113: SpO2, 99.0; 113: Perf, 1.614; 114: SpO2, 99.0; 114: Perf, 1.840; 115: SpO2, 99.0; 115: Perf, 1.343; 116: SpO2, 99.0; 116: Perf, 1.33; 117: SpO2, 98.845; 117: Perf, 1.616; 118: SpO2, 98.932; 118: Perf, 1.644; 119: SpO2, 99.0; 119: Perf, 2.028; 0: Age, 49; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 133.0; 0: Triage DBP, 83.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN,NEPHROSTOMY",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I considered the patient\u2019s vital signs, laboratory results (including normal lactate), and overall stable presentation. Despite a slight initial tachycardia and a possible urinary infection, there is no clear evidence of organ dysfunction or other signs of systemic infection necessitating a high sepsis risk designation. Thus, based on the available information, sepsis risk does not appear to be high within the next 12 hours.",
        "claims": [
            "I considered the patient's vital signs.",
            "I considered the patient's laboratory results.",
            "The laboratory results included normal lactate.",
            "I considered the patient's overall stable presentation.",
            "The patient exhibits a slight initial tachycardia.",
            "The patient may have a urinary infection.",
            "There is no clear evidence of organ dysfunction.",
            "There are no other signs of systemic infection.",
            "A high sepsis risk designation is not necessitated.",
            "Based on the available information, sepsis risk does not appear to be high within the next 12 hours."
        ],
        "relevant_claims": [
            "The laboratory results included normal lactate.",
            "The patient exhibits a slight initial tachycardia.",
            "There is no clear evidence of organ dysfunction.",
            "There are no other signs of systemic infection."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.7,
            0.2
        ],
        "alignment_category": [
            5,
            6,
            8,
            9
        ],
        "alignment_reasonings": [
            "The claim references lactate levels, which are directly related to the category of Elevated Serum Lactate (\u22652 mmol/L) used for assessing sepsis risk through tissue hypoperfusion signals. However, since the claim specifies that lactate levels are normal, it suggests lower sepsis risk rather than an elevated risk, thus resulting in a low alignment rating.",
            "Tachycardia (increased heart rate) is part of the calculation for Shock Index (heart rate \u00f7 systolic BP). However, the claim does not provide full details needed to determine if the Shock Index is indeed \u22651.0, nor does it confirm the presence of hypotension needed for a definitive sepsis-related shock risk. Thus, while there's a conceptual link with this category, the information is insufficient for strong alignment.",
            "The claim about the absence of organ dysfunction indirectly relates to the SOFA score, which is used to detect organ dysfunction. A statement of \"no clear evidence of organ dysfunction\" implies a low or absent SOFA score increase, aligning moderately well with the concept. The alignment is not fully direct, hence a rating below full alignment.",
            "The claim describes an absence of systemic infection signs, indirectly suggesting a lack of clinical suspicion necessary to trigger antibiotic administration or culture orders. It is loosely aligned with category 9 as the absence of signs might lead to a lack of action, but it doesn\u2019t directly reference the consideration of such actions. The alignment is weak since no direct connection to the category's concrete clinical actions is made."
        ],
        "final_alignment_score": 0.35,
        "accuracy": 1
    },
    {
        "input": "5: HR, 109.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 127.0; 5: DBP, 69.0; 5: MAP, 88.333; 5: Pain, 6.0; 5: Temp, 98.2; 81: WAM DIFTYP, AUTO; 81: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.34 K/uL; 81: BASOPHIL % (AUTO DIFF), 0.9 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.53 K/uL; 81: HEMATOCRIT (HCT), 43.5 %; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 81: PLATELET COUNT (PLT), 241 K/uL; 81: NEUTROPHIL % (AUTO DIFF), 64.0 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.78 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: MONOCYTE % (AUTO DIFF), 7.8 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 104.6 fL; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: EOSINOPHIL % (AUTO DIFF), 0.7 %; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 81: RED BLOOD CELLS (RBC), 4.16 MIL/uL; 81: LYMPHOCYTE % (AUTO DIFF), 26.3 %; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 81: HEMOGLOBIN (HGB), 13.0 g/dL; 81: WHITE BLOOD CELLS (WBC), 6.8 K/uL; 86: SpO2, 99.32; 87: SpO2, 99.552; 87: Perf, 2.687; 88: HR, 98.8; 88: RR, 19.467; 88: SpO2, 99.525; 88: Perf, 1.823; 88: 1min HRV, 17.223; 89: HR, 103.483; 89: RR, 18.948; 89: SpO2, 98.983; 89: Perf, 1.419; 89: 1min HRV, 28.598; 90: HR, 99.322; 90: RR, 22.068; 90: SpO2, 98.862; 90: Perf, 2.159; 90: 1min HRV, 16.204; 90: 5min HRV, 24.694; 91: HR, 96.356; 91: RR, 15.966; 91: SpO2, 98.983; 91: Perf, 2.292; 91: 1min HRV, 22.544; 91: SBP, 115.0; 91: DBP, 79.0; 91: MAP, 91.0; 92: HR, 95.0; 92: RR, 19.052; 92: SpO2, 98.879; 92: Perf, 3.058; 92: 1min HRV, 14.133; 93: HR, 95.932; 93: RR, 16.966; 93: SpO2, 98.746; 93: Perf, 4.128; 93: 1min HRV, 18.879; 94: HR, 96.397; 94: RR, 17.466; 94: SpO2, 98.052; 94: Perf, 4.146; 94: 1min HRV, 17.535; 95: HR, 96.424; 95: RR, 15.492; 95: SpO2, 98.627; 95: Perf, 3.096; 95: 1min HRV, 40.939; 95: 5min HRV, 25.220; 96: HR, 91.881; 96: RR, 11.475; 96: SpO2, 98.441; 96: Perf, 4.773; 96: 1min HRV, 19.820; 97: HR, 93.448; 97: RR, 13.672; 97: SpO2, 98.517; 97: Perf, 4.844; 97: 1min HRV, 17.150; 98: HR, 95.034; 98: RR, 9.695; 98: SpO2, 98.627; 98: Perf, 3.999; 98: 1min HRV, 20.632; 99: HR, 93.207; 99: RR, 12.017; 99: SpO2, 98.414; 99: Perf, 4.606; 99: 1min HRV, 19.888; 100: HR, 95.136; 100: RR, 11.525; 100: SpO2, 98.085; 100: Perf, 4.079; 100: 1min HRV, 21.264; 100: 5min HRV, 21.607; 101: HR, 94.678; 101: RR, 11.169; 101: SpO2, 98.729; 101: Perf, 2.924; 101: 1min HRV, 17.756; 102: HR, 94.517; 102: RR, 12.276; 102: SpO2, 98.741; 102: Perf, 3.257; 102: 1min HRV, 18.186; 103: HR, 94.288; 103: RR, 16.644; 103: SpO2, 98.797; 103: Perf, 2.705; 103: 1min HRV, 12.102; 104: HR, 95.414; 104: RR, 15.724; 104: SpO2, 98.207; 104: Perf, 1.763; 104: 1min HRV, 8.317; 105: HR, 94.797; 105: RR, 14.169; 105: SpO2, 99.068; 105: Perf, 1.365; 105: 1min HRV, 17.161; 105: 5min HRV, 15.655; 106: HR, 93.729; 106: RR, 13.593; 106: SpO2, 98.729; 106: Perf, 1.404; 106: 1min HRV, 12.790; 106: SBP, 126.0; 106: DBP, nan; 106: MAP, nan; 107: HR, 94.759; 107: RR, 13.276; 107: SpO2, 98.776; 107: Perf, 2.192; 107: 1min HRV, 34.534; 108: HR, 93.305; 108: RR, 16.305; 108: SpO2, 98.893; 108: Perf, 2.48; 108: 1min HRV, 38.104; 109: HR, 94.155; 109: RR, 11.897; 109: SpO2, 98.522; 109: Perf, 1.763; 109: 1min HRV, 21.272; 110: HR, 96.153; 110: RR, 11.661; 110: SpO2, 98.305; 110: Perf, 1.962; 110: 1min HRV, 20.947; 110: 5min HRV, 28.704; 111: HR, 98.356; 111: RR, 17.695; 111: SpO2, 98.627; 111: Perf, 1.963; 111: 1min HRV, 19.384; 112: HR, 98.379; 112: RR, 15.914; 112: SpO2, 98.534; 112: Perf, 1.66; 112: 1min HRV, 23.370; 113: HR, 96.068; 113: RR, 13.627; 113: SpO2, 98.661; 113: Perf, 1.335; 113: 1min HRV, 19.161; 114: CHLORIDE, 105 mmol/L; 114: GLOBULIN, 3.0 g/dL; 114: CO2, 23 mmol/L; 114: GLUCOSE, 126 mg/dL; 114: ALKALINE PHOSPHATASE, 91 U/L; 114: SODIUM, 140 mmol/L; 114: ALT (SGPT), 32 U/L; 114: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 114: PROTEIN TOTAL, 6.8 g/dL; 114: ANION GAP, 12 mmol/L; 114: CREATININE, 0.82 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 114: POTASSIUM, 4.6 mmol/L; 114: CORRECTED CALCIUM, 9.2 mg/dL; 114: CALCIUM, 9.0 mg/dL; 114: AST (SGOT), 40 U/L; 114: BILIRUBIN TOTAL, 0.3 mg/dL; 114: ALBUMIN, 3.8 g/dL; 114: HR, 94.655; 114: RR, 13.293; 114: SpO2, 99.241; 114: Perf, 1.235; 114: 1min HRV, 19.096; 115: HR, 94.017; 115: RR, 14.356; 115: SpO2, 99.322; 115: Perf, 1.177; 115: 1min HRV, 19.983; 115: 5min HRV, 23.273; 116: HR, 94.881; 116: RR, 19.356; 116: SpO2, 99.288; 116: Perf, 1.171; 116: 1min HRV, 23.524; 117: HR, 94.241; 117: RR, 14.534; 117: SpO2, 99.138; 117: Perf, 1.404; 117: 1min HRV, 19.643; 118: HR, 94.339; 118: RR, 19.746; 118: SpO2, 98.051; 118: Perf, 1.309; 118: 1min HRV, 33.339; 119: HR, 93.017; 119: RR, 15.897; 119: SpO2, 97.857; 119: Perf, 1.16; 119: 1min HRV, 24.704; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 109.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I began by checking vital signs for any red flags such as marked tachycardia, fever, or hypotension. Then, I reviewed the lab data to see if there were indicators of infection or organ dysfunction (for example, a high WBC count or abnormal kidney function). The patient\u2019s heart rate is mildly elevated, but their other vital signs and lab results appear stable and within normal ranges. Given these findings, I concluded the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I began by checking vital signs for any red flags.",
            "I checked for marked tachycardia as a red flag.",
            "I checked for fever as a red flag.",
            "I checked for hypotension as a red flag.",
            "I reviewed the lab data for indicators of infection or organ dysfunction.",
            "A high WBC count could indicate infection or organ dysfunction.",
            "Abnormal kidney function could indicate infection or organ dysfunction.",
            "The patient\u2019s heart rate is mildly elevated.",
            "The patient\u2019s other vital signs appear stable and within normal ranges.",
            "The patient's lab results appear stable and within normal ranges.",
            "Given these findings, I concluded the patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "I checked for marked tachycardia as a red flag.",
            "The patient\u2019s heart rate is mildly elevated."
        ],
        "alignment_scores": [
            0.8,
            0.5
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "Tachycardia is defined as a heart rate >90 bpm, which is a criterion under SIRS (Systemic Inflammatory Response Syndrome) positivity. The claim indicates checking for tachycardia, which directly aligns with the SIRS criteria for systemic inflammation and early detection of sepsis. While the claim does not specify the exact heart rate, it suggests that tachycardia was significant enough to be considered a red flag, indicating a strong alignment with this category.",
            "The claim mentions a mildly elevated heart rate, which aligns with one of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm). However, without specific values stating it exceeds 90\u202fbpm or additional SIRS criteria being met, the alignment is partial but notable."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 1
    },
    {
        "input": "4: HR, 91.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 168.0; 4: DBP, 100.0; 4: MAP, 122.667; 4: Pain, 6.0; 4: Temp, 97.9; 5: SBP, 159.0; 5: DBP, 100.0; 5: MAP, 119.667; 37: SpO2, 99.0; 38: SpO2, 98.932; 38: Perf, 3.107; 38: SBP, 158.0; 38: DBP, 127.0; 38: MAP, 137.333; 39: SpO2, 98.898; 39: Perf, 2.952; 40: SpO2, 98.638; 40: Perf, 2.714; 41: SpO2, 98.373; 41: Perf, 2.238; 42: SpO2, 98.552; 42: Perf, 2.528; 43: SpO2, 98.695; 43: Perf, 2.543; 44: SpO2, 98.322; 44: Perf, 2.768; 45: HR, 90.0; 45: SpO2, 98.741; 45: Perf, 2.907; 45: SBP, 163.0; 45: DBP, 113.0; 45: MAP, 129.667; 46: SpO2, 98.898; 46: Perf, 2.837; 46: SBP, 163.0; 46: DBP, 113.0; 46: MAP, 129.667; 47: SpO2, 98.621; 47: Perf, 2.756; 48: SpO2, 98.661; 48: Perf, 2.652; 49: SpO2, 98.085; 49: Perf, 2.790; 50: SpO2, 98.121; 50: Perf, 2.636; 51: SpO2, 98.356; 51: Perf, 2.65; 52: SpO2, 98.224; 52: Perf, 2.656; 53: SpO2, 98.119; 53: Perf, 2.71; 54: SpO2, 98.305; 54: Perf, 2.71; 55: SpO2, 98.621; 55: Perf, 2.71; 56: SpO2, 98.322; 56: Perf, 2.71; 57: SpO2, 98.328; 57: Perf, 2.71; 58: SpO2, 97.237; 58: Perf, 2.663; 59: SpO2, 98.373; 59: Perf, 2.71; 60: SpO2, 98.310; 60: Perf, 2.456; 60: KETOROLAC, 15 MG/ML INJ SOLN; 60: METOCLOPRAMIDE HCL, 5 MG/ML INJ SOLN; 60: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 61: SpO, 2: 98.780; 61: Perf, 1.355; 61: SBP, 177.0; 61: DBP, 119.0; 61: MAP, 138.333; 61: DIPHENHYDRAMINE HCL, 50 MG/ML INJ SOLN; 62: SpO, 2: 98.362; 62: Perf, 1.539; 63: SpO2, 98.525; 63: Perf, 2.468; 64: SpO2, 98.136; 64: Perf, 2.768; 65: SpO2, 98.190; 65: Perf, 3.867; 65: NS IV BOLUS -, 1000 ML; 66: SpO, 2: 98.085; 66: Perf, 2.609; 67: SpO2, 97.517; 67: Perf, 2.276; 68: SpO2, 97.897; 68: Perf, 3.014; 69: SpO2, 97.051; 69: Perf, 2.980; 70: SpO2, 97.407; 70: Perf, 3.188; 71: WAM DIFTYP, AUTO; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.18 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.3 pg; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 71: BASOPHIL % (AUTO DIFF), 1.1 %; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.35 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 88.6 fL; 71: RED BLOOD CELLS (RBC), 4.58 MIL/uL; 71: EOSINOPHIL % (AUTO DIFF), 3.3 %; 71: HEMATOCRIT (HCT), 40.6 %; 71: LYMPHOCYTE % (AUTO DIFF), 37.4 %; 71: NEUTROPHIL % (AUTO DIFF), 50.7 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 71: MONOCYTE % (AUTO DIFF), 7.3 %; 71: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 71: HEMOGLOBIN (HGB), 13.9 g/dL; 71: WHITE BLOOD CELLS (WBC), 6.3 K/uL; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: PLATELET COUNT (PLT), 218 K/uL; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 71: HR, 76.0; 71: SpO2, 96.672; 71: Perf, 4.325; 71: SBP, 177.0; 71: DBP, 119.0; 71: MAP, 138.333; 71: AMOXICILLIN-POT CLAVULANATE, 875-125 MG PO TABS; 71: LOSARTAN, 50 MG PO TABS; 72: SpO2, 96.847; 72: Perf, 4.581; 73: SpO2, 98.052; 73: Perf, 3.920; 74: SpO2, 97.390; 74: Perf, 3.688; 74: MAGNESIUM SULFATE IN D, 5W 1 GRAM/100 ML IV PGBK; 75: SpO, 2: 96.576; 75: Perf, 4.164; 76: SpO2, 97.119; 76: Perf, 4.159; 76: SBP, 138.0; 76: DBP, 85.0; 76: MAP, 102.667; 77: SpO2, 97.776; 77: Perf, 3.844; 78: HR, 78.0; 78: RR, 18.0; 78: SpO2, 96.948; 78: Perf, 4.500; 78: SBP, 138.0; 78: DBP, 85.0; 78: MAP, 102.667; 79: SpO2, 97.271; 79: Perf, 4.525; 80: SpO2, 97.914; 80: Perf, 4.377; 81: SpO2, 97.917; 81: Perf, 4.162; 82: SpO2, 97.828; 82: Perf, 4.318; 83: SpO2, 97.293; 83: Perf, 4.348; 84: SpO2, 97.0; 84: Perf, 4.549; 85: SpO2, 97.0; 85: Perf, 4.268; 86: SpO2, 97.153; 86: Perf, 3.840; 87: SpO2, 97.644; 87: Perf, 3.567; 88: SpO2, 97.655; 88: Perf, 3.958; 89: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 89: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 89: ALT (SGPT), 71 U/L; 89: CHLORIDE, 103 mmol/L; 89: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 89: SODIUM, 138 mmol/L; 89: ALBUMIN, 4.4 g/dL; 89: ANION GAP, 10 mmol/L; 89: CREATININE, 1.03 mg/dL; 89: POTASSIUM, 4.0 mmol/L; 89: ALKALINE PHOSPHATASE, 61 U/L; 89: GLUCOSE, 122 mg/dL; 89: AST (SGOT), 42 U/L; 89: CORRECTED CALCIUM, 9.2 mg/dL; 89: CO2, 25 mmol/L; 89: GLOBULIN, 2.4 g/dL; 89: MAGNESIUM, 2.1 mg/dL; 89: BILIRUBIN TOTAL, <.2 mg/dL; 89: CALCIUM, 9.5 mg/dL; 89: PROTEIN TOTAL, 6.8 g/dL; 89: SpO2, 97.864; 89: Perf, 4.193; 90: SpO2, 97.881; 90: Perf, 3.909; 91: SpO2, 98.390; 91: Perf, 4.445; 91: SBP, 130.0; 91: DBP, 81.0; 91: MAP, 97.333; 92: SpO2, 98.259; 92: Perf, 4.703; 93: SpO2, 98.0; 93: Perf, 3.96; 94: SpO2, 97.845; 94: Perf, 4.029; 95: SpO2, 97.593; 95: Perf, 3.823; 96: SpO2, 98.305; 96: Perf, 2.939; 97: SpO2, 98.224; 97: Perf, 3.344; 98: SpO2, 98.610; 98: Perf, 3.357; 99: SpO2, 97.879; 99: Perf, 4.154; 100: SpO2, 98.458; 100: Perf, 3.910; 101: SpO2, 98.5; 101: Perf, 3.063; 102: SpO2, 98.814; 102: Perf, 5.818; 103: SpO2, 98.128; 103: Perf, 7.793; 104: SpO2, 98.776; 105: SpO2, 98.881; 105: Perf, 3.678; 106: SpO2, 97.310; 106: Perf, 3.918; 106: SBP, 139.0; 106: DBP, 102.0; 106: MAP, 114.333; 107: SpO2, 97.746; 107: Perf, 3.92; 108: SpO2, 97.746; 108: Perf, 3.92; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 91.0; 0: Triage RR, 16.0; 0: Triage SBP, 168.0; 0: Triage DBP, 100.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first checked the vital signs and observed that the patient\u2019s blood pressure, heart rate, temperature, and respiratory rate did not indicate sepsis. I also examined the laboratory results, which did not show elevated white blood cells or other glaring indicators of infection or organ dysfunction. I questioned whether the treatments given might suggest a severe infection, but they appeared more aligned with routine comfort medications and mild antibiotic coverage. Therefore, I concluded that the patient is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The vital signs of the patient were checked.",
            "The patient's blood pressure did not indicate sepsis.",
            "The patient's heart rate did not indicate sepsis.",
            "The patient's temperature did not indicate sepsis.",
            "The patient's respiratory rate did not indicate sepsis.",
            "The laboratory results were examined.",
            "The laboratory results did not show elevated white blood cells.",
            "The laboratory results did not show other glaring indicators of infection.",
            "The laboratory results did not show indicators of organ dysfunction.",
            "There was a consideration of whether the treatments given might suggest a severe infection.",
            "The treatments appeared more aligned with routine comfort medications.",
            "The treatments included mild antibiotic coverage.",
            "I concluded that the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The laboratory results did not show elevated white blood cells."
        ],
        "alignment_scores": [
            0.4
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "The claim mentions the absence of elevated white blood cells, which is one of the SIRS criteria for identifying systemic inflammation in early sepsis. However, since the claim specifies normal WBC levels, it only indirectly relates to this category by suggesting the absence of a SIRS positive condition. Thus, the alignment is weak."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "8: HR, 114.0; 8: RR, 18.0; 8: SpO2, 98.0; 8: SBP, 100.0; 8: DBP, 62.0; 8: MAP, 74.667; 8: Temp, 101.9; 54: POC PH (V) ISTAT, 7.45; 54: POC PCO2 (V) ISTAT, 41.3 mmHg; 54: POC TCO2 (V) ISTAT, 30 mmol/L; 54: POC PO2 (V) ISTAT, 28 mmHg; 54: POC BASE EXCESS ISTAT, 5 mmol/L; 54: POC O2 SATURATION ISTAT VENOUS, 55 %; 54: POC HCO3 (V) ISTAT, 28.8 mmol/L; 54: POC LACTATE ISTAT, 1.14 mmol/L; 61: SpO2, 96.667; 61: SBP, 106.0; 61: DBP, 75.0; 61: MAP, 85.333; 62: SpO2, 95.780; 63: SpO2, 96.729; 63: Perf, 1.77; 64: SpO2, 97.0; 64: Perf, 1.786; 64: NORMOSOL-R IV BOLUS -, 1000 ML; 65: HR:, 112.0; 65: SpO2, 97.271; 65: Perf, 1.638; 65: SBP, 115.0; 65: DBP, 84.0; 65: MAP, 94.333; 65: ACETAMINOPHEN, 500 MG PO TABS; 66: SpO, 2: 98.293; 66: Perf, 1.373; 66: SBP, 115.0; 66: DBP, 84.0; 66: MAP, 94.333; 67: SpO2, 96.085; 67: Perf, 1.177; 68: SpO2, 95.678; 68: Perf, 1.127; 69: SpO2, 96.5; 69: Perf, 0.956; 70: SpO2, 95.356; 70: Perf, 0.855; 71: SpO2, 95.828; 71: Perf, 0.802; 72: SpO2, 95.559; 72: Perf, 0.764; 73: SpO2, 96.254; 73: Perf, 0.803; 74: SpO2, 96.931; 74: Perf, 0.899; 74: AMOXICILLIN, 500 MG PO CAPS; 74: AZITHROMYCIN, 250 MG PO TABS; 75: SpO2, 96.339; 75: Perf, 0.968; 76: SpO2, 96.052; 76: Perf, 0.902; 77: HR, 110.528; 77: RR, 13.625; 77: SpO2, 95.780; 77: Perf, 0.899; 77: 1min HRV, 2.757; 78: HR, 109.741; 78: RR, 19.190; 78: SpO2, 95.638; 78: Perf, 0.769; 78: 1min HRV, 3.116; 79: HR, 109.322; 79: RR, 23.814; 79: SpO2, 96.0; 79: Perf, 0.738; 79: 1min HRV, 2.266; 80: HR, 111.475; 80: RR, 21.068; 80: SpO2, 96.153; 80: Perf, 0.685; 80: 1min HRV, 3.989; 80: 5min HRV, 5.418; 80: SBP, 102.0; 80: DBP, 90.0; 80: MAP, 94.0; 81: HR, 114.534; 81: RR, 21.552; 81: SpO2, 95.455; 81: Perf, 0.641; 81: 1min HRV, 5.618; 81: SBP, 102.0; 81: DBP, 90.0; 81: MAP, 94.0; 82: HR, 117.169; 82: RR, 25.864; 82: SpO2, 95.508; 82: Perf, 0.54; 82: 1min HRV, 9.593; 83: HR, 121.276; 83: RR, 26.914; 83: SpO2, 94.328; 83: Perf, 0.548; 83: 1min HRV, 5.129; 84: HR, 124.678; 84: RR, 30.169; 84: SpO2, 93.492; 84: Perf, 0.55; 84: 1min HRV, 7.047; 85: HR, 127.04; 85: RR, 26.220; 85: SpO2, 93.136; 85: Perf, 0.55; 85: 1min HRV, 7.672; 85: 5min HRV, 18.936; 86: HR, 132.0; 86: RR, 28.845; 86: SpO2, 94.103; 86: Perf, 0.55; 86: 1min HRV, 9.623; 87: RR, 31.966; 87: SpO2, 94.0; 87: Perf, 0.55; 88: HR, 136.0; 88: RR, 35.690; 88: SpO2, 94.897; 88: Perf, 0.55; 88: 1min HRV, 0.0; 89: HR, 133.906; 89: RR, 30.373; 89: SpO2, 94.085; 89: Perf, 0.55; 89: 1min HRV, 173.207; 90: HR, 125.0; 90: RR, 33.390; 90: SpO2, 95.05; 90: Perf, 0.55; 90: 5min HRV, 97.885; 91: HR, 149.054; 91: RR, 31.534; 91: SpO2, 97.679; 91: Perf, 0.55; 91: 1min HRV, 10.808; 92: HR, 156.712; 92: RR, 30.0; 92: SpO2, 98.271; 92: Perf, 0.55; 92: 1min HRV, 60.644; 93: HR, 161.025; 93: RR, 33.034; 93: SpO2, 98.6; 93: Perf, 0.55; 93: 1min HRV, 22.283; 94: HR, 156.370; 94: RR, 36.712; 94: SpO2, 98.2; 94: Perf, 0.55; 94: 1min HRV, 94.293; 95: HR, 157.196; 95: RR, 34.339; 95: SpO2, 96.737; 95: Perf, 0.55; 95: 1min HRV, 16.234; 95: 5min HRV, 49.010; 95: SBP, 111.0; 95: DBP, 53.0; 95: MAP, 72.333; 96: PROTEIN, URINE (UA): Negative; 96: SPECIFIC GRAVITY, URINE (UA): 1.001; 96: NITRITE, URINE (UA): Negative; 96: KETONE, URINE (UA): Negative; 96: LEUKOCYTE ESTERASE, URINE (UA): Negative; 96: PH, URINE (UA): 7.0; 96: HR, 164.089; 96: RR, 36.5; 96: SpO2, 97.32; 96: Perf, 0.55; 96: 1min HRV, 26.799; 97: INR, 1.2; 97: PART. THROMBOPLASTIN TIME, 38.8 seconds; 97: PROTHROMBIN TIME, 15.3 seconds; 97: HR, 163.871; 97: RR, 36.424; 97: SpO2, 96.475; 97: Perf, 0.55; 97: 1min HRV, 13.300; 98: HR, 153.0; 98: RR, 40.224; 98: SpO2, 96.771; 98: Perf, 0.55; 98: 1min HRV, 124.873; 99: HR, 144.982; 99: RR, 34.576; 99: SpO2, 95.875; 99: Perf, 0.55; 99: 1min HRV, 12.892; 100: HR, 162.524; 100: RR, 33.407; 100: SpO2, 96.271; 100: Perf, 0.55; 100: 1min HRV, 1.961; 100: 5min HRV, 75.241; 101: HR, 165.897; 101: RR, 36.362; 101: SpO2, 97.0; 101: Perf, 0.55; 101: 1min HRV, 13.371; 102: HR, 166.962; 102: RR, 41.898; 102: SpO2, 96.746; 102: Perf, 0.55; 102: 1min HRV, 15.235; 103: HR, 164.707; 103: RR, 34.897; 103: SpO2, 97.155; 103: Perf, 0.55; 103: 1min HRV, 13.524; 104: HR, 166.322; 104: RR, 36.576; 104: SpO2, 97.492; 104: Perf, 0.55; 104: 1min HRV, 16.295; 105: HR, 165.821; 105: RR, 37.136; 105: SpO2, 97.0; 105: Perf, 0.55; 105: 1min HRV, 16.144; 105: 5min HRV, 15.305; 106: CREATININE, 1.17 mg/dL; 106: ALT (SGPT), 56 U/L; 106: BILIRUBIN TOTAL, 0.7 mg/dL; 106: AST (SGOT), 53 U/L; 106: CALCIUM, 8.8 mg/dL; 106: SODIUM, 129 mmol/L; 106: EGFR FOR AFRICAN AMERICAN, 93 mL/min/1.73 m2; 106: ALBUMIN, 3.9 g/dL; 106: GLOBULIN, 3.0 g/dL; 106: GLUCOSE, 298 mg/dL; 106: POTASSIUM, 3.1 mmol/L; 106: ALKALINE PHOSPHATASE, 76 U/L; 106: CORRECTED CALCIUM, 8.9 mg/dL; 106: CHLORIDE, 96 mmol/L; 106: CO2, 24 mmol/L; 106: ANION GAP, 9 mmol/L; 106: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 106: BLOOD UREA NITROGEN (BUN), 7 mg/dL; 106: PROTEIN TOTAL, 6.9 g/dL; 106: HR, 166.759; 106: RR, 37.879; 106: SpO2, 97.741; 106: Perf, 0.55; 106: 1min HRV, 18.752; 107: HR, 166.305; 107: RR, 35.915; 107: SpO2, 97.339; 107: Perf, 0.55; 107: 1min HRV, 13.251; 108: HR, 161.741; 108: RR, 39.034; 108: SpO2, 97.190; 108: Perf, 0.55; 108: 1min HRV, 70.909; 109: HR, 159.644; 109: RR, 38.186; 109: SpO2, 97.254; 109: Perf, 0.55; 109: 1min HRV, 59.905; 110: HR, 165.724; 110: RR, 34.431; 110: SpO2, 97.310; 110: Perf, 0.55; 110: 1min HRV, 11.562; 110: 5min HRV, 46.894; 111: HR, 164.068; 111: RR, 31.051; 111: SpO2, 97.085; 111: Perf, 0.55; 111: 1min HRV, 8.139; 112: HR, 161.678; 112: RR, 32.475; 112: SpO2, 97.533; 112: Perf, 0.55; 112: 1min HRV, 10.966; 113: HR, 161.448; 113: RR, 36.655; 113: SpO2, 98.0; 113: 1min HRV, 34.426; 114: HR, 159.678; 114: RR, 29.136; 114: SpO2, 97.683; 114: 1min HRV, 11.619; 115: HR, 155.552; 115: RR, 22.431; 115: SpO2, 98.0; 115: 1min HRV, 13.881; 115: 5min HRV, 19.683; 116: HR, 153.390; 116: RR, 21.559; 116: SpO2, 98.0; 116: 1min HRV, 15.817; 117: HR, 151.356; 117: RR, 20.356; 117: SpO2, 98.0; 117: 1min HRV, 17.470; 117: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 118: HR:, 150.379; 118: RR, 20.672; 118: SpO2, 97.845; 118: 1min HRV, 17.041; 119: HR, 149.695; 119: RR, 23.661; 119: SpO2, 97.0; 119: 1min HRV, 18.899; 0: Age, 33; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I notice the patient\u2019s persistent fever, tachycardia, and borderline hypotension despite fluid boluses and antibiotics. Next, I ask myself whether these vitals indicate early signs of organ dysfunction or worsening infection. Then, I see the escalating heart rate and respiratory rate, suggesting a trajectory toward possible sepsis. Finally, I conclude that these findings collectively point to a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient has a persistent fever.",
            "The patient has tachycardia.",
            "The patient has borderline hypotension despite fluid boluses and antibiotics.",
            "Persistent fever, tachycardia, and borderline hypotension can indicate early signs of organ dysfunction or worsening infection.",
            "The patient's heart rate is escalating.",
            "The patient's respiratory rate is escalating.",
            "The escalating heart rate and respiratory rate suggest a trajectory toward possible sepsis.",
            "The findings of persistent fever, tachycardia, borderline hypotension, and escalating vitals collectively point to a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has a persistent fever.",
            "The patient has tachycardia.",
            "The patient has borderline hypotension despite fluid boluses and antibiotics.",
            "Persistent fever, tachycardia, and borderline hypotension can indicate early signs of organ dysfunction or worsening infection.",
            "The patient's heart rate is escalating.",
            "The patient's respiratory rate is escalating.",
            "The escalating heart rate and respiratory rate suggest a trajectory toward possible sepsis.",
            "The findings of persistent fever, tachycardia, borderline hypotension, and escalating vitals collectively point to a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.8,
            0.8,
            0.7,
            0.6,
            0.8,
            0.8
        ],
        "alignment_category": [
            2,
            2,
            7,
            3,
            6,
            3,
            2,
            4
        ],
        "alignment_reasonings": [
            "A persistent fever is directly related to the SIRS criteria, specifically mentioning a temperature >38\u00b0C as part of the systemic inflammation indicator. Although the claim does not quantify the fever or confirm it exceeds this threshold, the presence of fever suggests potential SIRS relevance, aligning moderately well with this category.",
            "Tachycardia, defined as a heart rate >90 bpm, is one of the specific criteria listed for SIRS positivity. While the claim does not specify the heart rate number, tachycardia is directly related to the SIRS criteria for identifying systemic inflammation consistent with early sepsis. The alignment is fairly strong, but it would be stronger if additional SIRS criteria were met.",
            "The claim mentions \"borderline hypotension,\" which suggests a close relation to the criteria in this category regarding low blood pressure, a sign of potential progression toward septic shock. The mention of hypotension despite interventions with fluid boluses and antibiotics emphasizes its clinical relevance. However, the term \"borderline\" reduces the alignment strength since it may not fully satisfy the precise numerical criteria laid out, leading to an alignment rating below the perfect score.",
            "The claim refers to persistent fever (and likely elevation), tachycardia (elevated heart rate), and borderline hypotension, which aligns with parameters in the high qSOFA score (e.g., altered mentation, respiratory rate, blood pressure). This suggests a potential risk of sepsis-related organ dysfunction and mortality. While the claim aligns with several criteria, including potential SIRS positivity and hypotension, the specific reference to organ dysfunction most closely aligns with the qSOFA score, which is used to flag high risk of sepsis\u2011related organ dysfunction.",
            "An escalating heart rate can indicate haemodynamic instability, which is central to the concept of the shock index (heart rate \u00f7 systolic BP). While the claim does not provide complete information to calculate the shock index, an escalating heart rate suggests a potential rise in the shock index. It aligns conceptually with this category, but not directly enough for a higher rating.",
            "An escalating respiratory rate relates to the qSOFA criteria, where a respiratory rate of \u226522/min is one of the indicators. The claim does not specify whether the respiratory rate meets the threshold, but indicates a warning sign in a direction that aligns with qSOFA. Therefore, the alignment is indirect but relevant.",
            "The claim mentions both escalating heart rate and respiratory rate, which correspond to two of the SIRS criteria",
            "The claim mentions \"persistent fever, tachycardia, borderline hypotension, and escalating vitals,\" which align closely with criteria affecting a NEWS score. These vitals collectively indicate clinical deterioration compatible with sepsis, similar to what an elevated NEWS score would predict. However, the claim does not provide specific points or a direct NEWS score, so the alignment is not perfect but highly relevant."
        ],
        "final_alignment_score": 0.725,
        "accuracy": 1
    },
    {
        "input": "4: HR, 77.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 111.0; 4: DBP, 62.0; 4: MAP, 78.333; 4: Temp, 98.1; 30: SpO2, 95.364; 31: SpO2, 98.15; 31: Perf, 1.224; 31: SBP, 141.0; 31: DBP, 64.0; 31: MAP, 89.667; 32: SpO2, 99.776; 32: Perf, 0.976; 33: SpO2, 99.847; 33: Perf, 0.968; 34: SpO2, 98.625; 34: SBP, 126.0; 34: DBP, 74.0; 34: MAP, 91.333; 35: SpO2, 99.086; 35: Perf, 0.972; 36: SpO2, 99.542; 36: Perf, 0.932; 37: SpO2, 99.086; 37: Perf, 0.882; 38: SpO2, 99.172; 38: Perf, 0.910; 39: SpO2, 99.917; 39: Perf, 0.988; 40: SpO2, 99.707; 40: Perf, 0.895; 41: SpO2, 99.271; 41: Perf, 0.855; 42: SpO2, 99.517; 42: Perf, 0.907; 43: POC, HCG, ISTAT QUALITATIVE: Negative; 43: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 43: SpO2, 100.0; 43: Perf, 0.995; 44: SpO2, 98.831; 44: Perf, 0.989; 45: SpO2, 98.034; 45: Perf, 0.958; 46: SpO2, 99.305; 46: Perf, 0.772; 47: SpO2, 98.897; 47: Perf, 0.843; 48: SpO2, 99.593; 48: Perf, 0.885; 49: SpO2, 99.0; 49: SBP, 122.0; 49: DBP, 85.0; 49: MAP, 97.333; 50: SpO2, 98.831; 50: Perf, 0.945; 51: SpO2, 99.310; 51: Perf, 0.891; 52: SpO2, 99.237; 52: Perf, 0.859; 53: SpO2, 99.644; 53: Perf, 0.846; 54: SpO2, 97.429; 54: Perf, 0.83; 55: SpO2, 99.322; 55: Perf, 0.887; 56: SpO2, 99.305; 56: Perf, 0.819; 57: SpO2, 99.379; 57: Perf, 0.925; 58: SpO2, 98.271; 58: Perf, 0.880; 59: SpO2, 97.727; 59: Perf, 0.86; 60: SpO2, 98.362; 60: Perf, 0.852; 61: SpO2, 99.085; 61: Perf, 0.805; 62: SpO2, 97.741; 62: Perf, 0.81; 63: SpO2, 97.636; 63: Perf, 0.811; 64: SpO2, 98.1; 64: SBP, 120.0; 64: DBP, 100.0; 64: MAP, 106.667; 65: SpO2, 96.872; 66: SpO2, 98.068; 66: Perf, 0.520; 67: SpO2, 98.707; 67: Perf, 0.486; 68: SpO2, 98.559; 68: Perf, 0.544; 69: WAM DIFTYP, AUTO; 69: RED BLOOD CELLS (RBC), 4.54 MIL/uL; 69: HEMATOCRIT (HCT), 43.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 69: HEMOGLOBIN (HGB), 14.1 g/dL; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.32 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 12.2 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 95.6 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 241 K/uL; 69: BASOPHIL % (AUTO DIFF), 0.9 %; 69: MONOCYTE % (AUTO DIFF), 9.2 %; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 69: LYMPHOCYTE % (AUTO DIFF), 38.6 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: EOSINOPHIL % (AUTO DIFF), 1.7 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 49.3 %; 69: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.71 K/uL; 69: SpO2, 98.724; 69: Perf, 0.638; 70: SARS-COV-2 RNA, Not Detected; 70: SpO2, 97.845; 70: Perf, 0.540; 71: SpO2, 98.0; 71: Perf, 0.48; 72: SpO2, 96.611; 72: Perf, 0.48; 73: SpO2, 94.722; 73: Perf, 0.48; 74: SpO2, 98.588; 74: Perf, 0.488; 75: SpO2, 95.053; 75: Perf, 0.52; 76: GLUCOSE, URINE (UA): Negative; 76: PROTEIN, URINE (UA): Negative; 76: NITRITE, URINE (UA): Negative; 76: PH, URINE (UA): 6.0; 76: KETONE, URINE (UA): Negative; 76: SPECIFIC GRAVITY, URINE (UA): 1.013; 76: SpO2, 97.562; 77: SpO2, 88.5; 78: SpO2, 95.889; 79: SpO2, 94.88; 79: SBP, 115.0; 79: DBP, 75.0; 79: MAP, 88.333; 80: SpO2, 97.727; 80: Perf, 0.173; 81: SpO2, 94.140; 83: SpO2, 91.75; 84: SpO2, 91.464; 86: SpO2, 90.294; 87: SpO2, 92.613; 88: SpO2, 97.147; 89: SpO2, 96.1; 90: SpO2, 91.103; 91: SpO2, 93.606; 92: SpO2, 92.714; 93: CREATININE, 0.85 mg/dL; 93: POTASSIUM, 4.1 mmol/L; 93: GLUCOSE, 100 mg/dL; 93: CORRECTED CALCIUM, 8.8 mg/dL; 93: ALBUMIN, 4.8 g/dL; 93: CALCIUM, 9.4 mg/dL; 93: ANION GAP, 9 mmol/L; 93: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 93: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 93: BILIRUBIN TOTAL, 0.5 mg/dL; 93: LIPASE, 46 U/L; 93: ALKALINE PHOSPHATASE, 70 U/L; 93: AST (SGOT), 23 U/L; 93: CHLORIDE, 103 mmol/L; 93: SODIUM, 137 mmol/L; 93: EGFR FOR AFRICAN AMERICAN, 92 mL/min/1.73 m2; 93: CO2, 25 mmol/L; 93: PROTEIN TOTAL, 7.6 g/dL; 93: GLOBULIN, 2.8 g/dL; 93: ALT (SGPT), 18 U/L; 93: TSH, 2.77 uIU/mL; 93: SpO2, 88.762; 94: SpO2, 98.105; 94: SBP, 125.0; 94: DBP, 98.0; 94: MAP, 107.0; 95: SpO2, 95.966; 95: Perf, 0.92; 96: SpO2, 98.672; 96: Perf, 0.845; 97: SpO2, 98.169; 97: Perf, 0.894; 98: SpO2, 96.966; 98: Perf, 0.907; 99: SpO2, 96.175; 99: Perf, 0.898; 100: SpO2, 97.276; 100: Perf, 0.873; 101: SpO2, 98.288; 101: Perf, 0.865; 102: SpO2, 96.390; 102: Perf, 0.899; 103: SpO2, 98.508; 103: Perf, 1.044; 104: SpO2, 98.086; 104: Perf, 0.951; 105: SpO2, 96.68; 105: Perf, 0.95; 106: SpO2, 96.0; 106: Perf, 0.95; 107: SpO2, 97.746; 107: Perf, 0.898; 108: SpO2, 96.929; 108: Perf, 0.859; 109: SpO2, 96.611; 109: SBP, 114.0; 109: DBP, 72.0; 109: MAP, 86.0; 110: SpO2, 96.525; 110: Perf, 1.736; 111: SpO2, 98.786; 111: Perf, 1.821; 112: SpO2, 98.017; 112: Perf, 2.042; 113: SpO2, 98.153; 113: Perf, 1.672; 114: SpO2, 97.581; 114: Perf, 1.112; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 111.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first looked at the vital signs to see if there were indicators of infection or organ dysfunction. Then, I examined the lab results for abnormal white blood cell counts or other markers consistent with sepsis. Next, I noted that the blood pressures, heart rates, and temperatures remained relatively stable, without clear signs of organ dysfunction. Based on this overall assessment, there was not enough evidence of high sepsis risk within the next 12 hours.",
        "claims": [
            "I looked at the vital signs to see if there were indicators of infection or organ dysfunction.",
            "I examined the lab results for abnormal white blood cell counts.",
            "I looked for other markers consistent with sepsis.",
            "The blood pressures remained relatively stable.",
            "The heart rates remained relatively stable.",
            "The temperatures remained relatively stable.",
            "There were no clear signs of organ dysfunction.",
            "There was not enough evidence of high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The blood pressures remained relatively stable.",
            "There were no clear signs of organ dysfunction.",
            "There was not enough evidence of high sepsis risk within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.3
        ],
        "alignment_category": [
            6,
            8,
            9
        ],
        "alignment_reasonings": [
            "The claim of stable blood pressure suggests no immediate concern regarding shock index or sepsis-associated hypotension. However, if stable blood pressures are not normal but just stable, there could be an indirect consideration related to hemodynamic stability, which the shock index measures. The connection is weak given the lack of specific details, but moderately relevant.",
            "The claim mentions \"no clear signs of organ dysfunction,\" which relates to the SOFA score. A lack of organ dysfunction insinuates a stable SOFA score, indirectly aligning with the purpose of the SOFA criteria, which is to detect organ dysfunction. The alignment is moderate due to the absence of reference to specific SOFA score elements.",
            "The claim suggests a lack of evidence for high sepsis risk. The closest category is Early Antibiotic/Culture Orders, as lack of such orders might imply low suspicion of severe infection. However, the claim does not directly address clinical actions (or lack thereof), leading to a low alignment rating."
        ],
        "final_alignment_score": 0.43333333333333335,
        "accuracy": 1
    },
    {
        "input": "15: HR, 100.0; 15: RR, 22.0; 15: SpO2, 94.0; 15: SBP, 107.0; 15: DBP, 55.0; 15: MAP, 72.333; 15: Pain, 3.0; 15: Temp, 101.8; 28: SpO2, 87.0; 29: SpO2, 87.898; 30: HR, 101.765; 30: RR, 20.889; 30: SpO2, 90.632; 30: 1min HRV, 4.830; 30: SBP, 123.0; 30: DBP, 62.0; 30: MAP, 82.333; 31: HR, 101.333; 31: RR, 19.233; 31: SpO2, 92.1; 31: 1min HRV, 4.776; 32: HR, 100.138; 32: RR, 17.362; 32: SpO2, 91.483; 32: 1min HRV, 4.689; 32: 5min HRV, 6.331; 33: HR, 99.0; 33: RR, 17.983; 33: SpO2, 92.593; 33: 1min HRV, 3.153; 34: HR, 98.475; 34: RR, 23.085; 34: SpO2, 91.780; 34: 1min HRV, 7.334; 35: HR, 98.310; 35: RR, 19.121; 35: SpO2, 91.259; 35: 1min HRV, 6.017; 35: ACETAMINOPHEN, 325 MG PO TABS; 36: HR:, 97.169; 36: RR, 21.034; 36: SpO2, 91.119; 36: 1min HRV, 2.545; 37: HR, 96.707; 37: RR, 19.052; 37: SpO2, 90.759; 37: 1min HRV, 9.207; 37: 5min HRV, 7.719; 38: HR, 95.881; 38: RR, 21.695; 38: SpO2, 91.661; 38: 1min HRV, 13.105; 39: HR, 97.339; 39: RR, 26.017; 39: SpO2, 90.305; 39: 1min HRV, 6.039; 40: HR, 97.776; 40: RR, 20.672; 40: SpO2, 91.034; 40: 1min HRV, 4.908; 41: HR, 96.390; 41: RR, 18.407; 41: SpO2, 91.661; 41: 1min HRV, 9.422; 42: HR, 96.828; 42: RR, 20.569; 42: SpO2, 91.190; 42: 1min HRV, 8.440; 42: 5min HRV, 9.844; 43: HR, 96.466; 43: RR, 19.569; 43: SpO2, 90.586; 43: 1min HRV, 3.590; 44: HR, 96.339; 44: RR, 23.763; 44: SpO2, 91.542; 44: 1min HRV, 5.054; 45: HR, 95.831; 45: RR, 28.254; 45: SpO2, 90.932; 45: 1min HRV, 2.598; 46: HR, 95.525; 46: RR, 26.932; 46: SpO2, 90.136; 46: 1min HRV, 5.323; 47: HR, 95.483; 47: RR, 22.931; 47: SpO2, 90.621; 47: 1min HRV, 5.140; 47: 5min HRV, 5.528; 48: HR, 95.339; 48: RR, 27.0; 48: SpO2, 90.153; 48: 1min HRV, 4.641; 49: HR, 94.879; 49: RR, 24.948; 49: SpO2, 89.810; 49: 1min HRV, 4.375; 50: HR, 94.780; 50: RR, 22.0; 50: SpO2, 90.627; 50: 1min HRV, 2.481; 51: HR, 95.203; 51: RR, 27.576; 51: SpO2, 90.068; 51: 1min HRV, 2.493; 52: HR, 95.431; 52: RR, 23.103; 52: SpO2, 89.914; 52: 1min HRV, 4.808; 52: 5min HRV, 4.417; 53: HR, 94.864; 53: RR, 23.237; 53: SpO2, 90.610; 53: 1min HRV, 6.341; 54: HR, 95.655; 54: RR, 26.397; 54: SpO2, 91.241; 54: 1min HRV, 4.805; 55: HR, 96.431; 55: RR, 20.586; 55: SpO2, 91.345; 55: 1min HRV, 3.885; 56: POC PH (V) ISTAT, 7.40; 56: POC BASE EXCESS ISTAT, 9 mmol/L; 56: POC O2 SATURATION ISTAT VENOUS, 69 %; 56: POC PO2 (V) ISTAT, 37 mmHg; 56: POC HCO3 (V) ISTAT, 33.7 mmol/L; 56: POC LACTATE ISTAT, 1.52 mmol/L; 56: POC PCO2 (V) ISTAT, 53.9 mmHg; 56: POC TCO2 (V) ISTAT, 35 mmol/L; 56: HR, 95.881; 56: RR, 16.627; 56: SpO2, 91.695; 56: 1min HRV, 4.064; 57: HR, 95.966; 57: RR, 17.305; 57: SpO2, 92.153; 57: 1min HRV, 6.730; 57: 5min HRV, 6.051; 58: HR, 94.763; 58: RR, 16.831; 58: SpO2, 92.356; 58: 1min HRV, 16.739; 58: SBP, 134.0; 58: DBP, 72.0; 58: MAP, 92.667; 59: HR, 96.897; 59: RR, 19.690; 59: SpO2, 93.0; 59: 1min HRV, 4.855; 60: HR, 95.915; 60: RR, 19.458; 60: SpO2, 92.915; 60: 1min HRV, 8.370; 61: HR, 101.542; 61: RR, 22.881; 61: SpO2, 93.729; 61: 1min HRV, 16.173; 62: HR, 106.879; 62: RR, 23.190; 62: SpO2, 91.534; 62: Perf, 2.954; 62: 1min HRV, 17.762; 62: 5min HRV, 30.337; 72: WAM DIFTYP, AUTO; 72: EOSINOPHIL % (AUTO DIFF), 0.5 %; 72: MONOCYTE % (AUTO DIFF), 4.3 %; 72: HEMATOCRIT (HCT), 45.1 %; 72: NEUTROPHIL % (AUTO DIFF), 84.7 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.7 pg; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 72: PLATELET COUNT (PLT), 283 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: HEMOGLOBIN (HGB), 15.3 g/dL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 9.5 %; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.99 K/uL; 72: WHITE BLOOD CELLS (WBC), 10.4 K/uL; 72: RED BLOOD CELLS (RBC), 4.82 MIL/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.84 K/uL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 86: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 87: HR:, 93.0; 87: RR, 26.0; 87: SpO2, 92.0; 87: SBP, 114.0; 87: DBP, 49.0; 87: MAP, 70.667; 88: INR, 1.0; 88: PROTHROMBIN TIME, 12.5 seconds; 89: PART. THROMBOPLASTIN TIME, 27.9 seconds; 110: TROPONIN I, <.017 ng/mL; 113: CREATININE, 0.80 mg/dL; 113: SODIUM, 137 mmol/L; 113: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 113: EGFR FOR AFRICAN AMERICAN, 134 mL/min/1.73 m2; 113: BILIRUBIN TOTAL, 0.5 mg/dL; 113: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 113: POTASSIUM, 5.0 mmol/L; 113: PROTEIN TOTAL, 7.5 g/dL; 113: CO2, 25 mmol/L; 113: GLUCOSE, 127 mg/dL; 113: CHLORIDE, 99 mmol/L; 113: ANION GAP, 13 mmol/L; 113: ALBUMIN, 4.2 g/dL; 113: CORRECTED CALCIUM, 9.3 mg/dL; 113: ALT (SGPT), 74 U/L; 113: CALCIUM, 9.5 mg/dL; 113: AST (SGOT), 47 U/L; 113: ALKALINE PHOSPHATASE, 66 U/L; 113: GLOBULIN, 3.3 g/dL; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 100.0; 0: Triage RR, 22.0; 0: Triage SBP, 107.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, CHEST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I noted the patient\u2019s elevated temperature and slightly increased heart rate and respiratory rate, which could raise suspicion for sepsis. However, their lactate is within normal limits, blood pressure is borderline rather than severely low, and overall lab results do not indicate significant organ dysfunction. These observations suggest that although close monitoring is warranted, the patient is not at high",
        "claims": [
            "risk of developing sepsis within the next 12 hours.",
            "The patient has an elevated temperature.",
            "The patient has a slightly increased heart rate.",
            "The patient has a slightly increased respiratory rate.",
            "An elevated temperature, increased heart rate, and increased respiratory rate could raise suspicion for sepsis.",
            "The patient\u2019s lactate is within normal limits.",
            "The patient's blood pressure is borderline rather than severely low.",
            "The overall lab results do not indicate significant organ dysfunction.",
            "These observations suggest that close monitoring of the patient is warranted.",
            "The patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "An elevated temperature, increased heart rate, and increased respiratory rate could raise suspicion for sepsis.",
            "The overall lab results do not indicate significant organ dysfunction."
        ],
        "alignment_scores": [
            1.0,
            0.6
        ],
        "alignment_category": [
            2,
            8
        ],
        "alignment_reasonings": [
            "The claim refers to elevated temperature, increased heart rate, and increased respiratory rate, which are explicitly listed as SIRS criteria. The presence of these criteria directly identifies systemic inflammation consistent with early sepsis, showing perfect alignment with the category.",
            "The claim mentions the absence of significant organ dysfunction, which the SOFA score measures. A lack of organ dysfunction suggests a low likelihood of a SOFA score increase \u22652 points. While the claim aligns with the conceptual scope of SOFA criteria by addressing organ function, it indicates the opposite of what SOFA aims to detect (new organ dysfunction). Therefore, the alignment is present but indirect and thus rated at 0.6."
        ],
        "final_alignment_score": 0.8,
        "accuracy": 1
    },
    {
        "input": "4: HR, 98.0; 4: RR, 20.0; 4: SpO2, 98.0; 4: SBP, 156.0; 4: DBP, 91.0; 4: MAP, 112.667; 4: Pain, 9.0; 4: Temp, 97.3; 17: Pain, 9.0; 47: SpO2, 99.815; 47: Perf, 5.65; 48: SpO2, 99.698; 48: Perf, 4.866; 49: SpO2, 99.654; 49: Perf, 6.326; 50: SpO2, 98.283; 50: Perf, 6.188; 51: SpO2, 98.692; 51: Perf, 4.329; 52: SpO2, 99.887; 52: Perf, 5.396; 53: SpO2, 98.698; 53: Perf, 6.652; 54: SpO2, 97.788; 54: Perf, 6.915; 55: SpO2, 98.321; 55: Perf, 5.774; 56: SpO2, 98.769; 56: Perf, 5.436; 57: SpO2, 99.796; 57: Perf, 3.147; 58: SpO2, 99.981; 58: Perf, 5.669; 59: SpO2, 98.852; 59: Perf, 6.074; 60: SpO2, 98.962; 60: Perf, 5.853; 61: SpO2, 98.327; 61: Perf, 6.366; 62: SpO2, 97.887; 62: Perf, 4.309; 63: WAM DIFTYP, AUTO; 63: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 63: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 63: PLATELET COUNT (PLT), 111 K/uL; 63: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 63: RED BLOOD CELLS (RBC), 3.36 MIL/uL; 63: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 63: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 63: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 63: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 63: MONOCYTE % (AUTO DIFF), 6.5 %; 63: LYMPHOCYTE % (AUTO DIFF), 23.5 %; 63: NEUTROPHIL % (AUTO DIFF), 67.4 %; 63: MEAN CORPUSCULAR VOLUME (MCV), 90.8 fL; 63: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 63: HEMATOCRIT (HCT), 30.5 %; 63: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.21 K/uL; 63: BASOPHIL % (AUTO DIFF), 0.4 %; 63: EOSINOPHIL % (AUTO DIFF), 1.2 %; 63: HEMOGLOBIN (HGB), 10.0 g/dL; 63: NRBC PERCENT (HEMATOLOGY), 0.0 %; 63: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 63: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 63: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 63: SpO2, 98.472; 63: Perf, 5.038; 64: SpO2, 97.75; 64: Perf, 5.482; 65: SpO2, 98.811; 65: Perf, 4.566; 66: SpO2, 100.0; 66: Perf, 4.300; 67: SpO2, 99.679; 67: Perf, 4.146; 68: SpO2, 98.453; 68: Perf, 3.965; 69: SpO2, 97.692; 69: Perf, 3.954; 70: SpO2, 98.604; 70: Perf, 4.070; 71: SpO2, 98.963; 71: Perf, 3.789; 72: SpO2, 99.208; 72: Perf, 3.189; 73: SpO2, 99.226; 73: Perf, 3.142; 74: SpO2, 98.731; 74: Perf, 4.288; 75: SpO2, 99.830; 75: Perf, 4.364; 76: SpO2, 99.212; 76: Perf, 3.890; 77: SpO2, 99.358; 77: Perf, 2.905; 78: SpO2, 99.192; 78: Perf, 3.487; 79: SpO2, 100.0; 79: Perf, 2.814; 80: SpO2, 99.302; 80: Perf, 2.529; 81: SpO2, 99.827; 81: Perf, 2.478; 82: SpO2, 99.679; 82: Perf, 2.804; 83: SpO2, 99.358; 83: Perf, 3.397; 84: SpO2, 99.660; 84: Perf, 2.971; 85: SpO2, 99.722; 85: Perf, 3.593; 86: SpO2, 98.462; 86: Perf, 2.956; 87: SpO2, 99.094; 87: Perf, 2.975; 88: SpO2, 98.731; 88: Perf, 4.379; 89: SpO2, 99.226; 89: Perf, 7.745; 90: SpO2, 98.717; 90: Perf, 7.697; 91: SpO2, 98.885; 91: Perf, 5.139; 92: ANION GAP, 8 mmol/L; 92: PROTEIN TOTAL, 6.5 g/dL; 92: CREATININE, 1.69 mg/dL; 92: ALKALINE PHOSPHATASE, 204 U/L; 92: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 92: GLUCOSE, 194 mg/dL; 92: AST (SGOT), 103 U/L; 92: BILIRUBIN TOTAL, 1.9 mg/dL; 92: POTASSIUM, 4.2 mmol/L; 92: CHLORIDE, 107 mmol/L; 92: GLOBULIN, 3.7 g/dL; 92: CALCIUM, 8.2 mg/dL; 92: EGFR REFIT WITHOUT RACE (2021), 41 mL/min/1.73 m2; 92: CORRECTED CALCIUM, 9.2 mg/dL; 92: SODIUM, 137 mmol/L; 92: ALT (SGPT), 35 U/L; 92: CO2, 22 mmol/L; 92: LIPASE, 7 U/L; 92: ALBUMIN, 2.8 g/dL; 92: SpO2, 99.585; 92: Perf, 5.095; 93: SpO2, 100.0; 93: Perf, 4.939; 93: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 94: SpO, 2: 100.0; 94: Perf, 6.090; 95: SpO2, 99.547; 95: Perf, 7.254; 96: SpO2, 99.698; 96: Perf, 3.639; 96: HYDROMORPHONE, 1 MG/ML INJ SYRG; 97: SpO, 2: 100.0; 97: Perf, 2.333; 98: SpO2, 100.0; 98: Perf, 1.970; 99: SpO2, 100.0; 99: Perf, 1.992; 100: SpO2, 100.0; 100: Perf, 2.358; 101: SpO2, 100.0; 101: Perf, 2.456; 102: SpO2, 100.0; 102: Perf, 2.726; 103: SpO2, 100.0; 103: Perf, 2.592; 104: SpO2, 100.0; 104: Perf, 2.425; 105: SpO2, 100.0; 105: Perf, 2.096; 106: SpO2, 100.0; 106: Perf, 2.291; 107: SpO2, 99.679; 107: Perf, 2.310; 108: POC PH (V) ISTAT, 7.54; 108: POC PCO2 (V) ISTAT, 23.5 mmHg; 108: POC O2 SATURATION ISTAT VENOUS, 77 %; 108: POC PO2 (V) ISTAT, 35 mmHg; 108: POC BASE EXCESS ISTAT, -2 mmol/L; 108: POC LACTATE ISTAT, 1.68 mmol/L; 108: POC TCO2 (V) ISTAT, 21 mmol/L; 108: POC HCO3 (V) ISTAT, 20.3 mmol/L; 108: SpO2, 99.792; 108: Perf, 2.784; 109: SpO2, 100.0; 109: Perf, 2.668; 110: POC, HCG, ISTAT QUALITATIVE: Negative; 110: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 110: SpO2, 99.788; 110: Perf, 2.271; 110: LR IV BOLUS -, 500 ML; 111: SpO, 2: 100.0; 111: Perf, 2.174; 112: SpO2, 100.0; 112: Perf, 2.461; 113: SpO2, 99.925; 113: Perf, 2.120; 114: SpO2, 98.736; 114: Perf, 2.366; 114: SBP, 125.0; 114: DBP, 72.0; 114: MAP, 89.667; 115: SpO2, 94.868; 115: Perf, 2.387; 116: SpO2, 99.302; 116: Perf, 2.58; 117: HR, 94.0; 117: RR, 18.0; 117: SpO2, 99.642; 117: Perf, 2.295; 117: SBP, 125.0; 117: DBP, 72.0; 117: MAP, 89.667; 117: Pain, 9.0; 118: SpO2, 97.231; 118: Perf, 2.053; 119: SpO2, 90.167; 119: Perf, 2.086; 0: Age, 31; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 98.0; 0: Triage RR, 20.0; 0: Triage SBP, 156.0; 0: Triage DBP, 91.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first looked for classic sepsis indicators such as abnormal vital signs, elevated lactate, and significant changes in white blood cell count. Next, I noted that while the patient does show some abnormalities (e.g., mild thrombocytopenia and slightly elevated AST), there is no clear pattern of systemic infection or shock. Additionally, her lactate is not significantly elevated, and her blood pressure stays relatively stable. Consequently, I concluded that she is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I first looked for classic sepsis indicators.",
            "Classic sepsis indicators include abnormal vital signs, elevated lactate, and significant changes in white blood cell count.",
            "The patient shows some abnormalities such as mild thrombocytopenia and slightly elevated AST.",
            "There is no clear pattern of systemic infection or shock in the patient.",
            "The patient's lactate is not significantly elevated.",
            "The patient's blood pressure stays relatively stable.",
            "I concluded that the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Classic sepsis indicators include abnormal vital signs, elevated lactate, and significant changes in white blood cell count.",
            "The patient shows some abnormalities such as mild thrombocytopenia and slightly elevated AST.",
            "There is no clear pattern of systemic infection or shock in the patient.",
            "The patient's lactate is not significantly elevated."
        ],
        "alignment_scores": [
            0.4,
            0.7,
            0.3,
            0.2
        ],
        "alignment_category": [
            5,
            8,
            2,
            5
        ],
        "alignment_reasonings": [
            "The claim lists several indicators",
            "Mild thrombocytopenia, which refers to a low platelet count, relates to one of the SOFA criteria (platelets <100\u202f\u00d7\u202f10\u2079/L) suggesting possible new organ dysfunction. Slightly elevated AST indicates liver function abnormalities, which can further relate to organ dysfunction considered in the SOFA score. Though neither abnormality alone confirms a \u22652 point increase in SOFA, both point toward a risk of organ dysfunction, justifying a moderate alignment.",
            "The claim indicates an absence of a clear pattern of systemic infection or shock, which suggests that the patient does not meet the SIRS criteria typically indicative of systemic inflammation related to early sepsis. While it does not directly map to SIRS, it implies a lack of the systemic inflammatory response these criteria aim to identify. Thus, the alignment is tangential and weak.",
            "The claim discusses lactate levels, which aligns most closely with the category focused on elevated serum lactate as a marker for sepsis risk. However, the claim states that the lactate is \"not significantly elevated,\" indicating it does not meet the threshold of concern in this category. Thus, the alignment is indirect and low, because it mentions lactate without satisfying the risk criteria."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "8: HR, 120.0; 8: RR, 25.0; 8: SpO2, 86.0; 8: SBP, 105.0; 8: DBP, 77.0; 8: MAP, 86.333; 8: LPM O2, 2.0; 8: Pain, 0.0; 8: Temp, 98.8; 17: HR, 108.0; 17: SpO2, 91.538; 17: 1min HRV, 7.040; 18: HR, 112.138; 18: SpO2, 92.966; 18: Perf, 0.71; 18: 1min HRV, 6.005; 19: HR, 110.915; 19: RR, 24.2; 19: SpO2, 94.932; 19: Perf, 0.629; 19: 1min HRV, 24.315; 20: HR, 111.190; 20: RR, 17.7; 20: SpO2, 96.203; 20: Perf, 0.600; 20: 1min HRV, 4.859; 21: SpO2, 96.224; 21: Perf, 0.638; 21: 5min HRV, 16.412; 22: SpO2, 95.661; 22: Perf, 0.788; 23: HR, 110.6; 23: RR, 28.25; 23: SpO2, 96.310; 23: Perf, 0.871; 23: 1min HRV, 3.451; 24: HR, 110.644; 24: RR, 25.492; 24: SpO2, 95.441; 24: Perf, 0.802; 24: 1min HRV, 8.795; 25: POC PH (V) ISTAT, 7.33; 25: POC PCO2 (V) ISTAT, 34.3 mmHg; 25: POC HCO3 (V) ISTAT, 17.9 mmol/L; 25: POC O2 SATURATION ISTAT VENOUS, 63 %; 25: POC LACTATE ISTAT, 1.94 mmol/L; 25: POC PO2 (V) ISTAT, 35 mmHg; 25: POC TCO2 (V) ISTAT, 19 mmol/L; 25: POC BASE EXCESS ISTAT, -8 mmol/L; 25: HR, 110.576; 25: RR, 28.034; 25: SpO2, 92.746; 25: Perf, 0.727; 25: 1min HRV, 4.456; 26: HR, 109.914; 26: RR, 26.052; 26: SpO2, 92.931; 26: Perf, 0.758; 26: 1min HRV, 4.512; 26: 5min HRV, 6.624; 27: HR, 110.644; 27: RR, 27.237; 27: SpO2, 93.0; 27: Perf, 0.727; 27: 1min HRV, 6.069; 28: HR, 110.793; 28: RR, 24.707; 28: SpO2, 92.052; 28: Perf, 0.718; 28: 1min HRV, 5.125; 29: HR, 110.508; 29: RR, 24.441; 29: SpO2, 91.678; 29: Perf, 0.881; 29: 1min HRV, 24.560; 30: HR, 109.712; 30: RR, 27.068; 30: SpO2, 90.322; 30: Perf, 1.013; 30: 1min HRV, 7.817; 31: HR, 108.431; 31: RR, 26.759; 31: SpO2, 92.638; 31: Perf, 1.119; 31: 1min HRV, 6.071; 31: 5min HRV, 13.418; 31: LPM O2, 3.0; 32: HR, 106.271; 32: RR, 25.339; 32: SpO2, 94.542; 32: Perf, 1.045; 32: 1min HRV, 6.875; 32: SBP, 106.0; 32: DBP, 73.0; 32: MAP, 84.0; 33: HR, 107.586; 33: RR, 25.397; 33: SpO2, 95.0; 33: Perf, 1.158; 33: 1min HRV, 7.604; 35: POC, HCG, ISTAT QUALITATIVE: Negative; 35: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 36: 5min HRV, 7.778; 46: WAM DIFTYP, AUTO; 46: LYMPHOCYTE % (AUTO DIFF), 18.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 46: PLATELET COUNT (PLT), 209 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 78.8 fL; 46: RED BLOOD CELLS (RBC), 3.86 MIL/uL; 46: RED CELL DISTRIBUTION WIDTH (RDW), 18.5 %; 46: MONOCYTE % (AUTO DIFF), 11.2 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.77 K/uL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 46: HEMATOCRIT (HCT), 30.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.6 pg; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.63 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 46: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: HEMOGLOBIN (HGB), 9.9 g/dL; 46: NEUTROPHIL % (AUTO DIFF), 68.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.1 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.1 %; 74: CEFEPIME, 2 GRAM/20 ML IV PUSH; 80: SARS-COV-, 2 RNA: Not Detected; 80: VANCOMYCIN-WATER INJECT (PEG), 1 GRAM/200 ML IV PGBK; 83: ALT (SGPT):, 33 U/L; 83: ALKALINE PHOSPHATASE, 300 U/L; 83: AST (SGOT), 27 U/L; 83: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 83: PROTEIN TOTAL, 4.8 g/dL; 83: CALCIUM, 10.9 mg/dL; 83: CORRECTED CALCIUM, 12.3 mg/dL; 83: CREATININE, 1.40 mg/dL; 83: GLOBULIN, 2.5 g/dL; 83: ALBUMIN, 2.3 g/dL; 83: BILIRUBIN TOTAL, 1.2 mg/dL; 83: GLUCOSE, 117 mg/dL; 83: SODIUM, 125 mmol/L; 83: CHLORIDE, 98 mmol/L; 83: EGFR FOR AFRICAN AMERICAN, 56 mL/min/1.73 m2; 83: ANION GAP, 9 mmol/L; 83: POTASSIUM, 4.3 mmol/L; 83: EGFR REFIT WITHOUT RACE (2021), 48 mL/min/1.73 m2; 83: CO2, 18 mmol/L; 92: TROPONIN I, <.017 ng/mL; 99: GLUCOSE, URINE (UA): Negative; 99: NITRITE, URINE (UA): Negative; 99: SPECIFIC GRAVITY, URINE (UA): 1.009; 99: KETONE, URINE (UA): Negative; 99: PH, URINE (UA): 6.0; 117: BNP NT-PRO, 363 pg/mL; 0: Age, 35; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 105.0; 0: Triage DBP, 77.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first reviewed the vital signs and lab results to assess possible infection and systemic inflammation. I noted the elevated heart rate, increased respiratory rate, and elevated white blood cell count. I also considered that broad-spectrum antibiotics were administered, indicating a serious concern for infection. Based on these factors, there is a high likelihood that the patient is at increased risk of developing sepsis within 12 hours.",
        "claims": [
            "I first reviewed the vital signs and lab results.",
            "I reviewed the vital signs to assess possible infection.",
            "I reviewed the lab results to assess possible infection.",
            "I noted an elevated heart rate.",
            "I noted an increased respiratory rate.",
            "I noted an elevated white blood cell count.",
            "Broad-spectrum antibiotics were administered.",
            "The administration of broad-spectrum antibiotics indicates a serious concern for infection.",
            "Based on the assessed factors, there is a high likelihood that the patient is at increased risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "I reviewed the vital signs to assess possible infection.",
            "I noted an elevated heart rate.",
            "I noted an increased respiratory rate.",
            "I noted an elevated white blood cell count.",
            "Broad-spectrum antibiotics were administered.",
            "The administration of broad-spectrum antibiotics indicates a serious concern for infection.",
            "Based on the assessed factors, there is a high likelihood that the patient is at increased risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.6,
            0.7,
            1.0,
            1.0,
            0.9,
            0.3
        ],
        "alignment_category": [
            9,
            2,
            2,
            2,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim involves assessing vital signs for infection, hinting at a suspicion of infection. However, it does not describe any concrete actions like ordering antibiotics or cultures, which are essential components of this category. The alignment is weak because it stops short of explicit clinical actions toward treating or diagnosing sepsis.",
            "An elevated heart rate (>90\u202fbpm) is one of the criteria for SIRS, suggesting systemic inflammation in early sepsis. The claim directly mentions an elevated heart rate, which aligns with SIRS but does not provide enough context to confirm the full SIRS positivity with two or more criteria. The alignment is moderate since it covers one aspect of the SIRS criteria.",
            "The claim about an increased respiratory rate aligns with the SIRS criteria, which include a respiratory rate >20/min as a marker of systemic inflammation consistent with early sepsis. Without exact numbers, it's unclear if the criterion is fully met, so the alignment is strong but not definitive.",
            "An elevated white blood cell count is explicitly listed as one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The claim directly references this criterion, indicating a strong alignment with the SIRS Positivity category.",
            "The administration of broad-spectrum antibiotics indicates a clinician's suspicion of a serious infection, which is exactly what this category captures. The action of giving antibiotics aligns perfectly with the criteria described by this category, hence the full alignment rating.",
            "The claim directly mentions the administration of broad-spectrum antibiotics, an action explicitly identified in category 9. This action signifies a serious concern for infection, closely aligning it with the category's criteria. The reason it is rated at 0.9 rather than 1.0 could be due to the lack of specific timing information, which is usually required to fully meet the category's definition.",
            "The claim implies a general increased risk of sepsis but does not specify any particular clinical or laboratory criteria that directly align with a named category. However, the elevated NEWS score, which aggregates various clinical parameters to predict imminent clinical deterioration, conceptually fits the scenario of predicting increased sepsis risk within 12 hours. The alignment is generalized, as the claim lacks specificity in identified clinical factors."
        ],
        "final_alignment_score": 0.6857142857142857,
        "accuracy": 1
    },
    {
        "input": "5: HR, 136.0; 5: RR, 16.0; 5: SpO2, 98.0; 5: SBP, 122.0; 5: DBP, 79.0; 5: MAP, 93.333; 5: Temp, 100.8; 14: SpO2, 96.089; 15: HR, 129.462; 15: RR, 20.722; 15: SpO2, 97.431; 15: 1min HRV, 7.348; 16: HR, 127.492; 16: RR, 21.695; 16: SpO2, 97.356; 16: 1min HRV, 3.740; 17: HR, 129.172; 17: RR, 20.086; 17: SpO2, 97.517; 17: 1min HRV, 4.378; 18: HR, 128.814; 18: RR, 21.169; 18: SpO2, 97.864; 18: 1min HRV, 3.746; 18: 5min HRV, 5.221; 19: HR, 126.881; 19: RR, 26.492; 19: SpO2, 97.576; 19: 1min HRV, 9.624; 20: POC PH (V) ISTAT, 7.44; 20: POC LACTATE ISTAT, 1.52 mmol/L; 20: POC TCO2 (V) ISTAT, 26 mmol/L; 20: POC BASE EXCESS ISTAT, 1 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 78 %; 20: POC HCO3 (V) ISTAT, 25.2 mmol/L; 20: POC PO2 (V) ISTAT, 41 mmHg; 20: POC PCO2 (V) ISTAT, 37.1 mmHg; 20: HR, 125.397; 20: RR, 25.517; 20: SpO2, 97.310; 20: 1min HRV, 6.978; 21: HR, 127.136; 21: RR, 26.424; 21: SpO2, 97.559; 21: 1min HRV, 4.623; 22: HR, 127.121; 22: RR, 24.828; 22: SpO2, 97.328; 22: 1min HRV, 16.265; 23: HR, 128.102; 23: RR, 21.220; 23: SpO2, 97.864; 23: 1min HRV, 17.616; 23: 5min HRV, 12.635; 24: HR, 126.051; 24: RR, 24.424; 24: SpO2, 97.729; 24: 1min HRV, 5.951; 25: HR, 126.776; 25: RR, 24.155; 25: SpO2, 97.362; 25: 1min HRV, 4.675; 26: HR, 127.0; 26: RR, 23.508; 26: SpO2, 97.966; 26: 1min HRV, 4.440; 26: SBP, 116.0; 26: DBP, 77.0; 26: MAP, 90.0; 27: HR, 125.879; 27: RR, 27.259; 27: SpO2, 97.466; 27: 1min HRV, 5.543; 28: HR, 126.508; 28: RR, 25.475; 28: SpO2, 97.712; 28: 1min HRV, 7.168; 28: 5min HRV, 6.036; 28: SBP, 124.0; 28: DBP, 74.0; 28: MAP, 90.667; 28: Temp, 101.1; 29: HR, 124.603; 29: RR, 24.052; 29: SpO2, 98.0; 29: 1min HRV, 8.227; 29: SBP, 124.0; 29: DBP, 74.0; 29: MAP, 90.667; 30: HR, 126.407; 30: RR, 21.610; 30: SpO2, 97.949; 30: 1min HRV, 5.456; 31: HR, 126.0; 31: RR, 27.0; 31: SpO2, 97.322; 31: 1min HRV, 4.318; 32: HR, 124.552; 32: RR, 27.586; 32: SpO2, 97.552; 32: 1min HRV, 18.025; 33: HR, 125.746; 33: RR, 27.695; 33: SpO2, 97.610; 33: 1min HRV, 4.128; 33: 5min HRV, 9.856; 34: HR, 125.310; 34: RR, 27.845; 34: SpO2, 97.621; 34: 1min HRV, 4.438; 35: HR, 124.068; 35: RR, 25.729; 35: SpO2, 97.576; 35: 1min HRV, 5.781; 36: HR, 124.966; 36: RR, 25.814; 36: SpO2, 97.864; 36: 1min HRV, 6.834; 37: HR, 124.621; 37: RR, 23.603; 37: SpO2, 97.983; 37: 1min HRV, 6.626; 38: HR, 128.559; 38: RR, 27.322; 38: SpO2, 97.542; 38: 1min HRV, 11.386; 38: 5min HRV, 10.032; 38: ACETAMINOPHEN, 500 MG PO TABS; 39: HR:, 125.466; 39: RR, 23.931; 39: SpO2, 98.586; 39: 1min HRV, 13.072; 40: HR, 125.305; 40: RR, 18.831; 40: SpO2, 98.068; 40: Perf, 1.216; 40: 1min HRV, 22.549; 41: HR, 123.034; 41: RR, 23.966; 41: SpO2, 97.966; 41: Perf, 1.656; 41: 1min HRV, 10.291; 42: HR, 127.224; 42: RR, 23.828; 42: SpO2, 97.862; 42: Perf, 1.72; 42: 1min HRV, 8.718; 43: HR, 124.763; 43: RR, 24.034; 43: SpO2, 97.475; 43: Perf, 1.72; 43: 1min HRV, 5.967; 43: 5min HRV, 13.759; 44: HR, 123.293; 44: RR, 24.672; 44: SpO2, 97.121; 44: Perf, 1.72; 44: 1min HRV, 6.401; 44: SBP, 130.0; 44: DBP, 76.0; 44: MAP, 94.0; 45: HR, 123.475; 45: RR, 26.712; 45: SpO2, 97.237; 45: Perf, 1.72; 45: 1min HRV, 4.158; 46: HR, 123.492; 46: RR, 27.729; 46: SpO2, 97.305; 46: Perf, 1.72; 46: 1min HRV, 4.571; 47: HR, 125.310; 47: RR, 25.017; 47: SpO2, 97.5; 47: Perf, 1.72; 47: 1min HRV, 8.107; 48: HR, 122.814; 48: RR, 24.271; 48: SpO2, 97.831; 48: Perf, 1.72; 48: 1min HRV, 4.364; 48: 5min HRV, 6.794; 49: HR, 123.655; 49: RR, 24.121; 49: SpO2, 97.862; 49: Perf, 1.72; 49: 1min HRV, 4.398; 53: 5min HRV, 4.398; 57: ANTIBODY SCREEN 3, NEG; 57: ABO/RH (AUTOMATION), A Positive; 61: LR IV BOLUS -, 1000 ML; 62: INR:, 1.0; 62: PROTHROMBIN TIME, 13.3 seconds; 63: PART. THROMBOPLASTIN TIME, 36.0 seconds; 71: GLOBULIN, 2.3 g/dL; 71: CALCIUM, 9.5 mg/dL; 71: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 71: ALT (SGPT), 58 U/L; 71: BILIRUBIN TOTAL, 1.3 mg/dL; 71: CO2, 24 mmol/L; 71: ALKALINE PHOSPHATASE, 89 U/L; 71: AST (SGOT), 35 U/L; 71: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 71: PROTEIN TOTAL, 6.5 g/dL; 71: ALBUMIN, 4.2 g/dL; 71: GLUCOSE, 120 mg/dL; 71: CHLORIDE, 102 mmol/L; 71: POTASSIUM, 4.0 mmol/L; 71: ANION GAP, 11 mmol/L; 71: CREATININE, 0.79 mg/dL; 71: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 71: SODIUM, 137 mmol/L; 71: CORRECTED CALCIUM, 9.3 mg/dL; 95: SARS-COV-2 RNA, Not Detected; 116: CEFEPIME, 2 GRAM/20 ML IV PUSH; 118: HR:, 111.0; 118: RR, 20.0; 118: SpO2, 98.0; 118: SBP, 116.0; 118: DBP, 71.0; 118: MAP, 86.0; 118: Temp, 99.5; 0: Age, 62; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 136.0; 0: Triage RR, 16.0; 0: Triage SBP, 122.0; 0: Triage DBP, 79.0; 0: Triage acuity, 2-Emergent; 0: CC, CHILLS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I began by noting the patient\u2019s persistent fever, high heart rate, and repeated elevated respiratory rates, all of which suggest a possible infection and systemic inflammatory response. Next, I looked for indications of organ dysfunction, such as lactate or blood pressure abnormalities, but found that lactate is not significantly elevated and blood pressure is relatively stable. However, the clinical team\u2019s decision to administer IV fluids and broad-spectrum antibiotics early on indicates concern for se",
        "claims": [
            "The patient has a persistent fever.",
            "The patient has a high heart rate.",
            "The patient has repeated elevated respiratory rates.",
            "Persistent fever, high heart rate, and elevated respiratory rates suggest a possible infection.",
            "Persistent fever, high heart rate, and elevated respiratory rates suggest a systemic inflammatory response.",
            "Indications of organ dysfunction were sought.",
            "Lactate is not significantly elevated.",
            "Blood pressure is relatively stable.",
            "The clinical team decided to administer IV fluids early on.",
            "The clinical team decided to administer broad-spectrum antibiotics early on.",
            "The decision to administer IV fluids and antibiotics indicates concern for sepsis."
        ],
        "relevant_claims": [
            "The patient has a persistent fever.",
            "The patient has a high heart rate.",
            "The patient has repeated elevated respiratory rates.",
            "Persistent fever, high heart rate, and elevated respiratory rates suggest a possible infection.",
            "Persistent fever, high heart rate, and elevated respiratory rates suggest a systemic inflammatory response.",
            "The clinical team decided to administer IV fluids early on.",
            "The clinical team decided to administer broad-spectrum antibiotics early on.",
            "The decision to administer IV fluids and antibiotics indicates concern for sepsis."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.8,
            1.0,
            1.0,
            0.6,
            1.0,
            0.8
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            2,
            7,
            9,
            9
        ],
        "alignment_reasonings": [
            "A persistent fever is directly related to the SIRS criteria, specifically mentioning a temperature >38\u00b0C as part of the systemic inflammation indicator. Although the claim does not quantify the fever or confirm it exceeds this threshold, the presence of fever suggests potential SIRS relevance, aligning moderately well with this category.",
            "A high heart rate is specifically listed as one of the SIRS criteria (heart rate > 90 bpm). While the claim only mentions an elevated heart rate without additional SIRS criteria, it still indicates systemic inflammation that's consistent with early sepsis, making the connection relatively strong, but not total because it doesn't satisfy the requirement of having two or more SIRS criteria.",
            "The claim mentions repeated elevated respiratory rates, which aligns with one of the SIRS criteria (respiratory rate > 20 per minute). While the claim does not specify a specific respiratory rate, the repetition implies persistent elevation, suggesting potential systemic inflammation consistent with early sepsis. This makes it a strong but not complete alignment with the SIRS criterion.",
            "The claim references fever, high heart rate, and elevated respiratory rates, all of which are directly relevant to the SIRS criteria. The presence of \u22652 SIRS criteria, such as those mentioned here, directly identifies systemic inflammation that can be consistent with early sepsis, indicating a perfect alignment with the SIRS Positivity category.",
            "The claim explicitly mentions persistent fever, high heart rate, and elevated respiratory rates, which align with the SIRS criteria\u2014temperature >38\u00b0C, heart rate >90 bpm, and respiratory rate >20/min. This indicates systemic inflammation consistent with early sepsis, and the alignment with the listed criteria is perfect.",
            "Administering IV fluids can be associated with treating hypovolemia or hypotension, common in sepsis-linked hypotension. While the claim doesn\u2019t explicitly state hypotension and could relate to other conditions, IV fluids are typically a response to this specific risk factor. This makes the alignment moderately strong.",
            "The claim explicitly mentions the administration of broad-spectrum antibiotics as part of the early medical response, which is directly aligned with the category of early antibiotic or culture orders. This demonstrates a high level of clinician suspicion for a serious infection, perfectly matching the criteria outlined in the expert category.",
            "Administering IV fluids and antibiotics suggests a clinical response to suspected sepsis, aligning with the category for early treatment actions signaling suspicion of an infection. Administering antibiotics directly relates to a key clinical action listed in this category; however, while IV fluid administration is a response to suspected sepsis, it\u2019s not as definitive as antibiotic administration alone. Thus, the alignment is strong but not absolute."
        ],
        "final_alignment_score": 0.8125,
        "accuracy": 1
    },
    {
        "input": "3: HR, 113.0; 3: RR, 16.0; 3: SpO2, 99.0; 3: SBP, 100.0; 3: DBP, 53.0; 3: MAP, 68.667; 3: Pain, 9.0; 3: Temp, 97.7; 63: HR, 108.259; 63: RR, 23.222; 63: 1min HRV, 2.271; 64: HR, 107.390; 64: RR, 18.0; 64: SpO2, 98.5; 64: 1min HRV, 20.909; 65: HR, 104.797; 65: RR, 18.288; 65: SpO2, 99.0; 65: Perf, 0.282; 65: 1min HRV, 3.347; 66: HR, 104.569; 66: RR, 20.379; 66: SpO2, 99.589; 66: Perf, 0.233; 66: 1min HRV, 3.413; 66: 5min HRV, 13.865; 66: SBP, 99.0; 66: DBP, 60.0; 66: MAP, 73.0; 67: HR, 105.220; 67: RR, 20.559; 67: SpO2, 99.305; 67: Perf, 0.468; 67: 1min HRV, 3.043; 68: HR, 104.862; 68: RR, 17.431; 68: SpO2, 99.138; 68: Perf, 0.607; 68: 1min HRV, 19.816; 69: HR, 103.508; 69: RR, 17.339; 69: SpO2, 98.746; 69: Perf, 0.731; 69: 1min HRV, 5.278; 70: HR, 103.397; 70: RR, 18.759; 70: SpO2, 98.276; 70: Perf, 0.855; 70: 1min HRV, 4.453; 71: HR, 105.220; 71: RR, 16.814; 71: SpO2, 97.672; 71: Perf, 0.354; 71: 1min HRV, 3.284; 71: 5min HRV, 10.753; 72: HR, 106.254; 72: RR, 19.525; 72: SpO2, 98.0; 72: Perf, 0.328; 72: 1min HRV, 3.043; 73: HR, 105.086; 73: RR, 17.379; 73: SpO2, 97.966; 73: Perf, 0.460; 73: 1min HRV, 4.894; 74: HR, 105.169; 74: RR, 19.407; 74: SpO2, 98.475; 74: Perf, 0.698; 74: 1min HRV, 5.951; 75: HR, 103.897; 75: RR, 20.086; 75: SpO2, 98.431; 75: Perf, 0.831; 75: 1min HRV, 2.929; 76: HR, 101.593; 76: RR, 22.356; 76: SpO2, 98.115; 76: Perf, 0.738; 76: 1min HRV, 5.040; 76: 5min HRV, 10.054; 76: SBP, 99.0; 76: DBP, 60.0; 76: MAP, 73.0; 77: HR, 101.475; 77: RR, 23.559; 77: SpO2, 98.891; 77: Perf, 0.798; 77: 1min HRV, 7.057; 78: HR, 102.517; 78: RR, 18.845; 78: SpO2, 99.25; 78: Perf, 0.83; 78: 1min HRV, 6.585; 79: HR, 102.220; 79: RR, 18.034; 79: 1min HRV, 15.981; 80: HR, 101.448; 80: RR, 17.914; 80: 1min HRV, 3.591; 81: HR, 101.763; 81: RR, 19.525; 81: 1min HRV, 4.064; 81: 5min HRV, 9.065; 82: HR, 102.237; 82: RR, 19.847; 82: 1min HRV, 4.790; 82: SBP, 93.0; 82: DBP, 60.0; 82: MAP, 71.0; 83: HR, 103.759; 83: RR, 21.017; 83: 1min HRV, 2.918; 84: HR, 103.458; 84: RR, 22.153; 84: 1min HRV, 25.080; 85: HR, 102.741; 85: RR, 17.431; 85: 1min HRV, 3.035; 86: HR, 102.763; 86: RR, 20.508; 86: SpO2, 97.707; 86: 1min HRV, 16.972; 86: 5min HRV, 14.220; 87: HR, 102.932; 87: RR, 16.169; 87: SpO2, 96.898; 87: Perf, 0.732; 87: 1min HRV, 2.928; 88: HR, 102.310; 88: RR, 15.914; 88: SpO2, 97.379; 88: Perf, 0.589; 88: 1min HRV, 2.836; 89: HR, 101.136; 89: RR, 20.339; 89: SpO2, 96.407; 89: Perf, 0.467; 89: 1min HRV, 28.272; 90: HR, 102.690; 90: RR, 18.552; 90: SpO2, 97.052; 90: Perf, 0.338; 90: 1min HRV, 2.962; 91: HR, 102.186; 91: RR, 20.288; 91: SpO2, 97.789; 91: Perf, 0.322; 91: 1min HRV, 2.993; 91: 5min HRV, 13.305; 92: HR, 101.017; 92: RR, 19.271; 92: SpO2, 97.741; 92: Perf, 0.298; 92: 1min HRV, 3.328; 93: HR, 100.914; 93: RR, 20.259; 93: SpO2, 98.328; 93: Perf, 0.307; 93: 1min HRV, 4.303; 94: HR, 100.254; 94: RR, 19.305; 94: SpO2, 98.542; 94: Perf, 0.392; 94: 1min HRV, 16.879; 95: BLOOD UREA NITROGEN (BUN), 44 mg/dL; 95: EGFR REFIT WITHOUT RACE (2021), 22 mL/min/1.73 m2; 95: AST (SGOT), 66 U/L; 95: SODIUM, 130 mmol/L; 95: ANION GAP, 18 mmol/L; 95: CO2, 24 mmol/L; 95: ALKALINE PHOSPHATASE, 67 U/L; 95: ALT (SGPT), 19 U/L; 95: CREATININE, 2.50 mg/dL; 95: CHLORIDE, 88 mmol/L; 95: GLOBULIN, 5.0 g/dL; 95: PROTEIN TOTAL, 8.7 g/dL; 95: POTASSIUM, 5.6 mmol/L; 95: CALCIUM, 9.9 mg/dL; 95: CORRECTED CALCIUM, 10.1 mg/dL; 95: BILIRUBIN TOTAL, 0.5 mg/dL; 95: ALBUMIN, 3.7 g/dL; 95: GLUCOSE, 158 mg/dL; 95: HR, 100.638; 95: RR, 20.466; 95: SpO2, 99.0; 95: Perf, 0.416; 95: 1min HRV, 8.345; 96: SARS-COV-2 RNA, Not Detected; 96: HR, 100.288; 96: RR, 17.864; 96: SpO2, 99.169; 96: Perf, 0.434; 96: 1min HRV, 7.287; 96: 5min HRV, 9.559; 96: Pain, 10.0; 97: HR, 97.322; 97: RR, 15.288; 97: SpO2, 99.339; 97: Perf, 0.489; 97: 1min HRV, 6.903; 98: HR, 95.603; 98: RR, 12.103; 98: SpO2, 98.121; 98: Perf, 0.430; 98: 1min HRV, 5.772; 99: HR, 97.0; 99: RR, 14.576; 99: SpO2, 97.356; 99: Perf, 0.417; 99: 1min HRV, 27.925; 100: HR, 95.448; 100: RR, 18.810; 100: SpO2, 98.241; 100: Perf, 0.445; 100: 1min HRV, 7.272; 101: HR, 96.712; 101: RR, 21.085; 101: SpO2, 98.0; 101: Perf, 0.409; 101: 1min HRV, 5.961; 101: 5min HRV, 14.265; 102: HR, 96.845; 102: RR, 18.397; 102: SpO2, 98.948; 102: Perf, 0.392; 102: 1min HRV, 5.895; 103: HR, 95.492; 103: RR, 19.153; 103: SpO2, 98.814; 103: Perf, 0.334; 103: 1min HRV, 5.351; 104: HR, 95.305; 104: RR, 19.644; 104: SpO2, 98.780; 104: Perf, 0.324; 104: 1min HRV, 8.790; 105: HR, 94.190; 105: RR, 18.190; 105: SpO2, 99.475; 105: Perf, 0.292; 105: 1min HRV, 3.851; 106: HR, 95.220; 106: RR, 18.983; 106: SpO2, 99.282; 106: Perf, 0.21; 106: 1min HRV, 7.364; 106: 5min HRV, 8.084; 107: HR, 92.397; 107: RR, 20.379; 107: SpO2, 99.394; 107: Perf, 0.216; 107: 1min HRV, 8.601; 108: HR, 92.254; 108: RR, 16.695; 108: SpO2, 98.947; 108: Perf, 0.201; 108: 1min HRV, 8.056; 108: MORPHINE, 4 MG/ML IV SYRG; 109: HR:, 92.678; 109: RR, 18.356; 109: SpO2, 98.814; 109: Perf, 0.276; 109: 1min HRV, 9.551; 110: HR, 93.259; 110: RR, 19.069; 110: SpO2, 97.509; 110: Perf, 0.314; 110: 1min HRV, 5.623; 111: HR, 93.763; 111: RR, 19.864; 111: SpO2, 98.807; 111: Perf, 0.306; 111: 1min HRV, 5.628; 111: 5min HRV, 8.911; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 95.345; 112: RR, 19.483; 112: SpO2, 98.879; 112: Perf, 0.294; 112: 1min HRV, 6.629; 112: SBP, 79.0; 112: DBP, 59.0; 112: MAP, 65.667; 113: HR, 95.373; 113: RR, 18.051; 113: SpO2, 99.356; 113: Perf, 0.352; 113: 1min HRV, 6.753; 114: HR, 93.881; 114: RR, 19.763; 114: SpO2, 99.407; 114: Perf, 0.336; 114: 1min HRV, 7.098; 115: HR, 93.741; 115: RR, 18.879; 115: SpO2, 98.912; 115: Perf, 0.289; 115: 1min HRV, 7.738; 116: HR, 94.119; 116: RR, 17.847; 116: SpO2, 99.0; 116: Perf, 0.26; 116: 1min HRV, 8.469; 116: 5min HRV, 9.063; 117: HR, 91.983; 117: RR, 20.207; 117: SpO2, 99.316; 117: Perf, 0.245; 117: 1min HRV, 6.011; 118: HR, 92.186; 118: RR, 18.119; 118: SpO2, 100.0; 118: Perf, 0.156; 118: 1min HRV, 7.891; 119: HR, 94.458; 119: RR, 18.220; 119: SpO2, 100.0; 119: Perf, 0.13; 119: 1min HRV, 23.407; 119: SBP, 84.0; 119: DBP, 53.0; 119: MAP, 63.333; 0: Age, 59; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 113.0; 0: Triage RR, 16.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient\u2019s elevated heart rate and borderline low blood pressure, which signaled possible hemodynamic instability. Next, I considered the lab results showing elevated creatinine and BUN, suggesting potential organ dysfunction. Given the presence of a likely infection source (the wound) and the administration of IV fluids for possible hypotension, there is a heightened concern for sepsis. Therefore, the patient appears to be at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient has an elevated heart rate.",
            "The patient has borderline low blood pressure.",
            "Elevated heart rate and borderline low blood pressure signal possible hemodynamic instability.",
            "The lab results show elevated creatinine.",
            "The lab results show elevated BUN.",
            "Elevated creatinine and BUN suggest potential organ dysfunction.",
            "There is a likely infection source, which is the wound.",
            "IV fluids have been administered for possible hypotension.",
            "There is a heightened concern for sepsis due to the factors considered.",
            "The patient appears to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate.",
            "The patient has borderline low blood pressure.",
            "Elevated heart rate and borderline low blood pressure signal possible hemodynamic instability.",
            "Elevated creatinine and BUN suggest potential organ dysfunction.",
            "There is a likely infection source, which is the wound.",
            "IV fluids have been administered for possible hypotension.",
            "There is a heightened concern for sepsis due to the factors considered.",
            "The patient appears to be at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.6,
            0.8,
            0.7,
            0.6,
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            7,
            6,
            8,
            9,
            7,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim about an elevated heart rate aligns with the SIRS criteria, where a heart rate >90 bpm indicates systemic inflammation consistent with early sepsis. However, because the claim does not specify the exact heart rate or mention other accompanying SIRS criteria, the alignment is moderate rather than full.",
            "The claim mentions borderline low blood pressure, which is conceptually related to sepsis-associated hypotension. However, without specific values indicating hypotension as defined by the category (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop), the alignment is moderate rather than strong. The claim suggests potential hemodynamic instability, relevant to this category.",
            "The claim mentions both an elevated heart rate and borderline low blood pressure, which correlate with the definition of a high shock index. While the exact calculation of the shock index (heart rate \u00f7 systolic BP) isn't provided, the symptoms are suggestive of hemodynamic instability, hence a strong, but not complete, alignment with the elevated shock index category.",
            "Elevated creatinine is directly mentioned as part of the SOFA score criteria, indicating potential kidney dysfunction and organ failure associated with high sepsis risk. While BUN is not explicitly a SOFA criterion, it correlates with kidney function, supporting the indication of organ dysfunction. Therefore, this claim aligns closely, but not perfectly, with SOFA Score Increase, leading to a strong but not complete alignment rating.",
            "The claim about a likely infection source aligns with clinician suspicion of infection, often leading to actions such as early antibiotic use or culture ordering. While the claim indicates suspicion of infection, it doesn't explicitly mention early clinical actions like antibiotics or cultures, but it suggests a pathway leading to such steps. Therefore, the alignment is relatively moderate but not complete.",
            "The claim involves administering IV fluids for possible hypotension, which aligns with addressing low blood pressure, a key indicator in the Sepsis-Associated Hypotension category. While the claim indicates management of hypotension, it does not provide explicit blood pressure measurements or drops to confirm precise criteria under this category, resulting in an alignment rating that acknowledges the association but does not fully match specific numerical thresholds.",
            "The claim expresses a general concern for sepsis but lacks specific clinical details or criteria directly referencing any of the established sepsis risk factors. This aligns loosely with the notion of clinician suspicion, which might lead to early interventions such as antibiotics or culture orders, although such actions are not mentioned explicitly. The alignment is therefore weak and somewhat speculative.",
            "The claim suggests an overall prediction of high sepsis risk within a forthcoming timeframe, which aligns most broadly with the purpose of the NEWS score, as it predicts imminent clinical deterioration. However, the claim lacks specific details about deranged vitals or a quantifiable NEWS score, leading to a lower alignment rating since it's more general and lacks direct evidence detailed in the expert categories."
        ],
        "final_alignment_score": 0.5874999999999999,
        "accuracy": 1
    },
    {
        "input": "14: HR, 142.0; 14: RR, 20.0; 14: SpO2, 94.0; 14: SBP, 105.0; 14: DBP, 72.0; 14: MAP, 83.0; 14: Pain, 0.0; 14: Temp, 97.9; 36: POC PH (V) ISTAT, 7.30; 36: POC LACTATE ISTAT, 1.08 mmol/L; 36: POC TCO2 (V) ISTAT, 27 mmol/L; 36: POC HCO3 (V) ISTAT, 25.2 mmol/L; 36: POC PCO2 (V) ISTAT, 51.6 mmHg; 36: POC PO2 (V) ISTAT, 29 mmHg; 36: POC BASE EXCESS ISTAT, -1 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 48 %; 37: HR, 126.719; 37: RR, 25.732; 37: 1min HRV, 13.425; 37: SBP, 121.0; 37: DBP, 73.0; 37: MAP, 89.0; 37: LR IV BOLUS -, 1000 ML; 38: HR:, 126.638; 38: RR, 22.397; 38: SpO2, 96.0; 38: 1min HRV, 14.436; 38: SBP, 121.0; 38: DBP, 73.0; 38: MAP, 89.0; 39: HR, 129.441; 39: RR, 16.407; 39: 1min HRV, 10.516; 40: HR, 126.203; 40: RR, 19.780; 40: 1min HRV, 21.605; 40: 5min HRV, 16.186; 41: HR, 124.534; 41: RR, 19.672; 41: 1min HRV, 15.972; 42: HR, 124.169; 42: RR, 23.763; 42: 1min HRV, 13.252; 42: Pain, 6.0; 43: HR, 121.569; 43: RR, 16.466; 43: 1min HRV, 23.672; 44: HR, 122.220; 44: RR, 19.169; 44: 1min HRV, 26.307; 45: HR, 120.678; 45: RR, 19.627; 45: SpO2, 96.0; 45: 1min HRV, 16.388; 45: 5min HRV, 20.748; 45: SBP, 114.0; 45: DBP, 88.0; 45: MAP, 96.667; 46: HR, 117.397; 46: RR, 17.362; 46: 1min HRV, 21.886; 46: SBP, 114.0; 46: DBP, nan; 46: MAP, nan; 47: HR, 115.661; 47: RR, 17.085; 47: 1min HRV, 45.698; 48: HR, 120.776; 48: RR, 20.293; 48: 1min HRV, 21.509; 49: HR, 119.339; 49: RR, 20.898; 49: 1min HRV, 19.138; 50: HR, 117.356; 50: RR, 19.220; 50: 1min HRV, 21.795; 50: 5min HRV, 28.716; 51: HR, 116.655; 51: RR, 17.638; 51: 1min HRV, 40.855; 52: HR, 116.390; 52: RR, 19.119; 52: 1min HRV, 20.976; 53: HR, 114.414; 53: RR, 21.828; 53: 1min HRV, 22.699; 54: HR, 111.559; 54: RR, 20.797; 54: 1min HRV, 23.915; 55: HR, 112.424; 55: RR, 20.881; 55: 1min HRV, 37.342; 55: 5min HRV, 31.574; 56: HR, 113.276; 56: RR, 17.328; 56: 1min HRV, 19.370; 57: HR, 110.576; 57: RR, 20.203; 57: 1min HRV, 38.104; 58: HR, 105.931; 58: RR, 22.845; 58: 1min HRV, 14.892; 59: HR, 107.576; 59: RR, 23.864; 59: 1min HRV, 16.178; 60: HR, 109.724; 60: RR, 23.914; 60: 1min HRV, 33.069; 60: 5min HRV, 29.141; 61: HR, 109.492; 61: RR, 21.271; 61: 1min HRV, 36.478; 62: HR, 107.949; 62: RR, 23.068; 62: 1min HRV, 28.136; 63: HR, 109.397; 63: RR, 25.552; 63: 1min HRV, 31.885; 64: HR, 105.881; 64: RR, 21.712; 64: 1min HRV, 45.909; 65: HR, 105.052; 65: RR, 20.966; 65: 1min HRV, 35.182; 65: 5min HRV, 37.445; 66: HR, 107.271; 66: RR, 23.085; 66: 1min HRV, 36.498; 67: HR, 103.695; 67: RR, 20.864; 67: 1min HRV, 40.807; 68: POC HGB (CALC) ISTAT, 17.7 g/dL; 68: POC HCT ISTAT, 52 %; 68: POC POTASSIUM ISTAT, 7.0 mmol/L; 68: POC SODIUM ISTAT, 128 mmol/L; 68: POC GLUCOSE ISTAT, 97 mg/dL; 68: HR, 102.897; 68: RR, 21.103; 68: 1min HRV, 42.232; 69: WAM DIFTYP, AUTO; 69: MEAN CORPUSCULAR VOLUME (MCV), 85.0 fL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 69: HEMATOCRIT (HCT), 54.4 %; 69: BASOPHIL % (AUTO DIFF), 0.6 %; 69: LYMPHOCYTE % (AUTO DIFF), 12.2 %; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.58 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 69: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 69: RED BLOOD CELLS (RBC), 6.40 MIL/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: HEMOGLOBIN (HGB), 18.6 g/dL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 69: EOSINOPHIL % (AUTO DIFF), 1.6 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 1.42 K/uL; 69: MONOCYTE % (AUTO DIFF), 8.0 %; 69: PLATELET COUNT (PLT), 520 K/uL; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 77.1 %; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.28 K/uL; 69: HR, 106.203; 69: RR, 22.695; 69: 1min HRV, 24.347; 70: 5min HRV, 38.258; 78: CALCIUM GLUC IN NACL ISO-OSM, 1 GRAM/50 ML IV SOLN; 82: HIGH SENSITIVITY TROPONIN: <, 4 ng/L; 94: INFLUENZA A, Not Detected; 94: RSV, Not Detected; 94: SARS-COV-2 RNA, Not Detected; 94: INFLUENZA B, Not Detected; 98: RR, 23.0; 98: SpO2, 97.0; 98: LPM O2, 15.0; 98: ALBUTEROL CONTINUOUS NEBULIZER SOLUTION, 15 MG/HR (RT MIXTURE); 116: POC GLUCOSE BY METER:, 88 mg/dL; 119: DEXTROSE, 20 % IN WATER (D20W) IVPB BOLUS; 0: Age:, 18; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 142.0; 0: Triage RR, 20.0; 0: Triage SBP, 105.0; 0: Triage DBP, 72.0; 0: Triage acuity, 2-Emergent; 0: CC, RAPID HEART RATE",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I noted the patient\u2019s initially high heart rate but relatively normal blood pressure and normal lactate. I asked whether there was strong evidence of infection (like fever or positive viral tests), but these were absent. I then reviewed whether the patient met common sepsis criteria (e.g., suspected infection plus organ dysfunction), and those signs did not appear. Consequently, I concluded that the risk",
        "claims": [
            "The patient had an initially high heart rate.",
            "The patient had a relatively normal blood pressure.",
            "The patient had a normal lactate level.",
            "There was no strong evidence of infection present.",
            "The patient did not have a fever.",
            "The patient did not have positive viral tests.",
            "The patient did not meet common sepsis criteria.",
            "The common sepsis criteria include suspected infection plus organ dysfunction.",
            "The signs of sepsis did not appear in this patient.",
            "I concluded that the risk of sepsis is low."
        ],
        "relevant_claims": [
            "The patient had an initially high heart rate.",
            "There was no strong evidence of infection present.",
            "The patient did not meet common sepsis criteria."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            6,
            9,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions an initially high heart rate, which is a component of the shock index calculation (heart rate \u00f7 systolic BP). Although the claim does not directly mention the shock index or provide sufficient information to calculate it, a high heart rate suggests potential hemodynamic instability, which is relevant for this category. The alignment is indirect but still significant, granting it a moderately high rating.",
            "The claim suggests an absence of clear infection, which weakly aligns with this category as it implies that no immediate action like ordering antibiotics or cultures was taken due to the lack of convincing evidence. The alignment is weak because the claim doesn't directly reference any clinical action or lack thereof, and it doesn\u2019t relate directly to suspicion of infection unless negating it.",
            "The claim's mention of not meeting \"common sepsis criteria\" is indirectly related to SIRS, as SIRS criteria are part of early sepsis identification. However, the lack of specific criteria met reduces the alignment, suggesting only a weak connection to not meeting SIRS criteria."
        ],
        "final_alignment_score": 0.43333333333333335,
        "accuracy": 0
    },
    {
        "input": "8: HR, 70.0; 8: RR, 18.0; 8: SpO2, 100.0; 8: SBP, 159.0; 8: DBP, 83.0; 8: MAP, 108.333; 12: Pain, 9.0; 33: SpO2, 100.0; 34: HR, 82.0; 34: RR, 20.0; 34: SpO2, 100.0; 34: Perf, 1.700; 34: SBP, 138.0; 34: DBP, 81.0; 34: MAP, 100.0; 34: Temp, 97.9; 35: SpO2, 100.0; 35: Perf, 2.154; 36: SpO2, 100.0; 36: Perf, 2.221; 37: SpO2, 100.0; 37: Perf, 1.998; 38: SpO2, 100.0; 38: Perf, 1.810; 39: SpO2, 100.0; 39: Perf, 1.716; 40: SpO2, 99.915; 40: Perf, 1.645; 41: SpO2, 99.627; 41: Perf, 1.527; 42: SpO2, 99.897; 42: Perf, 1.582; 43: SpO2, 99.424; 43: Perf, 1.827; 44: HR, 80.0; 44: RR, 22.0; 44: SpO2, 99.328; 44: Perf, 1.891; 44: SBP, 159.0; 44: DBP, 92.0; 44: MAP, 114.333; 44: Pain, 9.0; 45: SpO2, 99.492; 45: Perf, 1.696; 45: SBP, 159.0; 45: DBP, 92.0; 45: MAP, 114.333; 46: SpO2, 99.898; 46: Perf, 1.302; 47: SpO2, 99.895; 47: Perf, 1.316; 48: SpO2, 100.0; 48: Perf, 1.239; 49: SpO2, 100.0; 49: Perf, 1.162; 50: SpO2, 99.932; 50: Perf, 1.170; 51: SpO2, 100.0; 51: Perf, 1.271; 52: SpO2, 100.0; 52: Perf, 1.272; 53: SpO2, 99.898; 53: Perf, 1.299; 54: POC, HCG, ISTAT QUALITATIVE: Negative; 54: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 54: SpO2, 99.914; 54: Perf, 1.518; 55: SpO2, 99.881; 55: Perf, 1.807; 56: SpO2, 99.776; 56: Perf, 1.771; 57: SpO2, 100.0; 57: Perf, 1.647; 58: SpO2, 100.0; 58: Perf, 1.594; 59: SpO2, 99.879; 59: Perf, 1.747; 60: SpO2, 99.814; 60: Perf, 1.711; 61: SpO2, 99.879; 61: Perf, 1.805; 62: SpO2, 99.831; 62: Perf, 2.869; 63: SpO2, 99.881; 63: Perf, 2.230; 64: SpO2, 100.0; 64: Perf, 1.868; 65: SpO2, 100.0; 65: Perf, 1.737; 66: SpO2, 100.0; 66: Perf, 1.750; 67: SpO2, 100.0; 67: Perf, 2.172; 68: SpO2, 99.475; 68: Perf, 3.406; 69: SpO2, 99.776; 69: Perf, 2.376; 70: SpO2, 99.593; 70: Perf, 1.955; 71: SpO2, 100.0; 71: Perf, 3.23; 72: SpO2, 99.288; 72: Perf, 7.179; 73: SpO2, 99.525; 73: Perf, 5.067; 74: SpO2, 98.741; 74: Perf, 1.804; 75: SpO2, 98.797; 75: Perf, 1.396; 76: SpO2, 99.0; 76: Perf, 1.391; 77: SpO2, 98.586; 77: Perf, 1.382; 78: SpO2, 98.458; 78: Perf, 1.414; 78: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 78: ACETAMINOPHEN 1,000 MG/100 ML (10 MG/ML) IV SOLN; 79: WAM DIFTYP, AUTO; 79: RED CELL DISTRIBUTION WIDTH (RDW), 18.6 %; 79: LYMPHOCYTE % (AUTO DIFF), 8.2 %; 79: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 79: PLATELET COUNT (PLT), 238 K/uL; 79: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 79: BASOPHIL % (AUTO DIFF), 0.8 %; 79: HEMOGLOBIN (HGB), 13.2 g/dL; 79: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 79: BASOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 79: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 79: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 79: EOSINOPHIL % (AUTO DIFF), 0.1 %; 79: NRBC PERCENT (HEMATOLOGY), 0.0 %; 79: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 79: MEAN CORPUSCULAR VOLUME (MCV), 83.1 fL; 79: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 79: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 79: WHITE BLOOD CELLS (WBC), 16.9 K/uL; 79: MONOCYTE % (AUTO DIFF), 5.4 %; 79: HEMATOCRIT (HCT), 44.1 %; 79: RED BLOOD CELLS (RBC), 5.31 MIL/uL; 79: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.42 K/uL; 79: NEUTROPHIL % (AUTO DIFF), 85.0 %; 79: SpO2, 99.897; 79: Perf, 1.471; 79: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 79: LR IV BOLUS -, 1000 ML; 80: SpO2, 99.864; 80: Perf, 1.835; 81: SpO2, 98.345; 81: Perf, 1.771; 82: SpO2, 98.356; 82: Perf, 1.736; 83: SpO2, 99.621; 83: Perf, 1.849; 84: SpO2, 99.475; 84: Perf, 1.761; 85: SpO2, 100.0; 85: Perf, 1.923; 86: SpO2, 99.707; 86: Perf, 1.697; 87: SpO2, 99.0; 87: Perf, 1.564; 88: SpO2, 99.0; 88: Perf, 1.585; 89: SpO2, 98.831; 89: Perf, 1.430; 90: INFLUENZA A, Not Detected; 90: SARS-COV-2 RNA, Not Detected; 90: RSV, Not Detected; 90: INFLUENZA B, Not Detected; 90: SpO2, 99.322; 90: Perf, 1.201; 91: SpO2, 99.845; 91: Perf, 1.121; 92: SpO2, 98.729; 92: Perf, 1.032; 93: SpO2, 98.276; 93: Perf, 1.166; 94: SpO2, 98.966; 94: Perf, 1.158; 95: SpO2, 98.712; 95: Perf, 1.161; 96: SpO2, 97.772; 96: Perf, 1.171; 97: SpO2, 99.068; 97: Perf, 1.172; 98: SpO2, 98.879; 98: Perf, 1.252; 99: SpO2, 98.695; 99: Perf, 1.220; 100: SpO2, 98.407; 100: Perf, 1.230; 101: SpO2, 99.0; 101: Perf, 1.339; 102: SpO2, 99.0; 102: Perf, 1.359; 103: SpO2, 99.0; 103: Perf, 1.370; 104: SpO2, 99.0; 104: Perf, 1.355; 105: SpO2, 99.0; 105: Perf, 1.396; 106: SpO2, 99.0; 106: Perf, 1.319; 107: SpO2, 99.0; 107: Perf, 1.301; 108: SpO2, 98.948; 108: Perf, 1.274; 109: SpO2, 99.0; 109: Perf, 1.318; 110: SpO2, 99.0; 110: Perf, 1.316; 111: SpO2, 99.0; 111: Perf, 1.387; 112: LIPASE, 22 U/L; 112: SpO2, 99.0; 112: Perf, 1.382; 113: SpO2, 99.0; 113: Perf, 1.321; 114: SpO2, 99.0; 114: Perf, 1.407; 115: SpO2, 99.0; 115: Perf, 1.360; 116: SpO2, 99.103; 116: Perf, 1.299; 117: SpO2, 99.576; 117: Perf, 1.475; 118: HR, 83.786; 118: SpO2, 99.517; 118: Perf, 1.436; 118: 1min HRV, 62.269; 119: HR, 83.746; 119: RR, 22.0; 119: SpO2, 99.610; 119: Perf, 1.606; 119: 1min HRV, 55.335; 119: 5min HRV, 60.184; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 70.0; 0: Triage RR, 18.0; 0: Triage SBP, 159.0; 0: Triage DBP, 83.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the patient\u2019s vital signs and labs to assess overall stability and signs of possible infection. While the white blood cell count is elevated, the patient\u2019s blood pressure, heart rate, respiratory rate, and temperature remain within relatively normal ranges. Thus, despite some concerning markers, there is no strong indication of high sepsis risk within the next 12 hours.",
        "claims": [
            "I reviewed the patient\u2019s vital signs and labs.",
            "I assessed the patient\u2019s overall stability.",
            "I assessed the patient for signs of possible infection.",
            "The white blood cell count is elevated.",
            "The patient\u2019s blood pressure remains within relatively normal ranges.",
            "The patient\u2019s heart rate remains within relatively normal ranges.",
            "The patient\u2019s respiratory rate remains within relatively normal ranges.",
            "The patient\u2019s temperature remains within relatively normal ranges.",
            "There are some concerning markers in the patient\u2019s condition.",
            "There is no strong indication of high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "There is no strong indication of high sepsis risk within the next 12 hours."
        ],
        "alignment_scores": [
            0.3
        ],
        "alignment_category": [
            9
        ],
        "alignment_reasonings": [
            "The claim suggests an absence of strong indicators for high sepsis risk, which implies a lack of actions or clinical findings typically aligning with imminent sepsis concern, such as early antibiotic orders or culture draws. Although it does not directly mention clinical actions, the essence of cautious evaluation with no immediate risk aligns most with category 9, which is concerned with early actions based on clinical suspicion of infection. The alignment is weak since the lack of strong sepsis indicators is not a direct measure of action taken, but is more about an assessment stance."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "3: HR, 112.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 120.0; 3: DBP, 90.0; 3: MAP, 100.0; 3: Pain, 8.0; 3: Temp, 99.1; 8: Pain, 8.0; 38: POC PH (V) ISTAT, 7.38; 38: POC O2 SATURATION ISTAT VENOUS, 46 %; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC LACTATE ISTAT, 0.87 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC HCO3 (V) ISTAT, 30.3 mmol/L; 38: POC PO2 (V) ISTAT, 26 mmHg; 53: WAM DIFTYP, AUTO; 53: RED BLOOD CELLS (RBC), 4.87 MIL/uL; 53: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 53: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 53: NRBC PERCENT (HEMATOLOGY), 0.0 %; 53: MEAN CORPUSCULAR VOLUME (MCV), 87.1 fL; 53: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 53: HEMOGLOBIN (HGB), 14.6 g/dL; 53: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 53: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 53: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 53: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 53: MONOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 53: NEUTROPHIL % (AUTO DIFF), 70.5 %; 53: PLATELET COUNT (PLT), 235 K/uL; 53: BASOPHIL % (AUTO DIFF), 0.2 %; 53: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 53: MONOCYTE % (AUTO DIFF), 10.9 %; 53: HEMATOCRIT (HCT), 42.4 %; 53: EOSINOPHIL % (AUTO DIFF), 0.5 %; 53: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 53: LYMPHOCYTE % (AUTO DIFF), 17.7 %; 53: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 53: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.06 K/uL; 81: ALKALINE PHOSPHATASE, 52 U/L; 81: CORRECTED CALCIUM, 9.3 mg/dL; 81: CALCIUM, 9.5 mg/dL; 81: CREATININE, 1.22 mg/dL; 81: POTASSIUM, 3.5 mmol/L; 81: GLUCOSE, 91 mg/dL; 81: ALT (SGPT), 15 U/L; 81: EGFR REFIT WITHOUT RACE (2021), 78 mL/min/1.73 m2; 81: GLOBULIN, 2.8 g/dL; 81: ANION GAP, 13 mmol/L; 81: BILIRUBIN TOTAL, 0.5 mg/dL; 81: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 81: AST (SGOT), 17 U/L; 81: CO2, 28 mmol/L; 81: ALBUMIN, 4.3 g/dL; 81: CHLORIDE, 98 mmol/L; 81: SODIUM, 139 mmol/L; 81: PROTEIN TOTAL, 7.1 g/dL; 90: SpO2, 97.667; 91: SpO2, 97.766; 92: SpO2, 98.676; 93: HR, 117.189; 93: RR, 17.417; 93: SpO2, 98.339; 93: 1min HRV, 35.892; 94: HR, 118.897; 94: RR, 19.397; 94: SpO2, 99.052; 94: Perf, 0.651; 94: 1min HRV, 36.582; 94: SBP, 110.0; 94: DBP, 70.0; 94: MAP, 83.333; 95: HR, 112.356; 95: RR, 14.763; 95: SpO2, 98.949; 95: Perf, 0.622; 95: 1min HRV, 23.354; 95: SBP, 110.0; 95: DBP, 70.0; 95: MAP, 83.333; 95: Temp, 100.3; 96: HR, 117.103; 96: RR, 16.034; 96: SpO2, 97.828; 96: Perf, 0.617; 96: 1min HRV, 12.359; 96: 5min HRV, 30.311; 97: SARS-COV-2 RNA, Not Detected; 97: HR, 114.542; 97: RR, 19.729; 97: SpO2, 96.661; 97: Perf, 0.561; 97: 1min HRV, 10.839; 98: HR, 115.746; 98: RR, 16.831; 98: SpO2, 97.271; 98: Perf, 0.554; 98: 1min HRV, 70.725; 99: HR, 112.448; 99: RR, 14.552; 99: SpO2, 99.638; 99: Perf, 0.597; 99: 1min HRV, 15.210; 99: SBP, 111.0; 99: DBP, 73.0; 99: MAP, 85.667; 99: Pain, 9.0; 100: HR, 115.424; 100: RR, 14.949; 100: SpO2, 97.814; 100: Perf, 0.601; 100: 1min HRV, 7.647; 101: HR, 115.259; 101: RR, 17.172; 101: SpO2, 97.328; 101: Perf, 0.575; 101: 1min HRV, 18.362; 101: 5min HRV, 33.974; 102: HR, 113.593; 102: RR, 14.017; 102: SpO2, 97.797; 102: Perf, 0.537; 102: 1min HRV, 29.787; 102: SBP, 111.0; 102: DBP, 73.0; 102: MAP, 85.667; 103: HR, 116.407; 103: RR, 19.034; 103: SpO2, 99.0; 103: Perf, 0.519; 103: 1min HRV, 21.083; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 116.672; 104: RR, 18.190; 104: SpO2, 98.207; 104: Perf, 0.492; 104: 1min HRV, 17.796; 105: HR, 114.729; 105: RR, 15.881; 105: SpO2, 98.119; 105: Perf, 0.471; 105: 1min HRV, 30.473; 105: LR IV BOLUS -, 1000 ML; 106: HR:, 116.379; 106: RR, 17.379; 106: SpO2, 97.638; 106: Perf, 0.471; 106: 1min HRV, 16.924; 106: 5min HRV, 24.392; 106: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 107: HR:, 115.593; 107: RR, 21.797; 107: SpO2, 97.881; 107: Perf, 0.519; 107: 1min HRV, 13.793; 108: HR, 116.288; 108: RR, 20.780; 108: SpO2, 97.746; 108: Perf, 0.519; 108: 1min HRV, 14.276; 109: HR, 114.776; 109: RR, 11.345; 109: SpO2, 98.931; 109: Perf, 0.505; 109: 1min HRV, 13.103; 110: HR, 115.254; 110: RR, 16.0; 110: SpO2, 97.424; 110: Perf, 0.498; 110: 1min HRV, 21.313; 111: HR, 116.034; 111: RR, 17.034; 111: SpO2, 97.310; 111: Perf, 0.484; 111: 1min HRV, 19.157; 111: 5min HRV, 16.964; 112: HR, 112.034; 112: RR, 18.373; 112: SpO2, 96.559; 112: Perf, 0.524; 112: 1min HRV, 14.941; 113: HR, 113.983; 113: RR, 18.586; 113: SpO2, 97.466; 113: Perf, 0.536; 113: 1min HRV, 11.433; 114: HR, 112.271; 114: RR, 20.407; 114: SpO2, 96.780; 114: Perf, 0.540; 114: 1min HRV, 15.690; 115: HR, 112.051; 115: RR, 15.034; 115: SpO2, 95.356; 115: Perf, 0.529; 115: 1min HRV, 20.846; 116: HR, 111.948; 116: RR, 16.379; 116: SpO2, 95.914; 116: Perf, 0.514; 116: 1min HRV, 13.143; 116: 5min HRV, 15.961; 117: HR, 112.644; 117: RR, 14.203; 117: SpO2, 97.339; 117: Perf, 0.507; 117: 1min HRV, 16.865; 118: HR, 113.810; 118: RR, 16.741; 118: SpO2, 95.983; 118: Perf, 0.52; 118: 1min HRV, 11.521; 119: HR, 114.186; 119: RR, 17.254; 119: SpO2, 96.119; 119: Perf, 0.52; 119: 1min HRV, 13.682; 0: Age, 38; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 112.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I considered the vital signs, laboratory values, and clinical context to evaluate sepsis risk. While there is mild tachycardia and occasional low-grade fever, the lactate level is normal, WBC count is not elevated, and there are no strong indicators of organ dysfunction. Overall, the available data do not suggest a high likelihood of sepsis within the next 12 hours.",
        "claims": [
            "I considered the vital signs, laboratory values, and clinical context to evaluate sepsis risk.",
            "There is mild tachycardia present.",
            "There is occasional low-grade fever.",
            "The lactate level is normal.",
            "The white blood cell (WBC) count is not elevated.",
            "There are no strong indicators of organ dysfunction.",
            "The available data do not suggest a high likelihood of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There is mild tachycardia present.",
            "The white blood cell (WBC) count is not elevated.",
            "The available data do not suggest a high likelihood of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.4,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions mild tachycardia, which is relevant to the SIRS criteria (heart rate >90 bpm). Though it suggests possible early systemic inflammation, the term \"mild\" could imply it isn't significantly above the threshold, leading to partial alignment.",
            "The claim about the WBC count not being elevated relates indirectly to SIRS criteria because it suggests the absence of one of the SIRS indicators for systemic inflammation. While it provides information on what is not present, it only partially aligns with the SIRS categorization, as no positive SIRS criteria are affirmed.",
            "The claim suggests a low likelihood of sepsis, which might reflect a low NEWS score since a higher NEWS score indicates imminent clinical deterioration compatible with sepsis. While the data doesn't suggest high sepsis risk, which would align with a NEWS score, this is inferred rather than directly stated. Hence, the alignment rating is moderate but low."
        ],
        "final_alignment_score": 0.43333333333333335,
        "accuracy": 1
    },
    {
        "input": "11: HR, 128.0; 11: RR, 22.0; 11: SpO2, 100.0; 11: SBP, 135.0; 11: DBP, 95.0; 11: MAP, 108.333; 11: LPM O2, 4.0; 11: Temp, 99.2; 20: Pain, 2.0; 46: HR, 122.0; 46: RR, 23.0; 46: SpO2, 100.0; 46: SBP, 150.0; 46: DBP, 110.0; 46: MAP, 123.333; 52: HR, 122.939; 52: RR, 23.25; 52: SpO2, 100.0; 52: 1min HRV, 5.704; 53: HR, 122.845; 53: RR, 21.517; 53: SpO2, 99.914; 53: Perf, 2.808; 53: 1min HRV, 5.565; 53: SBP, 150.0; 53: DBP, 110.0; 53: MAP, 123.333; 54: HR, 123.831; 54: RR, 24.644; 54: SpO2, 99.661; 54: Perf, 2.638; 54: 1min HRV, 10.795; 55: HR, 121.0; 55: RR, 25.508; 55: SpO2, 99.915; 55: Perf, 2.988; 55: 1min HRV, 10.056; 56: HR, 122.84; 56: RR, 26.149; 56: SpO2, 99.948; 56: Perf, 3.283; 56: 1min HRV, 8.571; 56: 5min HRV, 8.940; 57: HR, 122.576; 57: RR, 19.769; 57: SpO2, 99.864; 57: Perf, 3.919; 57: 1min HRV, 7.105; 58: HR, 122.879; 58: RR, 22.517; 58: SpO2, 99.879; 58: Perf, 4.124; 58: 1min HRV, 8.843; 59: HR, 123.034; 59: RR, 25.678; 59: SpO2, 100.0; 59: Perf, 3.976; 59: 1min HRV, 4.672; 60: HR, 122.508; 60: RR, 24.169; 60: SpO2, 100.0; 60: Perf, 3.974; 60: 1min HRV, 7.319; 61: HR, 120.776; 61: RR, 25.017; 61: SpO2, 100.0; 61: Perf, 3.710; 61: 1min HRV, 9.472; 61: 5min HRV, 8.257; 62: HR, 122.085; 62: RR, 21.136; 62: SpO2, 99.729; 62: Perf, 3.300; 62: 1min HRV, 5.797; 63: HR, 121.190; 63: RR, 22.569; 63: SpO2, 100.0; 63: Perf, 3.961; 63: 1min HRV, 6.137; 64: HR, 121.492; 64: RR, 23.712; 64: SpO2, 99.864; 64: Perf, 3.505; 64: 1min HRV, 7.056; 65: HR, 121.475; 65: RR, 21.966; 65: SpO2, 100.0; 65: Perf, 3.676; 65: 1min HRV, 5.555; 66: HR, 124.069; 66: RR, 25.638; 66: SpO2, 100.0; 66: Perf, 3.285; 66: 1min HRV, 6.096; 66: 5min HRV, 7.719; 67: HR, 122.441; 67: RR, 20.119; 67: SpO2, 99.932; 67: Perf, 3.020; 67: 1min HRV, 10.566; 68: POC PH (V) ISTAT, 7.27; 68: POC LACTATE ISTAT, <.30 mmol/L; 68: POC PO2 (V) ISTAT, 52 mmHg; 68: POC O2 SATURATION ISTAT VENOUS, 79 %; 68: POC BASE EXCESS ISTAT, 16 mmol/L; 68: POC TCO2 (V) ISTAT, 46 mmol/L; 68: POC PCO2 (V) ISTAT, 93.1 mmHg; 68: POC HCO3 (V) ISTAT, 43.1 mmol/L; 68: HR, 122.759; 68: RR, 22.862; 68: SpO2, 100.0; 68: Perf, 3.085; 68: 1min HRV, 6.594; 69: HR, 122.220; 69: RR, 24.593; 69: SpO2, 99.763; 69: Perf, 3.244; 69: 1min HRV, 11.331; 70: HR, 120.983; 70: RR, 23.356; 70: SpO2, 99.847; 70: Perf, 2.363; 70: 1min HRV, 7.587; 71: HR, 121.017; 71: RR, 22.431; 71: SpO2, 100.0; 71: Perf, 2.784; 71: 1min HRV, 9.820; 71: 5min HRV, 9.871; 72: HR, 120.864; 72: RR, 21.915; 72: SpO2, 99.915; 72: Perf, 3.830; 72: 1min HRV, 16.374; 73: HR, 120.103; 73: RR, 24.759; 73: SpO2, 100.0; 73: Perf, 3.610; 73: 1min HRV, 10.152; 74: HR, 118.492; 74: RR, 18.559; 74: SpO2, 99.492; 74: Perf, 3.811; 74: 1min HRV, 18.415; 75: HR, 101.776; 75: RR, 24.276; 75: SpO2, 98.810; 75: Perf, 3.638; 75: 1min HRV, 60.252; 76: HR, 112.729; 76: RR, 25.119; 76: SpO2, 97.441; 76: Perf, 4.093; 76: 1min HRV, 62.110; 76: 5min HRV, 53.036; 77: HR, 129.0; 77: RR, 21.203; 77: SpO2, 96.847; 77: Perf, 3.652; 77: 1min HRV, 4.517; 78: HR, 127.362; 78: RR, 21.466; 78: SpO2, 97.672; 78: Perf, 2.806; 78: 1min HRV, 9.283; 79: HR, 125.898; 79: RR, 30.441; 79: SpO2, 99.186; 79: Perf, 3.482; 79: 1min HRV, 7.209; 80: HR, 125.207; 80: RR, 27.448; 80: SpO2, 99.552; 80: Perf, 4.992; 80: 1min HRV, 7.198; 81: HR, 124.119; 81: RR, 25.729; 81: SpO2, 99.661; 81: Perf, 4.143; 81: 1min HRV, 4.572; 81: 5min HRV, 9.969; 82: HR, 122.712; 82: RR, 22.220; 82: SpO2, 99.814; 82: Perf, 4.987; 82: 1min HRV, 8.090; 83: HR, 121.931; 83: RR, 21.862; 83: SpO2, 99.621; 83: Perf, 2.813; 83: 1min HRV, 10.376; 86: 5min HRV, 9.461; 89: WAM DIFTYP, AUTO; 89: HEMATOCRIT (HCT), 40.8 %; 89: PLATELET COUNT (PLT), 327 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 89: HEMOGLOBIN (HGB), 12.1 g/dL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.7 g/dL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.84 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 89: LYMPHOCYTE % (AUTO DIFF), 6.7 %; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 89: MONOCYTE % (AUTO DIFF), 8.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 12.4 %; 89: EOSINOPHIL % (AUTO DIFF), 2.3 %; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: NEUTROPHIL % (AUTO DIFF), 81.9 %; 89: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 89: RED BLOOD CELLS (RBC), 4.48 MIL/uL; 89: BASOPHIL % (AUTO DIFF), 0.3 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.20 K/uL; 95: NS IV BOLUS -, 1000 ML; 97: INR:, 1.0; 97: PROTHROMBIN TIME, 13.2 seconds; 97: PART. THROMBOPLASTIN TIME, 29.0 seconds; 100: POC, BHCG, ISTAT QUANTITATIVE: 5.0 IU/L; 106: HR, 113.0; 106: RR, 17.0; 106: SpO2, 98.0; 106: SBP, 159.0; 106: DBP, 103.0; 106: MAP, 121.667; 106: LPM O2, 4.0; 110: CO2, 37 mmol/L; 110: CREATININE, 0.59 mg/dL; 110: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 110: ANION GAP, 7 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: GLUCOSE, 247 mg/dL; 110: CHLORIDE, 94 mmol/L; 110: CORRECTED CALCIUM, 9.9 mg/dL; 110: GLOBULIN, 3.4 g/dL; 110: AST (SGOT), 22 U/L; 110: ALKALINE PHOSPHATASE, 122 U/L; 110: SODIUM, 138 mmol/L; 110: PROTEIN TOTAL, 7.3 g/dL; 110: BILIRUBIN TOTAL, <.2 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: POTASSIUM, 4.4 mmol/L; 110: CALCIUM, 9.8 mg/dL; 110: ALBUMIN, 3.9 g/dL; 110: ALT (SGPT), 25 U/L; 111: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 0: Age:, 37; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 128.0; 0: Triage RR, 22.0; 0: Triage SBP, 135.0; 0: Triage DBP, 95.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I first considered whether the patient met criteria for sepsis based on abnormal vital signs and lab values, including lactate levels and blood pressure trends. Next, I noticed the patient\u2019s lactate was extremely low and her blood pressure remained stable or even elevated despite some tachycardia and mild tachypnea. Then, I asked if there were any signs of organ dysfunction, but the labs did not indicate significant problems aside from an elevated heart rate and slightly high WBC count. After weighing these factors, I decided there is no clear evidence that the patient is at high risk for developing sepsis within the next 12 hours.",
        "claims": [
            "The patient was assessed for criteria indicating sepsis based on vital signs and lab values.",
            "Abnormal vital signs and lab values include lactate levels and blood pressure trends.",
            "The patient\u2019s lactate level was extremely low.",
            "The patient's blood pressure remained stable or elevated.",
            "The patient experienced some tachycardia.",
            "The patient exhibited mild tachypnea.",
            "There were no significant signs of organ dysfunction observed.",
            "The lab results showed an elevated heart rate.",
            "The lab results revealed a slightly high white blood cell (WBC) count.",
            "After considering these factors, there is no clear evidence that the patient is at high risk for developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient experienced some tachycardia.",
            "The lab results showed an elevated heart rate."
        ],
        "alignment_scores": [
            0.7,
            0.7
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. While the claim indicates tachycardia, it does not specify the exact heart rate or mention other SIRS criteria being met. Thus, it aligns with the SIRS category but lacks completeness in information for full alignment.",
            "An elevated heart rate (>90 bpm) is one of the criteria used to determine SIRS positivity. While the claim lacks specific heart rate values to definitively meet the threshold, the mention of an elevated heart rate is directly relevant to this category. The alignment rating reflects that it's a strong indicator but does not confirm full criteria fulfillment."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 0
    },
    {
        "input": "2: SpO2, 95.604; 2: SBP, 73.0; 2: DBP, nan; 2: MAP, nan; 3: SpO2, 97.633; 3: Perf, 0.510; 4: SpO2, 98.0; 4: Perf, 0.485; 4: SBP, 71.0; 4: DBP, 48.0; 4: MAP, 55.667; 5: HR, 115.0; 5: RR, 19.0; 5: SpO2, 96.729; 5: Perf, 0.322; 5: SBP, 79.0; 5: DBP, 48.0; 5: MAP, 58.333; 5: Pain, 3.0; 5: Temp, 98.0; 6: SpO2, 95.264; 6: Perf, 0.711; 7: SpO2, 96.038; 7: Perf, 0.838; 8: SpO2, 97.849; 8: Perf, 0.911; 9: SpO2, 99.0; 9: Perf, 1.024; 10: SpO2, 98.212; 10: Perf, 0.978; 10: SBP, 73.0; 10: DBP, 43.0; 10: MAP, 53.0; 11: SpO2, 98.642; 11: Perf, 0.448; 12: SpO2, 98.712; 12: Perf, 0.979; 13: SpO2, 99.245; 13: Perf, 1.204; 14: SpO2, 99.212; 14: Perf, 1.499; 15: SpO2, 99.887; 15: Perf, 1.369; 16: SpO2, 99.478; 16: Perf, 1.329; 17: SpO2, 94.333; 17: Perf, 1.36; 19: SpO2, 93.769; 19: Perf, 0.170; 20: SpO2, 93.0; 20: Perf, 0.23; 20: SBP, 63.0; 20: DBP, 45.0; 20: MAP, 51.0; 21: SpO2, 94.0; 21: Perf, 0.286; 22: SpO2, 98.423; 22: Perf, 0.689; 23: SpO2, 98.0; 23: Perf, 0.410; 24: SpO2, 98.875; 24: Perf, 0.394; 24: LR IV BOLUS -, 500 ML; 25: SpO, 2: 96.395; 25: Perf, 0.432; 26: SpO2, 98.288; 26: Perf, 1.126; 27: SpO2, 95.981; 27: Perf, 1.025; 28: SpO2, 98.415; 28: Perf, 1.452; 28: SBP, 71.0; 28: DBP, 32.0; 28: MAP, 45.0; 29: SpO2, 99.192; 29: Perf, 0.813; 30: SpO2, 99.509; 30: Perf, 0.659; 31: POC PH (V) ISTAT, 7.63; 31: POC O2 SATURATION ISTAT VENOUS, 92 %; 31: POC TCO2 (V) ISTAT, 34 mmol/L; 31: POC BASE EXCESS ISTAT, 12 mmol/L; 31: POC PCO2 (V) ISTAT, 32.1 mmHg; 31: POC PO2 (V) ISTAT, 51 mmHg; 31: POC LACTATE ISTAT, 1.99 mmol/L; 31: POC HCO3 (V) ISTAT, 33.5 mmol/L; 31: SpO2, 99.385; 31: Perf, 0.763; 32: SpO2, 96.385; 32: Perf, 0.773; 33: SpO2, 96.094; 33: Perf, 0.739; 34: SpO2, 97.231; 34: Perf, 0.936; 35: SpO2, 99.094; 35: Perf, 1.320; 35: SBP, 76.0; 35: DBP, 54.0; 35: MAP, 61.333; 36: SpO2, 98.596; 36: Perf, 0.990; 37: SpO2, 98.094; 37: Perf, 0.757; 38: SpO2, 96.283; 38: Perf, 0.687; 39: SpO2, 95.712; 39: Perf, 0.747; 40: SpO2, 97.755; 40: Perf, 1.372; 41: SpO2, 97.923; 41: Perf, 1.720; 42: SpO2, 95.585; 42: Perf, 1.869; 43: SpO2, 94.72; 43: Perf, 1.339; 44: SpO2, 95.667; 44: Perf, 0.698; 45: SpO2, 96.019; 45: Perf, 0.370; 46: WAM DIFTYP, AUTO; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.2 %; 46: HEMATOCRIT (HCT), 30.5 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: PLATELET COUNT (PLT), 250 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.1 pg; 46: NEUTROPHIL % (AUTO DIFF), 75.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 46: HEMOGLOBIN (HGB), 10.0 g/dL; 46: MEAN CORPUSCULAR VOLUME (MCV), 97.8 fL; 46: LYMPHOCYTE % (AUTO DIFF), 12.8 %; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.82 K/uL; 46: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 46: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.6 %; 46: MONOCYTE % (AUTO DIFF), 9.9 %; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.82 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: SpO2, 98.75; 46: Perf, 1.011; 47: SpO2, 99.585; 47: Perf, 0.703; 48: SpO2, 98.830; 48: Perf, 0.596; 49: SpO2, 98.462; 49: Perf, 0.741; 50: SpO2, 97.868; 50: Perf, 0.314; 51: SpO2, 99.0; 51: Perf, 0.335; 52: SpO2, 99.82; 52: Perf, 0.290; 53: SpO2, 98.733; 53: Perf, 0.208; 54: SpO2, 99.442; 54: Perf, 0.407; 55: SpO2, 98.698; 55: Perf, 0.510; 56: SpO2, 97.885; 56: Perf, 0.373; 57: SpO2, 97.717; 57: Perf, 0.412; 58: SpO2, 99.5; 58: Perf, 0.699; 59: SpO2, 99.019; 59: Perf, 0.417; 60: SpO2, 99.226; 60: Perf, 0.292; 61: SpO2, 99.154; 61: Perf, 0.311; 62: SpO2, 99.434; 62: Perf, 0.488; 63: SpO2, 100.0; 63: Perf, 0.649; 63: SBP, 103.0; 63: DBP, 54.0; 63: MAP, 70.333; 67: ALT (SGPT), 20 U/L; 67: PROTEIN TOTAL, 7.8 g/dL; 67: BILIRUBIN TOTAL, 0.5 mg/dL; 67: ALKALINE PHOSPHATASE, 81 U/L; 67: SODIUM, 131 mmol/L; 67: CALCIUM, 8.9 mg/dL; 67: ANION GAP, 14 mmol/L; 67: ALBUMIN, 4.1 g/dL; 67: POTASSIUM, 4.5 mmol/L; 67: CO2, 28 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 14 mL/min/1.73 m2; 67: AST (SGOT), 54 U/L; 67: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 67: GLUCOSE, 118 mg/dL; 67: GLOBULIN, 3.7 g/dL; 67: CHLORIDE, 89 mmol/L; 67: CREATININE, 3.37 mg/dL; 67: CORRECTED CALCIUM, 8.8 mg/dL; 69: HR, 89.0; 69: SpO2, 99.0; 69: SBP, 87.0; 69: DBP, 58.0; 69: MAP, 67.667; 87: HR, 82.0; 87: RR, 18.0; 87: SpO2, 99.0; 87: SBP, 85.0; 87: DBP, 69.0; 87: MAP, 74.333; 95: INR, 1.1; 95: PROTHROMBIN TIME, 15.0 seconds; 96: PART. THROMBOPLASTIN TIME, 28.3 seconds; 114: SARS-COV-2 RNA, Not Detected; 114: INFLUENZA B, Not Detected; 114: RSV, Not Detected; 114: INFLUENZA A, Not Detected; 0: Age, 67; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 115.0; 0: Triage RR, 19.0; 0: Triage SBP, 101.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I considered the persistently low blood pressures and elevated creatinine as possible signs of organ dysfunction. I questioned whether the patient\u2019s hypotension, tachycardia, and laboratory findings could indicate sepsis risk. I examined trends in vital signs and noted that, despite fluid boluses, systolic blood pressures stayed dangerously low. These factors suggest a significant likelihood that the patient could develop sepsis within the next 12 hours.",
        "claims": [
            "The blood pressures are persistently low.",
            "Elevated creatinine is a possible sign of organ dysfunction.",
            "The patient's hypotension could indicate sepsis risk.",
            "Tachycardia could indicate sepsis risk.",
            "Laboratory findings could indicate sepsis risk.",
            "I examined trends in vital signs.",
            "Despite fluid boluses, systolic blood pressures stayed dangerously low.",
            "These factors suggest a significant likelihood of developing sepsis.",
            "The patient could develop sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The blood pressures are persistently low.",
            "Elevated creatinine is a possible sign of organ dysfunction.",
            "The patient's hypotension could indicate sepsis risk.",
            "Tachycardia could indicate sepsis risk.",
            "Laboratory findings could indicate sepsis risk.",
            "Despite fluid boluses, systolic blood pressures stayed dangerously low.",
            "These factors suggest a significant likelihood of developing sepsis."
        ],
        "alignment_scores": [
            0.9,
            1.0,
            0.9,
            0.8,
            0.3,
            1.0,
            0.3
        ],
        "alignment_category": [
            7,
            8,
            7,
            2,
            4,
            7,
            4
        ],
        "alignment_reasonings": [
            "Persistently low blood pressures suggest hypotension, which aligns well with the criteria for sepsis-associated hypotension in this category. However, without specific values, it does not confirm but strongly suggests a possible risk of progression toward septic shock. Hence, the alignment is rated as high but not absolute.",
            "Elevated creatinine is explicitly listed as a criterion under the SOFA score, indicating new organ dysfunction. This directly correlates with the category of SOFA Score Increase, making it a perfect alignment.",
            "The claim specifically mentions hypotension as a potential indicator of sepsis risk, which aligns directly with the category of sepsis-associated hypotension. However, the claim does not specify the exact criteria (e.g., SBP <90 mmHg) required to fully meet the category's definition; thus, it does not achieve perfect alignment but is strongly aligned.",
            "Tachycardia, defined as a heart rate >90 bpm, is explicitly listed as one of the SIRS criteria. It is used to identify systemic inflammation or early signs of sepsis. While the claim suggests a potential risk without specifying the heart rate, tachycardia is directly relevant to the SIRS criteria, but without knowing if other SIRS criteria are met, the alignment is not perfect. Therefore, the alignment rating is 0.8, reflecting strong but not absolute alignment.",
            "The claim speaks generally about laboratory findings indicating sepsis risk without specificity. While no exact categories mention \"laboratory findings\" directly, elevated NEWS scores can often reflect lab findings and deranged vitals, suggesting clinical deterioration. The alignment is broad and not strong due to lack of specific laboratory parameters being mentioned, thus a low rating of 0.3 is appropriate.",
            "The claim directly mentions \"systolic blood pressures stayed dangerously low,\" which is indicative of sepsis-associated hypotension. This perfectly aligns with the category, which defines hypotension as a systolic blood pressure <90 mmHg, and signals progression toward septic shock. The continued low pressures despite fluid boluses strongly suggest hypotensive shock associated with sepsis, confirming full alignment with this category.",
            "The claim is very general and does not provide specific clinical data or indicators that directly align with any category. The phrasing \"significant likelihood of developing sepsis\" conceptually relates to the concept of an elevated NEWS score, which is used to predict clinical deterioration and sepsis risk. However, since there is no concrete data provided, this association is weak and indirect."
        ],
        "final_alignment_score": 0.7428571428571428,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 92.286; 3: HR, 108.0; 3: RR, 18.0; 3: SpO2, 94.712; 3: SBP, 104.0; 3: DBP, 58.0; 3: MAP, 73.333; 3: Pain, 10.0; 3: Temp, 98.4; 4: SpO2, 94.424; 4: 1min HRV, 3.128; 5: HR, 105.679; 5: RR, 22.017; 5: SpO2, 95.345; 5: 1min HRV, 12.321; 5: 5min HRV, 12.071; 5: SBP, 104.0; 5: DBP, 58.0; 5: MAP, 73.333; 6: HR, 100.898; 6: RR, 14.288; 6: SpO2, 94.881; 6: 1min HRV, 13.117; 7: HR, 99.603; 7: RR, 16.103; 7: SpO2, 94.172; 7: 1min HRV, 11.406; 8: HR, 98.797; 8: RR, 15.797; 8: SpO2, 93.305; 8: Perf, 3.430; 8: 1min HRV, 10.144; 9: HR, 97.695; 9: RR, 22.237; 9: SpO2, 93.932; 9: Perf, 3.684; 9: 1min HRV, 4.646; 10: HR, 97.810; 10: RR, 27.793; 10: SpO2, 94.672; 10: Perf, 4.924; 10: 1min HRV, 6.557; 10: 5min HRV, 11.750; 11: HR, 98.678; 11: RR, 18.847; 11: SpO2, 96.0; 11: Perf, 4.99; 11: 1min HRV, 6.099; 12: HR, 101.091; 12: RR, 18.091; 12: SpO2, 95.455; 12: Perf, 4.99; 12: 1min HRV, 1.898; 14: HR, 101.0; 14: RR, 27.0; 14: SpO2, 95.0; 14: Perf, 4.99; 15: HR, 103.562; 15: RR, 26.562; 15: SpO2, 93.55; 15: Perf, 4.75; 15: 1min HRV, 2.806; 15: 5min HRV, 11.961; 16: HR, 102.559; 16: RR, 21.864; 16: SpO2, 93.712; 16: Perf, 3.154; 16: 1min HRV, 9.604; 16: SBP, 92.0; 16: DBP, 53.0; 16: MAP, 66.0; 17: HR, 101.559; 17: RR, 21.627; 17: SpO2, 94.424; 17: Perf, 1.920; 17: 1min HRV, 14.599; 18: HR, 96.690; 18: RR, 29.897; 18: SpO2, 94.741; 18: Perf, 2.758; 18: 1min HRV, 11.359; 19: HR, 93.864; 19: RR, 25.746; 19: SpO2, 94.542; 19: Perf, 3.453; 19: 1min HRV, 14.594; 20: HR, 96.052; 20: RR, 28.724; 20: SpO2, 95.0; 20: Perf, 3.637; 20: 1min HRV, 4.509; 20: 5min HRV, 23.489; 21: HR, 97.441; 21: RR, 32.508; 21: SpO2, 94.271; 21: Perf, 3.552; 21: 1min HRV, 4.268; 22: HR, 97.814; 22: RR, 31.441; 22: SpO2, 93.136; 22: Perf, 3.410; 22: 1min HRV, 4.070; 23: HR, 96.862; 23: RR, 30.345; 23: SpO2, 92.362; 23: Perf, 3.15; 23: 1min HRV, 6.574; 24: HR, 97.898; 24: RR, 29.271; 24: SpO2, 94.362; 24: Perf, 3.041; 24: 1min HRV, 6.397; 25: HR, 96.931; 25: RR, 33.103; 25: SpO2, 94.034; 25: 1min HRV, 2.760; 25: 5min HRV, 5.875; 26: HR, 98.356; 26: RR, 32.441; 26: SpO2, 93.780; 26: 1min HRV, 3.452; 27: HR, 99.542; 27: RR, 33.661; 27: SpO2, 94.0; 27: 1min HRV, 2.319; 28: HR, 100.103; 28: RR, 33.569; 28: SpO2, 93.810; 28: 1min HRV, 1.990; 29: HR, 100.729; 29: RR, 33.407; 29: SpO2, 94.0; 29: 1min HRV, 2.201; 30: HR, 100.879; 30: RR, 32.776; 30: SpO2, 93.931; 30: 1min HRV, 4.129; 30: 5min HRV, 5.757; 31: HR, 100.186; 31: RR, 32.424; 31: SpO2, 92.273; 31: 1min HRV, 9.024; 31: SBP, 99.0; 31: DBP, 47.0; 31: MAP, 64.333; 32: HR, 101.525; 32: RR, 33.542; 32: SpO2, 93.932; 32: 1min HRV, 2.930; 33: HR, 102.655; 33: RR, 32.517; 33: SpO2, 93.914; 33: 1min HRV, 2.312; 34: HR, 101.373; 34: RR, 28.576; 34: SpO2, 93.390; 34: 1min HRV, 9.428; 35: HR, 101.241; 35: RR, 22.172; 35: SpO2, 93.621; 35: Perf, 3.324; 35: 1min HRV, 8.231; 35: 5min HRV, 8.377; 36: HR, 102.712; 36: RR, 20.797; 36: SpO2, 94.254; 36: Perf, 3.239; 36: 1min HRV, 6.205; 37: HR, 101.576; 37: RR, 32.373; 37: SpO2, 93.322; 37: Perf, 2.84; 37: 1min HRV, 4.236; 38: HR, 102.293; 38: RR, 26.017; 38: SpO2, 93.638; 38: Perf, 2.84; 38: 1min HRV, 3.312; 39: HR, 101.237; 39: RR, 20.508; 39: SpO2, 94.149; 39: Perf, 2.84; 39: 1min HRV, 9.369; 40: HR, 100.190; 40: RR, 20.034; 40: SpO2, 93.845; 40: 1min HRV, 9.251; 40: 5min HRV, 9.019; 41: HR, 98.085; 41: RR, 22.288; 41: SpO2, 95.475; 41: 1min HRV, 11.561; 42: HR, 98.559; 42: RR, 28.881; 42: SpO2, 95.034; 42: 1min HRV, 3.942; 43: HR, 98.621; 43: RR, 28.138; 43: SpO2, 94.966; 43: 1min HRV, 5.115; 44: HR, 98.322; 44: RR, 32.017; 44: SpO2, 94.136; 44: 1min HRV, 8.521; 45: HR, 98.879; 45: RR, 33.534; 45: SpO2, 92.586; 45: Perf, 2.88; 45: 1min HRV, 4.662; 45: 5min HRV, 7.515; 46: HR, 98.966; 46: RR, 31.475; 46: SpO2, 92.0; 46: Perf, 3.082; 46: 1min HRV, 8.390; 46: SBP, 89.0; 46: DBP, 44.0; 46: MAP, 59.0; 47: HR, 101.818; 47: RR, 21.762; 47: SpO2, 92.535; 47: Perf, 2.787; 47: 1min HRV, 4.126; 47: SBP, 94.0; 47: DBP, 56.0; 47: MAP, 68.667; 50: HR, 102.0; 50: RR, 19.0; 50: SpO2, 94.0; 50: 5min HRV, 10.895; 50: SBP, 94.0; 50: DBP, 56.0; 50: MAP, 68.667; 77: SpO2, 95.176; 78: SpO2, 95.932; 78: Perf, 3.047; 79: SpO2, 95.397; 79: Perf, 2.886; 80: SpO2, 95.576; 80: Perf, 2.753; 81: SpO2, 95.153; 81: Perf, 2.917; 82: SpO2, 94.759; 82: Perf, 3.042; 83: SpO2, 95.0; 83: Perf, 2.844; 84: SpO2, 95.0; 84: Perf, 2.474; 85: SpO2, 95.0; 85: Perf, 2.152; 86: SpO2, 95.138; 86: Perf, 2.112; 87: SpO2, 95.492; 87: Perf, 2.163; 88: SpO2, 95.763; 88: Perf, 2.362; 89: SpO2, 95.586; 89: Perf, 2.067; 90: SpO2, 95.763; 90: Perf, 1.954; 91: SpO2, 95.644; 91: Perf, 1.944; 92: SpO2, 95.603; 92: Perf, 1.77; 93: SpO2, 94.932; 93: Perf, 1.731; 94: SpO2, 95.207; 94: Perf, 1.576; 95: SpO2, 95.0; 95: Perf, 1.505; 96: SpO2, 95.390; 96: Perf, 1.500; 97: SpO2, 95.759; 97: Perf, 1.497; 98: SpO2, 95.379; 98: Perf, 1.476; 99: SpO2, 95.780; 99: Perf, 1.509; 100: SpO2, 95.492; 100: Perf, 1.502; 101: SpO2, 95.593; 101: Perf, 1.464; 102: SpO2, 94.931; 102: Perf, 1.498; 103: SpO2, 95.576; 103: Perf, 1.543; 104: SpO2, 95.845; 104: Perf, 1.474; 105: SpO2, 95.644; 105: Perf, 1.305; 106: SpO2, 96.151; 106: Perf, 0.808; 107: SpO2, 97.207; 107: Perf, 0.534; 108: SpO2, 97.271; 108: Perf, 0.505; 109: SpO2, 95.793; 109: Perf, 0.665; 110: SpO2, 93.414; 110: Perf, 0.695; 111: SpO2, 96.983; 111: Perf, 0.61; 112: SpO2, 97.169; 112: Perf, 0.61; 113: SpO2, 97.525; 113: Perf, 0.61; 114: SpO2, 97.345; 114: Perf, 0.61; 115: SpO2, 96.644; 115: Perf, 0.61; 116: SpO2, 96.034; 116: Perf, 0.61; 117: SpO2, 95.932; 117: Perf, 0.61; 118: SpO2, 95.576; 118: Perf, 0.61; 118: SBP, 93.0; 118: DBP, nan; 118: MAP, nan; 119: SpO2, 96.172; 119: Perf, 0.612; 0: Age, 46; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.9; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 104.0; 0: Triage DBP, 58.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed that the patient\u2019s blood pressure repeatedly dropped near or below 90\u2013100 mmHg and the respiratory rate often exceeded 22 breaths per minute. These observations, combined with the elevated heart rate, raise concern for possible sepsis. I then asked whether other signs such as oxygen saturation or perfusion status supported this suspicion, finding multiple hours where SpO2 hovered near the lower 90s. Finally, seeing these consistent patterns of instability strongly suggested the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient\u2019s blood pressure repeatedly dropped near or below 90\u2013100 mmHg.",
            "The respiratory rate often exceeded 22 breaths per minute.",
            "An elevated heart rate raises concern for possible sepsis.",
            "I inquired whether other signs supported the suspicion of sepsis.",
            "The SpO2 levels hovered near the lower 90s for multiple hours.",
            "The consistent patterns of instability strongly suggest the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s blood pressure repeatedly dropped near or below 90\u2013100 mmHg.",
            "The respiratory rate often exceeded 22 breaths per minute.",
            "An elevated heart rate raises concern for possible sepsis.",
            "The SpO2 levels hovered near the lower 90s for multiple hours.",
            "The consistent patterns of instability strongly suggest the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.7,
            0.5,
            0.6
        ],
        "alignment_category": [
            7,
            3,
            2,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim refers to blood pressure repeatedly dropping near or below 90\u2013100 mmHg. While the situation isn't explicitly below the threshold of 90 mmHg for sepsis-associated hypotension, it suggests a trend toward hypotension. This category is closely related to the scenario, but since the systolic blood pressure occasionally remains above or around 90 mmHg, the alignment is not perfect. However, the recurrent proximity to the threshold indicates a significant association with potential progression toward sepsis-related hypotension.",
            "The claim directly mentions a respiratory rate exceeding 22 breaths per minute, which is one of the criteria for a high qSOFA score. Although the qSOFA score requires a total of \u22652 across different criteria (which requires additional information), the respiratory rate aspect fits well, justifying a high alignment rating but not perfect due to the lack of a full qSOFA assessment.",
            "An elevated heart rate is one of the criteria used to identify SIRS, which is associated with early sepsis. While the claim does not specify the exact heart rate, it does directly reference a concern for sepsis linked to this symptom, suggesting moderate alignment with the SIRS criteria.",
            "The claim about SpO2 levels hovering in the lower 90s indicates potential issues with oxygenation, though SpO2 itself is not directly measured by the SOFA criteria. The alignment is indirect as SOFA considers impaired oxygenation through PaO\u2082/FiO\u2082 ratios, but low SpO2 could suggest similar respiratory concerns or organ dysfunction. The alignment is moderate as it hints at possible deterioration or dysfunction consistent with sepsis risk, but does not directly match the SOFA scoring specifics.",
            "The phrase \"consistent patterns of instability\" suggests abnormalities in the patient's vitals that could contribute to an elevated NEWS score, which is used to predict clinical deterioration like that seen in sepsis. While the claim does not specify exact vital sign changes to directly quantify NEWS, it implies an assessment consistent with elevated risk, making this category somewhat relevant. The connection is indirect, hence the moderate alignment rating."
        ],
        "final_alignment_score": 0.6799999999999999,
        "accuracy": 1
    },
    {
        "input": "5: SBP, 156.0; 5: DBP, 80.0; 5: MAP, 105.333; 6: SpO2, 97.265; 7: SpO2, 96.695; 7: Perf, 0.607; 8: HR, 76.163; 8: RR, 21.787; 8: SpO2, 97.0; 8: Perf, 0.360; 8: 1min HRV, 18.003; 9: HR, 75.259; 9: RR, 20.603; 9: SpO2, 96.897; 9: Perf, 0.341; 9: 1min HRV, 20.634; 10: HR, 73.373; 10: RR, 18.593; 10: SpO2, 96.525; 10: Perf, 0.417; 10: 1min HRV, 9.648; 11: HR, 73.397; 11: RR, 18.828; 11: SpO2, 97.0; 11: Perf, 1.269; 11: 1min HRV, 13.256; 12: HR, 73.542; 12: RR, 18.068; 12: SpO2, 97.0; 12: Perf, 1.663; 12: 1min HRV, 9.717; 12: 5min HRV, 18.442; 12: SBP, 131.0; 12: DBP, 61.0; 12: MAP, 84.333; 13: HR, 74.542; 13: RR, 18.576; 13: SpO2, 96.508; 13: Perf, 1.742; 13: 1min HRV, 13.443; 13: SBP, 131.0; 13: DBP, 61.0; 13: MAP, 84.333; 14: HR, 74.414; 14: RR, 18.241; 14: SpO2, 96.655; 14: Perf, 1.770; 14: 1min HRV, 12.028; 15: HR, 76.310; 15: RR, 19.621; 15: SpO2, 96.466; 15: Perf, 1.963; 15: 1min HRV, 25.404; 16: HR, 80.407; 16: RR, 16.797; 16: SpO2, 96.763; 16: Perf, 1.335; 16: 1min HRV, 12.899; 17: HR, 79.448; 17: RR, 21.034; 17: SpO2, 96.983; 17: Perf, 1.158; 17: 1min HRV, 21.785; 17: 5min HRV, 30.540; 18: HR, 77.05; 18: RR, 22.217; 18: SpO2, 97.283; 18: Perf, 1.249; 18: 1min HRV, 13.935; 19: HR, 81.018; 19: RR, 18.386; 19: SpO2, 97.386; 19: Perf, 1.181; 19: 1min HRV, 20.072; 20: HR, 79.898; 20: RR, 22.593; 20: SpO2, 97.390; 20: Perf, 1.124; 20: 1min HRV, 20.390; 21: HR, 81.655; 21: RR, 23.069; 21: SpO2, 97.517; 21: Perf, 1.018; 21: 1min HRV, 15.768; 22: HR, 81.136; 22: RR, 22.102; 22: SpO2, 97.390; 22: Perf, 1.014; 22: 1min HRV, 27.226; 22: 5min HRV, 25.597; 23: HR, 81.217; 23: RR, 23.167; 23: SpO2, 97.05; 23: Perf, 1.053; 23: 1min HRV, 23.937; 23: Pain, 10.0; 24: HR, 81.018; 24: RR, 21.123; 24: SpO2, 96.877; 24: Perf, 1.125; 24: 1min HRV, 38.289; 25: HR, 83.017; 25: RR, 21.8; 25: SpO2, 97.233; 25: Perf, 1.119; 25: 1min HRV, 20.266; 26: HR, 81.404; 26: RR, 19.947; 26: SpO2, 96.912; 26: Perf, 1.140; 26: 1min HRV, 21.604; 27: HR, 80.864; 27: RR, 23.169; 27: SpO2, 97.203; 27: Perf, 1.119; 27: 1min HRV, 14.880; 27: 5min HRV, 25.481; 27: SBP, 154.0; 27: DBP, 79.0; 27: MAP, 104.0; 28: HR, 81.3; 28: RR, 21.967; 28: SpO2, 97.1; 28: Perf, 1.037; 28: 1min HRV, 17.820; 28: SBP, 154.0; 28: DBP, 79.0; 28: MAP, 104.0; 29: HR, 82.175; 29: RR, 24.035; 29: SpO2, 97.228; 29: Perf, 0.969; 29: 1min HRV, 21.252; 30: HR, 80.458; 30: RR, 22.508; 30: SpO2, 97.237; 30: Perf, 1.003; 30: 1min HRV, 19.101; 31: HR, 78.441; 31: RR, 19.797; 31: SpO2, 97.508; 31: Perf, 1.016; 31: 1min HRV, 22.356; 32: HR, 83.845; 32: RR, 16.293; 32: SpO2, 96.276; 32: Perf, 0.984; 32: 1min HRV, 16.489; 32: 5min HRV, 24.109; 33: HR, 79.475; 33: RR, 22.864; 33: SpO2, 96.915; 33: Perf, 0.929; 33: 1min HRV, 18.395; 34: HR, 79.814; 34: RR, 22.051; 34: SpO2, 97.254; 34: Perf, 0.933; 34: 1min HRV, 27.613; 35: HR, 76.172; 35: RR, 21.293; 35: SpO2, 96.914; 35: Perf, 1.011; 35: 1min HRV, 34.719; 36: HR, 78.847; 36: RR, 20.881; 36: SpO2, 96.932; 36: Perf, 1.105; 36: 1min HRV, 25.498; 37: HR, 79.638; 37: RR, 22.5; 37: SpO2, 97.448; 37: Perf, 0.987; 37: 1min HRV, 10.071; 37: 5min HRV, 27.434; 38: HR, 80.0; 38: RR, 21.220; 38: SpO2, 97.441; 38: Perf, 1.018; 38: 1min HRV, 14.389; 39: HR, 79.138; 39: RR, 23.638; 39: SpO2, 97.586; 39: Perf, 1.066; 39: 1min HRV, 13.513; 40: HR, 80.763; 40: RR, 21.729; 40: SpO2, 97.593; 40: Perf, 1.016; 40: 1min HRV, 11.630; 41: HR, 80.932; 41: RR, 22.169; 41: SpO2, 97.915; 41: Perf, 1.100; 41: 1min HRV, 13.254; 42: HR, 82.051; 42: RR, 20.322; 42: SpO2, 97.373; 42: Perf, 1.055; 42: 1min HRV, 29.948; 42: 5min HRV, 20.107; 43: HR, 79.724; 43: RR, 21.259; 43: SpO2, 97.276; 43: Perf, 1.029; 43: 1min HRV, 30.056; 43: SBP, 181.0; 43: DBP, 167.0; 43: MAP, 171.667; 44: HR, 80.712; 44: RR, 21.814; 44: SpO2, 97.593; 44: Perf, 0.926; 44: 1min HRV, 15.547; 45: HR, 80.661; 45: RR, 22.203; 45: SpO2, 97.407; 45: Perf, 1.028; 45: 1min HRV, 13.599; 47: 5min HRV, 21.117; 57: HR, 74.0; 57: RR, 18.0; 57: SpO2, 97.0; 57: SBP, 136.0; 57: DBP, 76.0; 57: MAP, 96.0; 81: WAM DIFTYP, AUTO; 81: RED BLOOD CELLS (RBC), 2.72 MIL/uL; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.43 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 81: BASOPHIL % (AUTO DIFF), 0.3 %; 81: MONOCYTE % (AUTO DIFF), 12.4 %; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.32 K/uL; 81: HEMOGLOBIN (HGB), 8.4 g/dL; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.9 pg; 81: NEUTROPHIL % (AUTO DIFF), 66.8 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.68 K/uL; 81: LYMPHOCYTE % (AUTO DIFF), 19.6 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 81: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 81: PLATELET COUNT (PLT), 176 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: HEMATOCRIT (HCT), 25.8 %; 81: EOSINOPHIL % (AUTO DIFF), 0.3 %; 81: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 111: HIGH SENSITIVITY TROPONIN, 14 ng/L; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 61.0; 0: Triage acuity, 3-Urgent; 0: CC, RIB PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I started by noting the patient\u2019s stable blood pressure, heart rate, and temperature, which do not suggest an acute infection. I also observed that the patient\u2019s white blood cell count is low rather than elevated, with no clear sign of a new or worsening infection. While the anemia and advanced age are concerns, they do not by themselves indicate imminent sepsis without other supporting vital or laboratory abnormalities.",
        "claims": [
            "The patient's blood pressure is stable.",
            "The patient's heart rate is stable.",
            "The patient's temperature is stable.",
            "Stable blood pressure, heart rate, and temperature do not suggest an acute infection.",
            "The patient's white blood cell count is low.",
            "A low white blood cell count does not indicate a new or worsening infection.",
            "The patient has anemia.",
            "The patient is of advanced age.",
            "Anemia and advanced age are concerns.",
            "Anemia and advanced age do not indicate imminent sepsis without other supporting vital or laboratory abnormalities."
        ],
        "relevant_claims": [
            "A low white blood cell count does not indicate a new or worsening infection.",
            "Anemia and advanced age do not indicate imminent sepsis without other supporting vital or laboratory abnormalities."
        ],
        "alignment_scores": [
            0.8,
            0.3
        ],
        "alignment_category": [
            2,
            1
        ],
        "alignment_reasonings": [
            "A low white blood cell count (WBC < 4,000/\u00b5L) is one of the criteria for SIRS, indicating systemic inflammation that can be associated with sepsis. While the claim states that a low WBC does not indicate a new or worsening infection, it is relevant to SIRS criteria, which are used to assess early signs of sepsis. The alignment is somewhat strong because the criteria for SIRS are directly mentioned, although the intent of the claim is to dismiss the connection.",
            "The claim references advanced age, which directly relates to the Elderly Susceptibility category. However, the statement negates advanced age as a sufficient indicator of imminent sepsis without other abnormalities, reducing the alignment to a moderate level. The category identifies advanced age as a risk factor, but the claim suggests it is not sufficient on its own, reflecting a partial alignment."
        ],
        "final_alignment_score": 0.55,
        "accuracy": 1
    },
    {
        "input": "10: HR, 96.0; 10: RR, 26.0; 10: SpO2, 98.0; 10: SBP, 133.0; 10: DBP, 76.0; 10: MAP, 95.0; 10: Temp, 99.1; 27: SpO2, 97.156; 27: SBP, 131.0; 27: DBP, nan; 27: MAP, nan; 28: SpO2, 97.357; 29: SpO2, 98.341; 30: SpO2, 97.492; 31: SpO2, 95.793; 31: SBP, 119.0; 31: DBP, 58.0; 31: MAP, 78.333; 32: SpO2, 95.237; 33: SpO2, 97.308; 34: SpO2, 97.517; 35: SpO2, 97.932; 36: SpO2, 97.569; 37: SpO2, 97.655; 38: SpO2, 97.367; 39: SpO2, 97.263; 40: SpO2, 97.914; 41: SpO2, 97.644; 42: SpO2, 97.724; 43: SpO2, 96.5; 44: SpO2, 99.0; 44: Perf, 3.644; 45: SpO2, 97.983; 45: Perf, 3.672; 46: HR, 69.0; 46: RR, 30.0; 46: SpO2, 96.958; 46: Perf, 3.73; 46: SBP, 130.0; 46: DBP, 116.0; 46: MAP, 120.667; 46: Temp, 98.3; 47: HR, 62.0; 47: SpO2, 95.103; 47: SBP, 130.0; 47: DBP, 116.0; 47: MAP, 120.667; 48: SpO2, 99.375; 49: SpO2, 97.864; 50: SpO2, 95.862; 51: SpO2, 95.644; 52: SpO2, 95.949; 53: SpO2, 96.712; 54: SpO2, 97.052; 55: SpO2, 97.102; 56: SpO2, 96.810; 57: SpO2, 96.276; 57: Perf, 3.434; 58: SpO2, 96.780; 58: Perf, 3.367; 59: SpO2, 96.276; 59: Perf, 3.348; 60: SpO2, 96.831; 60: Perf, 3.294; 61: SpO2, 96.879; 61: Perf, 3.28; 62: HR, 106.809; 62: RR, 19.659; 62: SpO2, 97.203; 62: Perf, 3.316; 62: 1min HRV, 66.908; 63: HR, 107.776; 63: RR, 20.328; 63: SpO2, 97.034; 63: Perf, 3.291; 63: 1min HRV, 64.980; 64: HR, 107.103; 64: RR, 23.525; 64: SpO2, 97.729; 64: Perf, 3.29; 64: 1min HRV, 61.610; 65: HR, 108.610; 65: RR, 14.053; 65: SpO2, 97.847; 65: Perf, 3.232; 65: 1min HRV, 71.515; 65: 5min HRV, 66.948; 66: HR, 107.789; 66: SpO2, 97.333; 66: Perf, 3.108; 66: 1min HRV, 64.832; 67: HR, 109.559; 67: SpO2, 97.305; 67: Perf, 3.065; 67: 1min HRV, 66.942; 68: HR, 111.069; 68: SpO2, 96.810; 68: Perf, 3.06; 68: 1min HRV, 67.297; 69: HR, 105.695; 69: SpO2, 96.085; 69: Perf, 3.204; 69: 1min HRV, 65.368; 70: WAM DIFTYP, AUTO; 70: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 70: HEMOGLOBIN (HGB), 16.0 g/dL; 70: HEMATOCRIT (HCT), 48.3 %; 70: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 70: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.47 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 9.7 %; 70: NEUTROPHIL % (AUTO DIFF), 81.6 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 70: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: BASOPHIL % (AUTO DIFF), 0.5 %; 70: PLATELET COUNT (PLT), 203 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 0.3 %; 70: HR, 107.627; 70: SpO2, 96.424; 70: Perf, 3.251; 70: 1min HRV, 60.198; 70: 5min HRV, 65.907; 71: HR, 104.517; 71: SpO2, 97.621; 71: Perf, 3.208; 71: 1min HRV, 76.915; 72: HR, 107.390; 72: SpO2, 97.119; 72: Perf, 3.320; 72: 1min HRV, 64.587; 73: HR, 105.534; 73: SpO2, 96.966; 73: Perf, 3.356; 73: 1min HRV, 65.170; 74: GLUCOSE, URINE (UA): Negative; 74: KETONE, URINE (UA): Negative; 74: PH, URINE (UA): 5.0; 74: LEUKOCYTE ESTERASE, URINE (UA): Negative; 74: NITRITE, URINE (UA): Negative; 74: SPECIFIC GRAVITY, URINE (UA): 1.027; 74: HR, 106.881; 74: SpO2, 96.153; 74: Perf, 3.34; 74: 1min HRV, 67.444; 75: HR, 109.949; 75: SpO2, 96.542; 75: Perf, 3.34; 75: 1min HRV, 64.928; 75: 5min HRV, 68.501; 76: HR, 106.569; 76: SpO2, 97.0; 76: Perf, 3.365; 76: 1min HRV, 66.408; 77: HR, 108.746; 77: SpO2, 97.203; 77: Perf, 3.376; 77: 1min HRV, 59.347; 78: HR, 111.0; 78: SpO2, 97.466; 78: Perf, 3.38; 78: 1min HRV, 72.866; 79: HR, 108.351; 79: RR, 29.957; 79: SpO2, 97.458; 79: Perf, 3.38; 79: 1min HRV, 69.164; 80: HR, 113.881; 80: RR, 28.872; 80: SpO2, 95.746; 80: Perf, 3.38; 80: 1min HRV, 56.213; 80: 5min HRV, 66.186; 81: HR, 111.0; 81: RR, 21.552; 81: SpO2, 97.931; 81: Perf, 3.390; 81: 1min HRV, 54.996; 82: HR, 109.322; 82: RR, 19.471; 82: SpO2, 97.864; 82: Perf, 3.436; 82: 1min HRV, 58.811; 83: HR, 110.707; 83: RR, 22.382; 83: SpO2, 97.810; 83: Perf, 3.44; 83: 1min HRV, 50.588; 84: HR, 110.203; 84: RR, 31.25; 84: SpO2, 97.085; 84: Perf, 3.44; 84: 1min HRV, 57.078; 85: HR, 104.948; 85: RR, 21.397; 85: SpO2, 97.0; 85: Perf, 3.421; 85: 1min HRV, 63.378; 85: 5min HRV, 57.972; 86: HR, 105.455; 86: RR, 19.75; 86: SpO2, 97.103; 86: Perf, 3.377; 86: 1min HRV, 62.959; 87: HR, 104.224; 87: RR, 21.069; 87: SpO2, 97.0; 87: Perf, 3.37; 87: 1min HRV, 65.987; 88: HR, 107.471; 88: RR, 25.810; 88: SpO2, 97.845; 88: Perf, 3.351; 88: 1min HRV, 59.549; 89: HR, 107.932; 89: RR, 13.639; 89: SpO2, 97.593; 89: Perf, 3.289; 89: 1min HRV, 63.945; 90: HR, 109.508; 90: RR, 16.552; 90: SpO2, 96.831; 90: Perf, 3.182; 90: 1min HRV, 64.924; 90: 5min HRV, 64.664; 91: HR, 107.0; 91: SpO2, 96.0; 91: Perf, 2.889; 93: INR, 1.2; 93: PROTHROMBIN TIME, 15.0 seconds; 94: PART. THROMBOPLASTIN TIME, 36.6 seconds; 102: BNP NT-PRO, 2531 pg/mL; 102: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 109: TROPONIN I: ., 030 ng/mL; 0: Age, 48; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 96.0; 0: Triage RR, 26.0; 0: Triage SBP, 133.0; 0: Triage DBP, 76.0; 0: Triage acuity, 3-Urgent; 0: CC, URINARY PAIN,FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed the patient\u2019s presenting complaint of urinary symptoms plus borderline fever, which raises concern for a possible infection. Several vital signs indicate physiologic stress, including a persistently elevated respiratory rate and intermittent tachycardia. Despite a normal white blood cell count, the presence of possible infection and abnormal vitals suggests an elevated risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient has a presenting complaint of urinary symptoms.",
            "The patient has a borderline fever.",
            "The combination of urinary symptoms and borderline fever raises concern for a possible infection.",
            "Several vital signs indicate physiologic stress.",
            "The patient has a persistently elevated respiratory rate.",
            "The patient has intermittent tachycardia.",
            "Despite having a normal white blood cell count, there is a presence of possible infection.",
            "Abnormal vital signs suggest an elevated risk of sepsis.",
            "There is an elevated risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has a presenting complaint of urinary symptoms.",
            "The patient has a borderline fever.",
            "The combination of urinary symptoms and borderline fever raises concern for a possible infection.",
            "Several vital signs indicate physiologic stress.",
            "The patient has a persistently elevated respiratory rate.",
            "The patient has intermittent tachycardia.",
            "Despite having a normal white blood cell count, there is a presence of possible infection.",
            "Abnormal vital signs suggest an elevated risk of sepsis.",
            "There is an elevated risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.5,
            0.7,
            0.7,
            0.7,
            0.3,
            0.7,
            0.3
        ],
        "alignment_category": [
            9,
            2,
            2,
            4,
            3,
            2,
            9,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions urinary symptoms, which could suggest a urinary tract infection\u2014a potential source of sepsis. However, without concrete evidence of clinical actions like the administration of antibiotics or culture orders, the alignment is weak. The symptom itself implies that further investigation might be needed, in line with category 9, but the claim lacks direct reference to actions typically anchoring a sepsis risk assessment.",
            "A borderline fever suggests the patient might be near the temperature threshold (>38\u00b0C) for SIRS criteria, making it marginally relevant. However, without a precise temperature value, it doesn't fully meet the SIRS criterion for systemic inflammation, leading to a low but present alignment with the category.",
            "The claim mentions \"borderline fever,\" which suggests a potential elevation in temperature close to the SIRS criteria of >38\u00b0C. It indirectly implies systemic inflammation due to infection. However, without specific temperature data or additional SIRS criteria being met, the alignment is suggestive but not definitive. The mention of \"possible infection\" further aligns with the context of systemic inflammatory response.",
            "The claim that several vital signs indicate physiologic stress aligns most closely with the Elevated NEWS Score category, which is derived from deranged vitals. While the claim does not specify an actual NEWS score or list specific vital signs contributing to the stress, it suggests that multiple vital signs are abnormal, which is consistent with the concept of NEWS. The alignment rating is 0.7 because the claim broadly hints at the relevant category without specifying sufficient detail to fully confirm it.",
            "A persistently elevated respiratory rate is directly mentioned as a component of the qSOFA criteria (respiratory rate\u202f\u2265\u202f22/min). Although the claim does not specify whether the respiratory rate meets this exact threshold, the persistent elevation suggests a possible alignment with high qSOFA. This connection is meaningful, as it implies higher risk due to respiratory involvement, but without specific rate details, the match isn't perfect.",
            "Intermittent tachycardia refers to episodes of elevated heart rate, which aligns with the SIRS criterion of heart rate >90 bpm. While it does indicate one criterion of systemic inflammation, the alignment is not complete because SIRS requires \u22652 criteria. Therefore, it moderately suggests a potential for early sepsis, reflected in the alignment rating.",
            "The presence of a possible infection suggests a clinical suspicion that might prompt early antibiotic therapy or culture orders, aligning with this category. However, the claim does not mention any specific diagnostic or treatment actions being taken, thus the alignment is weak.",
            "The claim mentions \"abnormal vital signs,\" which aligns well with the purpose of the NEWS score\u2014assessing deranged vitals to predict clinical deterioration that could indicate sepsis. While the claim does not specify the level of derangement needed for a NEWS score of \u22655, the concept of evaluating abnormal vitals closely matches the NEWS assessment strategy, thus a relatively high alignment rating.",
            "The claim suggests a general elevated risk of sepsis, which aligns with the purpose of scoring systems like the NEWS that predict clinical deterioration. However, it does not provide specific details or criteria met, such as a NEWS score value, reducing the strength of the alignment. The claim could theoretically fit several categories, but without specifics like deranged vitals or a specific measure, the connection is vague."
        ],
        "final_alignment_score": 0.4999999999999999,
        "accuracy": 0
    },
    {
        "input": "8: HR, 122.0; 8: 1min HRV, 6.485; 9: HR, 119.949; 9: 1min HRV, 5.774; 10: HR, 119.431; 10: RR, 25.0; 10: SpO2, 99.0; 10: 1min HRV, 7.438; 10: SBP, 157.0; 10: DBP, 111.0; 10: MAP, 126.333; 10: Pain, 10.0; 10: Temp, 97.7; 11: HR, 125.864; 11: 1min HRV, 5.985; 12: HR, 128.552; 12: 1min HRV, 12.354; 12: 5min HRV, 15.326; 13: HR, 132.763; 13: 1min HRV, 5.476; 14: HR, 128.237; 14: 1min HRV, 5.782; 15: HR, 127.052; 15: 1min HRV, 6.009; 16: HR, 129.576; 16: 1min HRV, 3.205; 17: HR, 131.397; 17: SpO2, 81.0; 17: 1min HRV, 3.718; 17: 5min HRV, 8.351; 18: HR, 134.780; 18: SpO2, 81.6; 18: 1min HRV, 3.966; 19: HR, 134.322; 19: 1min HRV, 3.130; 20: HR, 134.966; 20: 1min HRV, 2.578; 21: HR, 136.186; 21: 1min HRV, 3.903; 22: HR, 135.621; 22: 1min HRV, 2.507; 22: 5min HRV, 3.855; 23: HR, 135.915; 23: 1min HRV, 3.906; 24: HR, 138.593; 24: 1min HRV, 12.697; 25: HR, 137.172; 25: 1min HRV, 2.892; 26: HR, 137.729; 26: 1min HRV, 5.677; 27: HR, 141.534; 27: 1min HRV, 10.735; 27: 5min HRV, 9.730; 28: HR, 140.305; 28: 1min HRV, 3.041; 29: HR, 136.603; 29: 1min HRV, 7.352; 30: HR, 136.898; 30: SpO2, 72.030; 30: 1min HRV, 3.811; 31: HR, 141.288; 31: SpO2, 71.5; 31: 1min HRV, 10.722; 32: HR, 141.086; 32: 1min HRV, 6.121; 32: 5min HRV, 10.326; 33: HR, 140.068; 33: 1min HRV, 3.493; 34: HR, 140.362; 34: 1min HRV, 3.298; 35: HR, 145.552; 35: SpO2, 84.059; 35: 1min HRV, 11.218; 36: HR, 143.617; 36: 1min HRV, 12.918; 37: HR, 147.948; 37: 1min HRV, 17.235; 37: 5min HRV, 13.856; 38: HR, 145.186; 38: SpO2, 80.0; 38: 1min HRV, 11.901; 39: HR, 143.362; 39: SpO2, 80.611; 39: 1min HRV, 5.209; 40: HR, 141.119; 40: 1min HRV, 4.706; 41: HR, 143.576; 41: 1min HRV, 15.462; 42: HR, 143.431; 42: 1min HRV, 5.235; 42: 5min HRV, 10.431; 43: HR, 143.085; 43: 1min HRV, 16.664; 44: HR, 142.431; 44: 1min HRV, 3.801; 44: HYDROMORPHONE, 1 MG/ML INJ SYRG; 45: HR:, 141.322; 45: 1min HRV, 3.006; 46: HR, 140.729; 46: 1min HRV, 6.007; 47: HR, 144.759; 47: 1min HRV, 5.140; 47: 5min HRV, 9.141; 48: HR, 140.534; 48: 1min HRV, 12.333; 49: HR, 137.186; 49: 1min HRV, 2.207; 50: HR, 137.153; 50: 1min HRV, 3.967; 51: HR, 135.915; 51: 1min HRV, 3.492; 52: HR, 137.448; 52: 1min HRV, 5.259; 52: 5min HRV, 7.911; 53: HR, 140.576; 53: 1min HRV, 7.635; 54: HR, 140.586; 54: 1min HRV, 3.035; 55: HR, 139.763; 55: 1min HRV, 2.794; 56: HR, 136.746; 56: 1min HRV, 4.514; 57: HR, 136.224; 57: 1min HRV, 5.090; 57: 5min HRV, 7.816; 58: HR, 135.525; 58: 1min HRV, 2.689; 59: HR, 136.483; 59: 1min HRV, 3.506; 60: HR, 136.569; 60: 1min HRV, 2.851; 61: HR, 136.915; 61: 1min HRV, 15.564; 62: HR, 136.068; 62: 1min HRV, 2.720; 62: 5min HRV, 7.596; 63: HR, 135.356; 63: 1min HRV, 3.134; 64: HR, 136.552; 64: 1min HRV, 4.518; 65: HR, 139.661; 65: 1min HRV, 7.439; 66: HR, 133.0; 66: 1min HRV, 19.097; 67: HR, 132.492; 67: 1min HRV, 3.197; 67: 5min HRV, 12.820; 68: HR, 133.186; 68: 1min HRV, 4.656; 69: HR, 134.966; 69: 1min HRV, 3.943; 70: HR, 134.712; 70: 1min HRV, 2.937; 71: HR, 134.983; 71: 1min HRV, 3.785; 72: HR, 133.879; 72: 1min HRV, 2.891; 72: 5min HRV, 4.401; 73: HR, 133.85; 73: 1min HRV, 3.464; 74: HR, 135.828; 74: 1min HRV, 5.596; 75: HR, 139.271; 75: 1min HRV, 5.174; 76: HR, 142.5; 76: 1min HRV, 0.740; 77: SARS-COV-2 RNA, Not Detected; 77: 5min HRV, 9.243; 79: HR, 143.0; 79: 1min HRV, 1.797; 80: HR, 140.949; 80: 1min HRV, 16.120; 81: HR, 136.966; 81: 1min HRV, 3.455; 82: HR, 135.542; 82: 1min HRV, 2.452; 82: 5min HRV, 12.124; 83: HR, 134.797; 83: 1min HRV, 2.825; 84: HR, 135.483; 84: 1min HRV, 2.503; 84: LR IV BOLUS -, 1000 ML; 85: HR:, 135.068; 85: 1min HRV, 3.966; 86: HR, 135.310; 86: 1min HRV, 4.188; 87: HR, 135.288; 87: 1min HRV, 3.515; 87: 5min HRV, 3.577; 88: HR, 136.417; 88: 1min HRV, 2.231; 92: 5min HRV, 2.231; 93: SpO2, 94.778; 97: Pain, 8.0; 110: SpO2, 92.444; 0: Age, 40; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 157.0; 0: Triage DBP, 111.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,FLANK PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The patient\u2019s steadily elevated heart rate and repeated drops in oxygen saturation suggest escalating clinical instability. Abdominal/flank pain in conjunction with tachycardia and tachypnea raises suspicion for an infection-based etiology. The administration of IV fluids and the persistent abnormal vitals point to a systemic response that aligns with sepsis criteria. Given these factors, there is a high likelihood of sepsis developing within 12 hours.",
        "claims": [
            "The patient has a steadily elevated heart rate.",
            "The patient's heart rate is steadily elevated.",
            "There are repeated drops in the patient's oxygen saturation.",
            "The repeated drops in oxygen saturation suggest escalating clinical instability.",
            "Abdominal or flank pain is present in the patient.",
            "The patient exhibits tachycardia.",
            "The patient exhibits tachypnea.",
            "The combination of abdominal/flank pain, tachycardia, and tachypnea raises suspicion for an infection-based etiology.",
            "The patient has received IV fluids.",
            "The patient has persistent abnormal vital signs.",
            "The persistent abnormal vital signs point to a systemic response.",
            "The systemic response aligns with sepsis criteria.",
            "Given these factors, there is a high likelihood of sepsis developing within 12 hours."
        ],
        "relevant_claims": [
            "The patient has a steadily elevated heart rate.",
            "The patient's heart rate is steadily elevated.",
            "The repeated drops in oxygen saturation suggest escalating clinical instability.",
            "Abdominal or flank pain is present in the patient.",
            "The patient exhibits tachycardia.",
            "The patient exhibits tachypnea.",
            "The combination of abdominal/flank pain, tachycardia, and tachypnea raises suspicion for an infection-based etiology.",
            "The patient has received IV fluids.",
            "The patient has persistent abnormal vital signs.",
            "The persistent abnormal vital signs point to a systemic response.",
            "The systemic response aligns with sepsis criteria.",
            "Given these factors, there is a high likelihood of sepsis developing within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.5,
            0.7,
            0.3,
            0.5,
            0.8,
            0.8,
            0.3,
            0.7,
            0.7,
            0.8,
            0.3
        ],
        "alignment_category": [
            6,
            6,
            8,
            8,
            2,
            3,
            2,
            7,
            4,
            4,
            2,
            4
        ],
        "alignment_reasonings": [
            "An elevated heart rate can contribute to an elevated shock index, especially when also considering blood pressure. While the claim mentions an elevated heart rate and not directly an elevated shock index, the heart rate plays a significant role in calculating the shock index, which denotes haemodynamic instability and the risk of severe sepsis. The alignment is strong but not perfect due to the lack of direct reference to blood pressure or the shock index itself.",
            "An elevated heart rate is a component of the Shock Index calculation (heart rate \u00f7 systolic BP). While the claim does not provide the systolic blood pressure needed to calculate the Shock Index, a steadily elevated heart rate suggests a risk of hemodynamic instability, a concern captured in this category. The alignment is partial due to the absence of complete data for precise calculation of the Shock Index.",
            "The claim discusses drops in oxygen saturation, indicating potential respiratory compromise and clinical instability, which aligns conceptually with the SOFA score's concern for organ dysfunction, including impaired oxygenation (e.g., PaO\u2082/FiO\u2082 ratio). While not directly a SOFA measure, the repeated decline in saturation suggests a pattern of worsening organ function, similar to what a SOFA score increase might capture. The alignment is moderately strong due to the conceptual if not direct linkage.",
            "Abdominal or flank pain is not explicitly listed under any specific category. However, pain may suggest an underlying condition that could contribute to organ dysfunction or infection, which the SOFA score seeks to identify. The alignment is weak and indirect, as the pain on its own does not constitute a specific SOFA criterion or sepsis marker.",
            "Tachycardia alone is one of the criteria listed under the Systemic Inflammatory Response Syndrome (SIRS), which includes a heart\u202frate of\u202f>\u202f90\u202fbpm. While the presence of tachycardia alone does not fulfill the requirement of SIRS (which needs at least two criteria), it is still directly related to the SIRS criteria, warranting a moderate alignment rating.",
            "Tachypnea, an elevated respiratory rate, is explicitly part of the qSOFA score criteria (respiratory rate\u202f\u2265\u202f22\u202f/min). While the claim does not specify the exact rate to confirm if it meets qSOFA thresholds, tachypnea\u2019s association with an increased respiratory rate strongly aligns it with the High qSOFA Score category. Thus, the alignment is significant but not absolute due to the lack of specific rate details.",
            "The claim mentions tachycardia (increased heart rate) and tachypnea (increased respiratory rate), which are both criteria listed under SIRS for systemic inflammation relevant to early sepsis. While abdominal/flank pain is not directly a SIRS criterion, it can suggest an infection-based etiology relevant to the identification of sepsis. Two of the four SIRS criteria are recognized, resulting in a strong but not perfect alignment.",
            "The administration of IV fluids often occurs in response to hypotension, a symptom closely related to septic shock. While the claim does not specify hypotension, it suggests possible management of volume status which aligns conceptually with treating sepsis-associated hypotension or shock. However, without specific vital sign data indicating hypotension, the alignment is weak.",
            "The claim about persistent abnormal vital signs is indicative of a potentially high NEWS score, as the NEWS uses vital sign abnormalities to flag clinical deterioration. However, without specific details on the exact values of the vital signs, it only suggests but doesn't confirm a NEWS score of \u22655, leading to a strong but not complete alignment.",
            "The claim refers to \"persistent abnormal vital signs,\" which aligns with the concept of an elevated NEWS score resulting from deranged vitals. While the claim does not specify any particular NEWS score or abnormality, it suggests a systemic response similar to what the NEWS score captures regarding clinical deterioration. The alignment is moderate due to the lack of specific detail about the abnormalities or a quantified NEWS score.",
            "The claim indicates a systemic response that aligns with sepsis criteria. The SIRS criteria specifically identify systemic inflammation, which is consistent with early sepsis detection. However, the claim doesn't specify whether two or more criteria are met, which prevents full alignment with the category. Thus, the alignment rating reflects a strong but not perfect connection.",
            "The claim indicates a general prediction of high likelihood for sepsis development without specific clinical measures or scores. The Elevated NEWS Score category aligns generally with the prediction of imminent clinical deterioration and a high risk of sepsis. However, the claim lacks any specific mention of deranged vitals or NEWS Score, so the alignment is indirect and thus graded low."
        ],
        "final_alignment_score": 0.5916666666666667,
        "accuracy": 1
    },
    {
        "input": "9: HR, 95.0; 9: RR, 18.0; 9: SpO2, 77.0; 9: SBP, 112.0; 9: DBP, 84.0; 9: MAP, 93.333; 9: LPM O2, nan; 9: Temp, 98.1; 14: SpO2, 96.0; 14: LPM O2, 4.0; 45: HR, 82.0; 45: SpO2, 96.0; 45: SBP, 122.0; 45: DBP, 80.0; 45: MAP, 94.0; 45: LPM O2, 4.0; 49: SpO2, 96.0; 50: SpO2, 95.109; 50: Perf, 1.92; 51: SpO2, 94.774; 51: Perf, 1.96; 75: SpO2, 97.0; 76: SpO2, 96.566; 77: SpO2, 96.358; 78: SpO2, 96.808; 79: SpO2, 97.245; 80: SpO2, 97.135; 81: SpO2, 97.093; 82: SpO2, 97.321; 82: Perf, 0.838; 83: SpO2, 98.115; 83: Perf, 1.027; 84: SpO2, 98.811; 84: Perf, 1.008; 85: HR, 83.152; 85: RR, 23.25; 85: SpO2, 98.962; 85: Perf, 0.881; 85: 1min HRV, 92.396; 85: 5min HRV, 92.396; 86: HR, 83.981; 86: RR, 22.811; 86: SpO2, 99.415; 86: Perf, 0.951; 86: 1min HRV, 91.875; 87: HR, 83.189; 87: RR, 18.151; 87: SpO2, 98.906; 87: Perf, 0.996; 87: 1min HRV, 99.886; 88: HR, 84.346; 88: RR, 20.596; 88: SpO2, 98.904; 88: Perf, 0.978; 88: 1min HRV, 98.378; 89: HR, 87.698; 89: RR, 23.340; 89: SpO2, 98.684; 89: Perf, 0.97; 89: 1min HRV, 103.759; 90: HR, 86.269; 90: RR, 19.558; 90: SpO2, 98.0; 90: Perf, 0.974; 90: 1min HRV, 87.281; 90: 5min HRV, 97.058; 91: HR, 86.170; 91: RR, 24.434; 91: SpO2, 97.830; 91: Perf, 0.982; 91: 1min HRV, 114.745; 92: HR, 86.547; 92: RR, 20.755; 92: SpO2, 98.377; 92: Perf, 0.993; 92: 1min HRV, 96.649; 93: HR, 87.887; 93: RR, 25.377; 93: SpO2, 98.509; 93: Perf, 1.400; 93: 1min HRV, 128.835; 94: HR, 88.094; 94: RR, 23.755; 94: SpO2, 98.377; 94: Perf, 1.707; 94: 1min HRV, 115.796; 95: HR, 85.423; 95: RR, 20.481; 95: SpO2, 98.0; 95: Perf, 1.755; 95: 1min HRV, 87.944; 95: 5min HRV, 109.781; 96: HR, 84.811; 96: RR, 19.170; 96: SpO2, 98.308; 96: Perf, 1.494; 96: 1min HRV, 107.870; 97: HR, 83.887; 97: RR, 18.962; 97: SpO2, 98.0; 97: Perf, 1.488; 97: 1min HRV, 96.765; 98: HR, 83.654; 98: RR, 19.212; 98: SpO2, 98.269; 98: Perf, 1.531; 98: 1min HRV, 106.380; 99: HR, 83.415; 99: RR, 16.887; 99: SpO2, 98.576; 99: Perf, 1.367; 99: 1min HRV, 102.632; 100: HR, 83.846; 100: RR, 17.75; 100: SpO2, 97.923; 100: Perf, 1.313; 100: 1min HRV, 83.002; 100: 5min HRV, 99.817; 101: WAM DIFTYP, AUTO; 101: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 101: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.80 K/uL; 101: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 101: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 101: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 101: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 101: MONOCYTE % (AUTO DIFF), 9.9 %; 101: LYMPHOCYTE % (AUTO DIFF), 15.4 %; 101: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 101: NRBC PERCENT (HEMATOLOGY), 0.0 %; 101: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.35 K/uL; 101: EOSINOPHIL % (AUTO DIFF), 5.0 %; 101: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.07 K/uL; 101: MEAN CORPUSCULAR VOLUME (MCV), 114.1 fL; 101: NEUTROPHIL % (AUTO DIFF), 69.2 %; 101: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 35.9 pg; 101: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 101: HEMOGLOBIN (HGB), 10.4 g/dL; 101: HEMATOCRIT (HCT), 33.1 %; 101: PLATELET COUNT (PLT), 197 K/uL; 101: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 101: RED CELL DISTRIBUTION WIDTH (RDW), 14.4 %; 101: BASOPHIL % (AUTO DIFF), 0.4 %; 101: HR, 84.057; 101: RR, 19.132; 101: SpO2, 98.453; 101: Perf, 1.311; 101: 1min HRV, 120.978; 102: HR, 83.396; 102: RR, 17.943; 102: SpO2, 97.566; 102: Perf, 1.299; 102: 1min HRV, 100.458; 103: HR, 84.192; 103: RR, 21.981; 103: SpO2, 98.0; 103: Perf, 1.255; 103: 1min HRV, 117.417; 104: HR, 83.981; 104: RR, 19.226; 104: SpO2, 97.906; 104: Perf, 1.149; 104: 1min HRV, 95.129; 105: HR, 82.942; 105: RR, 17.558; 105: SpO2, 98.327; 105: Perf, 1.450; 105: 1min HRV, 86.174; 105: 5min HRV, 103.831; 105: LPM O2, 4.0; 106: HR, 83.509; 106: RR, 19.019; 106: SpO2, 97.566; 106: Perf, 1.604; 106: 1min HRV, 98.076; 107: HR, 83.472; 107: RR, 20.075; 107: SpO2, 98.019; 107: Perf, 1.633; 107: 1min HRV, 81.495; 108: HR, 82.925; 108: RR, 20.679; 108: SpO2, 98.245; 108: Perf, 0.948; 108: 1min HRV, 121.444; 109: HR, 83.075; 109: RR, 21.132; 109: SpO2, 98.434; 109: Perf, 0.889; 109: 1min HRV, 102.718; 110: HR, 81.923; 110: RR, 22.231; 110: SpO2, 97.962; 110: Perf, 1.283; 110: 1min HRV, 85.795; 110: 5min HRV, 99.079; 111: HR, 82.642; 111: RR, 20.585; 111: SpO2, 98.830; 111: Perf, 1.488; 111: 1min HRV, 84.665; 112: HR, 84.712; 112: RR, 20.635; 112: SpO2, 98.769; 112: Perf, 1.543; 112: 1min HRV, 110.879; 113: HR, 82.283; 113: RR, 25.396; 113: SpO2, 98.434; 113: Perf, 1.144; 113: 1min HRV, 86.141; 114: HR, 83.222; 114: RR, 20.778; 114: SpO2, 98.611; 114: Perf, 0.899; 114: 1min HRV, 84.949; 115: HR, 82.423; 115: RR, 21.827; 115: SpO2, 98.365; 115: Perf, 0.94; 115: 1min HRV, 89.629; 115: 5min HRV, 91.965; 116: HR, 82.755; 116: RR, 20.811; 116: SpO2, 98.755; 116: Perf, 1.107; 116: 1min HRV, 102.620; 117: HR, 83.712; 117: RR, 18.865; 117: SpO2, 98.308; 117: Perf, 1.218; 117: 1min HRV, 88.153; 118: HR, 83.094; 118: RR, 20.962; 118: SpO2, 97.792; 118: Perf, 1.218; 118: 1min HRV, 102.102; 119: HR, 85.111; 119: RR, 22.0; 119: SpO2, 98.0; 119: Perf, 1.23; 119: 1min HRV, 109.427; 0: Age, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 112.0; 0: Triage DBP, 84.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I checked the patient\u2019s vital signs and labs for potential signs of infection and organ dysfunction. The normal white blood cell count, stable hemodynamics, and relatively controlled heart rate with improved oxygen saturation do not point to a high sepsis risk. Therefore, the patient does not appear to be at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I checked the patient\u2019s vital signs and labs for potential signs of infection and organ dysfunction.",
            "The patient's white blood cell count is normal.",
            "The patient has stable hemodynamics.",
            "The patient has a relatively controlled heart rate.",
            "The patient has improved oxygen saturation.",
            "The normal white blood cell count, stable hemodynamics, and controlled heart rate with improved oxygen saturation do not point to a high sepsis risk.",
            "The patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The normal white blood cell count, stable hemodynamics, and controlled heart rate with improved oxygen saturation do not point to a high sepsis risk."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "The claim refers to a normal white blood cell count, stable hemodynamics, controlled heart rate, and improved oxygen saturation\u2014all factors that are part of the SIRS criteria evaluation (temperature, heart rate, respiratory rate, and WBC count define SIRS). The claim mentions the absence of conditions typically required to meet SIRS criteria for systemic inflammation. Thus, it indirectly correlates with SIRS criteria to indicate a low sepsis risk, providing a reasonable alignment."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "7: HR, 96.0; 7: RR, 16.0; 7: SpO2, 99.0; 7: SBP, 130.0; 7: DBP, 92.0; 7: MAP, 104.667; 7: Temp, 98.1; 20: Pain, 7.0; 45: SpO2, 96.406; 45: Perf, 1.377; 45: SBP, 128.0; 45: DBP, 97.0; 45: MAP, 107.333; 46: SpO2, 97.155; 46: Perf, 1.579; 47: SpO2, 96.644; 47: Perf, 2.137; 48: SpO2, 97.627; 48: Perf, 2.492; 49: SpO2, 97.831; 49: Perf, 2.683; 50: HR, 93.0; 50: RR, 19.0; 50: SpO2, 97.724; 50: Perf, 2.751; 50: SBP, 125.0; 50: DBP, 105.0; 50: MAP, 111.667; 51: SpO2, 97.797; 51: Perf, 3.935; 51: SBP, 125.0; 51: DBP, 105.0; 51: MAP, 111.667; 52: SpO2, 98.0; 52: Perf, 4.613; 53: SpO2, 98.0; 53: Perf, 4.703; 54: SpO2, 97.793; 54: Perf, 4.382; 55: SpO2, 97.712; 55: Perf, 3.319; 56: SpO2, 97.492; 56: Perf, 2.563; 57: SpO2, 97.414; 57: Perf, 2.518; 58: SpO2, 97.797; 58: Perf, 2.62; 59: SpO2, 97.655; 59: Perf, 2.570; 60: SpO2, 98.458; 60: Perf, 2.374; 61: SpO2, 98.746; 61: Perf, 1.605; 62: SpO2, 98.621; 62: Perf, 2.178; 63: SpO2, 98.119; 63: Perf, 3.291; 64: SpO2, 97.724; 64: Perf, 3.941; 65: SpO2, 97.898; 65: Perf, 4.344; 66: SpO2, 97.932; 66: Perf, 4.513; 66: SBP, 129.0; 66: DBP, 102.0; 66: MAP, 111.0; 67: SpO2, 97.379; 67: Perf, 4.306; 68: SpO2, 97.525; 68: Perf, 3.781; 69: SpO2, 97.466; 69: Perf, 2.854; 70: SpO2, 97.458; 70: Perf, 2.605; 71: SpO2, 98.203; 71: Perf, 2.407; 72: SpO2, 98.397; 72: Perf, 2.168; 73: SpO2, 98.746; 73: Perf, 2.085; 74: SpO2, 98.759; 74: Perf, 2.311; 75: SpO2, 97.814; 75: Perf, 2.402; 76: SpO2, 98.0; 76: Perf, 2.832; 77: SpO2, 98.0; 77: Perf, 3.784; 78: SpO2, 97.576; 78: Perf, 3.755; 79: INFLUENZA B, Not Detected; 79: RSV, Not Detected; 79: INFLUENZA A, Not Detected; 79: SARS-COV-2 RNA, Not Detected; 79: SpO2, 98.0; 79: Perf, 3.552; 80: SpO2, 97.373; 80: Perf, 3.137; 81: SpO2, 97.576; 81: Perf, 2.871; 81: SBP, 132.0; 81: DBP, 103.0; 81: MAP, 112.667; 82: SpO2, 97.931; 82: Perf, 2.412; 83: SpO2, 97.661; 83: Perf, 1.794; 84: SpO2, 97.603; 84: Perf, 2.579; 85: SpO2, 97.932; 85: Perf, 2.144; 86: SpO2, 97.879; 86: Perf, 2.266; 87: SpO2, 97.407; 87: Perf, 3.087; 88: SpO2, 97.525; 88: Perf, 2.095; 89: SpO2, 97.914; 89: Perf, 1.692; 90: SpO2, 98.644; 90: Perf, 1.534; 91: SpO2, 98.431; 91: Perf, 1.664; 92: SpO2, 97.915; 92: Perf, 2.03; 93: SpO2, 98.305; 93: Perf, 2.03; 94: SpO2, 98.052; 94: Perf, 2.03; 95: SpO2, 98.915; 95: Perf, 2.03; 96: HR, 50.0; 96: RR, 22.0; 96: SpO2, 99.0; 96: Perf, 1.996; 96: SBP, 137.0; 96: DBP, 110.0; 96: MAP, 119.0; 96: Pain, 3.0; 96: Temp, 98.9; 97: SpO2, 99.339; 97: Perf, 1.919; 98: SpO2, 99.034; 98: Perf, 1.779; 99: SpO2, 99.0; 99: Perf, 2.056; 100: WAM DIFTYP, AUTO; 100: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 100: MONOCYTE % (AUTO DIFF), 8.8 %; 100: NRBC PERCENT (HEMATOLOGY), 0.0 %; 100: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.15 K/uL; 100: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 100: HEMATOCRIT (HCT), 41.4 %; 100: PLATELET COUNT (PLT), 241 K/uL; 100: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.5 pg; 100: RED BLOOD CELLS (RBC), 4.47 MIL/uL; 100: RED CELL DISTRIBUTION WIDTH (RDW), 13.7 %; 100: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.34 K/uL; 100: LYMPHOCYTE % (AUTO DIFF), 27.8 %; 100: BASOPHIL % (AUTO DIFF), 0.7 %; 100: EOSINOPHIL % (AUTO DIFF), 1.8 %; 100: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 100: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 100: NEUTROPHIL % (AUTO DIFF), 60.4 %; 100: HEMOGLOBIN (HGB), 13.2 g/dL; 100: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 100: WHITE BLOOD CELLS (WBC), 8.4 K/uL; 100: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.09 K/uL; 100: MEAN CORPUSCULAR VOLUME (MCV), 92.6 fL; 100: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 100: SpO2, 98.475; 100: Perf, 2.900; 101: INR, 1.4; 101: PROTHROMBIN TIME, 16.5 seconds; 101: SpO2, 98.310; 101: Perf, 3.327; 102: SpO2, 98.424; 102: Perf, 3.066; 103: SpO2, 98.169; 103: Perf, 2.855; 104: SpO2, 98.897; 104: Perf, 2.206; 105: SpO2, 98.220; 105: Perf, 2.655; 106: SpO2, 97.983; 106: Perf, 2.997; 107: SpO2, 98.271; 107: Perf, 2.789; 108: SpO2, 97.966; 108: Perf, 2.631; 109: SpO2, 98.690; 109: Perf, 2.325; 110: SpO2, 98.576; 110: Perf, 2.028; 110: SBP, 129.0; 110: DBP, 103.0; 110: MAP, 111.667; 111: SpO2, 97.983; 111: Perf, 2.424; 111: SBP, 129.0; 111: DBP, 103.0; 111: MAP, 111.667; 112: LACTIC ACID, 1.2 mmol/L; 112: SpO2, 97.508; 112: Perf, 2.367; 113: SpO2, 98.831; 113: Perf, 2.098; 114: SpO2, 98.845; 114: Perf, 2.181; 115: SpO2, 98.169; 115: Perf, 2.054; 116: SpO2, 98.069; 116: Perf, 1.825; 117: SpO2, 99.0; 117: Perf, 1.891; 118: MAGNESIUM, 1.9 mg/dL; 118: AST (SGOT), 51 U/L; 118: ALBUMIN, 3.7 g/dL; 118: BILIRUBIN TOTAL, 0.2 mg/dL; 118: ALKALINE PHOSPHATASE, 57 U/L; 118: GLOBULIN, 3.1 g/dL; 118: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 118: SODIUM, 137 mmol/L; 118: PROTEIN TOTAL, 6.8 g/dL; 118: ALT (SGPT), 48 U/L; 118: BLOOD UREA NITROGEN (BUN), 21 mg/dL; 118: CORRECTED CALCIUM, 8.8 mg/dL; 118: ANION GAP, 10 mmol/L; 118: CREATININE, 1.03 mg/dL; 118: CALCIUM, 8.6 mg/dL; 118: CO2, 20 mmol/L; 118: CHLORIDE, 107 mmol/L; 118: POTASSIUM, 4.1 mmol/L; 118: GLUCOSE, 101 mg/dL; 118: SpO2, 98.017; 118: Perf, 2.516; 119: SpO2, 97.915; 119: Perf, 2.765; 0: Age, 43; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 96.0; 0: Triage RR, 16.0; 0: Triage SBP, 130.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, COUGH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I first noted the patient\u2019s stable vital signs (heart rate, blood pressure, normal temperature) and the absence of alarming shifts in respiratory rate or oxygen saturation. Next, I reviewed the lab results, including a normal lactate level and white blood cell count, which do not suggest an acute infectious or inflammatory process. I also considered that the patient does not exhibit signs of compromised organ function or hemodynamic instability. Finally, the negative respiratory pathogen tests and overall steady trends in measurements lead me to conclude that the patient\u2019s immediate risk of sepsis within the next 12 hours is low.",
        "claims": [
            "The patient's vital signs are stable.",
            "The patient's vital signs include heart rate and blood pressure.",
            "The patient's temperature is normal.",
            "There are no alarming shifts in respiratory rate.",
            "There are no alarming shifts in oxygen saturation.",
            "The lab results show a normal lactate level.",
            "The lab results show a normal white blood cell count.",
            "The normal lab results do not suggest an acute infectious process.",
            "The normal lab results do not suggest an inflammatory process.",
            "The patient does not exhibit signs of compromised organ function.",
            "The patient does not exhibit hemodynamic instability.",
            "The respiratory pathogen tests are negative.",
            "The overall trends in measurements are steady.",
            "The patient's immediate risk of sepsis within the next 12 hours is low."
        ],
        "relevant_claims": [
            "The patient's vital signs are stable.",
            "The normal lab results do not suggest an acute infectious process.",
            "The normal lab results do not suggest an inflammatory process.",
            "The patient does not exhibit hemodynamic instability."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.7,
            0.7
        ],
        "alignment_category": [
            4,
            9,
            2,
            6
        ],
        "alignment_reasonings": [
            "The claim that \"the patient's vital signs are stable\" suggests an absence of deranged vitals, which would be necessary to predict clinical deterioration as per the NEWS score criteria. While stable vitals indicate that the NEWS score is likely low, there's minimal alignment as no deranged vitals are present. A low alignment rating is given because the claim weakly points to the absence of the condition assessed by the category.",
            "The claim suggests a lack of immediate suspicion for infection due to normal lab results, which contrasts with the urgency associated with early antibiotic/culture orders in suspected sepsis cases. Hence, it indirectly hints at an absence of criteria for early clinical intervention for infection. The alignment is minimal, reflecting an indirect reference rather than direct alignment with any active sepsis indicator.",
            "The claim about normal lab results not suggesting an inflammatory process is indirectly related to the SIRS criteria, which involve signs of systemic inflammation (such as abnormal temperature, heart rate, respiratory rate, or WBC count). While the claim suggests a lack of evidence for systemic inflammation, and, by extension, sepsis, it is relevant in terms of assessing risk through the absence of SIRS criteria. The connection is strong, as it pertains to the absence of what SIRS criteria seek to identify.",
            "Hemodynamic instability is directly related to an elevated shock index, as this index denotes cardiovascular instability relevant to sepsis progression. While the claim mentions the absence of hemodynamic instability, making it counter-indicative of this category, it aligns with the intent behind assessing hemodynamic status. Thus, the alignment is moderate as it conceptually relates to the shock index but does not meet the specific criteria for elevation."
        ],
        "final_alignment_score": 0.475,
        "accuracy": 1
    },
    {
        "input": "10: HR, 124.0; 10: RR, 18.0; 10: SBP, 123.0; 10: DBP, 85.0; 10: MAP, 97.667; 10: Temp, 99.3; 34: SpO2, 98.474; 35: SpO2, 99.169; 35: Perf, 2.224; 36: SpO2, 98.948; 36: Perf, 2.137; 37: SpO2, 99.119; 37: Perf, 2.362; 38: SpO2, 98.603; 38: Perf, 1.824; 39: SpO2, 97.678; 39: Perf, 1.582; 40: SpO2, 98.458; 40: Perf, 1.283; 41: SpO2, 98.534; 41: Perf, 1.659; 42: SpO2, 98.746; 42: Perf, 1.824; 43: SpO2, 98.379; 43: Perf, 1.852; 44: SpO2, 98.441; 44: Perf, 1.785; 45: SpO2, 98.220; 45: Perf, 1.027; 46: SpO2, 98.690; 46: Perf, 1.103; 47: SpO2, 99.678; 47: Perf, 1.772; 48: SpO2, 99.810; 48: Perf, 2.277; 49: SpO2, 99.780; 49: Perf, 2.665; 50: SpO2, 98.661; 50: Perf, 2.874; 51: SpO2, 98.810; 51: Perf, 2.65; 52: SpO2, 99.0; 52: Perf, 1.746; 53: SpO2, 98.414; 53: Perf, 1.777; 54: SpO2, 98.237; 54: Perf, 1.994; 55: SpO2, 97.678; 55: Perf, 2.447; 56: SpO2, 99.017; 56: Perf, 2.373; 57: SpO2, 98.203; 57: Perf, 2.956; 58: SpO2, 98.914; 58: Perf, 3.224; 59: SpO2, 99.186; 59: Perf, 2.435; 60: SpO2, 98.271; 60: Perf, 1.618; 61: SpO2, 97.224; 61: Perf, 1.683; 62: SpO2, 96.339; 62: Perf, 0.938; 63: SpO2, 96.724; 63: Perf, 0.922; 64: SpO2, 97.153; 64: Perf, 0.700; 65: SpO2, 97.0; 65: Perf, 0.776; 66: SpO2, 97.186; 66: Perf, 1.047; 67: SpO2, 97.237; 67: Perf, 1.001; 68: SpO2, 96.845; 68: Perf, 0.894; 69: SpO2, 97.085; 69: Perf, 0.953; 70: POC, HCG, ISTAT QUALITATIVE: Negative; 70: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 70: SpO2, 99.138; 70: Perf, 1.017; 71: SpO2, 97.661; 71: Perf, 1.419; 72: POC PH (V) ISTAT, 7.40; 72: POC PCO2 (V) ISTAT, 40.6 mmHg; 72: POC PO2 (V) ISTAT, 36 mmHg; 72: POC O2 SATURATION ISTAT VENOUS, 69 %; 72: POC HCO3 (V) ISTAT, 25.0 mmol/L; 72: POC LACTATE ISTAT, 0.93 mmol/L; 72: POC BASE EXCESS ISTAT, 0 mmol/L; 72: POC TCO2 (V) ISTAT, 26 mmol/L; 72: SpO2, 98.0; 72: Perf, 1.794; 73: SpO2, 98.0; 73: Perf, 1.956; 74: SpO2, 98.0; 74: Perf, 2.021; 74: LR IV BOLUS -, 1000 ML; 75: SpO, 2: 97.293; 75: Perf, 1.599; 76: SpO2, 97.492; 76: Perf, 2.369; 77: SpO2, 97.424; 77: Perf, 2.6; 78: SpO2, 99.207; 78: Perf, 2.413; 79: SpO2, 98.678; 79: Perf, 2.122; 80: SpO2, 98.879; 80: Perf, 1.586; 81: SpO2, 98.898; 81: Perf, 1.792; 82: SpO2, 98.237; 82: Perf, 1.856; 83: SpO2, 98.897; 83: Perf, 1.813; 84: SpO2, 98.814; 84: Perf, 1.436; 85: SpO2, 99.138; 85: Perf, 1.005; 86: SpO2, 98.356; 86: Perf, 1.135; 87: SpO2, 98.034; 87: Perf, 1.147; 88: SpO2, 99.0; 88: Perf, 1.075; 89: SpO2, 98.712; 89: Perf, 1.979; 90: SpO2, 98.966; 90: Perf, 1.538; 91: SpO2, 97.746; 91: Perf, 0.917; 92: SpO2, 97.559; 92: Perf, 0.788; 93: SpO2, 98.293; 93: Perf, 0.755; 94: SpO2, 98.339; 94: Perf, 0.913; 95: SpO2, 98.121; 95: Perf, 1.300; 96: SpO2, 97.695; 96: Perf, 1.225; 97: SpO2, 97.569; 97: Perf, 1.103; 98: SpO2, 98.237; 98: Perf, 0.971; 99: SpO2, 98.254; 99: Perf, 1.076; 100: SpO2, 99.052; 100: Perf, 0.774; 101: SpO2, 99.610; 101: Perf, 0.882; 102: SpO2, 98.707; 102: Perf, 0.931; 103: SpO2, 99.542; 103: Perf, 0.719; 104: SpO2, 99.931; 104: Perf, 1.281; 105: SpO2, 100.0; 105: Perf, 1.238; 106: SpO2, 99.610; 106: Perf, 1.108; 107: SpO2, 99.086; 107: Perf, 0.759; 108: SpO2, 97.636; 108: Perf, 0.521; 109: SpO2, 98.611; 110: SpO2, 98.966; 110: Perf, 0.720; 111: SpO2, 99.593; 111: Perf, 0.645; 112: SpO2, 99.707; 112: Perf, 0.756; 113: SpO2, 98.966; 113: Perf, 0.805; 114: SpO2, 98.690; 114: Perf, 0.62; 115: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 115: PROTEIN TOTAL, 7.6 g/dL; 115: ANION GAP, 11 mmol/L; 115: ALT (SGPT), 12 U/L; 115: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 115: GLUCOSE, 132 mg/dL; 115: AST (SGOT), 16 U/L; 115: EGFR REFIT WITHOUT RACE (2021), 44 mL/min/1.73 m2; 115: GLOBULIN, 4.0 g/dL; 115: CHLORIDE, 105 mmol/L; 115: CORRECTED CALCIUM, 8.4 mg/dL; 115: SODIUM, 142 mmol/L; 115: ALKALINE PHOSPHATASE, 82 U/L; 115: POTASSIUM, 3.5 mmol/L; 115: CO2, 26 mmol/L; 115: CALCIUM, 8.1 mg/dL; 115: BILIRUBIN TOTAL, 0.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 51 mL/min/1.73 m2; 115: ALBUMIN, 3.6 g/dL; 115: CREATININE, 1.52 mg/dL; 115: RED CELL DISTRIBUTION WIDTH (RDW), 18.8 %; 115: HEMATOCRIT (HCT), 24.7 %; 115: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 115: WHITE BLOOD CELLS (WBC), 8.5 K/uL; 115: HEMOGLOBIN (HGB), 6.4 g/dL; 115: PLATELET COUNT (PLT), 369 K/uL; 115: MEAN CORPUSCULAR VOLUME (MCV), 69.0 fL; 115: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 25.9 g/dL; 115: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 115: NEUTROPHILS BANDS % (MANUAL DIFF), 0.0 %; 115: LYMPHOCYTES % (MANUAL DIFF), 10.4 %; 115: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.14 K/uL; 115: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.30 K/uL; 115: EOSINOPHILS % (MANUAL DIFF), 1.7 %; 115: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.19 K/uL; 115: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.89 K/uL; 115: MONOCYTES % (MANUAL DIFF), 3.5 %; 115: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 84.4 %; 115: SpO2, 98.576; 115: Perf, 0.578; 116: SpO2, 98.136; 116: Perf, 0.589; 117: SpO2, 98.414; 117: Perf, 0.684; 118: SpO2, 98.508; 118: Perf, 1.111; 119: SpO2, 98.593; 119: Perf, 1.259; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 124.0; 0: Triage RR, 18.0; 0: Triage SBP, 123.0; 0: Triage DBP, 85.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,EMESIS,DIARRHEA",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I note the vital signs, labs, and clinical context, then question whether the patient\u2019s presentation aligns with high-risk sepsis indicators such as marked hypotension, elevated lactate, or significant leukocytosis. I see stable blood pressure, normal lactate, and a normal white blood cell count. I challenge whether the mild tachycardia and borderline temperature indicate severe infection or sepsis, especially given the overall stable trends. Concluding that the data do not strongly suggest high sepsis risk, I label the patient as not at high risk.",
        "claims": [
            "I note the vital signs, labs, and clinical context.",
            "I question whether the patient\u2019s presentation aligns with high-risk sepsis indicators.",
            "High-risk sepsis indicators include marked hypotension, elevated lactate, or significant leukocytosis.",
            "I observe stable blood pressure.",
            "I observe normal lactate.",
            "I observe a normal white blood cell count.",
            "I challenge whether the mild tachycardia indicates severe infection or sepsis.",
            "I challenge whether the borderline temperature indicates severe infection or sepsis.",
            "The overall trends are stable.",
            "I conclude that the data do not strongly suggest high sepsis risk.",
            "I label the patient as not at high risk."
        ],
        "relevant_claims": [
            "I challenge whether the borderline temperature indicates severe infection or sepsis."
        ],
        "alignment_scores": [
            0.3
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "The claim questions whether a borderline temperature might indicate severe infection or sepsis, which falls within the realm of systemic inflammatory response potentially leading to sepsis. However, a borderline temperature does not meet the explicit temperature threshold (>38\u00b0C) required for SIRS positivity, resulting in a low alignment rating."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "13: HR, 128.0; 13: RR, 18.0; 13: SpO2, 99.0; 13: SBP, 120.0; 13: DBP, 51.0; 13: MAP, 74.0; 13: Temp, 99.5; 59: HR, 117.362; 59: RR, 23.914; 59: Perf, 0.43; 59: 1min HRV, 6.545; 60: HR, 117.915; 60: RR, 23.441; 60: SpO2, 100.0; 60: 1min HRV, 7.644; 61: HR, 119.576; 61: RR, 23.373; 61: SpO2, 99.610; 61: Perf, 0.551; 61: 1min HRV, 6.043; 61: 5min HRV, 7.955; 62: HR, 120.086; 62: RR, 23.328; 62: SpO2, 99.310; 62: Perf, 0.769; 62: 1min HRV, 4.305; 63: HR, 121.153; 63: RR, 25.085; 63: SpO2, 99.153; 63: Perf, 0.875; 63: 1min HRV, 4.458; 64: HR, 121.810; 64: RR, 24.466; 64: SpO2, 98.931; 64: Perf, 0.934; 64: 1min HRV, 3.305; 65: HR, 122.034; 65: RR, 22.525; 65: SpO2, 99.305; 65: Perf, 0.970; 65: 1min HRV, 7.228; 66: HR, 122.542; 66: RR, 25.068; 66: SpO2, 99.407; 66: Perf, 1.144; 66: 1min HRV, 9.828; 66: 5min HRV, 7.036; 67: HR, 121.397; 67: RR, 23.034; 67: SpO2, 99.621; 67: Perf, 1.108; 67: 1min HRV, 15.414; 68: HR, 121.966; 68: RR, 22.949; 68: SpO2, 99.780; 68: Perf, 0.948; 68: 1min HRV, 4.909; 69: HR, 121.517; 69: RR, 22.776; 69: SpO2, 99.017; 69: Perf, 1.183; 69: 1min HRV, 13.828; 70: HR, 122.475; 70: RR, 25.169; 70: SpO2, 99.203; 70: Perf, 1.144; 70: 1min HRV, 3.591; 71: HR, 123.259; 71: RR, 24.966; 71: SpO2, 99.810; 71: Perf, 1.064; 71: 1min HRV, 4.648; 71: 5min HRV, 10.297; 72: HR, 122.034; 72: RR, 23.254; 72: SpO2, 99.508; 72: Perf, 0.958; 72: 1min HRV, 10.127; 72: SBP, 102.0; 72: DBP, 58.0; 72: MAP, 72.667; 73: HR, 121.237; 73: RR, 24.169; 73: SpO2, 99.525; 73: Perf, 1.137; 73: 1min HRV, 4.810; 74: HR, 122.638; 74: RR, 24.983; 74: SpO2, 99.828; 74: Perf, 1.003; 74: 1min HRV, 3.128; 75: HR, 122.458; 75: RR, 24.254; 75: SpO2, 99.644; 75: Perf, 0.895; 75: 1min HRV, 8.975; 76: HR, 121.638; 76: RR, 25.379; 76: SpO2, 99.690; 76: Perf, 0.811; 76: 1min HRV, 12.485; 76: 5min HRV, 8.911; 77: HR, 122.915; 77: RR, 25.085; 77: SpO2, 99.729; 77: Perf, 0.893; 77: 1min HRV, 3.437; 78: HR, 123.034; 78: RR, 24.644; 78: SpO2, 99.915; 78: Perf, 0.860; 78: 1min HRV, 3.121; 79: HR, 122.190; 79: RR, 20.793; 79: SpO2, 99.759; 79: Perf, 0.882; 79: 1min HRV, 8.052; 80: HR, 119.610; 80: RR, 19.559; 80: SpO2, 99.322; 80: Perf, 0.682; 80: 1min HRV, 15.067; 81: HR, 119.586; 81: RR, 17.759; 81: SpO2, 98.586; 81: Perf, 0.478; 81: 1min HRV, 21.346; 81: 5min HRV, 14.003; 82: HR, 121.678; 82: RR, 23.390; 82: SpO2, 98.2; 82: Perf, 0.48; 82: 1min HRV, 7.006; 83: HR, 120.729; 83: RR, 22.237; 83: SpO2, 99.677; 83: Perf, 0.48; 83: 1min HRV, 10.215; 84: HR, 122.069; 84: RR, 25.603; 84: SpO2, 99.845; 84: Perf, 0.596; 84: 1min HRV, 2.628; 85: HR, 123.051; 85: RR, 24.407; 85: SpO2, 99.949; 85: Perf, 0.599; 85: 1min HRV, 4.199; 86: HR, 123.224; 86: RR, 24.138; 86: SpO2, 100.0; 86: Perf, 0.641; 86: 1min HRV, 6.186; 86: 5min HRV, 7.510; 87: HR, 120.254; 87: RR, 31.0; 87: SpO2, 99.939; 87: Perf, 0.620; 87: 1min HRV, 11.018; 87: SBP, 106.0; 87: DBP, 63.0; 87: MAP, 77.333; 88: HR, 118.186; 88: RR, 23.068; 88: SpO2, 99.949; 88: Perf, 0.555; 88: 1min HRV, 17.155; 89: HR, 119.828; 89: RR, 23.569; 89: SpO2, 99.789; 89: Perf, 0.579; 89: 1min HRV, 11.270; 90: HR, 118.927; 90: RR, 22.322; 90: SpO2, 99.641; 90: Perf, 0.542; 90: 1min HRV, 4.142; 91: HR, 122.190; 91: RR, 26.397; 91: Perf, 0.54; 91: 1min HRV, 5.678; 91: 5min HRV, 13.005; 92: HR, 122.339; 92: RR, 26.288; 92: 1min HRV, 12.070; 93: HR, 119.102; 93: RR, 23.966; 93: SpO2, 100.0; 93: Perf, 0.37; 93: 1min HRV, 17.897; 94: HR, 117.983; 94: RR, 25.293; 94: SpO2, 99.948; 94: Perf, 0.498; 94: 1min HRV, 11.574; 95: HR, 117.847; 95: RR, 23.915; 95: SpO2, 100.0; 95: Perf, 0.695; 95: 1min HRV, 13.356; 96: HR, 118.776; 96: RR, 22.707; 96: SpO2, 99.966; 96: Perf, 0.776; 96: 1min HRV, 3.920; 96: 5min HRV, 13.245; 97: HR, 118.102; 97: RR, 24.627; 97: SpO2, 99.102; 97: Perf, 0.695; 97: 1min HRV, 5.616; 98: HR, 120.102; 98: RR, 23.339; 98: SpO2, 98.661; 98: Perf, 0.927; 98: 1min HRV, 2.730; 99: HR, 121.190; 99: RR, 24.052; 99: SpO2, 99.759; 99: Perf, 0.931; 99: 1min HRV, 8.752; 100: HR, 121.864; 100: RR, 24.424; 100: SpO2, 100.0; 100: Perf, 1.029; 100: 1min HRV, 2.311; 101: HR, 122.828; 101: RR, 24.672; 101: SpO2, 99.655; 101: Perf, 1.052; 101: 1min HRV, 3.685; 101: 5min HRV, 8.392; 101: SBP, 105.0; 101: DBP, 61.0; 101: MAP, 75.667; 102: HR, 121.576; 102: RR, 24.915; 102: SpO2, 99.407; 102: Perf, 1.066; 102: 1min HRV, 3.417; 102: SBP, 105.0; 102: DBP, 61.0; 102: MAP, 75.667; 103: HR, 123.224; 103: RR, 24.828; 103: SpO2, 98.897; 103: Perf, 1.087; 103: 1min HRV, 2.370; 104: HR, 123.661; 104: RR, 26.085; 104: SpO2, 98.915; 104: Perf, 1.184; 104: 1min HRV, 3.678; 105: HR, 124.390; 105: RR, 25.390; 105: SpO2, 98.983; 105: Perf, 1.227; 105: 1min HRV, 2.959; 106: HR, 124.707; 106: RR, 23.983; 106: SpO2, 98.914; 106: Perf, 1.160; 106: 1min HRV, 6.864; 106: 5min HRV, 6.006; 107: SARS-COV-2 RNA, Not Detected; 107: HR, 124.390; 107: RR, 27.017; 107: SpO2, 99.034; 107: Perf, 1.212; 107: 1min HRV, 3.047; 108: HR, 124.897; 108: RR, 28.0; 108: SpO2, 99.103; 108: Perf, 1.169; 108: 1min HRV, 12.130; 109: HR, 124.339; 109: RR, 24.322; 109: SpO2, 99.288; 109: Perf, 0.893; 109: 1min HRV, 10.818; 110: HR, 124.271; 110: RR, 26.475; 110: SpO2, 98.949; 110: Perf, 0.796; 110: 1min HRV, 11.932; 111: HR, 123.069; 111: RR, 24.259; 111: SpO2, 99.845; 111: Perf, 0.678; 111: 1min HRV, 11.822; 111: 5min HRV, 10.934; 112: HR, 120.864; 112: RR, 28.068; 112: SpO2, 99.442; 112: Perf, 0.482; 112: 1min HRV, 24.982; 113: HR, 123.190; 113: RR, 27.034; 113: SpO2, 97.909; 113: Perf, 0.26; 113: 1min HRV, 8.670; 114: HR, 122.153; 114: RR, 26.780; 114: Perf, 0.26; 114: 1min HRV, 6.498; 115: HR, 123.627; 115: RR, 27.017; 115: SpO2, 98.0; 115: Perf, 0.224; 115: 1min HRV, 11.989; 116: HR, 123.948; 116: RR, 28.414; 116: 1min HRV, 4.802; 116: 5min HRV, 14.052; 117: HR, 122.932; 117: RR, 27.763; 117: 1min HRV, 4.905; 117: SBP, 110.0; 117: DBP, 58.0; 117: MAP, 75.333; 118: HR, 123.897; 118: RR, 25.638; 118: SpO2, 95.0; 118: 1min HRV, 3.633; 119: HR, 121.847; 119: RR, 32.153; 119: 1min HRV, 16.656; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 128.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 51.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I asked myself whether the elevated heart rate, borderline blood pressure, and rising respiratory rate suggest an impending septic process. I recalled sepsis screening tools, noting that persistent tachycardia, frequent tachypnea, and potential infection from the wound check raise concern. I then challenged whether any contradictory data existed, but found that the vitals consistently trended in a concerning direction. Therefore, I concluded the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The heart rate is elevated.",
            "The blood pressure is borderline.",
            "The respiratory rate is rising.",
            "Elevated heart rate, borderline blood pressure, and rising respiratory rate suggest an impending septic process.",
            "Sepsis screening tools indicate that persistent tachycardia raises concern.",
            "Frequent tachypnea raises concern for sepsis.",
            "Potential infection from the wound check raises concern for sepsis.",
            "I challenged whether any contradictory data existed.",
            "There was no contradictory data found.",
            "The vitals consistently trended in a concerning direction.",
            "I concluded that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is elevated.",
            "The blood pressure is borderline.",
            "The respiratory rate is rising.",
            "Elevated heart rate, borderline blood pressure, and rising respiratory rate suggest an impending septic process.",
            "Sepsis screening tools indicate that persistent tachycardia raises concern.",
            "Frequent tachypnea raises concern for sepsis.",
            "Potential infection from the wound check raises concern for sepsis.",
            "The vitals consistently trended in a concerning direction."
        ],
        "alignment_scores": [
            0.8,
            0.3,
            0.7,
            0.8,
            0.7,
            0.7,
            0.6,
            0.6
        ],
        "alignment_category": [
            2,
            7,
            3,
            3,
            2,
            3,
            9,
            4
        ],
        "alignment_reasonings": [
            "An elevated heart rate is one of the SIRS criteria (heart rate >90 bpm), which identifies systemic inflammation consistent with early sepsis. However, without additional context confirming the heart rate exceeds 90 bpm or other criteria are present, the alignment is not perfect but remains strong.",
            "The claim of \"borderline\" blood pressure suggests the potential presence of hypotension or near-hypotension, which is a concern for sepsis-associated hypotension. However, without specific blood pressure values or clear indication of hypotension, the alignment is weak. Thus, while there is some relevance, it doesn't fully satisfy the specific criteria outlined in Category 7, resulting in a low alignment rating.",
            "An increased respiratory rate is a component of the qSOFA score, which helps flag the risk of sepsis-related organ dysfunction. While the claim does not specify if the rate meets the threshold (\u226522/min), a rising respiratory rate aligns with qSOFA criteria indicating potential sepsis risk. However, lacking specific values leads to a slightly reduced alignment rating.",
            "The claim lists elevated heart rate, borderline blood pressure, and rising respiratory rate. Two of these factors (borderline blood pressure and respiratory rate) are components of the qSOFA score. Although qSOFA emphasizes a specific threshold for blood pressure and respiratory rate, the overall context of the claim suggests a concern for impending sepsis-related deterioration. The combination of these factors strongly aligns with the criteria for a high qSOFA score, but since the exact thresholds are not specified, I rated the alignment slightly lower than perfect.",
            "Persistent tachycardia is directly related to the SIRS criteria, as a heart rate >90 bpm qualifies as one of the systemic inflammation indicators for early sepsis detection. The claim highlights tachycardia, which aligns with SIRS criteria, though it doesn't confirm multiple criteria necessary for a full SIRS diagnosis. Thus, the alignment is fairly strong but not complete, reflecting a solid relationship to one part of the SIRS framework.",
            "Tachypnea (elevated respiratory rate) is a component of the qSOFA criteria for assessing sepsis risk (specifically, a respiratory rate of \u226522/min). Frequent tachypnea strongly aligns with the qSOFA consideration but does not provide full context, such as exact respiratory rate or other qSOFA criteria elements, which slightly reduces complete alignment.",
            "The claim expresses concern for sepsis due to a potential infection from a wound check. This aligns with the category involving suspicion of a serious infection leading to actions such as administering antibiotics or ordering cultures. However, the claim does not explicitly mention these actions, leading to a moderate alignment score.",
            "The claim refers to concerning trends in vital signs, which is conceptually related to an elevated NEWS score that is derived from vital measures and predicts clinical deterioration. While the statement isn't specific about the actual NEWS score value or the exact changes in vitals, the notion of broadly concerning vital sign trends aligns with the purpose of the NEWS score\u2014to highlight the risk of deterioration and potential sepsis. However, due to the lack of specifics, the alignment is not perfect but still meaningful."
        ],
        "final_alignment_score": 0.6499999999999999,
        "accuracy": 1
    },
    {
        "input": "2: HR, 135.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 148.0; 2: DBP, 93.0; 2: MAP, 111.333; 2: Temp, 97.5; 12: Pain, 0.0; 51: HR, 128.0; 51: 1min HRV, 19.943; 52: HR, 128.946; 52: RR, 22.490; 52: SpO2, 99.0; 52: 1min HRV, 4.637; 52: 5min HRV, 5.984; 52: SBP, 168.0; 52: DBP, 90.0; 52: MAP, 116.0; 53: HR, 128.136; 53: RR, 22.153; 53: SpO2, 98.746; 53: Perf, 0.575; 53: 1min HRV, 7.372; 54: HR, 127.397; 54: RR, 21.259; 54: SpO2, 98.810; 54: Perf, 0.537; 54: 1min HRV, 7.201; 55: HR, 128.407; 55: RR, 26.441; 55: SpO2, 98.153; 55: Perf, 0.493; 55: 1min HRV, 7.224; 56: HR, 126.897; 56: RR, 22.017; 56: SpO2, 98.793; 56: Perf, 0.455; 56: 1min HRV, 3.731; 57: HR, 126.379; 57: RR, 19.310; 57: SpO2, 98.552; 57: Perf, 0.399; 57: 1min HRV, 4.321; 57: 5min HRV, 6.676; 58: HR, 127.407; 58: RR, 19.593; 58: SpO2, 98.712; 58: Perf, 0.374; 58: 1min HRV, 3.207; 59: HR, 127.5; 59: RR, 19.966; 59: SpO2, 99.0; 59: Perf, 0.362; 59: 1min HRV, 3.383; 59: SBP, 168.0; 59: DBP, 93.0; 59: MAP, 118.0; 60: HR, 128.0; 60: RR, 23.085; 60: SpO2, 98.966; 60: Perf, 0.370; 60: 1min HRV, 4.359; 61: HR, 126.190; 61: RR, 22.966; 61: SpO2, 98.966; 61: Perf, 0.390; 61: 1min HRV, 5.101; 62: HR, 126.475; 62: RR, 26.017; 62: SpO2, 99.0; 62: Perf, 0.407; 62: 1min HRV, 3.753; 62: 5min HRV, 4.820; 63: HR, 125.746; 63: RR, 24.881; 63: SpO2, 98.898; 63: Perf, 0.429; 63: 1min HRV, 6.197; 64: HR, 125.828; 64: RR, 19.931; 64: SpO2, 99.0; 64: Perf, 0.400; 64: 1min HRV, 5.279; 64: LR IV BOLUS -, 1000 ML; 65: HR:, 125.915; 65: RR, 20.831; 65: SpO2, 99.0; 65: Perf, 0.416; 65: 1min HRV, 4.462; 66: HR, 126.569; 66: RR, 21.259; 66: SpO2, 99.0; 66: Perf, 0.439; 66: 1min HRV, 4.439; 67: HR, 126.155; 67: RR, 17.017; 67: SpO2, 99.0; 67: Perf, 0.456; 67: 1min HRV, 7.104; 67: 5min HRV, 5.712; 68: HR, 125.102; 68: RR, 16.831; 68: SpO2, 99.0; 68: Perf, 0.495; 68: 1min HRV, 7.596; 69: HR, 127.259; 69: RR, 23.638; 69: SpO2, 99.0; 69: Perf, 0.476; 69: 1min HRV, 5.688; 69: FAMOTIDINE (PF), 20 MG/2 ML IV SOLN; 70: HR:, 125.949; 70: RR, 22.576; 70: SpO2, 99.0; 70: Perf, 0.472; 70: 1min HRV, 4.833; 70: SBP, 168.0; 70: DBP, 93.0; 70: MAP, 118.0; 71: HR, 124.931; 71: RR, 20.845; 71: SpO2, 99.0; 71: Perf, 0.459; 71: 1min HRV, 6.740; 72: HR, 125.729; 72: RR, 18.881; 72: SpO2, 99.0; 72: Perf, 0.45; 72: 1min HRV, 4.659; 72: 5min HRV, 6.808; 72: SBP, 160.0; 72: DBP, 93.0; 72: MAP, 115.333; 73: INFLUENZA A, Not Detected; 73: INFLUENZA B, Not Detected; 73: RSV, Not Detected; 73: SARS-COV-2 RNA, Not Detected; 73: HR, 125.322; 73: RR, 16.864; 73: SpO2, 99.0; 73: Perf, 0.458; 73: 1min HRV, 6.378; 73: SBP, 160.0; 73: DBP, 93.0; 73: MAP, 115.333; 74: HR, 124.397; 74: RR, 18.431; 74: SpO2, 99.172; 74: Perf, 0.450; 74: 1min HRV, 8.981; 75: HR, 124.203; 75: RR, 17.186; 75: SpO2, 99.305; 75: Perf, 0.461; 75: 1min HRV, 7.082; 76: HR, 126.224; 76: RR, 18.759; 76: SpO2, 98.879; 76: Perf, 0.458; 76: 1min HRV, 7.494; 77: HR, 123.228; 77: RR, 18.439; 77: SpO2, 99.386; 77: Perf, 0.438; 77: 1min HRV, 5.823; 77: 5min HRV, 7.821; 78: HR, 124.55; 78: RR, 18.867; 78: SpO2, 99.133; 78: Perf, 0.445; 78: 1min HRV, 7.017; 79: HR, 122.614; 79: RR, 17.561; 79: SpO2, 99.0; 79: Perf, 0.436; 79: 1min HRV, 8.683; 80: HR, 125.017; 80: RR, 19.133; 80: SpO2, 99.05; 80: Perf, 0.435; 80: 1min HRV, 15.972; 81: HR, 125.690; 81: RR, 19.207; 81: SpO2, 99.310; 81: Perf, 0.393; 81: 1min HRV, 11.273; 82: HR, 124.475; 82: RR, 18.017; 82: SpO2, 99.576; 82: Perf, 0.411; 82: 1min HRV, 9.940; 82: 5min HRV, 11.653; 83: HR, 124.458; 83: RR, 20.898; 83: SpO2, 99.390; 83: Perf, 0.430; 83: 1min HRV, 6.755; 84: HR, 124.053; 84: RR, 20.544; 84: SpO2, 99.0; 84: Perf, 0.41; 84: 1min HRV, 12.448; 85: HR, 123.85; 85: RR, 21.683; 85: SpO2, 99.317; 85: Perf, 0.401; 85: 1min HRV, 9.913; 86: HR, 126.456; 86: RR, 22.053; 86: SpO2, 99.123; 86: Perf, 0.385; 86: 1min HRV, 7.107; 87: HR, 117.224; 87: RR, 25.190; 87: SpO2, 98.397; 87: Perf, 0.39; 87: 1min HRV, 72.391; 87: 5min HRV, 33.854; 88: HR, 132.881; 88: RR, 22.322; 88: SpO2, 99.3; 88: Perf, 0.401; 88: 1min HRV, 64.352; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL % (AUTO DIFF), 0.1 %; 89: HEMATOCRIT (HCT), 49.6 %; 89: BASOPHIL % (AUTO DIFF), 0.7 %; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.24 K/uL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 89: NEUTROPHIL % (AUTO DIFF), 81.2 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.28 K/uL; 89: RED BLOOD CELLS (RBC), 4.73 MIL/uL; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: HEMOGLOBIN (HGB), 15.6 g/dL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 89: MONOCYTE % (AUTO DIFF), 7.8 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.55 K/uL; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.4 %; 89: MEAN CORPUSCULAR VOLUME (MCV), 104.9 fL; 89: LYMPHOCYTE % (AUTO DIFF), 8.8 %; 89: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 33.0 pg; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 89: PLATELET COUNT (PLT), 291 K/uL; 89: HR, 137.879; 89: RR, 22.241; 89: SpO2, 99.224; 89: Perf, 0.513; 89: 1min HRV, 13.514; 90: HR, 133.712; 90: RR, 24.831; 90: SpO2, 99.0; 90: Perf, 0.515; 90: 1min HRV, 17.901; 91: HR, 129.291; 91: RR, 27.667; 91: SpO2, 99.0; 91: Perf, 0.474; 91: 1min HRV, 9.513; 92: 5min HRV, 36.740; 107: LORAZEPAM, 2 MG/ML INJ SOLN; 0: Age:, 58; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 135.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 93.0; 0: Triage acuity, 3-Urgent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first examined the vital signs and noted the persistent tachycardia combined with an elevated white blood cell count, suggesting possible infection. Next, I asked whether the respiratory rate, blood pressure, and temperature met additional criteria for sepsis risk. I recognized that the patient\u2019s consistently high heart rate, potential signs of infection, and lab abnormalities increase concern for sepsis. Given these factors, I concluded the patient is at high risk of",
        "claims": [
            "developing sepsis within the next 12 hours.",
            "The vital signs were examined.",
            "The examination noted persistent tachycardia.",
            "Persistent tachycardia is combined with an elevated white blood cell count.",
            "An elevated white blood cell count suggests possible infection.",
            "The respiratory rate, blood pressure, and temperature were assessed for additional criteria for sepsis risk.",
            "The patient has a consistently high heart rate.",
            "The patient has potential signs of infection.",
            "The patient has lab abnormalities.",
            "The combination of high heart rate, potential signs of infection, and lab abnormalities increases concern for sepsis.",
            "The conclusion was made that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The examination noted persistent tachycardia.",
            "An elevated white blood cell count suggests possible infection.",
            "The respiratory rate, blood pressure, and temperature were assessed for additional criteria for sepsis risk.",
            "The patient has a consistently high heart rate.",
            "The patient has potential signs of infection.",
            "The combination of high heart rate, potential signs of infection, and lab abnormalities increases concern for sepsis."
        ],
        "alignment_scores": [
            0.6,
            1.0,
            0.6,
            0.6,
            0.3,
            0.7
        ],
        "alignment_category": [
            2,
            2,
            2,
            6,
            9,
            2
        ],
        "alignment_reasonings": [
            "Tachycardia (heart rate\u202f>\u202f90\u202fbpm) is explicitly listed as one of the SIRS criteria, which are indicative of systemic inflammation and potentially early sepsis. However, since the claim only mentions tachycardia without mentioning any other SIRS criteria, the alignment is strong but not complete, thus warranting a rating of 0.6.",
            "The claim explicitly mentions an elevated white blood cell count, which is directly included in the SIRS criteria used for identifying systemic inflammation consistent with early sepsis. Therefore, the alignment with this category is perfect.",
            "The claim mentions the assessment of respiratory rate, blood pressure, and temperature. While these vitals partially match the criteria listed under SIRS (temperature and respiratory rate are directly mentioned), there is no specific mention that the measured values meet or exceed SIRS thresholds. However, the focus on these specific parameters strongly aligns with evaluating potentially relevant SIRS criteria and other sepsis risk indicators. Hence, the alignment is significant but not definitive.",
            "A consistently high heart rate contributes to an elevated Shock Index, which is heart rate divided by systolic blood pressure and indicates hemodynamic instability and a high probability of severe sepsis. However, without information on blood pressure, the alignment is moderate, as the Shock Index cannot be explicitly calculated.",
            "The claim about potential signs of infection is somewhat relevant to early sepsis suspicion, which would typically incite actions like ordering antibiotics or cultures. However, the claim lacks specificity regarding any actual intervention or clinical action (e.g., ordering labs or initiating treatment), so the alignment is weak.",
            "The claim references a high heart rate and potential signs of infection, both of which are components of the SIRS criteria. SIRS criteria require at least two signs of systemic inflammation, and the combination mentioned in the claim suggests a possible alignment with this category. However, specifics about meeting the full criteria are absent, preventing a perfect score. Additionally, \"lab abnormalities\" could relate to elevated WBC, another SIRS component. This multi-faceted concern underlines a moderate-to-strong yet not complete alignment."
        ],
        "final_alignment_score": 0.6333333333333333,
        "accuracy": 1
    },
    {
        "input": "6: HR, 107.0; 6: RR, 22.0; 6: SpO2, 98.0; 6: SBP, 150.0; 6: DBP, 92.0; 6: MAP, 111.333; 6: Temp, 98.1; 8: Pain, 6.0; 35: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 39: NS IV BOLUS -, 1000 ML; 40: SBP, 146.0; 40: DBP, 103.0; 40: MAP, 117.333; 43: SBP, 145.0; 43: DBP, 100.0; 43: MAP, 115.0; 44: SpO2, 99.0; 45: SpO2, 98.471; 46: SpO2, 98.593; 46: Perf, 5.352; 47: SpO2, 98.780; 47: Perf, 5.709; 48: SpO2, 98.632; 48: Perf, 5.135; 49: WAM DIFTYP, AUTO; 49: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 49: NRBC PERCENT (HEMATOLOGY), 0.0 %; 49: PLATELET COUNT (PLT), 394 K/uL; 49: HEMOGLOBIN (HGB), 14.0 g/dL; 49: BASOPHIL % (AUTO DIFF), 0.2 %; 49: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 49: HEMATOCRIT (HCT), 44.5 %; 49: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.22 K/uL; 49: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 49: LYMPHOCYTE % (AUTO DIFF), 14.6 %; 49: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 49: RED CELL DISTRIBUTION WIDTH (RDW), 17.6 %; 49: MONOCYTE % (AUTO DIFF), 9.4 %; 49: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 49: MONOCYTE ABSOLUTE (AUTO DIFF), 1.25 K/uL; 49: NEUTROPHIL % (AUTO DIFF), 73.6 %; 49: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 20.9 pg; 49: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 49: MEAN CORPUSCULAR VOLUME (MCV), 66.4 fL; 49: RED BLOOD CELLS (RBC), 6.70 MIL/uL; 49: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 49: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 49: EOSINOPHIL % (AUTO DIFF), 1.7 %; 49: SpO2, 98.814; 49: Perf, 5.578; 50: SpO2, 98.621; 50: Perf, 2.859; 51: SpO2, 98.0; 51: Perf, 3.014; 52: SpO2, 98.864; 52: Perf, 2.384; 53: SpO2, 98.259; 53: Perf, 4.219; 54: SpO2, 98.407; 54: Perf, 4.476; 55: SpO2, 99.017; 55: Perf, 3.234; 56: SpO2, 99.153; 56: Perf, 3.459; 57: SpO2, 99.169; 57: Perf, 4.327; 58: SpO2, 98.554; 58: Perf, 3.131; 58: SBP, 146.0; 58: DBP, 90.0; 58: MAP, 108.667; 59: SpO2, 98.948; 59: Perf, 3.605; 60: SpO2, 98.544; 60: Perf, 4.458; 61: SpO2, 98.508; 61: Perf, 4.895; 62: SpO2, 98.483; 62: Perf, 4.893; 63: SpO2, 98.810; 63: Perf, 3.064; 64: SpO2, 98.831; 64: Perf, 4.203; 65: SpO2, 98.759; 65: Perf, 5.463; 66: SpO2, 99.0; 66: Perf, 6.117; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.2 seconds; 67: PART. THROMBOPLASTIN TIME, 29.8 seconds; 67: SpO2, 98.458; 67: Perf, 7.107; 68: SARS-COV-2 RNA, Not Detected; 68: INFLUENZA B, Not Detected; 68: INFLUENZA A, Not Detected; 68: SpO2, 98.655; 68: Perf, 4.515; 69: SpO2, 99.102; 69: Perf, 5.877; 70: SpO2, 99.088; 70: Perf, 5.058; 71: SpO2, 98.661; 71: Perf, 5.588; 72: SpO2, 98.897; 72: Perf, 5.861; 73: SpO2, 99.324; 73: Perf, 6.02; 74: SpO2, 98.672; 74: Perf, 5.988; 75: SpO2, 98.322; 75: Perf, 5.623; 76: SpO2, 98.305; 76: Perf, 4.111; 77: SpO2, 98.155; 77: Perf, 2.146; 78: SpO2, 97.983; 78: Perf, 2.190; 79: SpO2, 98.203; 79: Perf, 2.648; 80: EGFR FOR AFRICAN AMERICAN, 156 mL/min/1.73 m2; 80: ALBUMIN, 4.7 g/dL; 80: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 80: CALCIUM, 9.8 mg/dL; 80: EGFR REFIT WITHOUT RACE (2021), 135 mL/min/1.73 m2; 80: AST (SGOT), 37 U/L; 80: ALKALINE PHOSPHATASE, 50 U/L; 80: ANION GAP, 13 mmol/L; 80: SODIUM, 138 mmol/L; 80: LIPASE, 33 U/L; 80: ALT (SGPT), 76 U/L; 80: GLOBULIN, 3.2 g/dL; 80: GLUCOSE, 140 mg/dL; 80: CREATININE, 0.61 mg/dL; 80: CHLORIDE, 101 mmol/L; 80: CORRECTED CALCIUM, 9.2 mg/dL; 80: POTASSIUM, 3.8 mmol/L; 80: CO2, 24 mmol/L; 80: BILIRUBIN TOTAL, 0.6 mg/dL; 80: PROTEIN TOTAL, 7.9 g/dL; 80: SpO2, 98.397; 80: Perf, 1.753; 81: SpO2, 98.5; 81: Perf, 1.938; 82: SpO2, 97.862; 82: Perf, 4.743; 83: SpO2, 98.356; 83: Perf, 3.823; 84: SpO2, 99.0; 84: Perf, 4.239; 85: SpO2, 98.879; 85: Perf, 3.032; 86: SpO2, 99.086; 86: Perf, 2.513; 87: SpO2, 99.458; 87: Perf, 2.665; 88: SpO2, 99.746; 88: Perf, 1.855; 89: SpO2, 99.525; 89: Perf, 2.494; 90: SpO2, 98.966; 90: Perf, 3.134; 91: SpO2, 98.763; 91: Perf, 2.510; 92: SpO2, 99.246; 92: Perf, 1.828; 93: SpO2, 99.534; 93: Perf, 1.934; 94: SpO2, 99.1; 94: Perf, 1.72; 95: SpO2, 97.860; 95: Perf, 1.700; 96: SpO2, 99.322; 96: Perf, 1.862; 97: POC GLUCOSE BY METER, 143 mg/dL; 97: SpO2, 99.379; 97: Perf, 2.176; 98: SpO2, 98.948; 98: Perf, 1.813; 99: SpO2, 99.695; 99: Perf, 2.000; 100: POC PH (V) ISTAT, 7.41; 100: POC HCO3 (V) ISTAT, 26.2 mmol/L; 100: POC BASE EXCESS ISTAT, 2 mmol/L; 100: POC PO2 (V) ISTAT, 28 mmHg; 100: POC LACTATE ISTAT, 1.44 mmol/L; 100: POC O2 SATURATION ISTAT VENOUS, 53 %; 100: POC PCO2 (V) ISTAT, 41.5 mmHg; 100: POC TCO2 (V) ISTAT, 27 mmol/L; 100: SpO2, 99.407; 100: Perf, 2.821; 101: SpO2, 99.186; 101: Perf, 2.667; 102: SpO2, 98.860; 102: Perf, 2.243; 103: SpO2, 98.729; 103: Perf, 3.206; 104: SpO2, 98.345; 104: Perf, 3.29; 105: SpO2, 98.695; 105: Perf, 3.340; 106: SpO2, 98.203; 106: Perf, 3.875; 107: SpO2, 98.368; 107: Perf, 4.513; 108: SpO2, 98.678; 108: Perf, 4.579; 109: SpO2, 98.103; 109: Perf, 4.212; 110: SpO2, 98.707; 110: Perf, 2.987; 111: SpO2, 99.153; 111: Perf, 2.532; 112: SpO2, 98.5; 112: Perf, 2.301; 113: SpO2, 98.0; 113: Perf, 1.517; 114: SpO2, 98.0; 114: Perf, 1.459; 115: SpO2, 98.475; 115: Perf, 1.668; 116: SpO2, 98.729; 116: Perf, 2.262; 117: SpO2, 98.431; 117: Perf, 2.479; 118: SpO2, 98.797; 118: Perf, 2.42; 119: SpO2, 98.621; 119: Perf, 2.42; 0: Age, 31; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 107.0; 0: Triage RR, 22.0; 0: Triage SBP, 150.0; 0: Triage DBP, 92.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the data and noted that although the patient\u2019s heart rate is slightly elevated and white blood cell count is above normal, the temperature is not feverish, the lactate level is within normal limits, and there are no clear signs of organ dysfunction. I questioned whether there could be an underlying infection driving these findings, but no definitive indication of sepsis is present. Re-examining the labs, vital signs, and clinical context further supported that the risk of sepsis within 12 hours appears low.",
        "claims": [
            "The patient's heart rate is slightly elevated.",
            "The patient's white blood cell count is above normal.",
            "The patient's temperature is not feverish.",
            "The patient's lactate level is within normal limits.",
            "There are no clear signs of organ dysfunction.",
            "There may be an underlying infection driving these findings.",
            "There is no definitive indication of sepsis present.",
            "Re-examining the labs further supported the findings.",
            "Re-examining the vital signs further supported the findings.",
            "Re-examining the clinical context further supported the findings.",
            "The risk of sepsis within 12 hours appears low."
        ],
        "relevant_claims": [
            "The patient's white blood cell count is above normal.",
            "The patient's temperature is not feverish.",
            "There is no definitive indication of sepsis present."
        ],
        "alignment_scores": [
            1.0,
            0.2,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            9
        ],
        "alignment_reasonings": [
            "An elevated white blood cell (WBC) count is explicitly included in the SIRS criteria, identifying systemic inflammation consistent with early sepsis. This claim directly aligns with the SIRS Positivity category showing strong alignment.",
            "The claim about the patient's temperature not being feverish indirectly relates to the absence of one potential SIRS criterion (fever). Since the lack of fever doesn't itself confirm the presence of SIRS positivity (\u22652 criteria), the alignment is low but exists conceptually since temperature is a variable within the SIRS criteria.",
            "The claim suggests uncertainty or a lack of concrete indicators of sepsis. While absence of sepsis indicators does not directly align with any of the given criteria for sepsis risk, it indirectly relates to the absence of aggressive early management (e.g., antibiotics or cultures) that would be warranted if sepsis were suspected. The alignment is weak as the claim points more to exclusion rather than confirmation of risk."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "1: SpO2, 98.630; 1: Perf, 3.019; 1: SBP, 152.0; 1: DBP, 96.0; 1: MAP, 114.667; 2: HR, 143.083; 2: RR, 16.192; 2: SpO2, 98.810; 2: Perf, 3.446; 2: 1min HRV, 2.178; 3: HR, 141.678; 3: RR, 24.271; 3: SpO2, 98.322; 3: Perf, 3.714; 3: 1min HRV, 2.554; 3: 5min HRV, 3.429; 4: HR, 140.724; 4: RR, 27.379; 4: SpO2, 96.655; 4: Perf, 3.744; 4: 1min HRV, 2.447; 5: HR, 138.881; 5: RR, 36.847; 5: SpO2, 94.780; 5: Perf, 3.694; 5: 1min HRV, 5.014; 6: HR, 136.017; 6: RR, 37.0; 6: SpO2, 94.576; 6: Perf, 4.768; 6: 1min HRV, 2.594; 7: HR, 136.638; 7: RR, 27.707; 7: SpO2, 94.828; 7: Perf, 4.575; 7: 1min HRV, 3.223; 8: HR, 136.288; 8: RR, 35.712; 8: SpO2, 94.831; 8: Perf, 5.021; 8: 1min HRV, 2.220; 8: 5min HRV, 6.473; 9: HR, 137.220; 9: RR, 35.932; 9: SpO2, 93.847; 9: Perf, 4.974; 9: 1min HRV, 3.275; 10: HR, 135.517; 10: RR, 37.828; 10: SpO2, 94.224; 10: Perf, 4.255; 10: 1min HRV, 2.338; 10: SBP, 148.0; 10: DBP, 88.0; 10: MAP, 108.0; 10: Pain, 2.0; 10: Temp, 98.2; 11: HR, 136.237; 11: RR, 35.797; 11: SpO2, 93.644; 11: Perf, 4.098; 11: 1min HRV, 1.728; 11: SBP, 148.0; 11: DBP, 88.0; 11: MAP, 108.0; 12: HR, 136.362; 12: RR, 34.328; 12: SpO2, 93.138; 12: Perf, 3.829; 12: 1min HRV, 1.689; 13: HR, 136.814; 13: RR, 33.814; 13: SpO2, 93.068; 13: Perf, 3.642; 13: 1min HRV, 2.513; 13: 5min HRV, 3.005; 14: HR, 133.508; 14: RR, 35.390; 14: SpO2, 94.0; 14: Perf, 3.389; 14: 1min HRV, 5.601; 14: SBP, 145.0; 14: DBP, 85.0; 14: MAP, 105.0; 15: HR, 135.707; 15: RR, 29.966; 15: SpO2, 93.259; 15: Perf, 3.463; 15: 1min HRV, 1.602; 16: HR, 135.831; 16: RR, 35.068; 16: SpO2, 92.644; 16: Perf, 3.218; 16: 1min HRV, 2.306; 17: HR, 137.483; 17: RR, 28.017; 17: SpO2, 92.483; 17: Perf, 2.914; 17: 1min HRV, 2.149; 18: HR, 139.525; 18: RR, 33.695; 18: SpO2, 93.831; 18: Perf, 3.005; 18: 1min HRV, 4.277; 18: 5min HRV, 7.611; 19: HR, 140.5; 19: RR, 30.155; 19: SpO2, 94.276; 19: Perf, 3.315; 19: 1min HRV, 2.195; 20: HR, 142.136; 20: RR, 26.153; 20: SpO2, 93.983; 20: Perf, 3.305; 20: 1min HRV, 4.383; 21: HR, 138.356; 21: RR, 39.475; 21: SpO2, 93.780; 21: Perf, 3.03; 21: 1min HRV, 3.559; 22: HR, 137.534; 22: RR, 24.172; 22: SpO2, 94.103; 22: Perf, 3.151; 22: 1min HRV, 4.053; 23: HR, 138.203; 23: RR, 26.0; 23: SpO2, 94.407; 23: Perf, 3.031; 23: 1min HRV, 3.148; 23: 5min HRV, 6.289; 23: SBP, 160.0; 23: DBP, 84.0; 23: MAP, 109.333; 24: HR, 138.379; 24: RR, 27.431; 24: SpO2, 95.414; 24: Perf, 2.772; 24: 1min HRV, 2.778; 24: SBP, 160.0; 24: DBP, 84.0; 24: MAP, 109.333; 25: HR, 138.424; 25: RR, 30.458; 25: SpO2, 94.610; 25: Perf, 2.843; 25: 1min HRV, 4.149; 26: HR, 137.729; 26: RR, 30.288; 26: SpO2, 94.593; 26: Perf, 2.971; 26: 1min HRV, 3.643; 27: HR, 136.034; 27: RR, 34.276; 27: SpO2, 94.431; 27: Perf, 3.723; 27: 1min HRV, 4.158; 28: HR, 135.525; 28: RR, 36.847; 28: SpO2, 94.322; 28: Perf, 3.027; 28: 1min HRV, 3.855; 28: 5min HRV, 5.509; 29: HR, 133.897; 29: RR, 37.845; 29: SpO2, 94.862; 29: Perf, 2.952; 29: 1min HRV, 2.374; 30: HR, 134.424; 30: RR, 36.119; 30: SpO2, 94.492; 30: Perf, 2.938; 30: 1min HRV, 2.384; 31: HR, 133.915; 31: RR, 35.661; 31: SpO2, 94.119; 31: Perf, 2.657; 31: 1min HRV, 3.336; 32: HR, 132.431; 32: RR, 29.241; 32: SpO2, 94.845; 32: Perf, 2.761; 32: 1min HRV, 29.569; 33: HR, 140.0; 33: RR, 40.0; 33: SpO2, 94.0; 33: 5min HRV, 14.178; 33: SBP, 140.0; 33: DBP, 93.0; 33: MAP, 108.667; 42: NORMOSOL-R IV BOLUS -, 500 ML; 43: POC CREATININE,ISTAT: .6 mg/dL; 43: POC EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 43: POC EGFR FOR AFRICAN AMERICAN, 118 mL/min/1.73 m2; 43: HR, 130.0; 43: RR, 34.0; 43: SpO2, 95.0; 43: SBP, 139.0; 43: DBP, 81.0; 43: MAP, 100.333; 53: HR, 131.0; 53: RR, 37.0; 53: SpO2, 96.0; 53: SBP, 154.0; 53: DBP, 85.0; 53: MAP, 108.0; 56: AZITHROMYCIN, 500 MG IN D5W 250 ML IVPB; 61: CEFEPIME, 2 GRAM/20 ML IV PUSH; 63: HR, 130.0; 63: RR, 38.0; 63: SpO2, 96.0; 63: SBP, 122.0; 63: DBP, 109.0; 63: MAP, 113.333; 73: HR, 134.0; 73: RR, 25.0; 73: SpO2, 95.0; 83: HR, 132.0; 83: RR, 23.0; 83: SpO2, 96.0; 83: SBP, 145.0; 83: DBP, 76.0; 83: MAP, 99.0; 93: HR, 129.0; 93: RR, 35.0; 93: SpO2, 96.0; 93: SBP, 138.0; 93: DBP, 82.0; 93: MAP, 100.667; 103: HR, 127.0; 103: RR, 36.0; 103: SpO2, 95.0; 103: SBP, 118.0; 103: DBP, 92.0; 103: MAP, 100.667; 112: ALBUMIN, 3.7 g/dL; 112: GLUCOSE, 197 mg/dL; 112: ALKALINE PHOSPHATASE, 450 U/L; 112: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 112: POTASSIUM, 3.7 mmol/L; 112: GLOBULIN, 3.1 g/dL; 112: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 112: CREATININE, 0.65 mg/dL; 112: CHLORIDE, 101 mmol/L; 112: LIPASE, 24 U/L; 112: AST (SGOT), 83 U/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: ANION GAP, 12 mmol/L; 112: SODIUM, 135 mmol/L; 112: MAGNESIUM, 1.9 mg/dL; 112: CALCIUM, 8.7 mg/dL; 112: BILIRUBIN TOTAL, 0.6 mg/dL; 112: CORRECTED CALCIUM, 8.9 mg/dL; 112: CO2, 22 mmol/L; 112: ALT (SGPT), 29 U/L; 112: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 112: TSH, 1.65 uIU/mL; 113: HR, 123.0; 113: RR, 29.0; 113: SpO2, 95.0; 113: SBP, 121.0; 113: DBP, 67.0; 113: MAP, 85.0; 114: TROPONIN I, <.017 ng/mL; 0: Age, 56; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 136.0; 0: Triage RR, 36.0; 0: Triage SBP, 148.0; 0: Triage DBP, 88.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noted the patient\u2019s persistent tachycardia and elevated respiratory rate, which are clinical warning signs. The administration of IV fluids and broad-spectrum antibiotics indicates a strong concern for infection. Reviewing the labs, there are no immediate indications of severe organ failure, but the clinical picture still raises suspicion. Given these factors, the patient is at high risk for sepsis within the next 12 hours.",
        "claims": [
            "The patient has persistent tachycardia.",
            "The patient has an elevated respiratory rate.",
            "Persistent tachycardia and elevated respiratory rate are clinical warning signs.",
            "The administration of IV fluids indicates a strong concern for infection.",
            "The administration of broad-spectrum antibiotics indicates a strong concern for infection.",
            "There are no immediate indications of severe organ failure in the lab results.",
            "The clinical picture still raises suspicion of infection.",
            "Given these factors, the patient is at high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has persistent tachycardia.",
            "The patient has an elevated respiratory rate.",
            "Persistent tachycardia and elevated respiratory rate are clinical warning signs.",
            "The administration of IV fluids indicates a strong concern for infection.",
            "The administration of broad-spectrum antibiotics indicates a strong concern for infection.",
            "The clinical picture still raises suspicion of infection.",
            "Given these factors, the patient is at high risk for sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.8,
            0.3,
            0.9,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            3,
            2,
            9,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "Tachycardia is defined as a heart rate greater than 90 bpm, which is one of the criteria for SIRS. While the claim does not mention other SIRS criteria, the presence of tachycardia alone is strongly aligned with SIRS positivity. Therefore, the alignment is high, but not perfect, as the claim does not specify meeting the other criterion needed for SIRS positivity.",
            "An elevated respiratory rate is a specific criterion included in the qSOFA score (respiratory rate \u226522/min), which flags a high risk of sepsis-related complications. However, without the specific respiratory rate provided, it is unclear if it meets the threshold of \u226522/min, resulting in a strong but not perfect alignment.",
            "The claim refers to persistent tachycardia and an elevated respiratory rate, both of which are explicitly part of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm, respiratory rate\u202f>\u202f20\u202f/min). The alignment is strong because the claim mentions two clinical signs that directly match the criteria for SIRS positivity, which is used to identify systemic inflammation consistent with early sepsis. However, the claim does not specify the exact values, so while the alignment is quite strong, there is a slight lack of specificity that prevents a perfect score.",
            "The administration of IV fluids does imply a significant concern for an infection or potential sepsis, often accompanying other interventions. However, this claim does not mention concrete actions like administering antibiotics or drawing cultures, which would directly align with category 9. Thus, the alignment is indirect and somewhat weak, resulting in a moderate alignment score.",
            "The claim directly mentions the administration of broad-spectrum antibiotics, which is a key component of this category. It signifies a clinician's strong suspicion of a serious infection, making it relevant for sepsis risk assessment. However, without additional context (such as the timing of administration relative to the onset of symptoms), it\u2019s not absolutely perfect alignment, hence the slight reduction to 0.9.",
            "The claim mentions a suspicion of infection, which aligns with the initial steps in sepsis risk assessment (such as considering early antibiotic or culture orders). However, without specific actions like ordering antibiotics or cultures, the alignment is weak. Hence, the rating reflects marginal relevance to the category.",
            "The claim mentions a high risk of sepsis within the next 12 hours, aligning with the concept of predicting imminent clinical deterioration. However, it lacks specific details on the criteria (like deranged vitals) that would confirm a NEWS or similar score. Thus, the alignment is broad and indirect, focusing on the potential for deterioration without specifying exact measurements, justifying a low rating."
        ],
        "final_alignment_score": 0.5857142857142856,
        "accuracy": 1
    },
    {
        "input": "7: HR, 91.596; 7: RR, 24.462; 7: SpO2, 96.562; 7: Perf, 0.259; 7: 1min HRV, 72.990; 8: POC PH (V) ISTAT, 7.25; 8: POC GLUCOSE ISTAT, 100 mg/dL; 8: POC SODIUM ISTAT, 141 mmol/L; 8: POC HGB (CALC) ISTAT, 11.6 g/dL; 8: POC POTASSIUM ISTAT, 4.1 mmol/L; 8: POC HCT ISTAT, 34 %; 8: POC HCO3 (V) ISTAT, 30.1 mmol/L; 8: POC BASE EXCESS ISTAT, 3 mmol/L; 8: POC TCO2 (V) ISTAT, 32 mmol/L; 8: POC LACTATE ISTAT, 0.83 mmol/L; 8: POC O2 SATURATION ISTAT VENOUS, 21 %; 8: POC PO2 (V) ISTAT, 19 mmHg; 8: POC PCO2 (V) ISTAT, 68.9 mmHg; 8: HR, 92.434; 8: RR, 24.623; 8: SpO2, 96.519; 8: Perf, 0.241; 8: 1min HRV, 51.204; 8: 5min HRV, 63.099; 9: HR, 93.135; 9: RR, 19.731; 9: SpO2, 95.95; 9: Perf, 0.217; 9: 1min HRV, 56.604; 10: HR, 91.208; 10: RR, 21.585; 10: SpO2, 96.679; 10: Perf, 0.21; 10: 1min HRV, 41.598; 11: HR, 92.302; 11: RR, 21.321; 11: Perf, 0.21; 11: 1min HRV, 56.135; 12: HR, 92.481; 12: RR, 20.827; 12: SpO2, 97.778; 12: Perf, 0.21; 12: 1min HRV, 33.525; 13: HR, 97.585; 13: RR, 25.849; 13: SpO2, 96.811; 13: Perf, 0.21; 13: 1min HRV, 41.248; 13: 5min HRV, 50.267; 14: HR, 105.887; 14: RR, 21.642; 14: SpO2, 95.947; 14: 1min HRV, 52.404; 15: HR, 104.755; 15: RR, 16.019; 15: SpO2, 97.0; 15: 1min HRV, 15.021; 16: HR, 99.509; 16: RR, 22.623; 16: SpO2, 97.868; 16: Perf, 0.806; 16: 1min HRV, 6.890; 17: HR, 99.327; 17: RR, 19.538; 17: SpO2, 98.462; 17: Perf, 1.002; 17: 1min HRV, 45.299; 18: HR, 98.204; 18: RR, 25.833; 18: SpO2, 98.5; 18: Perf, 0.96; 18: 1min HRV, 7.606; 18: 5min HRV, 37.717; 19: HR, 98.538; 19: RR, 26.731; 19: SpO2, 98.0; 19: Perf, 0.96; 19: 1min HRV, 21.760; 19: SBP, 171.0; 19: DBP, 137.0; 19: MAP, 148.333; 20: HR, 97.667; 20: RR, 20.407; 20: SpO2, 97.824; 20: Perf, 0.96; 20: 1min HRV, 38.205; 21: HR, 97.887; 21: RR, 21.245; 21: SpO2, 98.302; 21: Perf, 0.96; 21: 1min HRV, 38.711; 22: HR, 96.212; 22: RR, 21.673; 22: SpO2, 99.0; 22: Perf, 0.96; 22: 1min HRV, 15.498; 23: HR, 95.679; 23: RR, 23.340; 23: SpO2, 98.041; 23: Perf, 0.959; 23: 1min HRV, 12.652; 23: 5min HRV, 29.080; 23: SBP, 171.0; 23: DBP, 137.0; 23: MAP, 148.333; 23: LPM O2, 2.0; 23: Pain, 1.0; 23: Temp, 101.3; 24: HR, 95.058; 24: RR, 23.654; 24: SpO2, 97.385; 24: Perf, 0.820; 24: 1min HRV, 17.024; 25: HR, 94.755; 25: RR, 22.038; 25: SpO2, 96.925; 25: Perf, 0.358; 25: 1min HRV, 13.002; 26: HR, 93.923; 26: RR, 20.442; 26: SpO2, 96.981; 26: Perf, 0.331; 26: 1min HRV, 17.608; 27: HR, 93.5; 27: RR, 22.519; 27: SpO2, 96.704; 27: Perf, 0.344; 27: 1min HRV, 10.366; 27: SBP, 125.0; 27: DBP, 33.0; 27: MAP, 63.667; 27: LPM O2, 2.0; 28: HR, 93.887; 28: RR, 23.151; 28: SpO2, 96.302; 28: Perf, 0.353; 28: 1min HRV, 4.850; 28: 5min HRV, 13.955; 29: HR, 94.5; 29: RR, 25.077; 29: SpO2, 96.077; 29: Perf, 0.371; 29: 1min HRV, 42.092; 30: HR, 92.208; 30: RR, 29.113; 30: SpO2, 95.660; 30: Perf, 0.388; 30: 1min HRV, 19.633; 31: HR, 93.0; 31: RR, 22.519; 31: SpO2, 94.808; 31: Perf, 0.391; 31: 1min HRV, 28.109; 32: HR, 92.593; 32: RR, 20.204; 32: SpO2, 95.185; 32: Perf, 0.455; 32: 1min HRV, 18.466; 33: 5min HRV, 29.373; 38: ABO/RH, B Positive; 39: ANTIBODY SCREEN 3, NEG; 44: PH.SER/PLAS, 7.22; 44: CALCIUM IONIZED, 1.14 mmol/L; 45: WAM DIFTYP, AUTO; 45: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 45: WHITE BLOOD CELLS (WBC), 11.9 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.07 K/uL; 45: HEMOGLOBIN (HGB), 10.0 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: MEAN CORPUSCULAR VOLUME (MCV), 110.3 fL; 45: HEMATOCRIT (HCT), 32.0 %; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: PLATELET COUNT (PLT), 185 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.5 pg; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 45: NEUTROPHIL % (AUTO DIFF), 84.7 %; 45: MONOCYTE % (AUTO DIFF), 6.0 %; 45: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 45: BASOPHIL % (AUTO DIFF), 0.1 %; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.71 K/uL; 46: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 58: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 63: HR, 91.0; 63: SpO2, 100.0; 63: SBP, 109.0; 63: DBP, 44.0; 63: MAP, 65.667; 63: LPM O2, 2.0; 63: VANCOMYCIN-WATER INJECT (PEG), 2 GRAM/400 ML IV PGBK; 69: INR:, 1.1; 69: THROMBIN TIME, 20.9 seconds; 69: PART. THROMBOPLASTIN TIME, 40.8 seconds; 69: FIBRINOGEN, 654 mg/dL; 69: D-DIMER, 1.40 ug/mL FEU; 69: PROTHROMBIN TIME, 13.4 seconds; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 71: BLOOD TYPE VERIFICATION-MANUAL, B Positive; 75: MAGNESIUM, 2.1 mg/dL; 75: PHOSPHORUS, 2.6 mg/dL; 75: BNP NT-PRO, 2986 pg/mL; 88: TROPONIN I, 0.020 ng/mL; 116: KETONE, URINE (UA): Negative; 116: NITRITE, URINE (UA): Negative; 116: SPECIFIC GRAVITY, URINE (UA): 1.020; 116: PH, URINE (UA): 5.0; 116: GLUCOSE, URINE (UA): Negative; 116: LEUKOCYTE ESTERASE, URINE (UA): Negative; 0: Age, 81; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 38.5; 0: Triage HR, 94.0; 0: Triage RR, 23.0; 0: Triage SBP, 171.0; 0: Triage DBP, 137.0; 0: Triage acuity, 2-Emergent; 0: CC, ALTERED MENTAL STATUS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient\u2019s advanced age, presenting symptoms (fever, altered mental status), and the emergency acuity triage level, which raised initial concern for sepsis. Then I looked at vitals such as respiratory rate and blood pressure changes, as well as lab results (notably the elevated temperature, borderline low MAP, and WBC count), indicating a probable infection and possible organ dysfunction. I also considered the administration of broad-spectrum antibiotics, suggesting the clinical team\u2019s suspicion of severe infection. Finally, I integrated these factors and concluded that the patient is at high risk of progressing to sepsis within 12 hours.",
        "claims": [
            "The patient\u2019s advanced age is noted.",
            "The patient presents with symptoms of fever and altered mental status.",
            "The emergency acuity triage level raised initial concern for sepsis.",
            "Vital signs, such as respiratory rate and blood pressure changes, were examined.",
            "Lab results indicated an elevated temperature.",
            "The patient's mean arterial pressure (MAP) is borderline low.",
            "The white blood cell (WBC) count is considered in the assessment.",
            "The lab results indicate a probable infection and possible organ dysfunction.",
            "The administration of broad-spectrum antibiotics was observed.",
            "The administration of antibiotics suggests the clinical team\u2019s suspicion of severe infection.",
            "I integrated all these factors.",
            "I concluded that the patient is at high risk of progressing to sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s advanced age is noted.",
            "The patient presents with symptoms of fever and altered mental status.",
            "The emergency acuity triage level raised initial concern for sepsis.",
            "Vital signs, such as respiratory rate and blood pressure changes, were examined.",
            "The patient's mean arterial pressure (MAP) is borderline low.",
            "The white blood cell (WBC) count is considered in the assessment.",
            "The lab results indicate a probable infection and possible organ dysfunction.",
            "The administration of broad-spectrum antibiotics was observed.",
            "The administration of antibiotics suggests the clinical team\u2019s suspicion of severe infection."
        ],
        "alignment_scores": [
            0.9,
            0.8,
            0.7,
            0.3,
            0.7,
            0.7,
            0.7,
            0.9,
            0.8
        ],
        "alignment_category": [
            1,
            3,
            4,
            4,
            7,
            2,
            8,
            9,
            9
        ],
        "alignment_reasonings": [
            "The claim references the patient's advanced age, which is closely aligned with the \"Elderly Susceptibility\" category that highlights age (\u226565 years) as a significant risk factor for sepsis. The alignment is slightly less than perfect as the exact age isn't provided to confirm it meets the criterion threshold, but it's very likely applicable.",
            "The claim mentions fever, which could relate to SIRS, but doesn't specify it meets SIRS criteria. Altered mental status is explicitly a component of the qSOFA score. When combined with a potential second indicator like abnormal vitals (fever suggesting infection), it suggests a heightened sepsis risk via qSOFA. The alignment to qSOFA is strong but not perfect, as the claim doesn't confirm two definitive qSOFA criteria outright, but it does strongly imply them.",
            "The claim mentions emergency acuity triage level, which is related to assessing the severity of a patient's condition and potential clinical deterioration. While not directly stating NEWS, elevated acuity triage could imply deranged vitals and high-risk features often assessed by NEWS, indicating a potential risk of sepsis. It aligns indirectly with the category but strongly enough to merit a higher alignment rating.",
            "The claim mentions examination of vital signs, including respiratory rate and blood pressure, which are components used in calculating the NEWS score. However, the claim does not specify any thresholds or scores that would directly align with the NEWS category, limiting the alignment strength to a suggestion that NEWS could be relevant.",
            "The claim mentions a \"borderline low\" mean arterial pressure (MAP), which aligns with the criteria for sepsis-associated hypotension (MAP <70 mmHg). While it does not confirm whether the MAP is below the threshold, the mention of \"borderline low\" suggests proximity to a concerning level indicative of potential sepsis-related issues. Thus, it partially aligns with the category criteria.",
            "A white blood cell count is directly relevant to one of the SIRS criteria, which includes elevated (>12,000/\u00b5L) or decreased (<4,000/\u00b5L) WBC. However, the claim lacks specific details about whether the WBC count met these thresholds. It indicates consideration of systemic inflammation related to early sepsis, justifying a moderate alignment score.",
            "The claim mentions probable infection and possible organ dysfunction, which aligns conceptually with the SOFA score criteria that identify new organ dysfunction in the context of sepsis. While the claim does not specify a precise SOFA score or the calculated components, the suggestion of organ dysfunction is a relevant element for SOFA evaluation, leading to a reasonably strong alignment.",
            "The claim explicitly mentions the administration of broad-spectrum antibiotics, which is a key aspect of the \"Early Antibiotic/Culture Orders\" category. However, without specific timing details (within 2 hours), the alignment is not perfect but still very high, hence the rating of 0.9.",
            "The claim pertains to the administration of antibiotics, which is strongly associated with suspicion of a severe infection and aligns with the category's focus on early intervention (such as antibiotics or cultures) in sepsis risk assessment. However, the claim doesn\u2019t specify the timing of the antibiotic administration (within the first 2 hours), slightly reducing the alignment with the category."
        ],
        "final_alignment_score": 0.7222222222222222,
        "accuracy": 1
    },
    {
        "input": "3: SpO2, 97.5; 4: HR, 101.16; 4: RR, 25.739; 4: SpO2, 94.5; 4: 1min HRV, 6.414; 5: HR, 100.797; 5: RR, 24.475; 5: SpO2, 94.441; 5: Perf, 0.655; 5: 1min HRV, 35.949; 5: SBP, 158.0; 5: DBP, 97.0; 5: MAP, 117.333; 6: HR, 100.593; 6: RR, 23.966; 6: SpO2, 94.0; 6: Perf, 0.625; 6: 1min HRV, 17.024; 6: SBP, 158.0; 6: DBP, 97.0; 6: MAP, 117.333; 6: Temp, 98.8; 7: HR, 101.293; 7: RR, 22.828; 7: SpO2, 94.103; 7: Perf, 0.608; 7: 1min HRV, 37.928; 7: 5min HRV, 29.475; 8: HR, 100.593; 8: RR, 23.407; 8: SpO2, 94.186; 8: Perf, 0.596; 8: 1min HRV, 24.883; 9: HR, 99.707; 9: RR, 23.276; 9: SpO2, 93.172; 9: Perf, 0.576; 9: 1min HRV, 32.870; 10: HR, 99.847; 10: RR, 22.966; 10: SpO2, 93.644; 10: Perf, 0.543; 10: 1min HRV, 44.265; 11: HR, 100.051; 11: RR, 22.881; 11: SpO2, 93.271; 11: Perf, 0.491; 11: 1min HRV, 49.237; 12: HR, 99.776; 12: RR, 22.983; 12: SpO2, 93.845; 12: Perf, 0.489; 12: 1min HRV, 44.707; 12: 5min HRV, 40.246; 13: HR, 102.051; 13: RR, 21.831; 13: SpO2, 92.610; 13: Perf, 0.493; 13: 1min HRV, 37.201; 14: HR, 101.362; 14: RR, 23.224; 14: SpO2, 93.534; 14: Perf, 0.498; 14: 1min HRV, 58.304; 15: HR, 99.831; 15: RR, 23.186; 15: SpO2, 93.169; 15: Perf, 0.568; 15: 1min HRV, 33.361; 16: HR, 101.475; 16: RR, 19.525; 16: SpO2, 93.729; 16: Perf, 0.573; 16: 1min HRV, 54.280; 17: HR, 100.276; 17: RR, 22.017; 17: SpO2, 93.397; 17: Perf, 0.525; 17: 1min HRV, 41.692; 17: 5min HRV, 45.910; 18: HR, 100.271; 18: RR, 23.475; 18: SpO2, 92.932; 18: Perf, 0.523; 18: 1min HRV, 45.637; 19: HR, 99.724; 19: RR, 23.017; 19: SpO2, 93.552; 19: Perf, 0.519; 19: 1min HRV, 42.902; 20: HR, 100.203; 20: RR, 22.051; 20: SpO2, 93.492; 20: Perf, 0.52; 20: 1min HRV, 41.013; 21: HR, 100.186; 21: RR, 22.542; 21: SpO2, 93.271; 21: Perf, 0.513; 21: 1min HRV, 48.040; 22: HR, 101.069; 22: RR, 23.276; 22: SpO2, 93.483; 22: Perf, 0.511; 22: 1min HRV, 43.514; 22: 5min HRV, 44.399; 23: HR, 99.559; 23: RR, 24.441; 23: SpO2, 94.644; 23: Perf, 0.644; 23: 1min HRV, 36.599; 24: HR, 97.759; 24: RR, 21.293; 24: SpO2, 95.828; 24: Perf, 0.823; 24: 1min HRV, 42.457; 25: HR, 98.746; 25: RR, 20.220; 25: SpO2, 95.814; 25: Perf, 0.754; 25: 1min HRV, 75.012; 26: HR, 97.119; 26: RR, 20.695; 26: SpO2, 96.271; 26: Perf, 0.757; 26: 1min HRV, 44.336; 26: LPM O2, 2.0; 27: HR, 97.034; 27: RR, 19.276; 27: SpO2, 97.0; 27: Perf, 0.730; 27: 1min HRV, 55.894; 27: 5min HRV, 52.824; 28: HR, 98.305; 28: RR, 21.271; 28: SpO2, 97.627; 28: Perf, 0.694; 28: 1min HRV, 39.777; 29: HR, 96.069; 29: RR, 20.448; 29: SpO2, 97.914; 29: Perf, 0.660; 29: 1min HRV, 50.570; 30: HR, 94.949; 30: RR, 19.746; 30: SpO2, 97.576; 30: Perf, 0.699; 30: 1min HRV, 70.984; 31: HR, 94.707; 31: RR, 19.845; 31: SpO2, 97.655; 31: Perf, 0.726; 31: 1min HRV, 65.348; 32: HR, 94.780; 32: RR, 20.0; 32: SpO2, 98.0; 32: Perf, 0.718; 32: 1min HRV, 59.486; 32: 5min HRV, 58.790; 33: HR, 94.712; 33: RR, 19.712; 33: SpO2, 98.0; 33: Perf, 0.696; 33: 1min HRV, 44.407; 34: HR, 96.828; 34: RR, 21.931; 34: SpO2, 97.724; 34: Perf, 0.615; 34: 1min HRV, 56.587; 35: HR, 99.254; 35: RR, 20.797; 35: SpO2, 98.119; 35: Perf, 0.565; 35: 1min HRV, 41.004; 36: WAM DIFTYP, AUTO; 36: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 36: MONOCYTE % (AUTO DIFF), 5.1 %; 36: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 36: WHITE BLOOD CELLS (WBC), 9.4 K/uL; 36: NRBC PERCENT (HEMATOLOGY), 0.0 %; 36: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 36: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 36: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 36: MEAN CORPUSCULAR VOLUME (MCV), 92.2 fL; 36: HEMOGLOBIN (HGB), 11.6 g/dL; 36: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 36: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 36: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 36: MONOCYTE ABSOLUTE (AUTO DIFF), 0.48 K/uL; 36: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 36: PLATELET COUNT (PLT), 320 K/uL; 36: LYMPHOCYTE % (AUTO DIFF), 6.4 %; 36: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.24 K/uL; 36: HEMATOCRIT (HCT), 36.4 %; 36: BASOPHIL % (AUTO DIFF), 0.2 %; 36: NEUTROPHIL % (AUTO DIFF), 88.0 %; 36: EOSINOPHIL % (AUTO DIFF), 0.0 %; 36: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 36: HR, 96.517; 36: RR, 21.103; 36: SpO2, 98.948; 36: Perf, 0.573; 36: 1min HRV, 47.855; 37: HR, 96.814; 37: RR, 21.475; 37: SpO2, 98.797; 37: Perf, 0.501; 37: 1min HRV, 33.828; 37: 5min HRV, 45.940; 38: HR, 96.847; 38: RR, 21.085; 38: SpO2, 98.797; 38: Perf, 0.480; 38: 1min HRV, 51.357; 39: HR, 97.931; 39: RR, 22.310; 39: SpO2, 99.0; 39: Perf, 0.461; 39: 1min HRV, 18.436; 40: HR, 96.627; 40: RR, 21.424; 40: SpO2, 98.475; 40: Perf, 0.442; 40: 1min HRV, 59.154; 41: HR, 97.724; 41: RR, 22.190; 41: SpO2, 98.483; 41: Perf, 0.406; 41: 1min HRV, 20.682; 42: HR, 97.169; 42: RR, 23.458; 42: SpO2, 98.085; 42: Perf, 0.421; 42: 1min HRV, 42.586; 42: 5min HRV, 41.790; 43: HR, 98.814; 43: RR, 24.136; 43: SpO2, 98.254; 43: Perf, 0.396; 43: 1min HRV, 40.306; 44: HR, 96.845; 44: RR, 22.017; 44: SpO2, 98.603; 44: Perf, 0.434; 44: 1min HRV, 71.813; 45: HR, 95.847; 45: RR, 20.678; 45: SpO2, 97.831; 45: Perf, 0.465; 45: 1min HRV, 33.861; 47: 5min HRV, 52.008; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.0 seconds; 68: PART. THROMBOPLASTIN TIME, 30.7 seconds; 73: ABO/RH (AUTOMATION), A Positive; 73: ANTIBODY SCREEN 3, NEG; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA A, Not Detected; 77: INFLUENZA B, Not Detected; 100: TROPONIN I, <.017 ng/mL; 118: EGFR FOR AFRICAN AMERICAN, 119 mL/min/1.73 m2; 118: CO2, 18 mmol/L; 118: ANION GAP, 18 mmol/L; 118: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 118: CORRECTED CALCIUM, 9.5 mg/dL; 118: GLUCOSE, 97 mg/dL; 118: ALBUMIN, 3.5 g/dL; 118: BILIRUBIN TOTAL, 0.4 mg/dL; 118: MAGNESIUM, 1.8 mg/dL; 118: CREATININE, 0.38 mg/dL; 118: SODIUM, 141 mmol/L; 118: PROTEIN TOTAL, 6.5 g/dL; 118: LIPASE, 20 U/L; 118: POTASSIUM, 5.3 mmol/L; 118: AST (SGOT), 63 U/L; 118: ALT (SGPT), 9 U/L; 118: CALCIUM, 9.1 mg/dL; 118: ALKALINE PHOSPHATASE, 63 U/L; 118: GLOBULIN, 3.0 g/dL; 118: EGFR REFIT WITHOUT RACE (2021), 103 mL/min/1.73 m2; 118: CHLORIDE, 105 mmol/L; 0: Age, 78; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 37.1; 0: Triage HR, 100.0; 0: Triage RR, 24.0; 0: Triage SBP, 158.0; 0: Triage DBP, 97.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I first noted the patient\u2019s slightly elevated heart rate and respiratory rate, which could be early warning signs. Then I looked for more definitive indicators of infection or organ dysfunction, but the lab results, blood pressure, and oxygen levels remained relatively stable. Although the patient is older and has some mild abnormalities, there are no strong clinical signs of active severe infection or impending organ failure. Therefore, I concluded that the patient is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient's heart rate is slightly elevated.",
            "The patient's respiratory rate is slightly elevated.",
            "Slightly elevated heart rate and respiratory rate could be early warning signs.",
            "The lab results are relatively stable.",
            "The patient's blood pressure remains relatively stable.",
            "The patient's oxygen levels remain relatively stable.",
            "The patient is older.",
            "The patient has some mild abnormalities.",
            "There are no strong clinical signs of active severe infection.",
            "There are no signs of impending organ failure.",
            "The patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Slightly elevated heart rate and respiratory rate could be early warning signs.",
            "There are no strong clinical signs of active severe infection."
        ],
        "alignment_scores": [
            0.6,
            0.3
        ],
        "alignment_category": [
            2,
            9
        ],
        "alignment_reasonings": [
            "The claim mentions slightly elevated heart rate and respiratory rate, which relate to SIRS criteria (heart rate > 90 bpm, respiratory rate > 20/min). While the claim does not confirm these values exceed the SIRS thresholds, it implies they are slightly elevated, suggesting possible early systemic inflammation. This results in a moderate alignment, as it indicates possible early signs of sepsis.",
            "The claim suggests an absence of strong clinical indicators of severe infection, which indirectly implies that aggressive measures like early antibiotics or cultures are not yet warranted. While it doesn\u2019t directly reference clinical actions, the lack of severe infection signs affects the decision surrounding them. The alignment is weak, as it refers more to an absence of evidence than direct assessment criteria."
        ],
        "final_alignment_score": 0.44999999999999996,
        "accuracy": 0
    },
    {
        "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 92.0; 2: DBP, 49.0; 2: MAP, 63.333; 2: Pain, 10.0; 2: Temp, 97.5; 21: SpO2, 96.0; 22: HR, 109.821; 22: RR, 16.308; 22: SpO2, 95.831; 22: Perf, 0.709; 22: 1min HRV, 55.738; 22: SBP, 113.0; 22: DBP, 64.0; 22: MAP, 80.333; 23: HR, 109.412; 23: RR, 21.983; 23: SpO2, 95.897; 23: Perf, 1.001; 23: 1min HRV, 2.469; 24: HR, 109.655; 24: RR, 15.407; 24: SpO2, 97.678; 24: Perf, 0.791; 24: 1min HRV, 47.215; 25: HR, 105.810; 25: RR, 12.259; 25: SpO2, 98.0; 25: Perf, 0.890; 25: 1min HRV, 62.161; 25: 5min HRV, 51.744; 26: HR, 105.322; 26: RR, 14.644; 26: SpO2, 96.034; 26: Perf, 1.468; 26: 1min HRV, 66.515; 26: SBP, 111.0; 26: DBP, 64.0; 26: MAP, 79.667; 27: HR, 103.915; 27: RR, 13.644; 27: SpO2, 96.254; 27: Perf, 1.285; 27: 1min HRV, 50.293; 28: HR, 103.603; 28: RR, 18.483; 28: SpO2, 96.414; 28: Perf, 1.205; 28: 1min HRV, 56.883; 29: HR, 104.356; 29: RR, 16.508; 29: SpO2, 96.712; 29: Perf, 0.952; 29: 1min HRV, 74.698; 30: HR, 105.678; 30: RR, 17.475; 30: SpO2, 96.831; 30: Perf, 0.944; 30: 1min HRV, 41.682; 30: 5min HRV, 59.934; 31: HR, 105.345; 31: RR, 18.379; 31: SpO2, 97.276; 31: Perf, 0.855; 31: 1min HRV, 71.599; 32: HR, 104.492; 32: RR, 16.729; 32: SpO2, 96.898; 32: Perf, 1.194; 32: 1min HRV, 62.066; 33: HR, 105.069; 33: RR, 16.621; 33: SpO2, 96.397; 33: Perf, 1.545; 33: 1min HRV, 80.449; 34: HR, 104.746; 34: RR, 18.983; 34: SpO2, 95.983; 34: Perf, 1.803; 34: 1min HRV, 73.898; 35: HR, 105.576; 35: RR, 16.322; 35: SpO2, 95.729; 35: Perf, 1.834; 35: 1min HRV, 61.796; 35: 5min HRV, 70.356; 36: HR, 104.983; 36: RR, 15.448; 36: SpO2, 96.069; 36: Perf, 1.99; 36: 1min HRV, 83.070; 37: HR, 104.034; 37: RR, 16.475; 37: SpO2, 95.610; 37: Perf, 2.194; 37: 1min HRV, 102.005; 38: HR, 104.966; 38: RR, 15.845; 38: SpO2, 95.759; 38: Perf, 2.007; 38: 1min HRV, 69.008; 39: HR, 103.780; 39: RR, 14.119; 39: SpO2, 95.254; 39: Perf, 2.145; 39: 1min HRV, 83.238; 40: HR, 103.881; 40: RR, 19.559; 40: SpO2, 94.847; 40: Perf, 2.348; 40: 1min HRV, 76.667; 40: 5min HRV, 83.563; 40: SBP, 111.0; 40: DBP, 64.0; 40: MAP, 79.667; 41: HR, 102.759; 41: RR, 14.621; 41: SpO2, 95.552; 41: Perf, 2.174; 41: 1min HRV, 86.573; 41: SBP, 111.0; 41: DBP, 64.0; 41: MAP, 79.667; 42: HR, 102.576; 42: RR, 17.508; 42: SpO2, 95.102; 42: Perf, 2.320; 42: 1min HRV, 82.545; 43: HR, 102.966; 43: RR, 14.897; 43: SpO2, 94.948; 43: Perf, 2.434; 43: 1min HRV, 91.755; 44: HR, 103.017; 44: RR, 16.254; 44: SpO2, 94.712; 44: Perf, 2.529; 44: 1min HRV, 70.841; 45: HR, 103.898; 45: RR, 15.186; 45: SpO2, 95.305; 45: Perf, 2.507; 45: 1min HRV, 75.420; 45: 5min HRV, 82.383; 46: HR, 103.431; 46: RR, 17.828; 46: SpO2, 96.103; 46: Perf, 2.182; 46: 1min HRV, 83.408; 47: HR, 102.203; 47: RR, 19.492; 47: SpO2, 94.017; 47: Perf, 1.954; 47: 1min HRV, 77.013; 48: HR, 104.759; 48: RR, 18.517; 48: SpO2, 95.448; 48: Perf, 1.667; 48: 1min HRV, 72.746; 49: HR, 104.153; 49: RR, 17.983; 49: SpO2, 95.0; 49: Perf, 1.693; 49: 1min HRV, 76.780; 50: HR, 103.017; 50: RR, 17.397; 50: SpO2, 94.759; 50: Perf, 2.124; 50: 1min HRV, 79.480; 50: 5min HRV, 78.245; 51: HR, 104.136; 51: RR, 19.288; 51: SpO2, 95.254; 51: Perf, 2.163; 51: 1min HRV, 92.776; 52: HR, 103.847; 52: RR, 18.390; 52: SpO2, 97.542; 52: Perf, 1.824; 52: 1min HRV, 83.089; 53: HR, 103.034; 53: RR, 18.431; 53: SpO2, 97.328; 53: Perf, 1.928; 53: 1min HRV, 76.756; 54: HR, 102.508; 54: RR, 14.390; 54: SpO2, 96.424; 54: Perf, 2.107; 54: 1min HRV, 85.108; 55: HR, 104.121; 55: RR, 12.517; 55: SpO2, 95.310; 55: Perf, 2.358; 55: 1min HRV, 81.613; 55: 5min HRV, 83.963; 56: HR, 103.407; 56: RR, 18.271; 56: SpO2, 96.0; 56: Perf, 1.747; 56: 1min HRV, 82.473; 56: SBP, 117.0; 56: DBP, 67.0; 56: MAP, 83.667; 57: HR, 103.085; 57: RR, 16.525; 57: SpO2, 95.0; 57: Perf, 1.738; 57: 1min HRV, 90.579; 58: HR, 103.983; 58: RR, 15.431; 58: SpO2, 95.017; 58: Perf, 1.492; 58: 1min HRV, 82.048; 59: HR, 103.169; 59: RR, 14.203; 59: SpO2, 96.0; 59: Perf, 1.310; 59: 1min HRV, 69.464; 60: HR, 103.052; 60: RR, 19.690; 60: SpO2, 95.879; 60: Perf, 1.244; 60: 1min HRV, 78.540; 60: 5min HRV, 81.043; 61: HR, 104.271; 61: RR, 15.153; 61: SpO2, 97.153; 61: Perf, 1.157; 61: 1min HRV, 82.632; 65: 5min HRV, 82.632; 86: SARS-COV-2 RNA, Not Detected; 95: WAM DIFTYP, AUTO; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.40 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.04 K/uL; 95: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 95: NEUTROPHIL % (AUTO DIFF), 91.0 %; 95: HEMATOCRIT (HCT), 30.8 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.21 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.1 %; 95: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 95: NRBC PERCENT (HEMATOLOGY), 0.2 %; 95: LYMPHOCYTE % (AUTO DIFF), 3.3 %; 95: PLATELET COUNT (PLT), 666 K/uL; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 60.0 fL; 95: RED BLOOD CELLS (RBC), 5.13 MIL/uL; 95: BASOPHIL % (AUTO DIFF), 0.1 %; 95: HEMOGLOBIN (HGB), 9.2 g/dL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.7 %; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 95: MONOCYTE % (AUTO DIFF), 3.8 %; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.88 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.78 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 97: INR, 1.5; 97: PROTHROMBIN TIME, 17.6 seconds; 97: PART. THROMBOPLASTIN TIME, 34.5 seconds; 100: HR, 98.0; 100: RR, 17.0; 100: SpO2, 98.0; 100: SBP, 115.0; 100: DBP, 76.0; 100: MAP, 89.0; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 49.0; 0: Triage acuity, 2-Emergent; 0: CC, FALL,ALTERED MENTAL STATUS,BACK PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noted this older patient presented with hypotension, tachycardia, and an elevated white blood cell count, all of which suggest a significant infection or inflammatory process. Her symptoms and abnormal labs increase the concern for sepsis. Even though her blood pressure improved somewhat over time, the overall clinical picture remains worrisome. The presence of altered mental status and high neutrophil count further point to the likelihood of sepsis. Based on these risk factors, I concluded that she is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient is older.",
            "The patient presented with hypotension.",
            "The patient presented with tachycardia.",
            "The patient has an elevated white blood cell count.",
            "The symptoms suggest a significant infection or inflammatory process.",
            "The patient's abnormal labs increase the concern for sepsis.",
            "The patient's blood pressure improved somewhat over time.",
            "The overall clinical picture remains worrisome.",
            "The patient has altered mental status.",
            "The patient has a high neutrophil count.",
            "The presence of altered mental status and high neutrophil count point to the likelihood of sepsis.",
            "The risk factors indicate that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient presented with hypotension.",
            "The patient presented with tachycardia.",
            "The patient has an elevated white blood cell count.",
            "The symptoms suggest a significant infection or inflammatory process.",
            "The patient's abnormal labs increase the concern for sepsis.",
            "The patient's blood pressure improved somewhat over time.",
            "The patient has altered mental status.",
            "The patient has a high neutrophil count.",
            "The presence of altered mental status and high neutrophil count point to the likelihood of sepsis.",
            "The risk factors indicate that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            1.0,
            0.3,
            0.6,
            0.3,
            1.0,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            7,
            2,
            2,
            9,
            8,
            7,
            3,
            2,
            3,
            4
        ],
        "alignment_reasonings": [
            "The claim of \"hypotension\" is directly relevant to this category, which defines sepsis-associated hypotension. However, the claim lacks specific details such as blood pressure values or comparison to baseline, so while the claim broadly fits, there's a slight lack of specificity to warrant a perfect alignment rating.",
            "Tachycardia, or an elevated heart rate (>90 bpm), is one of the criteria for SIRS. The claim directly mentions tachycardia, which is explicitly listed under SIRS criteria for identifying systemic inflammation in early sepsis. However, meeting one SIRS criterion alone does not fulfill the full conditions of SIRS positivity (\u22652 criteria), so the alignment is strong but not complete.",
            "The claim about elevated white blood cell count directly aligns with one of the criteria listed under SIRS positivity. An elevated WBC count explicitly meets part of the \u22652 SIRS criteria used to identify systemic inflammation and risk of early sepsis, resulting in a perfect alignment.",
            "The claim mentions a \"significant infection or inflammatory process,\" which could imply clinician suspicion of sepsis. This aligns with the rationale for early antibiotic administration or culture orders. However, without explicit mention of these actions being taken, the alignment with the category is weak, thus a lower alignment rating is justified.",
            "The claim about \"abnormal labs increasing concern for sepsis\" aligns conceptually with the SOFA Score category, which deals with various laboratory abnormalities, such as issues with oxygenation, coagulation, liver function, kidney function, and neurological status. Although the specific abnormal labs are not detailed in the claim, the general concern for sepsis due to lab abnormalities fits within the framework of SOFA. The alignment is indirect due to the lack of specific lab metrics, but it is still significant.",
            "The claim indirectly pertains to blood pressure, which is relevant to sepsis-associated hypotension. However, it speaks to an improvement rather than identifying significant hypotension or a concerning blood pressure drop, making the alignment indirect and weak.",
            "Altered mentation is explicitly listed as one of the factors in the qSOFA score, which is used to assess sepsis risk. Since altered mental status is a direct component of this scoring system, the claim is perfectly aligned with this category.",
            "A high neutrophil count is often associated with inflammation and infection, which can be related to the SIRS criteria involving white blood cell abnormalities. While the claim notes an inflammatory indicator, it doesn't directly match the WBC count threshold of SIRS. However, the connection to systemic inflammation aligns with the SIRS concept, justifying a moderate rating.",
            "Altered mentation is directly mentioned as a parameter in the qSOFA score, which is utilized to assess sepsis risk. However, the claim also mentions a high neutrophil count, which does not directly align with any specific category but does suggest an infection/inflammatory process. Since altered mental status is an explicit component of the qSOFA scoring, there is a strong alignment, but the mention of neutrophil count slightly dilutes the directness of the alignment, hence a rating of 0.7.",
            "The claim indicates a general high risk of sepsis, suggesting clinical observations are pointing towards deterioration, aligning loosely with the purpose of a NEWS score. However, it lacks detail about specific vitals or a score, resulting in low alignment specificity."
        ],
        "final_alignment_score": 0.6399999999999999,
        "accuracy": 1
    },
    {
        "input": "6: Pain, 5.0; 11: HR, 102.0; 11: RR, 18.0; 11: SpO2, 99.0; 11: SBP, 100.0; 11: DBP, 65.0; 11: MAP, 76.667; 11: Pain, 5.0; 11: Temp, 98.2; 30: HR, 111.25; 30: RR, 14.657; 30: SpO2, 100.0; 30: 1min HRV, 81.817; 31: HR, 102.414; 31: RR, 16.914; 31: SpO2, 100.0; 31: Perf, 0.753; 31: 1min HRV, 98.629; 31: SBP, 110.0; 31: DBP, 75.0; 31: MAP, 86.667; 32: HR, 103.237; 32: RR, 17.898; 32: SpO2, 100.0; 32: Perf, 1.658; 32: 1min HRV, 78.261; 33: HR, 97.517; 33: RR, 15.517; 33: SpO2, 100.0; 33: Perf, 1.683; 33: 1min HRV, 150.061; 33: 5min HRV, 109.610; 34: HR, 80.729; 34: RR, 18.966; 34: SpO2, 99.926; 34: Perf, 2.32; 34: 1min HRV, 122.922; 34: SBP, 91.0; 34: DBP, 52.0; 34: MAP, 65.0; 35: HR, 89.085; 35: RR, 16.661; 35: SpO2, 100.0; 35: Perf, 2.199; 35: 1min HRV, 78.485; 36: HR, 92.931; 36: RR, 17.672; 36: SpO2, 100.0; 36: Perf, 2.005; 36: 1min HRV, 93.865; 37: HR, 85.085; 37: RR, 19.864; 37: SpO2, 100.0; 37: Perf, 2.101; 37: 1min HRV, 84.424; 38: HR, 91.086; 38: RR, 20.397; 38: SpO2, 100.0; 38: Perf, 1.374; 38: 1min HRV, 77.182; 38: 5min HRV, 98.481; 39: HR, 89.237; 39: RR, 17.610; 39: SpO2, 100.0; 39: Perf, 2.134; 39: 1min HRV, 48.857; 40: HR, 96.373; 40: RR, 19.288; 40: SpO2, 100.0; 40: Perf, 2.359; 40: 1min HRV, 75.919; 41: HR, 99.724; 41: RR, 14.759; 41: SpO2, 100.0; 41: Perf, 1.386; 41: 1min HRV, 88.768; 42: HR, 95.814; 42: RR, 16.593; 42: SpO2, 100.0; 42: Perf, 1.323; 42: 1min HRV, 64.111; 43: HR, 103.603; 43: RR, 14.776; 43: SpO2, 100.0; 43: Perf, 1.383; 43: 1min HRV, 67.070; 43: 5min HRV, 76.235; 44: HR, 102.017; 44: RR, 13.475; 44: SpO2, 100.0; 44: Perf, 1.581; 44: 1min HRV, 90.454; 45: HR, 90.586; 45: RR, 18.483; 45: SpO2, 100.0; 45: Perf, 2.140; 45: 1min HRV, 117.585; 46: HR, 86.678; 46: RR, 14.729; 46: SpO2, 100.0; 46: Perf, 1.606; 46: 1min HRV, 109.479; 47: HR, 88.390; 47: RR, 15.915; 47: SpO2, 99.898; 47: Perf, 1.572; 47: 1min HRV, 82.073; 48: HR, 92.207; 48: RR, 19.259; 48: SpO2, 100.0; 48: Perf, 1.086; 48: 1min HRV, 70.404; 48: 5min HRV, 102.281; 49: HR, 89.458; 49: RR, 14.542; 49: SpO2, 100.0; 49: Perf, 0.949; 49: 1min HRV, 91.342; 49: SBP, 120.0; 49: DBP, 91.0; 49: MAP, 100.667; 50: HR, 89.345; 50: RR, 21.069; 50: SpO2, 100.0; 50: Perf, 1.104; 50: 1min HRV, 58.674; 51: HR, 93.746; 51: RR, 17.288; 51: SpO2, 100.0; 51: Perf, 1.145; 51: 1min HRV, 52.221; 52: HR, 94.814; 52: RR, 13.254; 52: SpO2, 100.0; 52: Perf, 0.876; 52: 1min HRV, 103.907; 53: HR, 90.397; 53: RR, 16.0; 53: SpO2, 100.0; 53: Perf, 0.88; 53: 1min HRV, 81.909; 53: 5min HRV, 81.277; 54: HR, 86.441; 54: RR, 16.119; 54: SpO2, 100.0; 54: Perf, 0.841; 54: 1min HRV, 85.111; 55: HR, 92.845; 55: RR, 16.897; 55: SpO2, 100.0; 55: Perf, 1.127; 55: 1min HRV, 66.007; 56: HR, 96.271; 56: RR, 17.542; 56: SpO2, 100.0; 56: Perf, 1.338; 56: 1min HRV, 73.784; 57: HR, 100.729; 57: RR, 18.814; 57: SpO2, 100.0; 57: Perf, 1.393; 57: 1min HRV, 88.383; 58: HR, 88.517; 58: RR, 17.069; 58: SpO2, 100.0; 58: Perf, 1.814; 58: 1min HRV, 76.327; 58: 5min HRV, 85.133; 59: HR, 81.674; 59: RR, 17.568; 59: SpO2, 100.0; 59: Perf, 1.497; 59: 1min HRV, 79.274; 63: 5min HRV, 79.274; 72: NS IV BOLUS -, 1000 ML; 73: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 88: WAM DIFTYP, AUTO; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.71 K/uL; 88: RED BLOOD CELLS (RBC), 4.81 MIL/uL; 88: BASOPHIL % (AUTO DIFF), 0.7 %; 88: LYMPHOCYTE % (AUTO DIFF), 24.8 %; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NEUTROPHIL % (AUTO DIFF), 67.0 %; 88: EOSINOPHIL % (AUTO DIFF), 0.3 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 16.5 %; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.61 K/uL; 88: HEMATOCRIT (HCT), 36.7 %; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 23.7 pg; 88: PLATELET COUNT (PLT), 346 K/uL; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 88: HEMOGLOBIN (HGB), 11.4 g/dL; 88: MEAN CORPUSCULAR VOLUME (MCV), 76.3 fL; 88: MONOCYTE % (AUTO DIFF), 6.5 %; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: WHITE BLOOD CELLS (WBC), 6.9 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 107: SARS-COV-2 RNA, Not Detected; 107: RSV, Not Detected; 107: INFLUENZA A, Not Detected; 107: INFLUENZA B, Not Detected; 118: GLUCOSE, URINE (UA): Negative; 118: SPECIFIC GRAVITY, URINE (UA): 1.024; 118: PH, URINE (UA): 5.0; 118: NITRITE, URINE (UA): Negative; 118: PROTEIN, URINE (UA): Negative; 118: PROTEIN TOTAL, 8.2 g/dL; 118: SODIUM, 133 mmol/L; 118: ALT (SGPT), 13 U/L; 118: CO2, 13 mmol/L; 118: CHLORIDE, 98 mmol/L; 118: GLUCOSE, 64 mg/dL; 118: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 118: BILIRUBIN TOTAL, 0.7 mg/dL; 118: ALBUMIN, 5.5 g/dL; 118: CREATININE, 0.61 mg/dL; 118: ALKALINE PHOSPHATASE, 58 U/L; 118: GLOBULIN, 2.7 g/dL; 118: CALCIUM, 9.9 mg/dL; 118: EGFR FOR AFRICAN AMERICAN, 152 mL/min/1.73 m2; 118: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 118: CORRECTED CALCIUM, 8.7 mg/dL; 118: ANION GAP, 22 mmol/L; 118: POTASSIUM, 3.7 mmol/L; 118: AST (SGOT), 22 U/L; 0: Age, 20; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 102.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 65.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I considered the patient\u2019s vitals, labs, and clinical picture to see if they met sepsis criteria. The patient\u2019s vital signs do not show persistent hypotension, fever, or",
        "claims": [
            "elevated heart rate.",
            "The patient's vital signs do not show persistent hypotension.",
            "The patient's vital signs do not show fever.",
            "The patient's vital signs do not show elevated heart rate.",
            "I assessed the patient's vitals, labs, and clinical picture.",
            "I evaluated if the patient met sepsis criteria."
        ],
        "relevant_claims": [
            "The patient's vital signs do not show persistent hypotension.",
            "The patient's vital signs do not show fever."
        ],
        "alignment_scores": [
            0.7,
            0.3
        ],
        "alignment_category": [
            7,
            2
        ],
        "alignment_reasonings": [
            "The claim refers to the absence of persistent hypotension, which relates directly to the category concerning sepsis-associated hypotension. While the claim is about what is not present, it touches upon a key aspect of this category, but since there is no indication of hypotension, the alignment is not complete, hence a rating of 0.7.",
            "The absence of fever is indirectly relevant to SIRS Positivity, as fever is one of the criteria used to identify systemic inflammation in early sepsis. However, the claim indicates that this particular criterion is not met, resulting in a weak alignment with the category."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "14: HR, 156.0; 14: RR, 22.0; 14: SpO2, 93.0; 14: SBP, 184.0; 14: DBP, 168.0; 14: MAP, 173.333; 14: Temp, 97.3; 35: HR, 73.452; 35: RR, 33.366; 35: 1min HRV, 88.112; 36: HR, 70.379; 36: RR, 41.362; 36: 1min HRV, 83.043; 37: HR, 70.136; 37: RR, 39.831; 37: 1min HRV, 83.907; 38: HR, 71.271; 38: RR, 37.661; 38: 1min HRV, 104.463; 39: HR, 69.610; 39: RR, 38.0; 39: 1min HRV, 87.117; 39: 5min HRV, 90.988; 40: HR, 70.379; 40: RR, 38.190; 40: 1min HRV, 113.496; 41: HR, 70.678; 41: RR, 40.169; 41: 1min HRV, 117.322; 42: HR, 69.776; 42: RR, 37.0; 42: 1min HRV, 115.847; 43: HR, 68.390; 43: RR, 40.169; 43: 1min HRV, 110.946; 44: HR, 70.373; 44: RR, 41.017; 44: 1min HRV, 121.203; 44: 5min HRV, 116.373; 45: HR, 64.345; 45: RR, 38.948; 45: 1min HRV, 6.663; 46: HR, 62.780; 46: RR, 39.864; 46: 1min HRV, 92.436; 47: HR, 73.276; 47: RR, 24.948; 47: 1min HRV, 154.990; 48: HR, 69.915; 48: RR, 25.254; 48: 1min HRV, 110.643; 49: HR, 75.483; 49: RR, 23.448; 49: 1min HRV, 131.734; 49: 5min HRV, 125.448; 50: HR, 77.559; 50: RR, 23.831; 50: 1min HRV, 147.393; 51: HR, 76.407; 51: RR, 30.068; 51: 1min HRV, 107.678; 51: Temp, 100.6; 52: HR, 74.534; 52: RR, 38.569; 52: 1min HRV, 124.051; 53: HR, 71.661; 53: RR, 33.695; 53: 1min HRV, 122.241; 54: HR, 71.759; 54: RR, 36.5; 54: 1min HRV, 130.296; 54: 5min HRV, 130.490; 55: HR, 71.729; 55: RR, 36.305; 55: 1min HRV, 135.077; 56: HR, 68.153; 56: RR, 37.983; 56: 1min HRV, 125.658; 57: HR, 63.828; 57: RR, 36.776; 57: 1min HRV, 103.130; 58: HR, 65.407; 58: RR, 37.729; 58: 1min HRV, 103.953; 59: HR, 66.466; 59: RR, 38.414; 59: 1min HRV, 135.229; 59: 5min HRV, 127.500; 60: HR, 70.102; 60: RR, 31.085; 60: 1min HRV, 142.860; 61: HR, 68.017; 61: RR, 31.305; 61: 1min HRV, 147.320; 62: HR, 69.914; 62: RR, 31.121; 62: 1min HRV, 141.935; 63: HR, 67.271; 63: RR, 36.932; 63: 1min HRV, 139.864; 64: HR, 68.155; 64: RR, 38.310; 64: 1min HRV, 163.649; 64: 5min HRV, 147.753; 65: HR, 69.441; 65: RR, 34.898; 65: 1min HRV, 157.793; 66: HR, 69.780; 66: RR, 37.508; 66: SpO2, 97.0; 66: 1min HRV, 148.174; 67: HR, 66.0; 67: RR, 38.224; 67: 1min HRV, 146.767; 68: HR, 66.203; 68: RR, 36.678; 68: 1min HRV, 137.768; 69: HR, 64.672; 69: RR, 40.121; 69: 1min HRV, 136.136; 69: 5min HRV, 149.031; 70: HR, 63.220; 70: RR, 38.797; 70: 1min HRV, 133.571; 71: HR, 70.814; 71: RR, 38.542; 71: 1min HRV, 157.983; 72: HR, 65.414; 72: RR, 38.466; 72: 1min HRV, 144.074; 73: HR, 64.254; 73: RR, 34.102; 73: 1min HRV, 140.864; 74: HR, 68.517; 74: RR, 29.448; 74: 1min HRV, 137.646; 74: 5min HRV, 148.502; 75: HR, 68.627; 75: RR, 29.271; 75: 1min HRV, 140.437; 76: HR, 69.322; 76: RR, 30.797; 76: 1min HRV, 153.600; 77: HR, 69.052; 77: RR, 34.431; 77: 1min HRV, 154.615; 78: HR, 67.407; 78: RR, 35.729; 78: 1min HRV, 139.424; 79: HR, 69.086; 79: RR, 26.397; 79: 1min HRV, 140.216; 79: 5min HRV, 146.596; 80: HR, 64.390; 80: RR, 38.661; 80: 1min HRV, 146.641; 81: SARS-COV-2 RNA, Not Detected; 81: HR, 66.190; 81: RR, 35.707; 81: 1min HRV, 129.707; 82: HR, 65.186; 82: RR, 38.034; 82: 1min HRV, 128.806; 83: HR, 68.983; 83: RR, 34.644; 83: 1min HRV, 144.160; 84: HR, 70.931; 84: RR, 37.103; 84: 1min HRV, 154.379; 84: 5min HRV, 144.235; 85: HR, 68.661; 85: RR, 35.610; 85: 1min HRV, 154.297; 86: HR, 69.931; 86: RR, 37.397; 86: 1min HRV, 151.109; 87: HR, 70.390; 87: RR, 39.305; 87: 1min HRV, 156.446; 88: HR, 69.475; 88: RR, 36.949; 88: 1min HRV, 151.355; 89: HR, 67.793; 89: RR, 34.845; 89: 1min HRV, 149.483; 89: 5min HRV, 153.149; 90: HR, 65.017; 90: RR, 33.831; 90: SpO2, 96.0; 90: 1min HRV, 131.283; 91: HR, 67.5; 91: RR, 30.017; 91: 1min HRV, 139.116; 92: HR, 70.949; 92: RR, 38.763; 92: SpO2, 97.0; 92: 1min HRV, 174.120; 93: HR, 76.407; 93: RR, 32.576; 93: SpO2, 97.0; 93: 1min HRV, 141.376; 94: HR, 73.017; 94: RR, 34.138; 94: 1min HRV, 135.197; 94: 5min HRV, 152.108; 95: HR, 71.915; 95: RR, 36.458; 95: 1min HRV, 138.877; 96: HR, 71.190; 96: RR, 39.517; 96: 1min HRV, 156.430; 97: HR, 66.492; 97: RR, 34.322; 97: 1min HRV, 132.356; 98: HR, 69.119; 98: RR, 30.983; 98: 1min HRV, 147.886; 99: HR, 69.190; 99: RR, 34.5; 99: 1min HRV, 144.492; 99: 5min HRV, 145.686; 100: HR, 71.492; 100: RR, 38.237; 100: 1min HRV, 150.561; 101: HR, 71.293; 101: RR, 37.793; 101: 1min HRV, 138.640; 102: HR, 68.424; 102: RR, 38.237; 102: 1min HRV, 133.726; 103: HR, 67.881; 103: RR, 38.288; 103: 1min HRV, 135.745; 104: HR, 69.310; 104: RR, 39.690; 104: 1min HRV, 134.999; 104: 5min HRV, 139.607; 105: HR, 69.356; 105: RR, 40.051; 105: SpO2, 96.0; 105: 1min HRV, 160.859; 106: HR, 74.793; 106: RR, 39.690; 106: 1min HRV, 165.740; 107: HR, 66.797; 107: RR, 34.356; 107: SpO2, 94.5; 107: 1min HRV, 141.305; 108: HR, 65.424; 108: RR, 35.186; 108: SpO2, 94.0; 108: 1min HRV, 133.033; 109: HR, 67.914; 109: RR, 38.517; 109: SpO2, 94.889; 109: 1min HRV, 148.623; 109: 5min HRV, 153.681; 110: HR, 69.254; 110: RR, 36.085; 110: 1min HRV, 146.020; 111: HR, 69.397; 111: RR, 35.603; 111: SpO2, 100.0; 111: 1min HRV, 152.806; 111: SBP, 102.0; 111: DBP, 52.0; 111: MAP, 68.667; 112: HR, 68.237; 112: RR, 27.881; 112: 1min HRV, 181.621; 113: HR, 71.5; 113: RR, 30.466; 113: 1min HRV, 139.520; 114: HR, 66.407; 114: RR, 38.373; 114: SpO2, 93.2; 114: 1min HRV, 139.131; 114: 5min HRV, 152.803; 115: HR, 69.661; 115: RR, 34.288; 115: 1min HRV, 139.376; 115: SBP, 106.0; 115: DBP, 63.0; 115: MAP, 77.333; 116: HR, 69.448; 116: RR, 35.690; 116: 1min HRV, 141.771; 117: HR, 66.407; 117: RR, 37.017; 117: 1min HRV, 123.354; 118: HR, 67.810; 118: RR, 34.707; 118: 1min HRV, 144.249; 119: HR, 66.746; 119: RR, 34.610; 119: 1min HRV, 138.079; 119: 5min HRV, 138.635; 0: Age, 88; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 156.0; 0: Triage RR, 22.0; 0: Triage SBP, 184.0; 0: Triage DBP, 168.0; 0: Triage acuity, 3-Urgent; 0: CC, REFERRAL",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noted that the patient\u2019s early vitals showed significant tachycardia, followed by a fever and persistently elevated respiratory rates. Recognizing these as potential signs of systemic infection and physiological stress, I asked whether these abnormalities, combined with the new onset drop in blood pressure, might indicate impending sepsis. Given the combination of fever, tachycardia, tachypnea, and borderline hypotension, the patient appears to be at high risk of sepsis within 12 hours.",
        "claims": [
            "The patient\u2019s early vitals showed significant tachycardia.",
            "Significant tachycardia is a potential sign of systemic infection.",
            "The patient exhibited a fever.",
            "A fever is a potential sign of systemic infection.",
            "The patient had persistently elevated respiratory rates.",
            "Persistently elevated respiratory rates are potential signs of physiological stress.",
            "There was a new onset drop in blood pressure.",
            "The combination of fever, tachycardia, tachypnea, and borderline hypotension indicates possible impending sepsis.",
            "The patient appears to be at high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s early vitals showed significant tachycardia.",
            "Significant tachycardia is a potential sign of systemic infection.",
            "The patient had persistently elevated respiratory rates.",
            "Persistently elevated respiratory rates are potential signs of physiological stress.",
            "There was a new onset drop in blood pressure.",
            "The combination of fever, tachycardia, tachypnea, and borderline hypotension indicates possible impending sepsis.",
            "The patient appears to be at high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.7,
            0.8,
            0.9,
            0.9,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            7,
            2,
            4
        ],
        "alignment_reasonings": [
            "Tachycardia corresponds to one of the criteria under SIRS (heart rate >90 bpm) for identifying systemic inflammation consistent with early sepsis. The claim strongly aligns with the SIRS Positivity category, as it directly pertains to one of the specified criteria for diagnosing systemic inflammation indicative of possible sepsis. However, full alignment would require the presence of at least two SIRS criteria, hence the rating of 0.8.",
            "Tachycardia is explicitly mentioned as one of the criteria (heart rate\u202f>\u202f90\u202fbpm) for SIRS positivity, which is used to identify systemic inflammation consistent with early sepsis. The claim directly relates to one of the SIRS criteria, indicating a strong alignment, though not completely comprehensive without additional criteria.",
            "The claim of persistently elevated respiratory rates aligns with the SIRS criterion of a respiratory rate >20/min, indicative of systemic inflammation and possible early sepsis. Although it refers to only one of the SIRS criteria, it strongly suggests sepsis risk, making the alignment more significant than marginal.",
            "Persistently elevated respiratory rates are directly related to the SIRS criteria, where a respiratory rate\u202f>\u202f20/min is one of the indicators for systemic inflammation consistent with early sepsis. While the claim doesn't specify if the respiratory rate exceeds 20, the mention of persistent elevation indicates a significant deviation likely relevant to the SIRS category, warranting a high alignment rating.",
            "The claim describes a \"new onset drop in blood pressure,\" which is a strong indicator of sepsis-associated hypotension. This criterion focuses on the significant drop in blood pressure as a sign of septic shock progression. The alignment is very strong but not perfect due to the lack of specific numerical data about the blood pressure drop.",
            "The claim mentions fever, tachycardia, and tachypnea, which are specific criteria listed under SIRS Positivity. Although it also mentions \"borderline hypotension\" which relates somewhat to other categories (like Sepsis-Associated Hypotension or Elevated Shock Index), the strongest alignment is with SIRS Positivity because three clear SIRS criteria are mentioned. Therefore, the alignment with the SIRS category is assessed at 0.9 for its close but not exclusive fit.",
            "The claim is quite general, simply stating a high risk of sepsis within 12 hours without specifics. However, the Elevated NEWS Score category is broadly associated with predicting clinical deterioration, including sepsis, within a similar timeframe. Given the lack of detailed information, the alignment is weak and indirect."
        ],
        "final_alignment_score": 0.7428571428571428,
        "accuracy": 1
    },
    {
        "input": "5: HR, 148.0; 6: HR, 147.308; 6: RR, 33.12; 6: SpO2, 99.0; 6: 1min HRV, 1.682; 6: SBP, 129.0; 6: DBP, 87.0; 6: MAP, 101.0; 6: LPM O2, 6.0; 6: Pain, 0.0; 6: Temp, 98.2; 7: HR, 147.224; 7: RR, 33.569; 7: 1min HRV, 1.191; 8: HR, 146.763; 8: RR, 30.068; 8: 1min HRV, 2.764; 8: 5min HRV, 2.393; 9: HR, 145.961; 9: RR, 29.65; 9: 1min HRV, 1.375; 9: SBP, 127.0; 9: DBP, 80.0; 9: MAP, 95.667; 10: HR, 146.276; 10: RR, 31.103; 10: 1min HRV, 0.989; 11: HR, 145.441; 11: RR, 28.847; 11: 1min HRV, 2.797; 12: HR, 145.466; 12: RR, 27.776; 12: 1min HRV, 1.743; 13: HR, 145.424; 13: RR, 29.831; 13: 1min HRV, 1.490; 13: 5min HRV, 2.104; 14: HR, 145.610; 14: RR, 29.831; 14: SpO2, 100.0; 14: Perf, 0.57; 14: 1min HRV, 1.934; 15: HR, 147.259; 15: RR, 34.121; 15: SpO2, 100.0; 15: 1min HRV, 3.816; 16: HR, 147.864; 16: RR, 26.898; 16: 1min HRV, 3.060; 17: HR, 147.052; 17: RR, 31.310; 17: SpO2, 99.636; 17: 1min HRV, 4.018; 18: HR, 150.305; 18: RR, 24.373; 18: SpO2, 98.0; 18: 1min HRV, 2.201; 18: 5min HRV, 5.055; 19: HR, 151.169; 19: RR, 33.508; 19: SpO2, 99.062; 19: 1min HRV, 3.213; 20: HR, 147.517; 20: RR, 30.552; 20: SpO2, 99.176; 20: Perf, 0.37; 20: 1min HRV, 2.140; 21: HR, 148.102; 21: RR, 31.305; 21: SpO2, 99.133; 21: Perf, 0.389; 21: 1min HRV, 4.108; 22: HR, 148.052; 22: RR, 33.414; 22: SpO2, 99.0; 22: 1min HRV, 2.972; 23: HR, 146.593; 23: RR, 30.915; 23: SpO2, 99.0; 23: 1min HRV, 1.722; 23: 5min HRV, 5.107; 23: SBP, 128.0; 23: DBP, 83.0; 23: MAP, 98.0; 23: LPM O2, 6.0; 24: HR, 145.881; 24: RR, 31.136; 24: SpO2, 99.592; 24: 1min HRV, 1.097; 24: SBP, 128.0; 24: DBP, 83.0; 24: MAP, 98.0; 25: HR, 146.241; 25: RR, 28.759; 25: SpO2, 98.438; 25: Perf, 0.793; 25: 1min HRV, 1.190; 26: HR, 145.881; 26: RR, 28.119; 26: SpO2, 99.932; 26: Perf, 0.795; 26: 1min HRV, 0.960; 27: HR, 145.138; 27: RR, 28.672; 27: SpO2, 99.017; 27: Perf, 0.723; 27: 1min HRV, 1.042; 28: HR, 145.153; 28: RR, 28.593; 28: SpO2, 99.173; 28: Perf, 0.73; 28: 1min HRV, 1.207; 28: 5min HRV, 1.542; 29: HR, 145.525; 29: RR, 27.407; 29: Perf, 0.73; 29: 1min HRV, 1.633; 30: HR, 145.517; 30: RR, 27.552; 30: 1min HRV, 1.037; 31: HR, 145.915; 31: RR, 29.610; 31: SpO2, 97.195; 31: 1min HRV, 1.695; 32: HR, 147.879; 32: RR, 39.362; 32: SpO2, 97.889; 32: Perf, 0.77; 32: 1min HRV, 3.703; 33: HR, 146.678; 33: RR, 33.051; 33: 1min HRV, 2.117; 33: 5min HRV, 3.198; 66: WAM DIFTYP, AUTO; 66: HEMATOCRIT (HCT), 27.6 %; 66: EOSINOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 66: RED BLOOD CELLS (RBC), 2.95 MIL/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 66: PLATELET COUNT (PLT), 172 K/uL; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.83 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 10.6 %; 66: WHITE BLOOD CELLS (WBC), 6.2 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 19.5 %; 66: HEMOGLOBIN (HGB), 8.3 g/dL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 78.4 %; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 66: BASOPHIL % (AUTO DIFF), 0.3 %; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: MONOCYTE % (AUTO DIFF), 9.7 %; 99: CHLORIDE, 93 mmol/L; 99: ALKALINE PHOSPHATASE, 232 U/L; 99: EGFR REFIT WITHOUT RACE (2021), 155 mL/min/1.73 m2; 99: BLOOD UREA NITROGEN (BUN), 3 mg/dL; 99: POTASSIUM, 4.1 mmol/L; 99: CO2, 37 mmol/L; 99: SODIUM, 135 mmol/L; 99: AST (SGOT), 60 U/L; 99: EGFR FOR AFRICAN AMERICAN, 178 mL/min/1.73 m2; 99: GLOBULIN, 3.4 g/dL; 99: PROTEIN TOTAL, 5.9 g/dL; 99: CORRECTED CALCIUM, 9.9 mg/dL; 99: ANION GAP, 5 mmol/L; 99: BILIRUBIN TOTAL, 0.2 mg/dL; 99: ALBUMIN, 2.5 g/dL; 99: CREATININE, 0.25 mg/dL; 99: ALT (SGPT), 16 U/L; 99: CALCIUM, 8.7 mg/dL; 99: GLUCOSE, 104 mg/dL; 99: BNP NT-PRO, 415 pg/mL; 100: LR IV BOLUS -, 500 ML; 0: Age:, 38; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 147.0; 0: Triage RR, 29.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I notice the patient is persistently tachycardic (HR > 140) and tachypneic (RR > 28), which raises concern for systemic inflammatory response. Despite relatively normal blood pressure and WBC count, the combination of shortness of breath, low albumin, and abnormal liver enzymes suggests a possible underlying infection or organ stress. I also note that normal WBC does not rule out sepsis. Given these risk factors, the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient is persistently tachycardic with a heart rate greater than 140.",
            "The patient is tachypneic with a respiratory rate greater than 28.",
            "The presence of tachycardia and tachypnea raises concern for systemic inflammatory response.",
            "The patient's blood pressure is relatively normal.",
            "The patient's white blood cell (WBC) count is relatively normal.",
            "The combination of shortness of breath, low albumin, and abnormal liver enzymes suggests a possible underlying infection.",
            "The combination of shortness of breath, low albumin, and abnormal liver enzymes suggests possible organ stress.",
            "A normal WBC count does not rule out sepsis.",
            "Given these risk factors, the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient is persistently tachycardic with a heart rate greater than 140.",
            "The patient is tachypneic with a respiratory rate greater than 28.",
            "The presence of tachycardia and tachypnea raises concern for systemic inflammatory response.",
            "The combination of shortness of breath, low albumin, and abnormal liver enzymes suggests a possible underlying infection.",
            "The combination of shortness of breath, low albumin, and abnormal liver enzymes suggests possible organ stress.",
            "A normal WBC count does not rule out sepsis.",
            "Given these risk factors, the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            1.0,
            1.0,
            0.7,
            0.7,
            0.3,
            0.5
        ],
        "alignment_category": [
            6,
            3,
            2,
            8,
            8,
            2,
            4
        ],
        "alignment_reasonings": [
            "Persistent tachycardia, with a heart rate greater than 140 bpm, indicates an increased heart rate which is a component of the shock index. The claim specifically highlights tachycardia but lacks information on blood pressure (necessary to calculate the shock index accurately). However, the high heart rate suggests potential hemodynamic instability, making this category more relevant. While there is a connection, the absence of blood pressure data prevents a perfect alignment, thus justifying the 0.7 rating.",
            "The claim specifies a respiratory rate greater than 28, which directly aligns with one of the criteria for a qSOFA score component (respiratory rate \u226522/min). A qSOFA score of \u22652 is used to flag a high risk of sepsis-related organ dysfunction, making the alignment with this category strong and direct.",
            "The claim directly mentions tachycardia (elevated heart rate) and tachypnea (elevated respiratory rate), both of which are specific criteria within the SIRS category. These signs are indicative of a systemic inflammatory response consistent with early sepsis detection. Therefore, the alignment with the SIRS Positivity category is perfect.",
            "The claim mentions abnormal liver enzymes, which could correspond to bilirubin > 2 mg/dL, a component of the SOFA score, indicating liver dysfunction. Shortness of breath can align with impaired respiratory function, reflected by PaO\u2082/FiO\u2082 in SOFA criteria. While albumin is not directly a SOFA measure, low albumin can be associated with protein synthesis issues seen in liver dysfunction. Thus, the claim partially aligns with SOFA score criteria, but not all aspects are directly covered, warranting a high, but not perfect, alignment score.",
            "The claim mentions shortness of breath, low albumin, and abnormal liver enzymes, which are indicative of possible organ dysfunction. The SOFA score considers liver function (bilirubin) and respiratory issues that could be associated with shortness of breath. Although albumin is not explicitly a part of the SOFA score, its mention alongside other factors hints at deteriorating organ function. Therefore, there is a moderate alignment with the SOFA score's criteria for identifying organ dysfunction.",
            "The claim pertains to WBC count, which is a component of the SIRS criteria used to identify systemic inflammation potentially due to sepsis. However, the statement emphasizes the absence of abnormal WBC, which is indirectly related to SIRS positivity since abnormal WBC counts are what contribute to identifying the presence of SIRS. Thus, there is a low alignment since the claim concerns an exclusion rather than inclusion criterion for sepsis risk.",
            "The claim generally indicates a high risk of developing sepsis soon, which aligns with the purpose of the Elevated NEWS Score in predicting imminent clinical deterioration. However, the claim does not specify the exact metrics or scores used to derive this conclusion, resulting in a moderate alignment rating."
        ],
        "final_alignment_score": 0.7000000000000001,
        "accuracy": 1
    },
    {
        "input": "3: HR, 99.0; 3: RR, 22.0; 3: SpO2, 100.0; 3: SBP, 105.0; 3: DBP, 69.0; 3: MAP, 81.0; 3: Temp, 97.9; 22: SpO2, 93.583; 22: SBP, 117.0; 22: DBP, 84.0; 22: MAP, 95.0; 23: HR, 97.0; 23: SpO2, 99.780; 23: Perf, 2.001; 23: SBP, 117.0; 23: DBP, 84.0; 23: MAP, 95.0; 24: SpO2, 99.932; 24: Perf, 2.445; 25: SpO2, 99.661; 25: Perf, 2.122; 26: SpO2, 99.38; 26: Perf, 1.821; 27: SpO2, 97.827; 27: Perf, 1.817; 28: SpO2, 98.931; 28: Perf, 1.873; 29: SpO2, 99.366; 29: Perf, 1.780; 30: SpO2, 98.368; 30: Perf, 1.356; 31: SpO2, 98.845; 31: Perf, 0.549; 32: SpO2, 98.492; 32: Perf, 0.372; 33: SpO2, 99.379; 33: Perf, 0.356; 34: SpO2, 100.0; 34: Perf, 0.402; 35: SpO2, 99.069; 35: Perf, 0.376; 36: SpO2, 99.661; 36: Perf, 0.32; 37: SpO2, 99.828; 37: Perf, 0.361; 38: SpO2, 99.822; 38: Perf, 0.566; 39: SpO2, 99.897; 39: Perf, 0.906; 40: SpO2, 100.0; 40: Perf, 0.948; 41: SpO2, 99.6; 41: Perf, 0.961; 42: SpO2, 99.931; 42: Perf, 0.961; 43: SpO2, 99.881; 43: Perf, 1.230; 44: SpO2, 99.897; 44: Perf, 1.309; 45: SpO2, 99.627; 45: Perf, 1.438; 46: SpO2, 99.610; 46: Perf, 1.369; 47: SpO2, 99.879; 47: Perf, 1.217; 48: SpO2, 100.0; 48: Perf, 1.026; 49: SpO2, 99.289; 49: Perf, 1.059; 50: SpO2, 99.431; 50: Perf, 1.124; 51: SpO2, 99.051; 51: Perf, 1.196; 52: SpO2, 99.508; 52: Perf, 1.242; 53: SpO2, 99.741; 53: Perf, 1.119; 54: POC GLUCOSE BY METER, 362 mg/dL; 54: SpO2, 99.898; 54: Perf, 0.730; 54: Pain, 10.0; 55: SpO2, 99.897; 55: Perf, 0.728; 56: SpO2, 100.0; 56: Perf, 0.930; 57: SpO2, 99.909; 57: Perf, 1.122; 58: SpO2, 99.926; 58: Perf, 1.155; 59: SpO2, 99.017; 59: Perf, 1.204; 60: SpO2, 98.397; 60: Perf, 1.234; 61: SpO2, 99.254; 61: Perf, 1.24; 62: SpO2, 99.746; 62: Perf, 1.293; 63: SpO2, 100.0; 63: Perf, 1.296; 63: ACETAMINOPHEN, 325 MG PO TABS; 64: SpO, 2: 98.974; 64: Perf, 1.24; 65: SpO2, 100.0; 65: Perf, 0.973; 66: SpO2, 98.385; 66: Perf, 0.579; 67: SpO2, 99.3; 67: Perf, 0.605; 68: SpO2, 100.0; 68: Perf, 0.708; 69: SpO2, 100.0; 69: Perf, 0.72; 70: SpO2, 99.345; 70: Perf, 0.714; 71: SpO2, 97.136; 71: Perf, 0.901; 72: SpO2, 99.610; 72: Perf, 1.007; 73: WAM DIFTYP, AUTO; 73: NEUTROPHIL % (AUTO DIFF), 74.7 %; 73: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 73: PLATELET COUNT (PLT), 330 K/uL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.64 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 82.8 fL; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 73: WHITE BLOOD CELLS (WBC), 9.7 K/uL; 73: LYMPHOCYTE % (AUTO DIFF), 17.0 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: HEMOGLOBIN (HGB), 11.3 g/dL; 73: HEMATOCRIT (HCT), 33.8 %; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 73: RED CELL DISTRIBUTION WIDTH (RDW), 13.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 73: MONOCYTE % (AUTO DIFF), 7.2 %; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.7 pg; 73: EOSINOPHIL % (AUTO DIFF), 0.4 %; 73: SpO2, 96.224; 73: Perf, 0.768; 74: SpO2, 95.458; 74: Perf, 0.792; 75: SpO2, 98.293; 75: Perf, 0.817; 76: SpO2, 98.136; 76: Perf, 0.884; 77: SpO2, 99.517; 77: Perf, 0.841; 78: SpO2, 98.644; 78: Perf, 0.785; 79: SpO2, 97.102; 79: Perf, 0.917; 80: RSV, Not Detected; 80: INFLUENZA A, Not Detected; 80: RSV, Not Detected; 80: INFLUENZA B, Not Detected; 80: INFLUENZA B, Not Detected; 80: SARS-COV-2 RNA, Detected; 80: SARS-COV-2 RNA, Detected; 80: INFLUENZA A, Not Detected; 80: SpO2, 99.483; 80: Perf, 0.866; 81: SpO2, 96.712; 81: Perf, 0.947; 82: SpO2, 98.776; 82: Perf, 0.976; 83: SpO2, 99.017; 83: Perf, 0.907; 84: SpO2, 97.814; 84: Perf, 0.839; 85: SpO2, 99.155; 85: Perf, 1.053; 86: SpO2, 99.627; 86: Perf, 1.14; 87: SpO2, 99.517; 87: Perf, 1.522; 88: SpO2, 99.966; 88: Perf, 1.546; 89: SpO2, 99.627; 89: Perf, 1.1; 90: SpO2, 99.603; 90: Perf, 1.061; 91: C-REACTIVE PROTEIN (CRP), 0.2 mg/dL; 91: SpO2, 98.695; 91: Perf, 0.867; 92: SpO2, 98.672; 92: Perf, 0.728; 93: SpO2, 98.610; 93: Perf, 0.464; 94: SpO2, 98.390; 94: Perf, 0.468; 95: SpO2, 98.638; 95: Perf, 0.427; 96: SpO2, 98.508; 96: Perf, 0.42; 97: SpO2, 98.121; 97: Perf, 0.421; 98: SpO2, 98.305; 98: Perf, 0.429; 99: SpO2, 98.237; 99: Perf, 0.415; 100: SpO2, 99.241; 100: Perf, 0.502; 101: SpO2, 99.949; 101: Perf, 1.445; 102: SpO2, 99.566; 102: Perf, 1.361; 103: SpO2, 100.0; 103: Perf, 1.270; 104: SpO2, 100.0; 104: Perf, 1.095; 113: TSH, 1.50 uIU/mL; 113: DROPERIDOL, 2.5 MG/ML INJ SOLN; 116: SpO, 2: 97.286; 117: SpO2, 96.672; 117: Perf, 1.520; 118: SpO2, 99.041; 118: Perf, 1.304; 119: SpO2, 95.509; 119: Perf, 1.17; 0: Age, 29; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 99.0; 0: Triage RR, 22.0; 0: Triage SBP, 105.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, ELBOW PAIN,KNEE PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "I noted the patient\u2019s vital signs and labs remain relatively stable, with no indication of persistent hypotension, elevated inflammatory markers, or severe organ dysfunction. Although there is a positive COVID result, oxygen saturations are good and there is no evidence of acute respiratory compromise. The white blood cell count and CRP are not significantly elevated, and the patient\u2019s pain is more likely musculoskeletal in nature. Consequently, there is no strong sign of sepsis risk within the next 12 hours.",
        "claims": [
            "The patient\u2019s vital signs and labs remain relatively stable.",
            "There is no indication of persistent hypotension.",
            "There are no elevated inflammatory markers.",
            "There is no evidence of severe organ dysfunction.",
            "The patient has a positive COVID result.",
            "The oxygen saturations are good.",
            "There is no evidence of acute respiratory compromise.",
            "The white blood cell count is not significantly elevated.",
            "The CRP is not significantly elevated.",
            "The patient's pain is more likely musculoskeletal in nature.",
            "There is no strong sign of sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s vital signs and labs remain relatively stable.",
            "There is no indication of persistent hypotension.",
            "There are no elevated inflammatory markers.",
            "There is no evidence of severe organ dysfunction.",
            "The patient has a positive COVID result."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.2,
            0.7,
            0.3
        ],
        "alignment_category": [
            4,
            7,
            2,
            8,
            9
        ],
        "alignment_reasonings": [
            "The claim indicates that the patient's vital signs and labs remain relatively stable. This implies that there is no derangement, which would align with a low NEWS score, undercutting predicted sepsis risk. Though the claim relates to monitoring of vitals, implying relevance to the NEWS score, the stability suggests a low score rather than elevation. Hence, the connection is indirect and weak, contributing to a low alignment rating.",
            "The claim directly references the absence of persistent hypotension, which this category explicitly identifies as a high-risk factor for severe sepsis. The presence of hypotension would indicate a risk, so the lack thereof correlates with a lower risk prediction. However, the claim doesn't necessarily confirm sepsis absence, thus reducing the rating slightly from a perfect score.",
            "The absence of elevated inflammatory markers indirectly pertains to SIRS criteria, as elevated WBC (one of the inflammatory markers) is directly relevant to SIRS. While the claim does not confirm SIRS positivity, the lack of inflammatory markers suggests the absence of systemic inflammatory response, providing a minimal connection.",
            "The claim relates to the lack of severe organ dysfunction, which connects to the SOFA score system for assessing organ dysfunction severity in sepsis prediction. While the claim doesn't indicate an increased SOFA score, not having severe organ dysfunction may imply stability in parameters that are part of the SOFA score, thus partially aligning with the absence of increased SOFA components. This indirect alignment and the absence of dysfunction warrant a moderate alignment rating.",
            "A positive COVID test indicates an infection, which could prompt clinicians to perform further assessments or initiate treatment, aligning with suspicion of a serious infection. However, the claim doesn\u2019t specify actions like antibiotic administration or culture draws, so the alignment is indirect and somewhat weak."
        ],
        "final_alignment_score": 0.45999999999999996,
        "accuracy": 0
    },
    {
        "input": "3: SpO2, 98.0; 5: SpO2, 98.333; 6: HR, 93.0; 6: RR, 28.0; 6: SpO2, 95.75; 6: 1min HRV, 31.387; 6: SBP, 134.0; 6: DBP, 95.0; 6: MAP, 108.0; 6: Pain, 0.0; 6: Temp, 99.0; 7: HR, 84.458; 7: RR, 21.627; 7: SpO2, 98.0; 7: 1min HRV, 104.688; 8: HR, 94.293; 8: RR, 23.052; 8: SpO2, 96.0; 8: 1min HRV, 94.542; 9: HR, 93.038; 9: RR, 24.254; 9: SpO2, 98.083; 9: 1min HRV, 92.495; 10: HR, 90.259; 10: RR, 23.293; 10: SpO2, 97.0; 10: 1min HRV, 112.587; 10: 5min HRV, 101.228; 11: HR, 81.390; 11: RR, 22.051; 11: SpO2, 99.0; 11: 1min HRV, 72.280; 12: HR, 82.881; 12: RR, 22.407; 12: 1min HRV, 129.498; 13: HR, 88.017; 13: RR, 20.914; 13: SpO2, 97.0; 13: 1min HRV, 95.278; 14: HR, 78.102; 14: RR, 19.322; 14: SpO2, 96.667; 14: 1min HRV, 109.998; 15: HR, 82.964; 15: RR, 31.448; 15: SpO2, 96.0; 15: 1min HRV, 31.449; 15: 5min HRV, 113.038; 16: HR, 94.931; 16: RR, 24.847; 16: SpO2, 99.489; 16: 1min HRV, 69.945; 17: HR, 94.678; 17: RR, 25.644; 17: SpO2, 96.759; 17: 1min HRV, 40.994; 18: HR, 85.517; 18: RR, 24.517; 18: SpO2, 96.24; 18: 1min HRV, 93.672; 19: HR, 90.220; 19: RR, 21.763; 19: SpO2, 97.030; 19: 1min HRV, 79.258; 20: HR, 92.0; 20: RR, 19.586; 20: SpO2, 98.0; 20: 1min HRV, 87.822; 20: 5min HRV, 92.999; 21: HR, 82.475; 21: RR, 25.186; 21: SpO2, 95.4; 21: 1min HRV, 109.828; 21: SBP, 123.0; 21: DBP, 94.0; 21: MAP, 103.667; 22: HR, 85.414; 22: RR, 22.0; 22: SpO2, 94.0; 22: 1min HRV, 83.980; 23: HR, 81.847; 23: 1min HRV, 124.486; 24: HR, 94.831; 24: SpO2, 92.737; 24: 1min HRV, 63.324; 25: HR, 87.224; 25: 1min HRV, 86.715; 25: 5min HRV, 103.995; 26: HR, 79.339; 26: SpO2, 94.0; 26: 1min HRV, 94.155; 27: HR, 92.207; 27: 1min HRV, 83.240; 28: HR, 79.220; 28: 1min HRV, 81.363; 29: HR, 86.525; 29: SpO2, 96.0; 29: 1min HRV, 86.182; 30: HR, 92.190; 30: RR, 24.4; 30: SpO2, 84.0; 30: 1min HRV, 80.311; 30: 5min HRV, 98.806; 31: HR, 101.153; 31: RR, 24.610; 31: 1min HRV, 55.800; 32: WAM DIFTYP, AUTO; 32: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 32: RED CELL DISTRIBUTION WIDTH (RDW), 18.7 %; 32: BASOPHIL % (AUTO DIFF), 0.9 %; 32: RED BLOOD CELLS (RBC), 3.85 MIL/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 32: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 32: NRBC PERCENT (HEMATOLOGY), 0.0 %; 32: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.49 K/uL; 32: WHITE BLOOD CELLS (WBC), 4.4 K/uL; 32: EOSINOPHIL % (AUTO DIFF), 1.8 %; 32: LYMPHOCYTE % (AUTO DIFF), 32.9 %; 32: NEUTROPHIL % (AUTO DIFF), 56.8 %; 32: MEAN CORPUSCULAR VOLUME (MCV), 86.8 fL; 32: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 32: HEMATOCRIT (HCT), 33.4 %; 32: PLATELET COUNT (PLT), 481 K/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.2 g/dL; 32: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 32: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 32: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 32: MONOCYTE % (AUTO DIFF), 7.1 %; 32: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.44 K/uL; 32: HEMOGLOBIN (HGB), 10.1 g/dL; 32: HR, 101.455; 32: RR, 25.707; 32: SpO2, 76.0; 32: 1min HRV, 41.524; 33: HR, 94.418; 33: RR, 21.186; 33: SpO2, 85.639; 33: 1min HRV, 75.895; 34: HR, 79.864; 34: RR, 22.492; 34: SpO2, 83.6; 34: 1min HRV, 131.719; 35: HR, 81.966; 35: RR, 27.207; 35: 1min HRV, 94.631; 35: 5min HRV, 112.726; 35: SBP, 126.0; 35: DBP, 99.0; 35: MAP, 108.0; 36: HR, 77.385; 36: RR, 24.644; 36: 1min HRV, 64.092; 36: SBP, 126.0; 36: DBP, 99.0; 36: MAP, 108.0; 37: HR, 81.414; 37: RR, 18.862; 37: 1min HRV, 106.216; 38: HR, 84.932; 38: RR, 19.390; 38: 1min HRV, 120.461; 39: HR, 94.833; 39: RR, 22.524; 39: SpO2, 71.714; 39: 1min HRV, 104.928; 40: HR, 102.116; 40: RR, 28.2; 40: SpO2, 81.0; 40: 1min HRV, 76.230; 40: 5min HRV, 116.478; 41: HR, 100.567; 41: RR, 30.424; 41: SpO2, 84.0; 41: 1min HRV, 146.366; 42: HR, 96.966; 42: RR, 24.475; 42: SpO2, 92.895; 42: 1min HRV, 198.539; 43: HR, 95.579; 43: RR, 29.667; 43: 1min HRV, 31.594; 44: HR, 99.754; 44: RR, 25.74; 44: 1min HRV, 57.814; 45: HR, 96.348; 45: RR, 28.833; 45: 1min HRV, 11.723; 45: 5min HRV, 84.891; 46: HR, 91.780; 46: 1min HRV, 56.944; 47: HR, 88.333; 47: 1min HRV, 38.182; 48: HR, 88.205; 48: 1min HRV, 140.676; 49: HR, 89.158; 49: 1min HRV, 118.585; 50: HR, 98.868; 50: 1min HRV, 41.762; 50: 5min HRV, 81.611; 60: SpO2, 71.0; 61: Pain, 0.0; 62: HIGH SENSITIVITY TROPONIN, 24 ng/L; 63: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 63: CHLORIDE, 106 mmol/L; 63: ALBUMIN, 3.1 g/dL; 63: GLOBULIN, 4.1 g/dL; 63: CREATININE, 0.80 mg/dL; 63: ANION GAP, 9 mmol/L; 63: CORRECTED CALCIUM, 9.2 mg/dL; 63: POTASSIUM, 3.6 mmol/L; 63: GLUCOSE, 103 mg/dL; 63: ALKALINE PHOSPHATASE, 168 U/L; 63: PROTEIN TOTAL, 7.2 g/dL; 63: ALT (SGPT), 100 U/L; 63: AST (SGOT), 40 U/L; 63: SODIUM, 139 mmol/L; 63: EGFR REFIT WITHOUT RACE (2021), 110 mL/min/1.73 m2; 63: CALCIUM, 8.5 mg/dL; 63: BILIRUBIN TOTAL, 0.8 mg/dL; 63: CO2, 24 mmol/L; 63: BNP NT-PRO, 17298 pg/mL; 73: SpO2, 86.714; 82: HR, 88.833; 82: 1min HRV, 108.601; 83: HR, 79.333; 83: 1min HRV, 112.306; 84: HR, 74.733; 84: 1min HRV, 114.475; 85: 5min HRV, 121.752; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.2; 0: Triage HR, 105.0; 0: Triage RR, 19.0; 0: Triage SBP, 134.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I considered the patient\u2019s vital signs, including heart rate, respiratory rate, blood pressure, temperature, and oxygen saturation trends. While there are periods of hypoxia and tachypnea, the laboratory results do not strongly indicate an active infection, and there is no clear evidence of hemodynamic instability. Key sepsis indicators, such as a very high or very low white blood cell count, fever, or hypotension, are not definitively present. The elevated BNP suggests a possible cardiac etiology rather than sepsis. Therefore, the likelihood of developing sepsis within 12 hours appears low.",
        "claims": [
            "The patient's vital signs were considered.",
            "The vital signs include heart rate, respiratory rate, blood pressure, temperature, and oxygen saturation trends.",
            "There are periods of hypoxia and tachypnea.",
            "The laboratory results do not strongly indicate an active infection.",
            "There is no clear evidence of hemodynamic instability.",
            "Key sepsis indicators include a very high or very low white blood cell count, fever, or hypotension.",
            "Key sepsis indicators are not definitively present in this case.",
            "The elevated BNP suggests a possible cardiac etiology.",
            "The likelihood of developing sepsis within 12 hours appears low."
        ],
        "relevant_claims": [
            "There are periods of hypoxia and tachypnea.",
            "The laboratory results do not strongly indicate an active infection.",
            "There is no clear evidence of hemodynamic instability.",
            "Key sepsis indicators are not definitively present in this case."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.2,
            0.3
        ],
        "alignment_category": [
            3,
            9,
            6,
            9
        ],
        "alignment_reasonings": [
            "The claim mentions hypoxia and tachypnea. Tachypnea directly relates to the qSOFA criterion of a respiratory rate\u202f\u2265\u202f22\u202f/min. Although hypoxia itself is not directly mentioned in the qSOFA criteria, it suggests respiratory compromise, which aligns conceptually with this category. The alignment is not perfect because hypoxia is not explicitly a component of qSOFA, hence the rating of 0.7.",
            "The claim suggests that laboratory results do not strongly support the presence of an active infection. This indirectly relates to expert sepsis category 9, as the absence of strong indicators might affect the decision to perform early antibiotic or culture orders. However, the alignment is weak because no specific clinical actions or suspicions are described, and the claim is primarily about what the results do not show rather than what actions are taken.",
            "The claim addresses hemodynamic stability, which is related to the concept of shock or hemodynamic instability described in the Elevated Shock Index category. However, it specifies the absence of instability, making any alignment indirect and weak\u2014thus resulting in a low rating.",
            "The claim suggests a lack of definitive sepsis indicators, implying that no specific clinical actions have been taken yet, such as antibiotic administration or culture orders, which might help confirm or rule out sepsis. Since it's indirectly related to clinicians' suspicion as part of an investigation, there is a minimal but present alignment with the category."
        ],
        "final_alignment_score": 0.375,
        "accuracy": 1
    },
    {
        "input": "4: HR, 65.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 108.0; 4: DBP, 54.0; 4: MAP, 72.0; 4: Pain, 0.0; 4: Temp, 101.1; 15: SpO2, 97.0; 16: SpO2, 96.797; 16: Perf, 3.364; 17: SpO2, 96.5; 17: Perf, 4.262; 18: SpO2, 97.424; 18: Perf, 4.689; 18: SBP, 107.0; 18: DBP, 60.0; 18: MAP, 75.667; 19: SpO2, 96.169; 19: Perf, 6.684; 20: SpO2, 95.845; 20: Perf, 6.728; 21: SpO2, 95.847; 21: Perf, 5.936; 22: SpO2, 95.897; 22: Perf, 6.207; 23: SpO2, 96.0; 23: Perf, 5.800; 24: SpO2, 95.763; 24: Perf, 5.422; 25: SpO2, 95.879; 25: Perf, 4.448; 26: SpO2, 96.881; 26: Perf, 3.318; 27: SpO2, 96.897; 27: Perf, 3.804; 28: SpO2, 96.373; 28: Perf, 4.445; 29: SpO2, 96.153; 29: Perf, 4.615; 30: SpO2, 96.362; 30: Perf, 4.2; 31: SpO2, 96.119; 31: Perf, 4.233; 32: SpO2, 96.155; 32: Perf, 2.824; 33: SpO2, 96.797; 33: Perf, 2.251; 34: SpO2, 96.864; 34: Perf, 2.579; 35: SpO2, 96.879; 35: Perf, 2.442; 36: SpO2, 96.661; 36: Perf, 3.264; 37: SpO2, 96.207; 37: Perf, 3.824; 38: SpO2, 95.831; 38: Perf, 4.185; 39: SpO2, 97.068; 39: Perf, 4.148; 40: SpO2, 96.707; 40: Perf, 4.992; 41: HR, 66.0; 41: SpO2, 96.322; 41: Perf, 2.957; 41: SBP, 105.0; 41: DBP, 60.0; 41: MAP, 75.0; 42: SpO2, 96.793; 42: Perf, 2.268; 42: SBP, 105.0; 42: DBP, 60.0; 42: MAP, 75.0; 43: SpO2, 95.983; 43: Perf, 2.158; 44: SpO2, 96.276; 44: Perf, 1.960; 45: SpO2, 95.864; 45: Perf, 2.225; 46: SpO2, 96.085; 46: Perf, 2.727; 47: SpO2, 96.052; 47: Perf, 2.607; 48: SpO2, 95.712; 48: Perf, 2.585; 49: SpO2, 96.552; 49: Perf, 2.895; 50: SpO2, 97.0; 50: Perf, 3.872; 51: POC PH (V) ISTAT, 7.43; 51: POC LACTATE ISTAT, 1.50 mmol/L; 51: POC TCO2 (V) ISTAT, 28 mmol/L; 51: POC BASE EXCESS ISTAT, 2 mmol/L; 51: POC PO2 (V) ISTAT, 33 mmHg; 51: POC HCO3 (V) ISTAT, 26.7 mmol/L; 51: POC PCO2 (V) ISTAT, 40.1 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 65 %; 51: SpO2, 96.119; 51: Perf, 4.245; 52: SpO2, 95.379; 52: Perf, 4.339; 53: SpO2, 95.203; 53: Perf, 4.983; 54: SpO2, 95.414; 54: Perf, 4.544; 55: SpO2, 95.339; 55: Perf, 3.686; 56: SpO2, 95.492; 56: Perf, 2.525; 57: SpO2, 95.690; 57: Perf, 2.330; 58: SpO2, 96.322; 58: Perf, 2.288; 59: SpO2, 96.879; 59: Perf, 2.320; 60: SpO2, 96.576; 60: Perf, 2.423; 61: SpO2, 96.271; 61: Perf, 2.796; 62: SpO2, 96.603; 62: Perf, 2.776; 63: SpO2, 96.322; 63: Perf, 2.685; 64: SpO2, 96.569; 64: Perf, 2.665; 65: HR, 68.0; 65: RR, 18.0; 65: SpO2, 97.034; 65: Perf, 2.549; 65: Pain, 0.0; 65: Temp, 98.8; 66: SpO2, 96.153; 66: Perf, 3.064; 67: SpO2, 96.0; 67: Perf, 3.010; 68: SpO2, 96.0; 68: Perf, 3.140; 69: SpO2, 95.862; 69: Perf, 2.665; 70: SpO2, 96.017; 70: Perf, 2.534; 71: SpO2, 96.373; 71: Perf, 2.460; 72: SpO2, 95.724; 72: Perf, 2.733; 73: SpO2, 96.5; 73: Perf, 2.844; 74: SpO2, 97.475; 74: Perf, 2.574; 75: SpO2, 97.339; 75: Perf, 3.392; 76: SpO2, 96.776; 76: Perf, 3.584; 77: SpO2, 96.017; 77: Perf, 3.487; 78: SpO2, 96.102; 78: Perf, 3.156; 79: SpO2, 96.897; 79: Perf, 2.657; 80: SpO2, 97.356; 80: Perf, 1.940; 81: SpO2, 96.931; 81: Perf, 2.155; 82: SpO2, 97.254; 82: Perf, 3.481; 83: SpO2, 97.0; 83: Perf, 3.891; 84: SpO2, 96.948; 84: Perf, 4.301; 85: SpO2, 96.746; 85: Perf, 4.189; 86: SpO2, 96.879; 86: Perf, 4.32; 87: SpO2, 97.0; 87: Perf, 3.467; 88: SpO2, 97.0; 88: Perf, 3.842; 89: SpO2, 96.586; 89: Perf, 4.186; 90: SpO2, 97.288; 90: Perf, 2.210; 91: SpO2, 97.414; 91: Perf, 2.020; 92: SpO2, 97.627; 92: Perf, 2.045; 93: SpO2, 97.586; 93: Perf, 2.665; 94: SpO2, 97.102; 94: Perf, 2.485; 95: SpO2, 97.169; 95: Perf, 2.391; 96: SpO2, 97.741; 96: Perf, 1.804; 97: SpO2, 98.458; 97: Perf, 1.764; 98: INR, 1.3; 98: PROTHROMBIN TIME, 16.2 seconds; 98: SpO2, 97.724; 98: Perf, 1.940; 99: PART. THROMBOPLASTIN TIME, 40.6 seconds; 99: SpO2, 97.475; 99: Perf, 2.127; 100: SpO2, 97.220; 100: Perf, 2.529; 101: SpO2, 97.466; 101: Perf, 2.502; 102: SpO2, 98.0; 102: Perf, 2.511; 102: SBP, 102.0; 102: DBP, 60.0; 102: MAP, 74.0; 103: SpO2, 98.259; 103: Perf, 2.868; 104: SpO2, 97.237; 104: Perf, 3.350; 105: SpO2, 97.339; 105: Perf, 2.797; 106: SpO2, 97.138; 106: Perf, 2.413; 107: SpO2, 97.339; 107: Perf, 1.779; 108: SpO2, 97.172; 108: Perf, 2.104; 109: SpO2, 96.949; 109: Perf, 2.225; 110: SpO2, 97.169; 110: Perf, 1.982; 111: SpO2, 96.845; 111: Perf, 2.225; 112: ALKALINE PHOSPHATASE, 83 U/L; 112: GLUCOSE, 98 mg/dL; 112: POTASSIUM, 3.9 mmol/L; 112: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 112: CHLORIDE, 103 mmol/L; 112: CALCIUM, 9.1 mg/dL; 112: EGFR FOR AFRICAN AMERICAN, 102 mL/min/1.73 m2; 112: ALBUMIN, 3.9 g/dL; 112: ALT (SGPT), 30 U/L; 112: EGFR REFIT WITHOUT RACE (2021), 88 mL/min/1.73 m2; 112: CORRECTED CALCIUM, 9.2 mg/dL; 112: GLOBULIN, 2.9 g/dL; 112: BILIRUBIN TOTAL, 0.8 mg/dL; 112: CO2, 25 mmol/L; 112: ANION GAP, 10 mmol/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: SODIUM, 138 mmol/L; 112: CREATININE, 0.97 mg/dL; 112: AST (SGOT), 37 U/L; 112: SpO2, 97.271; 112: Perf, 2.201; 113: SpO2, 97.069; 113: Perf, 2.263; 114: SpO2, 97.441; 114: Perf, 2.106; 115: SpO2, 97.153; 115: Perf, 2.087; 116: SpO2, 97.638; 116: Perf, 1.803; 117: SpO2, 97.712; 117: Perf, 2.006; 118: SpO2, 97.621; 118: Perf, 3.632; 119: SpO2, 96.831; 119: Perf, 2.841; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.4; 0: Triage HR, 65.0; 0: Triage RR, 16.0; 0: Triage SBP, 108.0; 0: Triage DBP, 54.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I examined the patient\u2019s fever, vital signs, and lab work to assess sepsis risk. The patient\u2019s blood pressure and heart rate remain stable, and the normal lactate further lowers concern for acute sepsis. Although the patient has a fever, there is no sign of escalating infection or organ dysfunction. Therefore, the patient is at low risk of developing sepsis within 12 hours.",
        "claims": [
            "I examined the patient\u2019s fever, vital signs, and lab work to assess sepsis risk.",
            "The patient\u2019s blood pressure remains stable.",
            "The patient's heart rate remains stable.",
            "The normal lactate level lowers concern for acute sepsis.",
            "The patient has a fever.",
            "There are no signs of escalating infection.",
            "There are no signs of organ dysfunction.",
            "Therefore, the patient is at low risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has a fever."
        ],
        "alignment_scores": [
            0.5
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 129.0; 2: DBP, 90.0; 2: MAP, 103.0; 2: Temp, 97.5; 32: POC, HCG, ISTAT QUALITATIVE: Negative; 32: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 42: SpO2, 100.0; 42: SBP, 121.0; 42: DBP, 84.0; 42: MAP, 96.333; 43: SpO2, 100.0; 43: Perf, 1.407; 44: SpO2, 100.0; 44: Perf, 1.549; 45: SpO2, 99.949; 45: Perf, 1.471; 45: SBP, 139.0; 45: DBP, 90.0; 45: MAP, 106.333; 46: SpO2, 100.0; 46: Perf, 1.485; 47: SpO2, 100.0; 47: Perf, 1.395; 48: SpO2, 100.0; 48: Perf, 1.493; 49: SpO2, 100.0; 49: Perf, 1.580; 50: SpO2, 100.0; 50: Perf, 1.320; 51: SpO2, 100.0; 51: Perf, 1.367; 52: SpO2, 100.0; 52: Perf, 1.446; 53: SpO2, 100.0; 53: Perf, 1.679; 54: SpO2, 100.0; 54: Perf, 1.779; 55: SpO2, 100.0; 55: Perf, 1.764; 56: SpO2, 99.845; 56: Perf, 1.48; 57: SpO2, 100.0; 57: Perf, 1.282; 58: SpO2, 100.0; 58: Perf, 1.390; 59: SpO2, 100.0; 59: Perf, 1.111; 60: SpO2, 100.0; 60: Perf, 1.357; 60: SBP, 148.0; 60: DBP, 91.0; 60: MAP, 110.0; 61: SpO2, 99.759; 61: Perf, 1.514; 62: SpO2, 99.915; 62: Perf, 1.576; 63: SpO2, 99.898; 63: Perf, 1.522; 64: SpO2, 99.914; 64: Perf, 1.142; 65: SpO2, 99.763; 65: Perf, 1.102; 66: WAM DIFTYP, AUTO; 66: BASOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 66: HEMATOCRIT (HCT), 32.5 %; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 14.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.37 K/uL; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.03 K/uL; 66: MONOCYTE % (AUTO DIFF), 4.6 %; 66: RED BLOOD CELLS (RBC), 3.38 MIL/uL; 66: EOSINOPHIL % (AUTO DIFF), 4.7 %; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.39 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 96.2 fL; 66: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 16.6 %; 66: PLATELET COUNT (PLT), 349 K/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 66: HEMOGLOBIN (HGB), 10.3 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 73.0 %; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 66: SpO2, 100.0; 66: Perf, 1.377; 67: SpO2, 99.898; 67: Perf, 1.314; 68: SpO2, 99.864; 68: Perf, 1.382; 69: SpO2, 99.293; 69: Perf, 1.647; 70: SpO2, 99.864; 70: Perf, 1.749; 71: SpO2, 99.897; 71: Perf, 1.719; 72: SpO2, 100.0; 72: Perf, 1.875; 73: SpO2, 100.0; 73: Perf, 2.066; 74: SpO2, 99.828; 74: Perf, 1.824; 75: SpO2, 100.0; 75: Perf, 1.525; 75: SBP, 145.0; 75: DBP, 94.0; 75: MAP, 111.0; 76: SpO2, 100.0; 76: Perf, 1.591; 77: SpO2, 98.949; 77: Perf, 1.554; 78: SpO2, 99.793; 78: Perf, 1.474; 79: SpO2, 100.0; 79: Perf, 1.346; 80: SpO2, 100.0; 80: Perf, 1.755; 81: SpO2, 99.914; 81: Perf, 1.211; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 100.0; 82: Perf, 1.267; 83: SpO2, 99.879; 83: Perf, 1.263; 84: SpO2, 99.983; 84: Perf, 1.283; 85: SpO2, 100.0; 85: Perf, 1.625; 86: SpO2, 99.914; 86: Perf, 1.966; 87: SpO2, 100.0; 87: Perf, 1.905; 88: SpO2, 100.0; 88: Perf, 1.642; 89: SpO2, 100.0; 89: Perf, 1.408; 90: SpO2, 100.0; 90: Perf, 1.682; 90: SBP, 156.0; 90: DBP, 109.0; 90: MAP, 124.667; 91: SpO2, 100.0; 91: Perf, 1.419; 92: SpO2, 99.932; 92: Perf, 1.327; 93: SpO2, 99.828; 93: Perf, 1.536; 94: SpO2, 100.0; 94: Perf, 1.546; 95: SpO2, 99.525; 95: Perf, 1.69; 96: SpO2, 99.293; 96: Perf, 1.753; 97: SpO2, 100.0; 97: Perf, 1.554; 98: SpO2, 100.0; 98: Perf, 1.802; 99: SpO2, 100.0; 99: Perf, 1.849; 100: SpO2, 99.390; 100: Perf, 1.844; 101: SpO2, 99.897; 101: Perf, 1.603; 102: SpO2, 100.0; 102: Perf, 1.579; 103: SpO2, 99.897; 103: Perf, 1.589; 104: SpO2, 100.0; 104: Perf, 1.547; 105: SpO2, 100.0; 105: Perf, 1.587; 105: SBP, 168.0; 105: DBP, 155.0; 105: MAP, 159.333; 106: SpO2, 100.0; 106: Perf, 1.513; 107: SpO2, 100.0; 107: Perf, 1.597; 107: SBP, 149.0; 107: DBP, 98.0; 107: MAP, 115.0; 108: SpO2, 100.0; 108: Perf, 1.563; 109: SpO2, 100.0; 109: Perf, 1.600; 110: SpO2, 99.845; 110: Perf, 1.718; 111: SpO2, 100.0; 111: Perf, 1.665; 112: SpO2, 100.0; 112: Perf, 1.813; 113: SpO2, 99.931; 113: Perf, 1.657; 114: SpO2, 100.0; 114: Perf, 1.736; 115: SpO2, 99.793; 115: Perf, 1.530; 116: ALKALINE PHOSPHATASE, 72 U/L; 116: CORRECTED CALCIUM, 8.5 mg/dL; 116: BILIRUBIN TOTAL, 0.2 mg/dL; 116: EGFR REFIT WITHOUT RACE (2021), 63 mL/min/1.73 m2; 116: ALT (SGPT), 6 U/L; 116: PROTEIN TOTAL, 7.0 g/dL; 116: CO2, 18 mmol/L; 116: CHLORIDE, 102 mmol/L; 116: SODIUM, 136 mmol/L; 116: GLOBULIN, 3.1 g/dL; 116: AST (SGOT), 12 U/L; 116: GLUCOSE, 237 mg/dL; 116: ALBUMIN, 3.9 g/dL; 116: POTASSIUM, 4.3 mmol/L; 116: CALCIUM, 8.4 mg/dL; 116: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 116: LIPASE, 16 U/L; 116: ANION GAP, 16 mmol/L; 116: EGFR FOR AFRICAN AMERICAN, 73 mL/min/1.73 m2; 116: CREATININE, 1.05 mg/dL; 116: SpO2, 100.0; 116: Perf, 2.034; 117: SpO2, 100.0; 117: Perf, 1.921; 118: SpO2, 99.897; 118: Perf, 1.865; 119: SpO2, 99.932; 119: Perf, 1.826; 0: Age, 47; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I began by looking at vital signs, noting that the patient\u2019s heart rate, blood pressure, temperature, and respiratory rate remain relatively stable. Then I reviewed lab results, including white blood cell count and other measures, which do not show clear indicators of systemic infection or organ dysfunction. I also considered risk factors for sepsis such as hypotension, altered mental status, and elevated inflammatory markers, which appear absent. Based on these observations, I concluded that the patient does not appear to be at high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs remain relatively stable.",
            "The patient's heart rate is stable.",
            "The patient's blood pressure is stable.",
            "The patient's temperature is stable.",
            "The patient's respiratory rate is stable.",
            "The lab results do not show clear indicators of systemic infection.",
            "The lab results do not show clear indicators of organ dysfunction.",
            "Risk factors for sepsis include hypotension, altered mental status, and elevated inflammatory markers.",
            "Hypotension is absent in the patient.",
            "Altered mental status is absent in the patient.",
            "Elevated inflammatory markers are absent in the patient.",
            "Based on these observations, the patient does not appear to be at high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The lab results do not show clear indicators of systemic infection.",
            "The lab results do not show clear indicators of organ dysfunction.",
            "Hypotension is absent in the patient."
        ],
        "alignment_scores": [
            0.3,
            0.5,
            0.7
        ],
        "alignment_category": [
            2,
            8,
            7
        ],
        "alignment_reasonings": [
            "The claim suggests an absence of systemic infection indicators, which contrasts with the SIRS criteria that identify systemic inflammation. Although the claim is primarily about what is not present (i.e., systemic infection), it is still marginally relevant to SIRS since it bases on the lack of criteria rather than their presence. Hence, there is an inverse relationship, but the alignment is low.",
            "The claim mentions the absence of indicators of organ dysfunction, which is relevant to the SOFA Score's purpose of identifying new organ dysfunction. While the claim does not specify an actual increase in any SOFA component, the absence of these indicators still indirectly aligns with this category because it pertains to their monitoring. This results in a moderate alignment rating, as the focus is on what is not present rather than what is.",
            "The claim directly addresses hypotension, a key element of this category. However, it's the absence of hypotension that is noted, which does not align perfectly with the category's defined criteria for identifying high sepsis risk. Nonetheless, mentioning hypotension relates meaningfully since it is a condition often monitored for sepsis progression, hence a moderate alignment is applicable."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "5: HR, 108.0; 5: RR, 18.0; 5: SpO2, 95.0; 5: SBP, 150.0; 5: DBP, 70.0; 5: MAP, 96.667; 5: Temp, 100.6; 47: POC PH (V) ISTAT, 7.41; 47: POC PO2 (V) ISTAT, 14 mmHg; 47: POC HCO3 (V) ISTAT, 28.3 mmol/L; 47: POC O2 SATURATION ISTAT VENOUS, 18 %; 47: POC LACTATE ISTAT, 0.82 mmol/L; 47: POC TCO2 (V) ISTAT, 30 mmol/L; 47: POC PCO2 (V) ISTAT, 44.7 mmHg; 47: POC BASE EXCESS ISTAT, 4 mmol/L; 69: SpO2, 95.082; 69: Perf, 6.772; 70: SpO2, 95.159; 70: Perf, 7.448; 70: SBP, 126.0; 70: DBP, 55.0; 70: MAP, 78.667; 72: HR, 92.64; 72: RR, 27.7; 72: 1min HRV, 57.204; 73: HR, 92.593; 73: RR, 24.898; 73: 1min HRV, 53.127; 74: HR, 93.281; 74: RR, 22.719; 74: SpO2, 96.0; 74: 1min HRV, 43.048; 74: 5min HRV, 50.360; 74: SBP, 126.0; 74: DBP, 55.0; 74: MAP, 78.667; 74: Pain, 0.0; 74: Temp, 100.0; 75: WAM DIFTYP, AUTO; 75: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 75: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 75: RED BLOOD CELLS (RBC), 4.61 MIL/uL; 75: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 75: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 75: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 75: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 75: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 75: MONOCYTE % (AUTO DIFF), 6.6 %; 75: HEMOGLOBIN (HGB), 12.1 g/dL; 75: BASOPHIL % (AUTO DIFF), 0.3 %; 75: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 75: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.8 g/dL; 75: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.50 K/uL; 75: HEMATOCRIT (HCT), 39.3 %; 75: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.24 K/uL; 75: MONOCYTE ABSOLUTE (AUTO DIFF), 1.08 K/uL; 75: NRBC PERCENT (HEMATOLOGY), 0.0 %; 75: WHITE BLOOD CELLS (WBC), 16.3 K/uL; 75: PLATELET COUNT (PLT), 277 K/uL; 75: EOSINOPHIL % (AUTO DIFF), 1.5 %; 75: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 75: NEUTROPHIL % (AUTO DIFF), 83.0 %; 75: HR, 93.356; 75: RR, 27.746; 75: 1min HRV, 40.677; 76: HR, 91.914; 76: RR, 27.259; 76: 1min HRV, 8.585; 77: HR, 92.525; 77: RR, 27.780; 77: 1min HRV, 6.611; 78: HR, 92.661; 78: RR, 29.102; 78: 1min HRV, 7.071; 79: HR, 92.579; 79: RR, 27.789; 79: 1min HRV, 9.463; 79: 5min HRV, 19.702; 80: HR, 91.949; 80: RR, 27.085; 80: 1min HRV, 5.027; 81: HR, 91.138; 81: RR, 26.931; 81: 1min HRV, 4.219; 82: HR, 91.373; 82: RR, 27.576; 82: 1min HRV, 6.705; 83: HR, 92.158; 83: RR, 25.351; 83: 1min HRV, 9.338; 84: HR, 90.492; 84: RR, 25.271; 84: SpO2, 97.0; 84: 1min HRV, 9.232; 84: 5min HRV, 8.128; 84: SBP, 118.0; 84: DBP, 55.0; 84: MAP, 76.0; 85: HR, 90.085; 85: RR, 26.864; 85: 1min HRV, 59.939; 85: SBP, 118.0; 85: DBP, 55.0; 85: MAP, 76.0; 86: HR, 91.509; 86: RR, 27.386; 86: 1min HRV, 5.108; 87: HR, 90.017; 87: RR, 27.034; 87: 1min HRV, 10.785; 88: HR, 91.276; 88: RR, 27.017; 88: 1min HRV, 6.485; 89: HR, 90.034; 89: RR, 27.254; 89: 1min HRV, 41.373; 89: 5min HRV, 33.336; 90: HR, 90.949; 90: RR, 27.254; 90: 1min HRV, 7.295; 91: HR, 91.684; 91: RR, 28.228; 91: 1min HRV, 38.357; 92: HR, 90.593; 92: RR, 27.661; 92: 1min HRV, 14.779; 92: CEFEPIME, 2 GRAM/20 ML IV PUSH; 93: HR:, 91.034; 93: RR, 28.259; 93: 1min HRV, 5.225; 94: HR, 91.203; 94: RR, 27.831; 94: 1min HRV, 33.017; 94: 5min HRV, 24.101; 95: HR, 90.175; 95: RR, 28.053; 95: 1min HRV, 4.054; 96: HR, 90.085; 96: RR, 28.119; 96: 1min HRV, 9.153; 97: HR, 89.254; 97: RR, 28.356; 97: 1min HRV, 40.998; 98: HR, 91.983; 98: RR, 19.879; 98: 1min HRV, 13.356; 99: HR, 92.328; 99: RR, 25.224; 99: 1min HRV, 19.558; 99: 5min HRV, 23.573; 100: HR, 95.119; 100: RR, 19.356; 100: 1min HRV, 38.958; 100: SBP, 118.0; 100: DBP, 55.0; 100: MAP, 76.0; 100: LR IV BOLUS -, 1000 ML; 101: HR:, 92.828; 101: RR, 24.724; 101: 1min HRV, 7.677; 102: CO2, 27 mmol/L; 102: AST (SGOT), 20 U/L; 102: ALT (SGPT), 21 U/L; 102: CORRECTED CALCIUM, 9.8 mg/dL; 102: EGFR REFIT WITHOUT RACE (2021), 57 mL/min/1.73 m2; 102: CREATININE, 1.37 mg/dL; 102: SODIUM, 138 mmol/L; 102: BLOOD UREA NITROGEN (BUN), 20 mg/dL; 102: ANION GAP, 9 mmol/L; 102: GLUCOSE, 143 mg/dL; 102: GLOBULIN, 3.3 g/dL; 102: BILIRUBIN TOTAL, 0.2 mg/dL; 102: CALCIUM, 9.8 mg/dL; 102: ALBUMIN, 4.0 g/dL; 102: PROTEIN TOTAL, 7.3 g/dL; 102: ALKALINE PHOSPHATASE, 96 U/L; 102: POTASSIUM, 4.0 mmol/L; 102: CHLORIDE, 102 mmol/L; 102: HR, 92.780; 102: RR, 22.237; 102: 1min HRV, 7.634; 103: HR, 93.121; 103: RR, 23.086; 103: 1min HRV, 57.319; 104: HR, 91.729; 104: RR, 24.271; 104: 1min HRV, 9.637; 104: 5min HRV, 32.482; 105: HR, 92.414; 105: RR, 22.241; 105: 1min HRV, 3.310; 106: HR, 92.847; 106: RR, 23.424; 106: 1min HRV, 15.807; 107: HR, 92.845; 107: RR, 25.362; 107: 1min HRV, 9.563; 108: HR, 91.259; 108: RR, 25.034; 108: 1min HRV, 7.513; 109: INR, 1.2; 109: PART. THROMBOPLASTIN TIME, 30.9 seconds; 109: PROTHROMBIN TIME, 15.8 seconds; 109: HR, 90.627; 109: RR, 25.949; 109: 1min HRV, 7.505; 109: 5min HRV, 11.746; 110: HR, 94.879; 110: RR, 24.690; 110: 1min HRV, 19.871; 111: HR, 93.345; 111: RR, 28.793; 111: 1min HRV, 45.103; 112: HR, 91.661; 112: RR, 25.695; 112: 1min HRV, 6.633; 113: HR, 90.293; 113: RR, 25.155; 113: 1min HRV, 45.384; 114: HR, 89.881; 114: RR, 26.780; 114: 1min HRV, 42.987; 114: 5min HRV, 38.858; 115: HR, 89.789; 115: RR, 26.123; 115: 1min HRV, 8.617; 116: HR, 88.0; 116: RR, 28.0; 119: SARS-COV-2 RNA, Not Detected; 119: 5min HRV, 8.617; 0: Age, 65; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I considered the patient\u2019s initial presentation of fever, elevated heart rate, and reported infection symptoms alongside subsequent vital signs and labs indicating elevated respiratory rate, high WBC count, and the administration of IV fluids and antibiotics. These findings suggest a significant concern for a developing infection, fulfilling key systemic inflammatory response criteria. While lactate remained normal, the combination of clinical features and interventions points toward high suspicion for sepsis. Therefore, the patient appears to be at elevated risk for sepsis within the next 12 hours.",
        "claims": [
            "The patient presented with fever.",
            "The patient exhibited an elevated heart rate.",
            "The patient reported infection symptoms.",
            "Subsequent vital signs indicated an elevated respiratory rate.",
            "The patient had a high white blood cell (WBC) count.",
            "The patient received intravenous (IV) fluids.",
            "The patient was administered antibiotics.",
            "These findings suggest a significant concern for a developing infection.",
            "The clinical findings fulfill key systemic inflammatory response criteria.",
            "Lactate levels remained normal.",
            "The combination of clinical features and interventions points toward a high suspicion for sepsis.",
            "The patient appears to be at elevated risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient presented with fever.",
            "The patient exhibited an elevated heart rate.",
            "The patient reported infection symptoms.",
            "Subsequent vital signs indicated an elevated respiratory rate.",
            "The patient had a high white blood cell (WBC) count.",
            "The patient was administered antibiotics.",
            "These findings suggest a significant concern for a developing infection.",
            "The clinical findings fulfill key systemic inflammatory response criteria.",
            "The combination of clinical features and interventions points toward a high suspicion for sepsis.",
            "The patient appears to be at elevated risk for sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.3,
            0.7,
            1.0,
            0.9,
            0.4,
            1.0,
            0.6,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            9,
            3,
            2,
            9,
            9,
            2,
            9,
            4
        ],
        "alignment_reasonings": [
            "Fever is one of the criteria listed under SIRS, which indicates systemic inflammation consistent with early sepsis. However, the claim does not specify the exact temperature, so while fever is relevant to SIRS, the alignment is not perfect without additional context (e.g., exact temperature to confirm it meets the SIRS fever criterion).",
            "An elevated heart rate is one of the criteria listed under the SIRS category (heart rate >90 bpm). While the exact heart rate is not specified in the claim, an elevated heart rate is a key indicator of SIRS positivity, which aligns the claim reasonably well with this category. However, as the claim does not specify whether other SIRS criteria are met, the alignment is not perfect. Therefore, the alignment rating reflects this partial match.",
            "The claim suggests suspicion of infection, which might lead to early antibiotic or culture orders. However, it does not explicitly state that such actions were taken. The presence of infection symptoms aligns with the idea of assessing sepsis risk, but the alignment is weak without concrete actions involved.",
            "An elevated respiratory rate is a key component of the qSOFA score, which is used to flag patients at high risk of sepsis. While the claim does not specify whether the respiratory rate meets the exact threshold (\u226522/min) needed to contribute toward a qSOFA score of \u22652, the mention of an elevated respiratory rate suggests a potential alignment with the qSOFA criteria. Therefore, while the alignment indicates a potentially increased risk of sepsis, without the specifics, the alignment rating is medium-high but not perfect.",
            "A high white blood cell count is explicitly listed as one of the criteria under SIRS Positivity. The presence of two or more SIRS criteria is used to identify systemic inflammation consistent with early sepsis, and a high WBC count directly meets one of these criteria, resulting in perfect alignment.",
            "The administration of antibiotics is a direct action reflecting clinician suspicion of a serious infection, aligning with this category. However, the exact time frame of administration (whether it was within 2 hours) is not specified in the claim, preventing a perfect alignment.",
            "The claim indicates a concern for infection, which implies that further actions such as early orders for antibiotics or cultures may be warranted. However, there is no mention of actual clinical actions like administering antibiotics or drawing cultures within a specific timeframe, which would have established a stronger link to this category. The alignment is primarily based on the suspicion component related to serious infection.",
            "The claim indicates that key systemic inflammatory response criteria are fulfilled, which directly refers to the presence of \u22652 SIRS criteria. This category is designed to identify systemic inflammation consistent with early sepsis, so the alignment with the SIRS Positivity category is perfect.",
            "The claim indicates a \"high suspicion for sepsis\" based on \"clinical features and interventions,\" which correlates with the proactive clinician actions of ordering antibiotics or cultures, reflecting an acknowledgement of potential sepsis. The alignment is somewhat strong, though the claim does not specify these actions were taken, hence a rating of 0.6.",
            "The claim mentions an \"elevated risk for sepsis,\" which aligns with various categories implying risk assessment, such as an Elevated NEWS Score. However, the claim is too vague, lacking any specific parameters or scores that are directly linked to a NEWS score. Without details on deranged vitals or a specific score, the alignment is weak but shows a potential connection to general risk assessment for imminent clinical deterioration."
        ],
        "final_alignment_score": 0.6599999999999999,
        "accuracy": 0
    },
    {
        "input": "8: HR, 119.0; 8: RR, 18.0; 8: SpO2, 95.0; 8: SBP, 169.0; 8: DBP, 103.0; 8: MAP, 125.0; 8: Pain, 6.0; 8: Temp, 95.0; 33: POC PH (V) ISTAT, 7.45; 33: POC O2 SATURATION ISTAT VENOUS, 55 %; 33: POC LACTATE ISTAT, 1.54 mmol/L; 33: POC HCO3 (V) ISTAT, 29.1 mmol/L; 33: POC PO2 (V) ISTAT, 28 mmHg; 33: POC BASE EXCESS ISTAT, 5 mmol/L; 33: POC TCO2 (V) ISTAT, 30 mmol/L; 33: POC PCO2 (V) ISTAT, 42.3 mmHg; 44: HR, 88.590; 44: RR, 18.406; 44: SpO2, 99.0; 44: 1min HRV, 20.500; 44: 5min HRV, 20.500; 45: HR, 92.305; 45: RR, 15.068; 45: SpO2, 98.797; 45: Perf, 0.735; 45: 1min HRV, 15.914; 46: HR, 94.085; 46: RR, 17.729; 46: SpO2, 98.542; 46: Perf, 0.682; 46: 1min HRV, 20.121; 47: HR, 94.931; 47: RR, 12.603; 47: SpO2, 97.980; 47: Perf, 0.69; 47: 1min HRV, 17.878; 48: HR, 88.931; 48: RR, 11.190; 48: SpO2, 98.604; 48: Perf, 0.69; 48: 1min HRV, 25.098; 49: HR, 90.576; 49: RR, 14.102; 49: SpO2, 98.881; 49: Perf, 0.691; 49: 1min HRV, 22.655; 49: 5min HRV, 26.130; 50: HR, 88.254; 50: RR, 13.356; 50: SpO2, 99.797; 50: Perf, 0.768; 50: 1min HRV, 20.065; 51: HR, 85.797; 51: RR, 12.881; 51: SpO2, 99.847; 51: Perf, 0.780; 51: 1min HRV, 25.433; 51: NORMOSOL-R IV BOLUS -, 1000 ML; 52: HR:, 87.828; 52: RR, 14.483; 52: SpO2, 99.0; 52: Perf, 0.801; 52: 1min HRV, 17.872; 53: HR, 87.492; 53: RR, 13.441; 53: SpO2, 98.424; 53: Perf, 0.752; 53: 1min HRV, 14.349; 54: HR, 87.259; 54: RR, 12.741; 54: SpO2, 98.552; 54: Perf, 0.726; 54: 1min HRV, 21.211; 54: 5min HRV, 21.158; 54: SBP, 194.0; 54: DBP, 112.0; 54: MAP, 139.333; 55: HR, 87.797; 55: RR, 16.271; 55: SpO2, 98.909; 55: Perf, 0.696; 55: 1min HRV, 20.357; 55: SBP, 194.0; 55: DBP, 112.0; 55: MAP, 139.333; 56: HR, 88.542; 56: RR, 11.136; 56: SpO2, 99.164; 56: Perf, 0.578; 56: 1min HRV, 21.854; 56: SBP, 191.0; 56: DBP, 107.0; 56: MAP, 135.0; 56: Temp, 99.0; 57: HR, 85.724; 57: RR, 12.897; 57: SpO2, 98.638; 57: Perf, 0.604; 57: 1min HRV, 23.184; 57: SBP, 191.0; 57: DBP, 107.0; 57: MAP, 135.0; 58: HR, 86.508; 58: RR, 14.508; 58: SpO2, 99.409; 58: Perf, 0.57; 58: 1min HRV, 24.025; 59: HR, 85.845; 59: RR, 17.259; 59: SpO2, 99.310; 59: Perf, 0.546; 59: 1min HRV, 35.505; 59: 5min HRV, 27.028; 60: HR, 93.741; 60: RR, 23.621; 60: SpO2, 98.707; 60: Perf, 0.559; 60: 1min HRV, 31.804; 61: HR, 96.627; 61: RR, 13.831; 61: SpO2, 98.458; 61: Perf, 0.563; 61: 1min HRV, 16.269; 62: HR, 97.305; 62: RR, 14.695; 62: SpO2, 97.0; 62: Perf, 0.586; 62: 1min HRV, 13.340; 63: INR, 1.0; 63: PROTHROMBIN TIME, 12.6 seconds; 63: PART. THROMBOPLASTIN TIME, 27.5 seconds; 63: HR, 97.220; 63: RR, 14.390; 63: SpO2, 97.305; 63: Perf, 0.606; 63: 1min HRV, 40.075; 64: HR, 93.259; 64: RR, 13.259; 64: SpO2, 98.586; 64: Perf, 0.716; 64: 1min HRV, 16.946; 64: 5min HRV, 29.308; 64: SBP, 178.0; 64: DBP, 99.0; 64: MAP, 125.333; 65: HR, 89.305; 65: RR, 12.458; 65: SpO2, 99.153; 65: Perf, 0.709; 65: 1min HRV, 14.345; 65: SBP, 178.0; 65: DBP, 99.0; 65: MAP, 125.333; 66: HR, 89.914; 66: RR, 15.5; 66: SpO2, 99.069; 66: Perf, 0.746; 66: 1min HRV, 11.732; 67: HR, 89.983; 67: RR, 15.492; 67: SpO2, 98.881; 67: Perf, 0.7; 67: 1min HRV, 12.711; 68: HR, 90.356; 68: RR, 18.373; 68: SpO2, 98.610; 68: Perf, 0.700; 68: 1min HRV, 21.647; 69: HR, 88.190; 69: RR, 14.379; 69: SpO2, 98.828; 69: Perf, 0.804; 69: 1min HRV, 16.146; 69: 5min HRV, 16.123; 70: HR, 88.695; 70: RR, 13.322; 70: SpO2, 98.576; 70: Perf, 0.778; 70: 1min HRV, 12.567; 71: HR, 89.517; 71: RR, 14.190; 71: SpO2, 97.586; 71: Perf, 0.757; 71: 1min HRV, 18.283; 72: HR, 90.831; 72: RR, 13.034; 72: SpO2, 97.712; 72: Perf, 0.781; 72: 1min HRV, 30.201; 73: HR, 89.441; 73: RR, 13.441; 73: SpO2, 97.763; 73: Perf, 0.792; 73: 1min HRV, 17.698; 74: HR, 90.052; 74: RR, 15.517; 74: SpO2, 97.552; 74: Perf, 0.767; 74: 1min HRV, 18.816; 74: 5min HRV, 21.222; 75: AST (SGOT), 38 U/L; 75: EGFR FOR AFRICAN AMERICAN, 88 mL/min/1.73 m2; 75: CHLORIDE, 101 mmol/L; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CORRECTED CALCIUM, 9.4 mg/dL; 75: ALBUMIN, 4.4 g/dL; 75: CO2, 27 mmol/L; 75: ANION GAP, 13 mmol/L; 75: GLOBULIN, 2.5 g/dL; 75: CALCIUM, 9.7 mg/dL; 75: POTASSIUM, 3.7 mmol/L; 75: BILIRUBIN TOTAL, 0.6 mg/dL; 75: CREATININE, 0.85 mg/dL; 75: ALT (SGPT), 75 U/L; 75: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 75: ALKALINE PHOSPHATASE, 136 U/L; 75: PROTEIN TOTAL, 6.9 g/dL; 75: GLUCOSE, 134 mg/dL; 75: SODIUM, 141 mmol/L; 75: MAGNESIUM, 2.2 mg/dL; 75: C-REACTIVE PROTEIN (CRP), 12.9 mg/dL; 75: HR, 92.576; 75: RR, 15.492; 75: SpO2, 97.458; 75: Perf, 0.738; 75: 1min HRV, 15.039; 75: LABETALOL, 5 MG/ML IV SOLN; 76: HR:, 91.172; 76: RR, 14.914; 76: SpO2, 98.086; 76: Perf, 0.761; 76: 1min HRV, 22.991; 77: HR, 92.593; 77: RR, 12.966; 77: SpO2, 97.847; 77: Perf, 0.732; 77: 1min HRV, 12.759; 78: HR, 90.322; 78: RR, 11.407; 78: SpO2, 97.763; 78: Perf, 0.629; 78: 1min HRV, 29.457; 79: HR, 81.672; 79: RR, 11.603; 79: SpO2, 96.724; 79: Perf, 0.630; 79: 1min HRV, 12.557; 79: 5min HRV, 39.153; 80: SBP, 160.0; 80: DBP, 140.0; 80: MAP, 146.667; 98: PROCALCITONIN, 3.91 ng/mL; 100: ESR (AUTOMATED), 112 mm/hr; 110: TROPONIN I, 0.028 ng/mL; 0: Age, 57; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 119.0; 0: Triage RR, 18.0; 0: Triage SBP, 169.0; 0: Triage DBP, 103.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I noted the elevated procalcitonin (3.91 ng/mL) and high CRP (12.9 mg/dL), which both point toward a significant infection risk. I asked whether the tachycardia and inflammatory markers indicated a systemic response consistent with potential sepsis. I also considered that the patient\u2019s persistently abnormal vitals and laboratory results could signify ongoing, serious infection. This led me to conclude that the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The procalcitonin level is elevated at 3.91 ng/mL.",
            "An elevated procalcitonin level points toward a significant infection risk.",
            "The CRP level is high at 12.9 mg/dL.",
            "A high CRP level points toward a significant infection risk.",
            "The patient exhibits tachycardia.",
            "Tachycardia may indicate a systemic response consistent with potential sepsis.",
            "The patient has persistently abnormal vital signs.",
            "Persistently abnormal vital signs could signify ongoing, serious infection.",
            "The patient's laboratory results are persistently abnormal.",
            "Persistently abnormal laboratory results could signify ongoing, serious infection.",
            "The combination of these factors led to the conclusion that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The procalcitonin level is elevated at 3.91 ng/mL.",
            "An elevated procalcitonin level points toward a significant infection risk.",
            "The CRP level is high at 12.9 mg/dL.",
            "A high CRP level points toward a significant infection risk.",
            "The patient exhibits tachycardia.",
            "Tachycardia may indicate a systemic response consistent with potential sepsis.",
            "The patient has persistently abnormal vital signs.",
            "Persistently abnormal vital signs could signify ongoing, serious infection.",
            "The patient's laboratory results are persistently abnormal.",
            "Persistently abnormal laboratory results could signify ongoing, serious infection.",
            "The combination of these factors led to the conclusion that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.6,
            0.5,
            0.3,
            0.5,
            0.7,
            0.7,
            0.7,
            0.5,
            0.6,
            0.3
        ],
        "alignment_category": [
            5,
            9,
            2,
            2,
            2,
            2,
            4,
            4,
            8,
            9,
            4
        ],
        "alignment_reasonings": [
            "Procalcitonin is not directly listed among the expert sepsis prediction categories; however, it is commonly used as a marker of bacterial infection and sepsis, somewhat akin to elevated serum lactate which signals tissue hypoperfusion. Due to the lack of a direct match, the alignment is weak but still relevant in the context of sepsis risk assessment.",
            "Elevated procalcitonin is a biomarker used in diagnosing bacterial infections and sepsis, often prompting clinicians to consider early administration of antibiotics or further diagnostics like blood cultures. Although it directly aligns with actions in this category, the claim lacks a direct reference to receiving antibiotics or cultures within the specified timeframe, making the alignment moderately strong.",
            "While C-reactive protein (CRP) level is not explicitly one of the SIRS criteria, it is a marker of inflammation similar to an elevated white blood cell count, which is explicitly part of the SIRS criteria. A high CRP level suggests systemic inflammation, which can be indicative of early sepsis and aligns moderately with the goal of identifying systemic inflammatory response. Thus, it has a partial alignment with this category.",
            "While C-reactive protein (CRP) is not explicitly listed as a SIRS criterion, it is commonly used as a marker for systemic inflammation and infection, which aligns with the essence of the SIRS criteria that identifies systemic inflammation consistent with early sepsis. The relationship is indirect, as CRP is not a direct SIRS measure, resulting in a moderate alignment rating.",
            "Tachycardia alone is one of the criteria listed under the Systemic Inflammatory Response Syndrome (SIRS), which includes a heart\u202frate of\u202f>\u202f90\u202fbpm. While the presence of tachycardia alone does not fulfill the requirement of SIRS (which needs at least two criteria), it is still directly related to the SIRS criteria, warranting a moderate alignment rating.",
            "Tachycardia is one of the SIRS criteria (heart rate >90 bpm), which is used to identify systemic inflammation consistent with early sepsis. However, since the claim only mentions tachycardia and not other SIRS criteria, the alignment is not perfect but still strongly relevant.",
            "The claim of \"persistently abnormal vital signs\" suggests ongoing clinical instability, which aligns with the concept of the National Early Warning Score (NEWS) reflecting multiple deranged vital signs. While the claim does not provide specific NEWS calculations or thresholds, the general idea of persistent abnormality strongly hints at potential clinical deterioration as captured by elevated NEWS, thus indicating a reasonably strong alignment.",
            "Persistently abnormal vital signs are a core component of the NEWS score, which assesses the risk of clinical deterioration and potential for sepsis. While the claim doesn't specify a NEWS score, the description of ongoing abnormal vitals aligns conceptually with NEWS\u2019s role in predicting sepsis risk, though without explicit evidence of the requisite score. Thus, the alignment is substantial but not definitive.",
            "Persistently abnormal laboratory results could indicate organ dysfunction, which is aligned with the SOFA score's role in assessing organ function. However, the claim does not specify which laboratory results are abnormal or directly reference any specific measures for SOFA criteria, making the alignment indirect. Therefore, the alignment rating is moderate.",
            "The claim's reference to \"persistently abnormal laboratory results\" suggests a significant clinical concern about a serious infection that aligns with a situation where early orders for antibiotics or cultures would be considered. Although it lacks specifics about immediate actions taken, the notion of \"serious infection\" implies a level of urgency reflected in early intervention strategies such as antibiotics or cultures. Thus, it moderately aligns with this category.",
            "The claim mentions a combination of factors leading to a high risk of sepsis prediction, which slightly aligns with the concept of an elevated NEWS score, a composite measure derived from multiple vital signs pointing to clinical deterioration. However, the claim lacks specificity on the exact factors, so this alignment is weak and general."
        ],
        "final_alignment_score": 0.5181818181818181,
        "accuracy": 0
    },
    {
        "input": "2: SpO2, 98.912; 3: HR, 127.55; 3: RR, 25.833; 3: SpO2, 99.0; 3: 1min HRV, 9.900; 3: 5min HRV, 9.900; 3: SBP, 112.0; 3: DBP, 60.0; 3: MAP, 77.333; 4: HR, 123.810; 4: RR, 14.64; 4: SpO2, 93.6; 4: 1min HRV, 8.630; 5: HR, 123.759; 5: RR, 20.083; 5: SpO2, 100.0; 5: Perf, 0.17; 5: 1min HRV, 9.799; 6: HR, 121.237; 6: RR, 20.864; 6: SpO2, 100.0; 6: Perf, 0.173; 6: 1min HRV, 8.424; 7: HR, 122.534; 7: RR, 18.897; 7: SpO2, 99.806; 7: Perf, 0.180; 7: 1min HRV, 10.581; 8: HR, 122.237; 8: RR, 21.153; 8: SpO2, 100.0; 8: Perf, 0.165; 8: 1min HRV, 11.457; 8: 5min HRV, 10.763; 8: SBP, 112.0; 8: DBP, 60.0; 8: MAP, 77.333; 8: Pain, 0.0; 8: Temp, 99.1; 9: HR, 121.466; 9: RR, 22.138; 9: SpO2, 99.711; 9: Perf, 0.17; 9: 1min HRV, 12.729; 10: HR, 120.085; 10: RR, 18.373; 10: SpO2, 99.826; 10: Perf, 0.17; 10: 1min HRV, 8.977; 11: HR, 121.356; 11: RR, 20.847; 11: SpO2, 99.96; 11: Perf, 0.159; 11: 1min HRV, 6.412; 13: 5min HRV, 10.151; 20: POC PH (V) ISTAT, 7.35; 20: POC TCO2 (V) ISTAT, 32 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 28 %; 20: POC PCO2 (V) ISTAT, 54.3 mmHg; 20: POC HCO3 (V) ISTAT, 30.1 mmol/L; 20: POC LACTATE ISTAT, 0.86 mmol/L; 20: POC BASE EXCESS ISTAT, 5 mmol/L; 20: POC PO2 (V) ISTAT, 20 mmHg; 27: ABO/RH (AUTOMATION), AB Positive; 27: ANTIBODY SCREEN 3, NEG; 29: HR, 117.0; 29: RR, 20.0; 29: SpO2, 100.0; 29: SBP, 104.0; 29: DBP, 67.0; 29: MAP, 79.333; 40: WAM DIFTYP, AUTO; 40: PLATELET COUNT (PLT), 300 K/uL; 40: HEMATOCRIT (HCT), 29.4 %; 40: HEMOGLOBIN (HGB), 9.7 g/dL; 40: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 40: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 40: NEUTROPHIL ABSOLUTE (AUTO DIFF), 12.92 K/uL; 40: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 40: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 40: RED BLOOD CELLS (RBC), 3.45 MIL/uL; 40: EOSINOPHIL % (AUTO DIFF), 0.0 %; 40: BASOPHIL % (AUTO DIFF), 0.1 %; 40: NEUTROPHIL % (AUTO DIFF), 87.3 %; 40: MONOCYTE % (AUTO DIFF), 7.2 %; 40: NRBC PERCENT (HEMATOLOGY), 0.0 %; 40: WHITE BLOOD CELLS (WBC), 14.8 K/uL; 40: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 40: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 40: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 40: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.0 g/dL; 40: RED CELL DISTRIBUTION WIDTH (RDW), 17.3 %; 40: LYMPHOCYTE % (AUTO DIFF), 5.0 %; 40: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 40: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 43: HR, 114.0; 43: RR, 27.0; 43: SpO2, 100.0; 43: SBP, 107.0; 43: DBP, 62.0; 43: MAP, 77.0; 50: INR, 1.1; 50: PROTHROMBIN TIME, 14.4 seconds; 51: PART. THROMBOPLASTIN TIME, 33.5 seconds; 56: ETOMIDATE, 2 MG/ML IV SOLN; 58: SUCCINYLCHOLINE CHLORIDE, 20 MG/ML INJ SOLN; 60: ALT (SGPT), 47 U/L; 60: ANION GAP, 8 mmol/L; 60: ALBUMIN, 3.4 g/dL; 60: EGFR FOR AFRICAN AMERICAN, 150 mL/min/1.73 m2; 60: CALCIUM, 8.6 mg/dL; 60: CREATININE, 0.42 mg/dL; 60: GLUCOSE, 120 mg/dL; 60: CORRECTED CALCIUM, 9.1 mg/dL; 60: GLOBULIN, 3.2 g/dL; 60: BILIRUBIN TOTAL, 0.3 mg/dL; 60: EGFR REFIT WITHOUT RACE (2021), 130 mL/min/1.73 m2; 60: SODIUM, 130 mmol/L; 60: PROTEIN TOTAL, 6.6 g/dL; 60: ALKALINE PHOSPHATASE, 95 U/L; 60: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 60: AST (SGOT), 33 U/L; 60: CHLORIDE, 95 mmol/L; 60: CO2, 27 mmol/L; 60: POTASSIUM, 4.6 mmol/L; 63: HR, 59.0; 63: RR, 18.0; 63: SBP, 117.0; 63: DBP, 100.0; 63: MAP, 105.667; 68: HR, 59.0; 68: RR, 20.0; 68: SBP, 100.0; 68: DBP, 49.0; 68: MAP, 66.0; 69: HR, 59.0; 69: RR, 23.0; 69: SBP, 72.0; 69: DBP, 45.0; 69: MAP, 54.0; 69: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 70: RR:, 24.0; 70: SBP, 87.0; 70: DBP, 54.0; 70: MAP, 65.0; 71: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 72: TRANEXAMIC ACID, 100 MG/ML NEBULIZED INHALATION; 73: RR, 18.0; 73: SBP, 89.0; 73: DBP, 63.0; 73: MAP, 71.667; 74: HR, 140.0; 74: RR, 21.0; 74: SBP, 139.0; 74: DBP, 86.0; 74: MAP, 103.667; 74: NOREPINEPHRINE BITARTRATE-NACL, 4 MG/250 ML (16 MCG/ML) IV SOLN; 76: CALCIUM GLUCONATE IN, 0.9% NACL 1 GRAM/50 ML IV SOLN; 78: HR, 138.0; 78: RR, 16.0; 78: SpO2, 100.0; 78: SBP, 167.0; 78: DBP, 91.0; 78: MAP, 116.333; 82: HR, 138.0; 82: RR, 24.0; 82: SpO2, 100.0; 82: SBP, 118.0; 82: DBP, 89.0; 82: MAP, 98.667; 83: HR, 133.0; 83: RR, 14.0; 83: SpO2, 100.0; 83: SBP, 140.0; 83: DBP, 76.0; 83: MAP, 97.333; 85: PROPOFOL, 10 MG/ML IV INFUSION; 87: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 88: HR, 125.0; 88: RR, 13.0; 88: SpO2, 100.0; 88: SBP, 105.0; 88: DBP, 47.0; 88: MAP, 66.333; 93: HR, 119.0; 93: RR, 20.0; 93: SpO2, 99.0; 93: SBP, 133.0; 93: DBP, 50.0; 93: MAP, 77.667; 98: HR, 109.0; 98: RR, 21.0; 98: SpO2, 99.0; 98: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 102: POC PH (A), ISTAT: 7.21; 102: POC BASE EXCESS ISTAT, -11 mmol/L; 102: POC LACTATE ISTAT, 7.13 mmol/L; 102: POC HCO3 (A) ISTAT, 16.6 mmol/L; 102: POC O2 SATURATION ISTAT, 98 %; 102: POC PO2 (A) ISTAT, 122 mmHg; 102: POC TCO2 (A) ISTAT, 18 mmol/L; 102: POC PCO2 (A) ISTAT, 41.2 mmHg; 108: HR, 105.0; 108: RR, 20.0; 108: SpO2, 98.0; 113: HR, 89.0; 113: RR, 21.0; 113: SpO2, 100.0; 118: HR, 103.0; 118: RR, 20.0; 118: SpO2, 100.0; 118: Pain, 0.0; 118: Pain, 1.0; 0: Age, 37; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 112.0; 0: Triage DBP, 60.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed persistently high heart rates, elevated respiratory rates, and later development of lactic acidosis. I questioned whether the hypotension and need for vasopressor support indicated septic shock versus hemorrhagic shock, but the significant rise in lactate pointed strongly toward sepsis. I also noted leukocytosis, which further increased suspicion of infection. Finally, the patient\u2019s overall clinical picture demonstrated multiple criteria consistent with high sepsis risk.",
        "claims": [
            "Persistently high heart rates were observed.",
            "Elevated respiratory rates were noted.",
            "Lactic acidosis developed later.",
            "I questioned whether hypotension indicated septic shock.",
            "I considered the need for vasopressor support in the context of septic shock versus hemorrhagic shock.",
            "The significant rise in lactate pointed strongly toward sepsis.",
            "Leukocytosis was noted.",
            "Leukocytosis increased suspicion of infection.",
            "The patient\u2019s overall clinical picture demonstrated multiple criteria consistent with high sepsis risk."
        ],
        "relevant_claims": [
            "Persistently high heart rates were observed.",
            "Elevated respiratory rates were noted.",
            "Lactic acidosis developed later.",
            "I questioned whether hypotension indicated septic shock.",
            "I considered the need for vasopressor support in the context of septic shock versus hemorrhagic shock.",
            "The significant rise in lactate pointed strongly toward sepsis.",
            "Leukocytosis was noted.",
            "Leukocytosis increased suspicion of infection.",
            "The patient\u2019s overall clinical picture demonstrated multiple criteria consistent with high sepsis risk."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            0.8,
            0.8,
            0.8,
            1.0,
            1.0,
            1.0,
            0.7
        ],
        "alignment_category": [
            6,
            3,
            5,
            7,
            7,
            5,
            2,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim of \"persistently high heart rates\" aligns with the concept of an elevated shock index, which involves heart rate as a factor. High heart rates can contribute to a high shock index, indicating hemodynamic instability and the potential for severe sepsis. However, without additional information about blood pressure, the alignment is significant but not complete, hence the rating of 0.7.",
            "The claim of elevated respiratory rates directly relates to one component of the qSOFA criteria, which specifies a respiratory rate\u202f\u2265\u202f22\u202f/min as a risk factor. While the claim doesn't explicitly state the rate, the mention of elevation suggests potential alignment with qSOFA if the rate is high enough. This results in a strong, but not full, alignment since the exact rate isn't provided.",
            "Lactic acidosis implies elevated serum lactate levels, which is directly indicative of tissue hypoperfusion and aligns with criteria for elevated serum lactate associated with sepsis risk. However, the claim does not specify the exact lactate level or time of measurement, slightly reducing the alignment strength.",
            "The claim specifically mentions hypotension in the context of questioning its indication of septic shock. This aligns directly with the criteria for sepsis-associated hypotension, which denotes progression toward septic shock. However, because the claim is phrased as a question rather than a confirmed diagnosis or explicit alignment with defined parameters (e.g., specific blood pressure values), the alignment is strong but not absolute.",
            "The consideration of vasopressor support directly relates to managing hypotension, a key component of septic shock. This category encompasses sepsis-associated hypotension, which is often addressed with vasopressors when blood pressure is critically low. The claim involves differentiating between septic and hemorrhagic shock, both of which can involve hypotension, making the alignment strong but not exclusive to sepsis-related hypotension.",
            "The claim directly references a significant rise in lactate levels, which is a key criterion under this category for assessing sepsis risk through tissue hypoperfusion and increased mortality risk. The alignment is perfect as elevated serum lactate is specifically indicative of sepsis according to the provided expert category.",
            "Leukocytosis, indicated by an elevated white blood cell count, is explicitly part of the SIRS criteria (WBC > 12,000/\u00b5L), which are used to identify systemic inflammation consistent with early sepsis. Therefore, this claim fully aligns with this category.",
            "Leukocytosis, or an elevated white blood cell count, is explicitly included in the SIRS criteria. This criterion is used to identify systemic inflammation, which can be consistent with early sepsis. The claim directly references leukocytosis, making the alignment with this category strong and direct.",
            "The claim is general, indicating multiple criteria consistent with high sepsis risk but not specifying any particular criterion. The term \"overall clinical picture\" implies an assessment of various vital signs and clinical parameters, which aligns with the comprehensive nature of the NEWS score. However, because the claim lacks specificity about the actual elevated NEWS score or exact parameters, the alignment is not perfect but still significant."
        ],
        "final_alignment_score": 0.8444444444444446,
        "accuracy": 0
    },
    {
        "input": "1: HR, 79.882; 1: RR, 18.0; 1: SpO2, 92.348; 1: Perf, 2.965; 1: 1min HRV, 16.865; 2: HR, 79.475; 2: RR, 17.102; 2: SpO2, 92.459; 2: Perf, 3.261; 2: 1min HRV, 12.250; 2: 5min HRV, 13.874; 2: SBP, 91.0; 2: DBP, 56.0; 2: MAP, 67.667; 3: HR, 79.603; 3: RR, 17.552; 3: SpO2, 92.167; 3: Perf, 4.201; 3: 1min HRV, 9.150; 3: SBP, 89.0; 3: DBP, 54.0; 3: MAP, 65.667; 4: HR, 80.017; 4: RR, 19.814; 4: SpO2, 91.797; 4: Perf, 4.437; 4: 1min HRV, 7.918; 5: HR, 79.483; 5: RR, 17.897; 5: SpO2, 92.466; 5: Perf, 4.719; 5: 1min HRV, 19.889; 6: HR, 77.898; 6: RR, 17.203; 6: SpO2, 93.034; 6: Perf, 4.849; 6: 1min HRV, 8.734; 7: HR, 77.305; 7: RR, 17.915; 7: SpO2, 94.172; 7: Perf, 4.749; 7: 1min HRV, 29.252; 7: 5min HRV, 20.200; 7: SBP, 82.0; 7: DBP, 58.0; 7: MAP, 66.0; 8: HR, 77.603; 8: RR, 19.879; 8: SpO2, 94.845; 8: Perf, 4.85; 8: 1min HRV, 15.192; 9: HR, 77.932; 9: RR, 18.898; 9: SpO2, 95.729; 9: Perf, 5.131; 9: 1min HRV, 12.593; 10: HR, 77.845; 10: RR, 16.397; 10: SpO2, 96.293; 10: Perf, 4.86; 10: 1min HRV, 16.278; 10: SBP, 82.0; 10: DBP, 56.0; 10: MAP, 64.667; 11: HR, 77.458; 11: RR, 19.085; 11: SpO2, 96.492; 11: Perf, 5.061; 11: 1min HRV, 23.636; 12: HR, 77.441; 12: RR, 19.458; 12: SpO2, 96.0; 12: Perf, 4.676; 12: 1min HRV, 26.166; 12: 5min HRV, 19.846; 13: HR, 77.086; 13: RR, 19.672; 13: SpO2, 96.517; 13: Perf, 4.590; 13: 1min HRV, 27.453; 14: HR, 78.068; 14: RR, 20.780; 14: SpO2, 97.119; 14: Perf, 4.273; 14: 1min HRV, 29.638; 15: HR, 78.259; 15: RR, 18.069; 15: SpO2, 96.017; 15: Perf, 4.582; 15: 1min HRV, 26.424; 16: HR, 77.0; 16: RR, 21.712; 16: SpO2, 95.831; 16: Perf, 4.953; 16: 1min HRV, 21.531; 17: HR, 74.655; 17: RR, 19.983; 17: SpO2, 96.0; 17: Perf, 5.045; 17: 1min HRV, 32.942; 17: 5min HRV, 30.473; 18: HR, 76.627; 18: RR, 18.644; 18: SpO2, 96.881; 18: Perf, 4.553; 18: 1min HRV, 42.603; 18: SBP, 86.0; 18: DBP, 56.0; 18: MAP, 66.0; 19: HR, 76.746; 19: RR, 20.695; 19: SpO2, 96.085; 19: Perf, 4.913; 19: 1min HRV, 22.919; 20: HR, 75.914; 20: RR, 19.672; 20: SpO2, 96.810; 20: Perf, 4.996; 20: 1min HRV, 15.346; 21: HR, 75.695; 21: RR, 21.186; 21: SpO2, 96.068; 21: Perf, 4.31; 21: 1min HRV, 18.165; 22: HR, 75.0; 22: RR, 19.897; 22: SpO2, 96.0; 22: Perf, 5.584; 22: 1min HRV, 15.242; 22: 5min HRV, 26.758; 23: SpO2, 95.627; 23: Perf, 6.732; 24: SpO2, 95.847; 24: Perf, 6.377; 25: SpO2, 95.103; 25: Perf, 5.538; 26: SpO2, 95.271; 26: Perf, 4.859; 27: SpO2, 94.431; 27: Perf, 3.054; 28: SpO2, 97.0; 28: Perf, 3.627; 29: SpO2, 95.644; 29: Perf, 3.088; 30: SpO2, 96.862; 30: Perf, 2.077; 31: SpO2, 96.068; 31: Perf, 2.325; 32: SpO2, 97.759; 32: Perf, 1.248; 33: SpO2, 97.068; 33: Perf, 0.830; 33: SBP, 110.0; 33: DBP, 71.0; 33: MAP, 84.0; 34: SpO2, 97.949; 34: Perf, 0.764; 34: NORMOSOL-R IV BOLUS -, 1000 ML; 35: HR:, 75.0; 35: RR, 20.0; 35: SpO2, 96.828; 35: Perf, 0.739; 35: SBP, 110.0; 35: DBP, 71.0; 35: MAP, 84.0; 36: POC PH (V) ISTAT, 7.42; 36: POC PCO2 (V) ISTAT, 35.1 mmHg; 36: POC PO2 (V) ISTAT, 37 mmHg; 36: POC HCO3 (V) ISTAT, 22.7 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 73 %; 36: POC LACTATE ISTAT, 1.78 mmol/L; 36: POC TCO2 (V) ISTAT, 24 mmol/L; 36: POC BASE EXCESS ISTAT, -2 mmol/L; 36: HR, 73.935; 36: RR, 26.932; 36: SpO2, 95.593; 36: Perf, 1.088; 36: 1min HRV, 15.067; 37: HR, 76.224; 37: RR, 22.655; 37: SpO2, 97.5; 37: Perf, 1.012; 37: 1min HRV, 13.381; 37: 5min HRV, 18.055; 38: HR, 78.051; 38: RR, 28.356; 38: SpO2, 97.932; 38: Perf, 0.629; 38: 1min HRV, 16.546; 39: HR, 80.0; 39: RR, 25.254; 39: SpO2, 98.390; 39: Perf, 0.600; 39: 1min HRV, 21.224; 40: HR, 81.121; 40: RR, 23.741; 40: SpO2, 98.810; 40: Perf, 0.593; 40: 1min HRV, 13.943; 41: HR, 83.542; 41: RR, 26.373; 41: SpO2, 98.0; 41: Perf, 0.600; 41: 1min HRV, 19.886; 42: HR, 83.897; 42: RR, 29.414; 42: SpO2, 98.086; 42: Perf, 0.639; 42: 1min HRV, 17.444; 42: 5min HRV, 26.739; 43: HR, 84.475; 43: RR, 28.780; 43: SpO2, 98.661; 43: Perf, 0.669; 43: 1min HRV, 13.889; 44: HR, 85.712; 44: RR, 26.424; 44: SpO2, 98.644; 44: Perf, 0.677; 44: 1min HRV, 17.314; 47: 5min HRV, 16.253; 62: INR, 1.3; 62: PROTHROMBIN TIME, 15.6 seconds; 63: PART. THROMBOPLASTIN TIME, 35.1 seconds; 71: PIPERACILLIN-TAZOBACTAM-DEXTRS, 4.5 GRAM/100 ML IV PGBK; 74: LIPASE:, 3 U/L; 77: EGFR REFIT WITHOUT RACE (2021), 71 mL/min/1.73 m2; 77: ALT (SGPT), 20 U/L; 77: PROTEIN TOTAL, 5.4 g/dL; 77: CREATININE, 1.01 mg/dL; 77: POTASSIUM, 4.2 mmol/L; 77: GLOBULIN, 2.7 g/dL; 77: AST (SGOT), 62 U/L; 77: ALKALINE PHOSPHATASE, 362 U/L; 77: GLUCOSE, 194 mg/dL; 77: BILIRUBIN TOTAL, 2.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 82 mL/min/1.73 m2; 77: CORRECTED CALCIUM, 8.5 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 2.7 g/dL; 77: SODIUM, 133 mmol/L; 77: CALCIUM, 7.5 mg/dL; 77: BLOOD UREA NITROGEN (BUN), 23 mg/dL; 77: CO2, 23 mmol/L; 77: CHLORIDE, 99 mmol/L; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: PLATELET COUNT (PLT), 47 K/uL; 118: HEMATOCRIT (HCT), 33.3 %; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.4 pg; 118: RED BLOOD CELLS (RBC), 3.43 MIL/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.1 fL; 118: LYMPHOCYTES % (MANUAL DIFF), 6.0 %; 118: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 118: MONOCYTES % (MANUAL DIFF), 0.0 %; 118: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.75 K/uL; 118: NEUTROPHILS BANDS % (MANUAL DIFF), 16.0 %; 118: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 0: Age, 80; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 38.2; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 92.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noted several concerning factors, such as the patient's advanced age, fever on arrival, and episodes of hypotension. I asked if abnormal labs, including low platelets and a low white blood cell count with bandemia, could indicate an active infectious process. Recognizing that the patient received IV fluids and broad-spectrum antibiotics further raised suspicion for sepsis. Therefore, I concluded that the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient has advanced age.",
            "The patient had a fever on arrival.",
            "The patient experienced episodes of hypotension.",
            "Abnormal labs include low platelets.",
            "Abnormal labs include a low white blood cell count with bandemia.",
            "Low platelets and a low white blood cell count with bandemia could indicate an active infectious process.",
            "The patient received IV fluids.",
            "The patient received broad-spectrum antibiotics.",
            "The administration of IV fluids and broad-spectrum antibiotics raised suspicion for sepsis.",
            "The patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has advanced age.",
            "The patient experienced episodes of hypotension.",
            "Abnormal labs include low platelets.",
            "Abnormal labs include a low white blood cell count with bandemia.",
            "Low platelets and a low white blood cell count with bandemia could indicate an active infectious process.",
            "The patient received IV fluids.",
            "The patient received broad-spectrum antibiotics.",
            "The administration of IV fluids and broad-spectrum antibiotics raised suspicion for sepsis.",
            "The patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.8,
            0.8,
            1.0,
            0.8,
            0.3,
            0.9,
            0.9,
            0.5
        ],
        "alignment_category": [
            1,
            7,
            8,
            2,
            2,
            7,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions \"advanced age,\" which closely relates to Elderly Susceptibility (\u2265\u202f65\u202fyears) as a key risk factor for sepsis. However, without a specific mention of age (e.g., \"86 years old\"), the alignment is not perfect but very high, as \"advanced age\" strongly implies an age of 65 or older in this context.",
            "The claim directly mentions episodes of hypotension, which aligns with the category associated with sepsis-associated hypotension indicative of progression toward septic shock. While the claim does not provide specific blood pressure values to confirm full alignment, the mention of hypotension is highly relevant to this category.",
            "The claim mentions low platelets, which is directly relevant to one of the SOFA components (platelets < 100 \u00d7 10\u2079/L) indicating potential new organ dysfunction. This aligns well with the category, although specific platelet count details are missing for full congruence.",
            "The claim mentions a low white blood cell count, which is explicitly one of the criteria under SIRS (WBC\u202f<\u202f4\u202f000/\u00b5L). While bandemia is not directly listed, it often accompanies conditions like leukopenia in infection contexts, further supporting the SIRS relevance. The presence of a low WBC count directly aligns with the SIRS criteria, making the alignment strong and pertinent.",
            "The claim mentions low white blood cell count and bandemia, which can be relevant to SIRS criteria indicating systemic inflammation and an infectious process. However, while the SIRS criteria specifically list a WBC count of <4,000/\u00b5L or >12,000/\u00b5L, it doesn't directly address bandemia or low platelets. Therefore, the alignment is strong but not definitive, focusing primarily on the WBC aspect related to SIRS.",
            "The claim of the patient receiving IV fluids could imply a response to hypotension, which is relevant to this category. However, it does not provide specific details about blood pressure or explicitly indicate sepsis-associated hypotension. Thus, the alignment is weak and indirect.",
            "The administration of broad-spectrum antibiotics is a key indicator of clinician suspicion of a serious infection, which this category targets. However, without specific timing information (such as whether this occurred within two hours), it slightly reduces the alignment strength, preventing a perfect score.",
            "The claim specifically mentions the administration of broad-spectrum antibiotics and IV fluids, which suggests clinical suspicion of a severe infection like sepsis. This aligns closely with the category concerning early antibiotic/culture orders as an indication of suspected sepsis. The alignment rating is high because the criteria include antibiotic administration, although the administration timing relative to the 2-hour window is not mentioned, which slightly reduces the score from perfect alignment.",
            "The claim broadly states a high risk of developing sepsis soon, without specifying particular clinical indicators. The NEWS score aligns with predicting imminent deterioration, similar to \"high risk,\" but the claim doesn't directly mention any typical NEWS parameters or scores, resulting in moderate rather than strong alignment."
        ],
        "final_alignment_score": 0.7666666666666667,
        "accuracy": 1
    },
    {
        "input": "24: HR, 67.0; 24: RR, 21.0; 24: SpO2, 100.0; 24: SBP, 150.0; 24: DBP, 75.0; 24: MAP, 100.0; 24: Pain, 4.0; 24: Temp, 98.1; 72: SpO2, 96.85; 73: HR, 73.429; 73: SpO2, 97.448; 73: 1min HRV, 39.770; 74: HR, 76.576; 74: RR, 24.111; 74: SpO2, 97.847; 74: 1min HRV, 79.227; 74: 5min HRV, 75.764; 75: HR, 73.879; 75: RR, 24.069; 75: SpO2, 99.052; 75: 1min HRV, 64.406; 76: HR, 72.508; 76: RR, 22.203; 76: SpO2, 100.0; 76: 1min HRV, 40.756; 77: HR, 73.593; 77: RR, 22.881; 77: SpO2, 100.0; 77: 1min HRV, 84.321; 78: HR, 71.828; 78: RR, 26.414; 78: 1min HRV, 66.034; 79: HR, 71.915; 79: RR, 24.475; 79: SpO2, 99.0; 79: 1min HRV, 68.889; 79: 5min HRV, 66.426; 80: HR, 73.241; 80: RR, 26.810; 80: 1min HRV, 49.479; 81: HR, 72.729; 81: RR, 27.203; 81: 1min HRV, 70.379; 82: HR, 70.390; 82: RR, 27.136; 82: SpO2, 88.647; 82: 1min HRV, 80.163; 83: HR, 72.052; 83: RR, 27.034; 83: SpO2, 100.0; 83: 1min HRV, 56.723; 84: HR, 72.051; 84: RR, 24.610; 84: SpO2, 100.0; 84: 1min HRV, 74.728; 84: 5min HRV, 68.300; 85: HR, 71.586; 85: RR, 24.569; 85: SpO2, 99.909; 85: 1min HRV, 38.538; 86: HR, 70.627; 86: RR, 23.847; 86: SpO2, 100.0; 86: 1min HRV, 67.076; 87: POC PH (V) ISTAT, 7.30; 87: POC PCO2 (V) ISTAT, 51.4 mmHg; 87: POC O2 SATURATION ISTAT VENOUS, 30 %; 87: POC PO2 (V) ISTAT, 21 mmHg; 87: POC BASE EXCESS ISTAT, -1 mmol/L; 87: POC LACTATE ISTAT, 1.03 mmol/L; 87: POC TCO2 (V) ISTAT, 27 mmol/L; 87: POC HCO3 (V) ISTAT, 25.2 mmol/L; 87: HR, 70.966; 87: RR, 24.017; 87: SpO2, 100.0; 87: 1min HRV, 47.630; 88: HR, 70.305; 88: RR, 24.085; 88: SpO2, 100.0; 88: 1min HRV, 27.826; 89: HR, 70.034; 89: RR, 21.017; 89: SpO2, 100.0; 89: 1min HRV, 54.584; 89: 5min HRV, 49.265; 90: HR, 72.414; 90: RR, 21.862; 90: SpO2, 100.0; 90: 1min HRV, 61.558; 91: HR, 71.169; 91: RR, 22.051; 91: 1min HRV, 60.250; 92: HR, 71.121; 92: RR, 29.707; 92: SpO2, 99.957; 92: 1min HRV, 82.983; 93: HR, 71.661; 93: RR, 28.237; 93: SpO2, 99.569; 93: 1min HRV, 52.021; 94: HR, 72.932; 94: RR, 27.034; 94: SpO2, 99.322; 94: 1min HRV, 61.645; 94: 5min HRV, 65.404; 95: HR, 70.897; 95: RR, 23.328; 95: SpO2, 97.931; 95: 1min HRV, 83.476; 96: HR, 70.915; 96: RR, 22.610; 96: SpO2, 96.0; 96: 1min HRV, 129.629; 97: HR, 73.069; 97: RR, 22.310; 97: 1min HRV, 81.351; 98: HR, 70.983; 98: RR, 26.610; 98: SpO2, 96.923; 98: 1min HRV, 77.855; 99: HR, 72.441; 99: RR, 24.322; 99: SpO2, 97.844; 99: 1min HRV, 65.983; 99: 5min HRV, 85.807; 100: HR, 72.948; 100: RR, 31.707; 100: 1min HRV, 60.048; 101: HR, 70.661; 101: RR, 28.932; 101: SpO2, 96.357; 101: 1min HRV, 75.586; 102: HR, 71.569; 102: RR, 29.517; 102: SpO2, 98.471; 102: 1min HRV, 50.917; 103: HR, 71.983; 103: RR, 29.288; 103: SpO2, 98.017; 103: 1min HRV, 37.331; 104: HR, 72.390; 104: RR, 24.695; 104: SpO2, 96.373; 104: 1min HRV, 57.989; 104: 5min HRV, 58.190; 105: HR, 72.534; 105: RR, 29.086; 105: SpO2, 97.172; 105: 1min HRV, 42.429; 106: HR, 72.576; 106: RR, 29.508; 106: SpO2, 97.254; 106: 1min HRV, 54.927; 107: HR, 73.741; 107: RR, 26.862; 107: SpO2, 97.0; 107: 1min HRV, 34.070; 108: WAM DIFTYP, AUTO; 108: HEMATOCRIT (HCT), 32.9 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.50 K/uL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.91 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 35.1 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 108: EOSINOPHIL % (AUTO DIFF), 1.5 %; 108: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 108: BASOPHIL % (AUTO DIFF), 0.4 %; 108: NEUTROPHIL % (AUTO DIFF), 54.8 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 108: HEMOGLOBIN (HGB), 11.0 g/dL; 108: PLATELET COUNT (PLT), 181 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 80.6 fL; 108: HR, 73.237; 108: RR, 24.119; 108: SpO2, 96.424; 108: 1min HRV, 72.738; 109: HR, 73.610; 109: RR, 23.203; 109: SpO2, 96.0; 109: 1min HRV, 54.247; 109: 5min HRV, 53.550; 110: HR, 75.207; 110: RR, 22.914; 110: SpO2, 96.0; 110: 1min HRV, 47.829; 111: HR, 80.424; 111: RR, 25.814; 111: 1min HRV, 65.162; 112: HR, 81.845; 112: RR, 25.655; 112: SpO2, 96.0; 112: 1min HRV, 56.303; 113: HR, 79.576; 113: RR, 24.695; 113: SpO2, 96.405; 113: 1min HRV, 69.113; 114: HR, 79.864; 114: RR, 23.610; 114: SpO2, 97.0; 114: 1min HRV, 58.916; 114: 5min HRV, 62.870; 114: SBP, 162.0; 114: DBP, 89.0; 114: MAP, 113.333; 114: LPM O2, 2.0; 114: Pain, 4.0; 115: HR, 75.241; 115: RR, 26.397; 115: SpO2, 97.0; 115: 1min HRV, 74.272; 115: SBP, 162.0; 115: DBP, 89.0; 115: MAP, 113.333; 116: HR, 76.746; 116: RR, 30.831; 116: SpO2, 96.932; 116: 1min HRV, 60.360; 117: HR, 76.017; 117: RR, 29.034; 117: SpO2, 97.771; 117: 1min HRV, 54.618; 118: HR, 75.661; 118: RR, 28.203; 118: SpO2, 97.812; 118: 1min HRV, 64.985; 119: HR, 75.379; 119: RR, 25.707; 119: SpO2, 97.86; 119: 1min HRV, 44.094; 119: 5min HRV, 60.569; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 67.0; 0: Triage RR, 21.0; 0: Triage SBP, 150.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, MULTIPLE COMPLAINTS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I evaluated the vitals and labs for signs of infection and hemodynamic instability, noting that the patient\u2019s blood pressure is stable, lactate is normal, and WBC count is within normal range. I questioned whether the slightly elevated respiratory rate or any isolated abnormal value could indicate a high risk of sepsis, but there were no strong clinical flags. The patient\u2019s heart rate, temperature, and other key indicators do not meet sepsis criteria. Therefore, there is insufficient evidence to classify this patient as high risk for sepsis within 12 hours.",
        "claims": [
            "I evaluated the vitals and labs for signs of infection and hemodynamic instability.",
            "The patient\u2019s blood pressure is stable.",
            "The patient\u2019s lactate level is normal.",
            "The patient's WBC count is within the normal range.",
            "I questioned whether the slightly elevated respiratory rate could indicate a high risk of sepsis.",
            "There were no strong clinical flags indicating high risk of sepsis.",
            "The patient\u2019s heart rate does not meet sepsis criteria.",
            "The patient\u2019s temperature does not meet sepsis criteria.",
            "Other key indicators do not meet sepsis criteria.",
            "There is insufficient evidence to classify this patient as high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "I questioned whether the slightly elevated respiratory rate could indicate a high risk of sepsis.",
            "The patient\u2019s heart rate does not meet sepsis criteria.",
            "The patient\u2019s temperature does not meet sepsis criteria."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim refers to a \"slightly elevated respiratory rate,\" which directly interacts with the SIRS criterion related to respiratory rate (>20/min). An elevated respiratory rate is one of the SIRS criteria and could suggest early sepsis, thus the area mainly aligns with the claim. However, since the exact respiratory rate is not specified as exceeding the threshold, the alignment is not perfect, hence a rating of 0.7.",
            "The claim references the patient's heart rate in relation to sepsis criteria, making it pertinent to the SIRS Positivity category, which includes heart rate as one of its criteria. However, the claim specifically states that the heart rate does not meet sepsis criteria, indicating a lack of alignment with achieving SIRS Positivity. The alignment rating is thus low, as it highlights non-fulfillment of SIRS criteria rather than fulfillment or strong relevance.",
            "The claim specifically refers to temperature in the context of sepsis criteria, which aligns it with the SIRS (Systemic Inflammatory Response Syndrome) criteria, where temperature is one of the measurements considered. However, since the temperature does not meet the criteria for sepsis, the alignment is weak."
        ],
        "final_alignment_score": 0.43333333333333335,
        "accuracy": 1
    },
    {
        "input": "4: HR, 106.0; 4: RR, 16.0; 4: SpO2, 98.0; 4: SBP, 131.0; 4: DBP, 64.0; 4: MAP, 86.333; 4: Pain, 5.0; 4: Temp, 99.7; 21: POC PH (V) ISTAT, 7.51; 21: POC HCO3 (V) ISTAT, 23.9 mmol/L; 21: POC BASE EXCESS ISTAT, 1 mmol/L; 21: POC PCO2 (V) ISTAT, 30.3 mmHg; 21: POC LACTATE ISTAT, 1.29 mmol/L; 21: POC O2 SATURATION ISTAT VENOUS, 55 %; 21: POC PO2 (V) ISTAT, 26 mmHg; 21: POC TCO2 (V) ISTAT, 25 mmol/L; 45: WAM DIFTYP, AUTO; 45: MONOCYTE % (AUTO DIFF), 1.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 45: BASOPHIL % (AUTO DIFF), 0.2 %; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.09 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.7 pg; 45: HEMATOCRIT (HCT), 42.6 %; 45: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: RED BLOOD CELLS (RBC), 4.98 MIL/uL; 45: WHITE BLOOD CELLS (WBC), 6.6 K/uL; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.91 K/uL; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.2 %; 45: NEUTROPHIL % (AUTO DIFF), 90.0 %; 45: HEMOGLOBIN (HGB), 14.3 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 7.9 %; 45: MEAN CORPUSCULAR VOLUME (MCV), 85.5 fL; 45: PLATELET COUNT (PLT), 137 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 49: SpO2, 96.216; 50: HR, 97.929; 50: RR, 21.923; 50: SpO2, 97.105; 50: Perf, 2.812; 50: 1min HRV, 29.329; 50: SBP, 116.0; 50: DBP, 63.0; 50: MAP, 80.667; 51: HR, 96.559; 51: RR, 33.831; 51: SpO2, 97.361; 51: Perf, 2.605; 51: 1min HRV, 34.380; 52: HR, 96.328; 52: RR, 30.379; 52: SpO2, 97.172; 52: Perf, 3.327; 52: 1min HRV, 24.923; 52: 5min HRV, 30.085; 53: HR, 96.034; 53: RR, 25.712; 53: SpO2, 97.627; 53: Perf, 3.753; 53: 1min HRV, 25.405; 54: HR, 95.763; 54: RR, 37.576; 54: SpO2, 96.458; 54: Perf, 3.767; 54: 1min HRV, 28.660; 55: HR, 95.948; 55: RR, 28.862; 55: SpO2, 96.862; 55: Perf, 3.849; 55: 1min HRV, 23.770; 56: HR, 95.759; 56: RR, 34.759; 56: SpO2, 96.776; 56: Perf, 3.85; 56: 1min HRV, 25.753; 57: HR, 97.542; 57: RR, 29.661; 57: SpO2, 96.407; 57: Perf, 3.858; 57: 1min HRV, 28.382; 57: 5min HRV, 26.741; 58: HR, 96.424; 58: RR, 28.407; 58: SpO2, 96.051; 58: Perf, 3.928; 58: 1min HRV, 26.958; 59: HR, 98.508; 59: RR, 28.729; 59: SpO2, 96.322; 59: Perf, 4.044; 59: 1min HRV, 27.299; 59: NS IV BOLUS -, 1000 ML; 60: HR:, 97.828; 60: RR, 26.603; 60: SpO2, 96.483; 60: Perf, 3.747; 60: 1min HRV, 30.139; 61: HR, 96.102; 61: RR, 33.576; 61: SpO2, 95.220; 61: Perf, 3.977; 61: 1min HRV, 21.766; 62: HR, 95.276; 62: RR, 34.759; 62: SpO2, 95.103; 62: Perf, 4.003; 62: 1min HRV, 13.770; 62: 5min HRV, 26.118; 63: PART. THROMBOPLASTIN TIME, 28.5 seconds; 63: HR, 95.186; 63: RR, 32.966; 63: SpO2, 95.458; 63: Perf, 3.943; 63: 1min HRV, 18.218; 64: HR, 96.898; 64: RR, 28.034; 64: SpO2, 96.017; 64: Perf, 3.907; 64: 1min HRV, 26.648; 65: HR, 95.466; 65: RR, 26.655; 65: SpO2, 96.534; 65: Perf, 3.322; 65: 1min HRV, 19.805; 66: HR, 94.085; 66: RR, 35.492; 66: SpO2, 98.0; 66: Perf, 3.414; 66: 1min HRV, 27.787; 67: HR, 96.259; 67: RR, 24.069; 67: SpO2, 97.586; 67: Perf, 3.469; 67: 1min HRV, 20.987; 67: 5min HRV, 24.017; 68: HR, 101.203; 68: RR, 24.712; 68: SpO2, 98.627; 68: Perf, 3.187; 68: 1min HRV, 42.194; 69: HR, 102.483; 69: RR, 25.672; 69: SpO2, 98.466; 69: Perf, 2.435; 69: 1min HRV, 24.507; 70: HR, 98.305; 70: RR, 35.390; 70: SpO2, 97.797; 70: Perf, 3.664; 70: 1min HRV, 24.606; 71: HR, 97.966; 71: RR, 34.407; 71: SpO2, 97.0; 71: Perf, 4.119; 71: 1min HRV, 25.309; 72: HR, 97.552; 72: RR, 34.431; 72: SpO2, 96.897; 72: Perf, 4.384; 72: 1min HRV, 22.467; 72: 5min HRV, 30.756; 73: HR, 97.474; 73: RR, 32.919; 73: SpO2, 97.322; 73: Perf, 4.642; 73: 1min HRV, 24.391; 74: SpO2, 97.0; 74: Perf, 4.79; 75: BNP NT-PRO, 454 pg/mL; 75: HR, 98.0; 75: RR, 30.0; 75: SpO2, 97.0; 75: LPM O2, 2.0; 76: INR, 1.3; 76: PROTHROMBIN TIME, 15.8 seconds; 77: 5min HRV, 24.391; 82: HR, 95.0; 82: RR, 31.0; 82: SpO2, 96.0; 82: SBP, 104.0; 82: DBP, 58.0; 82: MAP, 73.333; 82: LPM O2, 2.0; 82: Pain, 0.0; 90: CREATININE, 1.38 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 90: EGFR FOR AFRICAN AMERICAN, 67 mL/min/1.73 m2; 90: ANION GAP, 15 mmol/L; 90: AST (SGOT), 42 U/L; 90: CO2, 23 mmol/L; 90: GLUCOSE, 131 mg/dL; 90: CORRECTED CALCIUM, 8.4 mg/dL; 90: ALT (SGPT), 17 U/L; 90: SODIUM, 138 mmol/L; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.9 mg/dL; 90: POTASSIUM, 3.6 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 21 mg/dL; 90: ALBUMIN, 4.1 g/dL; 90: CALCIUM, 8.5 mg/dL; 90: CHLORIDE, 100 mmol/L; 90: PROTEIN TOTAL, 7.0 g/dL; 90: ALKALINE PHOSPHATASE, 72 U/L; 93: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 109: SpO, 2: 97.0; 110: SpO2, 97.0; 110: Perf, 3.739; 111: SpO2, 97.0; 111: Perf, 3.808; 112: SpO2, 97.0; 112: Perf, 3.783; 113: SpO2, 97.0; 113: Perf, 3.796; 114: SpO2, 96.862; 114: Perf, 3.921; 115: PH, URINE (UA): 5.0; 115: KETONE, URINE (UA): Negative; 115: NITRITE, URINE (UA): Positive; 115: GLUCOSE, URINE (UA): Negative; 115: SPECIFIC GRAVITY, URINE (UA): 1.011; 115: SpO2, 96.593; 115: Perf, 6.781; 116: HR, 97.333; 116: RR, 34.308; 116: SpO2, 97.310; 116: Perf, 7.19; 116: 1min HRV, 16.514; 117: HR, 97.136; 117: RR, 32.847; 117: SpO2, 97.339; 117: Perf, 7.19; 117: 1min HRV, 11.804; 117: 5min HRV, 13.074; 118: HR, 96.881; 118: RR, 33.305; 118: SpO2, 97.0; 118: Perf, 7.1; 118: 1min HRV, 12.584; 119: HR, 96.310; 119: RR, 32.103; 119: SpO2, 96.759; 119: Perf, 6.88; 119: 1min HRV, 3.420; 0: Age, 56; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 106.0; 0: Triage RR, 16.0; 0: Triage SBP, 131.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,BREATHING PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I first noted the patient\u2019s tachycardia, elevated respiratory rate, and possible infection indicated by the positive nitrite on urinalysis. I then checked the lactate level, blood pressure, and renal markers for signs of organ dysfunction or potential shock. Even though the lactate is not markedly elevated, the combination of abnormal vitals and possible UTI source raises concern. Further observation of the patient\u2019s consistent respiratory and heart rate abnormalities suggests a high likelihood of sepsis. Thus, these findings support a \u201cYes\u201d prediction for high sepsis risk within 12 hours.",
        "claims": [
            "The patient exhibits tachycardia.",
            "The patient has an elevated respiratory rate.",
            "A positive nitrite on urinalysis indicates a possible infection.",
            "I checked the lactate level for signs of organ dysfunction.",
            "I checked the blood pressure for signs of potential shock.",
            "I checked renal markers for signs of organ dysfunction or potential shock.",
            "The lactate level is not markedly elevated.",
            "The combination of abnormal vitals raises concern for the patient.",
            "The possible UTI source contributes to the concern for the patient.",
            "There are consistent respiratory and heart rate abnormalities observed in the patient.",
            "These findings suggest a high likelihood of sepsis in the patient.",
            "The findings support a prediction of \"Yes\" for high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "The patient exhibits tachycardia.",
            "The patient has an elevated respiratory rate.",
            "A positive nitrite on urinalysis indicates a possible infection.",
            "I checked the lactate level for signs of organ dysfunction.",
            "I checked the blood pressure for signs of potential shock.",
            "I checked renal markers for signs of organ dysfunction or potential shock.",
            "The combination of abnormal vitals raises concern for the patient.",
            "The possible UTI source contributes to the concern for the patient.",
            "There are consistent respiratory and heart rate abnormalities observed in the patient.",
            "These findings suggest a high likelihood of sepsis in the patient.",
            "The findings support a prediction of \"Yes\" for high sepsis risk within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.7,
            0.6,
            0.7,
            0.6,
            0.7,
            0.7,
            0.3,
            0.8,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            3,
            9,
            5,
            7,
            8,
            4,
            9,
            2,
            4,
            4
        ],
        "alignment_reasonings": [
            "Tachycardia alone is one of the criteria listed under the Systemic Inflammatory Response Syndrome (SIRS), which includes a heart\u202frate of\u202f>\u202f90\u202fbpm. While the presence of tachycardia alone does not fulfill the requirement of SIRS (which needs at least two criteria), it is still directly related to the SIRS criteria, warranting a moderate alignment rating.",
            "An elevated respiratory rate is a specific criterion included in the qSOFA score (respiratory rate \u226522/min), which flags a high risk of sepsis-related complications. However, without the specific respiratory rate provided, it is unclear if it meets the threshold of \u226522/min, resulting in a strong but not perfect alignment.",
            "A positive nitrite on urinalysis suggests a bacterial infection, usually a urinary tract infection. This indicates clinical suspicion of an infection, which might prompt early interventions like antibiotic administration or culture orders within 2 hours. Although it indirectly suggests potential infection management, it doesn't state concrete actions, leading to a moderate alignment.",
            "The claim mentions checking lactate levels for signs of organ dysfunction. Elevated serum lactate is a known indicator of tissue hypoperfusion and is often used to assess organ dysfunction in the context of sepsis. Although the claim does not explicitly state an elevated lactate level, it suggests that lactate measurement is relevant for identifying organ dysfunction, which is closely associated with category 5. The alignment is not perfect due to the lack of specific elevated values, so the rating is set at 0.7.",
            "The claim involves monitoring blood pressure for signs of potential shock, which directly relates to the category of sepsis-associated hypotension. Sepsis-associated hypotension includes criteria like a significant drop in blood pressure, which can indicate progression toward septic shock. While the claim does not specify blood pressure values or changes, it suggests concern for hypotension-related parameters, which moderately aligns with this category.",
            "The claim mentions checking renal markers, which is relevant to the SOFA score component related to creatinine levels and kidney function. While it doesn't directly specify an increase in SOFA score, it does relate to evaluating potential organ dysfunction, suggesting a solid conceptual alignment. However, it does not provide specific evidence of an actual increase in SOFA score, resulting in a rating less than 1.0.",
            "The claim refers to \"abnormal vitals,\" which aligns with the NEWS system that evaluates the combination of deranged vital signs to predict clinical deterioration consistent with sepsis. While the specific NEWS score isn't stated, the concern raised by abnormal vitals suggests alignment with this scoring method rather than any single criterion, such as SIRS or qSOFA. Without exact values, the alignment isn't perfect, leading to a slightly less than strong rating.",
            "The claim mentions a possible UTI as a source of infection, which could lead to sepsis. However, it does not specify any immediate clinical actions like ordering antibiotics or cultures that strongly indicate sepsis risk assessment or intervention. The alignment is therefore indirect and weak, focused more on the presence of an infection rather than a direct sepsis risk assessment or intervention.",
            "The SIRS criteria include respiratory rate >20/min and heart rate >90 bpm, which closely aligns with the observed abnormalities in respiratory and heart rates mentioned in the claim. While the claim implies both criteria, it does not explicitly provide the exact measurements to confirm fulfillment of the SIRS positivity, hence the slightly less than perfect alignment.",
            "The claim of a \"high likelihood of sepsis\" is broad and non-specific. While the statement hints at an overall clinical impression that could be captured by a comprehensive scoring system like NEWS, which predicts clinical deterioration compatible with sepsis, there is no detail provided about specific criteria that align strongly with the expert categories. As such, the alignment is weak and based on general inference rather than specific evidence.",
            "The claim suggests that there are findings supportive of a high sepsis risk prediction within 12 hours, but it does not specify which findings. The Elevated NEWS Score is a comprehensive tool derived from various vital sign derangements that can predict imminent clinical deterioration aligned with sepsis risk, making it conceptually relevant. Without explicit detail, the alignment is speculative and weak."
        ],
        "final_alignment_score": 0.5636363636363636,
        "accuracy": 1
    },
    {
        "input": "6: HR, 113.0; 6: RR, 18.0; 6: SpO2, 100.0; 6: SBP, 129.0; 6: DBP, 99.0; 6: MAP, 109.0; 6: Pain, 8.0; 6: Temp, 97.5; 14: SpO2, 98.0; 14: Perf, 3.832; 15: SpO2, 98.0; 15: Perf, 2.722; 16: SpO2, 97.828; 16: Perf, 2.920; 17: SpO2, 98.797; 17: Perf, 4.697; 18: SpO2, 97.949; 18: Perf, 5.500; 19: SpO2, 97.776; 19: Perf, 4.514; 20: SpO2, 98.186; 20: Perf, 3.809; 21: SpO2, 98.0; 21: Perf, 5.181; 22: POC, HCG, ISTAT QUALITATIVE: Negative; 22: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 22: SpO2, 97.237; 22: Perf, 5.756; 23: POC PH (V) ISTAT, 7.44; 23: POC O2 SATURATION ISTAT VENOUS, 76 %; 23: POC BASE EXCESS ISTAT, 0 mmol/L; 23: POC LACTATE ISTAT, 1.46 mmol/L; 23: POC PO2 (V) ISTAT, 39 mmHg; 23: POC PCO2 (V) ISTAT, 36.1 mmHg; 23: POC HCO3 (V) ISTAT, 24.6 mmol/L; 23: POC TCO2 (V) ISTAT, 26 mmol/L; 23: SpO2, 98.051; 23: Perf, 3.662; 24: SpO2, 97.190; 24: Perf, 4.291; 25: SpO2, 97.559; 25: Perf, 2.529; 26: SpO2, 97.534; 26: Perf, 2.696; 27: SpO2, 98.780; 27: Perf, 3.376; 28: SpO2, 98.85; 28: Perf, 4.125; 38: HR, 96.0; 38: SpO2, 99.0; 38: SBP, 130.0; 38: DBP, 89.0; 38: MAP, 102.667; 38: Pain, 8.0; 40: SpO2, 98.781; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 40: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 41: SpO2, 98.552; 41: Perf, 1.926; 42: SpO2, 97.983; 42: Perf, 1.936; 43: SpO2, 97.793; 43: Perf, 1.598; 44: SpO2, 98.186; 44: Perf, 1.330; 45: SpO2, 97.627; 45: Perf, 4.355; 46: SpO2, 95.948; 46: Perf, 6.526; 47: SpO2, 95.814; 47: Perf, 7.211; 48: SpO2, 94.897; 48: Perf, 7.489; 49: SpO2, 94.949; 49: Perf, 7.38; 50: SpO2, 95.288; 50: Perf, 6.922; 51: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 51: RED CELL DISTRIBUTION WIDTH (RDW), 15.7 %; 51: PLATELET COUNT (PLT), 237 K/uL; 51: RED BLOOD CELLS (RBC), 4.69 MIL/uL; 51: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 51: HEMOGLOBIN (HGB), 13.8 g/dL; 51: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.8 g/dL; 51: HEMATOCRIT (HCT), 40.8 %; 51: MEAN CORPUSCULAR VOLUME (MCV), 87.0 fL; 51: SpO2, 95.534; 51: Perf, 6.612; 52: SpO2, 95.136; 52: Perf, 6.263; 53: SpO2, 95.724; 53: Perf, 5.561; 54: SpO2, 96.712; 54: Perf, 4.76; 55: SpO2, 97.237; 55: Perf, 5.833; 56: SpO2, 96.362; 56: Perf, 4.918; 57: SpO2, 95.847; 57: Perf, 3.894; 58: SpO2, 97.052; 58: Perf, 3.035; 59: SpO2, 97.932; 59: Perf, 1.960; 60: SpO2, 97.508; 60: Perf, 1.363; 61: SpO2, 98.621; 61: Perf, 0.817; 62: SpO2, 98.441; 62: Perf, 0.831; 63: SpO2, 97.811; 63: Perf, 0.81; 64: SpO2, 97.457; 64: Perf, 0.933; 65: SpO2, 98.0; 65: Perf, 1.696; 66: SpO2, 97.017; 66: Perf, 2.477; 67: SpO2, 97.0; 67: Perf, 2.975; 68: SpO2, 96.293; 68: Perf, 3.856; 69: SpO2, 97.017; 69: Perf, 2.624; 70: BILIRUBIN TOTAL, 0.8 mg/dL; 70: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 70: EGFR FOR AFRICAN AMERICAN, 83 mL/min/1.73 m2; 70: CALCIUM, 8.7 mg/dL; 70: EGFR REFIT WITHOUT RACE (2021), 72 mL/min/1.73 m2; 70: ALT (SGPT), 35 U/L; 70: CHLORIDE, 104 mmol/L; 70: PROTEIN TOTAL, 6.4 g/dL; 70: GLOBULIN, 3.0 g/dL; 70: SODIUM, 137 mmol/L; 70: CO2, 23 mmol/L; 70: ANION GAP, 10 mmol/L; 70: POTASSIUM, 4.2 mmol/L; 70: CORRECTED CALCIUM, 9.2 mg/dL; 70: GLUCOSE, 197 mg/dL; 70: CREATININE, 1.04 mg/dL; 70: AST (SGOT), 58 U/L; 70: ALBUMIN, 3.4 g/dL; 70: ALKALINE PHOSPHATASE, 152 U/L; 70: SpO2, 96.458; 70: Perf, 3.956; 71: SpO2, 95.983; 71: Perf, 3.871; 72: SpO2, 97.136; 72: Perf, 2.959; 73: SpO2, 97.552; 73: Perf, 1.859; 74: SpO2, 96.831; 74: Perf, 1.531; 75: SpO2, 96.672; 75: Perf, 2.519; 76: SpO2, 96.034; 76: Perf, 4.384; 77: SpO2, 96.068; 77: Perf, 5.572; 78: SpO2, 96.259; 78: Perf, 5.864; 79: SpO2, 96.339; 79: Perf, 4.983; 80: SpO2, 95.948; 80: Perf, 4.156; 81: SpO2, 96.0; 81: Perf, 6.151; 82: SpO2, 95.322; 82: Perf, 6.860; 83: SpO2, 95.569; 83: Perf, 6.102; 84: SpO2, 97.542; 84: Perf, 2.928; 85: SpO2, 97.603; 85: Perf, 2.236; 86: SpO2, 97.407; 86: Perf, 1.993; 87: SpO2, 97.763; 87: Perf, 2.127; 88: SpO2, 98.517; 88: Perf, 1.963; 89: SpO2, 98.163; 89: Perf, 2.272; 90: SpO2, 97.983; 90: Perf, 1.775; 91: SpO2, 98.712; 91: Perf, 1.189; 92: SpO2, 98.136; 92: Perf, 1.692; 93: SpO2, 98.0; 93: Perf, 1.553; 94: SpO2, 97.695; 94: Perf, 1.424; 95: SpO2, 97.828; 95: Perf, 1.935; 96: SpO2, 97.864; 96: Perf, 2.417; 97: SpO2, 97.424; 97: Perf, 3.952; 98: SpO2, 97.948; 98: Perf, 2.007; 98: Pain, 8.0; 98: HYDROMORPHONE, 1 MG/ML INJ SYRG; 99: SpO, 2: 97.407; 99: Perf, 1.745; 100: SpO2, 97.207; 100: Perf, 2.058; 101: SpO2, 98.475; 101: Perf, 1.515; 102: SpO2, 96.559; 102: Perf, 4.064; 103: SpO2, 95.672; 103: Perf, 6.009; 104: SpO2, 95.797; 104: Perf, 6.499; 105: LIPASE, 3 U/L; 105: SpO2, 96.690; 105: Perf, 6.050; 106: SpO2, 96.085; 106: Perf, 4.536; 107: HR, 100.0; 107: RR, 16.0; 107: SpO2, 96.103; 107: Perf, 3.992; 107: SBP, 122.0; 107: DBP, 83.0; 107: MAP, 96.0; 107: Pain, 7.0; 107: LR IV BOLUS -, 1000 ML; 108: SpO, 2: 95.830; 108: Perf, 4.809; 109: SpO2, 96.593; 109: Perf, 2.287; 110: SpO2, 96.862; 110: Perf, 3.286; 111: SpO2, 96.814; 111: Perf, 5.008; 112: SpO2, 96.155; 112: Perf, 6.273; 113: SpO2, 96.0; 113: Perf, 7.343; 114: SpO2, 96.0; 114: Perf, 8.217; 115: SpO2, 96.0; 115: Perf, 8.392; 116: SpO2, 96.0; 116: Perf, 8.23; 117: SpO2, 96.0; 117: Perf, 7.856; 118: SpO2, 96.186; 118: Perf, 7.616; 119: SpO2, 96.254; 119: Perf, 5.937; 0: Age, 30; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The patient\u2019s vital signs remain largely stable, with normal blood pressures, acceptable oxygen saturations, and a low lactate level. Although the patient has a slightly elevated heart rate and white blood cell count, there are no clear signs of severe infection or organ dysfunction based on these data. Taken together, these findings do not support a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient\u2019s vital signs remain largely stable.",
            "The patient has normal blood pressures.",
            "The patient has acceptable oxygen saturations.",
            "The patient has a low lactate level.",
            "The patient has a slightly elevated heart rate.",
            "The patient has a slightly elevated white blood cell count.",
            "There are no clear signs of severe infection based on these data.",
            "There are no clear signs of organ dysfunction based on these data.",
            "The findings do not support a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There are no clear signs of severe infection based on these data."
        ],
        "alignment_scores": [
            0.3
        ],
        "alignment_category": [
            9
        ],
        "alignment_reasonings": [
            "The claim suggests a lower likelihood of serious infection, which contrasts with the category associated with clinician suspicion of severe infection. Since there are no clear signs of infection, it implies that there might not be any immediate actions such as administering antibiotics or obtaining cultures, typically linked to the Early Antibiotic/Culture Orders category. The alignment is minimal as the claim leans to negate sepsis indicators rather than confirm clinician suspicion or required actions."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 0
    },
    {
        "input": "6: Pain, 3.0; 11: HR, 110.0; 11: RR, 16.0; 11: SpO2, 98.0; 11: SBP, 101.0; 11: DBP, 71.0; 11: MAP, 81.0; 11: Temp, 100.6; 72: HR, 92.222; 72: RR, 21.875; 72: 1min HRV, 43.704; 73: HR, 89.305; 73: RR, 17.288; 73: SpO2, 98.8; 73: 1min HRV, 29.523; 73: 5min HRV, 33.011; 74: HR, 90.915; 74: RR, 18.271; 74: SpO2, 99.339; 74: 1min HRV, 25.600; 75: HR, 91.966; 75: RR, 12.310; 75: SpO2, 99.067; 75: 1min HRV, 33.168; 76: HR, 92.542; 76: RR, 11.017; 76: SpO2, 98.478; 76: 1min HRV, 25.871; 77: HR, 90.724; 77: RR, 11.052; 77: 1min HRV, 46.247; 78: HR, 91.0; 78: RR, 13.983; 78: 1min HRV, 41.994; 78: 5min HRV, 36.581; 79: HR, 89.271; 79: RR, 21.220; 79: SpO2, 98.630; 79: 1min HRV, 38.635; 80: HR, 90.362; 80: RR, 17.621; 80: SpO2, 98.793; 80: 1min HRV, 25.565; 81: HR, 89.724; 81: RR, 16.879; 81: SpO2, 99.707; 81: Perf, 1.096; 81: 1min HRV, 23.929; 82: HR, 91.424; 82: RR, 17.610; 82: SpO2, 98.949; 82: Perf, 1.005; 82: 1min HRV, 24.082; 83: HR, 88.458; 83: RR, 18.373; 83: SpO2, 98.864; 83: Perf, 0.826; 83: 1min HRV, 38.059; 83: 5min HRV, 31.944; 83: ACETAMINOPHEN, 500 MG PO TABS; 83: OXYCODONE, 5 MG PO TABS; 83: KETOROLAC, 15 MG/ML INJ SOLN; 84: HR:, 90.254; 84: RR, 16.983; 84: SpO2, 99.051; 84: Perf, 0.804; 84: 1min HRV, 30.058; 85: HR, 90.534; 85: RR, 12.517; 85: SpO2, 98.579; 85: Perf, 0.836; 85: 1min HRV, 27.375; 86: HR, 96.610; 86: RR, 15.678; 86: SpO2, 98.797; 86: Perf, 0.833; 86: 1min HRV, 31.678; 87: HR, 91.914; 87: RR, 20.276; 87: SpO2, 99.5; 87: Perf, 0.746; 87: 1min HRV, 29.713; 88: HR, 91.593; 88: RR, 20.780; 88: SpO2, 99.339; 88: Perf, 0.707; 88: 1min HRV, 20.362; 88: 5min HRV, 31.524; 89: HR, 88.186; 89: RR, 24.390; 89: SpO2, 99.847; 89: Perf, 0.611; 89: 1min HRV, 28.514; 90: HR, 86.017; 90: RR, 24.776; 90: SpO2, 99.0; 90: Perf, 0.495; 90: 1min HRV, 31.844; 91: HR, 86.780; 91: RR, 23.254; 91: SpO2, 99.339; 91: Perf, 0.51; 91: 1min HRV, 45.691; 92: HR, 89.655; 92: RR, 23.328; 92: SpO2, 98.966; 92: Perf, 0.562; 92: 1min HRV, 34.010; 93: HR, 90.207; 93: RR, 21.879; 93: SpO2, 99.862; 93: Perf, 0.567; 93: 1min HRV, 20.106; 93: 5min HRV, 35.050; 93: Pain, 2.0; 94: POC PH (V) ISTAT, 7.42; 94: POC BASE EXCESS ISTAT, 3 mmol/L; 94: POC PO2 (V) ISTAT, 21 mmHg; 94: POC TCO2 (V) ISTAT, 29 mmol/L; 94: POC PCO2 (V) ISTAT, 42.8 mmHg; 94: POC O2 SATURATION ISTAT VENOUS, 35 %; 94: POC LACTATE ISTAT, 0.65 mmol/L; 94: POC HCO3 (V) ISTAT, 27.7 mmol/L; 94: HR, 90.55; 94: RR, 17.9; 94: SpO2, 98.942; 94: Perf, 0.58; 94: 1min HRV, 31.606; 95: HR, 88.534; 95: RR, 22.086; 95: SpO2, 99.622; 95: Perf, 0.550; 95: 1min HRV, 26.931; 96: HR, 91.017; 96: RR, 22.576; 96: SpO2, 98.847; 96: Perf, 0.441; 96: 1min HRV, 25.494; 96: NORMOSOL-R IV BOLUS -, 2000 ML; 97: HR:, 85.966; 97: RR, 27.155; 97: SpO2, 99.810; 97: Perf, 0.425; 97: 1min HRV, 25.770; 98: HR, 86.593; 98: RR, 22.780; 98: SpO2, 99.559; 98: Perf, 0.628; 98: 1min HRV, 36.433; 98: 5min HRV, 32.757; 99: HR, 84.576; 99: RR, 19.424; 99: SpO2, 99.763; 99: Perf, 1.418; 99: 1min HRV, 43.134; 100: HR, 88.603; 100: RR, 20.328; 100: SpO2, 99.517; 100: Perf, 0.829; 100: 1min HRV, 28.072; 101: HR, 88.305; 101: RR, 22.542; 101: SpO2, 99.288; 101: Perf, 0.703; 101: 1min HRV, 62.987; 102: HR, 87.517; 102: RR, 19.776; 102: SpO2, 99.259; 102: Perf, 0.7; 102: 1min HRV, 30.948; 103: HR, 90.356; 103: RR, 20.305; 103: SpO2, 99.288; 103: Perf, 0.7; 103: 1min HRV, 20.254; 103: 5min HRV, 41.813; 104: HR, 89.086; 104: RR, 18.121; 104: SpO2, 99.362; 104: Perf, 0.7; 104: 1min HRV, 24.861; 105: HR, 90.034; 105: RR, 20.847; 105: SpO2, 99.305; 105: Perf, 0.7; 105: 1min HRV, 22.729; 106: HR, 91.475; 106: RR, 18.712; 106: SpO2, 99.542; 106: Perf, 0.7; 106: 1min HRV, 11.326; 107: HR, 90.534; 107: RR, 21.293; 107: SpO2, 99.45; 107: Perf, 0.7; 107: 1min HRV, 20.989; 108: HR, 91.729; 108: RR, 18.898; 108: SpO2, 99.390; 108: 1min HRV, 17.928; 108: 5min HRV, 21.353; 109: HR, 90.345; 109: RR, 19.448; 109: SpO2, 99.034; 109: 1min HRV, 23.798; 110: HR, 90.932; 110: RR, 20.780; 110: SpO2, 99.492; 110: 1min HRV, 14.083; 111: HR, 90.237; 111: RR, 21.593; 111: SpO2, 98.932; 111: 1min HRV, 14.092; 112: HR, 93.510; 112: RR, 25.067; 112: SpO2, 99.034; 112: 1min HRV, 24.214; 113: HR, 93.155; 113: RR, 25.04; 113: SpO2, 98.797; 113: Perf, 3.01; 113: 1min HRV, 17.315; 113: 5min HRV, 21.145; 114: HR, 89.483; 114: RR, 25.684; 114: SpO2, 99.362; 114: Perf, 3.138; 114: 1min HRV, 30.205; 115: HR, 94.583; 115: RR, 22.361; 115: SpO2, 98.712; 115: Perf, 2.212; 115: 1min HRV, 17.856; 116: HR, 89.814; 116: RR, 19.729; 116: SpO2, 98.864; 116: Perf, 2.262; 116: 1min HRV, 43.068; 117: HR, 86.914; 117: RR, 15.966; 117: SpO2, 99.069; 117: Perf, 2.278; 117: 1min HRV, 71.766; 118: HR, 82.414; 118: RR, 12.276; 118: SpO2, 98.690; 118: Perf, 2.049; 118: 1min HRV, 73.083; 118: 5min HRV, 61.493; 119: HR, 86.949; 119: RR, 17.169; 119: SpO2, 98.915; 119: Perf, 1.853; 119: 1min HRV, 53.403; 0: Age, 25; 0: Gender, M; 0: Race, White; 0: Means of arrival, Other/Unknown; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 16.0; 0: Triage SBP, 101.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the vital signs, laboratory values, and clinical indicators of potential infection. The patient\u2019s blood pressure and lactate level remain within normal limits, and although the heart rate and temperature are somewhat elevated, there is no clear sign of organ dysfunction. The respiratory rate occasionally increases, but it never stays dangerously high. Based on these observations, there is insufficient evidence to suggest a high sepsis risk within the next 12 hours.",
        "claims": [
            "I reviewed the vital signs, laboratory values, and clinical indicators of potential infection.",
            "The patient\u2019s blood pressure remains within normal limits.",
            "The patient\u2019s lactate level remains within normal limits.",
            "The heart rate is somewhat elevated.",
            "The temperature is somewhat elevated.",
            "There is no clear sign of organ dysfunction.",
            "The respiratory rate occasionally increases.",
            "The respiratory rate never stays dangerously high.",
            "There is insufficient evidence to suggest a high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is somewhat elevated.",
            "The temperature is somewhat elevated."
        ],
        "alignment_scores": [
            0.6,
            0.3
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions an elevated heart rate, which aligns with the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm) as an indicator of systemic inflammation. However, the term \"somewhat elevated\" is vague and doesn't confirm meeting the specific criteria, thus resulting in a moderate alignment.",
            "The claim mentions a somewhat elevated temperature, which is related to the SIRS criteria that include temperature >38\u00b0C as a marker of systemic inflammation. However, \"somewhat elevated\" is vague and does not specify meeting the threshold of >38\u00b0C, leading to a weaker alignment."
        ],
        "final_alignment_score": 0.44999999999999996,
        "accuracy": 1
    },
    {
        "input": "4: HR, 82.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 146.0; 4: DBP, 98.0; 4: MAP, 114.0; 4: Pain, 7.0; 4: Temp, 98.1; 7: Pain, 7.0; 33: WAM DIFTYP, AUTO; 33: NEUTROPHIL % (AUTO DIFF), 62.5 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: MONOCYTE % (AUTO DIFF), 7.0 %; 33: PLATELET COUNT (PLT), 367 K/uL; 33: HEMATOCRIT (HCT), 38.3 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: BASOPHIL % (AUTO DIFF), 0.3 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: HEMOGLOBIN (HGB), 13.4 g/dL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.79 K/uL; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.63 K/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 2.2 %; 33: MEAN CORPUSCULAR VOLUME (MCV), 90.3 fL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 11.2 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 33: LYMPHOCYTE % (AUTO DIFF), 27.5 %; 33: WHITE BLOOD CELLS (WBC), 13.8 K/uL; 33: RED BLOOD CELLS (RBC), 4.24 MIL/uL; 38: HR, 80.0; 38: SpO2, 99.0; 38: SBP, 162.0; 38: DBP, 101.0; 38: MAP, 121.333; 39: HR, 83.0; 39: SpO2, 98.407; 39: Perf, 2.286; 39: SBP, 159.0; 39: DBP, 107.0; 39: MAP, 124.333; 40: SpO2, 98.793; 40: Perf, 1.983; 41: SpO2, 99.017; 41: Perf, 1.678; 42: SpO2, 98.831; 42: Perf, 1.288; 43: SpO2, 99.103; 43: Perf, 1.572; 44: SpO2, 98.773; 44: Perf, 2.47; 44: SBP, 142.0; 44: DBP, 97.0; 44: MAP, 112.0; 45: SpO2, 99.310; 45: Perf, 2.105; 46: SpO2, 98.525; 46: Perf, 2.503; 47: PH, URINE (UA): 6.0; 47: KETONE, URINE (UA): Negative; 47: SPECIFIC GRAVITY, URINE (UA): 1.010; 47: PROTEIN, URINE (UA): Negative; 47: LEUKOCYTE ESTERASE, URINE (UA): Negative; 47: NITRITE, URINE (UA): Negative; 47: GLUCOSE, URINE (UA): Negative; 47: SpO2, 98.169; 47: Perf, 2.853; 48: HR, 79.0; 48: RR, 18.0; 48: SpO2, 98.138; 48: Perf, 2.775; 48: SBP, 142.0; 48: DBP, 97.0; 48: MAP, 112.0; 49: SpO2, 98.695; 49: Perf, 3.093; 50: SpO2, 98.621; 50: Perf, 3.136; 51: SpO2, 97.881; 51: Perf, 3.083; 52: SpO2, 98.222; 52: Perf, 2.428; 60: SODIUM, 137 mmol/L; 60: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 60: ALT (SGPT), 95 U/L; 60: BILIRUBIN TOTAL, 0.4 mg/dL; 60: ALBUMIN, 4.5 g/dL; 60: PROTEIN TOTAL, 8.5 g/dL; 60: CALCIUM, 9.7 mg/dL; 60: CHLORIDE, 101 mmol/L; 60: CORRECTED CALCIUM, 9.3 mg/dL; 60: GLOBULIN, 4.0 g/dL; 60: GLUCOSE, 167 mg/dL; 60: CREATININE, 0.44 mg/dL; 60: ALKALINE PHOSPHATASE, 96 U/L; 60: AST (SGOT), 58 U/L; 60: POTASSIUM, 3.7 mmol/L; 60: ANION GAP, 12 mmol/L; 60: CO2, 24 mmol/L; 60: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 66: SpO2, 98.273; 66: SBP, 138.0; 66: DBP, 91.0; 66: MAP, 106.667; 67: SpO2, 98.119; 67: Perf, 1.559; 68: HR, 79.0; 68: SpO2, 98.776; 68: Perf, 2.141; 68: SBP, 138.0; 68: DBP, 91.0; 68: MAP, 106.667; 69: SpO2, 98.102; 69: Perf, 2.627; 70: SpO2, 97.431; 70: Perf, 2.77; 71: SpO2, 97.424; 71: Perf, 2.602; 72: SpO2, 98.138; 72: Perf, 1.685; 73: SpO2, 98.203; 73: Perf, 1.359; 74: SpO2, 98.542; 74: Perf, 1.387; 75: SpO2, 97.017; 75: Perf, 1.193; 76: SpO2, 99.658; 76: Perf, 1.508; 77: SpO2, 99.052; 77: Perf, 4.531; 78: SpO2, 99.458; 78: Perf, 3.426; 79: SpO2, 98.797; 79: Perf, 3.575; 80: SpO2, 98.276; 80: Perf, 2.550; 81: SpO2, 97.102; 81: Perf, 2.810; 82: SpO2, 95.966; 82: Perf, 2.693; 83: SpO2, 98.203; 83: Perf, 1.976; 84: SpO2, 97.356; 84: Perf, 2.381; 85: SpO2, 97.362; 85: Perf, 2.297; 86: SpO2, 95.390; 86: Perf, 2.546; 87: SpO2, 95.190; 87: Perf, 2.503; 88: SpO2, 95.932; 88: Perf, 2.038; 89: SpO2, 95.593; 89: Perf, 1.964; 90: SpO2, 98.121; 90: Perf, 1.987; 91: SpO2, 98.593; 91: Perf, 1.973; 92: SpO2, 99.121; 92: Perf, 2.620; 93: SpO2, 97.0; 93: Perf, 3.478; 94: SpO2, 93.322; 94: Perf, 3.164; 95: SpO2, 98.707; 95: Perf, 1.441; 96: SpO2, 97.729; 96: Perf, 1.631; 97: SpO2, 99.0; 97: Perf, 1.952; 98: SpO2, 99.102; 98: Perf, 2.415; 99: SpO2, 98.695; 99: Perf, 2.855; 100: SpO2, 98.5; 100: Perf, 3.036; 101: SpO2, 98.237; 101: Perf, 2.378; 102: SpO2, 98.241; 102: Perf, 2.211; 103: SpO2, 98.797; 103: Perf, 3.313; 104: SpO2, 98.845; 104: Perf, 2.617; 105: SpO2, 98.559; 105: Perf, 2.219; 106: SpO2, 98.492; 106: Perf, 1.441; 107: SpO2, 98.483; 107: Perf, 1.413; 108: SpO2, 98.356; 108: Perf, 1.123; 109: HIGH SENSITIVITY TROPONIN, <4 ng/L; 109: SpO2, 97.897; 109: Perf, 1.762; 110: SpO2, 97.966; 110: Perf, 2.066; 111: SpO2, 98.339; 111: Perf, 4.271; 112: SpO2, 98.724; 112: Perf, 4.038; 113: SpO2, 98.678; 113: Perf, 3.599; 114: SpO2, 98.879; 114: Perf, 5.345; 115: SpO2, 99.169; 115: Perf, 4.547; 116: SpO2, 98.627; 116: Perf, 4.874; 117: INFLUENZA B, Not Detected; 117: RSV, Not Detected; 117: SARS-COV-2 RNA, Not Detected; 117: INFLUENZA A, Not Detected; 117: SpO2, 98.397; 117: Perf, 2.488; 118: HR, 74.0; 118: RR, 16.0; 118: SpO2, 99.339; 118: Perf, 2.690; 118: SBP, 138.0; 118: DBP, 90.0; 118: MAP, 106.0; 119: SpO2, 98.897; 119: Perf, 4.056; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 82.0; 0: Triage RR, 16.0; 0: Triage SBP, 146.0; 0: Triage DBP, 98.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I started by reviewing the vital signs, which remain largely within normal limits without evidence of fever, tachycardia, or hypotension. Next, I examined the laboratory results, which show only a mild leukocytosis but no other concerning factors such as lactic acidosis or organ dysfunction. Finally, there is no indication of new infection or systemic inflammatory response criteria. Based on these observations, the patient does not appear to be at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The vital signs are largely within normal limits.",
            "There is no evidence of fever.",
            "There is no evidence of tachycardia.",
            "There is no evidence of hypotension.",
            "The laboratory results show only a mild leukocytosis.",
            "There are no other concerning factors such as lactic acidosis.",
            "There is no evidence of organ dysfunction.",
            "There is no indication of new infection.",
            "There are no signs of systemic inflammatory response criteria.",
            "Based on these observations, the patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There is no evidence of fever.",
            "There is no evidence of hypotension.",
            "The laboratory results show only a mild leukocytosis.",
            "There is no evidence of organ dysfunction.",
            "There are no signs of systemic inflammatory response criteria."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.5,
            0.2,
            1.0
        ],
        "alignment_category": [
            2,
            7,
            2,
            8,
            2
        ],
        "alignment_reasonings": [
            "The absence of fever is indirectly related to SIRS criteria, as it rules out one possible criterion needed for SIRS positivity. It suggests a lack of systemic inflammation typically identified in early sepsis but doesn\u2019t directly indicate sepsis or significantly fulfill any criteria. Thus, the alignment is minimal.",
            "The claim directly mentions the absence of hypotension, which is covered in the \"Sepsis-Associated Hypotension\" category. The alignment is low because the claim is about the lack of evidence for hypotension, which suggests a lower risk rather than confirming the presence of a sepsis risk factor.",
            "Mild leukocytosis involves an elevated white blood cell count, which aligns with one of the SIRS criteria for systemic inflammation. However, since the claim specifies \"mild\" leukocytosis, it may not fully meet the threshold for the SIRS criterion, and it does not encompass other required criteria (e.g., temperature or heart rate abnormalities). Thus, the alignment is moderate.",
            "The claim directly relates to the presence or absence of organ dysfunction, which relates to the SOFA score, as this score is used to identify new organ dysfunction. However, the statement indicates the absence of dysfunction, making the alignment weak because confirming no organ dysfunction doesn't directly involve the SOFA score criteria.",
            "The claim directly references the absence of systemic inflammatory response criteria, which is central to the SIRS Positivity category. The claim's focus on systemic inflammatory response directly aligns with identifying or refuting sepsis risk based on SIRS criteria."
        ],
        "final_alignment_score": 0.45999999999999996,
        "accuracy": 1
    },
    {
        "input": "6: SpO2, 100.0; 6: 1min HRV, 0.0; 6: 5min HRV, 0.0; 7: HR, 89.619; 7: RR, 22.685; 7: SpO2, 99.944; 7: 1min HRV, 11.931; 7: SBP, 121.0; 7: DBP, 79.0; 7: MAP, 93.0; 7: Pain, 0.0; 7: Temp, 99.2; 8: HR, 85.983; 8: RR, 17.322; 8: SpO2, 98.407; 8: Perf, 1.51; 8: 1min HRV, 15.479; 9: HR, 85.186; 9: RR, 17.966; 9: SpO2, 99.610; 9: Perf, 1.854; 9: 1min HRV, 12.859; 10: HR, 82.138; 10: RR, 21.569; 10: SpO2, 99.983; 10: Perf, 3.417; 10: 1min HRV, 8.644; 10: SBP, 121.0; 10: DBP, 79.0; 10: MAP, 93.0; 11: HR, 80.610; 11: RR, 20.407; 11: SpO2, 98.983; 11: Perf, 3.693; 11: 1min HRV, 9.208; 11: 5min HRV, 28.237; 12: HR, 80.879; 12: RR, 20.310; 12: SpO2, 99.724; 12: Perf, 3.354; 12: 1min HRV, 7.965; 12: SBP, 126.0; 12: DBP, 74.0; 12: MAP, 91.333; 13: HR, 80.627; 13: RR, 19.339; 13: SpO2, 99.407; 13: Perf, 4.203; 13: 1min HRV, 21.634; 14: HR, 83.407; 14: RR, 19.881; 14: SpO2, 100.0; 14: Perf, 3.270; 14: 1min HRV, 14.516; 15: HR, 83.828; 15: RR, 20.741; 15: SpO2, 100.0; 15: Perf, 2.916; 15: 1min HRV, 13.868; 16: HR, 82.780; 16: RR, 20.559; 16: SpO2, 100.0; 16: Perf, 3.216; 16: 1min HRV, 14.416; 16: 5min HRV, 18.190; 17: HR, 83.379; 17: RR, 19.776; 17: SpO2, 99.914; 17: Perf, 3.048; 17: 1min HRV, 12.498; 18: HR, 83.593; 18: RR, 18.475; 18: SpO2, 99.780; 18: Perf, 3.221; 18: 1min HRV, 9.845; 19: HR, 83.483; 19: RR, 18.414; 19: SpO2, 100.0; 19: Perf, 3.773; 19: 1min HRV, 15.395; 20: HR, 82.102; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 4.452; 20: 1min HRV, 12.347; 21: HR, 80.983; 21: RR, 21.644; 21: SpO2, 100.0; 21: Perf, 4.297; 21: 1min HRV, 8.791; 21: 5min HRV, 14.222; 22: HR, 81.534; 22: RR, 22.586; 22: SpO2, 100.0; 22: Perf, 4.374; 22: 1min HRV, 10.385; 23: HR, 81.695; 23: RR, 21.814; 23: SpO2, 100.0; 23: Perf, 4.000; 23: 1min HRV, 8.485; 24: HR, 84.0; 24: RR, 18.103; 24: SpO2, 99.828; 24: Perf, 3.904; 24: 1min HRV, 17.086; 25: HR, 80.932; 25: RR, 21.949; 25: SpO2, 99.898; 25: Perf, 2.998; 25: 1min HRV, 14.699; 26: HR, 79.661; 26: RR, 23.542; 26: SpO2, 100.0; 26: Perf, 3.536; 26: 1min HRV, 11.626; 26: 5min HRV, 18.159; 27: HR, 80.069; 27: RR, 19.241; 27: SpO2, 100.0; 27: Perf, 3.759; 27: 1min HRV, 11.552; 28: HR, 81.407; 28: RR, 21.831; 28: SpO2, 100.0; 28: Perf, 4.380; 28: 1min HRV, 42.345; 29: HR, 80.741; 29: RR, 23.379; 29: SpO2, 99.281; 29: Perf, 4.449; 29: 1min HRV, 15.668; 30: HR, 86.542; 30: RR, 24.441; 30: SpO2, 98.974; 30: Perf, 4.22; 30: 1min HRV, 10.281; 31: HR, 80.729; 31: RR, 22.153; 31: SpO2, 99.068; 31: Perf, 4.201; 31: 1min HRV, 41.651; 31: 5min HRV, 37.735; 32: HR, 77.362; 32: RR, 20.603; 32: SpO2, 98.741; 32: Perf, 4.049; 32: 1min HRV, 74.029; 33: HR, 78.610; 33: RR, 22.712; 33: SpO2, 99.0; 33: Perf, 3.340; 33: 1min HRV, 21.139; 34: HR, 79.241; 34: RR, 20.379; 34: SpO2, 99.793; 34: Perf, 2.175; 34: 1min HRV, 30.534; 35: HR, 77.492; 35: RR, 22.356; 35: SpO2, 100.0; 35: Perf, 1.999; 35: 1min HRV, 34.039; 36: HR, 78.0; 36: RR, 15.576; 36: SpO2, 100.0; 36: Perf, 2.634; 36: 1min HRV, 21.351; 36: 5min HRV, 41.722; 37: HR, 78.241; 37: RR, 23.914; 37: SpO2, 100.0; 37: Perf, 2.585; 37: 1min HRV, 27.046; 38: HR, 78.254; 38: RR, 23.542; 38: SpO2, 100.0; 38: Perf, 2.801; 38: 1min HRV, 22.826; 38: NS IV BOLUS -, 1000 ML; 39: HR:, 80.776; 39: RR, 20.483; 39: SpO2, 100.0; 39: Perf, 2.416; 39: 1min HRV, 23.835; 39: ACETAMINOPHEN, 500 MG PO TABS; 40: HR:, 82.458; 40: RR, 18.847; 40: SpO2, 100.0; 40: Perf, 1.982; 40: 1min HRV, 21.585; 41: HR, 83.915; 41: RR, 22.644; 41: SpO2, 99.203; 41: Perf, 1.928; 41: 1min HRV, 31.481; 41: 5min HRV, 34.632; 42: HR, 80.259; 42: RR, 25.103; 42: SpO2, 99.586; 42: Perf, 1.913; 42: 1min HRV, 22.326; 42: SBP, 127.0; 42: DBP, 98.0; 42: MAP, 107.667; 43: HR, 77.593; 43: RR, 25.203; 43: SpO2, 100.0; 43: Perf, 3.700; 43: 1min HRV, 23.540; 44: HR, 77.241; 44: RR, 23.707; 44: SpO2, 100.0; 44: Perf, 4.000; 44: 1min HRV, 17.694; 45: HR, 78.949; 45: RR, 19.847; 45: SpO2, 99.746; 45: Perf, 3.578; 45: 1min HRV, 71.802; 46: 5min HRV, 40.598; 54: WAM DIFTYP, AUTO; 54: MONOCYTE % (AUTO DIFF), 17.1 %; 54: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.40 K/uL; 54: PLATELET COUNT (PLT), 251 K/uL; 54: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 54: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.2 %; 54: HEMATOCRIT (HCT), 30.9 %; 54: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 54: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 54: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 54: LYMPHOCYTE % (AUTO DIFF), 36.6 %; 54: BASOPHIL % (AUTO DIFF), 1.8 %; 54: EOSINOPHIL % (AUTO DIFF), 0.6 %; 54: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.3 g/dL; 54: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 54: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 54: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 54: NEUTROPHIL % (AUTO DIFF), 42.7 %; 54: RED CELL DISTRIBUTION WIDTH (RDW), 16.8 %; 54: NRBC PERCENT (HEMATOLOGY), 0.0 %; 54: HEMOGLOBIN (HGB), 10.9 g/dL; 54: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 54: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.4 pg; 54: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 95: HR, 89.0; 95: RR, 20.0; 95: SpO2, 99.0; 95: SBP, 135.0; 95: DBP, 73.0; 95: MAP, 93.667; 95: GABAPENTIN, 600 MG PO TABS; 111: TROPONIN I: <., 017 ng/mL; 0: Age, 71; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 81.0; 0: Triage RR, 18.0; 0: Triage SBP, 121.0; 0: Triage DBP, 79.0; 0: Triage acuity, 3-Urgent; 0: CC, RAPID HEART RATE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the patient\u2019s vital signs, labs, and interventions to see if they suggested a high risk for sepsis. Although the heart rate occasionally trended higher and the respiratory rate sometimes approached tachypneic levels, measurements did not persistently indicate systemic instability. Additionally, the labs did not clearly demonstrate marked abnormalities consistent with severe infection (for instance, the WBC count is low but not definitively linked to an acute infectious process here). With no clear evidence of acute organ dysfunction or hemodynamic compromise, the overall risk of sepsis appears low.",
        "claims": [
            "I reviewed the patient\u2019s vital signs, labs, and interventions.",
            "The review aimed to assess the risk for sepsis.",
            "The heart rate occasionally trended higher.",
            "The respiratory rate sometimes approached tachypneic levels.",
            "Measurements did not persistently indicate systemic instability.",
            "The labs did not clearly demonstrate marked abnormalities consistent with severe infection.",
            "The WBC count is low.",
            "The low WBC count is not definitively linked to an acute infectious process.",
            "There is no clear evidence of acute organ dysfunction.",
            "There is no clear evidence of hemodynamic compromise.",
            "The overall risk of sepsis appears low."
        ],
        "relevant_claims": [
            "The heart rate occasionally trended higher.",
            "The respiratory rate sometimes approached tachypneic levels.",
            "Measurements did not persistently indicate systemic instability.",
            "The labs did not clearly demonstrate marked abnormalities consistent with severe infection.",
            "The low WBC count is not definitively linked to an acute infectious process.",
            "There is no clear evidence of acute organ dysfunction.",
            "There is no clear evidence of hemodynamic compromise."
        ],
        "alignment_scores": [
            0.5,
            0.3,
            0.3,
            0.3,
            0.5,
            0.7,
            0.2
        ],
        "alignment_category": [
            2,
            2,
            6,
            8,
            2,
            8,
            6
        ],
        "alignment_reasonings": [
            "The claim about a higher heart rate relates to the SIRS criteria, which includes a heart rate >90 bpm. However, the phrase \"occasionally trended higher\" does not specify if the heart rate consistently exceeded the threshold necessary for SIRS positivity. Therefore, the alignment is partial, reflecting some relevance to systemic inflammation assessment used in early sepsis prediction.",
            "While the claim mentions the respiratory rate approaching tachypneic levels, it does not provide specific values that reach the SIRS threshold (respiratory rate > 20/min). The mention of \"approaching tachypneic levels\" hints at potential systemic inflammation, but without clear data on criteria met, the alignment is loose and rated low.",
            "The claim references \"systemic instability,\" which can relate to hemodynamic measures such as the shock index indicating instability. However, as the claim mentions an absence of persistent systemic instability, the alignment is weak and not directly indicative of any specific single category, leading to a low alignment rating.",
            "The claim references a lack of marked abnormalities, which indirectly suggests there is no clear indication of new or worsening organ dysfunction commonly measured by the SOFA score. The alignment is weak, as nothing directly references the components measured by SOFA, but the statement somewhat aligns with a lack of organ dysfunction.",
            "A low white blood cell (WBC) count can be related to one of the SIRS criteria, which recognizes a WBC count of <4,000/\u00b5L as indicative of systemic inflammation or infection. However, the claim specifically states that the low WBC count is not definitively linked to an acute infectious process, suggesting some ambiguity in its relevance to sepsis risk. Hence, while the claim relates to SIRS, the lack of definitive association with an infection results in moderate alignment.",
            "The claim regarding \"no clear evidence of acute organ dysfunction\" most directly pertains to the SOFA Score, which is a measure used to assess organ dysfunction. The absence of evidence for acute organ dysfunction implies that there has not been an increase in the SOFA score, which would otherwise signal high sepsis risk. Therefore, this category aligns with the claim, although the alignment is regarding the absence of criteria rather than their presence, warranting a strong but not perfect alignment rating.",
            "Hemodynamic compromise might relate to the shock index, which denotes hemodynamic instability. Since the claim states there is no clear evidence of hemodynamic compromise, this suggests an absence of factors like an elevated shock index. The alignment is weak because the claim implies no risk rather than confirming any significant criterion directly related to hemodynamics or other listed categories."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "2: HR, 117.0; 2: RR, 18.0; 2: SpO2, 97.0; 2: SBP, 127.0; 2: DBP, 74.0; 2: MAP, 91.667; 2: Temp, 101.0; 11: Pain, 4.0; 25: RR, 18.0; 28: POC PH (V) ISTAT, 7.45; 28: POC BASE EXCESS ISTAT, 6 mmol/L; 28: POC PO2 (V) ISTAT, 20 mmHg; 28: POC O2 SATURATION ISTAT VENOUS, 33 %; 28: POC LACTATE ISTAT, 1.05 mmol/L; 28: POC HCO3 (V) ISTAT, 30.4 mmol/L; 28: POC PCO2 (V) ISTAT, 44.3 mmHg; 28: POC TCO2 (V) ISTAT, 32 mmol/L; 30: ACETAMINOPHEN, 500 MG PO TABS; 55: INR:, 1.0; 55: PROTHROMBIN TIME, 14.0 seconds; 56: PART. THROMBOPLASTIN TIME, 30.6 seconds; 61: SARS-COV-2 RNA, Not Detected; 72: HR, 109.543; 72: RR, 14.92; 72: 1min HRV, 10.910; 72: SBP, 125.0; 72: DBP, 77.0; 72: MAP, 93.0; 73: HR, 108.661; 73: RR, 20.322; 73: SpO2, 98.0; 73: 1min HRV, 9.919; 73: 5min HRV, 10.791; 73: SBP, 125.0; 73: DBP, 77.0; 73: MAP, 93.0; 73: Pain, 6.0; 73: Temp, 97.2; 74: HR, 109.780; 74: RR, 15.373; 74: 1min HRV, 9.975; 75: HR, 107.241; 75: RR, 18.914; 75: 1min HRV, 13.266; 76: HR, 105.356; 76: RR, 21.169; 76: 1min HRV, 8.440; 77: CREATININE, 0.89 mg/dL; 77: PROTEIN TOTAL, 8.4 g/dL; 77: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 77: AST (SGOT), 46 U/L; 77: CO2, 27 mmol/L; 77: ALT (SGPT), 31 U/L; 77: BILIRUBIN TOTAL, 0.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: CHLORIDE, 95 mmol/L; 77: POTASSIUM, 4.2 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 77: GLUCOSE, 112 mg/dL; 77: CALCIUM, 8.8 mg/dL; 77: GLOBULIN, 4.1 g/dL; 77: CORRECTED CALCIUM, 8.6 mg/dL; 77: SODIUM, 133 mmol/L; 77: ALBUMIN, 4.3 g/dL; 77: ALKALINE PHOSPHATASE, 73 U/L; 77: LIPASE, 27 U/L; 77: HR, 107.517; 77: RR, 19.690; 77: 1min HRV, 13.170; 78: HR, 104.915; 78: RR, 19.475; 78: 1min HRV, 7.905; 78: 5min HRV, 13.380; 79: HR, 106.678; 79: RR, 23.237; 79: 1min HRV, 10.356; 80: HR, 106.966; 80: RR, 19.397; 80: 1min HRV, 10.673; 81: HR, 107.102; 81: RR, 21.559; 81: 1min HRV, 22.506; 82: HR, 105.466; 82: RR, 19.345; 82: 1min HRV, 10.033; 83: HR, 105.288; 83: RR, 18.017; 83: 1min HRV, 16.411; 83: 5min HRV, 15.158; 84: HR, 104.847; 84: RR, 18.441; 84: 1min HRV, 15.242; 85: HR, 105.603; 85: RR, 12.879; 85: 1min HRV, 14.937; 86: HR, 103.780; 86: RR, 20.780; 86: 1min HRV, 11.609; 87: HR, 105.857; 87: RR, 17.079; 87: 1min HRV, 23.708; 88: HR, 106.169; 88: RR, 18.333; 88: 1min HRV, 11.407; 88: 5min HRV, 16.147; 89: HR, 104.897; 89: RR, 20.810; 89: 1min HRV, 18.039; 90: HR, 104.621; 90: RR, 15.621; 90: 1min HRV, 10.529; 91: HR, 105.695; 91: RR, 19.712; 91: 1min HRV, 22.887; 92: HR, 106.069; 92: RR, 21.328; 92: 1min HRV, 19.021; 93: HR, 104.0; 93: RR, 17.542; 93: 1min HRV, 7.265; 93: 5min HRV, 17.503; 94: HR, 102.845; 94: RR, 21.983; 94: 1min HRV, 10.541; 95: HR, 102.102; 95: RR, 21.593; 95: 1min HRV, 11.068; 96: HR, 104.576; 96: RR, 23.237; 96: 1min HRV, 11.313; 97: HR, 104.759; 97: RR, 21.138; 97: 1min HRV, 19.620; 98: HR, 102.559; 98: RR, 21.288; 98: 1min HRV, 11.768; 98: 5min HRV, 14.812; 99: HR, 103.246; 99: RR, 22.807; 99: 1min HRV, 22.341; 100: HEMATOCRIT (HCT), 43.7 %; 100: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.0 pg; 100: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 100: RED CELL DISTRIBUTION WIDTH (RDW), 10.9 %; 100: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 100: RED BLOOD CELLS (RBC), 4.80 MIL/uL; 100: MEAN CORPUSCULAR VOLUME (MCV), 91.0 fL; 100: PLATELET COUNT (PLT), 199 K/uL; 100: HEMOGLOBIN (HGB), 14.9 g/dL; 100: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 35.7 %; 100: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: EOSINOPHILS % (MANUAL DIFF), 0.9 %; 100: NEUTROPHILS BANDS % (MANUAL DIFF), 36.4 %; 100: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 5.08 K/uL; 100: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.73 K/uL; 100: BASOPHILS % (MANUAL DIFF), 0.9 %; 100: MONOCYTES % (MANUAL DIFF), 10.4 %; 100: LYMPHOCYTES VARIANT % (MANUAL DIFF), 0.9 %; 100: LYMPHOCYTES % (MANUAL DIFF), 14.8 %; 100: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.04 K/uL; 100: HR, 103.576; 100: RR, 20.627; 100: 1min HRV, 14.543; 101: HR, 102.746; 101: RR, 25.254; 101: 1min HRV, 13.129; 102: HR, 108.08; 102: RR, 20.714; 102: 1min HRV, 31.538; 103: HR, 105.153; 103: RR, 10.763; 103: 1min HRV, 17.801; 103: 5min HRV, 22.944; 104: HR, 101.862; 104: RR, 16.569; 104: 1min HRV, 9.539; 104: SBP, 122.0; 104: DBP, 83.0; 104: MAP, 96.0; 105: HR, 102.441; 105: RR, 18.356; 105: 1min HRV, 22.460; 106: HR, 100.254; 106: RR, 22.322; 106: 1min HRV, 10.142; 107: HR, 104.276; 107: RR, 26.655; 107: 1min HRV, 19.422; 108: HR, 99.552; 108: RR, 17.017; 108: 1min HRV, 14.436; 108: 5min HRV, 19.297; 109: HR, 100.879; 109: RR, 17.431; 109: 1min HRV, 18.475; 110: HR, 100.983; 110: RR, 15.661; 110: 1min HRV, 17.022; 111: HR, 102.424; 111: RR, 16.0; 111: 1min HRV, 21.414; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 101.5; 112: RR, 19.879; 112: 1min HRV, 23.754; 113: HR, 99.153; 113: RR, 18.525; 113: 1min HRV, 11.421; 113: 5min HRV, 19.897; 114: HR, 99.812; 114: RR, 16.667; 114: 1min HRV, 11.782; 118: 5min HRV, 11.782; 0: Age, 53; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I began by reviewing the patient\u2019s vital signs and laboratory results to look for red flags such as hypotension, elevated lactate, or severe leukocytosis. Although there is a mild fever and some tachycardia, the lactate and white blood cell count remain within normal limits, and there is no clear sign of acute organ dysfunction. These findings do not strongly suggest imminent sepsis risk. Therefore, based on the available data, the patient does not appear to be at high risk for developing sepsis within the next 12 hours.",
        "claims": [
            "I began by reviewing the patient\u2019s vital signs and laboratory results.",
            "I looked for red flags such as hypotension, elevated lactate, or severe leukocytosis.",
            "There is a mild fever in the patient.",
            "There is some tachycardia in the patient.",
            "The lactate level remains within normal limits.",
            "The white blood cell count remains within normal limits.",
            "There is no clear sign of acute organ dysfunction.",
            "These findings do not strongly suggest imminent sepsis risk.",
            "Based on the available data, the patient does not appear to be at high risk for developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There is some tachycardia in the patient."
        ],
        "alignment_scores": [
            0.8
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is directly mentioned as one of the SIRS criteria. Although the claim doesn't specify the heart rate to confirm it fully meets the criterion, the presence of tachycardia strongly suggests alignment with the SIRS criteria, indicating systemic inflammation consistent with early sepsis. Thus, the alignment is quite strong, though not perfect due to the lack of specific heart rate data."
        ],
        "final_alignment_score": 0.8,
        "accuracy": 1
    },
    {
        "input": "4: HR, 107.811; 4: RR, 20.453; 4: SpO2, 97.875; 4: 1min HRV, 98.468; 5: HR, 103.660; 5: RR, 17.604; 5: SpO2, 95.154; 5: 1min HRV, 130.891; 5: 5min HRV, 117.559; 5: SBP, 109.0; 5: DBP, 67.0; 5: MAP, 81.0; 5: Temp, 97.7; 6: HR, 103.808; 6: RR, 18.712; 6: SpO2, 94.0; 6: 1min HRV, 119.633; 7: HR, 101.774; 7: RR, 22.0; 7: SpO2, 94.0; 7: 1min HRV, 106.343; 8: HR, 102.558; 8: RR, 17.635; 8: SpO2, 98.775; 8: 1min HRV, 142.784; 9: HR, 106.604; 9: RR, 20.283; 9: SpO2, 98.818; 9: 1min HRV, 114.243; 10: HR, 110.170; 10: RR, 19.623; 10: SpO2, 97.115; 10: 1min HRV, 130.733; 10: 5min HRV, 125.114; 11: HR, 105.981; 11: RR, 21.327; 11: SpO2, 97.545; 11: 1min HRV, 110.793; 12: HR, 97.075; 12: RR, 18.962; 12: SpO2, 99.139; 12: 1min HRV, 154.971; 13: HR, 105.923; 13: RR, 19.308; 13: SpO2, 98.674; 13: 1min HRV, 121.821; 14: HR, 102.08; 14: RR, 23.057; 14: SpO2, 99.053; 14: Perf, 0.24; 14: 1min HRV, 127.983; 15: HR, 107.358; 15: RR, 19.962; 15: SpO2, 99.729; 15: Perf, 0.255; 15: 1min HRV, 142.063; 15: 5min HRV, 135.303; 16: HR, 105.404; 16: RR, 19.48; 16: SpO2, 99.654; 16: Perf, 0.268; 16: 1min HRV, 131.069; 16: SBP, 108.0; 16: DBP, 72.0; 16: MAP, 84.0; 17: HR, 102.113; 17: RR, 21.333; 17: SpO2, 99.5; 17: Perf, 0.287; 17: 1min HRV, 118.922; 18: HR, 107.404; 18: RR, 22.25; 18: SpO2, 99.25; 18: Perf, 0.292; 18: 1min HRV, 136.870; 19: HR, 105.396; 19: RR, 19.660; 19: SpO2, 99.020; 19: Perf, 0.297; 19: 1min HRV, 112.584; 20: HR, 104.755; 20: RR, 18.279; 20: SpO2, 99.06; 20: Perf, 0.268; 20: 1min HRV, 145.764; 20: 5min HRV, 130.300; 21: HR, 105.942; 21: RR, 22.827; 21: SpO2, 99.913; 21: Perf, 0.25; 21: 1min HRV, 160.123; 22: HR, 107.887; 22: RR, 24.566; 22: SpO2, 99.0; 22: Perf, 0.25; 22: 1min HRV, 97.245; 23: HR, 107.404; 23: RR, 18.673; 23: Perf, 0.25; 23: 1min HRV, 100.277; 24: HR, 107.16; 24: RR, 22.472; 24: Perf, 0.25; 24: 1min HRV, 50.432; 25: HR, 109.396; 25: RR, 19.453; 25: SpO2, 98.679; 25: 1min HRV, 151.744; 25: 5min HRV, 130.502; 26: HR, 98.442; 26: RR, 18.8; 26: SpO2, 98.312; 26: 1min HRV, 145.506; 27: HR, 104.396; 27: RR, 18.717; 27: SpO2, 96.943; 27: Perf, 0.498; 27: 1min HRV, 123.708; 28: HR, 104.385; 28: RR, 23.7; 28: SpO2, 98.282; 28: Perf, 0.492; 28: 1min HRV, 128.235; 29: HR, 104.660; 29: RR, 17.019; 29: SpO2, 98.0; 29: Perf, 0.49; 29: 1min HRV, 135.629; 30: HR, 107.936; 30: RR, 26.5; 30: SpO2, 97.933; 30: Perf, 0.481; 30: 1min HRV, 148.137; 30: 5min HRV, 137.295; 31: HR, 102.453; 31: RR, 19.388; 31: SpO2, 97.849; 31: Perf, 0.506; 31: 1min HRV, 146.413; 31: SBP, 107.0; 31: DBP, 76.0; 31: MAP, 86.333; 32: HR, 106.038; 32: RR, 19.491; 32: SpO2, 97.226; 32: Perf, 0.482; 32: 1min HRV, 113.776; 33: HR, 101.851; 33: RR, 21.538; 33: SpO2, 99.419; 33: Perf, 0.433; 33: 1min HRV, 146.124; 34: HR, 107.151; 34: RR, 17.962; 34: SpO2, 98.293; 34: Perf, 0.418; 34: 1min HRV, 115.549; 35: HR, 106.904; 35: RR, 18.519; 35: SpO2, 98.0; 35: Perf, 0.41; 35: 1min HRV, 112.346; 35: 5min HRV, 126.538; 36: HR, 100.914; 36: RR, 22.019; 36: Perf, 0.41; 36: 1min HRV, 61.116; 37: HR, 108.041; 37: RR, 15.395; 37: Perf, 0.41; 37: 1min HRV, 132.412; 38: HR, 105.7; 38: RR, 21.02; 38: SpO2, 98.682; 38: Perf, 0.412; 38: 1min HRV, 134.087; 39: HR, 103.717; 39: RR, 19.906; 39: SpO2, 97.769; 39: Perf, 0.465; 39: 1min HRV, 134.831; 40: HR, 98.962; 40: RR, 19.744; 40: SpO2, 98.636; 40: Perf, 0.478; 40: 1min HRV, 183.842; 40: 5min HRV, 150.445; 41: WAM DIFTYP, AUTO; 41: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 41: NRBC PERCENT (HEMATOLOGY), 0.0 %; 41: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 41: BASOPHIL % (AUTO DIFF), 0.1 %; 41: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 41: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 41: PLATELET COUNT (PLT), 195 K/uL; 41: HEMOGLOBIN (HGB), 11.5 g/dL; 41: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 41: WHITE BLOOD CELLS (WBC), 16.4 K/uL; 41: NEUTROPHIL % (AUTO DIFF), 87.1 %; 41: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.27 K/uL; 41: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 41: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.6 g/dL; 41: HEMATOCRIT (HCT), 37.6 %; 41: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 41: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 41: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 41: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 41: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 41: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 41: EOSINOPHIL % (AUTO DIFF), 0.1 %; 41: MONOCYTE % (AUTO DIFF), 4.6 %; 41: HR, 103.824; 41: RR, 19.275; 41: SpO2, 96.981; 41: Perf, 0.493; 41: 1min HRV, 149.126; 45: 5min HRV, 149.126; 68: ALT (SGPT), 63 U/L; 68: BLOOD UREA NITROGEN (BUN), 31 mg/dL; 68: CO2, 21 mmol/L; 68: PROTEIN TOTAL, 6.4 g/dL; 68: CHLORIDE, 106 mmol/L; 68: ALKALINE PHOSPHATASE, 107 U/L; 68: ANION GAP, 12 mmol/L; 68: EGFR FOR AFRICAN AMERICAN, 62 mL/min/1.73 m2; 68: AST (SGOT), 82 U/L; 68: BILIRUBIN TOTAL, 0.4 mg/dL; 68: SODIUM, 139 mmol/L; 68: GLUCOSE, 239 mg/dL; 68: POTASSIUM, 4.3 mmol/L; 68: CORRECTED CALCIUM, 10.5 mg/dL; 68: EGFR REFIT WITHOUT RACE (2021), 54 mL/min/1.73 m2; 68: CREATININE, 0.88 mg/dL; 68: GLOBULIN, 3.2 g/dL; 68: CALCIUM, 9.9 mg/dL; 68: ALBUMIN, 3.2 g/dL; 89: SARS-COV-2 RNA, Not Detected; 91: LIPASE, 25 U/L; 91: BNP NT-PRO, 28823 pg/mL; 107: TROPONIN I, 0.665 ng/mL; 107: TROPONIN I, 0.665 ng/mL; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 13.0; 0: Triage SBP, 109.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE,IRREGULAR HEART BEAT,ARM SWELLING",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noted signs of a possible infection in an elderly patient with significant leukocytosis, elevated heart rate, and borderline low blood pressures. These findings align with common sepsis criteria. Given the clinical picture and risk factors, the likelihood of developing sepsis within 12 hours appears high.",
        "claims": [
            "Signs of a possible infection were noted in an elderly patient.",
            "The patient has significant leukocytosis.",
            "The patient has an elevated heart rate.",
            "The patient has borderline low blood pressures.",
            "These findings align with common sepsis criteria.",
            "The clinical picture and risk factors suggest a high likelihood of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Signs of a possible infection were noted in an elderly patient.",
            "The patient has significant leukocytosis.",
            "The patient has an elevated heart rate.",
            "The patient has borderline low blood pressures.",
            "These findings align with common sepsis criteria.",
            "The clinical picture and risk factors suggest a high likelihood of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            1.0,
            0.7,
            0.7,
            0.3,
            0.7
        ],
        "alignment_category": [
            1,
            2,
            2,
            7,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions both a possible infection and that the patient is elderly. While it doesn't specify the patient's exact age, it suggests that the patient is in the higher age risk category. The main focus on elderly susceptibility aligns well with category 1, though it lacks explicit detail on the age threshold, hence the high, but not perfect, alignment rating.",
            "Leukocytosis, or an elevated white blood cell count, is explicitly mentioned as one of the Systemic Inflammatory Response Syndrome (SIRS) criteria. This criterion helps identify systemic inflammation consistent with early sepsis, which makes the claim directly relevant and perfectly aligned with this category.",
            "The claim about an elevated heart rate aligns with the SIRS criteria, where a heart rate >90 bpm indicates systemic inflammation consistent with early sepsis. However, because the claim does not specify the exact heart rate or mention other accompanying SIRS criteria, the alignment is moderate rather than full.",
            "The claim of \"borderline low blood pressures\" suggests a potential concern for hypotension, which aligns with the sepsis category that focuses on blood pressure criteria. However, without specific values indicating severe hypotension (SBP <90 mmHg, MAP <70 mmHg, or a \u226540 mmHg drop), the alignment is not perfect, resulting in a 0.7 rating due to indirect relevance.",
            "The claim broadly references alignment with \"common sepsis criteria,\" which is often associated with initial sepsis identification methods like the SIRS criteria. However, without specific details or explicit criteria being mentioned, the claim's alignment with any particular expert category remains vague and tenuous, warranting a low alignment rating.",
            "The claim suggests a clinical assessment of potential deterioration relevant to predicting sepsis, which aligns with the purpose of a NEWS score. The lack of specific vital derangements mentioned in the claim reduces alignment strength slightly. However, it's indicative of an overall assessment capturing multiple risk factors, much like a NEWS score, which predicts imminent clinical deterioration."
        ],
        "final_alignment_score": 0.7000000000000001,
        "accuracy": 1
    },
    {
        "input": "8: Pain, 7.0; 27: HR, 120.0; 27: RR, 22.0; 27: SpO2, 95.0; 27: SBP, 81.0; 27: DBP, 55.0; 27: MAP, 63.667; 27: LPM O2, 3.0; 27: Temp, 98.1; 56: POC, HCG, ISTAT QUALITATIVE: Negative; 56: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 65: SpO2, 87.3; 65: SBP, 88.0; 65: DBP, 64.0; 65: MAP, 72.0; 66: SpO2, 86.370; 66: SBP, 94.0; 66: DBP, 62.0; 66: MAP, 72.667; 67: SpO2, 92.661; 67: Perf, 0.203; 68: HR, 118.385; 68: RR, 15.385; 68: SpO2, 94.729; 68: Perf, 0.220; 68: 1min HRV, 64.080; 69: HR, 117.793; 69: RR, 22.241; 69: SpO2, 95.897; 69: Perf, 0.259; 69: 1min HRV, 9.480; 69: SBP, 94.0; 69: DBP, 62.0; 69: MAP, 72.667; 69: LPM O2, 4.0; 69: Temp, 98.3; 70: HR, 117.559; 70: RR, 24.136; 70: SpO2, 96.492; 70: Perf, 0.284; 70: 1min HRV, 10.843; 70: 5min HRV, 30.738; 71: HR, 116.224; 71: RR, 27.121; 71: SpO2, 97.017; 71: Perf, 0.290; 71: 1min HRV, 14.608; 72: HR, 114.831; 72: RR, 30.288; 72: SpO2, 97.966; 72: Perf, 0.360; 72: 1min HRV, 4.378; 73: HR, 116.862; 73: RR, 27.328; 73: SpO2, 97.0; 73: Perf, 0.743; 73: 1min HRV, 5.068; 74: HR, 117.119; 74: RR, 22.373; 74: SpO2, 96.746; 74: Perf, 0.788; 74: 1min HRV, 9.255; 75: HR, 117.373; 75: RR, 23.390; 75: SpO2, 96.3; 75: Perf, 0.743; 75: 1min HRV, 16.879; 75: 5min HRV, 11.855; 76: HR, 117.175; 76: RR, 25.877; 76: SpO2, 96.035; 76: Perf, 0.527; 76: 1min HRV, 4.554; 77: HR, 117.167; 77: RR, 22.95; 77: SpO2, 96.417; 77: Perf, 0.435; 77: 1min HRV, 7.411; 78: HR, 117.983; 78: RR, 23.345; 78: SpO2, 97.534; 78: Perf, 0.455; 78: 1min HRV, 8.065; 79: HR, 118.559; 79: RR, 18.492; 79: SpO2, 97.610; 79: Perf, 0.357; 79: 1min HRV, 1.958; 80: HR, 119.051; 80: RR, 19.610; 80: SpO2, 97.508; 80: Perf, 0.352; 80: 1min HRV, 2.552; 80: 5min HRV, 6.305; 80: SBP, 93.0; 80: DBP, 64.0; 80: MAP, 73.667; 80: LPM O2, 4.0; 81: HR, 118.448; 81: RR, 22.879; 81: SpO2, 96.759; 81: Perf, 0.407; 81: 1min HRV, 5.158; 81: SBP, 93.0; 81: DBP, 64.0; 81: MAP, 73.667; 82: HR, 117.492; 82: RR, 24.661; 82: SpO2, 96.712; 82: Perf, 0.428; 82: 1min HRV, 11.514; 83: HR, 115.707; 83: RR, 28.534; 83: SpO2, 96.966; 83: Perf, 0.454; 83: 1min HRV, 2.751; 84: HR, 115.661; 84: RR, 26.186; 84: SpO2, 97.797; 84: Perf, 0.500; 84: 1min HRV, 20.359; 85: PART. THROMBOPLASTIN TIME, 31.0 seconds; 85: HR, 115.559; 85: RR, 29.542; 85: SpO2, 96.966; 85: Perf, 0.760; 85: 1min HRV, 4.553; 85: 5min HRV, 11.994; 86: HR, 115.690; 86: RR, 27.034; 86: SpO2, 96.414; 86: Perf, 0.943; 86: 1min HRV, 2.962; 87: HR, 116.339; 87: RR, 26.288; 87: SpO2, 96.0; 87: Perf, 1.029; 87: 1min HRV, 4.366; 88: HR, 116.362; 88: RR, 23.948; 88: SpO2, 96.448; 88: Perf, 0.671; 88: 1min HRV, 4.347; 89: HR, 116.237; 89: RR, 24.593; 89: SpO2, 97.610; 89: Perf, 0.564; 89: 1min HRV, 8.873; 90: HR, 116.915; 90: RR, 25.898; 90: SpO2, 97.169; 90: Perf, 0.406; 90: 1min HRV, 5.612; 90: 5min HRV, 6.027; 91: HR, 116.603; 91: RR, 22.534; 91: SpO2, 96.862; 91: Perf, 0.308; 91: 1min HRV, 8.173; 92: HR, 115.4; 92: RR, 25.944; 92: SpO2, 97.702; 92: Perf, 0.309; 92: 1min HRV, 2.095; 93: POC PH (V) ISTAT, 7.32; 93: POC O2 SATURATION ISTAT VENOUS, 76 %; 93: POC HCO3 (V) ISTAT, 10.5 mmol/L; 93: POC LACTATE ISTAT, 0.73 mmol/L; 93: POC PCO2 (V) ISTAT, 20.6 mmHg; 93: POC BASE EXCESS ISTAT, -16 mmol/L; 93: POC TCO2 (V) ISTAT, 11 mmol/L; 93: POC PO2 (V) ISTAT, 43 mmHg; 95: 5min HRV, 7.487; 96: INR, 1.4; 96: PROTHROMBIN TIME, 16.8 seconds; 102: BILIRUBIN TOTAL, 1.0 mg/dL; 102: GLUCOSE, 105 mg/dL; 102: CREATININE, 2.37 mg/dL; 102: POTASSIUM, 5.5 mmol/L; 102: ALKALINE PHOSPHATASE, 99 U/L; 102: AST (SGOT), 95 U/L; 102: GLOBULIN, 4.4 g/dL; 102: BLOOD UREA NITROGEN (BUN), 41 mg/dL; 102: CHLORIDE, 105 mmol/L; 102: EGFR REFIT WITHOUT RACE (2021), 27 mL/min/1.73 m2; 102: CORRECTED CALCIUM, 9.3 mg/dL; 102: ALBUMIN, 3.5 g/dL; 102: SODIUM, 131 mmol/L; 102: ALT (SGPT), 395 U/L; 102: PROTEIN TOTAL, 7.9 g/dL; 102: CO2, 12 mmol/L; 102: CALCIUM, 8.9 mg/dL; 102: ANION GAP, 14 mmol/L; 102: BNP NT-PRO, 16041 pg/mL; 106: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 106: HEMOGLOBIN (HGB), 10.4 g/dL; 106: RED BLOOD CELLS (RBC), 4.59 MIL/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 19.9 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 75.4 fL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: WHITE BLOOD CELLS (WBC), 11.4 K/uL; 106: PLATELET COUNT (PLT), 292 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 22.7 pg; 106: HEMATOCRIT (HCT), 34.6 %; 106: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 9.25 K/uL; 106: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 106: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 106: LYMPHOCYTES VARIANT % (MANUAL DIFF), 1.0 %; 106: NEUTROPHILS BANDS % (MANUAL DIFF), 3.0 %; 106: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.26 K/uL; 106: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.69 K/uL; 106: LYMPHOCYTES % (MANUAL DIFF), 11.0 %; 106: EOSINOPHILS % (MANUAL DIFF), 1.0 %; 106: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 106: MONOCYTES % (MANUAL DIFF), 6.0 %; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 0: Age:, 32; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 120.0; 0: Triage RR, 22.0; 0: Triage SBP, 81.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The patient presents with persistent hypotension, tachycardia, and metabolic abnormalities that suggest organ dysfunction. These findings, alongside her symptoms and abnormal laboratory results, raise significant concern for a developing infectious process. Thus, she appears to be at high risk of progressing to sepsis within the next 12 hours.",
        "claims": [
            "The patient presents with persistent hypotension.",
            "The patient presents with tachycardia.",
            "The patient presents with metabolic abnormalities.",
            "The metabolic abnormalities suggest organ dysfunction.",
            "The findings raise significant concern for a developing infectious process.",
            "The patient's symptoms raise significant concern for a developing infectious process.",
            "The patient's abnormal laboratory results raise significant concern for a developing infectious process.",
            "The patient appears to be at high risk of progressing to sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient presents with persistent hypotension.",
            "The patient presents with tachycardia.",
            "The patient presents with metabolic abnormalities.",
            "The metabolic abnormalities suggest organ dysfunction.",
            "The findings raise significant concern for a developing infectious process.",
            "The patient's symptoms raise significant concern for a developing infectious process.",
            "The patient's abnormal laboratory results raise significant concern for a developing infectious process.",
            "The patient appears to be at high risk of progressing to sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.8,
            0.5,
            0.7,
            0.5,
            0.4,
            0.6,
            0.3
        ],
        "alignment_category": [
            7,
            2,
            8,
            8,
            9,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim directly mentions \"persistent hypotension,\" which strongly aligns with the criteria for sepsis-associated hypotension, as this condition indicates progression toward septic shock. While the exact values for SBP or MAP are not provided, the persistent nature of the hypotension suggests a strong association with this category, hence the high alignment rating.",
            "Tachycardia (heart rate >90 bpm) is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The claim directly mentions tachycardia, aligning well with the SIRS criteria, though a complete SIRS diagnosis requires the presence of two or more criteria. The alignment rating reflects the relevance of one specific aspect of SIRS.",
            "Metabolic abnormalities can indirectly relate to several SOFA components, such as bilirubin, creatinine, and PaO\u2082/FiO\u2082 ratios, which reflect organ dysfunction. While the claim is non-specific, it signifies potential organ impairment consistent with a rising SOFA score. However, without specifics on which metabolic parameters are deranged, the alignment remains moderate.",
            "Metabolic abnormalities often imply organ dysfunction, which aligns conceptually with the criteria for a SOFA score increase (e.g., changes in bilirubin levels, creatinine, etc.). Although the claim does not refer to specific SOFA components, it aligns with the general idea of identifying new organ dysfunction, which is linked to high sepsis risk. The alignment is strong but indirect due to the lack of specific organ markers mentioned.",
            "The claim reflects a general suspicion of an infectious process, which aligns with the need for early diagnostic and therapeutic actions that category 9 addresses (i.e., ordering antibiotics or blood cultures). However, the claim lacks specificity regarding concrete clinical actions, such as administering antibiotics or obtaining cultures, which would make the alignment stronger.",
            "The claim indicates a suspicion of an infectious process, which relates conceptually to the need for early action, such as ordering antibiotics or cultures. However, it does not explicitly mention any immediate clinical actions being taken (e.g., ordering antibiotics or cultures within 2 hours), leading to a moderate alignment.",
            "The claim indicates a significant concern for a developing infectious process based on laboratory results, suggesting clinical suspicion of an infection. This aligns with the category of early actions taken when there is a suspicion of serious infection. However, the claim lacks specific reference to actions like antibiotic administration or blood culture draws, so the alignment is partial rather than complete.",
            "The claim is very general and does not provide specific clinical markers of sepsis risk. The phrase \"high risk of progressing to sepsis\" is more closely aligned with the idea of predicting imminent clinical deterioration, as indicated by an elevated NEWS score. However, without specific scoring data or vitals provided in the claim, the alignment is weak and more conceptual, resulting in a lower rating."
        ],
        "final_alignment_score": 0.5875,
        "accuracy": 1
    },
    {
        "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 149.0; 4: DBP, 80.0; 4: MAP, 103.0; 4: Temp, 98.1; 5: Pain, 10.0; 35: SBP, 156.0; 35: DBP, 95.0; 35: MAP, 115.333; 36: SpO2, 96.429; 37: SpO2, 97.121; 37: Perf, 7.669; 38: SpO2, 97.576; 38: Perf, 8.638; 39: SpO2, 97.0; 39: Perf, 9.328; 40: SpO2, 97.0; 40: Perf, 9.307; 41: SpO2, 97.0; 41: Perf, 8.818; 42: SpO2, 97.0; 42: Perf, 8.903; 43: SpO2, 97.153; 43: Perf, 8.949; 44: SpO2, 96.810; 44: Perf, 8.050; 44: SBP, 148.0; 44: DBP, 87.0; 44: MAP, 107.333; 45: SpO2, 97.220; 45: Perf, 6.380; 46: SpO2, 97.898; 46: Perf, 4.710; 47: SpO2, 97.759; 47: Perf, 5.927; 48: SpO2, 97.186; 48: Perf, 5.645; 49: SpO2, 97.672; 49: Perf, 6.817; 50: SpO2, 98.237; 50: Perf, 7.622; 51: SpO2, 98.051; 51: Perf, 6.411; 52: SpO2, 97.534; 52: Perf, 6.707; 53: SpO2, 97.305; 53: Perf, 6.303; 54: SpO2, 97.776; 54: Perf, 5.712; 55: SpO2, 97.305; 55: Perf, 6.576; 56: SpO2, 97.237; 56: Perf, 7.164; 57: SpO2, 97.724; 57: Perf, 6.803; 58: SpO2, 98.407; 58: Perf, 6.343; 59: SpO2, 97.913; 59: Perf, 7.230; 60: SpO2, 97.667; 60: Perf, 6.017; 61: SpO2, 98.0; 61: Perf, 6.329; 62: SpO2, 98.0; 62: Perf, 5.887; 63: SpO2, 98.169; 63: Perf, 4.860; 64: SpO2, 98.0; 64: Perf, 4.885; 65: SpO2, 98.390; 65: Perf, 4.871; 66: SARS-COV-2 RNA, Not Detected; 66: SpO2, 97.914; 66: Perf, 3.335; 67: SpO2, 97.729; 67: Perf, 4.893; 68: SpO2, 97.847; 68: Perf, 4.188; 69: SpO2, 98.155; 69: Perf, 3.854; 70: SpO2, 97.661; 70: Perf, 4.066; 71: SpO2, 98.0; 71: Perf, 3.812; 72: SpO2, 98.0; 72: Perf, 3.116; 73: SpO2, 97.814; 73: Perf, 3.468; 74: SpO2, 97.310; 74: Perf, 4.189; 75: SpO2, 97.881; 75: Perf, 4.555; 76: SpO2, 97.810; 76: Perf, 4.746; 77: SpO2, 97.576; 77: Perf, 4.867; 78: SpO2, 97.763; 78: Perf, 5.017; 79: SpO2, 98.0; 79: Perf, 3.619; 80: WAM DIFTYP, AUTO; 80: RED BLOOD CELLS (RBC), 3.98 MIL/uL; 80: HEMATOCRIT (HCT), 37.6 %; 80: PLATELET COUNT (PLT), 330 K/uL; 80: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 80: NRBC PERCENT (HEMATOLOGY), 0.0 %; 80: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 80: MONOCYTE % (AUTO DIFF), 7.6 %; 80: NEUTROPHIL % (AUTO DIFF), 75.6 %; 80: EOSINOPHIL % (AUTO DIFF), 1.7 %; 80: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 80: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 80: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.91 K/uL; 80: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 80: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.4 pg; 80: BASOPHIL % (AUTO DIFF), 0.6 %; 80: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 80: MEAN CORPUSCULAR VOLUME (MCV), 94.5 fL; 80: HEMOGLOBIN (HGB), 12.5 g/dL; 80: LYMPHOCYTE % (AUTO DIFF), 14.3 %; 80: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 80: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 80: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 80: RED CELL DISTRIBUTION WIDTH (RDW), 13.1 %; 80: SpO2, 98.0; 80: Perf, 5.174; 81: SpO2, 98.0; 81: Perf, 5.211; 82: SpO2, 98.0; 82: Perf, 5.194; 83: SpO2, 98.0; 83: Perf, 5.017; 84: SpO2, 97.983; 84: Perf, 5.164; 85: SpO2, 97.373; 85: Perf, 5.423; 86: SpO2, 97.448; 86: Perf, 5.285; 87: SpO2, 98.203; 87: Perf, 4.216; 88: SpO2, 98.0; 88: Perf, 4.705; 89: SpO2, 98.0; 89: Perf, 4.904; 90: INR, 1.0; 90: PROTHROMBIN TIME, 13.6 seconds; 90: SpO2, 97.797; 90: Perf, 4.908; 91: PART. THROMBOPLASTIN TIME, 34.5 seconds; 91: SpO2, 97.966; 91: Perf, 5.132; 92: SpO2, 97.759; 92: Perf, 4.758; 93: SpO2, 97.0; 93: Perf, 4.934; 94: SpO2, 97.220; 94: Perf, 4.892; 95: SpO2, 97.305; 95: Perf, 5.384; 96: SpO2, 97.241; 96: Perf, 4.886; 97: SpO2, 97.492; 97: Perf, 4.839; 98: SpO2, 97.310; 98: Perf, 4.930; 99: SpO2, 97.102; 99: Perf, 4.921; 100: SpO2, 97.254; 100: Perf, 4.941; 101: SpO2, 98.0; 101: Perf, 4.536; 102: HR, 64.0; 102: SpO2, 97.373; 102: Perf, 4.608; 102: SBP, 180.0; 102: DBP, 75.0; 102: MAP, 110.0; 103: SpO2, 97.931; 103: Perf, 4.404; 104: CHLORIDE, 100 mmol/L; 104: AST (SGOT), 18 U/L; 104: PROTEIN TOTAL, 6.9 g/dL; 104: ALBUMIN, 4.2 g/dL; 104: SODIUM, 137 mmol/L; 104: GLOBULIN, 2.7 g/dL; 104: CALCIUM, 9.0 mg/dL; 104: ALT (SGPT), 10 U/L; 104: EGFR REFIT WITHOUT RACE (2021), 83 mL/min/1.73 m2; 104: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 104: GLUCOSE, 118 mg/dL; 104: BILIRUBIN TOTAL, 0.3 mg/dL; 104: CREATININE, 0.66 mg/dL; 104: CORRECTED CALCIUM, 8.8 mg/dL; 104: ALKALINE PHOSPHATASE, 68 U/L; 104: ANION GAP, 10 mmol/L; 104: POTASSIUM, 4.3 mmol/L; 104: CO2, 27 mmol/L; 104: SpO2, 97.214; 104: Perf, 4.583; 104: SBP, 180.0; 104: DBP, 75.0; 104: MAP, 110.0; 105: SpO2, 97.138; 105: Perf, 3.575; 106: SpO2, 98.0; 106: Perf, 4.002; 107: SpO2, 97.407; 107: Perf, 4.150; 108: SpO2, 97.948; 108: Perf, 4.002; 109: SpO2, 97.373; 109: Perf, 4.398; 110: SpO2, 97.458; 110: Perf, 4.330; 111: SpO2, 97.707; 111: Perf, 4.44; 112: SpO2, 97.475; 112: Perf, 4.413; 113: SpO2, 97.121; 113: Perf, 4.282; 114: SpO2, 97.102; 114: Perf, 4.464; 115: SpO2, 97.136; 115: Perf, 4.567; 116: SpO2, 97.586; 116: Perf, 4.080; 117: SpO2, 98.441; 117: Perf, 3.871; 118: SpO2, 98.207; 118: Perf, 4.447; 119: SpO2, 97.932; 119: Perf, 4.550; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 80.0; 0: Triage acuity, 3-Urgent; 0: CC, HEMORRHOIDS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the patient\u2019s vital signs, which remain mostly normal without tachycardia or hypotension. The laboratory tests, including WBC and other markers, do not suggest a significant infection or inflammatory issue. In addition, there is no indication of systemic organ dysfunction or hemodynamic instability at this time. Therefore, the patient does not appear to be at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient\u2019s vital signs remain mostly normal.",
            "The patient does not exhibit tachycardia.",
            "The patient does not exhibit hypotension.",
            "The laboratory tests, including WBC and other markers, do not suggest a significant infection.",
            "The laboratory tests do not suggest an inflammatory issue.",
            "There is no indication of systemic organ dysfunction at this time.",
            "There is no indication of hemodynamic instability at this time.",
            "The patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient does not exhibit hypotension.",
            "The laboratory tests, including WBC and other markers, do not suggest a significant infection.",
            "There is no indication of systemic organ dysfunction at this time."
        ],
        "alignment_scores": [
            0.4,
            0.3,
            0.7
        ],
        "alignment_category": [
            7,
            2,
            8
        ],
        "alignment_reasonings": [
            "The claim directly addresses the absence of a key criterion within the \"Sepsis-Associated Hypotension\" category. While \"no hypotension\" suggests low risk because it is the opposite of what would indicate sepsis risk in this category, it still highlights an aspect crucial to this category's assessment. Thus, there's partial alignment in considering absence of hypotensive measures as supporting a low-risk prediction.",
            "The claim references laboratory tests like WBC, which are part of the SIRS criteria for identifying systemic inflammation and early sepsis. However, the claim states that these tests do not indicate a significant infection, which suggests only a marginal connection to the SIRS Positivity criteria, as it does not meet the necessary thresholds. Thus, the alignment is weak.",
            "The claim mentions \"no indication of systemic organ dysfunction,\" which is most closely related to the SOFA score, as a SOFA score increase indicates new organ dysfunction. The absence of organ dysfunction suggests the lack of criteria for an increase in the SOFA score. The alignment is not direct, as the claim states what is not present rather than what is, but the concept of organ dysfunction is central to the SOFA score, justifying a relatively high alignment rating."
        ],
        "final_alignment_score": 0.4666666666666666,
        "accuracy": 1
    },
    {
        "input": "16: Pain, 0.0; 18: HR, 117.0; 18: RR, 16.0; 18: SpO2, 100.0; 18: SBP, 103.0; 18: DBP, 74.0; 18: MAP, 83.667; 18: LPM O2, 2.0; 18: Temp, 97.7; 67: POC PH (V) ISTAT, 7.33; 67: POC PCO2 (V) ISTAT, 61.8 mmHg; 67: POC HCO3 (V) ISTAT, 32.6 mmol/L; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 20 %; 67: POC TCO2 (V) ISTAT, 34 mmol/L; 67: POC PO2 (V) ISTAT, 17 mmHg; 67: POC LACTATE ISTAT, 2.77 mmol/L; 71: SpO2, 100.0; 71: Perf, 0.388; 72: HR, 114.091; 72: RR, 27.833; 72: SpO2, 100.0; 72: Perf, 0.453; 72: 1min HRV, 5.252; 72: SBP, 116.0; 72: DBP, 90.0; 72: MAP, 98.667; 72: LPM O2, 2.0; 73: HR, 113.862; 73: RR, 27.0; 73: SpO2, 99.943; 73: Perf, 0.43; 73: 1min HRV, 4.683; 74: HR, 114.983; 74: RR, 26.542; 74: SpO2, 100.0; 74: Perf, 0.382; 74: 1min HRV, 6.631; 75: HR, 115.356; 75: RR, 25.407; 75: SpO2, 100.0; 75: Perf, 0.301; 75: 1min HRV, 2.988; 76: HR, 115.224; 76: RR, 25.172; 76: SpO2, 100.0; 76: Perf, 0.226; 76: 1min HRV, 3.239; 76: 5min HRV, 5.415; 76: SBP, nan; 76: DBP, nan; 76: MAP, nan; 77: HR, 115.627; 77: RR, 25.254; 77: SpO2, 100.0; 77: Perf, 0.193; 77: 1min HRV, 8.700; 78: HR, 115.305; 78: RR, 27.966; 78: SpO2, 100.0; 78: Perf, 0.199; 78: 1min HRV, 5.428; 79: HR, 121.586; 79: RR, 29.397; 79: SpO2, 100.0; 79: 1min HRV, 6.808; 80: HR, 126.0; 80: RR, 33.339; 80: SpO2, 100.0; 80: Perf, 0.239; 80: 1min HRV, 11.828; 81: HR, 121.310; 81: RR, 27.914; 81: SpO2, 100.0; 81: Perf, 0.251; 81: 1min HRV, 11.118; 81: 5min HRV, 19.998; 82: HR, 117.305; 82: RR, 28.763; 82: SpO2, 100.0; 82: Perf, 0.367; 82: 1min HRV, 9.659; 83: HR, 117.017; 83: RR, 26.627; 83: SpO2, 99.915; 83: Perf, 0.396; 83: 1min HRV, 5.729; 84: HR, 116.534; 84: RR, 25.293; 84: SpO2, 99.674; 84: Perf, 0.363; 84: 1min HRV, 6.921; 85: HR, 116.833; 85: RR, 29.647; 85: SpO2, 99.085; 85: 1min HRV, 9.961; 86: HR, 116.741; 86: RR, 27.552; 86: SpO2, 100.0; 86: Perf, 0.321; 86: 1min HRV, 4.353; 86: 5min HRV, 7.542; 87: HR, 114.610; 87: RR, 23.576; 87: SpO2, 100.0; 87: Perf, 0.332; 87: 1min HRV, 7.569; 88: HR, 114.831; 88: RR, 25.373; 88: SpO2, 100.0; 88: Perf, 0.202; 88: 1min HRV, 13.931; 89: HR, 117.069; 89: RR, 30.741; 89: SpO2, 100.0; 89: Perf, 0.278; 89: 1min HRV, 16.662; 90: WAM DIFTYP, AUTO; 90: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 90: LYMPHOCYTE % (AUTO DIFF), 19.4 %; 90: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 90: MONOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 90: EOSINOPHIL % (AUTO DIFF), 1.2 %; 90: RED CELL DISTRIBUTION WIDTH (RDW), 18.2 %; 90: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.82 K/uL; 90: NEUTROPHIL % (AUTO DIFF), 70.8 %; 90: MONOCYTE % (AUTO DIFF), 7.6 %; 90: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 90: NRBC PERCENT (HEMATOLOGY), 0.0 %; 90: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.20 K/uL; 90: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.6 pg; 90: HEMATOCRIT (HCT), 44.7 %; 90: PLATELET COUNT (PLT), 472 K/uL; 90: MEAN CORPUSCULAR VOLUME (MCV), 84.3 fL; 90: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.23 K/uL; 90: WHITE BLOOD CELLS (WBC), 16.7 K/uL; 90: HEMOGLOBIN (HGB), 14.1 g/dL; 90: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 90: BASOPHIL % (AUTO DIFF), 0.2 %; 90: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 90: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 90: HR, 115.475; 90: RR, 23.610; 90: SpO2, 100.0; 90: Perf, 0.508; 90: 1min HRV, 6.293; 91: HR, 111.569; 91: RR, 21.431; 91: SpO2, 100.0; 91: Perf, 0.309; 91: 1min HRV, 21.705; 91: 5min HRV, 17.493; 92: HR, 111.254; 92: RR, 22.220; 92: SpO2, 100.0; 92: Perf, 0.163; 92: 1min HRV, 30.123; 93: HR, 116.879; 93: RR, 23.310; 93: SpO2, 100.0; 93: Perf, 0.206; 93: 1min HRV, 22.858; 94: HR, 108.288; 94: RR, 20.068; 94: SpO2, 100.0; 94: Perf, 0.269; 94: 1min HRV, 42.586; 95: HR, 117.898; 95: RR, 23.373; 95: SpO2, 100.0; 95: Perf, 0.270; 95: 1min HRV, 9.268; 96: HR, 110.034; 96: RR, 21.431; 96: SpO2, 100.0; 96: Perf, 0.355; 96: 1min HRV, 31.907; 96: 5min HRV, 32.721; 97: HR, 116.644; 97: RR, 24.763; 97: SpO2, 100.0; 97: Perf, 0.210; 97: 1min HRV, 12.208; 98: HR, 115.414; 98: RR, 21.086; 98: SpO2, 100.0; 98: Perf, 0.311; 98: 1min HRV, 13.967; 99: HR, 110.627; 99: RR, 21.593; 99: SpO2, 100.0; 99: Perf, 0.155; 99: 1min HRV, 30.190; 100: HR, 114.186; 100: RR, 23.339; 100: SpO2, 100.0; 100: Perf, 0.215; 100: 1min HRV, 10.330; 101: HR, 109.569; 101: RR, 22.655; 101: SpO2, 100.0; 101: Perf, 0.227; 101: 1min HRV, 24.137; 101: 5min HRV, 22.116; 102: HR, 117.085; 102: RR, 25.593; 102: SpO2, 100.0; 102: Perf, 0.183; 102: 1min HRV, 12.517; 103: HR, 115.603; 103: RR, 22.310; 103: SpO2, 100.0; 103: Perf, 0.356; 103: 1min HRV, 8.259; 104: HR, 114.559; 104: RR, 20.492; 104: SpO2, 100.0; 104: Perf, 0.360; 104: 1min HRV, 6.277; 105: HR, 114.542; 105: RR, 22.119; 105: SpO2, 100.0; 105: Perf, 0.311; 105: 1min HRV, 8.614; 106: HR, 114.483; 106: RR, 20.293; 106: SpO2, 100.0; 106: Perf, 0.302; 106: 1min HRV, 6.211; 106: 5min HRV, 9.837; 107: HR, 113.763; 107: RR, 20.237; 107: SpO2, 100.0; 107: Perf, 0.289; 107: 1min HRV, 7.220; 108: HR, 113.638; 108: RR, 21.931; 108: SpO2, 100.0; 108: Perf, 0.341; 108: 1min HRV, 6.759; 109: HR, 113.373; 109: RR, 21.864; 109: SpO2, 100.0; 109: Perf, 0.333; 109: 1min HRV, 5.955; 110: HR, 114.121; 110: RR, 20.603; 110: SpO2, 100.0; 110: Perf, 0.326; 110: 1min HRV, 8.640; 111: HR, 115.678; 111: RR, 24.254; 111: SpO2, 100.0; 111: Perf, 0.299; 111: 1min HRV, 4.160; 111: 5min HRV, 7.704; 112: HR, 113.322; 112: RR, 23.966; 112: SpO2, 100.0; 112: Perf, 0.428; 112: 1min HRV, 8.932; 113: HR, 114.017; 113: RR, 21.207; 113: SpO2, 100.0; 113: Perf, 0.405; 113: 1min HRV, 6.271; 114: HR, 112.797; 114: RR, 21.695; 114: SpO2, 100.0; 114: Perf, 0.374; 114: 1min HRV, 8.015; 115: HR, 113.288; 115: RR, 21.085; 115: SpO2, 100.0; 115: Perf, 0.393; 115: 1min HRV, 7.768; 116: HR, 113.586; 116: RR, 23.466; 116: SpO2, 100.0; 116: Perf, 0.332; 116: 1min HRV, 10.202; 116: 5min HRV, 8.462; 117: HR, 112.898; 117: RR, 20.695; 117: SpO2, 100.0; 117: Perf, 0.350; 117: 1min HRV, 5.507; 118: HR, 112.552; 118: RR, 20.552; 118: SpO2, 100.0; 118: Perf, 0.328; 118: 1min HRV, 9.157; 119: HR, 112.424; 119: RR, 20.814; 119: SpO2, 100.0; 119: Perf, 0.293; 119: 1min HRV, 7.331; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 117.0; 0: Triage RR, 16.0; 0: Triage SBP, 103.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABNORMAL LAB",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I considered the patient\u2019s persistently elevated heart rate, high respiratory rate, and markedly elevated white blood cell count. I noted that the lactate level is also above normal, suggesting possible tissue hypoperfusion. These findings together meet common screening criteria for suspected sepsis. Therefore, I concluded that the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient has a persistently elevated heart rate.",
            "The patient has a high respiratory rate.",
            "The patient has a markedly elevated white blood cell count.",
            "The patient\u2019s lactate level is above normal.",
            "An elevated lactate level suggests possible tissue hypoperfusion.",
            "The findings of elevated heart rate, high respiratory rate, and elevated white blood cell count meet common screening criteria for suspected sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has a persistently elevated heart rate.",
            "The patient has a high respiratory rate.",
            "The patient\u2019s lactate level is above normal.",
            "An elevated lactate level suggests possible tissue hypoperfusion.",
            "The findings of elevated heart rate, high respiratory rate, and elevated white blood cell count meet common screening criteria for suspected sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.5,
            0.7,
            1.0,
            1.0,
            0.3
        ],
        "alignment_category": [
            2,
            3,
            5,
            5,
            2,
            4
        ],
        "alignment_reasonings": [
            "A persistently elevated heart rate (>90 bpm) is one of the criteria for SIRS. This directly suggests systemic inflammation consistent with early sepsis, making it highly relevant to the SIRS Positivity category. However, as the claim doesn\u2019t mention other SIRS criteria being met, the alignment rating is high but not full (0.8).",
            "A high respiratory rate is directly aligned with the qSOFA criteria, which includes respiratory rate \u226522/min. However, the claim does not specify if the respiratory rate meets the qSOFA threshold of \u226522/min, so while the claim is indicative of potential high sepsis risk, it does not fully confirm alignment without specific information. Therefore, the alignment rating is moderate.",
            "The claim refers to an elevated lactate level, which is directly relevant to this category as it signifies potential tissue hypoperfusion and increased sepsis risk. However, the claim does not specify if the lactate level is \u22652 mmol/L, which is the threshold for this category, resulting in a less than perfect alignment.",
            "The claim directly refers to elevated lactate levels, which is a principal indicator of tissue hypoperfusion and strongly aligns with the category focused on serum lactate levels. The category identifies elevated lactate as a significant marker of sepsis risk, so the alignment is perfect.",
            "The claim specifically mentions elevated heart rate, high respiratory rate, and elevated white blood cell count, all of which are individual components of the SIRS criteria. To meet the SIRS criteria, the presence of \u22652 of these conditions is necessary, directly aligning with category 2. The claim explicitly references common screening criteria for suspected sepsis, making the alignment perfect.",
            "The claim broadly indicates a high risk of sepsis, which could be associated with multiple factors like deranged vitals predicting imminent deterioration, similar to what the NEWS score assesses. However, without explicitly mentioning any specific clinical parameters or scores, the alignment with any particular category is weak and speculative. Therefore, the category selected reflects a general predictor of clinical deterioration compatible with sepsis risk, but only weakly aligns without specific data."
        ],
        "final_alignment_score": 0.7166666666666667,
        "accuracy": 1
    },
    {
        "input": "5: SBP, 154.0; 5: DBP, 59.0; 5: MAP, 90.667; 6: HR, 109.0; 6: RR, 24.0; 6: SpO2, 86.4; 6: SBP, 154.0; 6: DBP, 59.0; 6: MAP, 90.667; 6: LPM O2, 2.0; 6: Pain, 10.0; 6: Temp, 102.7; 7: SpO2, 93.186; 7: Perf, 0.338; 8: SpO2, 95.897; 8: Perf, 0.303; 9: SpO2, 99.492; 9: Perf, 0.292; 10: SpO2, 99.833; 10: Perf, 0.281; 11: SpO2, 99.667; 11: Perf, 0.23; 12: SpO2, 100.0; 12: Perf, 0.244; 13: SpO2, 100.0; 13: Perf, 0.268; 14: SpO2, 99.853; 14: Perf, 0.239; 15: SpO2, 99.0; 15: Perf, 0.23; 17: SpO2, 98.833; 18: SpO2, 99.25; 18: Perf, 0.273; 19: SpO2, 96.306; 19: Perf, 0.232; 20: SpO2, 98.294; 20: Perf, 0.191; 24: SpO2, 99.0; 24: Perf, 0.15; 25: SpO2, 98.481; 25: Perf, 0.146; 26: SpO2, 99.667; 26: Perf, 0.157; 29: SpO2, 94.727; 29: Perf, 0.12; 30: SpO2, 97.0; 30: Perf, 0.13; 31: SpO2, 97.643; 31: Perf, 0.14; 32: SpO2, 98.333; 32: Perf, 0.143; 33: SpO2, 97.047; 33: Perf, 0.167; 34: SpO2, 94.625; 34: Perf, 0.175; 35: SpO2, 98.143; 35: Perf, 0.149; 36: SpO2, 98.321; 36: Perf, 0.145; 38: SpO2, 97.625; 38: Perf, 0.195; 39: SpO2, 97.818; 39: Perf, 0.2; 40: SpO2, 98.5; 40: Perf, 0.228; 41: SpO2, 96.922; 41: Perf, 0.204; 42: SpO2, 96.756; 42: Perf, 0.2; 43: SpO2, 98.595; 43: Perf, 0.2; 44: SpO2, 97.765; 44: Perf, 0.2; 45: SpO2, 99.407; 46: SpO2, 99.776; 46: Perf, 0.282; 47: SpO2, 99.362; 47: Perf, 0.349; 48: SpO2, 98.814; 48: Perf, 0.31; 49: SpO2, 99.424; 49: Perf, 0.279; 50: SpO2, 99.690; 50: Perf, 0.335; 50: ACETAMINOPHEN, 500 MG PO TABS; 51: POC PH (V), ISTAT: 7.37; 51: POC HCO3 (V) ISTAT, 28.5 mmol/L; 51: POC LACTATE ISTAT, 2.34 mmol/L; 51: POC TCO2 (V) ISTAT, 30 mmol/L; 51: POC BASE EXCESS ISTAT, 3 mmol/L; 51: POC PCO2 (V) ISTAT, 49.8 mmHg; 51: POC PO2 (V) ISTAT, 19 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 28 %; 51: SpO2, 97.780; 51: Perf, 0.297; 52: SpO2, 99.08; 52: Perf, 0.267; 53: SpO2, 99.224; 53: Perf, 0.257; 54: SpO2, 99.679; 54: Perf, 0.240; 55: SpO2, 99.26; 55: Perf, 0.221; 56: SpO2, 99.244; 56: Perf, 0.211; 57: SpO2, 97.9; 57: Perf, 0.213; 58: SpO2, 98.714; 58: Perf, 0.22; 59: SpO2, 99.0; 59: Perf, 0.22; 60: SpO2, 99.0; 60: Perf, 0.19; 61: SpO2, 99.12; 61: Perf, 0.205; 62: SpO2, 99.727; 62: Perf, 0.21; 63: SpO2, 98.524; 63: Perf, 0.206; 64: SpO2, 98.727; 64: Perf, 0.224; 65: SpO2, 98.981; 65: Perf, 0.262; 66: SpO2, 98.644; 66: Perf, 0.277; 67: SpO2, 99.667; 67: Perf, 0.278; 68: SpO2, 99.254; 68: Perf, 0.27; 69: POC, BHCG, ISTAT QUANTITATIVE: 17.6 IU/L; 69: SpO2, 99.537; 69: Perf, 0.286; 70: SpO2, 99.169; 70: Perf, 0.317; 71: SpO2, 98.068; 71: Perf, 0.315; 72: SpO2, 99.328; 72: Perf, 0.351; 73: SpO2, 99.797; 73: Perf, 0.553; 74: SpO2, 99.345; 74: Perf, 0.623; 75: SpO2, 98.288; 75: Perf, 0.858; 79: HR, 96.0; 79: RR, 22.0; 79: SpO2, 100.0; 79: SBP, 139.0; 79: DBP, 76.0; 79: MAP, 97.0; 82: NORMOSOL-R IV BOLUS -, 1000 ML; 106: WAM, DIFTYP: AUTO; 106: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 106: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.4 pg; 106: RED BLOOD CELLS (RBC), 4.06 MIL/uL; 106: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 106: NEUTROPHIL % (AUTO DIFF), 85.0 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 84.2 fL; 106: WHITE BLOOD CELLS (WBC), 21.5 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: MONOCYTE % (AUTO DIFF), 3.4 %; 106: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 106: HEMATOCRIT (HCT), 34.2 %; 106: PLATELET COUNT (PLT), 209 K/uL; 106: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 106: HEMOGLOBIN (HGB), 10.3 g/dL; 106: LYMPHOCYTE % (AUTO DIFF), 10.1 %; 106: EOSINOPHIL % (AUTO DIFF), 0.2 %; 106: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 17.2 %; 106: BASOPHIL % (AUTO DIFF), 0.3 %; 106: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 106: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.31 K/uL; 106: NRBC PERCENT (HEMATOLOGY), 0.0 %; 112: CEFEPIME, 2 GRAM/20 ML IV PUSH; 115: POTASSIUM:, 3.6 mmol/L; 115: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 115: BILIRUBIN TOTAL, 1.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 115: CORRECTED CALCIUM, 8.8 mg/dL; 115: ANION GAP, 10 mmol/L; 115: PROTEIN TOTAL, 7.0 g/dL; 115: ALT (SGPT), 17 U/L; 115: CHLORIDE, 95 mmol/L; 115: CO2, 24 mmol/L; 115: AST (SGOT), 30 U/L; 115: GLOBULIN, 3.4 g/dL; 115: CREATININE, 1.14 mg/dL; 115: ALKALINE PHOSPHATASE, 83 U/L; 115: ALBUMIN, 3.6 g/dL; 115: GLUCOSE, 97 mg/dL; 115: SODIUM, 129 mmol/L; 115: CALCIUM, 8.5 mg/dL; 115: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 115: C-REACTIVE PROTEIN (CRP), 21.1 mg/dL; 116: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age:, 51; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 39.3; 0: Triage HR, 109.0; 0: Triage RR, 24.0; 0: Triage SBP, 154.0; 0: Triage DBP, 59.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG PAIN,FEVER,CHILLS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I noticed the patient\u2019s elevated heart rate, fever, and respiratory rate, along with a significantly high white blood cell count and elevated lactate, all of which raise concern for an acute infectious process. These observations prompted me to consider whether the patient meets the criteria for sepsis based on suspected infection and possible organ involvement. While reviewing the labs and vital signs, the presence of tachycardia, tachypnea, and potential inflammatory response aligned with the definition of sepsis. Given the data, I concluded the patient is at high risk for developing sepsis within 12 hours.",
        "claims": [
            "The patient has an elevated heart rate.",
            "The patient has a fever.",
            "The patient has an elevated respiratory rate.",
            "The patient has a significantly high white blood cell count.",
            "The patient has an elevated lactate.",
            "These observations raise concern for an acute infectious process.",
            "I am considering whether the patient meets the criteria for sepsis.",
            "The criteria for sepsis are based on suspected infection and possible organ involvement.",
            "The presence of tachycardia aligns with the definition of sepsis.",
            "The presence of tachypnea aligns with the definition of sepsis.",
            "The presence of a potential inflammatory response aligns with the definition of sepsis.",
            "Given the data, I concluded that the patient is at high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate.",
            "The patient has a fever.",
            "The patient has an elevated respiratory rate.",
            "The patient has a significantly high white blood cell count.",
            "The patient has an elevated lactate.",
            "These observations raise concern for an acute infectious process.",
            "The criteria for sepsis are based on suspected infection and possible organ involvement.",
            "The presence of tachycardia aligns with the definition of sepsis.",
            "The presence of tachypnea aligns with the definition of sepsis.",
            "The presence of a potential inflammatory response aligns with the definition of sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.5,
            0.7,
            1.0,
            1.0,
            0.4,
            0.7,
            1.0,
            0.8,
            0.7
        ],
        "alignment_category": [
            2,
            2,
            3,
            2,
            5,
            9,
            8,
            2,
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim about an elevated heart rate aligns with the SIRS criteria, where a heart rate >90 bpm indicates systemic inflammation consistent with early sepsis. However, because the claim does not specify the exact heart rate or mention other accompanying SIRS criteria, the alignment is moderate rather than full.",
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis.",
            "An elevated respiratory rate is a specific criterion included in the qSOFA score (respiratory rate \u226522/min), which flags a high risk of sepsis-related complications. However, without the specific respiratory rate provided, it is unclear if it meets the threshold of \u226522/min, resulting in a strong but not perfect alignment.",
            "A significantly high white blood cell count is explicitly part of the SIRS criteria, which helps in identifying systemic inflammation consistent with early sepsis. Therefore, this matches perfectly with the SIRS Positivity category.",
            "The claim explicitly mentions the patient's elevated serum lactate. This is directly relevant to the \"Elevated Serum Lactate\" category, which signifies tissue hypoperfusion and a high risk of sepsis. There is perfect alignment between the claim and this category.",
            "The claim expresses a general concern for an acute infectious process, which aligns with category 9 as it indicates suspicion of infection. However, without specific actions like ordering antibiotics or drawing cultures, the alignment is conceptually rather than directly based on the criteria described. There is an implicit connection due to the concern for infection potentially leading to sepsis, so the alignment isn't strong.",
            "The claim mentions \"suspected infection and possible organ involvement,\" which aligns with the SOFA criteria that confirm new organ dysfunction. While the claim does not specify an increase in SOFA score, the mention of organ involvement suggests a conceptual link to this category. The alignment is fairly strong given the focus on organ dysfunction but lacks specific evidence of a \u22652 points SOFA score increase, preventing a perfect score.",
            "The claim references tachycardia, which is explicitly listed as a criterion (>90 bpm) under the SIRS categories used to identify systemic inflammation consistent with early sepsis. This perfectly aligns with one of the SIRS criteria.",
            "Tachypnea, or rapid breathing, is directly associated with the SIRS criterion of a respiratory rate >20/min, which is used to identify systemic inflammation in early sepsis. The claim aligns strongly with this specific aspect of the SIRS criteria, indicating a close relationship with sepsis risk; however, tachypnea alone does not meet the full SIRS positivity criterion, which requires at least 2 criteria being met, thus a slight deduction in alignment rating.",
            "While the claim does not specify the exact criteria met, the mention of an \"inflammatory response\" closely relates to the concept of systemic inflammation that SIRS criteria are designed to identify. The alignment is not perfect because it lacks explicit mention of specific SIRS criteria being met, but the concept is clearly aligned with SIRS."
        ],
        "final_alignment_score": 0.75,
        "accuracy": 1
    },
    {
        "input": "11: Pain, 8.0; 18: HR, 114.0; 18: RR, 22.0; 18: SpO2, 95.0; 18: SBP, 101.0; 18: DBP, 62.0; 18: MAP, 75.0; 18: LPM O2, 2.0; 18: Temp, 102.2; 21: ACETAMINOPHEN, 500 MG PO TABS; 29: POC PH (V), ISTAT: 7.44; 29: POC PCO2 (V) ISTAT, 45.7 mmHg; 29: POC HCO3 (V) ISTAT, 30.9 mmol/L; 29: POC O2 SATURATION ISTAT VENOUS, 57 %; 29: POC LACTATE ISTAT, 1.00 mmol/L; 29: POC PO2 (V) ISTAT, 29 mmHg; 29: POC TCO2 (V) ISTAT, 32 mmol/L; 29: POC BASE EXCESS ISTAT, 7 mmol/L; 40: SpO2, 89.769; 40: Perf, 1.475; 40: SBP, 110.0; 40: DBP, nan; 40: MAP, nan; 41: HR, 109.95; 41: SpO2, 88.828; 41: Perf, 1.977; 41: 1min HRV, 14.576; 42: HR, 110.525; 42: SpO2, 90.525; 42: Perf, 2.646; 42: 1min HRV, 16.205; 43: HR, 109.678; 43: SpO2, 91.881; 43: Perf, 3.402; 43: 1min HRV, 21.374; 43: 5min HRV, 18.328; 44: HR, 109.672; 44: SpO2, 95.172; 44: Perf, 3.964; 44: 1min HRV, 21.182; 45: HR, 108.390; 45: SpO2, 95.153; 45: Perf, 4.616; 45: 1min HRV, 21.246; 46: HR, 108.569; 46: SpO2, 94.914; 46: Perf, 4.833; 46: 1min HRV, 17.993; 47: HR, 107.085; 47: SpO2, 95.017; 47: Perf, 5.151; 47: 1min HRV, 18.946; 48: HR, 108.356; 48: SpO2, 95.373; 48: Perf, 5.283; 48: 1min HRV, 19.931; 48: 5min HRV, 20.167; 49: HR, 107.138; 49: SpO2, 95.155; 49: Perf, 5.190; 49: 1min HRV, 17.870; 50: HR, 106.424; 50: SpO2, 96.0; 50: Perf, 5.102; 50: 1min HRV, 19.279; 51: HR, 106.241; 51: SpO2, 96.0; 51: Perf, 4.463; 51: 1min HRV, 16.673; 52: HR, 107.186; 52: SpO2, 96.068; 52: Perf, 4.564; 52: 1min HRV, 20.341; 53: HR, 105.525; 53: RR, 17.0; 53: SpO2, 96.0; 53: Perf, 5.102; 53: 1min HRV, 18.524; 53: 5min HRV, 18.733; 54: HR, 106.276; 54: SpO2, 96.0; 54: Perf, 5.207; 54: 1min HRV, 18.691; 55: HR, 108.814; 55: SpO2, 94.339; 55: Perf, 5.860; 55: 1min HRV, 19.011; 56: HR, 108.017; 56: SpO2, 93.828; 56: Perf, 5.531; 56: 1min HRV, 17.191; 57: HR, 108.102; 57: SpO2, 93.831; 57: Perf, 5.456; 57: 1min HRV, 20.965; 58: HR, 107.322; 58: SpO2, 93.627; 58: Perf, 5.796; 58: 1min HRV, 18.570; 58: 5min HRV, 19.512; 59: HR, 107.897; 59: SpO2, 93.328; 59: Perf, 5.545; 59: 1min HRV, 18.361; 60: HR, 107.508; 60: SpO2, 95.729; 60: Perf, 4.673; 60: 1min HRV, 16.617; 61: HR, 106.672; 61: SpO2, 95.310; 61: Perf, 4.716; 61: 1min HRV, 18.259; 62: HR, 106.797; 62: SpO2, 95.678; 62: Perf, 4.453; 62: 1min HRV, 17.616; 63: HR, 107.831; 63: SpO2, 96.322; 63: Perf, 3.808; 63: 1min HRV, 23.819; 63: 5min HRV, 19.307; 64: HR, 105.172; 64: SpO2, 96.0; 64: Perf, 4.299; 64: 1min HRV, 23.239; 65: HR, 106.254; 65: RR, 22.056; 65: SpO2, 95.915; 65: Perf, 4.105; 65: 1min HRV, 17.162; 66: HR, 104.517; 66: SpO2, 95.828; 66: Perf, 4.427; 66: 1min HRV, 18.875; 67: HR, 104.085; 67: SpO2, 96.0; 67: Perf, 4.424; 67: 1min HRV, 17.668; 68: HR, 105.525; 68: SpO2, 95.017; 68: Perf, 5.536; 68: 1min HRV, 17.378; 68: 5min HRV, 19.579; 69: HR, 104.914; 69: SpO2, 94.0; 69: Perf, 5.951; 69: 1min HRV, 15.239; 70: HR, 104.695; 70: SpO2, 93.797; 70: Perf, 6.006; 70: 1min HRV, 14.047; 71: HR, 104.810; 71: SpO2, 93.224; 71: Perf, 5.726; 71: 1min HRV, 12.730; 72: HR, 103.288; 72: RR, 29.375; 72: SpO2, 93.661; 72: Perf, 5.810; 72: 1min HRV, 10.750; 73: HR, 103.431; 73: RR, 14.259; 73: SpO2, 94.0; 73: Perf, 5.949; 73: 1min HRV, 15.137; 73: 5min HRV, 14.475; 74: HR, 102.508; 74: RR, 18.593; 74: SpO2, 93.576; 74: Perf, 5.645; 74: 1min HRV, 18.665; 75: HR, 104.203; 75: RR, 18.559; 75: SpO2, 94.085; 75: Perf, 5.729; 75: 1min HRV, 19.603; 76: HR, 104.931; 76: RR, 19.655; 76: SpO2, 94.828; 76: Perf, 6.026; 76: 1min HRV, 17.125; 77: HR, 102.932; 77: RR, 20.729; 77: SpO2, 95.627; 77: Perf, 5.371; 77: 1min HRV, 16.380; 78: HR, 101.224; 78: RR, 20.241; 78: SpO2, 96.0; 78: Perf, 5.247; 78: 1min HRV, 17.340; 78: 5min HRV, 19.426; 79: HR, 100.607; 79: RR, 20.898; 79: SpO2, 95.424; 79: Perf, 4.697; 79: 1min HRV, 12.174; 80: HR, 100.847; 80: RR, 21.186; 80: SpO2, 95.136; 80: Perf, 4.427; 80: 1min HRV, 16.551; 83: INFLUENZA B, Not Detected; 83: SARS-COV-2 RNA, Not Detected; 83: RSV, Not Detected; 83: INFLUENZA A, Not Detected; 83: 5min HRV, 14.374; 98: PART. THROMBOPLASTIN TIME, 37.6 seconds; 103: INR, 1.3; 103: WAM DIFTYP, AUTO; 103: PROTHROMBIN TIME, 16.4 seconds; 103: MONOCYTE ABSOLUTE (AUTO DIFF), 1.80 K/uL; 103: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.45 K/uL; 103: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 103: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.14 K/uL; 103: NEUTROPHIL % (AUTO DIFF), 64.1 %; 103: LYMPHOCYTE % (AUTO DIFF), 8.7 %; 103: HEMOGLOBIN (HGB), 8.8 g/dL; 103: EOSINOPHIL % (AUTO DIFF), 15.1 %; 103: BASOPHIL % (AUTO DIFF), 0.5 %; 103: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 103: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 103: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.63 K/uL; 103: EOSINOPHIL ABSOLUTE (AUTO DIFF), 2.50 K/uL; 103: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 103: NRBC PERCENT (HEMATOLOGY), 0.0 %; 103: WHITE BLOOD CELLS (WBC), 16.6 K/uL; 103: PLATELET COUNT (PLT), 637 K/uL; 103: HEMATOCRIT (HCT), 27.0 %; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 103: MONOCYTE % (AUTO DIFF), 10.8 %; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 103: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 0: Age, 39; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 114.0; 0: Triage RR, 22.0; 0: Triage SBP, 101.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "I looked at the patient\u2019s",
        "claims": [
            "The patient\u2019s electronic health record data was analyzed.",
            "The analysis was conducted during the first 2 hours of the patient\u2019s emergency department admission.",
            "The goal of the analysis was to predict the risk of developing sepsis.",
            "The prediction focuses on whether the patient is at high risk of developing sepsis within the next 12 hours.",
            "EHR data can provide important insights into the patient\u2019s condition.",
            "Specific indicators within the EHR data can help assess sepsis risk.",
            "Timely identification of high-risk patients is crucial for effective intervention.",
            "Assessing sepsis risk early can improve patient outcomes."
        ],
        "relevant_claims": [
            "Specific indicators within the EHR data can help assess sepsis risk."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            5
        ],
        "alignment_reasonings": [
            "The claim is vague and broadly references the use of Electronic Health Record (EHR) data for assessing sepsis risk, which can encompass multiple categories since EHRs can include almost all health metrics. However, serum lactate is a specific numeric indicator that is often used in EHRs to assess sepsis risk, and elevated lactate levels are strongly associated with sepsis. Although the claim does not specifically mention lactate, the alignment with specific indicators within EHR suggests a minimal connection, warranting a low alignment rating."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 0
    },
    {
        "input": "4: HR, 110.0; 4: RR, 18.0; 4: SpO2, 100.0; 4: SBP, 157.0; 4: DBP, 87.0; 4: MAP, 110.333; 4: Temp, 97.0; 12: Pain, 8.0; 52: SpO2, 98.0; 53: SpO2, 94.484; 53: Perf, 0.343; 54: SpO2, 93.154; 54: Perf, 0.300; 55: SpO2, 91.959; 55: Perf, 0.278; 56: SpO2, 93.019; 56: Perf, 0.450; 57: SpO2, 96.132; 57: Perf, 0.738; 58: SpO2, 97.0; 58: Perf, 0.945; 59: SpO2, 95.849; 59: Perf, 0.823; 60: SpO2, 94.981; 60: Perf, 0.576; 61: SpO2, 96.528; 61: Perf, 0.527; 62: SpO2, 95.509; 62: Perf, 0.607; 63: SpO2, 95.346; 63: Perf, 0.519; 64: SpO2, 95.604; 64: Perf, 0.626; 65: SpO2, 95.537; 65: Perf, 0.59; 66: SpO2, 94.458; 66: Perf, 0.586; 67: SpO2, 94.265; 67: Perf, 0.579; 68: SpO2, 95.0; 68: Perf, 0.574; 69: SpO2, 95.774; 69: Perf, 0.547; 70: SpO2, 95.774; 70: Perf, 0.425; 71: SpO2, 96.192; 71: Perf, 0.397; 72: HR, 111.0; 72: SpO2, 97.226; 72: Perf, 0.378; 72: SBP, 158.0; 72: DBP, 100.0; 72: MAP, 119.333; 73: SpO2, 97.0; 73: Perf, 0.373; 73: SBP, 158.0; 73: DBP, 100.0; 73: MAP, 119.333; 74: SpO2, 96.906; 74: Perf, 0.377; 75: SpO2, 96.5; 75: Perf, 0.406; 75: Pain, 0.0; 76: SpO2, 96.192; 76: Perf, 0.429; 77: SpO2, 96.415; 77: Perf, 0.455; 78: SpO2, 96.75; 78: Perf, 0.47; 79: SpO2, 97.377; 79: Perf, 0.436; 80: SpO2, 96.0; 80: Perf, 0.454; 81: SpO2, 95.308; 81: Perf, 0.439; 82: SpO2, 97.547; 82: Perf, 0.467; 83: SpO2, 97.942; 83: Perf, 0.528; 84: HR, 108.562; 84: RR, 23.333; 84: SpO2, 97.415; 84: Perf, 0.52; 84: 1min HRV, 6.283; 84: SBP, 146.0; 84: DBP, 95.0; 84: MAP, 112.0; 85: HR, 107.315; 85: RR, 18.796; 85: SpO2, 98.148; 85: Perf, 0.52; 85: 1min HRV, 9.190; 86: HR, 107.75; 86: RR, 22.269; 86: SpO2, 98.308; 86: Perf, 0.52; 86: 1min HRV, 7.709; 87: HR, 106.396; 87: RR, 16.415; 87: SpO2, 97.094; 87: Perf, 0.487; 87: 1min HRV, 8.475; 87: 5min HRV, 9.826; 88: HR, 106.115; 88: RR, 17.192; 88: SpO2, 96.75; 88: Perf, 0.403; 88: 1min HRV, 8.518; 89: HR, 108.278; 89: RR, 20.204; 89: SpO2, 95.852; 89: Perf, 0.376; 89: 1min HRV, 7.594; 90: HR, 109.377; 90: RR, 17.302; 90: SpO2, 95.321; 90: Perf, 0.383; 90: 1min HRV, 3.874; 91: HR, 109.135; 91: RR, 17.923; 91: SpO2, 96.673; 91: Perf, 0.398; 91: 1min HRV, 6.186; 92: HR, 105.509; 92: RR, 17.604; 92: SpO2, 97.0; 92: Perf, 0.399; 92: 1min HRV, 2.008; 92: 5min HRV, 10.216; 93: HR, 107.769; 93: RR, 18.365; 93: SpO2, 97.0; 93: Perf, 0.384; 93: 1min HRV, 5.526; 94: HR, 108.642; 94: RR, 19.679; 94: SpO2, 96.396; 94: Perf, 0.349; 94: 1min HRV, 5.896; 95: HR, 107.615; 95: RR, 19.865; 95: SpO2, 96.827; 95: Perf, 0.360; 95: 1min HRV, 6.318; 96: HR, 107.811; 96: RR, 19.604; 96: SpO2, 96.887; 96: Perf, 0.342; 96: 1min HRV, 9.593; 97: HR, 107.833; 97: RR, 17.630; 97: SpO2, 96.926; 97: Perf, 0.343; 97: 1min HRV, 8.945; 97: 5min HRV, 7.989; 98: HR, 109.115; 98: RR, 16.962; 98: SpO2, 96.365; 98: Perf, 0.352; 98: 1min HRV, 4.041; 99: HR, 108.132; 99: RR, 17.679; 99: SpO2, 96.057; 99: Perf, 0.367; 99: 1min HRV, 8.423; 100: HR, 111.019; 100: RR, 15.231; 100: SpO2, 96.442; 100: Perf, 0.388; 100: 1min HRV, 3.575; 101: HR, 110.585; 101: RR, 16.189; 101: SpO2, 96.943; 101: Perf, 0.372; 101: 1min HRV, 3.269; 102: HR, 110.226; 102: RR, 14.868; 102: SpO2, 96.472; 102: Perf, 0.343; 102: 1min HRV, 7.359; 102: 5min HRV, 7.762; 103: HR, 110.192; 103: RR, 17.404; 103: SpO2, 96.904; 103: Perf, 0.35; 103: 1min HRV, 6.722; 104: HR, 110.660; 104: RR, 18.623; 104: SpO2, 96.113; 104: Perf, 0.352; 104: 1min HRV, 5.132; 105: HR, 110.288; 105: RR, 17.885; 105: SpO2, 96.5; 105: Perf, 0.466; 105: 1min HRV, 7.060; 106: HR, 111.434; 106: RR, 16.811; 106: SpO2, 98.094; 106: Perf, 0.522; 106: 1min HRV, 29.379; 107: HR, 109.887; 107: RR, 16.623; 107: SpO2, 97.943; 107: Perf, 0.512; 107: 1min HRV, 6.777; 107: 5min HRV, 14.634; 108: HR, 111.75; 108: RR, 19.442; 108: SpO2, 97.981; 108: Perf, 0.464; 108: 1min HRV, 4.427; 108: SBP, 138.0; 108: DBP, 96.0; 108: MAP, 110.0; 109: HR, 110.113; 109: RR, 16.415; 109: SpO2, 96.811; 109: Perf, 0.469; 109: 1min HRV, 4.230; 110: HR, 108.358; 110: RR, 17.170; 110: SpO2, 97.642; 110: Perf, 0.568; 110: 1min HRV, 7.919; 111: HR, 109.226; 111: RR, 17.925; 111: SpO2, 97.472; 111: Perf, 0.575; 111: 1min HRV, 4.075; 112: HR, 109.340; 112: RR, 13.604; 112: SpO2, 96.887; 112: Perf, 0.533; 112: 1min HRV, 5.584; 112: 5min HRV, 7.998; 113: HR, 109.566; 113: RR, 12.717; 113: SpO2, 97.113; 113: Perf, 0.497; 113: 1min HRV, 6.331; 113: SBP, 139.0; 113: DBP, 88.0; 113: MAP, 105.0; 114: HR, 108.962; 114: RR, 18.830; 114: SpO2, 97.415; 114: Perf, 0.552; 114: 1min HRV, 10.085; 115: LACTATE.WHOLE BLD, 1.6 mmol/L; 115: HR, 109.115; 115: RR, 22.096; 115: SpO2, 94.069; 115: Perf, 0.574; 115: 1min HRV, 5.739; 116: HR, 109.038; 116: RR, 20.528; 116: SpO2, 95.778; 116: 1min HRV, 3.933; 117: HR, 109.774; 117: RR, 19.698; 117: 1min HRV, 5.480; 117: 5min HRV, 6.848; 118: HR, 109.154; 118: RR, 22.981; 118: 1min HRV, 4.851; 119: HR, 110.434; 119: RR, 22.302; 119: 1min HRV, 4.683; 0: Age, 59; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 157.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM,SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "I reviewed the vital signs for possible indicators of sepsis, including elevated heart rate, respiratory rate, and temperature trends. While the patient is tachycardic, the blood pressure, lactate level, and oxygen saturation remain relatively stable. Evaluating these parameters together did not reveal clear signs of acute organ dysfunction or worsening infection. Therefore, I concluded the patient is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "I reviewed the vital signs for possible indicators of sepsis.",
            "Indicators of sepsis include elevated heart rate, respiratory rate, and temperature trends.",
            "The patient is tachycardic.",
            "The blood pressure remains relatively stable.",
            "The lactate level remains relatively stable.",
            "The oxygen saturation remains relatively stable.",
            "Evaluating these parameters together did not reveal clear signs of acute organ dysfunction.",
            "Evaluating these parameters together did not reveal clear signs of worsening infection.",
            "Therefore, I concluded the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Indicators of sepsis include elevated heart rate, respiratory rate, and temperature trends.",
            "The patient is tachycardic."
        ],
        "alignment_scores": [
            0.9,
            0.8
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim references an elevated heart rate, respiratory rate, and temperature trends. These are directly associated with SIRS criteria",
            "Tachycardia (heart rate > 90 bpm) is one of the specific criteria mentioned under the SIRS category used to identify systemic inflammation consistent with early sepsis. The alignment rating is high because tachycardia is directly listed as a SIRS criterion, but the final SIRS positivity requires meeting at least two criteria, so it is not a perfect alignment by itself."
        ],
        "final_alignment_score": 0.8500000000000001,
        "accuracy": 1
    }
]